data_2lge_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lge _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.494 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . . . . . . 0 CA--C 1.525 0.657 0 N-CA-C 107.37 -2.292 . . . . 0.0 107.37 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.52 -162.49 1.32 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.037 1.735 . . . . 0.0 110.329 -164.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 33.5 mtp -128.59 165.08 21.48 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 128.551 2.741 . . . . 0.0 105.069 156.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -146.78 154.92 41.95 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.512 1.125 . . . . 0.0 110.733 177.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -146.62 120.96 9.6 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.744 2.018 . . . . 0.0 107.773 174.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.1 p -99.67 151.86 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.963 1.305 . . . . 0.0 109.465 170.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.91 154.18 43.15 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.108 0.963 . . . . 0.0 110.089 168.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 tp -139.42 111.81 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 C-N-CA 126.034 1.734 . . . . 0.0 107.209 172.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.64 150.76 20.0 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 159.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -128.86 106.88 9.21 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.396 1.878 . . . . 0.0 107.524 -168.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 m -113.14 167.8 10.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.85 -172.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.6 -150.64 41.63 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -172.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -87.21 34.4 0.69 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -158.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -58.55 -6.09 0.65 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -165.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 54.5 mtt-85 -86.29 0.78 53.09 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.34 1.456 . . . . 0.0 113.424 -167.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.9 m -135.92 32.41 2.95 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.72 1.608 . . . . 0.0 110.149 -174.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -143.27 102.33 3.96 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.867 1.267 . . . . 0.0 109.964 -166.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.1 mm -69.21 96.88 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 125.455 1.502 . . . . 0.0 110.732 -170.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? -110.39 160.79 16.27 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.441 1.096 . . . . 0.0 112.052 -164.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.2 m -145.52 126.29 14.35 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.271 0.628 . . . . 0.0 110.957 -158.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.4 t -135.64 155.74 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.218 1.007 . . . . 0.0 110.11 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 p -119.4 154.6 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 128.924 2.89 . . . . 0.0 107.964 173.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 t -145.61 127.25 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 168.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.2 t -127.79 125.5 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.17 112.17 17.37 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.107 0.963 . . . . 0.0 109.826 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -74.51 128.08 34.66 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.687 1.195 . . . . 0.0 108.902 170.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.41 1.08 74.55 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 115.698 1.039 . . . . 0.0 115.698 163.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -153.44 175.87 12.67 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 119.002 1.401 . . . . 0.0 110.387 175.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -100.0 161.01 13.88 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.675 1.19 . . . . 0.0 109.432 174.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 tp -89.9 171.62 9.46 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.31 0.644 . . . . 0.0 109.657 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -137.74 139.54 40.17 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.101 0.96 . . . . 0.0 108.738 173.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -93.82 128.56 40.13 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.978 1.711 . . . . 0.0 109.986 -173.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.04 -21.59 76.96 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.811 -0.994 . . . . 0.0 114.277 -174.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.11 78.68 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.436 1.118 . . . . 0.0 112.03 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.3 p -145.56 -28.58 0.44 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.993 1.317 . . . . 0.0 111.511 -159.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.28 13.93 62.94 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.374 1.464 . . . . 0.0 112.888 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -62.73 138.0 58.4 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.139 1.376 . . . . 0.0 107.296 171.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.1 m -68.7 150.78 47.52 Favored 'General case' 0 N--CA 1.426 -1.669 0 C-N-CA 125.804 1.642 . . . . 0.0 110.411 165.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.2 mt -136.32 142.05 43.84 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.315 1.046 . . . . 0.0 110.725 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.78 78.01 4.29 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.46 1.104 . . . . 0.0 111.144 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 p -54.68 156.28 6.65 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.171 0.988 . . . . 0.0 110.888 168.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -79.64 146.73 76.79 Favored 'Cis proline' 0 CA--C 1.537 0.639 0 CA-C-N 119.355 0.805 . . . . 0.0 111.69 2.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.8 t -140.26 159.14 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.63 1.172 . . . . 0.0 110.263 -171.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.1 mm -119.85 142.33 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 C-N-CA 129.023 2.929 . . . . 0.0 105.44 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -108.42 128.1 54.48 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 171.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.1 m -94.29 173.65 7.53 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.397 1.479 . . . . 0.0 109.404 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.2 -36.1 76.89 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -169.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -63.35 -36.94 85.37 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.593 0.757 . . . . 0.0 111.019 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -75.68 -36.77 59.98 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.8 mt -86.53 24.54 1.4 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.339 2.256 . . . . 0.0 110.73 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.16 -4.88 58.68 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.023 0.929 . . . . 0.0 112.618 174.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.1 m -82.76 163.22 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 118.807 0.73 . . . . 0.0 110.475 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -62.11 -34.85 77.11 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.542 1.137 . . . . 0.0 112.277 173.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -152.25 139.22 19.08 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -172.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -118.74 152.4 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 161.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.7 m -129.82 131.29 46.1 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 103.512 -2.773 . . . . 0.0 103.512 164.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.0 mp -132.3 144.71 50.77 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 170.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.61 -173.05 3.67 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.098 -165.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 p -120.61 138.12 54.07 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.704 0.801 . . . . 0.0 110.917 -171.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 68.5 p -78.94 -12.0 60.02 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -168.32 -157.17 10.94 Favored Glycine 0 N--CA 1.447 -0.605 0 O-C-N 120.475 -1.39 . . . . 0.0 110.597 -167.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.494 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -73.36 91.68 1.76 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.39 1.476 . . . . 0.0 109.506 -168.356 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.91 155.52 21.64 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.831 1.252 . . . . 0.0 108.44 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.0 -5.88 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.867 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -148.92 159.19 44.42 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 119.726 1.148 . . . . 0.0 109.308 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.16 143.09 49.73 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 125.054 1.471 . . . . 0.0 107.831 151.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.27 129.3 27.09 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 166.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.2 t -139.85 100.59 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -168.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.2 t -120.11 158.8 26.13 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 178.08 171.53 41.55 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-O 121.571 0.539 . . . . 0.0 112.695 172.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.35 -172.67 40.44 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.971 1.748 . . . . 0.0 109.425 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.236 0.374 0 C-N-CA 124.548 1.139 . . . . 0.0 109.196 -177.497 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.79 -179.54 4.31 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 121.866 1.711 . . . . 0.0 113.618 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.8 ptm -138.01 174.3 10.72 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.945 0.898 . . . . 0.0 111.115 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -141.86 162.17 36.14 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.723 1.209 . . . . 0.0 109.729 175.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -128.47 108.64 10.71 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 126.485 1.914 . . . . 0.0 106.543 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.4 t -96.69 109.44 23.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.2 m -131.37 135.34 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.555 1.142 . . . . 0.0 109.25 -162.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.5 m -143.1 155.68 44.64 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -171.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.25 130.37 54.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -121.52 160.8 23.49 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 127.196 2.198 . . . . 0.0 109.396 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.43 -161.13 0.74 Allowed 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 127.334 2.254 . . . . 0.0 108.981 -172.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -62.83 20.84 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.386 1.874 . . . . 0.0 112.992 162.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 133.03 46.35 0.11 Allowed Glycine 0 C--N 1.34 0.759 0 O-C-N 120.187 -1.571 . . . . 0.0 113.725 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -170.3 154.92 5.02 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 125.769 1.627 . . . . 0.0 108.497 160.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.406 ' O ' ' HE2' ' A' ' 104' ' ' LYS . 33.7 tt0 -72.71 146.86 46.18 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.481 1.113 . . . . 0.0 108.271 165.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.32 -29.86 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 117.981 -1.009 . . . . 0.0 111.617 170.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -131.64 147.18 52.5 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 120.395 1.452 . . . . 0.0 109.278 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.6 ptmm? -148.99 91.1 1.82 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 -164.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -129.05 171.41 12.4 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 123.564 1.65 . . . . 0.0 111.762 -168.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.4 t -148.11 165.74 29.93 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 111.963 -2.38 . . . . 0.0 105.252 162.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.5 mt -144.06 160.58 40.63 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.902 2.081 . . . . 0.0 108.045 168.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 p -126.35 123.16 62.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 125.426 1.491 . . . . 0.0 108.205 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 CA--C 1.516 -0.332 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 175.409 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.3 t70 . . . . . 0 N--CA 1.468 0.431 0 CA-C-O 120.484 0.183 . . . . 0.0 111.474 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 16.2 tp -111.08 131.18 55.29 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 165.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.13 36.42 0.68 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.062 1.745 . . . . 0.0 110.935 -168.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.8 mt -83.65 155.15 23.33 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.293 1.037 . . . . 0.0 110.985 -171.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -160.36 156.79 26.79 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 126.674 1.989 . . . . 0.0 111.635 169.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -151.52 160.49 43.67 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 127.288 2.235 . . . . 0.0 110.04 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.4 p30 . . . . . 0 C--O 1.245 0.866 0 C-N-CA 123.288 0.635 . . . . 0.0 110.384 161.694 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.426 0 CA-C-O 119.021 -0.877 . . . . 0.0 112.736 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -118.09 128.67 54.97 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 160.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.2 mtp -78.9 160.53 27.24 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 147.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -132.97 146.32 51.67 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 170.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -148.7 121.41 8.64 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.847 1.259 . . . . 0.0 107.713 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.3 p -101.49 151.16 5.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 125.351 1.46 . . . . 0.0 108.146 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.0 p -123.68 162.74 22.48 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 122.702 1.239 . . . . 0.0 109.448 165.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.0 tp -133.0 144.64 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 159.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -134.69 98.31 4.02 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 103.803 -2.666 . . . . 0.0 103.803 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -81.29 108.7 15.14 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -133.95 164.86 26.34 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 118.688 0.676 . . . . 0.0 112.469 172.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.76 -176.37 11.3 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -145.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -75.83 120.79 21.67 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.357 -1.084 . . . . 0.0 110.906 -168.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -109.78 19.08 19.52 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 120.049 1.295 . . . . 0.0 112.269 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -81.61 -10.54 59.4 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -172.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.4 p -128.14 25.86 5.82 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.757 1.623 . . . . 0.0 113.721 -169.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -125.62 168.18 14.07 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 119.312 -2.118 . . . . 0.0 110.076 -165.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.7 mp -120.62 89.01 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.67 147.26 47.65 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 120.971 -1.081 . . . . 0.0 109.55 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.28 129.16 17.36 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.665 1.986 . . . . 0.0 105.909 170.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.8 t -131.15 126.5 59.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 160.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -91.85 130.07 41.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 167.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.264 12.6 p -134.27 150.67 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 120.243 1.383 . . . . 0.0 110.509 167.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 83.8 t -135.18 158.83 41.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 127.728 2.411 . . . . 0.0 104.524 -176.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.73 127.77 20.75 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 156.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -77.85 115.8 17.87 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 171.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.02 -9.76 22.99 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 118.452 -1.193 . . . . 0.0 115.309 159.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.5 t -157.07 -173.15 4.31 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.252 1.526 . . . . 0.0 110.219 -176.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -96.2 177.03 5.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.882 1.273 . . . . 0.0 110.277 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -117.33 161.94 18.72 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 127.122 2.169 . . . . 0.0 107.897 -169.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -139.03 128.51 24.38 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -170.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -80.46 113.78 18.89 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.12 9.02 58.91 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.056 -0.858 . . . . 0.0 113.578 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.36 -64.44 0.92 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 119.664 1.732 . . . . 0.0 108.267 157.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.85 -20.12 3.2 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.31 0.644 . . . . 0.0 111.852 -156.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.98 46.83 2.36 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 124.692 1.139 . . . . 0.0 110.96 175.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -100.32 132.21 45.82 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 p -76.75 131.18 38.59 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.3 mt -121.63 168.63 11.55 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 126.464 1.905 . . . . 0.0 108.983 -176.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -123.47 109.57 14.0 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.652 1.981 . . . . 0.0 107.985 -167.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.8 165.11 28.03 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -174.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -70.45 172.25 52.59 Favored 'Cis proline' 0 C--N 1.348 0.546 0 C-N-CA 124.694 -0.961 . . . . 0.0 110.027 -18.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.4 p -148.86 148.16 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 121.482 0.658 . . . . 0.0 109.77 -174.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.4 mm -116.74 112.27 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 104.767 -2.309 . . . . 0.0 104.767 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -76.34 99.86 4.95 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 162.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 75.6 m -91.7 -175.62 4.22 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 173.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -63.04 -24.92 68.14 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -166.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -64.93 -47.59 77.16 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.192 1.397 . . . . 0.0 109.878 173.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -74.11 -13.74 60.87 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.168 0.987 . . . . 0.0 111.027 -174.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.0 mt -116.79 19.55 14.4 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.991 1.716 . . . . 0.0 111.048 -175.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.73 13.54 0.36 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.006 1.722 . . . . 0.0 113.418 174.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.29 160.17 42.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 127.338 2.255 . . . . 0.0 109.257 -162.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.79 -32.1 73.5 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.975 0.91 . . . . 0.0 113.032 -176.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -163.94 121.16 1.74 Allowed 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -158.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 t -132.1 93.17 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -170.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.3 m -82.35 130.2 35.05 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 175.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -130.95 146.48 52.37 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 176.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.4 t -145.75 171.46 14.73 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.342 0.657 . . . . 0.0 110.114 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.5 p -79.14 165.45 23.31 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.493 0.664 . . . . 0.0 110.165 168.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 61.1 p -89.85 1.17 56.51 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.522 -0.736 . . . . 0.0 111.439 166.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -172.53 -163.52 26.49 Favored Glycine 0 N--CA 1.444 -0.794 0 O-C-N 120.926 -1.109 . . . . 0.0 113.806 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.34 119.3 3.95 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 128.47 2.708 . . . . 0.0 109.663 171.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -125.38 167.15 15.35 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.465 0.706 . . . . 0.0 110.455 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -125.71 -3.06 5.32 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 C-N-CA 124.354 1.062 . . . . 0.0 110.861 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -151.52 162.71 40.5 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 119.736 1.153 . . . . 0.0 109.823 171.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -161.47 72.3 0.41 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.347 1.459 . . . . 0.0 109.108 176.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.27 144.09 55.0 Favored 'General case' 0 C--N 1.333 -0.144 0 O-C-N 121.735 -0.603 . . . . 0.0 110.198 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 64.9 t -142.06 114.04 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 126.643 1.977 . . . . 0.0 106.526 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.9 m -129.13 158.85 37.82 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.003 0.921 . . . . 0.0 108.649 171.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 154.08 -172.44 32.72 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-N 118.569 0.622 . . . . 0.0 111.777 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.75 173.4 41.43 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.355 1.455 . . . . 0.0 111.375 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.537 0.444 0 C-N-CA 125.345 1.458 . . . . 0.0 110.651 172.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 . . . . . 0 C--O 1.224 -0.255 0 CA-C-O 118.77 -0.633 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -81.65 -179.35 4.82 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.342 2.028 . . . . 0.0 113.985 -172.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 6.5 ptm -133.82 168.6 18.45 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.221 1.01 . . . . 0.0 111.786 -166.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -140.56 153.51 46.16 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 126.702 2.001 . . . . 0.0 107.443 170.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -116.17 114.61 24.69 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 103.943 -2.614 . . . . 0.0 103.943 172.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.9 t -94.23 127.02 46.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 164.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 m -139.26 94.02 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 -163.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.7 m -95.57 164.94 12.58 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.8 t -135.61 122.86 35.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 164.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -96.05 156.81 16.18 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 125.93 1.692 . . . . 0.0 107.744 168.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.409 ' HG2' HD21 ' A' ' 102' ' ' ASN . 31.4 tttt -108.72 -162.48 0.82 Allowed 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.505 1.922 . . . . 0.0 106.956 171.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.409 HD21 ' HG2' ' A' ' 101' ' ' LYS . 0.9 OUTLIER -63.02 82.83 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.268 1.827 . . . . 0.0 109.396 170.425 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.34 16.31 59.13 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.459 1.504 . . . . 0.0 115.146 167.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -153.35 168.92 24.42 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.633 1.717 . . . . 0.0 111.368 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -97.91 135.25 39.9 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.426 1.491 . . . . 0.0 108.823 176.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.21 -14.52 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.72 1.145 . . . . 0.0 113.859 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -129.9 153.42 48.34 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 173.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.9 tttm -160.39 78.77 0.65 Allowed 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.4 169.4 11.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.566 0.698 . . . . 0.0 110.435 177.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.4 t -156.84 155.24 31.16 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.03 -174.56 3.41 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 125.906 1.682 . . . . 0.0 107.078 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.4 p -167.87 119.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 126.308 1.843 . . . . 0.0 108.515 -158.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.467 0.415 0 O-C-N 121.555 -0.716 . . . . 0.0 110.353 171.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.532 0.283 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 mt -113.15 128.02 56.36 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.304 1.042 . . . . 0.0 111.598 -175.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -139.75 82.84 1.9 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 128.473 2.709 . . . . 0.0 106.6 174.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.2 mp -120.01 128.57 53.66 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.854 1.262 . . . . 0.0 107.875 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.5 72.34 1.38 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -176.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -74.6 150.09 39.81 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.284 175.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 . . . . . 0 C--O 1.257 1.466 0 C-N-CA 126.738 2.015 . . . . 0.0 109.989 179.997 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.982 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.97 177.55 9.05 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.062 1.431 . . . . 0.0 111.335 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.11 150.96 21.83 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.366 1.866 . . . . 0.0 108.723 157.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.409 ' N ' ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -157.44 134.69 10.34 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 128.428 2.691 . . . . 0.0 109.664 178.339 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -127.33 137.58 52.83 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 128.199 2.599 . . . . 0.0 104.96 169.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.1 p -110.16 150.14 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 165.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.0 p -124.03 159.53 29.66 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 164.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 tp -129.1 135.23 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 C-N-CA 127.94 2.496 . . . . 0.0 105.645 168.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -111.03 138.7 47.11 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 155.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -121.67 116.53 24.72 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 m -143.76 171.76 13.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 118.335 0.516 . . . . 0.0 110.985 -172.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.71 -95.18 2.07 Favored Glycine 0 C--N 1.334 0.453 0 N-CA-C 105.066 -3.214 . . . . 0.0 105.066 -164.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -142.19 173.33 11.62 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.495 1.518 . . . . 0.0 107.448 165.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -157.71 8.33 0.16 Allowed 'General case' 0 C--N 1.328 -0.361 0 O-C-N 120.852 -1.155 . . . . 0.0 112.173 169.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -54.95 -41.74 71.48 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.478 1.111 . . . . 0.0 113.297 -172.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 m -128.37 51.89 1.95 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.623 1.169 . . . . 0.0 109.788 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -122.85 107.97 12.47 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 51.3 mt -73.22 88.64 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 125.515 1.526 . . . . 0.0 108.481 -168.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.4 pttm -112.41 125.32 54.08 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.414 1.485 . . . . 0.0 110.351 -166.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.6 m -127.95 159.7 34.15 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.728 1.211 . . . . 0.0 109.317 168.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 85.8 t -140.45 133.68 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.4 t -84.88 135.79 24.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 125.731 1.612 . . . . 0.0 107.196 169.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.6 t -136.58 128.26 43.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 168.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.3 t -138.65 119.4 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.96 156.22 36.77 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 167.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -118.83 119.49 34.52 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.737 1.615 . . . . 0.0 109.613 -175.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.24 -6.81 56.27 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.769 1.176 . . . . 0.0 114.857 161.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -140.67 -164.14 1.67 Allowed 'General case' 0 C--O 1.242 0.695 0 C-N-CA 126.548 1.939 . . . . 0.0 107.813 -176.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -122.05 177.49 5.3 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 120.904 -1.123 . . . . 0.0 109.308 174.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.83 167.58 10.38 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 125.038 1.335 . . . . 0.0 109.013 -173.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -136.67 114.12 10.92 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.225 1.01 . . . . 0.0 108.53 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -69.23 127.05 31.69 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.62 -22.43 69.82 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-O 118.226 -1.319 . . . . 0.0 113.85 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.07 -51.7 68.59 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 119.505 1.653 . . . . 0.0 110.322 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.81 -9.35 1.6 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.955 0.902 . . . . 0.0 111.552 -160.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.6 13.22 80.51 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.262 0.934 . . . . 0.0 112.506 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -55.1 123.56 14.04 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.901 1.681 . . . . 0.0 108.699 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.83 104.35 12.14 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.8 mt -85.7 163.16 18.41 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.699 0.8 . . . . 0.0 109.483 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.95 109.92 17.64 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.604 1.962 . . . . 0.0 106.243 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 66.2 m -82.36 151.33 65.62 Favored Pre-proline 0 C--N 1.323 -0.55 0 C-N-CA 126.895 2.078 . . . . 0.0 111.913 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.61 163.87 89.43 Favored 'Cis proline' 0 CA--C 1.535 0.561 0 CA-C-N 119.13 0.725 . . . . 0.0 111.658 -1.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 p -156.61 157.87 3.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 123.607 0.763 . . . . 0.0 109.758 170.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.9 mm -116.15 116.37 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 125.896 1.678 . . . . 0.0 107.082 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.8 mt -71.94 145.29 48.54 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 165.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 m -108.59 176.77 5.0 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.24 171.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -58.39 -22.96 55.78 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.611 1.964 . . . . 0.0 112.665 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -66.18 -27.29 67.88 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.147 1.779 . . . . 0.0 112.47 175.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -100.76 -24.06 14.48 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.637 1.575 . . . . 0.0 110.463 -171.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.7 mt -97.72 15.82 22.47 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.673 1.989 . . . . 0.0 110.297 -175.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.46 14.57 0.17 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.907 1.683 . . . . 0.0 114.278 -175.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.7 m -128.03 170.91 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 126.919 2.088 . . . . 0.0 111.008 -162.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -76.36 -20.43 57.21 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.055 0.942 . . . . 0.0 112.651 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.14 133.78 16.68 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.599 1.56 . . . . 0.0 110.006 -168.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.5 t -140.04 82.37 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.415 0.626 . . . . 0.0 110.209 173.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 90.4 m -73.44 130.54 40.33 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.74 1.216 . . . . 0.0 109.436 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -132.4 129.56 39.5 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.548 1.067 . . . . 0.0 109.112 175.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.0 t -141.28 168.18 20.39 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.768 1.627 . . . . 0.0 108.481 175.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.33 153.77 18.99 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 123.961 0.904 . . . . 0.0 110.231 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.3 p -83.33 11.48 6.68 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.726 1.21 . . . . 0.0 112.063 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 173.34 -172.49 45.22 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 173.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.61 141.28 48.67 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.671 1.236 . . . . 0.0 109.165 174.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.75 178.38 5.5 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.496 1.118 . . . . 0.0 108.547 172.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.2 mm -116.13 -11.61 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.863 0.865 . . . . 0.0 111.113 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -143.89 156.2 44.36 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.366 1.066 . . . . 0.0 108.746 169.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -145.08 103.28 3.85 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 160.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.86 122.12 46.92 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.12 121.94 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 C-N-CA 127.752 2.421 . . . . 0.0 109.162 -171.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.1 t -147.56 153.16 39.1 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -169.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.76 -177.02 43.44 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 171.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.05 176.41 38.47 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 106.196 -2.762 . . . . 0.0 106.196 167.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--N 1.323 -0.546 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 166.757 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 . . . . . 0 CA--C 1.535 0.372 0 CA-C-O 119.409 -0.329 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -84.6 -175.99 2.33 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.29 2.66 . . . . 0.0 112.792 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 19.5 ptm -148.03 176.19 10.39 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.339 -0.851 . . . . 0.0 113.254 -160.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -142.3 157.18 45.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.462 1.905 . . . . 0.0 108.39 169.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 21.9 m0 -116.23 122.07 43.91 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 162.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.274 7.1 p -116.69 103.92 15.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 168.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.0 m -97.53 168.91 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.46 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.2 m -156.2 147.37 22.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.7 t -121.46 132.04 71.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -119.31 117.01 27.42 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.868 1.667 . . . . 0.0 107.246 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.3 tptt -74.8 -164.73 0.31 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.414 1.886 . . . . 0.0 108.784 172.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.17 79.93 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.037 2.535 . . . . 0.0 108.769 173.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.16 36.77 50.33 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.178 1.371 . . . . 0.0 114.133 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -157.32 152.5 26.05 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 118.199 1.0 . . . . 0.0 109.651 164.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -77.98 140.28 39.19 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 166.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 3.0 pt -130.92 -17.43 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -148.92 144.32 26.77 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -174.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -148.14 39.27 0.91 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -174.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.04 148.52 41.88 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.683 -1.261 . . . . 0.0 111.964 -173.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.9 p -122.04 153.16 38.98 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 127.575 2.35 . . . . 0.0 109.138 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.0 mt -131.9 170.47 14.83 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.237 1.415 . . . . 0.0 109.3 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 t -146.44 146.8 18.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 124.719 1.208 . . . . 0.0 108.406 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 . . . . . 0 C--O 1.235 0.297 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 152.23 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.3 t0 . . . . . 0 C--O 1.234 0.249 0 CA-C-O 121.068 0.461 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.9 tt -89.74 115.45 27.11 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 162.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -139.6 113.36 8.61 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 167.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 62.9 mt -139.62 115.2 10.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -177.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -134.2 129.7 36.13 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -141.51 163.07 33.91 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.453 1.501 . . . . 0.0 108.549 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 117.013 -1.47 . . . . 0.0 111.071 -174.418 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.469 ' HA2' ' HE3' ' A' ' 71' ' ' LYS . . . . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 114.792 0.677 . . . . 0.0 114.792 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.51 122.32 36.25 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 163.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 35.3 mtp -75.18 175.01 8.68 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 145.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.412 ' CE2' ' HB2' ' A' ' 75' ' ' PHE . 1.4 p90 -167.57 171.28 10.44 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 125.499 1.52 . . . . 0.0 110.88 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -161.21 105.9 1.33 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.974 1.31 . . . . 0.0 107.565 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.6 p -80.75 158.57 4.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 119.917 -1.739 . . . . 0.0 109.445 166.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.6 p -128.7 158.95 37.16 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.826 1.25 . . . . 0.0 108.132 168.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.0 tp -136.85 97.99 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 172.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -75.0 147.17 41.02 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 164.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -118.26 150.25 39.77 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 161.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.0 162.82 34.59 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.54 -153.81 39.58 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -173.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -83.89 76.87 9.99 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 124.9 1.28 . . . . 0.0 109.898 -169.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -75.18 13.07 0.76 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 116.716 -1.611 . . . . 0.0 113.73 -175.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.6 mtt-85 -106.28 5.29 29.6 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 121.465 1.939 . . . . 0.0 114.766 -164.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.0 m -144.48 53.93 1.26 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.822 1.192 . . . . 0.0 111.959 175.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -135.47 137.6 42.32 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.238 1.015 . . . . 0.0 109.746 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.8 mm -78.28 93.67 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.583 1.153 . . . . 0.0 108.812 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -89.87 151.11 21.91 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 121.146 -0.971 . . . . 0.0 109.24 -176.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.1 m -138.79 142.99 38.74 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.347 1.059 . . . . 0.0 109.448 174.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.4 t -138.92 128.04 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 166.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.1 t -107.91 105.83 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 171.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.5 p -117.61 128.93 74.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 125.796 1.639 . . . . 0.0 110.583 -171.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.4 t -133.53 138.24 51.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -175.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.38 107.49 9.55 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 164.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.443 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 24.6 t-20 -63.6 113.98 3.67 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 171.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.66 -12.71 64.46 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.264 1.411 . . . . 0.0 116.108 169.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.9 t -149.82 172.06 15.75 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.351 2.076 . . . . 0.0 110.996 -172.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -89.74 160.85 16.35 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 122.641 1.21 . . . . 0.0 110.525 173.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.91 162.37 16.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 112.894 -1.957 . . . . 0.0 108.145 169.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -123.9 124.76 43.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 171.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -74.48 120.59 20.25 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.13 -20.83 75.25 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 117.636 -1.647 . . . . 0.0 113.695 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.64 -42.1 74.71 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.713 1.756 . . . . 0.0 112.583 -170.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 p -126.97 0.57 6.58 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.121 0.873 . . . . 0.0 112.896 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.11 28.63 40.42 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 123.812 0.72 . . . . 0.0 111.471 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -77.72 172.35 13.56 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.12 1.368 . . . . 0.0 109.055 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.8 t -123.73 130.73 53.09 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.648 0.737 . . . . 0.0 110.084 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 49.8 mt -118.91 121.32 39.69 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.362 -1.745 . . . . 0.0 108.864 -163.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.95 92.19 1.61 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.5 p -73.5 165.11 55.9 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-O 118.332 -0.842 . . . . 0.0 109.995 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -60.74 149.61 50.16 Favored 'Cis proline' 0 N--CA 1.452 -0.958 0 CA-C-N 120.354 1.162 . . . . 0.0 110.673 -13.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.4 p -142.31 158.71 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.8 mm -114.83 117.11 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 104.215 -2.513 . . . . 0.0 104.215 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 64.3 mt -77.69 159.9 28.83 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 169.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.5 m -138.82 -173.52 3.59 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.523 1.529 . . . . 0.0 108.256 -176.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -55.85 -41.3 74.13 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.407 1.483 . . . . 0.0 113.138 -174.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -67.19 -39.33 86.35 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.234 1.014 . . . . 0.0 111.133 -176.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -67.68 -22.51 65.28 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.729 0.812 . . . . 0.0 110.281 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 16.6 mt -115.82 20.12 14.75 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.664 1.985 . . . . 0.0 111.259 -173.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.15 3.89 7.86 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.667 1.187 . . . . 0.0 113.584 -172.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.3 m -122.8 167.13 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.539 1.536 . . . . 0.0 111.105 -165.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -57.08 -23.09 44.3 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.64 134.68 5.37 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 117.157 -1.401 . . . . 0.0 108.92 -168.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.0 t -126.45 161.94 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 164.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.4 m -142.04 127.21 18.54 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.989 1.715 . . . . 0.0 106.901 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -128.75 132.21 47.92 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.6 t -148.41 164.5 33.93 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 126.346 1.859 . . . . 0.0 106.601 -169.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.5 p -97.37 157.74 15.82 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 122.976 1.369 . . . . 0.0 112.869 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.6 p -76.2 -25.24 54.95 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.326 171.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -152.17 -169.11 17.21 Favored Glycine 0 CA--C 1.531 1.074 0 O-C-N 120.879 -1.138 . . . . 0.0 112.025 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.545 ' HE2' ' CD1' ' A' ' 73' ' ' ILE . 71.8 tttt -48.17 139.34 8.5 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 168.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -125.04 178.48 5.51 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 161.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.545 ' CD1' ' HE2' ' A' ' 71' ' ' LYS . 5.1 mm -111.43 -15.16 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.722 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.443 ' HG2' ' HB2' ' A' ' 35' ' ' ASN . 7.6 pt-20 -156.82 159.42 38.22 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -174.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.412 ' HB2' ' CE2' ' A' ' 13' ' ' TYR . 11.6 t80 -146.88 104.58 3.72 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.044 1.738 . . . . 0.0 109.738 165.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.41 148.19 22.48 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 118.548 -0.739 . . . . 0.0 109.724 176.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 t -149.17 112.65 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 124.97 1.308 . . . . 0.0 108.719 176.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.4 p -131.63 171.36 13.55 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 120.047 -1.658 . . . . 0.0 110.2 167.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 164.88 -99.05 0.16 Allowed Glycine 0 C--N 1.333 0.401 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 168.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.17 -175.3 15.7 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.371 0.986 . . . . 0.0 111.1 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.516 -0.345 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 CA--C 1.535 0.399 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -82.67 174.01 9.98 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.615 2.21 . . . . 0.0 112.637 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.3 ptm -143.9 163.25 33.97 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.574 0.749 . . . . 0.0 112.365 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -133.64 162.06 32.96 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.116 1.766 . . . . 0.0 109.617 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.4 m0 -127.52 150.42 49.69 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 125.922 1.689 . . . . 0.0 107.523 171.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.3 t -128.21 134.77 64.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 159.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 m -135.84 70.29 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -168.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.6 m -85.49 138.4 32.24 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -173.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.6 t -113.1 120.62 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -103.84 157.17 17.27 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 122.944 1.354 . . . . 0.0 108.325 168.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -116.34 176.62 5.02 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 130.127 3.371 . . . . 0.0 105.955 172.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -47.96 87.68 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 129.395 3.078 . . . . 0.0 108.941 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.4 58.64 10.5 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.133 1.349 . . . . 0.0 114.604 -171.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.409 ' HD2' ' H ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -168.83 154.09 6.2 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.045 1.922 . . . . 0.0 109.893 150.254 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.409 ' H ' ' HD2' ' A' ' 104' ' ' LYS . 18.7 tt0 -73.12 143.02 47.5 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.573 1.149 . . . . 0.0 108.906 165.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.1 pt -135.48 5.28 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 119.092 0.86 . . . . 0.0 113.065 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -152.73 160.15 43.13 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 120.548 -1.345 . . . . 0.0 108.522 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.9 tttm -158.09 86.71 0.9 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.176 0.898 . . . . 0.0 110.941 168.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.08 158.04 34.79 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 121.452 -0.78 . . . . 0.0 110.849 168.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.18 160.05 42.05 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 129.517 3.127 . . . . 0.0 107.46 177.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.9 mt -126.09 154.73 42.67 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.241 1.016 . . . . 0.0 108.297 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.5 p -136.31 130.57 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 . . . . . 0 N--CA 1.446 -0.664 0 C-N-CA 124.239 1.015 . . . . 0.0 108.715 176.838 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 C--O 1.235 0.319 0 N-CA-C 111.461 0.171 . . . . 0.0 111.461 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.46 91.82 2.58 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -153.65 81.72 1.16 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.866 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mp -114.85 146.87 40.61 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 126.692 1.997 . . . . 0.0 110.54 -173.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.99 110.25 3.73 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 177.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -115.16 117.19 29.82 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--O 1.246 0.883 0 C-N-CA 124.293 1.037 . . . . 0.0 110.039 -179.608 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.769 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -154.02 -157.01 0.73 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.696 1.198 . . . . 0.0 109.659 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 37.3 mtp -121.61 161.5 22.32 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 154.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -133.9 152.02 51.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 123.836 0.71 . . . . 0.0 109.477 167.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -147.63 121.47 9.32 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.7 p -123.05 145.95 29.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 124.854 1.262 . . . . 0.0 108.868 -168.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 73.3 p -118.0 162.67 17.78 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 122.186 0.993 . . . . 0.0 110.647 174.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.1 tp -144.73 90.92 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 165.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -75.56 132.97 41.05 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 162.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -112.43 111.26 21.99 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.705 2.002 . . . . 0.0 106.864 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -87.56 177.95 6.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.836 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.85 -134.2 52.07 Favored Glycine 0 C--N 1.335 0.485 0 C-N-CA 123.201 0.429 . . . . 0.0 112.756 163.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.74 38.78 1.15 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -162.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.462 ' HA ' ' SD ' ' A' ' 93' ' ' MET . 25.0 p90 -55.86 4.19 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 119.699 3.222 . . . . 0.0 119.699 -162.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.67 13.61 17.41 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 126.349 1.859 . . . . 0.0 113.152 -155.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.7 m -150.87 23.19 0.77 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -169.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -135.26 129.89 34.31 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.323 1.049 . . . . 0.0 108.453 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -68.69 93.32 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 119.704 1.138 . . . . 0.0 110.553 -177.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.79 151.37 22.93 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.433 -0.792 . . . . 0.0 110.522 173.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.6 m -140.04 150.49 44.45 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.273 1.829 . . . . 0.0 107.066 170.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.4 t -140.69 115.05 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.89 150.9 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 164.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.8 p -136.1 133.51 50.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 158.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.4 t -114.55 153.15 16.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 170.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.48 159.56 44.39 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.099 0.96 . . . . 0.0 108.547 169.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -125.04 117.09 23.21 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 127.09 2.156 . . . . 0.0 107.075 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.05 -1.29 67.56 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-O 118.365 -1.241 . . . . 0.0 114.607 163.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -159.3 174.91 14.05 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.8 1.8 . . . . 0.0 109.153 174.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -97.75 176.08 5.94 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.263 1.025 . . . . 0.0 111.173 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.37 161.41 13.94 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.337 1.055 . . . . 0.0 109.14 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -133.54 131.61 39.96 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 125.704 1.601 . . . . 0.0 107.227 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -101.22 119.5 38.85 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 123.918 0.761 . . . . 0.0 109.943 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.84 -7.99 5.26 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 118.016 -1.435 . . . . 0.0 114.205 171.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.94 -45.73 82.55 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 120.462 2.131 . . . . 0.0 111.509 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.23 -11.38 0.12 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.821 1.248 . . . . 0.0 112.508 -167.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.3 2.02 55.71 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.507 1.051 . . . . 0.0 112.199 -166.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -63.15 119.27 9.22 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.849 1.324 . . . . 0.0 110.203 -173.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.76 134.82 35.48 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.648 1.579 . . . . 0.0 108.8 172.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.3 mt -129.71 169.81 14.62 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.884 1.273 . . . . 0.0 109.384 -173.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.03 101.88 7.96 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 126.36 1.864 . . . . 0.0 108.179 -166.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.4 168.59 23.55 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 125.33 1.452 . . . . 0.0 112.438 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -72.28 141.57 71.27 Favored 'Cis proline' 0 C--N 1.35 0.639 0 N-CA-C 109.559 -0.977 . . . . 0.0 109.559 -8.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.9 p -145.11 161.51 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 121.435 -0.79 . . . . 0.0 110.125 -175.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.4 mm -118.66 114.62 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -177.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -80.5 133.65 35.85 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 169.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.408 ' H ' ' HG2' ' A' ' 58' ' ' GLU . 6.9 m -101.88 -177.91 3.56 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.944 1.697 . . . . 0.0 110.082 -175.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -52.64 -46.3 67.06 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.423 1.489 . . . . 0.0 111.676 -173.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -74.19 -30.25 62.13 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.212 0.605 . . . . 0.0 112.627 -171.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 55' ' ' SER . 2.2 mm-40 -67.75 -32.9 73.82 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.266 0.626 . . . . 0.0 109.993 173.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.69 7.25 44.34 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.106 1.762 . . . . 0.0 112.373 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.85 45.02 0.68 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.857 1.663 . . . . 0.0 112.488 -170.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.0 m -138.52 170.0 17.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 127.978 2.511 . . . . 0.0 109.537 -175.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -72.57 -24.83 61.16 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.207 -0.933 . . . . 0.0 112.964 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -152.46 145.93 24.88 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 t -120.9 153.06 24.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 160.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 93.0 m -149.2 135.84 19.51 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 120.148 -1.595 . . . . 0.0 108.551 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -134.8 164.05 28.42 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 125.24 1.416 . . . . 0.0 109.019 -172.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.0 t -152.86 158.53 42.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.783 0.833 . . . . 0.0 108.876 173.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.0 p -65.84 138.3 57.79 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.551 1.541 . . . . 0.0 109.205 163.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 74.3 p -75.29 -16.74 60.41 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 120.359 1.436 . . . . 0.0 113.449 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -156.83 -163.8 12.82 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 -174.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.35 115.7 7.29 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.44 176.04 6.74 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.859 1.264 . . . . 0.0 111.312 -173.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -137.41 5.37 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -172.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -147.55 164.55 33.1 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 121.178 1.808 . . . . 0.0 111.982 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -156.41 86.44 1.01 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.324 1.45 . . . . 0.0 107.679 155.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.01 138.89 34.79 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 121.482 -0.761 . . . . 0.0 109.209 166.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.2 t -143.15 130.83 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.8 m -143.71 169.22 18.15 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.051 1.341 . . . . 0.0 108.059 166.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 164.69 -175.15 40.72 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -174.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.8 -175.27 41.46 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 176.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.533 0.304 0 C-N-CA 126.838 2.055 . . . . 0.0 108.415 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 CA--C 1.532 0.28 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -81.17 178.85 6.4 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.077 1.851 . . . . 0.0 112.436 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.462 ' SD ' ' HA ' ' A' ' 23' ' ' PHE . 15.7 ptm -146.28 163.27 36.01 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 122.008 0.908 . . . . 0.0 111.145 173.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -122.82 158.77 29.53 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.394 1.477 . . . . 0.0 107.715 177.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 21.0 m0 -126.64 132.93 51.11 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 176.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.273 2.1 p -130.03 106.97 14.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.0 m -117.75 106.05 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 125.779 1.632 . . . . 0.0 106.98 -166.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.2 m -88.38 160.42 17.59 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 174.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.5 t -125.73 138.38 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 159.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -116.03 151.4 35.57 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 126.904 2.082 . . . . 0.0 107.843 170.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.441 ' HG2' HD21 ' A' ' 102' ' ' ASN . 15.3 tttm -99.69 -172.54 2.26 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 128.986 2.914 . . . . 0.0 107.895 174.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.441 HD21 ' HG2' ' A' ' 101' ' ' LYS . 0.1 OUTLIER -61.82 75.36 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.682 1.593 . . . . 0.0 110.547 167.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.43 42.44 6.95 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.711 1.624 . . . . 0.0 114.292 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -159.21 151.67 21.43 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.351 1.576 . . . . 0.0 108.448 165.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -76.17 137.73 40.23 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 159.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.7 pt -130.12 -18.39 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 118.295 -0.86 . . . . 0.0 113.262 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -143.7 139.23 29.4 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 120.156 1.344 . . . . 0.0 110.062 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -144.94 104.14 3.96 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -174.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -141.8 174.58 10.45 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 173.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.7 t -148.35 159.6 43.84 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.12 1.368 . . . . 0.0 109.271 174.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.3 mt -125.34 164.86 19.46 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.613 1.965 . . . . 0.0 109.001 -176.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.56 86.2 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 125.704 1.602 . . . . 0.0 108.828 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 . . . . . 0 C--O 1.234 0.274 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 168.227 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.539 0.534 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -132.18 134.65 45.62 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.814 1.643 . . . . 0.0 110.872 172.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.72 89.06 1.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 158.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 29.6 mt -110.15 140.43 44.26 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -153.64 73.93 0.98 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.729 1.612 . . . . 0.0 108.28 -176.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -73.39 148.31 43.48 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 121.661 -0.649 . . . . 0.0 109.843 170.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.5 p30 . . . . . 0 C--O 1.248 1.008 0 C-N-CA 127.116 2.166 . . . . 0.0 106.058 156.484 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.401 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . . . . . . 0 CA--C 1.523 0.587 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -143.34 -160.52 1.12 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.764 1.226 . . . . 0.0 110.92 -171.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 30.4 mtp -135.27 167.06 21.72 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 128.58 2.752 . . . . 0.0 107.307 157.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -154.92 156.05 35.39 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.417 1.887 . . . . 0.0 108.87 -174.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -168.41 126.66 1.12 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.234 2.214 . . . . 0.0 106.23 -172.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.6 m -136.72 158.94 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 125.656 1.583 . . . . 0.0 110.177 -170.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.6 p -126.5 159.24 33.96 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.334 0.654 . . . . 0.0 111.062 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 tp -132.33 111.12 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 167.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -97.42 145.67 25.95 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 162.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -127.32 128.52 46.06 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.945 1.698 . . . . 0.0 107.717 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.1 m -149.85 178.88 8.5 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.524 1.53 . . . . 0.0 108.791 -167.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.52 -149.4 51.25 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -166.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -80.04 60.21 3.51 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.108 1.363 . . . . 0.0 111.691 -173.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.434 ' HA ' ' HE2' ' A' ' 93' ' ' MET . 52.1 p90 -76.44 30.57 0.12 Allowed 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.397 -1.439 . . . . 0.0 114.462 -174.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.9 mtt85 -106.83 -10.18 16.13 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -163.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.4 t -154.03 83.37 1.14 Allowed 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -145.95 165.85 27.75 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.975 0.91 . . . . 0.0 110.538 172.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.4 mt -132.11 88.47 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 125.473 1.509 . . . . 0.0 107.767 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.71 168.12 16.55 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.098 -1.002 . . . . 0.0 111.336 176.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.0 t -124.75 161.03 27.29 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 161.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -140.55 113.92 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 160.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.5 t -74.94 131.45 34.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 159.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.2 t -129.43 143.48 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 C-N-CA 124.541 1.136 . . . . 0.0 108.184 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 t -138.25 147.06 25.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.24 119.62 11.59 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.998 1.319 . . . . 0.0 108.111 169.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -76.78 127.39 32.67 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 118.166 -0.921 . . . . 0.0 109.859 173.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.82 0.05 69.36 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.085 1.326 . . . . 0.0 114.946 163.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.5 t -161.47 -179.43 7.34 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.621 1.21 . . . . 0.0 110.666 -170.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -104.42 169.94 8.18 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.073 1.349 . . . . 0.0 109.689 169.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.3 tp -101.77 164.43 11.74 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 127.274 2.23 . . . . 0.0 109.299 -174.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -130.11 114.21 15.46 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 126.144 1.777 . . . . 0.0 106.622 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -69.61 118.79 12.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 174.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.88 -7.24 55.31 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 117.671 -1.627 . . . . 0.0 113.52 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.2 -60.11 4.27 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 120.567 2.183 . . . . 0.0 110.067 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.98 3.09 3.7 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.304 1.841 . . . . 0.0 111.46 -167.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.57 17.73 67.76 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.843 1.211 . . . . 0.0 112.153 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -69.79 124.85 25.04 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.98 1.312 . . . . 0.0 109.854 -169.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.77 111.99 10.53 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.354 1.062 . . . . 0.0 109.933 173.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.4 mt -121.66 142.78 49.8 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 123.593 0.757 . . . . 0.0 109.44 -177.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.86 95.09 9.97 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.434 1.111 . . . . 0.0 108.6 175.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.3 p -51.24 154.51 2.82 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.199 157.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.76 130.57 20.85 Favored 'Cis proline' 0 N--CA 1.457 -0.648 0 CA-C-N 120.747 1.302 . . . . 0.0 111.159 -2.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.0 p -132.28 154.21 39.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 124.554 1.142 . . . . 0.0 108.618 -169.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.4 mm -117.55 120.14 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.1 mt -87.89 136.19 33.07 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.85 171.1 14.97 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.239 1.816 . . . . 0.0 108.932 171.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -61.23 -35.4 77.14 Favored 'General case' 0 C--O 1.22 -0.463 0 O-C-N 121.031 -1.043 . . . . 0.0 109.903 164.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -59.56 -25.69 64.76 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.707 1.203 . . . . 0.0 111.937 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -90.98 -28.55 17.95 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.768 1.227 . . . . 0.0 110.716 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.3 mt -113.08 5.08 16.96 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 124.376 1.07 . . . . 0.0 113.587 -169.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.03 45.66 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.387 2.675 . . . . 0.0 111.224 168.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.6 m -119.74 160.4 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 129.135 2.974 . . . . 0.0 108.303 173.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.64 -44.65 93.44 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 121.564 -0.71 . . . . 0.0 111.25 170.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.23 152.1 29.93 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 120.794 -1.191 . . . . 0.0 109.221 -175.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.9 p -142.19 165.4 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.419 0.628 . . . . 0.0 109.35 158.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.8 m -111.7 142.66 43.75 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 127.212 2.205 . . . . 0.0 105.993 170.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -123.33 133.27 54.15 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 169.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.47 177.89 8.14 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -174.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.1 p -119.19 147.29 44.38 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 118.894 0.77 . . . . 0.0 112.984 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.7 p -71.64 -12.63 61.44 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.634 1.173 . . . . 0.0 113.16 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -165.72 -169.73 29.71 Favored Glycine 0 N--CA 1.448 -0.562 0 O-C-N 120.596 -1.315 . . . . 0.0 110.522 -165.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.401 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 14.5 ttpt -55.46 115.6 2.39 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.624 1.57 . . . . 0.0 109.343 -176.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -111.33 145.42 38.87 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.3 mt -131.23 -11.23 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 118.878 -0.582 . . . . 0.0 112.02 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -144.4 137.87 27.36 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -125.69 100.2 6.32 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 165.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.21 152.89 21.34 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 163.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.32 123.79 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 170.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.4 p -142.33 170.49 15.61 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.759 0.709 . . . . 0.0 111.027 164.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 142.41 -75.96 0.31 Allowed Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 176.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.43 ' H ' HD12 ' A' ' 124' ' ' LEU . . . 69.95 -152.38 51.22 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 CA--C 1.534 0.35 0 C-N-CA 124.315 1.046 . . . . 0.0 110.477 -176.765 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 . . . . . 0 CA--C 1.536 0.434 0 CA-C-O 119.661 -0.209 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -78.65 173.57 13.49 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.442 2.761 . . . . 0.0 112.741 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.519 ' CE ' ' HE1' ' A' ' 95' ' ' TRP . 2.7 ptm -125.2 162.23 25.13 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.355 -0.841 . . . . 0.0 111.508 176.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -142.8 144.81 32.72 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 124.992 1.317 . . . . 0.0 108.147 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.519 ' HE1' ' CE ' ' A' ' 93' ' ' MET . 52.7 m0 -123.35 156.92 34.43 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.2 t -133.26 117.92 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.7 m -128.54 123.85 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -165.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.2 m -121.75 156.96 32.04 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -173.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.9 t -131.65 131.56 62.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 123.808 0.843 . . . . 0.0 108.955 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -114.45 166.35 11.79 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.205 1.802 . . . . 0.0 109.099 170.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.02 -156.0 0.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.383 1.873 . . . . 0.0 108.094 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -65.76 68.7 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.563 1.145 . . . . 0.0 112.151 164.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.17 38.0 4.7 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.826 1.203 . . . . 0.0 113.428 166.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.54 152.72 12.35 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.555 1.177 . . . . 0.0 109.831 168.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -64.33 137.91 58.15 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 157.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.4 pt -123.86 -27.92 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 117.579 -1.201 . . . . 0.0 112.209 172.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -140.15 149.96 43.65 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.376 1.444 . . . . 0.0 109.39 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -152.83 108.94 3.36 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.663 1.985 . . . . 0.0 105.784 -174.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.68 154.09 39.17 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.175 170.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.87 157.83 27.91 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 125.593 1.557 . . . . 0.0 109.268 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 73.8 mt -129.82 147.64 51.62 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.432 1.093 . . . . 0.0 108.199 -163.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.9 p -129.82 100.87 5.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.62 0.724 . . . . 0.0 109.175 -171.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 N--CA 1.449 -0.505 0 CA-C-O 122.119 0.962 . . . . 0.0 108.488 167.555 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.274 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.43 HD12 ' H ' ' A' ' 80' ' ' GLY . 19.6 mt -111.16 96.18 5.98 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 -176.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -153.65 58.97 0.75 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.617 175.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 83.2 mt -107.91 145.36 33.88 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -153.18 72.19 0.93 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.002 0.906 . . . . 0.0 109.794 -176.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -65.15 133.53 51.76 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 171.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.3 p30 . . . . . 0 C--O 1.255 1.38 0 C-N-CA 125.363 1.465 . . . . 0.0 109.863 175.335 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.403 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . . . . . . 0 CA--C 1.518 0.236 0 N-CA-C 106.899 -2.48 . . . . 0.0 106.899 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.64 174.58 11.3 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.238 1.019 . . . . 0.0 109.232 -176.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.8 mtp -84.39 -174.05 5.06 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 119.764 -1.835 . . . . 0.0 109.253 154.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -153.2 148.6 27.08 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.366 0.667 . . . . 0.0 110.487 152.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -142.06 144.63 33.68 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.898 2.079 . . . . 0.0 108.354 172.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 p -138.53 153.54 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 126.957 2.103 . . . . 0.0 110.105 175.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -114.31 153.84 29.06 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.465 1.506 . . . . 0.0 109.185 167.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.2 tp -105.34 148.4 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 155.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -139.92 115.25 9.88 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 167.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -104.59 128.65 52.65 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 126.014 1.726 . . . . 0.0 107.474 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -138.02 173.92 11.11 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 122.702 0.401 . . . . 0.0 110.666 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.64 -82.34 1.59 Allowed Glycine 0 CA--C 1.52 0.373 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -175.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.414 ' CG ' HH11 ' A' ' 24' ' ' ARG . 17.9 t0 -168.54 104.32 0.43 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 117.997 0.899 . . . . 0.0 112.927 175.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -96.25 24.61 5.57 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.515 -1.366 . . . . 0.0 112.363 -178.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.414 HH11 ' CG ' ' A' ' 22' ' ' ASP . 69.6 mtt85 -69.34 -47.23 64.98 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -172.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.4 m -127.26 69.15 1.28 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.807 1.185 . . . . 0.0 109.465 -177.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -143.02 117.66 9.81 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.7 mm -84.62 79.06 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.538 ' HD3' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -79.44 145.41 33.32 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.209 1.403 . . . . 0.0 108.614 167.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.4 m -135.8 174.72 10.3 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 169.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.2 t -141.52 160.51 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 174.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.8 p -114.56 151.34 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 158.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.5 p -139.31 139.25 39.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 118.626 0.648 . . . . 0.0 110.413 162.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.5 t -126.47 144.81 35.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 126.49 1.916 . . . . 0.0 106.299 169.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.61 95.43 2.65 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.981 1.312 . . . . 0.0 109.048 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -62.56 100.3 0.18 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.314 1.446 . . . . 0.0 110.072 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.65 1.28 25.94 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 117.405 1.722 . . . . 0.0 117.405 159.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 t -157.78 179.11 9.52 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.934 2.367 . . . . 0.0 109.086 174.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -91.38 161.35 15.04 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.481 0.658 . . . . 0.0 110.471 175.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.3 mt -84.42 171.93 12.17 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.563 0.745 . . . . 0.0 109.731 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -135.74 129.09 32.07 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.779 1.232 . . . . 0.0 108.42 170.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -89.4 117.19 28.14 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.634 1.173 . . . . 0.0 109.808 173.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.96 11.72 5.86 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.079 1.323 . . . . 0.0 114.235 175.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.72 -48.16 56.01 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 120.123 1.962 . . . . 0.0 108.973 168.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.31 -9.71 0.57 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.686 1.194 . . . . 0.0 111.715 -167.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.86 13.4 55.01 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.244 1.878 . . . . 0.0 112.903 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -68.51 138.5 55.24 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -174.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.7 m -71.54 147.23 47.89 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 170.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 mt -130.07 158.8 38.64 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 118.491 0.587 . . . . 0.0 109.56 171.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.48 103.59 10.25 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 126.77 2.028 . . . . 0.0 108.267 -173.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.95 165.54 52.38 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.233 169.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.98 140.05 64.91 Favored 'Cis proline' 0 N--CA 1.454 -0.813 0 N-CA-C 109.791 -0.888 . . . . 0.0 109.791 -8.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.2 p -143.37 160.05 17.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.03 0.932 . . . . 0.0 110.891 -177.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.0 mm -118.89 125.06 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 126.968 2.107 . . . . 0.0 107.111 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.3 mt -83.11 144.59 29.76 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 166.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.25 175.7 5.32 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.36 2.264 . . . . 0.0 109.544 176.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -59.39 -35.37 73.82 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.725 1.21 . . . . 0.0 113.428 -175.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -70.68 -28.48 64.8 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.962 0.801 . . . . 0.0 112.611 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -70.29 -52.98 18.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 32.1 mt -77.28 24.61 0.18 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.786 2.034 . . . . 0.0 111.379 -175.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.07 -11.11 59.89 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.459 1.104 . . . . 0.0 112.155 175.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.9 m -84.1 148.61 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.442 1.097 . . . . 0.0 110.177 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -61.78 -33.24 73.75 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.638 -0.664 . . . . 0.0 112.19 173.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -154.4 141.05 18.96 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 -166.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.98 158.62 23.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -134.46 119.46 18.55 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -175.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 17.7 mt -136.65 137.79 40.42 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 118.991 0.814 . . . . 0.0 109.626 -172.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -147.62 -168.23 3.01 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -168.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.22 147.54 42.41 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 127.369 2.268 . . . . 0.0 108.99 176.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 79.9 p -73.93 -20.84 60.26 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.515 -0.74 . . . . 0.0 111.302 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -156.59 -156.37 7.83 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 124.25 0.928 . . . . 0.0 111.05 -177.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.403 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 12.4 ttpt -67.75 137.37 55.4 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.875 0.87 . . . . 0.0 109.793 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -138.16 174.62 10.36 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.079 1.752 . . . . 0.0 109.783 172.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.73 21.07 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 123.544 0.738 . . . . 0.0 109.426 -174.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -155.0 158.08 38.61 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 119.217 -2.177 . . . . 0.0 109.371 168.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.75 85.22 1.42 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.15 1.38 . . . . 0.0 107.547 160.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.85 137.59 37.75 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 171.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.3 t -148.88 105.88 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 126.811 2.044 . . . . 0.0 106.445 -174.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.0 m -141.55 173.02 11.89 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.699 1.2 . . . . 0.0 111.082 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.66 -89.7 0.11 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 123.992 0.806 . . . . 0.0 111.361 167.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.01 133.43 7.94 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 108.796 -1.721 . . . . 0.0 108.796 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 CA--C 1.532 0.26 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.96 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 . . . . . 0 N--CA 1.464 0.226 0 CA-C-O 118.823 -0.608 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -84.24 178.78 4.98 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.923 2.415 . . . . 0.0 112.312 176.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.5 ptm -148.37 171.2 16.41 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.287 -0.883 . . . . 0.0 112.164 -169.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -140.04 159.12 42.9 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 126.882 2.073 . . . . 0.0 107.547 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.0 m0 -128.3 141.58 51.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.018 1.327 . . . . 0.0 107.672 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -124.81 105.42 15.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 103.59 -2.745 . . . . 0.0 103.59 164.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.0 m -83.25 157.45 3.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 155.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 28.6 m -138.79 133.43 32.11 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 169.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.9 t -112.52 141.15 28.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -125.0 138.85 54.21 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.79 2.036 . . . . 0.0 108.529 -175.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -101.14 -174.79 2.69 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.341 1.457 . . . . 0.0 107.613 174.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -68.78 65.89 0.13 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.608 2.363 . . . . 0.0 109.031 -177.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 165.21 -68.81 0.2 Allowed Glycine 0 N--CA 1.448 -0.55 0 CA-C-O 118.675 -1.069 . . . . 0.0 112.278 -172.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -157.01 -176.59 6.07 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.534 1.133 . . . . 0.0 111.289 -174.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.86 139.03 14.03 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.899 1.68 . . . . 0.0 110.037 169.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.9 pt -129.12 -22.9 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 117.822 -1.085 . . . . 0.0 112.253 171.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -124.09 128.01 48.66 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 120.092 1.315 . . . . 0.0 110.411 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -126.6 90.89 3.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.052 1.741 . . . . 0.0 107.479 175.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -130.51 162.85 28.32 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 167.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.6 t -151.06 151.98 32.8 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.63 1.572 . . . . 0.0 107.026 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 36.9 mt -121.68 161.87 21.76 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.621 1.568 . . . . 0.0 109.112 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.0 p -137.75 132.82 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 N--CA 1.446 -0.654 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -174.39 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.6 t0 . . . . . 0 C--O 1.233 0.223 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.0 tp -122.55 114.98 21.39 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -154.28 53.71 0.68 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.345 1.458 . . . . 0.0 110.531 -159.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.3 mt -118.56 140.11 50.4 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -171.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -151.71 67.65 0.88 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.968 1.307 . . . . 0.0 109.451 -168.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -64.89 159.76 22.03 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.003 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.8 t30 . . . . . 0 C--O 1.25 1.094 0 C-N-CA 128.408 2.683 . . . . 0.0 106.123 -176.388 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.843 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -152.02 -175.3 5.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.52 1.928 . . . . 0.0 108.694 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 49.5 mtp -103.54 166.86 10.17 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 155.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -133.61 153.89 51.31 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.558 1.143 . . . . 0.0 108.033 169.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -148.36 145.19 27.98 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.29 133.76 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 127.195 2.198 . . . . 0.0 106.512 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 p -94.4 171.36 8.87 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.507 HG22 ' H ' ' A' ' 64' ' ' VAL . 11.3 tp -132.87 146.49 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 160.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -136.24 117.57 14.63 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 161.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -107.06 128.97 54.85 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 173.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.3 p -149.1 168.4 23.3 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 122.141 -0.35 . . . . 0.0 111.335 171.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.48 -114.53 3.96 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 107.284 -2.326 . . . . 0.0 107.284 -170.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.417 ' CG ' ' HE ' ' A' ' 24' ' ' ARG . 12.6 t0 -116.11 90.24 3.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 122.008 0.909 . . . . 0.0 110.709 -174.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -102.57 21.76 14.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.958 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.417 ' HE ' ' CG ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -133.0 19.31 4.1 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.552 1.541 . . . . 0.0 112.311 -168.425 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.8 m -134.75 -1.27 2.77 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.302 1.441 . . . . 0.0 113.484 -173.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -119.24 -174.47 2.73 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.363 1.065 . . . . 0.0 108.328 -171.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.9 mp -129.87 80.8 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.457 ' HE2' ' OD2' ' A' ' 56' ' ' ASP . 2.3 pttt -81.1 162.42 23.71 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 121.835 -0.541 . . . . 0.0 110.091 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 m -145.35 158.06 43.91 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 171.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 74.4 t -142.28 105.77 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -68.49 149.11 11.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 159.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.04 142.23 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 124.982 1.313 . . . . 0.0 108.207 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.4 t -137.58 149.33 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 171.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.0 93.84 2.64 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 172.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -69.82 104.71 2.54 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.11 7.05 38.75 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.75 -1.028 . . . . 0.0 114.284 165.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.9 t -161.89 177.59 9.69 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.546 1.173 . . . . 0.0 109.024 -174.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -100.05 170.29 8.59 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.091 0.956 . . . . 0.0 108.739 171.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 tp -84.48 170.14 13.79 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.316 0.646 . . . . 0.0 109.396 164.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -134.67 120.19 19.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.898 1.279 . . . . 0.0 108.087 171.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -69.49 129.32 39.38 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.124 0.97 . . . . 0.0 109.37 176.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.69 -8.79 84.06 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 118.892 -0.949 . . . . 0.0 113.126 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.57 -46.75 86.9 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.128 1.464 . . . . 0.0 108.635 173.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.68 -16.04 1.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.688 0.795 . . . . 0.0 112.088 -160.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.38 63.27 2.82 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -173.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -123.48 140.11 53.33 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.481 1.112 . . . . 0.0 108.333 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.85 112.16 17.98 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -178.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.7 mt -97.09 128.23 43.82 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.75 0.786 . . . . 0.0 109.352 -174.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.16 79.54 6.7 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.35 1.46 . . . . 0.0 109.493 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.2 m -63.02 163.67 15.96 Favored Pre-proline 0 N--CA 1.444 -0.767 0 C-N-CA 123.724 0.809 . . . . 0.0 110.949 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -68.93 140.66 59.29 Favored 'Cis proline' 0 CA--C 1.536 0.617 0 CA-C-N 119.211 0.754 . . . . 0.0 110.625 -9.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.7 p -145.68 149.24 16.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 124.002 0.921 . . . . 0.0 109.651 -171.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.4 mm -125.47 98.24 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 124.032 0.933 . . . . 0.0 109.295 -173.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.2 mt -72.43 131.19 42.27 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 175.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.7 m -87.93 -177.05 5.68 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.11 1.364 . . . . 0.0 109.709 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.457 ' OD2' ' HE2' ' A' ' 28' ' ' LYS . 12.5 t70 -61.21 -43.89 98.16 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.902 0.881 . . . . 0.0 112.16 -172.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -67.83 -38.85 83.74 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -174.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.15 -32.55 73.96 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.33 20.33 0.15 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.919 1.688 . . . . 0.0 115.22 176.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.36 19.34 0.08 Allowed 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 120.691 1.587 . . . . 0.0 114.993 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.8 m -95.92 153.94 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 O-C-N 120.567 -1.333 . . . . 0.0 111.554 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -75.62 -41.43 54.31 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.561 -0.712 . . . . 0.0 111.853 175.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.72 107.36 0.87 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -166.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.507 ' H ' HG22 ' A' ' 17' ' ' ILE . 93.1 t -138.6 118.91 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 123.14 1.448 . . . . 0.0 111.239 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.9 m -69.26 125.53 26.97 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 128.231 2.613 . . . . 0.0 109.093 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.49 140.8 47.81 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.479 1.036 . . . . 0.0 108.225 170.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.4 t -150.69 178.17 9.36 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.08 1.352 . . . . 0.0 107.781 176.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.9 p -87.55 165.42 15.5 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.245 0.618 . . . . 0.0 110.484 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.8 p -80.41 -13.55 59.05 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.855 -0.528 . . . . 0.0 111.372 165.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -166.43 -170.73 31.71 Favored Glycine 0 CA--C 1.527 0.812 0 O-C-N 120.388 -1.445 . . . . 0.0 113.457 -167.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -63.02 132.43 51.96 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.432 1.093 . . . . 0.0 109.057 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -133.61 160.66 36.83 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.624 1.17 . . . . 0.0 111.741 -175.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.2 14.35 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 118.478 -0.772 . . . . 0.0 110.35 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -149.27 158.05 43.85 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.483 1.492 . . . . 0.0 110.701 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -161.48 99.33 1.15 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.197 1.399 . . . . 0.0 107.664 165.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.95 142.2 28.02 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.348 1.459 . . . . 0.0 110.949 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 t -145.63 107.84 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 124.526 1.13 . . . . 0.0 108.274 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.8 m -141.07 166.65 24.21 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 121.041 -1.037 . . . . 0.0 109.67 169.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.04 -65.22 0.3 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 167.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.65 176.22 25.04 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 121.123 0.29 . . . . 0.0 112.378 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 C--O 1.235 0.325 0 C-N-CA 126.006 1.722 . . . . 0.0 107.368 165.793 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -75.69 167.01 27.26 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.264 1.976 . . . . 0.0 112.36 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.0 ppp? -149.36 174.19 12.71 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.02 0.528 . . . . 0.0 111.11 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -135.1 156.4 49.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.138 1.375 . . . . 0.0 108.753 173.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -141.25 90.9 2.35 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -178.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.7 t -82.28 137.18 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 168.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 m -144.63 54.7 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 125.254 1.422 . . . . 0.0 108.67 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.0 m -65.93 140.23 58.32 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 120.703 -1.248 . . . . 0.0 108.206 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.9 m -103.83 154.63 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 CA-C-O 122.889 1.328 . . . . 0.0 109.693 172.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -127.26 172.84 10.24 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 126.889 2.076 . . . . 0.0 108.098 167.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -120.92 -162.13 0.94 Allowed 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 130.644 3.578 . . . . 0.0 105.234 -176.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.99 72.72 0.18 Allowed 'General case' 0 CA--C 1.551 1.002 0 O-C-N 121.226 -0.921 . . . . 0.0 109.416 165.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.25 29.37 56.47 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 126.003 1.763 . . . . 0.0 115.067 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -136.04 178.64 6.9 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.744 1.772 . . . . 0.0 108.209 166.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -120.53 140.7 51.08 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 127.322 2.249 . . . . 0.0 106.705 170.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -117.09 -27.33 2.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 125.353 1.461 . . . . 0.0 111.768 175.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -149.82 143.54 25.42 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.253 0.933 . . . . 0.0 109.164 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.8 tttt -137.45 43.77 2.29 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.517 0.727 . . . . 0.0 110.359 -173.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -69.26 142.4 54.16 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.4 t -138.76 160.14 40.39 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.268 1.827 . . . . 0.0 107.828 168.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 31.3 mt -125.32 144.5 50.46 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.993 1.717 . . . . 0.0 107.984 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 98.7 t -135.27 126.82 46.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.315 1.446 . . . . 0.0 107.24 -175.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 . . . . . 0 CA--C 1.535 0.378 0 C-N-CA 124.324 1.049 . . . . 0.0 109.174 175.579 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.09 112.63 6.86 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 172.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -144.38 70.02 1.28 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -176.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.84 139.79 44.51 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.71 2.004 . . . . 0.0 107.224 -176.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -153.08 135.72 15.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 169.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -119.93 148.32 43.67 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.837 1.255 . . . . 0.0 109.09 171.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.3 p30 . . . . . 0 C--O 1.248 0.974 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 152.823 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.66 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.15 -178.06 6.28 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.7 0.8 . . . . 0.0 111.227 -170.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.9 mtp -107.39 156.15 19.24 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 160.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -133.94 137.52 44.92 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.843 0.857 . . . . 0.0 110.637 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -133.93 133.54 41.53 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 127.984 2.514 . . . . 0.0 107.921 171.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.05 155.78 11.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 126.511 1.924 . . . . 0.0 108.094 168.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.32 143.92 36.07 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 172.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.5 tp -133.29 97.0 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.46 143.83 34.6 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 161.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -120.67 130.79 54.25 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 173.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 m -112.18 165.79 11.83 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 122.385 0.274 . . . . 0.0 110.388 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 62.19 -147.8 48.84 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -79.3 77.38 5.83 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-O 122.112 0.958 . . . . 0.0 110.34 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -83.8 -5.97 59.32 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.006 -1.059 . . . . 0.0 112.541 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 90.9 mtt-85 -70.14 -57.43 4.95 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.8 m -78.74 35.34 0.24 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.735 1.614 . . . . 0.0 113.272 -157.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -154.49 113.77 3.71 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.788 1.235 . . . . 0.0 111.392 -158.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.6 pt -67.68 74.99 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 127.791 2.436 . . . . 0.0 112.649 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -77.85 160.62 28.19 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 128.181 2.592 . . . . 0.0 111.851 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.5 t -156.63 152.91 27.75 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.636 -0.665 . . . . 0.0 109.798 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.5 t -128.19 139.95 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 125.628 1.571 . . . . 0.0 108.4 175.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.4 t -106.15 129.05 60.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 127.878 2.471 . . . . 0.0 104.761 164.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.62 147.08 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 119.696 1.135 . . . . 0.0 110.234 176.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.9 t -140.87 150.56 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.2 100.52 3.29 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 170.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -68.67 118.36 11.57 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.012 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.19 -14.11 40.17 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 119.408 -0.662 . . . . 0.0 114.106 159.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.4 t -148.87 178.3 8.8 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.872 1.269 . . . . 0.0 110.052 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -89.8 155.03 19.45 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.462 0.705 . . . . 0.0 109.816 173.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.5 tp -77.47 166.96 22.42 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.423 1.089 . . . . 0.0 108.883 168.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -137.07 128.36 28.07 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.152 1.781 . . . . 0.0 107.209 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -84.67 121.32 27.49 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.93 -8.25 57.52 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-O 119.125 -0.819 . . . . 0.0 113.693 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.8 -26.52 40.53 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.047 1.423 . . . . 0.0 111.729 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 p -134.09 -43.91 0.79 Allowed 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 124.299 1.04 . . . . 0.0 110.808 -169.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.57 13.1 56.16 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.724 -1.042 . . . . 0.0 111.058 -163.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -67.29 156.9 35.22 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 118.705 1.252 . . . . 0.0 109.253 168.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.4 p -112.96 133.62 54.84 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.39 1.476 . . . . 0.0 108.962 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.9 mt -130.93 137.58 49.36 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.79 0.836 . . . . 0.0 109.515 -162.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -85.02 63.28 8.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.227 1.411 . . . . 0.0 111.059 -167.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.7 m -53.5 150.64 12.12 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-O 118.832 -0.604 . . . . 0.0 110.948 172.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.03 140.61 68.28 Favored 'Cis proline' 0 CA--C 1.535 0.541 0 CA-C-N 119.857 0.985 . . . . 0.0 113.359 2.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.0 t -144.7 165.48 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.384 1.873 . . . . 0.0 108.222 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.4 mm -114.69 138.96 43.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 C-N-CA 126.63 1.972 . . . . 0.0 107.001 172.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -115.71 125.98 53.52 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.53 174.04 12.0 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 126.018 1.727 . . . . 0.0 110.461 -172.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -51.38 -38.88 55.65 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.743 1.617 . . . . 0.0 112.705 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -70.2 -39.6 75.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.078 0.551 . . . . 0.0 110.876 -175.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -63.92 -40.18 95.87 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.06 11.92 10.66 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.605 1.962 . . . . 0.0 113.376 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.87 19.26 0.07 Allowed 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 122.21 2.277 . . . . 0.0 115.83 -172.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.7 m -124.97 169.76 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 120.185 -1.572 . . . . 0.0 112.795 -159.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -66.78 -30.22 70.37 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.201 -0.937 . . . . 0.0 112.193 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -154.32 151.35 28.98 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 119.475 1.034 . . . . 0.0 110.278 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -125.45 156.69 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 158.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.5 m -136.59 126.23 25.42 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 126.165 1.786 . . . . 0.0 106.529 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.9 mp -140.7 146.61 38.02 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 120.319 1.418 . . . . 0.0 110.695 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.9 t -132.4 -167.08 1.83 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.43 1.092 . . . . 0.0 109.743 -177.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.94 147.55 36.85 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.749 1.62 . . . . 0.0 108.609 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.1 p -77.47 -14.14 59.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.438 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.53 -167.21 20.73 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -173.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -66.36 133.08 49.77 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.1 153.76 38.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 173.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -113.61 -0.7 9.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 123.392 0.677 . . . . 0.0 109.473 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -149.88 157.72 43.46 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 119.394 0.997 . . . . 0.0 108.487 173.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.5 157.23 44.96 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.513 1.925 . . . . 0.0 106.182 159.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.26 143.95 36.2 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 164.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.8 t -129.68 90.85 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 102.97 -2.974 . . . . 0.0 102.97 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.1 t -125.17 160.43 29.18 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.37 -152.35 21.49 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 -165.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.68 -165.39 24.81 Favored Glycine 0 C--O 1.239 0.451 0 N-CA-C 107.829 -2.109 . . . . 0.0 107.829 -167.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.443 -0.79 0 C-N-CA 123.74 0.816 . . . . 0.0 109.228 177.613 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 . . . . . 0 N--CA 1.465 0.285 0 CA-C-O 120.926 0.393 . . . . 0.0 111.606 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.18 175.36 10.01 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.896 1.731 . . . . 0.0 112.93 164.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.1 ptm -154.6 -179.27 7.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.903 1.681 . . . . 0.0 107.805 -172.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -169.25 165.66 10.83 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.093 1.357 . . . . 0.0 107.375 171.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -104.21 144.39 31.67 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 162.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 96.9 t -128.52 79.31 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 101.42 -3.548 . . . . 0.0 101.42 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.0 m -83.92 144.65 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.3 m -133.61 142.98 48.35 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.5 t -127.84 130.86 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -117.43 142.74 46.76 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.195 1.398 . . . . 0.0 109.127 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.475 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 18.5 ttpt -83.08 -162.33 0.59 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 163.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.475 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 7.1 p30 -59.09 74.24 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.352 2.261 . . . . 0.0 110.043 167.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.38 40.16 24.34 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.864 1.221 . . . . 0.0 114.643 173.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.14 148.93 28.22 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.429 1.491 . . . . 0.0 107.765 167.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -77.7 146.58 35.92 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 169.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 39.7 pt -132.05 -21.9 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.849 1.26 . . . . 0.0 112.165 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -137.78 146.39 43.53 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.018 -1.051 . . . . 0.0 108.732 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 41.9 tttt -142.35 27.14 1.75 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.524 1.13 . . . . 0.0 110.584 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -80.54 131.67 35.56 Favored 'General case' 0 CA--C 1.517 -0.29 0 O-C-N 121.538 -0.726 . . . . 0.0 110.239 -171.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 p -106.49 167.53 9.78 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 125.895 1.678 . . . . 0.0 109.021 177.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.9 mt -127.92 -177.2 4.03 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.466 1.507 . . . . 0.0 108.073 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.9 p -151.21 146.86 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 175.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 . . . . . 0 C--O 1.238 0.483 0 C-N-CA 125.956 1.703 . . . . 0.0 108.18 162.649 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.0 t0 . . . . . 0 CA--C 1.523 -0.072 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.04 111.71 14.37 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -169.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -138.41 50.53 1.88 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.545 1.138 . . . . 0.0 109.757 -172.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.6 mt -101.68 144.75 30.0 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.055 -1.028 . . . . 0.0 108.614 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -156.71 149.57 23.8 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.736 1.614 . . . . 0.0 107.864 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -144.91 152.51 40.33 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.671 1.189 . . . . 0.0 109.247 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.6 p30 . . . . . 0 C--O 1.251 1.142 0 C-N-CA 125.479 1.511 . . . . 0.0 109.167 166.075 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.747 0 N-CA-C 106.158 -2.777 . . . . 0.0 106.158 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.78 145.59 38.42 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 118.716 1.258 . . . . 0.0 110.235 -172.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.1 mtp -63.03 147.0 51.98 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 154.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -135.18 148.63 49.74 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 164.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -143.77 110.36 5.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.338 1.855 . . . . 0.0 106.679 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 p -89.25 142.94 12.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 169.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.02 156.23 36.85 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 169.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.3 tp -138.16 143.2 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 169.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -129.89 97.06 4.37 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 172.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -83.78 125.46 31.95 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.6 t -151.43 167.73 27.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.5 -158.2 52.59 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -159.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -76.7 52.26 0.81 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.288 1.044 . . . . 0.0 113.779 -170.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -64.35 -8.5 13.32 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.336 -1.477 . . . . 0.0 114.427 -174.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -58.88 -60.73 3.39 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 119.25 0.932 . . . . 0.0 109.902 -174.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.9 m -79.1 28.38 0.23 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.183 1.793 . . . . 0.0 113.352 -167.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.415 ' O ' ' HE3' ' A' ' 28' ' ' LYS . 40.4 m-85 -123.95 123.1 39.66 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.075 0.95 . . . . 0.0 108.58 -172.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.4 mm -70.09 98.44 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -177.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.415 ' HE3' ' O ' ' A' ' 26' ' ' PHE . 2.2 mptt -75.29 131.35 40.25 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.639 0.776 . . . . 0.0 109.258 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.2 m -137.53 134.41 35.66 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.275 1.03 . . . . 0.0 108.603 169.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 89.8 t -137.34 113.91 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 165.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.5 p -70.24 132.75 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 158.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.94 143.69 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 126.33 1.852 . . . . 0.0 108.163 176.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.7 t -140.58 158.31 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.879 1.272 . . . . 0.0 107.739 -171.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.62 154.43 34.18 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.308 1.043 . . . . 0.0 108.809 168.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -118.16 101.84 8.54 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 124.979 1.312 . . . . 0.0 109.587 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.17 -80.23 0.27 Allowed Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 106.186 -2.765 . . . . 0.0 106.186 171.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.9 t -70.79 174.76 5.64 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 125.31 1.444 . . . . 0.0 110.505 -175.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -110.32 172.82 6.64 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.149 0.98 . . . . 0.0 111.149 -175.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.26 164.49 11.93 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.1 1.36 . . . . 0.0 108.424 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -138.48 124.15 19.72 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.61 0.764 . . . . 0.0 109.66 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -73.78 126.78 31.14 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 123.956 0.785 . . . . 0.0 109.607 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.99 6.66 19.1 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 117.58 -1.678 . . . . 0.0 114.321 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.49 -62.07 1.7 Allowed 'General case' 0 C--O 1.23 0.066 0 CA-C-N 120.621 2.21 . . . . 0.0 109.065 171.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.93 7.62 4.73 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.68 1.192 . . . . 0.0 111.787 -170.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.19 32.19 83.11 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -65.9 126.78 29.62 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 175.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.94 104.78 17.33 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -170.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 68.7 mt -91.06 -175.01 4.18 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.424 1.489 . . . . 0.0 110.673 -165.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.15 109.27 5.78 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.064 1.346 . . . . 0.0 107.427 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.44 165.01 46.92 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.822 -0.549 . . . . 0.0 110.74 174.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.67 142.74 65.34 Favored 'Cis proline' 0 CA--C 1.537 0.673 0 CA-C-N 118.569 0.525 . . . . 0.0 111.722 -9.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.5 p -145.09 165.05 12.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 126.092 1.757 . . . . 0.0 111.12 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.4 mm -119.59 118.5 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 126.222 1.809 . . . . 0.0 107.361 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.2 mt -73.6 104.68 4.63 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 159.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.0 m -76.5 179.73 5.73 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.55 1.14 . . . . 0.0 110.479 168.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -50.96 -34.23 27.9 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.126 1.37 . . . . 0.0 112.32 170.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -66.84 -32.42 73.68 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.55 1.14 . . . . 0.0 112.169 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -86.84 -47.77 8.77 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.2 mt -76.04 21.56 0.17 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.614 1.966 . . . . 0.0 111.887 174.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.78 -4.87 37.32 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.104 1.362 . . . . 0.0 112.893 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.4 m -108.54 160.89 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 127.333 2.253 . . . . 0.0 110.875 -177.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -68.19 -33.12 73.85 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.289 1.036 . . . . 0.0 112.319 -176.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -143.77 126.31 15.91 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -165.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -136.17 90.44 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -172.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.2 m -81.58 114.86 20.57 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.787 0.835 . . . . 0.0 109.418 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -116.08 132.12 56.75 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 t -147.64 168.52 21.82 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.274 0.559 . . . . 0.0 109.569 -175.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.19 139.51 32.25 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.188 1.795 . . . . 0.0 111.133 -171.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.3 p -68.14 -28.93 67.73 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -175.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -132.81 -86.37 0.3 Allowed Glycine 0 C--N 1.338 0.672 0 CA-C-N 118.82 0.736 . . . . 0.0 112.891 -173.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.99 139.48 20.5 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 130.764 3.625 . . . . 0.0 107.614 162.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -101.51 -169.13 1.65 Allowed 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 169.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.1 mm -115.32 -19.71 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.788 170.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -150.4 164.62 35.39 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.643 -1.286 . . . . 0.0 109.571 -160.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -164.52 124.03 1.92 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.66 1.584 . . . . 0.0 109.982 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.35 155.85 19.54 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 120.037 1.29 . . . . 0.0 109.73 167.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.7 t -150.16 92.76 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 127.501 2.32 . . . . 0.0 105.287 174.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.9 m -137.0 159.93 40.43 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.287 -0.883 . . . . 0.0 110.437 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.24 -97.3 0.18 Allowed Glycine 0 C--N 1.333 0.38 0 N-CA-C 106.978 -2.449 . . . . 0.0 106.978 176.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.9 -168.38 21.31 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -175.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.234 0.265 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 161.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.05 175.68 10.92 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.712 2.275 . . . . 0.0 111.129 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.0 ptm -146.61 168.86 20.23 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -142.87 160.08 41.01 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 122.295 1.045 . . . . 0.0 109.292 172.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.0 m0 -127.07 112.1 14.81 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 171.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.5 t -92.87 132.39 37.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 159.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.82 161.95 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 174.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.91 155.84 28.43 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.276 -1.749 . . . . 0.0 106.276 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 75.8 t -125.27 91.61 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 171.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -72.58 163.14 28.53 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 170.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -127.63 -154.33 0.63 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.478 2.311 . . . . 0.0 109.552 -168.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -62.17 61.34 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.719 2.007 . . . . 0.0 111.449 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.34 65.99 2.93 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 120.264 -1.522 . . . . 0.0 110.964 -169.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -165.74 165.13 18.76 Favored 'General case' 0 C--N 1.335 -0.059 0 C-N-CA 125.746 1.618 . . . . 0.0 107.999 150.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -77.83 147.75 35.04 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.925 1.69 . . . . 0.0 107.442 159.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 6.4 pt -134.51 -10.36 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.367 1.467 . . . . 0.0 112.553 166.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -145.97 159.35 43.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.237 1.815 . . . . 0.0 108.78 -165.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -153.69 25.76 0.51 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -173.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -47.67 128.16 12.47 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.94 0.896 . . . . 0.0 111.394 177.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.0 p -147.42 140.46 25.09 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.286 1.034 . . . . 0.0 109.469 -177.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.73 -173.45 3.24 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 123.256 1.503 . . . . 0.0 109.645 -174.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.7 p -159.83 141.34 4.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 128.96 2.904 . . . . 0.0 108.689 -177.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 . . . . . 0 C--O 1.238 0.449 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 172.016 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.7 tp -134.56 112.81 11.17 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -156.11 54.11 0.57 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 126.93 2.092 . . . . 0.0 107.925 -172.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tp -106.43 143.27 34.78 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.23 1.012 . . . . 0.0 108.984 -171.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -158.95 136.88 10.39 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.199 0.6 . . . . 0.0 109.461 -167.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -137.48 127.36 25.64 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 128.278 2.631 . . . . 0.0 106.062 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.257 1.494 0 C-N-CA 128.987 2.915 . . . . 0.0 104.888 153.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.466 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . . . . . . 0 CA--C 1.524 0.616 0 N-CA-C 108.471 -1.851 . . . . 0.0 108.471 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.52 165.44 17.81 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.544 0.738 . . . . 0.0 112.291 -163.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.2 mtp -116.02 170.15 8.72 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 144.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -173.71 160.8 3.78 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 131.131 3.773 . . . . 0.0 106.902 -178.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -153.43 112.24 3.72 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.58 158.35 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.173 0.989 . . . . 0.0 109.169 175.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 p -136.43 160.27 39.25 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 160.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.7 tp -130.04 143.69 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 126.479 1.912 . . . . 0.0 106.031 173.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -131.63 139.18 49.06 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 126.944 2.098 . . . . 0.0 106.671 170.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -104.13 144.85 31.03 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.441 1.496 . . . . 0.0 107.975 176.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.3 t -154.38 170.7 20.72 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.816 1.246 . . . . 0.0 108.76 -176.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 54.66 -147.46 24.35 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.564 1.078 . . . . 0.0 110.646 -165.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -84.22 95.87 8.8 Favored 'General case' 0 C--O 1.222 -0.357 0 O-C-N 121.622 -0.928 . . . . 0.0 110.451 175.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -96.52 8.18 44.73 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 120.344 -1.473 . . . . 0.0 112.73 -175.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -94.92 -5.6 44.45 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -157.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.5 t -127.13 23.45 6.49 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.11 0.868 . . . . 0.0 110.972 -165.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -135.99 118.29 15.63 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.082 0.953 . . . . 0.0 110.908 -164.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.7 mt -66.63 108.44 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -80.75 149.93 29.46 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.547 1.139 . . . . 0.0 109.237 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 m -150.85 138.21 19.46 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 169.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.4 t -136.41 139.48 45.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.1 t -106.19 132.16 54.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 128.321 2.649 . . . . 0.0 108.695 169.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.4 p -126.56 166.29 23.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 126.613 1.965 . . . . 0.0 109.219 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.1 p -139.4 165.0 23.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 158.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.29 100.13 3.82 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 162.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -66.26 106.44 1.68 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.38 6.7 58.56 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 117.974 -1.459 . . . . 0.0 115.71 166.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 t -155.14 -174.39 4.96 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.913 1.856 . . . . 0.0 109.473 167.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -92.14 164.4 13.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.687 1.195 . . . . 0.0 111.703 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.5 tp -90.13 163.12 14.97 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.781 1.232 . . . . 0.0 108.426 172.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -125.2 117.66 24.34 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.357 1.463 . . . . 0.0 107.204 174.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -75.97 114.73 14.93 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.514 1.133 . . . . 0.0 109.166 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.91 0.68 35.97 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-O 118.524 -1.153 . . . . 0.0 114.283 -173.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.25 -40.6 81.89 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 119.837 1.819 . . . . 0.0 111.427 170.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.94 -18.97 1.17 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.001 0.92 . . . . 0.0 113.006 -169.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.23 19.43 57.21 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 119.25 -0.75 . . . . 0.0 111.936 -170.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -71.19 128.82 37.2 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.574 1.187 . . . . 0.0 109.171 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.65 133.21 50.64 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 126.334 1.854 . . . . 0.0 110.043 169.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 30.6 mt -128.93 152.22 48.8 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.612 1.165 . . . . 0.0 111.048 176.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.63 91.67 5.87 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.718 1.207 . . . . 0.0 110.156 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.81 153.46 42.58 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.643 0.777 . . . . 0.0 111.672 173.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.02 128.73 15.2 Favored 'Cis proline' 0 C--N 1.349 0.599 0 CA-C-N 120.229 1.117 . . . . 0.0 111.709 -8.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.8 t -96.42 155.71 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 172.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 18.2 mm -114.12 120.53 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 105.234 -2.135 . . . . 0.0 105.234 166.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.69 163.37 26.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 122.123 0.963 . . . . 0.0 109.017 172.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.511 ' H ' ' HG2' ' A' ' 58' ' ' GLU . 4.9 m -129.32 -153.79 0.59 Allowed 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 127.95 2.5 . . . . 0.0 109.106 -169.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.01 -29.69 13.99 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.774 1.63 . . . . 0.0 110.935 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -67.05 -40.27 87.07 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 125.221 1.409 . . . . 0.0 110.516 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.511 ' HG2' ' H ' ' A' ' 55' ' ' SER . 1.8 pp20? -62.31 -29.83 70.72 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 123.92 0.888 . . . . 0.0 112.265 -177.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.9 mt -89.14 27.9 1.31 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.401 2.281 . . . . 0.0 111.457 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.46 17.36 2.19 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.616 -1.303 . . . . 0.0 114.163 -172.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.9 m -123.93 -163.84 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 120.74 1.609 . . . . 0.0 108.337 166.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -76.02 -30.64 58.55 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 169.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -153.3 131.54 11.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 117.217 -1.373 . . . . 0.0 111.808 -162.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.86 165.31 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 119.618 1.099 . . . . 0.0 108.85 176.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.4 m -134.83 127.72 31.33 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 128.081 2.552 . . . . 0.0 106.386 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -129.52 133.2 47.12 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 121.218 1.826 . . . . 0.0 108.255 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.6 t -135.26 176.18 8.91 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.308 -0.87 . . . . 0.0 108.867 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.6 p -90.09 153.73 20.33 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 166.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.7 p -76.21 -13.36 60.18 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.859 -0.525 . . . . 0.0 112.311 173.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.63 -168.12 18.17 Favored Glycine 0 N--CA 1.449 -0.491 0 O-C-N 120.875 -1.141 . . . . 0.0 110.903 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.466 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 5.0 ttpt -60.26 139.02 57.82 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 170.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -135.16 177.81 7.52 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 168.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.2 mm -115.5 -11.04 12.11 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 118.087 -0.959 . . . . 0.0 111.017 -177.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -152.39 155.33 37.36 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 120.568 1.531 . . . . 0.0 110.556 172.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -141.45 107.43 5.17 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.369 1.468 . . . . 0.0 109.565 170.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.91 153.98 21.18 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.643 1.111 . . . . 0.0 110.45 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.8 t -146.53 95.72 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 173.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.7 m -131.19 159.83 36.58 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.581 -0.699 . . . . 0.0 109.404 174.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.92 -179.58 19.77 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-N 119.206 0.912 . . . . 0.0 113.267 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.43 -160.38 24.08 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 123.92 0.771 . . . . 0.0 111.308 -169.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.463 0 C-N-CA 126.04 1.736 . . . . 0.0 110.822 -176.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.42 175.07 9.29 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.74 2.293 . . . . 0.0 112.683 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 6.9 ptm -137.26 173.64 11.47 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.658 0.783 . . . . 0.0 110.291 -172.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -138.85 147.78 42.88 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.47 1.108 . . . . 0.0 108.763 170.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -117.61 133.11 56.31 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 170.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.1 t -128.16 111.7 24.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 -177.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.6 t -134.38 121.18 35.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 -160.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.6 m -110.87 159.8 17.35 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -173.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.9 t -125.61 129.4 72.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 162.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -97.04 134.91 39.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 104.74 -2.319 . . . . 0.0 104.74 163.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.3 tptm -91.56 -173.33 3.52 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 172.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.35 74.21 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.047 2.139 . . . . 0.0 109.581 167.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 157.33 -72.32 0.24 Allowed Glycine 0 CA--C 1.523 0.545 0 C-N-CA 126.72 2.105 . . . . 0.0 111.64 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.45 -177.15 6.35 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.291 1.436 . . . . 0.0 111.024 -171.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.16 144.06 7.57 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.452 1.501 . . . . 0.0 109.846 173.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.6 pt -133.41 -27.41 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 123.897 0.879 . . . . 0.0 111.624 168.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -148.21 151.44 35.51 Favored 'General case' 0 N--CA 1.461 0.082 0 CA-C-N 119.746 1.157 . . . . 0.0 111.517 -162.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -151.59 68.49 0.9 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.124 1.769 . . . . 0.0 110.453 -159.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.429 ' HE2' HD12 ' A' ' 126' ' ' LEU . 6.0 mmmt -86.25 118.76 25.91 Favored 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 120.539 -1.35 . . . . 0.0 109.225 176.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.54 139.46 52.3 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 125.064 1.345 . . . . 0.0 110.087 178.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mp -131.44 -178.37 4.82 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.484 2.314 . . . . 0.0 109.564 -177.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.7 p -154.08 44.79 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 124.793 1.237 . . . . 0.0 112.204 -162.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.536 0.429 0 O-C-N 121.407 -0.808 . . . . 0.0 112.53 -173.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 p30 . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.5 tp -138.25 121.71 17.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -167.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -141.26 80.86 1.76 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 169.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.429 HD12 ' HE2' ' A' ' 109' ' ' LYS . 1.4 tp -109.07 151.38 26.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -152.72 126.86 9.12 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -178.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -117.83 161.78 19.17 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.61 1.564 . . . . 0.0 110.521 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.39 0 C-N-CA 128.283 2.633 . . . . 0.0 106.849 164.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.18 -162.2 1.19 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.31 1.044 . . . . 0.0 108.324 -164.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.1 mtp -137.1 161.42 36.15 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 127.894 2.478 . . . . 0.0 105.332 161.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -136.65 148.89 47.67 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 173.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -143.6 138.05 28.77 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 103.676 -2.712 . . . . 0.0 103.676 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.2 157.5 38.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 169.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 p -124.83 154.09 41.54 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 164.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.402 HD11 ' CD2' ' A' ' 95' ' ' TRP . 7.1 tt -120.65 156.95 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 C-N-CA 122.44 0.296 . . . . 0.0 110.514 155.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -139.98 131.96 27.78 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 166.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -117.12 109.04 16.44 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.801 2.04 . . . . 0.0 107.13 -165.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.5 p -139.27 179.88 6.27 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 175.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.26 -157.96 17.69 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -152.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -85.15 106.93 16.96 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.176 0.988 . . . . 0.0 112.604 -168.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -113.79 -4.57 13.34 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 121.402 1.91 . . . . 0.0 115.299 -172.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.97 34.0 1.43 Allowed 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.316 -0.865 . . . . 0.0 111.159 -171.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.8 m -143.67 7.0 1.46 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.4 1.08 . . . . 0.0 112.317 -165.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -140.97 152.44 44.96 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 120.404 1.456 . . . . 0.0 111.346 -159.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 84.9 mt -84.95 95.29 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 174.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.64 148.32 22.39 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 172.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.8 t -142.6 157.55 44.59 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.409 1.884 . . . . 0.0 108.158 -175.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -143.48 160.03 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 165.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -128.69 141.45 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 126.713 2.005 . . . . 0.0 106.182 160.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.9 t -137.87 130.98 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.6 t -140.23 138.59 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.81 89.88 2.29 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.57 1.077 . . . . 0.0 111.896 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.539 ' H ' ' HB2' ' A' ' 74' ' ' GLU . 39.3 t-20 -58.16 105.26 0.26 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.223 1.409 . . . . 0.0 112.689 -174.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.44 -1.25 27.9 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 118.602 -1.11 . . . . 0.0 114.185 164.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.3 t -154.18 -168.1 2.84 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.054 1.427 . . . . 0.0 110.236 -169.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -116.75 159.51 22.18 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.017 1.727 . . . . 0.0 109.484 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.2 164.16 17.37 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 124.289 1.035 . . . . 0.0 108.693 176.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -133.06 123.16 25.27 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 173.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -79.9 117.19 20.54 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 166.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.83 -17.82 55.44 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.625 -1.097 . . . . 0.0 114.339 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.85 -39.11 87.86 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 119.855 1.827 . . . . 0.0 110.205 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.06 -10.58 1.13 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -169.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.1 29.36 64.76 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -171.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -69.13 115.31 8.27 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 170.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.78 103.69 11.64 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.5 mt -91.24 -173.7 3.71 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.156 0.983 . . . . 0.0 108.923 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.52 94.24 3.61 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -177.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.52 162.31 27.66 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.596 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.32 143.81 66.04 Favored 'Cis proline' 0 N--CA 1.459 -0.519 0 CA-C-N 120.142 1.086 . . . . 0.0 112.696 -1.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.7 t -142.07 149.11 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.28 1.432 . . . . 0.0 108.818 -169.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.8 mm -135.89 97.72 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 126.61 1.964 . . . . 0.0 107.124 -159.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -82.5 140.94 33.05 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.076 0.95 . . . . 0.0 108.913 -174.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.4 p -110.24 -166.23 1.07 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.22 1.008 . . . . 0.0 110.477 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -64.09 -48.28 76.75 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.684 1.994 . . . . 0.0 111.782 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -61.23 -27.44 68.44 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 125.04 1.336 . . . . 0.0 110.797 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -95.1 -11.9 27.44 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.317 0.647 . . . . 0.0 110.344 -169.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -96.98 17.77 16.18 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.862 2.065 . . . . 0.0 112.673 176.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.15 39.69 0.15 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.174 1.789 . . . . 0.0 113.378 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.1 m -136.46 162.48 35.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 126.281 1.832 . . . . 0.0 108.778 -170.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -85.5 -17.06 37.51 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.293 -0.88 . . . . 0.0 113.04 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -155.14 151.67 28.52 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 125.196 1.398 . . . . 0.0 107.911 -166.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.2 t -143.77 140.9 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 164.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.3 m -118.07 135.09 54.41 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 168.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.5 mt -140.0 146.04 38.58 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.6 169.25 22.01 Favored 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 121.649 -0.657 . . . . 0.0 110.148 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.3 p -95.44 155.97 16.52 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 117.801 0.273 . . . . 0.0 111.163 174.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.4 p -82.3 -3.38 55.17 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.524 -0.735 . . . . 0.0 112.015 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.72 -156.88 15.68 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -176.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.414 ' HE2' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -60.93 137.13 58.24 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 117.483 0.641 . . . . 0.0 110.218 -168.446 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -129.33 141.63 51.03 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 176.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.414 HD13 ' HE2' ' A' ' 71' ' ' LYS . 0.8 OUTLIER -133.94 21.5 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 C-N-CA 123.723 0.809 . . . . 0.0 110.254 174.718 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.539 ' HB2' ' H ' ' A' ' 35' ' ' ASN . 40.3 mt-10 -142.77 147.33 35.37 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 168.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -154.56 86.11 1.13 Allowed 'General case' 0 C--O 1.232 0.164 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 157.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.4 145.9 39.04 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.164 175.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.2 t -143.92 108.7 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.105 1.362 . . . . 0.0 107.712 166.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.6 t -109.38 173.67 6.22 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 152.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 150.55 -166.07 30.14 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 -170.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 146.21 166.77 12.28 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.513 1.054 . . . . 0.0 110.822 174.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.464 0.254 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 174.331 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 . . . . . 0 CA--C 1.541 0.617 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -76.73 175.33 11.51 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.058 2.505 . . . . 0.0 112.913 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.3 ptm -139.94 164.0 31.16 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.722 1.209 . . . . 0.0 111.646 -173.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -140.26 156.52 46.44 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.208 1.403 . . . . 0.0 109.66 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.402 ' CD2' HD11 ' A' ' 17' ' ' ILE . 1.5 m0 -127.19 124.69 39.58 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 176.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 t -95.68 121.23 46.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 162.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.6 p -127.54 137.41 57.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 170.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.9 m -148.22 142.61 26.31 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.438 ' H ' ' HB3' ' A' ' 107' ' ' GLU . 3.4 t -117.01 145.31 22.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 124.209 1.004 . . . . 0.0 108.399 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -128.77 130.77 47.49 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 128.034 2.534 . . . . 0.0 106.103 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -84.45 -163.71 0.84 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.13 77.45 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.313 1.045 . . . . 0.0 109.261 166.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 151.87 -56.81 0.44 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.162 -1.355 . . . . 0.0 114.428 168.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.71 -176.84 5.96 Favored 'General case' 0 C--N 1.34 0.196 0 CA-C-N 119.958 1.879 . . . . 0.0 110.966 176.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -44.78 138.32 3.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 130.034 3.334 . . . . 0.0 111.935 176.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.8 pt -139.07 -2.03 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.95 1.7 . . . . 0.0 112.226 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.438 ' HB3' ' H ' ' A' ' 99' ' ' VAL . 0.0 OUTLIER -127.02 170.89 11.83 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.358 1.463 . . . . 0.0 107.43 -176.762 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.6 tttm -159.62 21.47 0.18 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.262 1.425 . . . . 0.0 111.628 175.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.41 87.9 1.57 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.388 -1.445 . . . . 0.0 110.54 -174.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 p -73.15 161.97 29.98 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.3 1.04 . . . . 0.0 110.441 170.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.2 mt -140.39 138.21 34.6 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.338 1.455 . . . . 0.0 108.417 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.5 p -142.61 81.69 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 122.489 1.138 . . . . 0.0 110.11 -172.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 . . . . . 0 C--O 1.238 0.465 0 C-N-CA 125.423 1.489 . . . . 0.0 110.399 178.864 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.6 p30 . . . . . 0 C--O 1.233 0.209 0 CA-C-O 117.732 -1.127 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 37.0 mt -142.25 101.22 3.87 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 120.16 1.345 . . . . 0.0 110.456 -165.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -130.01 51.53 2.08 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.174 2.189 . . . . 0.0 107.402 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 mp -107.55 139.17 42.5 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.801 1.24 . . . . 0.0 108.916 177.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -151.32 91.2 1.65 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -83.68 153.46 24.21 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.283 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 177.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.414 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . . . . . . 0 CA--C 1.523 0.549 0 N-CA-C 107.79 -2.124 . . . . 0.0 107.79 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.88 179.03 6.62 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.079 0.952 . . . . 0.0 109.991 -168.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.2 mtp -107.96 166.21 10.89 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 155.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.439 ' HB3' ' CD2' ' A' ' 75' ' ' PHE . 71.0 m-85 -147.65 139.99 24.47 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -142.4 120.93 12.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -178.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p -105.36 161.69 5.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 123.002 1.382 . . . . 0.0 109.063 176.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 p -132.86 148.7 52.3 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.519 1.528 . . . . 0.0 106.977 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.4 tp -139.51 132.65 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 174.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -132.95 123.73 26.47 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 127.133 2.173 . . . . 0.0 106.563 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -103.86 137.54 41.72 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.031 0.932 . . . . 0.0 109.291 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 m -135.99 172.15 13.44 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.295 -0.878 . . . . 0.0 110.707 170.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.88 -150.54 32.66 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-O 121.642 0.579 . . . . 0.0 111.987 173.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -72.89 98.09 2.39 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 159.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -113.71 23.59 12.94 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.146 0.498 . . . . 0.0 110.65 170.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.2 mtt180 -102.92 -29.32 11.5 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 118.498 -0.763 . . . . 0.0 111.693 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.8 m -114.55 22.44 13.62 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -152.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -128.41 144.83 51.19 Favored 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 121.476 -0.765 . . . . 0.0 109.251 -173.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.2 mp -76.03 89.11 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 171.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -89.64 146.99 24.16 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.006 1.322 . . . . 0.0 108.953 -177.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.3 t -138.69 148.91 44.55 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.457 1.503 . . . . 0.0 108.536 -174.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.4 t -136.87 106.79 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 161.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.3 t -65.73 117.01 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 160.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 91.8 t -116.72 123.62 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 175.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.72 156.76 42.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 162.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.29 120.91 9.79 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.969 1.708 . . . . 0.0 107.42 165.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -75.1 109.31 8.47 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 118.039 -0.981 . . . . 0.0 108.707 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.43 10.66 50.35 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 116.844 1.498 . . . . 0.0 116.844 161.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.8 t -157.0 -174.8 5.09 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 119.536 1.668 . . . . 0.0 107.969 164.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -106.46 165.27 11.39 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 122.309 1.052 . . . . 0.0 113.699 168.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.15 169.07 13.43 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 112.272 -2.24 . . . . 0.0 109.772 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -144.15 123.5 13.08 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.301 1.441 . . . . 0.0 109.215 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -71.93 131.77 43.43 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.301 1.04 . . . . 0.0 110.341 -177.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.07 -18.41 72.83 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.31 -1.272 . . . . 0.0 113.904 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.0 -60.38 3.96 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 119.057 1.428 . . . . 0.0 109.367 174.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.28 0.61 1.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -157.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.04 12.35 83.44 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-O 119.854 -0.414 . . . . 0.0 112.371 174.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -65.12 130.43 43.34 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.3 m -68.82 125.01 25.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 175.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.7 mt -112.71 128.92 56.54 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -174.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -95.81 88.36 4.93 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.303 1.041 . . . . 0.0 109.088 -170.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.7 m -51.15 156.67 1.76 Allowed Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 128.423 2.689 . . . . 0.0 112.128 172.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -73.42 154.22 99.49 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 N-CA-C 109.435 -1.025 . . . . 0.0 109.435 -8.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.2 t -138.55 144.21 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.0 mm -120.68 81.35 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 28.4 mt -63.1 136.19 57.64 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 m -110.27 175.74 5.32 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 125.902 1.681 . . . . 0.0 110.088 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -46.9 -48.04 21.34 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 127.306 2.243 . . . . 0.0 113.744 -175.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -69.6 -40.53 76.6 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.512 0.596 . . . . 0.0 110.89 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -68.4 -10.88 58.14 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.064 0.945 . . . . 0.0 111.081 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.9 mt -121.29 10.49 10.61 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.179 2.191 . . . . 0.0 111.141 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.92 11.97 0.46 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.067 1.347 . . . . 0.0 112.662 171.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.1 m -66.44 -168.5 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 126.054 1.742 . . . . 0.0 111.135 164.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -110.91 -36.24 5.73 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.909 1.684 . . . . 0.0 111.466 168.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.18 143.03 26.78 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 127.327 2.251 . . . . 0.0 105.941 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.2 p -146.63 102.6 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 120.363 1.438 . . . . 0.0 112.436 161.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m -66.04 134.48 52.96 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.434 -1.417 . . . . 0.0 109.933 172.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 mt -132.99 146.52 51.85 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 124.307 1.043 . . . . 0.0 108.455 -175.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.4 t -162.7 160.12 25.16 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -161.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -86.85 151.23 23.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.422 0.629 . . . . 0.0 112.466 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.2 p -82.75 -20.91 35.01 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.614 1.566 . . . . 0.0 112.165 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -146.55 -163.87 10.67 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 125.873 1.702 . . . . 0.0 108.871 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.414 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 16.1 ttpt -77.47 141.91 39.44 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 175.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -132.95 175.52 9.29 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.957 0.903 . . . . 0.0 109.833 171.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 mm -121.6 -13.53 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.409 1.084 . . . . 0.0 110.205 -167.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -151.51 162.2 41.37 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.614 1.166 . . . . 0.0 108.828 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.439 ' CD2' ' HB3' ' A' ' 13' ' ' TYR . 3.0 t80 -155.58 85.91 1.06 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.695 0.798 . . . . 0.0 109.202 173.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.16 149.72 28.99 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.998 -0.439 . . . . 0.0 110.73 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 t -142.65 124.25 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 125.248 1.419 . . . . 0.0 108.368 171.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.09 169.76 17.24 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 158.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.35 -125.74 0.88 Allowed Glycine 0 CA--C 1.52 0.394 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 173.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.32 173.03 13.48 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 123.614 0.626 . . . . 0.0 112.203 173.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.2 m . . . . . 0 C--N 1.33 -0.255 0 C-N-CA 125.232 1.413 . . . . 0.0 109.175 173.994 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 . . . . . 0 CA--C 1.523 -0.08 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -73.0 175.19 10.8 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.485 1.457 . . . . 0.0 111.976 176.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -138.16 168.72 19.13 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.068 0.947 . . . . 0.0 110.414 177.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -135.98 157.04 47.79 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 169.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 33.2 m0 -123.46 133.82 54.0 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 168.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.1 t -90.28 135.57 26.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 151.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.7 130.68 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 172.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 m -135.94 147.63 48.17 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -176.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.2 t -118.07 131.2 71.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -116.1 166.92 11.46 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 128.682 2.793 . . . . 0.0 107.988 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.447 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 33.1 tttt -118.67 -154.3 0.56 Allowed 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 129.224 3.01 . . . . 0.0 107.616 -171.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.447 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 2.6 p30 -69.34 85.43 0.4 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 162.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.75 16.64 69.96 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 117.98 -1.456 . . . . 0.0 115.258 164.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.7 167.49 28.02 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 120.785 2.293 . . . . 0.0 112.116 172.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -90.21 141.05 29.08 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.09 1.356 . . . . 0.0 109.16 -174.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.8 pt -129.02 -19.81 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 119.124 0.874 . . . . 0.0 113.357 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -132.42 160.5 36.2 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -157.79 87.16 0.93 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 176.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.33 164.05 24.4 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 171.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.5 t -138.93 163.33 32.61 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 24.2 mt -126.14 157.49 37.98 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 123.61 0.764 . . . . 0.0 109.013 -177.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.3 p -147.2 114.68 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 -173.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 . . . . . 0 C--O 1.237 0.438 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.445 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.146 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.75 143.49 50.78 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.884 1.274 . . . . 0.0 108.834 174.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -153.1 25.17 0.55 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.779 1.632 . . . . 0.0 111.586 -157.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 88.3 mt -97.15 124.41 41.18 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.71 1.604 . . . . 0.0 107.829 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -139.89 46.64 1.86 Allowed 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.542 0.737 . . . . 0.0 109.019 -170.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -55.26 137.67 46.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.85 -168.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.086 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 167.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.433 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . . . . . . 0 CA--C 1.52 0.383 0 N-CA-C 107.137 -2.385 . . . . 0.0 107.137 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.64 161.4 35.23 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.724 0.81 . . . . 0.0 110.86 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 7.8 mtp -91.89 153.62 19.39 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 158.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.444 ' CD1' ' HB2' ' A' ' 75' ' ' PHE . 8.6 m-85 -143.65 114.66 7.81 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 126.282 1.833 . . . . 0.0 106.448 -170.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -127.29 144.76 50.99 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.743 2.017 . . . . 0.0 106.885 172.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.42 132.94 38.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 127.133 2.173 . . . . 0.0 108.89 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.5 p -96.0 163.56 13.08 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.749 0.785 . . . . 0.0 109.913 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 tp -140.75 112.6 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 167.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -114.29 135.97 53.48 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -176.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -122.19 115.4 22.33 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 124.287 1.035 . . . . 0.0 108.732 -161.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 m -120.92 -179.01 3.88 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.17 -99.29 0.56 Allowed Glycine 0 C--N 1.338 0.651 0 C-N-CA 127.301 2.382 . . . . 0.0 110.417 176.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.6 113.39 9.11 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -117.53 11.02 13.69 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -170.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -102.57 -1.06 31.09 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.079 1.352 . . . . 0.0 113.941 -168.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.1 m -143.45 95.12 2.7 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 164.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -176.94 110.83 0.08 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 128.08 2.552 . . . . 0.0 106.433 174.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.3 pt -66.39 86.8 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 127.221 2.208 . . . . 0.0 112.36 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.42 144.68 55.63 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 121.113 -0.992 . . . . 0.0 109.942 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.9 m -148.36 130.03 15.03 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 170.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.8 t -140.39 165.77 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 175.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.0 t -141.13 52.42 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 125.786 1.635 . . . . 0.0 110.806 -157.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.7 p -65.91 135.85 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 O-C-N 119.248 -2.157 . . . . 0.0 111.215 -170.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.6 t -117.56 148.12 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 171.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.32 133.74 20.77 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.93 0.892 . . . . 0.0 108.615 171.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -102.7 85.83 2.64 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.186 1.394 . . . . 0.0 109.022 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.09 -78.76 0.29 Allowed Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 162.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.8 t -76.55 179.51 5.9 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.106 0.963 . . . . 0.0 109.914 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -96.67 168.05 10.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.833 1.253 . . . . 0.0 111.232 174.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.59 168.31 15.48 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.38 1.472 . . . . 0.0 109.38 176.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -137.01 128.14 27.83 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.795 1.638 . . . . 0.0 109.524 172.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -92.2 110.32 21.71 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.547 1.939 . . . . 0.0 109.45 -165.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -57.69 -23.12 49.06 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 118.989 0.813 . . . . 0.0 114.553 -169.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.87 -56.97 15.32 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.325 1.45 . . . . 0.0 112.032 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.5 p -125.67 0.15 7.46 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.608 1.563 . . . . 0.0 111.144 -164.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.78 22.56 54.04 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 125.395 1.474 . . . . 0.0 112.171 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.32 158.2 26.17 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 118.24 1.02 . . . . 0.0 109.358 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.4 m -117.4 106.15 12.9 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 122.391 1.091 . . . . 0.0 110.207 -167.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 45.3 mt -93.59 159.47 15.21 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 125.109 1.364 . . . . 0.0 111.874 -164.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.86 95.69 9.67 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.926 2.09 . . . . 0.0 108.763 -172.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.2 p -58.74 167.72 1.73 Allowed Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.053 0.941 . . . . 0.0 111.468 172.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.72 145.38 79.18 Favored 'Cis proline' 0 CA--C 1.537 0.629 0 N-CA-C 109.733 -0.91 . . . . 0.0 109.733 -19.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.6 p -135.19 156.93 39.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 O-C-N 121.242 -0.911 . . . . 0.0 109.939 -170.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.5 mm -114.02 126.83 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 175.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.8 mt -92.43 164.83 13.33 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 128.154 2.582 . . . . 0.0 110.327 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.495 ' H ' ' HG2' ' A' ' 58' ' ' GLU . 57.4 p -132.64 -163.35 1.33 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.417 2.287 . . . . 0.0 111.126 -165.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -88.08 -21.01 24.96 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 126.565 1.946 . . . . 0.0 110.292 175.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.32 -36.52 61.05 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.286 1.434 . . . . 0.0 111.973 -177.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.495 ' HG2' ' H ' ' A' ' 55' ' ' SER . 2.3 pp20? -75.95 -32.09 59.37 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.262 1.825 . . . . 0.0 111.776 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.6 mt -95.99 24.16 5.78 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.5 1.12 . . . . 0.0 112.655 -176.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -77.41 33.24 0.16 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.629 1.972 . . . . 0.0 113.467 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.6 m -130.45 -167.83 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.511 1.924 . . . . 0.0 109.871 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -98.57 -24.08 15.25 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.335 1.454 . . . . 0.0 113.246 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -159.64 148.89 18.04 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 117.838 -1.077 . . . . 0.0 108.927 171.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.26 165.22 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 165.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 83.3 m -134.59 124.06 24.83 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 128.553 2.741 . . . . 0.0 105.685 171.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.6 140.51 49.54 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 174.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.1 t -145.42 -177.08 5.38 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.284 0.634 . . . . 0.0 110.405 -174.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.92 136.01 53.05 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 128.339 2.656 . . . . 0.0 110.306 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.9 p -75.24 -43.21 52.83 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 118.752 -1.179 . . . . 0.0 109.647 -171.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -107.98 -98.71 2.57 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.433 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -147.23 147.64 30.66 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.959 1.703 . . . . 0.0 109.964 174.235 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.23 -178.56 4.48 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.345 1.058 . . . . 0.0 109.088 170.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.84 -0.03 6.52 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.598 0 CA-C-O 117.664 -1.16 . . . . 0.0 110.814 176.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -149.63 158.0 43.77 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 120.561 1.528 . . . . 0.0 110.435 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.444 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -153.53 117.52 4.79 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 166.045 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -121.95 135.32 54.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.2 t -137.53 112.94 10.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -172.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.3 m -136.06 178.4 7.08 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.226 0.61 . . . . 0.0 110.134 173.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.01 -85.17 0.13 Allowed Glycine 0 C--N 1.333 0.39 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 155.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.34 179.12 18.98 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 127.37 2.414 . . . . 0.0 108.328 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.6 p . . . . . 0 CA--C 1.531 0.218 0 CA-C-N 118.577 1.189 . . . . 0.0 109.379 178.205 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 N--CA 1.468 0.443 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.55 174.38 11.9 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.959 2.44 . . . . 0.0 113.547 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.7 ptp -148.0 -176.01 5.11 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.998 0.919 . . . . 0.0 111.131 -168.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -141.15 161.34 38.1 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 128.143 2.577 . . . . 0.0 106.616 169.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.4 m0 -130.68 112.28 12.97 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 104.972 -2.233 . . . . 0.0 104.972 173.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.02 127.3 45.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 168.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 m -139.39 104.45 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -167.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.3 m -118.63 153.29 34.54 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -169.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.93 124.89 51.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -174.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -121.14 121.06 37.02 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.962 1.705 . . . . 0.0 108.246 -172.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.521 ' CG ' ' H ' ' A' ' 102' ' ' ASN . 15.6 tttm -73.05 -166.52 0.31 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.594 1.958 . . . . 0.0 109.771 174.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.521 ' H ' ' CG ' ' A' ' 101' ' ' LYS . 7.7 p30 -58.66 90.44 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 163.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.4 29.58 75.57 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.535 2.017 . . . . 0.0 115.771 171.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -145.06 176.44 9.5 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 120.016 1.908 . . . . 0.0 109.746 165.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -98.1 154.33 17.81 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.97 1.708 . . . . 0.0 108.278 170.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 43.1 pt -132.17 -13.44 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.698 1.199 . . . . 0.0 112.753 168.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -140.91 150.12 42.77 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 119.776 1.171 . . . . 0.0 108.101 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -146.55 52.67 1.11 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.698 1.199 . . . . 0.0 108.076 170.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -75.85 169.7 17.64 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 122.23 1.014 . . . . 0.0 109.888 174.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.8 t -152.02 164.99 36.05 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.095 1.758 . . . . 0.0 106.455 171.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 37.6 mt -135.32 174.48 10.57 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.105 2.162 . . . . 0.0 109.033 176.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 p -152.9 68.05 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.394 1.077 . . . . 0.0 109.169 -175.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 . . . . . 0 C--O 1.236 0.357 0 C-N-CA 125.033 1.333 . . . . 0.0 109.517 178.944 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.395 0 CA-C-O 120.853 0.359 . . . . 0.0 111.74 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.47 106.27 16.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 176.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -161.86 87.11 0.65 Allowed 'General case' 0 C--O 1.234 0.286 0 O-C-N 123.479 0.487 . . . . 0.0 111.024 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.7 mt -133.67 150.15 51.54 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.171 1.388 . . . . 0.0 109.511 -172.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -143.23 146.86 34.02 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.843 1.657 . . . . 0.0 109.397 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -145.78 155.08 42.7 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.414 1.486 . . . . 0.0 109.069 172.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--O 1.249 1.065 0 C-N-CA 126.569 1.948 . . . . 0.0 106.663 173.37 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.031 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.21 168.62 26.55 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.526 1.663 . . . . 0.0 109.767 -174.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.6 mtp -107.86 164.58 12.14 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.484 1.114 . . . . 0.0 111.82 162.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -177.36 153.78 0.96 Allowed 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 131.132 3.773 . . . . 0.0 110.054 -169.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -145.1 147.84 32.98 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.601 2.76 . . . . 0.0 105.137 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -124.06 146.74 29.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 125.83 1.652 . . . . 0.0 108.438 175.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 p -130.01 116.35 18.44 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 176.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -79.09 143.81 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 117.532 -1.667 . . . . 0.0 106.9 160.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -124.0 117.94 25.89 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 104.167 -2.531 . . . . 0.0 104.167 158.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -94.53 110.19 22.02 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 173.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 m -84.35 158.39 21.16 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 123.343 0.402 . . . . 0.0 110.184 172.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.97 -145.26 25.66 Favored Glycine 0 C--O 1.241 0.59 0 O-C-N 123.784 0.677 . . . . 0.0 112.684 168.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -82.67 128.91 34.79 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 168.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -132.64 17.94 4.3 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.681 1.192 . . . . 0.0 111.091 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -120.95 35.23 4.95 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.088 1.355 . . . . 0.0 110.402 -168.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.1 t -145.57 -6.33 0.62 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.245 1.418 . . . . 0.0 110.835 -173.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.416 ' HB3' ' CG2' ' A' ' 81' ' ' VAL . 20.7 m-85 -101.98 170.55 8.05 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 120.699 -1.25 . . . . 0.0 108.2 -153.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.2 mp -137.53 96.76 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -169.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.8 tptt 174.32 -162.03 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.739 2.015 . . . . 0.0 110.81 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.3 m -155.65 174.42 15.31 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.683 1.993 . . . . 0.0 110.569 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 t -115.97 144.69 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.026 1.331 . . . . 0.0 107.426 170.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.7 t -99.62 150.48 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 126.454 1.902 . . . . 0.0 108.247 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -145.33 145.32 20.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 124.073 0.949 . . . . 0.0 110.542 163.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.3 t -135.97 137.82 48.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 165.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.7 107.41 5.91 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.318 1.047 . . . . 0.0 108.517 173.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -59.85 112.0 1.68 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.071 1.349 . . . . 0.0 109.737 -177.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.25 32.76 27.72 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-O 118.395 -1.225 . . . . 0.0 114.743 165.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.4 t -156.51 -170.5 3.36 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.137 1.469 . . . . 0.0 110.103 175.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -111.87 164.64 12.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.941 1.696 . . . . 0.0 110.506 159.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.55 168.67 10.22 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 127.973 2.509 . . . . 0.0 108.255 176.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -130.23 132.24 45.89 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.328 1.851 . . . . 0.0 106.642 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -82.57 116.71 22.1 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 164.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.59 -10.02 62.9 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 118.573 -1.126 . . . . 0.0 114.476 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.16 -52.49 58.78 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 118.912 1.356 . . . . 0.0 109.922 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.33 -9.48 5.79 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.053 1.341 . . . . 0.0 111.47 -170.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.73 56.28 5.52 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -176.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -102.29 129.59 48.77 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 38.1 t -71.89 145.38 48.56 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.014 0.824 . . . . 0.0 109.069 172.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 24.1 mt -137.66 130.05 29.45 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 124.842 1.257 . . . . 0.0 110.089 -170.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -86.36 87.64 7.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.912 -177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.43 156.7 40.16 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-O 117.864 -1.065 . . . . 0.0 110.679 170.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.4 144.17 79.66 Favored 'Cis proline' 0 C--N 1.348 0.546 0 CA-C-N 120.305 1.144 . . . . 0.0 111.268 -2.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.8 p -157.57 162.14 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.229 1.011 . . . . 0.0 111.168 -170.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.8 mm -129.99 107.98 15.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 126.623 1.969 . . . . 0.0 108.494 -169.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.2 mt -70.62 125.3 26.43 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.337 0.655 . . . . 0.0 109.812 175.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.47 -172.11 3.88 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.48 2.312 . . . . 0.0 110.589 -176.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -61.18 -42.55 98.77 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.502 -1.374 . . . . 0.0 112.72 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -51.42 -45.3 62.55 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.065 0.946 . . . . 0.0 110.798 -176.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -68.59 -40.02 80.68 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.293 1.437 . . . . 0.0 109.704 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -89.02 11.7 17.58 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.35 1.86 . . . . 0.0 112.258 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.19 16.87 0.21 Allowed 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.046 -1.659 . . . . 0.0 113.03 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.1 m -131.62 163.75 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 126.319 1.847 . . . . 0.0 111.252 -172.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -65.62 -27.32 68.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.122 1.369 . . . . 0.0 112.75 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -152.48 126.54 9.11 Favored 'General case' 0 CA--C 1.511 -0.555 0 O-C-N 121.088 -1.008 . . . . 0.0 109.962 -173.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.3 t -120.54 140.68 43.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 173.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.5 m -138.0 106.89 5.96 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.071 1.348 . . . . 0.0 108.446 -163.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.2 mt -124.0 139.3 54.08 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -167.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.6 t -145.45 159.99 42.25 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.5 p -72.84 140.95 47.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.733 168.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.5 p -71.85 -53.0 14.61 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.093 174.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -112.54 170.58 13.55 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 124.992 1.282 . . . . 0.0 110.014 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.46 134.56 56.77 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.111 0.964 . . . . 0.0 109.646 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.97 179.76 3.99 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 125.678 1.591 . . . . 0.0 107.541 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.1 mm -117.19 -10.63 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.503 0.721 . . . . 0.0 111.163 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -148.05 165.14 31.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 167.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -144.33 107.31 4.5 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.683 1.593 . . . . 0.0 107.716 168.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.66 153.09 19.71 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.391 0.676 . . . . 0.0 109.958 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.5 t -144.98 115.35 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 127.274 2.23 . . . . 0.0 105.84 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 95.4 p -154.63 -172.73 4.3 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 120.688 -1.258 . . . . 0.0 111.162 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.48 -161.34 12.77 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -170.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.6 175.22 36.63 Favored Glycine 0 N--CA 1.464 0.531 0 N-CA-C 106.752 -2.539 . . . . 0.0 106.752 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.416 ' CG2' ' HB3' ' A' ' 26' ' ' PHE . 1.8 p . . . . . 0 N--CA 1.465 0.313 0 CA-C-N 120.697 2.249 . . . . 0.0 109.79 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -80.47 -166.95 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.849 3.033 . . . . 0.0 112.288 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.4 ptm -145.62 167.44 23.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.638 0.732 . . . . 0.0 111.923 -171.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -132.61 131.52 41.51 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 168.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -79.9 105.0 10.86 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 156.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.3 t -79.59 135.89 24.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 149.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.9 t -138.76 91.21 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 172.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.22 152.02 38.39 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.013 1.325 . . . . 0.0 108.415 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 t -134.81 131.7 53.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 175.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -102.91 159.24 15.67 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 128.208 2.603 . . . . 0.0 107.634 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -129.21 -172.1 2.65 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 127.848 2.459 . . . . 0.0 105.41 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -54.1 50.12 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 130.166 3.386 . . . . 0.0 115.387 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 169.03 -58.2 0.2 Allowed Glycine 0 CA--C 1.524 0.622 0 O-C-N 119.541 -1.974 . . . . 0.0 112.145 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.76 -175.32 5.08 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.217 1.407 . . . . 0.0 111.339 -171.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -55.15 141.18 35.87 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.625 1.57 . . . . 0.0 108.923 175.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 15.9 pt -121.39 -34.05 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 125.57 1.548 . . . . 0.0 111.066 167.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -133.34 149.99 51.87 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 120.241 1.382 . . . . 0.0 109.723 -175.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.7 pttt -155.46 42.29 0.43 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.249 2.219 . . . . 0.0 108.857 -153.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.53 149.3 31.59 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.655 0.782 . . . . 0.0 110.744 -172.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.0 t -142.06 162.34 35.73 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.22 1.408 . . . . 0.0 109.341 -169.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.61 -163.71 1.2 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.618 1.967 . . . . 0.0 106.409 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.57 144.89 15.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 127.641 2.377 . . . . 0.0 107.331 168.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 . . . . . 0 C--O 1.232 0.162 0 N-CA-C 106.503 -1.665 . . . . 0.0 106.503 170.9 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.465 0.308 0 N-CA-C 111.633 0.234 . . . . 0.0 111.633 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.0 tp -138.17 146.4 42.68 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.427 0.632 . . . . 0.0 109.38 169.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -176.48 76.67 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.811 2.044 . . . . 0.0 105.966 -171.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.7 tp -126.12 137.34 53.59 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.919 0.888 . . . . 0.0 109.214 -168.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -140.45 144.52 36.13 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.019 1.328 . . . . 0.0 109.697 -176.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -140.18 155.54 46.9 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.485 1.514 . . . . 0.0 109.108 171.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.0 p30 . . . . . 0 C--O 1.25 1.097 0 C-N-CA 127.591 2.356 . . . . 0.0 105.906 158.308 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.563 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . . . . . . 0 CA--C 1.525 0.686 0 N-CA-C 107.736 -2.146 . . . . 0.0 107.736 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.18 167.88 20.17 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.787 0.835 . . . . 0.0 112.009 -167.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.9 mtp -86.41 153.26 22.04 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 161.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -147.55 130.39 16.14 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 125.834 1.959 . . . . 0.0 108.578 -175.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -140.96 149.75 42.21 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.217 2.207 . . . . 0.0 106.814 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.2 p -144.86 158.95 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 C-N-CA 124.833 1.253 . . . . 0.0 109.686 177.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.2 124.88 14.95 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 -165.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.1 tp -119.51 109.24 25.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -171.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -108.96 122.66 47.7 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.743 2.017 . . . . 0.0 109.537 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -105.45 139.69 39.69 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.179 -0.95 . . . . 0.0 109.982 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.5 m -143.46 166.99 23.26 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.781 0.832 . . . . 0.0 111.321 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.83 -156.32 28.33 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -168.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -76.59 92.0 3.44 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 121.39 -1.065 . . . . 0.0 108.801 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -97.5 14.76 25.35 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -173.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.38 9.05 10.27 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -158.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.0 m -141.17 40.17 1.77 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.08 2.152 . . . . 0.0 108.749 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.404 ' O ' ' HE2' ' A' ' 28' ' ' LYS . 46.7 m-85 -136.23 130.18 32.71 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 124.999 1.319 . . . . 0.0 109.36 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.9 mt -72.76 90.35 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 26' ' ' PHE . 27.0 mtmt -79.78 162.0 25.38 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.815 1.246 . . . . 0.0 110.252 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.4 t -146.72 154.18 41.12 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.902 0.881 . . . . 0.0 110.302 165.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 69.9 t -142.73 109.45 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 127.208 2.203 . . . . 0.0 105.676 164.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.9 p -73.02 147.5 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 149.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 p -131.58 137.71 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 126.202 1.801 . . . . 0.0 106.52 167.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 t -119.59 163.31 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 123.878 0.871 . . . . 0.0 108.923 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.56 153.42 40.35 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.844 1.258 . . . . 0.0 109.906 169.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -129.16 105.45 8.17 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 169.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.42 29.24 50.06 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 118.598 -1.112 . . . . 0.0 114.618 165.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -164.3 -164.72 0.88 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.21 1.804 . . . . 0.0 106.698 158.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -123.89 170.69 10.33 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.125 1.37 . . . . 0.0 109.974 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.41 166.01 12.28 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.904 1.281 . . . . 0.0 109.789 -175.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -134.52 116.79 15.49 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 125.338 1.455 . . . . 0.0 107.827 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -82.84 132.04 35.18 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 124.982 1.313 . . . . 0.0 109.167 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.28 -22.47 50.61 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 118.842 -0.977 . . . . 0.0 113.854 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.24 -52.31 16.36 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 127.572 2.349 . . . . 0.0 111.746 -177.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 t -148.17 -4.84 0.46 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.759 -0.638 . . . . 0.0 111.379 175.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.41 27.96 8.84 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 119.863 1.21 . . . . 0.0 111.668 -160.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -64.13 124.28 21.25 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.63 110.81 20.66 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.184 1.794 . . . . 0.0 111.029 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.9 mt -114.12 145.78 41.17 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 122.375 1.083 . . . . 0.0 112.631 -163.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.14 67.91 5.09 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.05 1.34 . . . . 0.0 112.153 -171.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.2 m -52.83 156.2 3.54 Favored Pre-proline 0 CA--C 1.543 0.692 0 O-C-N 121.054 -1.029 . . . . 0.0 113.097 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.9 144.85 75.85 Favored 'Cis proline' 0 CA--C 1.536 0.606 0 CA-C-N 119.071 0.704 . . . . 0.0 112.495 -5.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.6 t -140.73 155.38 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 126.134 1.774 . . . . 0.0 107.815 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.3 mm -116.59 144.74 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 125.575 1.55 . . . . 0.0 106.857 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.4 mt -120.97 115.89 24.06 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.983 1.313 . . . . 0.0 107.686 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 m -72.16 174.41 7.21 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 124.753 1.283 . . . . 0.0 110.389 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.65 -31.77 68.46 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.822 1.649 . . . . 0.0 113.074 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -63.82 -42.46 97.65 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 121.355 -0.84 . . . . 0.0 110.478 174.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -75.6 -32.12 60.19 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -175.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.8 mt -85.63 27.36 0.85 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.673 1.989 . . . . 0.0 111.792 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.05 1.4 27.9 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 176.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.8 m -88.76 149.12 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 119.427 1.012 . . . . 0.0 111.498 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -57.25 -37.01 71.68 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.451 1.101 . . . . 0.0 112.76 172.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -165.39 149.09 8.28 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -176.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.5 p -149.99 167.29 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 166.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.1 t -121.92 158.97 27.85 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 167.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 mt -135.89 155.03 50.92 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 173.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.4 t -164.44 158.03 17.98 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.5 p -78.34 158.17 28.89 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 122.858 0.463 . . . . 0.0 110.551 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.3 p -75.4 -13.67 60.41 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.349 -0.844 . . . . 0.0 111.722 171.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -167.37 -167.51 28.16 Favored Glycine 0 C--N 1.336 0.535 0 O-C-N 120.662 -1.274 . . . . 0.0 111.559 -175.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.563 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 2.6 ttpt -52.01 130.85 30.79 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 168.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -134.59 176.63 8.45 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.306 1.442 . . . . 0.0 107.629 173.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.61 9.29 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 118.707 -0.663 . . . . 0.0 109.705 176.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -146.46 151.76 37.93 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 120.191 1.36 . . . . 0.0 113.115 168.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.58 66.41 0.94 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.454 2.302 . . . . 0.0 108.888 165.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.87 138.91 33.73 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.244 -0.91 . . . . 0.0 109.705 174.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 69.1 t -138.58 124.19 23.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 125.689 1.595 . . . . 0.0 107.598 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.3 t -142.69 170.46 15.65 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.61 -88.66 0.12 Allowed Glycine 0 C--N 1.332 0.335 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.89 -165.51 16.26 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -176.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.408 0 N-CA-C 106.347 -1.724 . . . . 0.0 106.347 159.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 118.592 -0.718 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -82.94 -177.86 3.57 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.633 2.889 . . . . 0.0 112.179 -178.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 13.0 ptm -141.38 171.36 14.16 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.279 0.632 . . . . 0.0 112.249 -171.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -144.86 165.4 28.21 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.041 1.336 . . . . 0.0 109.445 166.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -128.42 136.29 50.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 170.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.2 t -115.86 129.35 72.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 161.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.9 t -114.54 151.67 16.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 103.895 -2.631 . . . . 0.0 103.895 166.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.3 m -135.94 136.7 40.64 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.3 t -116.5 141.61 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -123.67 148.03 46.88 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.046 1.738 . . . . 0.0 107.185 174.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.542 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 4.0 ttpm? -111.96 -159.29 0.68 Allowed 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.355 1.062 . . . . 0.0 108.295 178.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.542 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 3.3 p30 -60.96 81.65 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.029 1.332 . . . . 0.0 107.961 159.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 152.46 -74.83 0.25 Allowed Glycine 0 N--CA 1.45 -0.376 0 O-C-N 121.12 -0.987 . . . . 0.0 112.577 169.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.23 -171.45 3.87 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.076 1.75 . . . . 0.0 110.127 -173.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -46.1 141.27 3.37 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.829 2.052 . . . . 0.0 109.727 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.1 pt -141.95 -11.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 124.225 1.01 . . . . 0.0 113.492 178.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -142.16 149.27 39.54 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.663 1.12 . . . . 0.0 108.354 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -144.68 93.61 2.44 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.011 0.924 . . . . 0.0 109.124 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.69 151.48 43.09 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.772 0.796 . . . . 0.0 112.246 163.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.52 155.59 42.63 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 127.162 2.185 . . . . 0.0 107.785 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.404 ' HB3' ' H ' ' A' ' 112' ' ' VAL . 0.2 OUTLIER -133.33 -174.22 3.43 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 123.804 1.764 . . . . 0.0 107.139 -172.47 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.404 ' H ' ' HB3' ' A' ' 111' ' ' LEU . 9.9 p -154.02 146.9 13.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 C-N-CA 127.085 2.154 . . . . 0.0 109.88 -177.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.1 t80 . . . . . 0 C--O 1.237 0.4 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 165.741 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 t0 . . . . . 0 N--CA 1.474 0.743 0 CA-C-O 121.671 0.748 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 tp -126.72 111.08 13.84 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -159.38 71.24 0.5 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.792 0.837 . . . . 0.0 109.624 166.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 mp -82.72 149.86 27.05 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.584 1.154 . . . . 0.0 109.637 170.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -137.65 125.81 23.03 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 127.427 2.291 . . . . 0.0 106.536 171.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -127.39 145.12 50.93 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 164.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 C--O 1.257 1.461 0 C-N-CA 127.17 2.188 . . . . 0.0 108.355 -168.971 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.77 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.24 -175.24 4.18 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.372 1.869 . . . . 0.0 107.626 167.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.2 mmm -97.14 163.1 13.07 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 144.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -146.8 154.41 41.34 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 125.233 1.413 . . . . 0.0 109.609 171.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -152.49 134.76 15.06 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 127.594 2.357 . . . . 0.0 106.359 -175.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 p -125.61 152.91 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 125.446 1.498 . . . . 0.0 110.144 174.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.4 p -120.48 157.7 28.84 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.108 0.963 . . . . 0.0 110.002 171.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.8 tp -143.08 110.46 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 174.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -107.92 132.33 53.58 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -116.76 120.96 40.2 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.286 1.034 . . . . 0.0 109.64 -169.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 m -134.5 172.39 12.98 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.418 0.687 . . . . 0.0 110.593 174.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.6 -163.76 46.28 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -163.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -86.0 59.18 5.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.744 0.783 . . . . 0.0 111.021 -160.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -63.0 21.7 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.782 2.433 . . . . 0.0 115.825 -178.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -115.62 12.04 15.96 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.125 1.77 . . . . 0.0 109.009 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.4 m -143.39 -0.74 1.08 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -157.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -137.49 126.48 24.27 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.69 1.196 . . . . 0.0 109.73 -168.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.4 mt -61.87 89.82 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.488 1.115 . . . . 0.0 110.511 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -74.66 163.45 27.7 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.996 0.903 . . . . 0.0 109.083 176.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.8 p -158.99 137.56 10.89 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.14 1.776 . . . . 0.0 108.965 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 t -138.45 98.1 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 119.454 1.024 . . . . 0.0 108.353 172.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.4 t -68.09 127.3 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 163.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.0 t -139.11 127.82 28.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 119.694 1.134 . . . . 0.0 109.114 171.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.4 t -109.8 154.79 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.491 1.516 . . . . 0.0 108.743 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.08 103.19 3.71 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.943 0.897 . . . . 0.0 109.917 165.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -58.76 100.87 0.07 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.549 1.54 . . . . 0.0 109.12 168.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.44 7.97 50.54 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 117.219 -1.878 . . . . 0.0 117.74 158.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 t -165.14 178.45 6.98 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 121.016 2.408 . . . . 0.0 108.615 162.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -94.8 161.47 14.16 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.281 1.032 . . . . 0.0 110.785 -175.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.46 169.03 11.4 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.928 1.291 . . . . 0.0 109.288 -178.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -137.09 119.92 16.31 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 124.741 1.216 . . . . 0.0 107.892 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -75.64 148.44 38.74 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.606 0.717 . . . . 0.0 109.755 176.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.1 -25.26 67.93 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 118.399 -1.223 . . . . 0.0 112.636 167.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.21 -60.48 2.92 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 126.609 1.963 . . . . 0.0 111.164 -171.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 t -144.74 8.43 1.3 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.182 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.4 24.7 56.21 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 118.969 0.804 . . . . 0.0 111.136 -165.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -55.86 118.73 4.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.713 1.205 . . . . 0.0 108.507 174.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 m -78.78 122.17 25.71 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 174.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 76.6 mt -113.03 134.19 54.63 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.76 1.224 . . . . 0.0 110.881 -170.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.36 73.92 1.36 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.85 2.06 . . . . 0.0 113.144 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.1 150.97 37.63 Favored Pre-proline 0 CA--C 1.545 0.785 0 O-C-N 120.979 -1.075 . . . . 0.0 111.151 171.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.52 155.74 85.92 Favored 'Cis proline' 0 C--N 1.348 0.509 0 CA-C-N 119.504 0.859 . . . . 0.0 110.785 -12.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.4 p -144.46 161.34 14.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 175.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.6 mm -108.69 99.24 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 166.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.83 104.94 3.05 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.384 -1.709 . . . . 0.0 106.384 168.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.9 m -74.05 175.15 7.7 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.64 0.733 . . . . 0.0 109.443 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -49.72 -37.98 31.47 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.794 1.637 . . . . 0.0 110.601 175.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -69.23 -32.16 71.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.484 1.913 . . . . 0.0 112.621 -175.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -76.61 -32.27 57.97 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.31 1.044 . . . . 0.0 108.93 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -90.13 16.28 8.75 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.701 1.6 . . . . 0.0 112.708 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.71 45.1 0.18 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.714 2.005 . . . . 0.0 112.295 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.0 m -140.85 162.92 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 128.434 2.694 . . . . 0.0 108.668 -173.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -75.19 -26.83 59.33 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.294 -0.879 . . . . 0.0 113.003 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.39 147.05 10.55 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.214 1.006 . . . . 0.0 109.436 -174.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -132.59 161.14 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.95 0.881 . . . . 0.0 109.81 163.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 m -128.5 116.28 19.45 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 130.029 3.331 . . . . 0.0 104.968 172.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -119.9 132.12 55.44 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 119.506 1.048 . . . . 0.0 108.342 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.43 166.49 24.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.02 -170.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 p -80.62 142.97 33.49 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.913 1.685 . . . . 0.0 110.125 -178.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.8 p -80.33 -51.22 9.14 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.503 -0.748 . . . . 0.0 110.74 172.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -106.6 -80.74 1.35 Allowed Glycine 0 C--N 1.335 0.486 0 O-C-N 121.534 -0.729 . . . . 0.0 112.407 -162.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.0 tttt -168.84 135.69 1.86 Allowed 'General case' 0 C--O 1.239 0.516 1 C-N-CA 131.849 4.06 . . . . 0.0 104.12 170.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -133.37 165.47 24.76 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 123.163 0.585 . . . . 0.0 110.066 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.23 -0.89 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 123.308 0.643 . . . . 0.0 110.673 -165.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -153.02 156.12 38.21 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.039 -1.038 . . . . 0.0 108.282 168.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.08 109.44 5.61 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 166.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.52 127.68 54.76 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.5 t -129.66 118.09 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 -174.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.0 157.94 45.09 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -169.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 154.85 -167.57 32.71 Favored Glycine 0 C--N 1.331 0.284 0 O-C-N 121.87 -0.519 . . . . 0.0 112.037 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.82 179.88 43.08 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.407 1.004 . . . . 0.0 112.155 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.54 0.584 0 C-N-CA 126.396 1.878 . . . . 0.0 108.463 171.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.534 0.328 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -84.35 -179.03 3.67 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.248 1.966 . . . . 0.0 111.5 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.498 ' CE ' ' HE1' ' A' ' 95' ' ' TRP . 4.6 ptm -131.31 160.28 35.43 Favored 'General case' 0 C--O 1.231 0.109 0 O-C-N 121.154 -0.966 . . . . 0.0 112.977 -176.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -142.01 143.31 33.11 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.536 1.134 . . . . 0.0 108.94 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.498 ' HE1' ' CE ' ' A' ' 93' ' ' MET . 54.4 m0 -116.9 139.46 50.61 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.23 1.012 . . . . 0.0 108.366 174.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.16 141.08 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 153.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.5 m -141.62 160.33 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 C-N-CA 127.074 2.149 . . . . 0.0 106.443 -177.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.8 m -152.59 142.94 22.55 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 174.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.36 136.59 48.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 169.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -123.19 113.69 19.29 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.698 2.399 . . . . 0.0 106.862 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -68.02 171.51 6.75 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 161.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -44.19 83.2 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.561 2.344 . . . . 0.0 114.128 -175.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 62.46 43.69 98.68 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.273 1.416 . . . . 0.0 113.465 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.0 mmtt -155.55 141.26 18.0 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.815 1.807 . . . . 0.0 109.463 155.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -68.31 143.83 55.05 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 125.932 1.693 . . . . 0.0 108.507 170.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.95 -13.94 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 120.218 1.372 . . . . 0.0 113.234 172.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -142.88 162.04 36.53 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.66 1.584 . . . . 0.0 107.085 -167.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.4 pttt -162.78 37.8 0.1 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.152 0.887 . . . . 0.0 112.637 -175.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -73.55 166.8 22.59 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.219 -1.55 . . . . 0.0 110.373 -176.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.7 t -151.59 160.08 43.81 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 127.168 2.187 . . . . 0.0 106.234 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 94.3 mt -132.6 141.49 48.7 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.924 0.89 . . . . 0.0 109.238 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.4 p -135.87 114.77 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 126.196 1.798 . . . . 0.0 107.319 174.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.51 -0.569 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 166.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 . . . . . 0 N--CA 1.466 0.341 0 N-CA-C 111.312 0.116 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.92 124.6 47.47 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.669 0.788 . . . . 0.0 109.314 -155.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -148.96 32.67 0.76 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.985 2.114 . . . . 0.0 111.802 -157.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.2 mp -80.77 148.58 30.0 Favored 'General case' 0 C--O 1.24 0.566 0 O-C-N 121.45 -0.781 . . . . 0.0 110.559 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -159.51 136.09 9.19 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.978 2.111 . . . . 0.0 109.963 173.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -142.17 158.66 43.48 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.078 2.151 . . . . 0.0 110.297 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.3 p30 . . . . . 0 C--O 1.249 1.035 0 C-N-CA 126.816 2.046 . . . . 0.0 109.3 177.926 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.483 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . . . . . . 0 CA--C 1.527 0.786 0 N-CA-C 107.697 -2.161 . . . . 0.0 107.697 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.66 -172.61 2.96 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.158 0.979 . . . . 0.0 112.667 -162.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.1 mtp -113.69 158.77 20.47 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 147.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -144.77 143.2 30.55 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 125.256 1.597 . . . . 0.0 108.951 174.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -142.94 143.81 32.14 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.619 2.368 . . . . 0.0 105.065 172.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p -122.07 155.11 26.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 124.557 1.143 . . . . 0.0 109.108 171.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.04 151.11 52.07 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 173.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.6 tp -133.2 114.42 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.11 138.02 41.21 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 126.361 1.864 . . . . 0.0 107.45 176.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -128.46 122.34 31.04 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.453 1.101 . . . . 0.0 108.96 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.97 165.31 11.67 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.296 1.038 . . . . 0.0 108.772 172.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.49 -154.07 52.12 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 176.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -75.67 75.38 2.66 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 123.733 1.73 . . . . 0.0 113.108 -170.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -81.49 17.33 1.42 Allowed 'General case' 0 C--N 1.324 -0.536 0 O-C-N 119.715 -1.866 . . . . 0.0 114.116 -171.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 ptt-85 -137.64 28.34 2.7 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.559 1.527 . . . . 0.0 113.123 -170.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.4 m -127.97 17.29 6.74 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -171.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -134.81 -169.18 2.3 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.9 1.227 . . . . 0.0 112.556 -165.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.7 mm -114.91 87.88 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 106.104 -1.814 . . . . 0.0 106.104 163.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.16 160.22 19.97 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.246 0.93 . . . . 0.0 110.588 168.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.34 156.67 42.81 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.065 0.946 . . . . 0.0 108.565 169.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.1 t -138.02 104.02 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.198 1.399 . . . . 0.0 107.334 170.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.9 t -69.07 135.37 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 163.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.9 t -138.19 138.41 43.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.5 t -135.18 150.14 29.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.08 141.98 49.37 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.265 1.826 . . . . 0.0 109.955 168.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -118.27 103.61 9.98 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 130.158 3.383 . . . . 0.0 106.481 -178.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.47 0.98 32.9 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 125.163 1.364 . . . . 0.0 113.205 172.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 t -165.74 -174.44 3.08 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.582 1.191 . . . . 0.0 109.23 -174.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.408 ' HB2' ' HG1' ' A' ' 69' ' ' THR . 10.1 mt-30 -109.73 -175.75 2.83 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.871 1.668 . . . . 0.0 109.702 178.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.5 mt -119.18 165.58 14.03 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.313 1.445 . . . . 0.0 109.677 -177.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -138.26 122.6 18.26 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.095 0.958 . . . . 0.0 110.113 -170.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -70.08 135.29 49.09 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.755 0.822 . . . . 0.0 109.977 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.84 0.34 86.35 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-O 117.867 -1.518 . . . . 0.0 115.29 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.14 -51.35 15.88 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 120.196 1.998 . . . . 0.0 108.331 174.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.57 -22.8 3.56 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.836 1.254 . . . . 0.0 111.413 -167.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.94 20.55 28.06 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 118.444 -1.198 . . . . 0.0 112.24 -172.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -57.89 136.87 57.09 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 118.978 1.389 . . . . 0.0 109.42 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.13 138.77 49.93 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.268 1.027 . . . . 0.0 108.573 167.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.8 mt -126.91 -171.2 2.35 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.167 1.387 . . . . 0.0 109.306 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -143.03 117.94 9.98 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.685 1.994 . . . . 0.0 106.588 173.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.52 172.0 10.53 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.137 177.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.81 157.99 94.53 Favored 'Cis proline' 0 C--O 1.239 0.567 0 N-CA-C 108.525 -1.375 . . . . 0.0 108.525 -5.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 p -144.8 147.47 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 O-C-N 121.534 -0.728 . . . . 0.0 109.084 -171.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 18.0 mm -120.13 114.18 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 175.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.68 128.01 36.02 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 169.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.4 m -95.72 -175.69 3.51 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.93 1.692 . . . . 0.0 110.884 -174.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.93 -37.71 85.72 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 123.769 0.828 . . . . 0.0 111.848 -170.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -66.76 -36.4 82.35 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.072 0.949 . . . . 0.0 111.212 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -66.73 -36.49 82.59 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 122.44 1.114 . . . . 0.0 110.073 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.8 10.47 32.95 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.581 1.952 . . . . 0.0 112.874 -174.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.17 31.07 0.06 Allowed 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 120.392 1.451 . . . . 0.0 114.111 -174.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.7 m -131.37 167.27 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.504 1.522 . . . . 0.0 111.691 -169.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -59.38 -34.15 72.07 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.471 1.508 . . . . 0.0 113.415 175.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -157.95 147.28 19.68 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-O 117.116 -1.421 . . . . 0.0 109.913 -177.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 t -129.58 163.02 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 119.106 0.866 . . . . 0.0 108.74 163.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.3 m -139.29 109.39 6.41 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.702 2.801 . . . . 0.0 107.791 -172.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -122.4 131.58 53.95 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 121.053 1.751 . . . . 0.0 109.618 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.49 176.29 8.75 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.244 0.618 . . . . 0.0 111.455 -168.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 p -101.95 148.48 25.29 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.812 0.845 . . . . 0.0 109.954 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.408 ' HG1' ' HB2' ' A' ' 38' ' ' GLN . 30.3 p -84.27 -0.7 53.37 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.61 -0.681 . . . . 0.0 112.442 176.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.64 -172.73 37.95 Favored Glycine 0 N--CA 1.448 -0.525 0 O-C-N 119.877 -1.764 . . . . 0.0 109.498 -171.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.483 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 7.1 ttpt -70.43 129.35 39.05 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -126.4 169.69 12.71 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.121 0.568 . . . . 0.0 110.536 176.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -119.46 -2.69 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -175.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -141.65 172.48 12.62 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.836 1.198 . . . . 0.0 110.605 -177.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -164.61 89.75 0.52 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 120.073 1.306 . . . . 0.0 111.312 166.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.77 150.4 25.82 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.584 0.354 . . . . 0.0 110.766 176.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 t -140.76 123.6 15.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 126.207 1.803 . . . . 0.0 106.241 164.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 m -140.59 156.62 46.23 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 174.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.4 -153.35 23.46 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -167.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.38 -168.96 31.56 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -175.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 125.178 1.391 . . . . 0.0 109.323 165.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 . . . . . 0 CA--C 1.532 0.263 0 CA-C-O 119.725 -0.179 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -72.37 169.21 22.22 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 121.083 1.188 . . . . 0.0 111.722 171.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.4 ptm -139.59 172.53 12.66 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 125.046 1.338 . . . . 0.0 110.33 -174.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -143.91 153.3 42.16 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.23 1.012 . . . . 0.0 109.422 -177.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -127.59 140.75 51.91 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.518 1.527 . . . . 0.0 108.982 176.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.9 t -132.8 110.75 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 164.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 m -92.07 143.07 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 163.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 m -129.59 142.12 50.81 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.8 t -122.14 126.1 73.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -113.57 119.0 35.99 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 175.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.469 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 2.2 ttpt -80.01 -156.91 0.13 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 175.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.469 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 4.6 p30 -66.02 83.34 0.08 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 163.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 139.2 -43.48 1.16 Allowed Glycine 0 CA--C 1.524 0.615 0 CA-C-O 118.03 -1.428 . . . . 0.0 115.2 156.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -151.93 -174.98 5.04 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 119.66 1.73 . . . . 0.0 111.309 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -55.74 143.44 30.79 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 171.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 6.7 pt -128.14 -24.85 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-O 117.674 -1.155 . . . . 0.0 112.706 168.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -150.94 148.9 28.97 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 120.631 1.559 . . . . 0.0 108.319 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -148.67 54.79 1.0 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.107 1.363 . . . . 0.0 107.97 -169.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.17 113.02 2.35 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.72 135.0 50.54 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.955 1.302 . . . . 0.0 108.014 -169.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.12 -172.8 3.03 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 122.275 1.036 . . . . 0.0 109.85 -170.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 78.3 t -148.09 111.46 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 127.554 2.342 . . . . 0.0 106.481 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.8 t80 . . . . . 0 C--O 1.233 0.213 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 169.075 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 . . . . . 0 N--CA 1.467 0.421 0 CA-C-O 120.656 0.265 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.1 tp -104.93 104.47 14.23 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -156.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.73 66.67 0.93 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -166.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 mp -119.58 141.78 48.97 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -161.19 111.39 1.69 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -97.64 146.57 25.19 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.204 1.002 . . . . 0.0 109.618 169.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.267 0 C-N-CA 126.868 2.067 . . . . 0.0 109.431 171.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.461 ' H ' ' HD2' ' A' ' 71' ' ' LYS . . . . . . . . 0 CA--C 1.522 0.471 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -147.3 152.41 38.21 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 117.499 0.65 . . . . 0.0 112.57 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.5 mtp -83.51 154.4 23.9 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.477 1.111 . . . . 0.0 108.685 158.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -137.88 152.71 49.31 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.607 1.163 . . . . 0.0 109.026 168.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -141.32 134.42 29.25 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 165.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.65 145.87 31.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 125.262 1.425 . . . . 0.0 107.854 -173.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.2 p -123.24 152.78 40.97 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -175.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.4 tp -136.31 92.87 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 170.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -72.74 139.52 47.21 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 165.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -124.02 126.25 45.95 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 173.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -136.47 176.72 8.44 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.037 0.935 . . . . 0.0 111.73 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.55 -83.46 1.62 Allowed Glycine 0 C--N 1.334 0.431 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 -175.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -149.78 158.9 44.61 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.336 1.855 . . . . 0.0 106.482 172.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -146.44 71.9 1.26 Allowed 'General case' 0 C--N 1.327 -0.375 0 O-C-N 119.739 -1.85 . . . . 0.0 109.355 164.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -133.45 -0.75 3.22 Favored 'General case' 0 C--N 1.332 -0.155 0 O-C-N 120.782 -1.198 . . . . 0.0 112.872 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.4 t -152.5 53.08 0.78 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.999 1.272 . . . . 0.0 110.304 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -148.02 116.56 6.63 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 116.675 -1.631 . . . . 0.0 109.729 -178.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.0 mt -55.14 98.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 125.333 1.453 . . . . 0.0 108.969 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.6 mtmm -82.86 136.73 34.53 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 170.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t -142.46 144.2 32.94 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 172.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.8 t -135.05 155.79 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 167.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 p -119.22 147.39 22.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 103.967 -2.605 . . . . 0.0 103.967 156.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.7 p -148.81 131.11 6.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 171.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.5 t -128.65 164.34 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.916 0.886 . . . . 0.0 108.798 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.58 107.1 4.07 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 166.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -65.22 89.55 0.09 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.248 1.023 . . . . 0.0 110.217 172.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.38 -79.63 0.34 Allowed Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 169.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -81.19 -165.02 0.84 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.255 1.022 . . . . 0.0 111.017 -174.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -110.29 162.28 14.78 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.916 1.686 . . . . 0.0 111.156 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -84.41 156.31 21.86 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.764 1.626 . . . . 0.0 109.651 167.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -128.63 114.46 16.7 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 127.275 2.23 . . . . 0.0 107.308 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.74 119.31 17.79 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.657 1.983 . . . . 0.0 109.088 -176.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.91 -3.39 50.99 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.56 1.076 . . . . 0.0 113.74 176.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.45 -51.91 67.51 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.933 1.293 . . . . 0.0 110.098 169.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.3 p -152.39 9.3 0.48 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.454 1.502 . . . . 0.0 112.394 -161.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.32 13.82 79.58 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 120.486 -1.384 . . . . 0.0 112.617 -175.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -65.65 124.19 21.71 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.772 1.229 . . . . 0.0 111.092 -171.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.2 m -74.2 127.28 32.55 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 169.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 75.8 mt -119.76 176.64 5.3 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.397 1.079 . . . . 0.0 109.925 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.99 110.13 12.23 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.043 1.337 . . . . 0.0 109.553 -173.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.0 p -77.12 170.37 16.67 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.284 1.434 . . . . 0.0 112.175 -172.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.66 146.41 76.73 Favored 'Cis proline' 0 CA--C 1.535 0.526 0 N-CA-C 109.287 -1.082 . . . . 0.0 109.287 -19.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.8 p -137.13 147.15 27.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 118.439 0.563 . . . . 0.0 110.842 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.7 mm -114.08 127.29 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 127.543 2.337 . . . . 0.0 107.044 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -103.33 140.41 37.46 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.666 0.787 . . . . 0.0 109.414 172.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.3 m -81.0 172.48 13.68 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.846 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.77 -24.96 67.98 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.418 2.287 . . . . 0.0 112.547 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -72.57 -37.03 68.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 118.465 -0.779 . . . . 0.0 111.519 172.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -74.21 -44.16 54.29 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -173.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.76 8.09 2.65 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.968 1.307 . . . . 0.0 114.357 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.66 41.39 0.09 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.221 2.208 . . . . 0.0 113.581 -174.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.6 m -133.1 159.1 43.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 126.013 1.725 . . . . 0.0 111.087 -171.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -67.05 -27.19 67.18 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.278 1.431 . . . . 0.0 113.546 -175.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -158.62 137.39 11.16 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 -172.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -123.04 150.67 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 158.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.5 m -133.65 134.52 43.26 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 173.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 31.4 mt -134.2 147.78 50.78 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -170.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.5 t -157.71 165.91 34.18 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -173.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.78 141.55 28.32 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.248 1.419 . . . . 0.0 109.659 -177.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 58.2 p -80.34 -1.0 39.22 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 175.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -158.94 -99.32 0.15 Allowed Glycine 0 C--N 1.339 0.743 0 O-C-N 120.61 -1.306 . . . . 0.0 112.851 -174.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.461 ' HD2' ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -134.69 152.06 51.48 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 126.67 1.988 . . . . 0.0 108.655 166.3 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.13 -178.71 4.05 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 158.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.424 HD11 ' HZ2' ' A' ' 71' ' ' LYS . 7.9 mm -111.44 -14.01 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.582 0.706 . . . . 0.0 109.746 173.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -148.9 163.2 38.13 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 126.521 1.928 . . . . 0.0 107.262 -163.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -154.34 96.22 1.9 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 128.991 2.917 . . . . 0.0 105.818 168.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -91.63 114.93 27.6 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.328 0.651 . . . . 0.0 110.433 177.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 52.7 t -129.1 115.57 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.913 1.285 . . . . 0.0 108.654 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.7 t -139.71 168.54 19.59 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.933 2.093 . . . . 0.0 108.255 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.65 -156.57 27.75 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 127.075 2.274 . . . . 0.0 108.299 -162.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 139.27 123.97 2.14 Favored Glycine 0 N--CA 1.473 1.141 0 CA-C-N 119.171 1.485 . . . . 0.0 112.554 174.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.252 0 CA-C-O 121.767 0.794 . . . . 0.0 110.038 -169.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 . . . . . 0 CA--C 1.532 0.256 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.59 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -78.5 178.24 7.79 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.769 2.98 . . . . 0.0 111.784 173.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.3 ptm -138.12 169.53 17.62 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 122.558 1.17 . . . . 0.0 111.197 -172.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -140.54 151.26 44.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.823 2.049 . . . . 0.0 106.325 175.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -118.11 151.19 38.03 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 168.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.7 t -125.89 134.23 67.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 161.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.7 t -144.31 124.25 7.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 -168.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.4 m -141.43 150.7 42.66 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 -163.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 37.1 t -124.47 135.52 63.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.59 0.709 . . . . 0.0 111.002 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -118.35 158.66 24.83 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 128.467 2.707 . . . . 0.0 107.938 173.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.4 tptt -124.88 -153.44 0.56 Allowed 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 127.573 2.349 . . . . 0.0 107.402 -168.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -55.86 68.47 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.895 2.078 . . . . 0.0 110.633 160.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 64.14 58.98 9.09 Favored Glycine 0 CA--C 1.531 1.061 0 O-C-N 120.106 -1.621 . . . . 0.0 113.172 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -179.61 153.3 0.55 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 128.546 2.738 . . . . 0.0 107.595 162.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -64.84 155.85 32.7 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.358 1.463 . . . . 0.0 109.659 167.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.0 pt -136.18 -17.4 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 125.032 1.333 . . . . 0.0 113.949 167.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -150.7 129.1 12.09 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -170.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -136.98 106.98 6.28 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -175.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.2 pttt -145.58 173.18 12.27 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.817 0.818 . . . . 0.0 112.724 169.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.55 171.94 13.73 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 127.702 2.401 . . . . 0.0 109.79 173.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.3 mt -138.85 151.61 47.13 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.7 p -129.93 138.68 53.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 . . . . . 0 N--CA 1.446 -0.64 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -178.877 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.468 0.469 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.07 78.58 6.64 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -116.32 58.36 0.75 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.046 1.739 . . . . 0.0 109.25 -172.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 63.5 mt -124.83 107.95 11.43 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -177.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -132.54 81.92 1.98 Allowed 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -175.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -70.81 132.17 44.91 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 165.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 . . . . . 0 C--O 1.25 1.105 0 C-N-CA 128.315 2.646 . . . . 0.0 109.093 174.468 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.449 ' CA ' ' HE2' ' A' ' 71' ' ' LYS . . . . . . . . 0 CA--C 1.528 0.877 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -148.13 -164.14 1.94 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.205 1.802 . . . . 0.0 111.163 -162.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.4 mtp -120.87 163.67 17.83 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 125.584 1.554 . . . . 0.0 108.101 147.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -143.13 143.87 31.99 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 125.91 2.006 . . . . 0.0 110.845 -178.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -150.65 145.09 25.63 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.939 1.696 . . . . 0.0 107.355 174.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.47 144.5 32.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 126.657 1.983 . . . . 0.0 107.936 176.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.7 127.98 54.95 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 167.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 tp -100.29 154.15 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 163.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.644 ' CD ' ' H ' ' A' ' 96' ' ' VAL . 0.0 OUTLIER -152.83 -174.63 4.99 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 127.801 2.44 . . . . 0.0 106.941 176.941 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -148.27 166.32 28.35 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 168.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -141.81 165.85 26.33 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 124.141 0.976 . . . . 0.0 110.381 171.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.69 -147.66 39.9 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -75.22 111.91 10.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.394 0.616 . . . . 0.0 110.274 177.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -113.15 33.38 5.11 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.32 1.048 . . . . 0.0 109.679 173.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -124.95 0.5 7.97 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.435 1.494 . . . . 0.0 110.363 -166.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.11 28.67 0.59 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.182 1.393 . . . . 0.0 112.837 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -122.64 116.7 24.26 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 120.72 -1.238 . . . . 0.0 107.773 172.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.7 mm -65.63 121.97 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 175.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -90.69 160.65 15.74 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.155 0.982 . . . . 0.0 110.345 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.4 m -152.48 136.69 16.57 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.373 1.869 . . . . 0.0 107.569 158.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.3 t -137.84 147.18 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 170.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 82.1 t -117.19 128.21 74.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 126.874 2.069 . . . . 0.0 105.851 170.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.33 147.63 19.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 167.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.9 t -128.69 147.73 33.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 170.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.76 91.75 1.91 Allowed 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 173.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -65.06 127.28 30.98 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 172.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.69 -14.66 19.89 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-O 118.735 -1.036 . . . . 0.0 114.503 153.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 t -161.07 -168.49 2.07 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -101.44 160.86 14.07 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.797 0.839 . . . . 0.0 111.302 173.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 tp -74.86 165.23 25.58 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 170.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -133.67 129.96 37.54 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 171.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -84.01 129.51 34.91 Favored 'General case' 0 CA--C 1.52 -0.211 0 O-C-N 123.719 0.637 . . . . 0.0 109.545 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.47 -23.16 70.13 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 118.107 -1.385 . . . . 0.0 112.986 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.72 -61.25 2.56 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.019 1.41 . . . . 0.0 111.116 -176.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.03 10.84 7.61 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.139 0.975 . . . . 0.0 111.029 -177.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.24 23.99 77.47 Favored Glycine 0 N--CA 1.446 -0.639 0 O-C-N 121.141 -0.974 . . . . 0.0 111.544 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -74.98 125.35 28.71 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -171.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.2 m -64.42 129.27 39.24 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 165.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 34.2 mt -107.42 -164.18 0.96 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.801 1.64 . . . . 0.0 108.247 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.67 98.26 3.37 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.693 -0.63 . . . . 0.0 110.55 173.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.5 m -73.48 168.37 26.09 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 122.705 0.402 . . . . 0.0 111.798 177.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -61.26 149.27 52.92 Favored 'Cis proline' 0 CA--C 1.538 0.691 0 N-CA-C 110.366 -0.667 . . . . 0.0 110.366 -16.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.6 t -127.48 151.48 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 18.0 mm -113.95 132.52 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 169.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.9 153.93 21.27 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 122.293 1.044 . . . . 0.0 108.899 170.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.72 -177.94 4.58 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.822 2.449 . . . . 0.0 107.601 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -61.19 -43.95 98.07 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -172.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -62.35 -31.26 71.88 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 123.546 0.738 . . . . 0.0 110.8 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -83.21 -17.98 40.9 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 118.755 -0.64 . . . . 0.0 110.202 -173.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 mt -114.25 6.09 16.06 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.897 1.679 . . . . 0.0 113.921 -168.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.57 34.21 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 128.429 2.692 . . . . 0.0 114.428 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.5 m -100.94 175.38 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 127.777 2.431 . . . . 0.0 110.346 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -95.3 -31.01 13.66 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 118.394 -0.812 . . . . 0.0 111.672 164.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 18' ' ' GLU . 71.7 tttt -157.43 139.12 14.02 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 125.223 1.409 . . . . 0.0 109.189 176.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.0 t -135.73 130.65 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 119.415 1.007 . . . . 0.0 108.53 162.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.8 m -78.27 138.54 38.66 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 121.079 -1.013 . . . . 0.0 108.418 158.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.8 mt -125.51 137.82 53.96 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 167.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.93 -174.59 4.12 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -172.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.83 146.68 37.24 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.329 1.061 . . . . 0.0 110.932 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.3 p -73.59 -22.91 59.9 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.136 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.21 -165.22 13.89 Favored Glycine 0 N--CA 1.449 -0.497 0 O-C-N 121.192 -0.943 . . . . 0.0 110.798 -170.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.449 ' HE2' ' CA ' ' A' ' 10' ' ' GLY . 47.7 tttt -57.86 135.81 56.91 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 168.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -137.03 161.47 35.97 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 174.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.34 -7.94 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 123.51 0.724 . . . . 0.0 109.945 -164.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -144.67 150.63 37.67 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -137.56 156.33 48.22 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 155.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -158.13 152.41 24.38 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 121.014 -1.054 . . . . 0.0 108.785 174.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.8 t -142.39 106.32 1.37 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.2 t -116.39 169.48 9.28 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.734 1.214 . . . . 0.0 107.888 156.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.22 -165.3 30.32 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 125.173 1.368 . . . . 0.0 110.277 -172.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.54 175.48 38.11 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 108.088 -2.005 . . . . 0.0 108.088 172.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 C--O 1.235 0.339 0 C-N-CA 124.296 1.038 . . . . 0.0 108.446 169.243 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.538 0.495 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -84.37 -177.0 2.77 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.564 2.842 . . . . 0.0 111.954 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.5 ptp -141.67 163.46 32.85 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 172.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -138.99 150.19 45.56 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 126.018 1.727 . . . . 0.0 108.976 173.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 20.7 m0 -125.3 151.05 46.51 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.547 1.539 . . . . 0.0 108.689 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.644 ' H ' ' CD ' ' A' ' 18' ' ' GLU . 13.7 p -136.45 81.04 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 126.85 2.06 . . . . 0.0 108.766 169.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 p -83.98 89.12 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.64 145.29 31.74 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 176.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.99 140.66 46.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -126.7 145.6 50.52 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 128.417 2.687 . . . . 0.0 107.883 -172.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.54 -174.69 2.51 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.03 1.332 . . . . 0.0 107.553 170.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -52.32 69.09 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.708 2.803 . . . . 0.0 113.053 176.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.53 -15.96 3.6 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 115.957 -2.58 . . . . 0.0 116.326 171.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.54 177.79 0.18 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 121.714 2.757 . . . . 0.0 111.918 175.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -50.99 150.81 2.85 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 128.724 2.81 . . . . 0.0 110.913 175.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.47 -20.44 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.638 1.175 . . . . 0.0 111.572 162.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -152.65 151.79 31.0 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 120.315 1.416 . . . . 0.0 110.739 -170.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -141.17 22.69 2.22 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 125.494 1.518 . . . . 0.0 112.842 -161.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -60.95 142.54 56.38 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.612 0.72 . . . . 0.0 110.106 -175.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.07 137.57 15.06 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 125.258 1.423 . . . . 0.0 109.703 -163.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.2 mp -126.85 177.87 6.31 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 123.413 1.578 . . . . 0.0 108.462 -166.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.2 p -149.93 146.8 16.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-N 111.438 -2.619 . . . . 0.0 110.945 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 . . . . . 0 C--O 1.234 0.243 0 C-N-CA 126.571 1.948 . . . . 0.0 107.237 169.128 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -120.93 120.7 36.24 Favored 'General case' 0 CA--C 1.517 -0.288 0 O-C-N 120.691 -1.256 . . . . 0.0 107.79 173.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -150.68 72.09 1.07 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 125.671 1.589 . . . . 0.0 110.522 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.5 mp -119.08 154.22 33.54 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.761 1.224 . . . . 0.0 110.727 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -145.83 148.89 33.38 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.31 2.244 . . . . 0.0 109.172 175.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -141.26 142.53 33.9 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.195 2.198 . . . . 0.0 107.813 177.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.5 p30 . . . . . 0 C--O 1.258 1.535 0 C-N-CA 128.202 2.601 . . . . 0.0 107.047 170.512 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.705 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 73.27 -80.85 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 126.663 1.985 . . . . 0.0 107.534 -170.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -164.47 155.18 14.88 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.139 1.776 . . . . 0.0 106.731 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -125.36 171.09 10.71 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 127.552 2.341 . . . . 0.0 109.282 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -154.8 85.57 3.61 Favored Pre-proline 0 N--CA 1.448 -0.554 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 -159.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.02 165.12 26.59 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.055 1.837 . . . . 0.0 109.926 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 121.21 110.88 2.19 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 -174.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 106.19 -176.91 22.12 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 123.935 0.779 . . . . 0.0 111.86 162.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -134.46 165.95 23.99 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 124.947 1.299 . . . . 0.0 108.83 -167.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.494 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . 158.7 -154.18 25.28 Favored Glycine 0 C--N 1.313 -0.697 0 C-N-CA 130.207 3.765 . . . . 0.0 107.37 175.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.52 -162.49 1.32 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.037 1.735 . . . . 0.0 110.329 -164.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 33.5 mtp -128.59 165.08 21.48 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 128.551 2.741 . . . . 0.0 105.069 156.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -146.78 154.92 41.95 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.512 1.125 . . . . 0.0 110.733 177.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -146.62 120.96 9.6 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.744 2.018 . . . . 0.0 107.773 174.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.1 p -99.67 151.86 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.963 1.305 . . . . 0.0 109.465 170.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.91 154.18 43.15 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.108 0.963 . . . . 0.0 110.089 168.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 tp -139.42 111.81 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 C-N-CA 126.034 1.734 . . . . 0.0 107.209 172.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.64 150.76 20.0 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 159.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -128.86 106.88 9.21 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.396 1.878 . . . . 0.0 107.524 -168.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 m -113.14 167.8 10.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.85 -172.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.6 -150.64 41.63 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -172.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -87.21 34.4 0.69 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -158.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -58.55 -6.09 0.65 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -165.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 54.5 mtt-85 -86.29 0.78 53.09 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.34 1.456 . . . . 0.0 113.424 -167.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.9 m -135.92 32.41 2.95 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.72 1.608 . . . . 0.0 110.149 -174.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -143.27 102.33 3.96 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.867 1.267 . . . . 0.0 109.964 -166.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.1 mm -69.21 96.88 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 125.455 1.502 . . . . 0.0 110.732 -170.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? -110.39 160.79 16.27 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.441 1.096 . . . . 0.0 112.052 -164.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.2 m -145.52 126.29 14.35 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.271 0.628 . . . . 0.0 110.957 -158.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.4 t -135.64 155.74 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.218 1.007 . . . . 0.0 110.11 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 p -119.4 154.6 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 128.924 2.89 . . . . 0.0 107.964 173.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 t -145.61 127.25 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 168.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.2 t -127.79 125.5 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.17 112.17 17.37 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.107 0.963 . . . . 0.0 109.826 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -74.51 128.08 34.66 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.687 1.195 . . . . 0.0 108.902 170.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.41 1.08 74.55 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 115.698 1.039 . . . . 0.0 115.698 163.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -153.44 175.87 12.67 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 119.002 1.401 . . . . 0.0 110.387 175.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -100.0 161.01 13.88 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.675 1.19 . . . . 0.0 109.432 174.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 tp -89.9 171.62 9.46 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.31 0.644 . . . . 0.0 109.657 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -137.74 139.54 40.17 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.101 0.96 . . . . 0.0 108.738 173.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -93.82 128.56 40.13 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.978 1.711 . . . . 0.0 109.986 -173.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.04 -21.59 76.96 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.811 -0.994 . . . . 0.0 114.277 -174.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.11 78.68 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.436 1.118 . . . . 0.0 112.03 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.3 p -145.56 -28.58 0.44 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.993 1.317 . . . . 0.0 111.511 -159.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.28 13.93 62.94 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.374 1.464 . . . . 0.0 112.888 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -62.73 138.0 58.4 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.139 1.376 . . . . 0.0 107.296 171.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.1 m -68.7 150.78 47.52 Favored 'General case' 0 N--CA 1.426 -1.669 0 C-N-CA 125.804 1.642 . . . . 0.0 110.411 165.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.2 mt -136.32 142.05 43.84 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.315 1.046 . . . . 0.0 110.725 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.78 78.01 4.29 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.46 1.104 . . . . 0.0 111.144 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 p -54.68 156.28 6.65 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.171 0.988 . . . . 0.0 110.888 168.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -79.64 146.73 76.79 Favored 'Cis proline' 0 CA--C 1.537 0.639 0 CA-C-N 119.355 0.805 . . . . 0.0 111.69 2.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.8 t -140.26 159.14 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.63 1.172 . . . . 0.0 110.263 -171.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.1 mm -119.85 142.33 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 C-N-CA 129.023 2.929 . . . . 0.0 105.44 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -108.42 128.1 54.48 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 171.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.1 m -94.29 173.65 7.53 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.397 1.479 . . . . 0.0 109.404 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.2 -36.1 76.89 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -169.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -63.35 -36.94 85.37 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.593 0.757 . . . . 0.0 111.019 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -75.68 -36.77 59.98 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.8 mt -86.53 24.54 1.4 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.339 2.256 . . . . 0.0 110.73 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.16 -4.88 58.68 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.023 0.929 . . . . 0.0 112.618 174.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.1 m -82.76 163.22 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 118.807 0.73 . . . . 0.0 110.475 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -62.11 -34.85 77.11 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.542 1.137 . . . . 0.0 112.277 173.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -152.25 139.22 19.08 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -172.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -118.74 152.4 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 161.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.7 m -129.82 131.29 46.1 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 103.512 -2.773 . . . . 0.0 103.512 164.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.0 mp -132.3 144.71 50.77 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 170.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.61 -173.05 3.67 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.098 -165.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 p -120.61 138.12 54.07 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.704 0.801 . . . . 0.0 110.917 -171.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 68.5 p -78.94 -12.0 60.02 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -168.32 -157.17 10.94 Favored Glycine 0 N--CA 1.447 -0.605 0 O-C-N 120.475 -1.39 . . . . 0.0 110.597 -167.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.494 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -73.36 91.68 1.76 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.39 1.476 . . . . 0.0 109.506 -168.356 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.91 155.52 21.64 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.831 1.252 . . . . 0.0 108.44 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.0 -5.88 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.867 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -148.92 159.19 44.42 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 119.726 1.148 . . . . 0.0 109.308 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.16 143.09 49.73 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 125.054 1.471 . . . . 0.0 107.831 151.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.27 129.3 27.09 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 166.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.2 t -139.85 100.59 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -168.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.2 t -120.11 158.8 26.13 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 178.08 171.53 41.55 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-O 121.571 0.539 . . . . 0.0 112.695 172.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.35 -172.67 40.44 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.971 1.748 . . . . 0.0 109.425 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.2 p -146.67 -174.94 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 124.548 1.139 . . . . 0.0 109.196 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.3 m -133.81 -164.75 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 126.089 1.756 . . . . 0.0 109.675 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -148.57 100.51 3.13 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 160.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -151.1 22.22 0.98 Allowed Glycine 0 C--O 1.228 -0.266 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -170.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -82.19 57.45 3.58 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 122.771 1.272 . . . . 0.0 110.022 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.8 t0 45.42 36.32 2.35 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.309 2.244 . . . . 0.0 112.17 -173.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.22 14.59 78.64 Favored Glycine 0 C--N 1.337 0.587 0 CA-C-O 118.455 -1.192 . . . . 0.0 113.461 171.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.9 p -58.0 131.34 21.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 120.028 1.914 . . . . 0.0 109.117 173.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.7 t -90.71 138.05 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 171.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -145.04 -154.69 0.55 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.877 2.471 . . . . 0.0 106.341 -177.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -111.21 165.46 12.69 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 124.994 1.318 . . . . 0.0 108.743 168.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.79 -179.54 4.31 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 121.866 1.711 . . . . 0.0 113.618 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.8 ptm -138.01 174.3 10.72 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.945 0.898 . . . . 0.0 111.115 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -141.86 162.17 36.14 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.723 1.209 . . . . 0.0 109.729 175.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -128.47 108.64 10.71 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 126.485 1.914 . . . . 0.0 106.543 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.4 t -96.69 109.44 23.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.2 m -131.37 135.34 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.555 1.142 . . . . 0.0 109.25 -162.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.5 m -143.1 155.68 44.64 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -171.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.25 130.37 54.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -121.52 160.8 23.49 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 127.196 2.198 . . . . 0.0 109.396 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.43 -161.13 0.74 Allowed 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 127.334 2.254 . . . . 0.0 108.981 -172.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -62.83 20.84 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.386 1.874 . . . . 0.0 112.992 162.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 133.03 46.35 0.11 Allowed Glycine 0 C--N 1.34 0.759 0 O-C-N 120.187 -1.571 . . . . 0.0 113.725 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -170.3 154.92 5.02 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 125.769 1.627 . . . . 0.0 108.497 160.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.406 ' O ' ' HE2' ' A' ' 104' ' ' LYS . 33.7 tt0 -72.71 146.86 46.18 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.481 1.113 . . . . 0.0 108.271 165.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.32 -29.86 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 117.981 -1.009 . . . . 0.0 111.617 170.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -131.64 147.18 52.5 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 120.395 1.452 . . . . 0.0 109.278 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.6 ptmm? -148.99 91.1 1.82 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 -164.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -129.05 171.41 12.4 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 123.564 1.65 . . . . 0.0 111.762 -168.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.4 t -148.11 165.74 29.93 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 111.963 -2.38 . . . . 0.0 105.252 162.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.5 mt -144.06 160.58 40.63 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.902 2.081 . . . . 0.0 108.045 168.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 p -126.35 123.16 62.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 125.426 1.491 . . . . 0.0 108.205 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -111.64 147.48 35.42 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.9 mtm105 -141.17 166.66 24.18 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.186 0.517 . . . . 0.0 110.932 -176.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -65.5 169.8 5.67 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 125.535 1.534 . . . . 0.0 111.873 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 151.2 -78.21 0.22 Allowed Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt -171.8 171.72 5.1 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 127.141 2.176 . . . . 0.0 110.069 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -51.14 138.78 19.51 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.661 1.985 . . . . 0.0 110.771 166.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.2 pp -154.12 -178.02 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 127.784 2.434 . . . . 0.0 107.312 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.6 p -133.47 103.63 6.02 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.106 1.762 . . . . 0.0 107.019 173.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 25.6 p -127.49 117.79 22.77 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.13 66.28 0.27 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 158.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -72.45 -28.43 62.93 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.347 -0.846 . . . . 0.0 111.474 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 16.2 tp -111.08 131.18 55.29 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 165.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.13 36.42 0.68 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.062 1.745 . . . . 0.0 110.935 -168.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.8 mt -83.65 155.15 23.33 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.293 1.037 . . . . 0.0 110.985 -171.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -160.36 156.79 26.79 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 126.674 1.989 . . . . 0.0 111.635 169.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -151.52 160.49 43.67 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 127.288 2.235 . . . . 0.0 110.04 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.4 p30 . . . . . 0 C--O 1.245 0.866 0 C-N-CA 123.288 0.635 . . . . 0.0 110.384 161.694 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.671 0 N-CA-C 104.729 -3.348 . . . . 0.0 104.729 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -140.64 60.01 1.54 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 103.194 -2.891 . . . . 0.0 103.194 -148.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -143.87 156.03 44.31 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.689 2.395 . . . . 0.0 104.545 -142.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -138.74 121.74 16.71 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 125.177 1.391 . . . . 0.0 111.797 -163.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.39 60.46 3.14 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 124.835 1.254 . . . . 0.0 111.383 -171.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -69.73 97.97 0.66 Allowed 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 121.601 1.534 . . . . 0.0 112.837 -172.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.1 13.42 58.79 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.522 -0.763 . . . . 0.0 114.187 -176.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -130.27 -49.67 0.12 Allowed Glycine 0 CA--C 1.526 0.739 0 CA-C-N 119.286 1.543 . . . . 0.0 113.368 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.6 mttt -124.09 109.77 13.89 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -163.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.38 84.08 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 CA-C-O 119.021 -0.877 . . . . 0.0 112.736 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -118.09 128.67 54.97 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 160.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.2 mtp -78.9 160.53 27.24 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 147.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -132.97 146.32 51.67 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 170.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -148.7 121.41 8.64 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.847 1.259 . . . . 0.0 107.713 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.3 p -101.49 151.16 5.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 125.351 1.46 . . . . 0.0 108.146 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.0 p -123.68 162.74 22.48 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 122.702 1.239 . . . . 0.0 109.448 165.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.0 tp -133.0 144.64 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 159.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -134.69 98.31 4.02 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 103.803 -2.666 . . . . 0.0 103.803 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -81.29 108.7 15.14 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -133.95 164.86 26.34 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 118.688 0.676 . . . . 0.0 112.469 172.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.76 -176.37 11.3 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -145.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -75.83 120.79 21.67 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.357 -1.084 . . . . 0.0 110.906 -168.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -109.78 19.08 19.52 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 120.049 1.295 . . . . 0.0 112.269 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -81.61 -10.54 59.4 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -172.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.4 p -128.14 25.86 5.82 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.757 1.623 . . . . 0.0 113.721 -169.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -125.62 168.18 14.07 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 119.312 -2.118 . . . . 0.0 110.076 -165.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.7 mp -120.62 89.01 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.67 147.26 47.65 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 120.971 -1.081 . . . . 0.0 109.55 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.28 129.16 17.36 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.665 1.986 . . . . 0.0 105.909 170.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.8 t -131.15 126.5 59.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 160.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -91.85 130.07 41.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 167.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.264 12.6 p -134.27 150.67 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 120.243 1.383 . . . . 0.0 110.509 167.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 83.8 t -135.18 158.83 41.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 127.728 2.411 . . . . 0.0 104.524 -176.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.73 127.77 20.75 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 156.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -77.85 115.8 17.87 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 171.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.02 -9.76 22.99 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 118.452 -1.193 . . . . 0.0 115.309 159.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.5 t -157.07 -173.15 4.31 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.252 1.526 . . . . 0.0 110.219 -176.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -96.2 177.03 5.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.882 1.273 . . . . 0.0 110.277 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -117.33 161.94 18.72 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 127.122 2.169 . . . . 0.0 107.897 -169.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -139.03 128.51 24.38 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -170.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -80.46 113.78 18.89 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.12 9.02 58.91 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.056 -0.858 . . . . 0.0 113.578 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.36 -64.44 0.92 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 119.664 1.732 . . . . 0.0 108.267 157.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.85 -20.12 3.2 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.31 0.644 . . . . 0.0 111.852 -156.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.98 46.83 2.36 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 124.692 1.139 . . . . 0.0 110.96 175.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -100.32 132.21 45.82 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 p -76.75 131.18 38.59 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.3 mt -121.63 168.63 11.55 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 126.464 1.905 . . . . 0.0 108.983 -176.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -123.47 109.57 14.0 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.652 1.981 . . . . 0.0 107.985 -167.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.8 165.11 28.03 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -174.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -70.45 172.25 52.59 Favored 'Cis proline' 0 C--N 1.348 0.546 0 C-N-CA 124.694 -0.961 . . . . 0.0 110.027 -18.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.4 p -148.86 148.16 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 121.482 0.658 . . . . 0.0 109.77 -174.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.4 mm -116.74 112.27 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 104.767 -2.309 . . . . 0.0 104.767 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -76.34 99.86 4.95 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 162.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 75.6 m -91.7 -175.62 4.22 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 173.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -63.04 -24.92 68.14 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -166.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -64.93 -47.59 77.16 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.192 1.397 . . . . 0.0 109.878 173.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -74.11 -13.74 60.87 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.168 0.987 . . . . 0.0 111.027 -174.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.0 mt -116.79 19.55 14.4 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.991 1.716 . . . . 0.0 111.048 -175.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.73 13.54 0.36 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.006 1.722 . . . . 0.0 113.418 174.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.29 160.17 42.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 127.338 2.255 . . . . 0.0 109.257 -162.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.79 -32.1 73.5 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.975 0.91 . . . . 0.0 113.032 -176.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -163.94 121.16 1.74 Allowed 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -158.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 t -132.1 93.17 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -170.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.3 m -82.35 130.2 35.05 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 175.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -130.95 146.48 52.37 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 176.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.4 t -145.75 171.46 14.73 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.342 0.657 . . . . 0.0 110.114 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.5 p -79.14 165.45 23.31 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.493 0.664 . . . . 0.0 110.165 168.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 61.1 p -89.85 1.17 56.51 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.522 -0.736 . . . . 0.0 111.439 166.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -172.53 -163.52 26.49 Favored Glycine 0 N--CA 1.444 -0.794 0 O-C-N 120.926 -1.109 . . . . 0.0 113.806 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.34 119.3 3.95 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 128.47 2.708 . . . . 0.0 109.663 171.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -125.38 167.15 15.35 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.465 0.706 . . . . 0.0 110.455 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -125.71 -3.06 5.32 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 C-N-CA 124.354 1.062 . . . . 0.0 110.861 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -151.52 162.71 40.5 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 119.736 1.153 . . . . 0.0 109.823 171.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -161.47 72.3 0.41 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.347 1.459 . . . . 0.0 109.108 176.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.27 144.09 55.0 Favored 'General case' 0 C--N 1.333 -0.144 0 O-C-N 121.735 -0.603 . . . . 0.0 110.198 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 64.9 t -142.06 114.04 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 126.643 1.977 . . . . 0.0 106.526 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.9 m -129.13 158.85 37.82 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.003 0.921 . . . . 0.0 108.649 171.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 154.08 -172.44 32.72 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-N 118.569 0.622 . . . . 0.0 111.777 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.75 173.4 41.43 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.355 1.455 . . . . 0.0 111.375 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -147.92 134.34 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.345 1.458 . . . . 0.0 110.651 172.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -141.23 155.06 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 126.342 1.857 . . . . 0.0 110.387 159.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -53.91 121.87 8.88 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 127.907 2.483 . . . . 0.0 108.133 -174.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.83 -4.72 85.92 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 118.47 -1.183 . . . . 0.0 113.61 -173.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -135.38 172.26 13.26 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.184 1.492 . . . . 0.0 112.115 -162.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -138.32 32.52 2.33 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 127.28 2.232 . . . . 0.0 108.908 -175.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -151.24 -6.02 0.16 Allowed Glycine 0 CA--C 1.52 0.35 0 CA-C-O 118.375 -1.236 . . . . 0.0 113.822 -170.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.4 t -129.81 83.41 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 CA-C-N 120.023 1.912 . . . . 0.0 106.773 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.8 t -59.96 98.96 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.796 1.238 . . . . 0.0 107.738 176.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -112.98 161.29 17.2 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 126.872 2.069 . . . . 0.0 109.841 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -74.32 152.1 87.9 Favored Pre-proline 0 C--O 1.224 -0.255 0 CA-C-O 118.77 -0.633 . . . . 0.0 109.453 169.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -81.65 -179.35 4.82 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.342 2.028 . . . . 0.0 113.985 -172.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 6.5 ptm -133.82 168.6 18.45 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.221 1.01 . . . . 0.0 111.786 -166.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -140.56 153.51 46.16 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 126.702 2.001 . . . . 0.0 107.443 170.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -116.17 114.61 24.69 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 103.943 -2.614 . . . . 0.0 103.943 172.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.9 t -94.23 127.02 46.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 164.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 m -139.26 94.02 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 -163.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.7 m -95.57 164.94 12.58 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.8 t -135.61 122.86 35.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 164.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -96.05 156.81 16.18 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 125.93 1.692 . . . . 0.0 107.744 168.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.409 ' HG2' HD21 ' A' ' 102' ' ' ASN . 31.4 tttt -108.72 -162.48 0.82 Allowed 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.505 1.922 . . . . 0.0 106.956 171.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.409 HD21 ' HG2' ' A' ' 101' ' ' LYS . 0.9 OUTLIER -63.02 82.83 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.268 1.827 . . . . 0.0 109.396 170.425 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.34 16.31 59.13 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.459 1.504 . . . . 0.0 115.146 167.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -153.35 168.92 24.42 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.633 1.717 . . . . 0.0 111.368 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -97.91 135.25 39.9 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.426 1.491 . . . . 0.0 108.823 176.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.21 -14.52 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.72 1.145 . . . . 0.0 113.859 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -129.9 153.42 48.34 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 173.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.9 tttm -160.39 78.77 0.65 Allowed 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.4 169.4 11.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.566 0.698 . . . . 0.0 110.435 177.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.4 t -156.84 155.24 31.16 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.03 -174.56 3.41 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 125.906 1.682 . . . . 0.0 107.078 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.4 p -167.87 119.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 126.308 1.843 . . . . 0.0 108.515 -158.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -143.4 167.96 20.95 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.555 -0.716 . . . . 0.0 110.353 171.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -144.26 173.83 11.42 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.23 1.412 . . . . 0.0 108.704 -173.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.26 141.6 4.51 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 126.949 2.1 . . . . 0.0 111.233 164.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 108.6 8.66 28.17 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-O 118.525 -1.153 . . . . 0.0 115.331 157.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -138.63 93.22 2.7 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 119.651 1.725 . . . . 0.0 111.715 -174.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -64.34 100.12 0.33 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.779 0.832 . . . . 0.0 111.624 169.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.5 pp -145.57 174.58 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 128.105 2.562 . . . . 0.0 107.696 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -168.78 7.24 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 168.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.0 p -135.78 30.47 3.11 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 125.097 1.359 . . . . 0.0 110.396 -166.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -153.12 56.94 0.78 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.39 -83.37 0.37 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -177.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 mt -113.15 128.02 56.36 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.304 1.042 . . . . 0.0 111.598 -175.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -139.75 82.84 1.9 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 128.473 2.709 . . . . 0.0 106.6 174.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.2 mp -120.01 128.57 53.66 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.854 1.262 . . . . 0.0 107.875 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.5 72.34 1.38 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -176.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -74.6 150.09 39.81 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.284 175.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 . . . . . 0 C--O 1.257 1.466 0 C-N-CA 126.738 2.015 . . . . 0.0 109.989 179.997 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.676 0 N-CA-C 108.033 -2.027 . . . . 0.0 108.033 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.0 t70 74.19 108.82 0.07 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 104.017 -2.586 . . . . 0.0 104.017 -131.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -143.53 154.26 43.44 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 -157.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -145.7 155.77 43.2 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 125.858 1.663 . . . . 0.0 107.755 -158.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -157.15 86.6 2.76 Favored Pre-proline 0 C--O 1.237 0.412 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -64.46 149.15 90.51 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 120.693 0.929 . . . . 0.0 109.898 173.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 162.33 62.45 0.02 OUTLIER Glycine 0 C--N 1.333 0.373 0 N-CA-C 115.949 1.14 . . . . 0.0 115.949 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.68 -102.77 0.18 Allowed Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 164.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -162.97 154.32 17.44 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.026 1.731 . . . . 0.0 107.207 -175.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.66 -147.0 4.96 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.384 1.945 . . . . 0.0 109.28 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.97 177.55 9.05 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.062 1.431 . . . . 0.0 111.335 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.11 150.96 21.83 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.366 1.866 . . . . 0.0 108.723 157.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.409 ' N ' ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -157.44 134.69 10.34 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 128.428 2.691 . . . . 0.0 109.664 178.339 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -127.33 137.58 52.83 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 128.199 2.599 . . . . 0.0 104.96 169.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.1 p -110.16 150.14 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 165.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.0 p -124.03 159.53 29.66 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 164.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 tp -129.1 135.23 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 C-N-CA 127.94 2.496 . . . . 0.0 105.645 168.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -111.03 138.7 47.11 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 155.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -121.67 116.53 24.72 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 m -143.76 171.76 13.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 118.335 0.516 . . . . 0.0 110.985 -172.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.71 -95.18 2.07 Favored Glycine 0 C--N 1.334 0.453 0 N-CA-C 105.066 -3.214 . . . . 0.0 105.066 -164.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -142.19 173.33 11.62 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.495 1.518 . . . . 0.0 107.448 165.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -157.71 8.33 0.16 Allowed 'General case' 0 C--N 1.328 -0.361 0 O-C-N 120.852 -1.155 . . . . 0.0 112.173 169.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -54.95 -41.74 71.48 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.478 1.111 . . . . 0.0 113.297 -172.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 m -128.37 51.89 1.95 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.623 1.169 . . . . 0.0 109.788 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -122.85 107.97 12.47 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 51.3 mt -73.22 88.64 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 125.515 1.526 . . . . 0.0 108.481 -168.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.4 pttm -112.41 125.32 54.08 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.414 1.485 . . . . 0.0 110.351 -166.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.6 m -127.95 159.7 34.15 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.728 1.211 . . . . 0.0 109.317 168.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 85.8 t -140.45 133.68 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.4 t -84.88 135.79 24.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 125.731 1.612 . . . . 0.0 107.196 169.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.6 t -136.58 128.26 43.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 168.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.3 t -138.65 119.4 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.96 156.22 36.77 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 167.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -118.83 119.49 34.52 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.737 1.615 . . . . 0.0 109.613 -175.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.24 -6.81 56.27 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.769 1.176 . . . . 0.0 114.857 161.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -140.67 -164.14 1.67 Allowed 'General case' 0 C--O 1.242 0.695 0 C-N-CA 126.548 1.939 . . . . 0.0 107.813 -176.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -122.05 177.49 5.3 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 120.904 -1.123 . . . . 0.0 109.308 174.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.83 167.58 10.38 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 125.038 1.335 . . . . 0.0 109.013 -173.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -136.67 114.12 10.92 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.225 1.01 . . . . 0.0 108.53 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -69.23 127.05 31.69 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.62 -22.43 69.82 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-O 118.226 -1.319 . . . . 0.0 113.85 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.07 -51.7 68.59 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 119.505 1.653 . . . . 0.0 110.322 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.81 -9.35 1.6 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.955 0.902 . . . . 0.0 111.552 -160.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.6 13.22 80.51 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.262 0.934 . . . . 0.0 112.506 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -55.1 123.56 14.04 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.901 1.681 . . . . 0.0 108.699 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.83 104.35 12.14 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.8 mt -85.7 163.16 18.41 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.699 0.8 . . . . 0.0 109.483 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.95 109.92 17.64 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.604 1.962 . . . . 0.0 106.243 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 66.2 m -82.36 151.33 65.62 Favored Pre-proline 0 C--N 1.323 -0.55 0 C-N-CA 126.895 2.078 . . . . 0.0 111.913 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.61 163.87 89.43 Favored 'Cis proline' 0 CA--C 1.535 0.561 0 CA-C-N 119.13 0.725 . . . . 0.0 111.658 -1.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 p -156.61 157.87 3.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 123.607 0.763 . . . . 0.0 109.758 170.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.9 mm -116.15 116.37 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 125.896 1.678 . . . . 0.0 107.082 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.8 mt -71.94 145.29 48.54 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 165.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 m -108.59 176.77 5.0 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.24 171.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -58.39 -22.96 55.78 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.611 1.964 . . . . 0.0 112.665 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -66.18 -27.29 67.88 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.147 1.779 . . . . 0.0 112.47 175.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -100.76 -24.06 14.48 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.637 1.575 . . . . 0.0 110.463 -171.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.7 mt -97.72 15.82 22.47 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.673 1.989 . . . . 0.0 110.297 -175.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.46 14.57 0.17 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.907 1.683 . . . . 0.0 114.278 -175.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.7 m -128.03 170.91 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 126.919 2.088 . . . . 0.0 111.008 -162.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -76.36 -20.43 57.21 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.055 0.942 . . . . 0.0 112.651 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.14 133.78 16.68 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.599 1.56 . . . . 0.0 110.006 -168.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.5 t -140.04 82.37 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.415 0.626 . . . . 0.0 110.209 173.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 90.4 m -73.44 130.54 40.33 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.74 1.216 . . . . 0.0 109.436 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -132.4 129.56 39.5 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.548 1.067 . . . . 0.0 109.112 175.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.0 t -141.28 168.18 20.39 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.768 1.627 . . . . 0.0 108.481 175.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.33 153.77 18.99 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 123.961 0.904 . . . . 0.0 110.231 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.3 p -83.33 11.48 6.68 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.726 1.21 . . . . 0.0 112.063 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 173.34 -172.49 45.22 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 173.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.61 141.28 48.67 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.671 1.236 . . . . 0.0 109.165 174.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.75 178.38 5.5 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.496 1.118 . . . . 0.0 108.547 172.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.2 mm -116.13 -11.61 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.863 0.865 . . . . 0.0 111.113 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -143.89 156.2 44.36 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.366 1.066 . . . . 0.0 108.746 169.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -145.08 103.28 3.85 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 160.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.86 122.12 46.92 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.12 121.94 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 C-N-CA 127.752 2.421 . . . . 0.0 109.162 -171.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.1 t -147.56 153.16 39.1 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -169.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.76 -177.02 43.44 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 171.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.05 176.41 38.47 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 106.196 -2.762 . . . . 0.0 106.196 167.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.2 p -156.37 155.92 5.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 166.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.01 172.93 10.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 125.613 1.565 . . . . 0.0 107.635 168.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.91 136.44 47.19 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 160.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -107.2 -12.53 23.4 Favored Glycine 0 C--N 1.322 -0.214 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 170.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -93.37 162.03 14.15 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -159.69 66.69 0.38 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 173.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 160.33 -13.7 0.18 Allowed Glycine 0 CA--C 1.531 1.065 0 N-CA-C 115.474 0.95 . . . . 0.0 115.474 -167.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.0 p -122.36 136.4 59.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-N 119.782 1.791 . . . . 0.0 107.495 165.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.99 119.5 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 124.48 1.112 . . . . 0.0 108.402 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -139.36 138.36 36.53 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 171.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.75 154.46 94.3 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 119.409 -0.329 . . . . 0.0 110.117 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -84.6 -175.99 2.33 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.29 2.66 . . . . 0.0 112.792 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 19.5 ptm -148.03 176.19 10.39 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.339 -0.851 . . . . 0.0 113.254 -160.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -142.3 157.18 45.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.462 1.905 . . . . 0.0 108.39 169.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 21.9 m0 -116.23 122.07 43.91 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 162.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.274 7.1 p -116.69 103.92 15.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 168.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.0 m -97.53 168.91 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.46 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.2 m -156.2 147.37 22.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.7 t -121.46 132.04 71.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -119.31 117.01 27.42 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.868 1.667 . . . . 0.0 107.246 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.3 tptt -74.8 -164.73 0.31 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.414 1.886 . . . . 0.0 108.784 172.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.17 79.93 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.037 2.535 . . . . 0.0 108.769 173.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.16 36.77 50.33 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.178 1.371 . . . . 0.0 114.133 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -157.32 152.5 26.05 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 118.199 1.0 . . . . 0.0 109.651 164.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -77.98 140.28 39.19 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 166.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 3.0 pt -130.92 -17.43 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -148.92 144.32 26.77 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -174.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -148.14 39.27 0.91 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -174.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.04 148.52 41.88 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.683 -1.261 . . . . 0.0 111.964 -173.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.9 p -122.04 153.16 38.98 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 127.575 2.35 . . . . 0.0 109.138 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.0 mt -131.9 170.47 14.83 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.237 1.415 . . . . 0.0 109.3 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 t -146.44 146.8 18.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 124.719 1.208 . . . . 0.0 108.406 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -139.5 145.19 38.44 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 152.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -140.79 103.89 4.59 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 172.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 14.9 t0 58.59 -175.9 0.08 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.259 1.424 . . . . 0.0 111.405 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 137.45 -63.85 0.57 Allowed Glycine 0 CA--C 1.5 -0.902 0 C-N-CA 126.328 1.918 . . . . 0.0 109.728 160.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.19 169.79 0.22 Allowed 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 129.066 2.947 . . . . 0.0 108.059 167.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.32 141.72 40.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 125.168 1.387 . . . . 0.0 110.774 156.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 pp -165.37 -172.83 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 129.925 3.29 . . . . 0.0 105.377 173.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.5 p -114.43 156.69 24.05 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 154.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.6 t -153.01 150.76 29.53 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -116.07 30.43 7.35 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 125.281 1.432 . . . . 0.0 108.085 -169.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -61.68 -36.19 80.16 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 128.124 2.57 . . . . 0.0 111.387 -168.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.9 tt -89.74 115.45 27.11 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 162.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -139.6 113.36 8.61 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 167.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 62.9 mt -139.62 115.2 10.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -177.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -134.2 129.7 36.13 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -141.51 163.07 33.91 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.453 1.501 . . . . 0.0 108.549 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 117.013 -1.47 . . . . 0.0 111.071 -174.418 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.212 0 N-CA-C 107.849 -2.1 . . . . 0.0 107.849 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.2 t0 61.21 90.37 0.07 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 -111.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -150.67 112.68 4.56 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 128.358 2.663 . . . . 0.0 103.962 -168.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -158.78 125.35 4.67 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 120.352 1.433 . . . . 0.0 108.249 170.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -153.82 85.38 4.0 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 127.214 2.206 . . . . 0.0 106.457 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -81.01 176.19 9.16 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.197 2.598 . . . . 0.0 110.103 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -153.7 -127.58 1.19 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 107.516 -2.234 . . . . 0.0 107.516 163.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -106.84 28.1 14.23 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-O 118.796 -1.002 . . . . 0.0 114.37 -174.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -108.74 93.97 4.8 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.932 1.366 . . . . 0.0 110.1 171.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.469 ' HA2' ' HE3' ' A' ' 71' ' ' LYS . . . 118.77 130.44 4.15 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 124.275 0.941 . . . . 0.0 114.792 155.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.51 122.32 36.25 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 163.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 35.3 mtp -75.18 175.01 8.68 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 145.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.412 ' CE2' ' HB2' ' A' ' 75' ' ' PHE . 1.4 p90 -167.57 171.28 10.44 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 125.499 1.52 . . . . 0.0 110.88 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -161.21 105.9 1.33 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.974 1.31 . . . . 0.0 107.565 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.6 p -80.75 158.57 4.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 119.917 -1.739 . . . . 0.0 109.445 166.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.6 p -128.7 158.95 37.16 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.826 1.25 . . . . 0.0 108.132 168.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.0 tp -136.85 97.99 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 172.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -75.0 147.17 41.02 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 164.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -118.26 150.25 39.77 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 161.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.0 162.82 34.59 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.54 -153.81 39.58 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -173.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -83.89 76.87 9.99 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 124.9 1.28 . . . . 0.0 109.898 -169.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -75.18 13.07 0.76 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 116.716 -1.611 . . . . 0.0 113.73 -175.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.6 mtt-85 -106.28 5.29 29.6 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 121.465 1.939 . . . . 0.0 114.766 -164.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.0 m -144.48 53.93 1.26 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.822 1.192 . . . . 0.0 111.959 175.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -135.47 137.6 42.32 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.238 1.015 . . . . 0.0 109.746 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.8 mm -78.28 93.67 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.583 1.153 . . . . 0.0 108.812 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -89.87 151.11 21.91 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 121.146 -0.971 . . . . 0.0 109.24 -176.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.1 m -138.79 142.99 38.74 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.347 1.059 . . . . 0.0 109.448 174.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.4 t -138.92 128.04 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 166.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.1 t -107.91 105.83 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 171.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.5 p -117.61 128.93 74.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 125.796 1.639 . . . . 0.0 110.583 -171.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.4 t -133.53 138.24 51.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -175.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.38 107.49 9.55 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 164.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.443 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 24.6 t-20 -63.6 113.98 3.67 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 171.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.66 -12.71 64.46 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.264 1.411 . . . . 0.0 116.108 169.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.9 t -149.82 172.06 15.75 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.351 2.076 . . . . 0.0 110.996 -172.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -89.74 160.85 16.35 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 122.641 1.21 . . . . 0.0 110.525 173.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.91 162.37 16.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 112.894 -1.957 . . . . 0.0 108.145 169.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -123.9 124.76 43.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 171.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -74.48 120.59 20.25 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.13 -20.83 75.25 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 117.636 -1.647 . . . . 0.0 113.695 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.64 -42.1 74.71 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.713 1.756 . . . . 0.0 112.583 -170.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 p -126.97 0.57 6.58 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.121 0.873 . . . . 0.0 112.896 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.11 28.63 40.42 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 123.812 0.72 . . . . 0.0 111.471 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -77.72 172.35 13.56 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.12 1.368 . . . . 0.0 109.055 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.8 t -123.73 130.73 53.09 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.648 0.737 . . . . 0.0 110.084 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 49.8 mt -118.91 121.32 39.69 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.362 -1.745 . . . . 0.0 108.864 -163.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.95 92.19 1.61 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.5 p -73.5 165.11 55.9 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-O 118.332 -0.842 . . . . 0.0 109.995 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -60.74 149.61 50.16 Favored 'Cis proline' 0 N--CA 1.452 -0.958 0 CA-C-N 120.354 1.162 . . . . 0.0 110.673 -13.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.4 p -142.31 158.71 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.8 mm -114.83 117.11 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 104.215 -2.513 . . . . 0.0 104.215 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 64.3 mt -77.69 159.9 28.83 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 169.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.5 m -138.82 -173.52 3.59 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.523 1.529 . . . . 0.0 108.256 -176.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -55.85 -41.3 74.13 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.407 1.483 . . . . 0.0 113.138 -174.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -67.19 -39.33 86.35 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.234 1.014 . . . . 0.0 111.133 -176.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -67.68 -22.51 65.28 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.729 0.812 . . . . 0.0 110.281 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 16.6 mt -115.82 20.12 14.75 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.664 1.985 . . . . 0.0 111.259 -173.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.15 3.89 7.86 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.667 1.187 . . . . 0.0 113.584 -172.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.3 m -122.8 167.13 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.539 1.536 . . . . 0.0 111.105 -165.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -57.08 -23.09 44.3 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.64 134.68 5.37 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 117.157 -1.401 . . . . 0.0 108.92 -168.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.0 t -126.45 161.94 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 164.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.4 m -142.04 127.21 18.54 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.989 1.715 . . . . 0.0 106.901 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -128.75 132.21 47.92 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.6 t -148.41 164.5 33.93 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 126.346 1.859 . . . . 0.0 106.601 -169.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.5 p -97.37 157.74 15.82 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 122.976 1.369 . . . . 0.0 112.869 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.6 p -76.2 -25.24 54.95 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.326 171.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -152.17 -169.11 17.21 Favored Glycine 0 CA--C 1.531 1.074 0 O-C-N 120.879 -1.138 . . . . 0.0 112.025 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.545 ' HE2' ' CD1' ' A' ' 73' ' ' ILE . 71.8 tttt -48.17 139.34 8.5 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 168.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -125.04 178.48 5.51 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 161.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.545 ' CD1' ' HE2' ' A' ' 71' ' ' LYS . 5.1 mm -111.43 -15.16 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.722 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.443 ' HG2' ' HB2' ' A' ' 35' ' ' ASN . 7.6 pt-20 -156.82 159.42 38.22 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -174.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.412 ' HB2' ' CE2' ' A' ' 13' ' ' TYR . 11.6 t80 -146.88 104.58 3.72 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.044 1.738 . . . . 0.0 109.738 165.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.41 148.19 22.48 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 118.548 -0.739 . . . . 0.0 109.724 176.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 t -149.17 112.65 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 124.97 1.308 . . . . 0.0 108.719 176.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.4 p -131.63 171.36 13.55 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 120.047 -1.658 . . . . 0.0 110.2 167.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 164.88 -99.05 0.16 Allowed Glycine 0 C--N 1.333 0.401 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 168.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.17 -175.3 15.7 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.371 0.986 . . . . 0.0 111.1 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.98 93.39 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.0 p -75.29 148.78 7.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 161.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.17 153.7 17.95 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.926 1.69 . . . . 0.0 107.601 166.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -125.48 13.2 7.39 Favored Glycine 0 N--CA 1.457 0.096 0 CA-C-O 117.724 -1.598 . . . . 0.0 112.99 -172.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -126.9 -179.17 4.69 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 118.834 1.317 . . . . 0.0 110.645 -176.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -169.26 125.53 0.9 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 125.999 1.72 . . . . 0.0 106.903 -169.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.86 -8.52 69.34 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.234 -0.759 . . . . 0.0 113.102 173.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.9 m -58.56 165.46 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.463 1.105 . . . . 0.0 110.052 168.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.3 t -124.95 78.62 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -102.42 179.31 4.34 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 125.332 1.453 . . . . 0.0 109.98 -170.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -109.2 162.96 18.14 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 123.482 0.713 . . . . 0.0 109.707 162.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -82.67 174.01 9.98 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.615 2.21 . . . . 0.0 112.637 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.3 ptm -143.9 163.25 33.97 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.574 0.749 . . . . 0.0 112.365 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -133.64 162.06 32.96 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.116 1.766 . . . . 0.0 109.617 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.4 m0 -127.52 150.42 49.69 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 125.922 1.689 . . . . 0.0 107.523 171.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.3 t -128.21 134.77 64.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 159.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 m -135.84 70.29 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -168.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.6 m -85.49 138.4 32.24 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -173.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.6 t -113.1 120.62 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -103.84 157.17 17.27 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 122.944 1.354 . . . . 0.0 108.325 168.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -116.34 176.62 5.02 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 130.127 3.371 . . . . 0.0 105.955 172.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -47.96 87.68 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 129.395 3.078 . . . . 0.0 108.941 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.4 58.64 10.5 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.133 1.349 . . . . 0.0 114.604 -171.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.409 ' HD2' ' H ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -168.83 154.09 6.2 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.045 1.922 . . . . 0.0 109.893 150.254 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.409 ' H ' ' HD2' ' A' ' 104' ' ' LYS . 18.7 tt0 -73.12 143.02 47.5 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.573 1.149 . . . . 0.0 108.906 165.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.1 pt -135.48 5.28 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 119.092 0.86 . . . . 0.0 113.065 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -152.73 160.15 43.13 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 120.548 -1.345 . . . . 0.0 108.522 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.9 tttm -158.09 86.71 0.9 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.176 0.898 . . . . 0.0 110.941 168.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.08 158.04 34.79 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 121.452 -0.78 . . . . 0.0 110.849 168.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.18 160.05 42.05 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 129.517 3.127 . . . . 0.0 107.46 177.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.9 mt -126.09 154.73 42.67 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.241 1.016 . . . . 0.0 108.297 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.5 p -136.31 130.57 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -129.66 173.6 10.47 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.239 1.015 . . . . 0.0 108.715 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 12.5 mtm180 -136.64 12.26 3.19 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.506 1.922 . . . . 0.0 111.739 -166.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.9 t70 63.49 170.61 0.16 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.228 2.211 . . . . 0.0 111.636 -163.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 51.58 54.83 22.81 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 127.813 2.625 . . . . 0.0 115.579 170.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.8 mmtt -154.59 125.74 7.28 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 118.995 1.398 . . . . 0.0 112.255 -176.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -56.47 159.86 3.47 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.964 1.706 . . . . 0.0 111.101 159.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.74 159.5 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 125.247 1.419 . . . . 0.0 109.307 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.72 28.55 0.05 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.505 1.122 . . . . 0.0 111.074 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 20.9 p -104.43 171.32 7.4 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.14 1.376 . . . . 0.0 110.089 -170.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -83.08 28.77 0.5 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.427 1.091 . . . . 0.0 110.576 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -52.52 -40.03 61.99 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.796 1.638 . . . . 0.0 111.461 -170.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.46 91.82 2.58 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -153.65 81.72 1.16 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.866 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mp -114.85 146.87 40.61 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 126.692 1.997 . . . . 0.0 110.54 -173.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.99 110.25 3.73 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 177.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -115.16 117.19 29.82 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--O 1.246 0.883 0 C-N-CA 124.293 1.037 . . . . 0.0 110.039 -179.608 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.809 0 N-CA-C 106.412 -2.675 . . . . 0.0 106.412 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -145.31 115.94 7.68 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 -169.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -153.4 80.46 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 -163.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -159.38 147.24 17.41 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.535 1.534 . . . . 0.0 107.649 -159.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -154.21 69.37 6.13 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 124.146 0.978 . . . . 0.0 109.805 167.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.44 132.72 32.17 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.815 1.677 . . . . 0.0 112.826 -174.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.31 -98.65 0.15 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.738 1.637 . . . . 0.0 110.36 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 103.26 157.08 24.95 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 124.85 1.214 . . . . 0.0 111.525 166.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -132.23 137.07 47.41 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -177.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.56 -130.72 2.19 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 128.114 2.768 . . . . 0.0 108.185 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -154.02 -157.01 0.73 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.696 1.198 . . . . 0.0 109.659 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 37.3 mtp -121.61 161.5 22.32 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 154.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -133.9 152.02 51.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 123.836 0.71 . . . . 0.0 109.477 167.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -147.63 121.47 9.32 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.7 p -123.05 145.95 29.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 124.854 1.262 . . . . 0.0 108.868 -168.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 73.3 p -118.0 162.67 17.78 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 122.186 0.993 . . . . 0.0 110.647 174.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.1 tp -144.73 90.92 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 165.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -75.56 132.97 41.05 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 162.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -112.43 111.26 21.99 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.705 2.002 . . . . 0.0 106.864 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -87.56 177.95 6.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.836 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.85 -134.2 52.07 Favored Glycine 0 C--N 1.335 0.485 0 C-N-CA 123.201 0.429 . . . . 0.0 112.756 163.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.74 38.78 1.15 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -162.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.462 ' HA ' ' SD ' ' A' ' 93' ' ' MET . 25.0 p90 -55.86 4.19 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 119.699 3.222 . . . . 0.0 119.699 -162.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.67 13.61 17.41 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 126.349 1.859 . . . . 0.0 113.152 -155.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.7 m -150.87 23.19 0.77 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -169.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -135.26 129.89 34.31 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.323 1.049 . . . . 0.0 108.453 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -68.69 93.32 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 119.704 1.138 . . . . 0.0 110.553 -177.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.79 151.37 22.93 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.433 -0.792 . . . . 0.0 110.522 173.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.6 m -140.04 150.49 44.45 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.273 1.829 . . . . 0.0 107.066 170.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.4 t -140.69 115.05 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.89 150.9 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 164.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.8 p -136.1 133.51 50.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 158.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.4 t -114.55 153.15 16.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 170.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.48 159.56 44.39 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.099 0.96 . . . . 0.0 108.547 169.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -125.04 117.09 23.21 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 127.09 2.156 . . . . 0.0 107.075 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.05 -1.29 67.56 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-O 118.365 -1.241 . . . . 0.0 114.607 163.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -159.3 174.91 14.05 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.8 1.8 . . . . 0.0 109.153 174.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -97.75 176.08 5.94 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.263 1.025 . . . . 0.0 111.173 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.37 161.41 13.94 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.337 1.055 . . . . 0.0 109.14 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -133.54 131.61 39.96 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 125.704 1.601 . . . . 0.0 107.227 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -101.22 119.5 38.85 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 123.918 0.761 . . . . 0.0 109.943 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.84 -7.99 5.26 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 118.016 -1.435 . . . . 0.0 114.205 171.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.94 -45.73 82.55 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 120.462 2.131 . . . . 0.0 111.509 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.23 -11.38 0.12 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.821 1.248 . . . . 0.0 112.508 -167.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.3 2.02 55.71 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.507 1.051 . . . . 0.0 112.199 -166.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -63.15 119.27 9.22 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.849 1.324 . . . . 0.0 110.203 -173.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.76 134.82 35.48 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.648 1.579 . . . . 0.0 108.8 172.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.3 mt -129.71 169.81 14.62 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.884 1.273 . . . . 0.0 109.384 -173.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.03 101.88 7.96 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 126.36 1.864 . . . . 0.0 108.179 -166.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.4 168.59 23.55 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 125.33 1.452 . . . . 0.0 112.438 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -72.28 141.57 71.27 Favored 'Cis proline' 0 C--N 1.35 0.639 0 N-CA-C 109.559 -0.977 . . . . 0.0 109.559 -8.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.9 p -145.11 161.51 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 121.435 -0.79 . . . . 0.0 110.125 -175.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.4 mm -118.66 114.62 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -177.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -80.5 133.65 35.85 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 169.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.408 ' H ' ' HG2' ' A' ' 58' ' ' GLU . 6.9 m -101.88 -177.91 3.56 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.944 1.697 . . . . 0.0 110.082 -175.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -52.64 -46.3 67.06 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.423 1.489 . . . . 0.0 111.676 -173.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -74.19 -30.25 62.13 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.212 0.605 . . . . 0.0 112.627 -171.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 55' ' ' SER . 2.2 mm-40 -67.75 -32.9 73.82 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.266 0.626 . . . . 0.0 109.993 173.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.69 7.25 44.34 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.106 1.762 . . . . 0.0 112.373 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.85 45.02 0.68 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.857 1.663 . . . . 0.0 112.488 -170.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.0 m -138.52 170.0 17.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 127.978 2.511 . . . . 0.0 109.537 -175.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -72.57 -24.83 61.16 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.207 -0.933 . . . . 0.0 112.964 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -152.46 145.93 24.88 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 t -120.9 153.06 24.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 160.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 93.0 m -149.2 135.84 19.51 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 120.148 -1.595 . . . . 0.0 108.551 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -134.8 164.05 28.42 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 125.24 1.416 . . . . 0.0 109.019 -172.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.0 t -152.86 158.53 42.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.783 0.833 . . . . 0.0 108.876 173.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.0 p -65.84 138.3 57.79 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.551 1.541 . . . . 0.0 109.205 163.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 74.3 p -75.29 -16.74 60.41 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 120.359 1.436 . . . . 0.0 113.449 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -156.83 -163.8 12.82 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 -174.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.35 115.7 7.29 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.44 176.04 6.74 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.859 1.264 . . . . 0.0 111.312 -173.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -137.41 5.37 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -172.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -147.55 164.55 33.1 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 121.178 1.808 . . . . 0.0 111.982 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -156.41 86.44 1.01 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.324 1.45 . . . . 0.0 107.679 155.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.01 138.89 34.79 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 121.482 -0.761 . . . . 0.0 109.209 166.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.2 t -143.15 130.83 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.8 m -143.71 169.22 18.15 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.051 1.341 . . . . 0.0 108.059 166.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 164.69 -175.15 40.72 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -174.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.8 -175.27 41.46 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 176.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -148.31 162.99 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 126.838 2.055 . . . . 0.0 108.415 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.2 m -119.1 167.25 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 C-N-CA 126.405 1.882 . . . . 0.0 107.671 158.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -114.2 148.59 37.08 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 112.539 -2.119 . . . . 0.0 105.668 138.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -143.96 36.94 1.47 Allowed Glycine 0 C--N 1.318 -0.458 0 C-N-CA 125.505 1.526 . . . . 0.0 111.269 176.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -108.94 149.72 28.78 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.423 0.63 . . . . 0.0 109.468 177.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -148.12 95.18 2.43 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -166.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 121.11 22.22 2.96 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 123.745 0.688 . . . . 0.0 113.337 -171.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.0 m -124.89 -179.66 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.003 1.721 . . . . 0.0 109.064 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.3 t -137.59 86.84 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 174.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -78.09 -178.43 5.58 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.675 1.19 . . . . 0.0 109.494 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -120.77 160.72 43.36 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 125.144 1.378 . . . . 0.0 107.784 157.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -81.17 178.85 6.4 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.077 1.851 . . . . 0.0 112.436 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.462 ' SD ' ' HA ' ' A' ' 23' ' ' PHE . 15.7 ptm -146.28 163.27 36.01 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 122.008 0.908 . . . . 0.0 111.145 173.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -122.82 158.77 29.53 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.394 1.477 . . . . 0.0 107.715 177.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 21.0 m0 -126.64 132.93 51.11 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 176.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.273 2.1 p -130.03 106.97 14.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.0 m -117.75 106.05 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 125.779 1.632 . . . . 0.0 106.98 -166.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.2 m -88.38 160.42 17.59 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 174.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.5 t -125.73 138.38 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 159.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -116.03 151.4 35.57 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 126.904 2.082 . . . . 0.0 107.843 170.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.441 ' HG2' HD21 ' A' ' 102' ' ' ASN . 15.3 tttm -99.69 -172.54 2.26 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 128.986 2.914 . . . . 0.0 107.895 174.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.441 HD21 ' HG2' ' A' ' 101' ' ' LYS . 0.1 OUTLIER -61.82 75.36 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.682 1.593 . . . . 0.0 110.547 167.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.43 42.44 6.95 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.711 1.624 . . . . 0.0 114.292 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -159.21 151.67 21.43 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.351 1.576 . . . . 0.0 108.448 165.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -76.17 137.73 40.23 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 159.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.7 pt -130.12 -18.39 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 118.295 -0.86 . . . . 0.0 113.262 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -143.7 139.23 29.4 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 120.156 1.344 . . . . 0.0 110.062 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -144.94 104.14 3.96 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -174.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -141.8 174.58 10.45 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 173.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.7 t -148.35 159.6 43.84 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.12 1.368 . . . . 0.0 109.271 174.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.3 mt -125.34 164.86 19.46 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.613 1.965 . . . . 0.0 109.001 -176.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.56 86.2 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 125.704 1.602 . . . . 0.0 108.828 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -72.14 173.11 8.98 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 168.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -139.42 171.92 13.57 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 123.039 1.4 . . . . 0.0 110.409 176.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -109.55 164.69 12.29 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 130.154 3.381 . . . . 0.0 110.791 -166.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.38 -76.12 0.79 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 126.701 2.096 . . . . 0.0 110.85 -170.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . 0.292 0.0 OUTLIER -164.76 16.32 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -152.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -131.18 108.24 9.58 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.4 pp -151.8 168.05 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.684 0 C-N-CA 127.829 2.452 . . . . 0.0 108.862 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.7 p -114.48 160.28 19.38 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 122.217 1.008 . . . . 0.0 108.931 162.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 17.2 p -83.57 -7.96 59.42 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.293 1.037 . . . . 0.0 112.434 171.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 50.3 p30 -114.43 15.28 17.94 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -159.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.41 -18.83 64.13 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -172.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -132.18 134.65 45.62 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.814 1.643 . . . . 0.0 110.872 172.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.72 89.06 1.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 158.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 29.6 mt -110.15 140.43 44.26 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -153.64 73.93 0.98 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.729 1.612 . . . . 0.0 108.28 -176.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -73.39 148.31 43.48 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 121.661 -0.649 . . . . 0.0 109.843 170.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.5 p30 . . . . . 0 C--O 1.248 1.008 0 C-N-CA 127.116 2.166 . . . . 0.0 106.058 156.484 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.084 0 N-CA-C 105.767 -2.933 . . . . 0.0 105.767 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -151.84 109.32 3.61 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 103.013 -2.958 . . . . 0.0 103.013 -136.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -159.32 125.58 4.45 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 127.422 2.289 . . . . 0.0 105.425 -164.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -155.42 166.69 32.76 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.413 1.006 . . . . 0.0 112.102 -176.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -154.27 87.14 3.59 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 125.766 1.626 . . . . 0.0 107.518 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -80.49 63.75 8.8 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.359 2.706 . . . . 0.0 110.863 -167.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.81 1.76 78.79 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.126 -1.035 . . . . 0.0 115.144 -148.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.57 154.49 16.5 Favored Glycine 0 C--O 1.24 0.508 0 C-N-CA 124.532 1.063 . . . . 0.0 110.529 -172.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -153.1 166.4 32.6 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 128.608 2.763 . . . . 0.0 105.571 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.401 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . -160.53 -131.76 1.27 Allowed Glycine 0 CA--C 1.523 0.587 0 C-N-CA 124.235 0.921 . . . . 0.0 111.204 175.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -143.34 -160.52 1.12 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.764 1.226 . . . . 0.0 110.92 -171.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 30.4 mtp -135.27 167.06 21.72 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 128.58 2.752 . . . . 0.0 107.307 157.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -154.92 156.05 35.39 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.417 1.887 . . . . 0.0 108.87 -174.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -168.41 126.66 1.12 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.234 2.214 . . . . 0.0 106.23 -172.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.6 m -136.72 158.94 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 125.656 1.583 . . . . 0.0 110.177 -170.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.6 p -126.5 159.24 33.96 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.334 0.654 . . . . 0.0 111.062 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 tp -132.33 111.12 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 167.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -97.42 145.67 25.95 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 162.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -127.32 128.52 46.06 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.945 1.698 . . . . 0.0 107.717 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.1 m -149.85 178.88 8.5 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.524 1.53 . . . . 0.0 108.791 -167.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.52 -149.4 51.25 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -166.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -80.04 60.21 3.51 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.108 1.363 . . . . 0.0 111.691 -173.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.434 ' HA ' ' HE2' ' A' ' 93' ' ' MET . 52.1 p90 -76.44 30.57 0.12 Allowed 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.397 -1.439 . . . . 0.0 114.462 -174.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.9 mtt85 -106.83 -10.18 16.13 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -163.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.4 t -154.03 83.37 1.14 Allowed 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -145.95 165.85 27.75 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.975 0.91 . . . . 0.0 110.538 172.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.4 mt -132.11 88.47 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 125.473 1.509 . . . . 0.0 107.767 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.71 168.12 16.55 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.098 -1.002 . . . . 0.0 111.336 176.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.0 t -124.75 161.03 27.29 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 161.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -140.55 113.92 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 160.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.5 t -74.94 131.45 34.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 159.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.2 t -129.43 143.48 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 C-N-CA 124.541 1.136 . . . . 0.0 108.184 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 t -138.25 147.06 25.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.24 119.62 11.59 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.998 1.319 . . . . 0.0 108.111 169.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -76.78 127.39 32.67 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 118.166 -0.921 . . . . 0.0 109.859 173.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.82 0.05 69.36 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.085 1.326 . . . . 0.0 114.946 163.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.5 t -161.47 -179.43 7.34 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.621 1.21 . . . . 0.0 110.666 -170.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -104.42 169.94 8.18 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.073 1.349 . . . . 0.0 109.689 169.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.3 tp -101.77 164.43 11.74 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 127.274 2.23 . . . . 0.0 109.299 -174.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -130.11 114.21 15.46 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 126.144 1.777 . . . . 0.0 106.622 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -69.61 118.79 12.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 174.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.88 -7.24 55.31 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 117.671 -1.627 . . . . 0.0 113.52 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.2 -60.11 4.27 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 120.567 2.183 . . . . 0.0 110.067 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.98 3.09 3.7 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.304 1.841 . . . . 0.0 111.46 -167.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.57 17.73 67.76 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.843 1.211 . . . . 0.0 112.153 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -69.79 124.85 25.04 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.98 1.312 . . . . 0.0 109.854 -169.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.77 111.99 10.53 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.354 1.062 . . . . 0.0 109.933 173.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.4 mt -121.66 142.78 49.8 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 123.593 0.757 . . . . 0.0 109.44 -177.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.86 95.09 9.97 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.434 1.111 . . . . 0.0 108.6 175.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.3 p -51.24 154.51 2.82 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.199 157.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.76 130.57 20.85 Favored 'Cis proline' 0 N--CA 1.457 -0.648 0 CA-C-N 120.747 1.302 . . . . 0.0 111.159 -2.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.0 p -132.28 154.21 39.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 124.554 1.142 . . . . 0.0 108.618 -169.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.4 mm -117.55 120.14 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.1 mt -87.89 136.19 33.07 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.85 171.1 14.97 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.239 1.816 . . . . 0.0 108.932 171.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -61.23 -35.4 77.14 Favored 'General case' 0 C--O 1.22 -0.463 0 O-C-N 121.031 -1.043 . . . . 0.0 109.903 164.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -59.56 -25.69 64.76 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.707 1.203 . . . . 0.0 111.937 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -90.98 -28.55 17.95 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.768 1.227 . . . . 0.0 110.716 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.3 mt -113.08 5.08 16.96 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 124.376 1.07 . . . . 0.0 113.587 -169.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.03 45.66 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.387 2.675 . . . . 0.0 111.224 168.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.6 m -119.74 160.4 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 129.135 2.974 . . . . 0.0 108.303 173.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.64 -44.65 93.44 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 121.564 -0.71 . . . . 0.0 111.25 170.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.23 152.1 29.93 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 120.794 -1.191 . . . . 0.0 109.221 -175.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.9 p -142.19 165.4 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.419 0.628 . . . . 0.0 109.35 158.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.8 m -111.7 142.66 43.75 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 127.212 2.205 . . . . 0.0 105.993 170.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -123.33 133.27 54.15 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 169.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.47 177.89 8.14 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -174.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.1 p -119.19 147.29 44.38 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 118.894 0.77 . . . . 0.0 112.984 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.7 p -71.64 -12.63 61.44 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.634 1.173 . . . . 0.0 113.16 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -165.72 -169.73 29.71 Favored Glycine 0 N--CA 1.448 -0.562 0 O-C-N 120.596 -1.315 . . . . 0.0 110.522 -165.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.401 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 14.5 ttpt -55.46 115.6 2.39 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.624 1.57 . . . . 0.0 109.343 -176.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -111.33 145.42 38.87 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.3 mt -131.23 -11.23 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 118.878 -0.582 . . . . 0.0 112.02 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -144.4 137.87 27.36 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -125.69 100.2 6.32 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 165.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.21 152.89 21.34 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 163.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.32 123.79 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 170.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.4 p -142.33 170.49 15.61 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.759 0.709 . . . . 0.0 111.027 164.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 142.41 -75.96 0.31 Allowed Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 176.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.43 ' H ' HD12 ' A' ' 124' ' ' LEU . . . 69.95 -152.38 51.22 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.9 p -159.13 157.27 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.315 1.046 . . . . 0.0 110.477 -176.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.8 p -143.24 170.14 10.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 128.131 2.573 . . . . 0.0 104.727 156.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -106.9 144.04 34.11 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 118.597 0.635 . . . . 0.0 109.343 165.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.89 -21.96 34.66 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-O 119.279 -0.734 . . . . 0.0 112.142 -176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -68.76 150.61 47.67 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 118.393 1.097 . . . . 0.0 109.195 -170.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.88 10.32 7.64 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.387 1.075 . . . . 0.0 110.662 -174.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.82 19.07 3.54 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 127.23 2.348 . . . . 0.0 112.316 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.6 t -133.91 137.07 52.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.7 p -134.94 147.89 29.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.9 1.68 . . . . 0.0 106.644 173.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -150.0 -168.87 3.23 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 123.438 0.695 . . . . 0.0 109.414 -164.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -87.84 165.74 28.15 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 123.768 0.827 . . . . 0.0 110.895 158.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -78.65 173.57 13.49 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.442 2.761 . . . . 0.0 112.741 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.519 ' CE ' ' HE1' ' A' ' 95' ' ' TRP . 2.7 ptm -125.2 162.23 25.13 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.355 -0.841 . . . . 0.0 111.508 176.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -142.8 144.81 32.72 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 124.992 1.317 . . . . 0.0 108.147 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.519 ' HE1' ' CE ' ' A' ' 93' ' ' MET . 52.7 m0 -123.35 156.92 34.43 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.2 t -133.26 117.92 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.7 m -128.54 123.85 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -165.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.2 m -121.75 156.96 32.04 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -173.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.9 t -131.65 131.56 62.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 123.808 0.843 . . . . 0.0 108.955 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -114.45 166.35 11.79 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.205 1.802 . . . . 0.0 109.099 170.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.02 -156.0 0.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.383 1.873 . . . . 0.0 108.094 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -65.76 68.7 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.563 1.145 . . . . 0.0 112.151 164.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.17 38.0 4.7 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.826 1.203 . . . . 0.0 113.428 166.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.54 152.72 12.35 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.555 1.177 . . . . 0.0 109.831 168.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -64.33 137.91 58.15 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 157.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.4 pt -123.86 -27.92 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 117.579 -1.201 . . . . 0.0 112.209 172.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -140.15 149.96 43.65 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.376 1.444 . . . . 0.0 109.39 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -152.83 108.94 3.36 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.663 1.985 . . . . 0.0 105.784 -174.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.68 154.09 39.17 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.175 170.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.87 157.83 27.91 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 125.593 1.557 . . . . 0.0 109.268 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 73.8 mt -129.82 147.64 51.62 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.432 1.093 . . . . 0.0 108.199 -163.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.9 p -129.82 100.87 5.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.62 0.724 . . . . 0.0 109.175 -171.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -92.32 179.56 5.51 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 122.119 0.962 . . . . 0.0 108.488 167.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 48.0 mtm180 -134.23 -164.36 1.49 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.918 2.087 . . . . 0.0 106.833 -168.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -47.05 146.95 1.54 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.213 1.005 . . . . 0.0 108.888 164.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -55.81 -34.18 60.84 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-O 119.485 -0.62 . . . . 0.0 113.376 -173.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -89.64 19.4 4.66 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 -169.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -160.38 91.92 0.95 Allowed 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 127.892 2.477 . . . . 0.0 111.979 -161.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.8 pp -142.43 159.59 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 O-C-N 118.729 -2.482 . . . . 0.0 111.391 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.8 p 179.87 82.32 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.582 1.553 . . . . 0.0 111.343 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.63 151.71 46.21 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 -170.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.73 56.49 1.16 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 158.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.28 -82.65 0.03 OUTLIER 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.838 1.255 . . . . 0.0 110.429 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.43 HD12 ' H ' ' A' ' 80' ' ' GLY . 19.6 mt -111.16 96.18 5.98 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 -176.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -153.65 58.97 0.75 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.617 175.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 83.2 mt -107.91 145.36 33.88 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -153.18 72.19 0.93 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.002 0.906 . . . . 0.0 109.794 -176.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -65.15 133.53 51.76 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 171.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.3 p30 . . . . . 0 C--O 1.255 1.38 0 C-N-CA 125.363 1.465 . . . . 0.0 109.863 175.335 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.76 0 N-CA-C 105.053 -3.219 . . . . 0.0 105.053 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 75.1 68.55 0.08 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 163.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -153.38 149.44 27.81 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 129.004 2.922 . . . . 0.0 106.281 -134.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -171.18 164.55 7.31 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 128.257 2.623 . . . . 0.0 106.979 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -153.64 85.19 4.1 Favored Pre-proline 0 C--O 1.237 0.397 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -79.35 161.18 25.79 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.406 2.071 . . . . 0.0 110.837 176.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.38 32.79 0.64 Allowed Glycine 0 CA--C 1.525 0.713 0 O-C-N 121.273 -0.892 . . . . 0.0 111.512 -173.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.87 -174.92 14.31 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 125.229 1.395 . . . . 0.0 111.077 -171.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -146.27 166.05 27.42 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.403 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . -177.06 -135.42 2.19 Favored Glycine 0 C--N 1.317 -0.484 0 C-N-CA 127.842 2.639 . . . . 0.0 106.899 177.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.64 174.58 11.3 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.238 1.019 . . . . 0.0 109.232 -176.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.8 mtp -84.39 -174.05 5.06 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 119.764 -1.835 . . . . 0.0 109.253 154.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -153.2 148.6 27.08 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.366 0.667 . . . . 0.0 110.487 152.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -142.06 144.63 33.68 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.898 2.079 . . . . 0.0 108.354 172.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 p -138.53 153.54 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 126.957 2.103 . . . . 0.0 110.105 175.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -114.31 153.84 29.06 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.465 1.506 . . . . 0.0 109.185 167.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.2 tp -105.34 148.4 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 155.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -139.92 115.25 9.88 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 167.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -104.59 128.65 52.65 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 126.014 1.726 . . . . 0.0 107.474 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -138.02 173.92 11.11 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 122.702 0.401 . . . . 0.0 110.666 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.64 -82.34 1.59 Allowed Glycine 0 CA--C 1.52 0.373 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -175.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.414 ' CG ' HH11 ' A' ' 24' ' ' ARG . 17.9 t0 -168.54 104.32 0.43 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 117.997 0.899 . . . . 0.0 112.927 175.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -96.25 24.61 5.57 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.515 -1.366 . . . . 0.0 112.363 -178.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.414 HH11 ' CG ' ' A' ' 22' ' ' ASP . 69.6 mtt85 -69.34 -47.23 64.98 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -172.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.4 m -127.26 69.15 1.28 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.807 1.185 . . . . 0.0 109.465 -177.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -143.02 117.66 9.81 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.7 mm -84.62 79.06 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.538 ' HD3' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -79.44 145.41 33.32 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.209 1.403 . . . . 0.0 108.614 167.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.4 m -135.8 174.72 10.3 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 169.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.2 t -141.52 160.51 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 174.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.8 p -114.56 151.34 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 158.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.5 p -139.31 139.25 39.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 118.626 0.648 . . . . 0.0 110.413 162.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.5 t -126.47 144.81 35.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 126.49 1.916 . . . . 0.0 106.299 169.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.61 95.43 2.65 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.981 1.312 . . . . 0.0 109.048 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -62.56 100.3 0.18 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.314 1.446 . . . . 0.0 110.072 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.65 1.28 25.94 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 117.405 1.722 . . . . 0.0 117.405 159.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 t -157.78 179.11 9.52 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.934 2.367 . . . . 0.0 109.086 174.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -91.38 161.35 15.04 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.481 0.658 . . . . 0.0 110.471 175.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.3 mt -84.42 171.93 12.17 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.563 0.745 . . . . 0.0 109.731 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -135.74 129.09 32.07 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.779 1.232 . . . . 0.0 108.42 170.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -89.4 117.19 28.14 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.634 1.173 . . . . 0.0 109.808 173.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.96 11.72 5.86 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.079 1.323 . . . . 0.0 114.235 175.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.72 -48.16 56.01 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 120.123 1.962 . . . . 0.0 108.973 168.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.31 -9.71 0.57 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.686 1.194 . . . . 0.0 111.715 -167.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.86 13.4 55.01 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.244 1.878 . . . . 0.0 112.903 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -68.51 138.5 55.24 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -174.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.7 m -71.54 147.23 47.89 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 170.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 mt -130.07 158.8 38.64 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 118.491 0.587 . . . . 0.0 109.56 171.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.48 103.59 10.25 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 126.77 2.028 . . . . 0.0 108.267 -173.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.95 165.54 52.38 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.233 169.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.98 140.05 64.91 Favored 'Cis proline' 0 N--CA 1.454 -0.813 0 N-CA-C 109.791 -0.888 . . . . 0.0 109.791 -8.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.2 p -143.37 160.05 17.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.03 0.932 . . . . 0.0 110.891 -177.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.0 mm -118.89 125.06 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 126.968 2.107 . . . . 0.0 107.111 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.3 mt -83.11 144.59 29.76 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 166.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.25 175.7 5.32 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.36 2.264 . . . . 0.0 109.544 176.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -59.39 -35.37 73.82 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.725 1.21 . . . . 0.0 113.428 -175.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -70.68 -28.48 64.8 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.962 0.801 . . . . 0.0 112.611 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -70.29 -52.98 18.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 32.1 mt -77.28 24.61 0.18 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.786 2.034 . . . . 0.0 111.379 -175.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.07 -11.11 59.89 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.459 1.104 . . . . 0.0 112.155 175.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.9 m -84.1 148.61 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.442 1.097 . . . . 0.0 110.177 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -61.78 -33.24 73.75 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.638 -0.664 . . . . 0.0 112.19 173.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -154.4 141.05 18.96 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 -166.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.98 158.62 23.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -134.46 119.46 18.55 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -175.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 17.7 mt -136.65 137.79 40.42 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 118.991 0.814 . . . . 0.0 109.626 -172.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -147.62 -168.23 3.01 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -168.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.22 147.54 42.41 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 127.369 2.268 . . . . 0.0 108.99 176.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 79.9 p -73.93 -20.84 60.26 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.515 -0.74 . . . . 0.0 111.302 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -156.59 -156.37 7.83 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 124.25 0.928 . . . . 0.0 111.05 -177.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.403 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 12.4 ttpt -67.75 137.37 55.4 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.875 0.87 . . . . 0.0 109.793 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -138.16 174.62 10.36 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.079 1.752 . . . . 0.0 109.783 172.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.73 21.07 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 123.544 0.738 . . . . 0.0 109.426 -174.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -155.0 158.08 38.61 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 119.217 -2.177 . . . . 0.0 109.371 168.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.75 85.22 1.42 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.15 1.38 . . . . 0.0 107.547 160.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.85 137.59 37.75 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 171.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.3 t -148.88 105.88 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 126.811 2.044 . . . . 0.0 106.445 -174.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.0 m -141.55 173.02 11.89 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.699 1.2 . . . . 0.0 111.082 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.66 -89.7 0.11 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 123.992 0.806 . . . . 0.0 111.361 167.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.01 133.43 7.94 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 108.796 -1.721 . . . . 0.0 108.796 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.4 p -96.07 168.86 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.8 p -125.74 -177.96 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 175.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -112.18 105.03 13.27 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -94.99 7.99 70.08 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 124.484 1.04 . . . . 0.0 112.741 -165.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -122.3 176.79 5.67 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.557 1.543 . . . . 0.0 107.308 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -167.08 125.51 1.33 Allowed 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.06 1.744 . . . . 0.0 106.406 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.64 30.7 66.04 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.538 1.066 . . . . 0.0 112.188 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.6 m -102.62 -164.6 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 125.771 1.628 . . . . 0.0 109.901 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.28 110.65 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 160.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -141.11 -179.38 6.06 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.947 1.699 . . . . 0.0 107.251 165.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -119.71 160.2 43.3 Favored Pre-proline 0 C--N 1.33 -0.271 0 C-N-CA 124.646 1.179 . . . . 0.0 109.424 172.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -84.24 178.78 4.98 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.923 2.415 . . . . 0.0 112.312 176.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.5 ptm -148.37 171.2 16.41 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.287 -0.883 . . . . 0.0 112.164 -169.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -140.04 159.12 42.9 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 126.882 2.073 . . . . 0.0 107.547 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.0 m0 -128.3 141.58 51.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.018 1.327 . . . . 0.0 107.672 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -124.81 105.42 15.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 103.59 -2.745 . . . . 0.0 103.59 164.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.0 m -83.25 157.45 3.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 155.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 28.6 m -138.79 133.43 32.11 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 169.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.9 t -112.52 141.15 28.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -125.0 138.85 54.21 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.79 2.036 . . . . 0.0 108.529 -175.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -101.14 -174.79 2.69 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.341 1.457 . . . . 0.0 107.613 174.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -68.78 65.89 0.13 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.608 2.363 . . . . 0.0 109.031 -177.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 165.21 -68.81 0.2 Allowed Glycine 0 N--CA 1.448 -0.55 0 CA-C-O 118.675 -1.069 . . . . 0.0 112.278 -172.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -157.01 -176.59 6.07 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.534 1.133 . . . . 0.0 111.289 -174.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.86 139.03 14.03 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.899 1.68 . . . . 0.0 110.037 169.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.9 pt -129.12 -22.9 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 117.822 -1.085 . . . . 0.0 112.253 171.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -124.09 128.01 48.66 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 120.092 1.315 . . . . 0.0 110.411 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -126.6 90.89 3.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.052 1.741 . . . . 0.0 107.479 175.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -130.51 162.85 28.32 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 167.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.6 t -151.06 151.98 32.8 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.63 1.572 . . . . 0.0 107.026 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 36.9 mt -121.68 161.87 21.76 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.621 1.568 . . . . 0.0 109.112 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.0 p -137.75 132.82 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -120.96 106.44 11.61 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -147.39 104.37 3.64 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -169.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -169.72 -166.86 0.61 Allowed 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 127.491 2.317 . . . . 0.0 106.894 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.76 14.6 0.34 Allowed Glycine 0 CA--C 1.525 0.713 0 CA-C-O 118.931 -0.927 . . . . 0.0 112.242 169.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -141.62 174.74 10.28 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.817 1.308 . . . . 0.0 109.17 -170.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -60.39 133.27 55.94 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 173.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.9 pp -150.99 176.6 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 126.801 2.04 . . . . 0.0 107.488 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.1 m -157.83 90.11 1.05 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.411 1.484 . . . . 0.0 107.661 166.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.56 164.57 24.56 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 122.203 1.001 . . . . 0.0 109.251 156.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -116.94 60.22 0.75 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 162.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -68.07 -15.8 63.75 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -173.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.0 tp -122.55 114.98 21.39 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -154.28 53.71 0.68 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.345 1.458 . . . . 0.0 110.531 -159.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.3 mt -118.56 140.11 50.4 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -171.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -151.71 67.65 0.88 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.968 1.307 . . . . 0.0 109.451 -168.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -64.89 159.76 22.03 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.003 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.8 t30 . . . . . 0 C--O 1.25 1.094 0 C-N-CA 128.408 2.683 . . . . 0.0 106.123 -176.388 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.635 0 N-CA-C 105.915 -2.874 . . . . 0.0 105.915 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -175.12 128.64 0.28 Allowed 'General case' 0 C--O 1.245 0.86 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 -155.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -136.49 -12.11 1.83 Allowed 'General case' 0 C--O 1.236 0.365 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -156.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -85.29 106.22 16.53 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.935 1.698 . . . . 0.0 109.63 169.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -154.26 82.52 4.33 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 162.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -78.52 142.43 18.43 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.95 2.433 . . . . 0.0 110.222 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -109.37 -61.15 0.52 Allowed Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.67 -149.04 21.14 Favored Glycine 0 C--N 1.333 0.413 0 O-C-N 121.352 -1.087 . . . . 0.0 110.845 -168.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.2 pttt -129.76 150.7 50.96 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 125.8 1.64 . . . . 0.0 108.995 -174.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.26 -126.55 1.14 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 129.684 3.516 . . . . 0.0 107.688 172.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -152.02 -175.3 5.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.52 1.928 . . . . 0.0 108.694 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 49.5 mtp -103.54 166.86 10.17 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 155.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -133.61 153.89 51.31 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.558 1.143 . . . . 0.0 108.033 169.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -148.36 145.19 27.98 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.29 133.76 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 127.195 2.198 . . . . 0.0 106.512 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 p -94.4 171.36 8.87 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.507 HG22 ' H ' ' A' ' 64' ' ' VAL . 11.3 tp -132.87 146.49 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 160.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -136.24 117.57 14.63 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 161.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -107.06 128.97 54.85 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 173.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.3 p -149.1 168.4 23.3 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 122.141 -0.35 . . . . 0.0 111.335 171.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.48 -114.53 3.96 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 107.284 -2.326 . . . . 0.0 107.284 -170.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.417 ' CG ' ' HE ' ' A' ' 24' ' ' ARG . 12.6 t0 -116.11 90.24 3.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 122.008 0.909 . . . . 0.0 110.709 -174.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -102.57 21.76 14.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.958 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.417 ' HE ' ' CG ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -133.0 19.31 4.1 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.552 1.541 . . . . 0.0 112.311 -168.425 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.8 m -134.75 -1.27 2.77 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.302 1.441 . . . . 0.0 113.484 -173.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -119.24 -174.47 2.73 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.363 1.065 . . . . 0.0 108.328 -171.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.9 mp -129.87 80.8 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.457 ' HE2' ' OD2' ' A' ' 56' ' ' ASP . 2.3 pttt -81.1 162.42 23.71 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 121.835 -0.541 . . . . 0.0 110.091 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 m -145.35 158.06 43.91 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 171.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 74.4 t -142.28 105.77 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -68.49 149.11 11.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 159.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.04 142.23 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 124.982 1.313 . . . . 0.0 108.207 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.4 t -137.58 149.33 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 171.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.0 93.84 2.64 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 172.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -69.82 104.71 2.54 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.11 7.05 38.75 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.75 -1.028 . . . . 0.0 114.284 165.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.9 t -161.89 177.59 9.69 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.546 1.173 . . . . 0.0 109.024 -174.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -100.05 170.29 8.59 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.091 0.956 . . . . 0.0 108.739 171.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 tp -84.48 170.14 13.79 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.316 0.646 . . . . 0.0 109.396 164.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -134.67 120.19 19.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.898 1.279 . . . . 0.0 108.087 171.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -69.49 129.32 39.38 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.124 0.97 . . . . 0.0 109.37 176.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.69 -8.79 84.06 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 118.892 -0.949 . . . . 0.0 113.126 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.57 -46.75 86.9 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.128 1.464 . . . . 0.0 108.635 173.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.68 -16.04 1.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.688 0.795 . . . . 0.0 112.088 -160.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.38 63.27 2.82 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -173.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -123.48 140.11 53.33 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.481 1.112 . . . . 0.0 108.333 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.85 112.16 17.98 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -178.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.7 mt -97.09 128.23 43.82 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.75 0.786 . . . . 0.0 109.352 -174.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.16 79.54 6.7 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.35 1.46 . . . . 0.0 109.493 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.2 m -63.02 163.67 15.96 Favored Pre-proline 0 N--CA 1.444 -0.767 0 C-N-CA 123.724 0.809 . . . . 0.0 110.949 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -68.93 140.66 59.29 Favored 'Cis proline' 0 CA--C 1.536 0.617 0 CA-C-N 119.211 0.754 . . . . 0.0 110.625 -9.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.7 p -145.68 149.24 16.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 124.002 0.921 . . . . 0.0 109.651 -171.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.4 mm -125.47 98.24 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 124.032 0.933 . . . . 0.0 109.295 -173.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.2 mt -72.43 131.19 42.27 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 175.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.7 m -87.93 -177.05 5.68 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.11 1.364 . . . . 0.0 109.709 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.457 ' OD2' ' HE2' ' A' ' 28' ' ' LYS . 12.5 t70 -61.21 -43.89 98.16 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.902 0.881 . . . . 0.0 112.16 -172.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -67.83 -38.85 83.74 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -174.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.15 -32.55 73.96 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.33 20.33 0.15 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.919 1.688 . . . . 0.0 115.22 176.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.36 19.34 0.08 Allowed 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 120.691 1.587 . . . . 0.0 114.993 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.8 m -95.92 153.94 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 O-C-N 120.567 -1.333 . . . . 0.0 111.554 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -75.62 -41.43 54.31 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.561 -0.712 . . . . 0.0 111.853 175.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.72 107.36 0.87 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -166.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.507 ' H ' HG22 ' A' ' 17' ' ' ILE . 93.1 t -138.6 118.91 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 123.14 1.448 . . . . 0.0 111.239 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.9 m -69.26 125.53 26.97 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 128.231 2.613 . . . . 0.0 109.093 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.49 140.8 47.81 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.479 1.036 . . . . 0.0 108.225 170.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.4 t -150.69 178.17 9.36 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.08 1.352 . . . . 0.0 107.781 176.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.9 p -87.55 165.42 15.5 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.245 0.618 . . . . 0.0 110.484 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.8 p -80.41 -13.55 59.05 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.855 -0.528 . . . . 0.0 111.372 165.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -166.43 -170.73 31.71 Favored Glycine 0 CA--C 1.527 0.812 0 O-C-N 120.388 -1.445 . . . . 0.0 113.457 -167.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -63.02 132.43 51.96 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.432 1.093 . . . . 0.0 109.057 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -133.61 160.66 36.83 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.624 1.17 . . . . 0.0 111.741 -175.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.2 14.35 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 118.478 -0.772 . . . . 0.0 110.35 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -149.27 158.05 43.85 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.483 1.492 . . . . 0.0 110.701 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -161.48 99.33 1.15 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.197 1.399 . . . . 0.0 107.664 165.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.95 142.2 28.02 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.348 1.459 . . . . 0.0 110.949 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 t -145.63 107.84 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 124.526 1.13 . . . . 0.0 108.274 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.8 m -141.07 166.65 24.21 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 121.041 -1.037 . . . . 0.0 109.67 169.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.04 -65.22 0.3 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 167.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.65 176.22 25.04 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 121.123 0.29 . . . . 0.0 112.378 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.5 m -128.86 158.97 41.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 126.006 1.722 . . . . 0.0 107.368 165.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.2 p -114.68 158.9 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 169.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -98.4 8.01 45.43 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.104 0.962 . . . . 0.0 111.344 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.15 23.27 1.83 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.745 1.64 . . . . 0.0 116.178 -158.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -54.87 146.66 16.9 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 118.766 1.283 . . . . 0.0 108.444 167.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -148.95 89.05 1.64 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 137.82 -6.58 3.5 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.93 1.252 . . . . 0.0 113.206 -170.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.4 p -143.13 166.69 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 126.42 1.888 . . . . 0.0 107.653 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.6 p -116.35 159.42 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 171.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -129.73 163.12 26.87 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 174.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -82.16 165.5 42.51 Favored Pre-proline 0 CA--C 1.538 0.518 0 O-C-N 121.502 -0.749 . . . . 0.0 110.192 164.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -75.69 167.01 27.26 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.264 1.976 . . . . 0.0 112.36 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.0 ppp? -149.36 174.19 12.71 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.02 0.528 . . . . 0.0 111.11 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -135.1 156.4 49.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.138 1.375 . . . . 0.0 108.753 173.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -141.25 90.9 2.35 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -178.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.7 t -82.28 137.18 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 168.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 m -144.63 54.7 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 125.254 1.422 . . . . 0.0 108.67 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.0 m -65.93 140.23 58.32 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 120.703 -1.248 . . . . 0.0 108.206 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.9 m -103.83 154.63 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 CA-C-O 122.889 1.328 . . . . 0.0 109.693 172.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -127.26 172.84 10.24 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 126.889 2.076 . . . . 0.0 108.098 167.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -120.92 -162.13 0.94 Allowed 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 130.644 3.578 . . . . 0.0 105.234 -176.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.99 72.72 0.18 Allowed 'General case' 0 CA--C 1.551 1.002 0 O-C-N 121.226 -0.921 . . . . 0.0 109.416 165.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.25 29.37 56.47 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 126.003 1.763 . . . . 0.0 115.067 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -136.04 178.64 6.9 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.744 1.772 . . . . 0.0 108.209 166.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -120.53 140.7 51.08 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 127.322 2.249 . . . . 0.0 106.705 170.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -117.09 -27.33 2.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 125.353 1.461 . . . . 0.0 111.768 175.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -149.82 143.54 25.42 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.253 0.933 . . . . 0.0 109.164 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.8 tttt -137.45 43.77 2.29 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.517 0.727 . . . . 0.0 110.359 -173.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -69.26 142.4 54.16 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.4 t -138.76 160.14 40.39 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.268 1.827 . . . . 0.0 107.828 168.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 31.3 mt -125.32 144.5 50.46 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.993 1.717 . . . . 0.0 107.984 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 98.7 t -135.27 126.82 46.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.315 1.446 . . . . 0.0 107.24 -175.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -116.58 166.37 12.18 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.324 1.049 . . . . 0.0 109.174 175.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 30.7 mtt-85 -136.81 -2.04 2.17 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 117.322 -1.323 . . . . 0.0 114.168 -168.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 61.98 133.84 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.748 1.219 . . . . 0.0 110.198 -152.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.35 60.22 4.88 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.554 1.074 . . . . 0.0 112.442 172.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -129.87 139.34 51.2 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.715 -1.462 . . . . 0.0 112.997 -173.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -78.77 112.2 15.66 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 126.005 1.722 . . . . 0.0 108.718 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.2 pp -131.96 169.88 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.804 2.041 . . . . 0.0 109.814 176.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.7 t -146.92 -179.6 6.91 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.006 0.922 . . . . 0.0 108.909 168.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.0 p -72.86 37.03 0.08 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 128.078 2.551 . . . . 0.0 115.101 -162.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -134.62 20.72 3.6 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.464 1.506 . . . . 0.0 109.997 174.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.15 -39.12 66.22 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.193 1.397 . . . . 0.0 112.519 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.09 112.63 6.86 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 172.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -144.38 70.02 1.28 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -176.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.84 139.79 44.51 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.71 2.004 . . . . 0.0 107.224 -176.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -153.08 135.72 15.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 169.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -119.93 148.32 43.67 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.837 1.255 . . . . 0.0 109.09 171.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.3 p30 . . . . . 0 C--O 1.248 0.974 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 152.823 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.483 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 t0 66.97 74.88 0.32 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 127.82 2.448 . . . . 0.0 106.777 -172.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -101.09 62.71 0.98 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 112.265 -2.243 . . . . 0.0 107.023 -138.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 5' ' ' GLU . 10.3 t70 58.15 -178.89 0.07 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.079 2.152 . . . . 0.0 110.985 -146.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.472 ' H ' ' CG ' ' A' ' 4' ' ' ASP . 5.5 pt-20 -168.5 66.42 0.68 Allowed Pre-proline 0 CA--C 1.548 0.897 0 O-C-N 120.257 -1.527 . . . . 0.0 108.962 -167.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.1 176.37 10.21 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.269 2.646 . . . . 0.0 112.278 -173.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.41 -67.9 0.28 Allowed Glycine 0 C--N 1.337 0.595 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.65 167.78 39.42 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 173.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -137.73 153.24 49.77 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.623 1.169 . . . . 0.0 108.937 -171.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.37 -137.68 4.55 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 127.119 2.295 . . . . 0.0 108.523 172.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.15 -178.06 6.28 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.7 0.8 . . . . 0.0 111.227 -170.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.9 mtp -107.39 156.15 19.24 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 160.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -133.94 137.52 44.92 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.843 0.857 . . . . 0.0 110.637 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -133.93 133.54 41.53 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 127.984 2.514 . . . . 0.0 107.921 171.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.05 155.78 11.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 126.511 1.924 . . . . 0.0 108.094 168.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.32 143.92 36.07 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 172.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.5 tp -133.29 97.0 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.46 143.83 34.6 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 161.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -120.67 130.79 54.25 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 173.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 m -112.18 165.79 11.83 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 122.385 0.274 . . . . 0.0 110.388 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 62.19 -147.8 48.84 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -79.3 77.38 5.83 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-O 122.112 0.958 . . . . 0.0 110.34 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -83.8 -5.97 59.32 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.006 -1.059 . . . . 0.0 112.541 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 90.9 mtt-85 -70.14 -57.43 4.95 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.8 m -78.74 35.34 0.24 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.735 1.614 . . . . 0.0 113.272 -157.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -154.49 113.77 3.71 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.788 1.235 . . . . 0.0 111.392 -158.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.6 pt -67.68 74.99 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 127.791 2.436 . . . . 0.0 112.649 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -77.85 160.62 28.19 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 128.181 2.592 . . . . 0.0 111.851 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.5 t -156.63 152.91 27.75 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.636 -0.665 . . . . 0.0 109.798 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.5 t -128.19 139.95 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 125.628 1.571 . . . . 0.0 108.4 175.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.4 t -106.15 129.05 60.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 127.878 2.471 . . . . 0.0 104.761 164.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.62 147.08 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 119.696 1.135 . . . . 0.0 110.234 176.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.9 t -140.87 150.56 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.2 100.52 3.29 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 170.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -68.67 118.36 11.57 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.012 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.19 -14.11 40.17 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 119.408 -0.662 . . . . 0.0 114.106 159.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.4 t -148.87 178.3 8.8 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.872 1.269 . . . . 0.0 110.052 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -89.8 155.03 19.45 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.462 0.705 . . . . 0.0 109.816 173.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.5 tp -77.47 166.96 22.42 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.423 1.089 . . . . 0.0 108.883 168.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -137.07 128.36 28.07 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.152 1.781 . . . . 0.0 107.209 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -84.67 121.32 27.49 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.93 -8.25 57.52 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-O 119.125 -0.819 . . . . 0.0 113.693 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.8 -26.52 40.53 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.047 1.423 . . . . 0.0 111.729 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 p -134.09 -43.91 0.79 Allowed 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 124.299 1.04 . . . . 0.0 110.808 -169.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.57 13.1 56.16 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.724 -1.042 . . . . 0.0 111.058 -163.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -67.29 156.9 35.22 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 118.705 1.252 . . . . 0.0 109.253 168.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.4 p -112.96 133.62 54.84 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.39 1.476 . . . . 0.0 108.962 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.9 mt -130.93 137.58 49.36 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.79 0.836 . . . . 0.0 109.515 -162.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -85.02 63.28 8.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.227 1.411 . . . . 0.0 111.059 -167.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.7 m -53.5 150.64 12.12 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-O 118.832 -0.604 . . . . 0.0 110.948 172.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.03 140.61 68.28 Favored 'Cis proline' 0 CA--C 1.535 0.541 0 CA-C-N 119.857 0.985 . . . . 0.0 113.359 2.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.0 t -144.7 165.48 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.384 1.873 . . . . 0.0 108.222 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.4 mm -114.69 138.96 43.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 C-N-CA 126.63 1.972 . . . . 0.0 107.001 172.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -115.71 125.98 53.52 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.53 174.04 12.0 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 126.018 1.727 . . . . 0.0 110.461 -172.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -51.38 -38.88 55.65 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.743 1.617 . . . . 0.0 112.705 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -70.2 -39.6 75.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.078 0.551 . . . . 0.0 110.876 -175.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -63.92 -40.18 95.87 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.06 11.92 10.66 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.605 1.962 . . . . 0.0 113.376 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.87 19.26 0.07 Allowed 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 122.21 2.277 . . . . 0.0 115.83 -172.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.7 m -124.97 169.76 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 120.185 -1.572 . . . . 0.0 112.795 -159.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -66.78 -30.22 70.37 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.201 -0.937 . . . . 0.0 112.193 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -154.32 151.35 28.98 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 119.475 1.034 . . . . 0.0 110.278 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -125.45 156.69 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 158.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.5 m -136.59 126.23 25.42 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 126.165 1.786 . . . . 0.0 106.529 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.9 mp -140.7 146.61 38.02 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 120.319 1.418 . . . . 0.0 110.695 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.9 t -132.4 -167.08 1.83 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.43 1.092 . . . . 0.0 109.743 -177.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.94 147.55 36.85 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.749 1.62 . . . . 0.0 108.609 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.1 p -77.47 -14.14 59.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.438 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.53 -167.21 20.73 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -173.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -66.36 133.08 49.77 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.1 153.76 38.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 173.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -113.61 -0.7 9.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 123.392 0.677 . . . . 0.0 109.473 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -149.88 157.72 43.46 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 119.394 0.997 . . . . 0.0 108.487 173.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.5 157.23 44.96 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.513 1.925 . . . . 0.0 106.182 159.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.26 143.95 36.2 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 164.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.8 t -129.68 90.85 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 102.97 -2.974 . . . . 0.0 102.97 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.1 t -125.17 160.43 29.18 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.37 -152.35 21.49 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 -165.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.68 -165.39 24.81 Favored Glycine 0 C--O 1.239 0.451 0 N-CA-C 107.829 -2.109 . . . . 0.0 107.829 -167.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.9 p -146.6 163.78 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 C-N-CA 123.74 0.816 . . . . 0.0 109.228 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 p -133.7 155.88 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 167.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -86.24 127.16 34.71 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -95.91 3.41 64.85 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.893 1.711 . . . . 0.0 112.868 173.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -121.64 172.67 7.95 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.673 1.989 . . . . 0.0 109.28 -176.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -177.45 101.03 0.05 OUTLIER 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.111 2.165 . . . . 0.0 106.149 168.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 145.17 -38.44 1.25 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 125.096 1.331 . . . . 0.0 111.584 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.3 p -81.6 82.94 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 118.743 1.272 . . . . 0.0 109.178 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.0 t -60.99 95.82 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 124.776 1.23 . . . . 0.0 109.664 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -107.8 -156.98 0.6 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.148 1.779 . . . . 0.0 108.977 -173.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -96.89 164.71 17.37 Favored Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 120.856 1.662 . . . . 0.0 111.606 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.18 175.36 10.01 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.896 1.731 . . . . 0.0 112.93 164.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.1 ptm -154.6 -179.27 7.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.903 1.681 . . . . 0.0 107.805 -172.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -169.25 165.66 10.83 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.093 1.357 . . . . 0.0 107.375 171.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -104.21 144.39 31.67 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 162.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 96.9 t -128.52 79.31 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 101.42 -3.548 . . . . 0.0 101.42 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.0 m -83.92 144.65 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.3 m -133.61 142.98 48.35 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.5 t -127.84 130.86 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -117.43 142.74 46.76 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.195 1.398 . . . . 0.0 109.127 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.475 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 18.5 ttpt -83.08 -162.33 0.59 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 163.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.475 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 7.1 p30 -59.09 74.24 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.352 2.261 . . . . 0.0 110.043 167.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.38 40.16 24.34 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.864 1.221 . . . . 0.0 114.643 173.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.14 148.93 28.22 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.429 1.491 . . . . 0.0 107.765 167.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -77.7 146.58 35.92 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 169.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 39.7 pt -132.05 -21.9 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.849 1.26 . . . . 0.0 112.165 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -137.78 146.39 43.53 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.018 -1.051 . . . . 0.0 108.732 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 41.9 tttt -142.35 27.14 1.75 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.524 1.13 . . . . 0.0 110.584 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -80.54 131.67 35.56 Favored 'General case' 0 CA--C 1.517 -0.29 0 O-C-N 121.538 -0.726 . . . . 0.0 110.239 -171.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 p -106.49 167.53 9.78 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 125.895 1.678 . . . . 0.0 109.021 177.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.9 mt -127.92 -177.2 4.03 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.466 1.507 . . . . 0.0 108.073 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.9 p -151.21 146.86 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 175.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -157.11 172.37 18.79 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.956 1.703 . . . . 0.0 108.18 162.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 12.6 mtm180 -138.97 174.22 10.75 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.454 1.102 . . . . 0.0 111.099 168.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -55.55 145.59 22.72 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 129.394 3.078 . . . . 0.0 112.361 167.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 47.67 51.51 17.19 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 127.323 2.392 . . . . 0.0 112.635 164.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 30.2 mmtt -143.89 166.4 25.04 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.319 1.059 . . . . 0.0 111.9 -170.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -46.54 143.29 2.7 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.36 1.464 . . . . 0.0 110.513 160.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.4 pp -142.57 167.34 14.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 127.867 2.467 . . . . 0.0 104.829 170.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.3 m -133.3 149.96 51.91 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 168.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.18 59.34 1.34 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.416 1.486 . . . . 0.0 108.334 168.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.6 p30 -143.28 -1.27 1.06 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.497 1.519 . . . . 0.0 113.981 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -64.57 -38.16 90.04 Favored 'General case' 0 CA--C 1.523 -0.072 0 C-N-CA 124.033 0.933 . . . . 0.0 111.918 -162.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.04 111.71 14.37 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -169.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -138.41 50.53 1.88 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.545 1.138 . . . . 0.0 109.757 -172.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.6 mt -101.68 144.75 30.0 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.055 -1.028 . . . . 0.0 108.614 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -156.71 149.57 23.8 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.736 1.614 . . . . 0.0 107.864 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -144.91 152.51 40.33 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.671 1.189 . . . . 0.0 109.247 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.6 p30 . . . . . 0 C--O 1.251 1.142 0 C-N-CA 125.479 1.511 . . . . 0.0 109.167 166.075 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.582 0 N-CA-C 107.592 -2.203 . . . . 0.0 107.592 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 175.55 145.17 0.07 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 128.387 2.675 . . . . 0.0 103.831 -155.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.95 14.54 0.72 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.634 0.773 . . . . 0.0 112.461 175.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -68.14 158.25 33.55 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.079 0.952 . . . . 0.0 110.534 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -161.9 60.57 1.15 Allowed Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 124.571 1.148 . . . . 0.0 110.743 -175.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.08 146.85 25.93 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.398 2.065 . . . . 0.0 111.655 -172.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -162.63 -81.67 0.04 OUTLIER Glycine 0 C--N 1.335 0.479 0 N-CA-C 110.464 -1.055 . . . . 0.0 110.464 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.39 -152.58 9.48 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 117.79 0.795 . . . . 0.0 113.048 -175.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -134.25 114.82 13.44 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.965 0.906 . . . . 0.0 110.255 -169.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.98 -130.51 1.8 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 106.158 -2.777 . . . . 0.0 106.158 169.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.78 145.59 38.42 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 118.716 1.258 . . . . 0.0 110.235 -172.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.1 mtp -63.03 147.0 51.98 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 154.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -135.18 148.63 49.74 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 164.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -143.77 110.36 5.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.338 1.855 . . . . 0.0 106.679 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 p -89.25 142.94 12.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 169.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.02 156.23 36.85 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 169.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.3 tp -138.16 143.2 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 169.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -129.89 97.06 4.37 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 172.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -83.78 125.46 31.95 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.6 t -151.43 167.73 27.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.5 -158.2 52.59 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -159.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -76.7 52.26 0.81 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.288 1.044 . . . . 0.0 113.779 -170.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -64.35 -8.5 13.32 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.336 -1.477 . . . . 0.0 114.427 -174.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -58.88 -60.73 3.39 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 119.25 0.932 . . . . 0.0 109.902 -174.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.9 m -79.1 28.38 0.23 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.183 1.793 . . . . 0.0 113.352 -167.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.415 ' O ' ' HE3' ' A' ' 28' ' ' LYS . 40.4 m-85 -123.95 123.1 39.66 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.075 0.95 . . . . 0.0 108.58 -172.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.4 mm -70.09 98.44 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -177.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.415 ' HE3' ' O ' ' A' ' 26' ' ' PHE . 2.2 mptt -75.29 131.35 40.25 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.639 0.776 . . . . 0.0 109.258 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.2 m -137.53 134.41 35.66 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.275 1.03 . . . . 0.0 108.603 169.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 89.8 t -137.34 113.91 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 165.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.5 p -70.24 132.75 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 158.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.94 143.69 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 126.33 1.852 . . . . 0.0 108.163 176.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.7 t -140.58 158.31 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.879 1.272 . . . . 0.0 107.739 -171.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.62 154.43 34.18 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.308 1.043 . . . . 0.0 108.809 168.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -118.16 101.84 8.54 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 124.979 1.312 . . . . 0.0 109.587 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.17 -80.23 0.27 Allowed Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 106.186 -2.765 . . . . 0.0 106.186 171.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.9 t -70.79 174.76 5.64 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 125.31 1.444 . . . . 0.0 110.505 -175.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -110.32 172.82 6.64 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.149 0.98 . . . . 0.0 111.149 -175.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.26 164.49 11.93 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.1 1.36 . . . . 0.0 108.424 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -138.48 124.15 19.72 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.61 0.764 . . . . 0.0 109.66 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -73.78 126.78 31.14 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 123.956 0.785 . . . . 0.0 109.607 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.99 6.66 19.1 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 117.58 -1.678 . . . . 0.0 114.321 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.49 -62.07 1.7 Allowed 'General case' 0 C--O 1.23 0.066 0 CA-C-N 120.621 2.21 . . . . 0.0 109.065 171.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.93 7.62 4.73 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.68 1.192 . . . . 0.0 111.787 -170.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.19 32.19 83.11 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -65.9 126.78 29.62 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 175.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.94 104.78 17.33 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -170.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 68.7 mt -91.06 -175.01 4.18 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.424 1.489 . . . . 0.0 110.673 -165.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.15 109.27 5.78 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.064 1.346 . . . . 0.0 107.427 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.44 165.01 46.92 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.822 -0.549 . . . . 0.0 110.74 174.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.67 142.74 65.34 Favored 'Cis proline' 0 CA--C 1.537 0.673 0 CA-C-N 118.569 0.525 . . . . 0.0 111.722 -9.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.5 p -145.09 165.05 12.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 126.092 1.757 . . . . 0.0 111.12 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.4 mm -119.59 118.5 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 126.222 1.809 . . . . 0.0 107.361 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.2 mt -73.6 104.68 4.63 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 159.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.0 m -76.5 179.73 5.73 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.55 1.14 . . . . 0.0 110.479 168.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -50.96 -34.23 27.9 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.126 1.37 . . . . 0.0 112.32 170.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -66.84 -32.42 73.68 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.55 1.14 . . . . 0.0 112.169 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -86.84 -47.77 8.77 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.2 mt -76.04 21.56 0.17 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.614 1.966 . . . . 0.0 111.887 174.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.78 -4.87 37.32 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.104 1.362 . . . . 0.0 112.893 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.4 m -108.54 160.89 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 127.333 2.253 . . . . 0.0 110.875 -177.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -68.19 -33.12 73.85 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.289 1.036 . . . . 0.0 112.319 -176.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -143.77 126.31 15.91 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -165.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -136.17 90.44 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -172.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.2 m -81.58 114.86 20.57 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.787 0.835 . . . . 0.0 109.418 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -116.08 132.12 56.75 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 t -147.64 168.52 21.82 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.274 0.559 . . . . 0.0 109.569 -175.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.19 139.51 32.25 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.188 1.795 . . . . 0.0 111.133 -171.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.3 p -68.14 -28.93 67.73 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -175.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -132.81 -86.37 0.3 Allowed Glycine 0 C--N 1.338 0.672 0 CA-C-N 118.82 0.736 . . . . 0.0 112.891 -173.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.99 139.48 20.5 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 130.764 3.625 . . . . 0.0 107.614 162.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -101.51 -169.13 1.65 Allowed 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 169.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.1 mm -115.32 -19.71 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.788 170.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -150.4 164.62 35.39 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.643 -1.286 . . . . 0.0 109.571 -160.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -164.52 124.03 1.92 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.66 1.584 . . . . 0.0 109.982 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.35 155.85 19.54 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 120.037 1.29 . . . . 0.0 109.73 167.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.7 t -150.16 92.76 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 127.501 2.32 . . . . 0.0 105.287 174.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.9 m -137.0 159.93 40.43 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.287 -0.883 . . . . 0.0 110.437 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.24 -97.3 0.18 Allowed Glycine 0 C--N 1.333 0.38 0 N-CA-C 106.978 -2.449 . . . . 0.0 106.978 176.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.9 -168.38 21.31 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -175.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -138.64 161.21 30.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 161.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.6 p -143.24 139.74 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 171.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -65.38 146.6 54.7 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.55 1.14 . . . . 0.0 110.077 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.6 -7.92 85.46 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.897 1.236 . . . . 0.0 111.835 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -147.77 154.21 40.22 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 122.017 0.913 . . . . 0.0 112.138 -171.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -146.3 102.06 3.56 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 159.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 144.0 5.12 0.66 Allowed Glycine 0 CA--C 1.536 1.406 0 N-CA-C 115.992 1.157 . . . . 0.0 115.992 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.9 m -117.62 179.86 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 119.806 1.803 . . . . 0.0 109.637 173.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.47 98.94 7.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.463 1.105 . . . . 0.0 108.134 175.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -113.12 -163.88 0.88 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.229 1.812 . . . . 0.0 106.944 176.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -123.37 163.5 33.82 Favored Pre-proline 0 CA--C 1.533 0.322 0 O-C-N 121.331 -0.856 . . . . 0.0 108.938 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.05 175.68 10.92 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.712 2.275 . . . . 0.0 111.129 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.0 ptm -146.61 168.86 20.23 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -142.87 160.08 41.01 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 122.295 1.045 . . . . 0.0 109.292 172.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.0 m0 -127.07 112.1 14.81 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 171.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.5 t -92.87 132.39 37.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 159.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.82 161.95 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 174.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.91 155.84 28.43 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.276 -1.749 . . . . 0.0 106.276 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 75.8 t -125.27 91.61 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 171.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -72.58 163.14 28.53 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 170.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -127.63 -154.33 0.63 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.478 2.311 . . . . 0.0 109.552 -168.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -62.17 61.34 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.719 2.007 . . . . 0.0 111.449 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.34 65.99 2.93 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 120.264 -1.522 . . . . 0.0 110.964 -169.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -165.74 165.13 18.76 Favored 'General case' 0 C--N 1.335 -0.059 0 C-N-CA 125.746 1.618 . . . . 0.0 107.999 150.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -77.83 147.75 35.04 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.925 1.69 . . . . 0.0 107.442 159.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 6.4 pt -134.51 -10.36 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.367 1.467 . . . . 0.0 112.553 166.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -145.97 159.35 43.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.237 1.815 . . . . 0.0 108.78 -165.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -153.69 25.76 0.51 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -173.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -47.67 128.16 12.47 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.94 0.896 . . . . 0.0 111.394 177.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.0 p -147.42 140.46 25.09 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.286 1.034 . . . . 0.0 109.469 -177.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.73 -173.45 3.24 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 123.256 1.503 . . . . 0.0 109.645 -174.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.7 p -159.83 141.34 4.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 128.96 2.904 . . . . 0.0 108.689 -177.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -138.97 171.38 14.41 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 172.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -133.11 162.23 32.28 Favored 'General case' 0 CA--C 1.513 -0.481 0 O-C-N 121.699 -0.626 . . . . 0.0 111.325 -162.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -61.5 116.73 4.94 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 124.153 0.908 . . . . 0.0 109.224 164.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.36 55.3 3.49 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 160.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -145.13 99.29 3.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 117.156 0.478 . . . . 0.0 110.413 174.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -62.0 145.79 52.03 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 158.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.7 pp -150.52 -177.44 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 127.066 2.147 . . . . 0.0 107.52 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.5 m -160.33 118.19 2.56 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.087 1.755 . . . . 0.0 106.345 155.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 16.2 p -148.46 152.29 36.67 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.661 1.184 . . . . 0.0 109.96 -172.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.16 31.1 0.1 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.103 1.761 . . . . 0.0 110.679 175.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.43 -17.04 41.7 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.238 1.415 . . . . 0.0 113.111 -166.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.7 tp -134.56 112.81 11.17 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -156.11 54.11 0.57 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 126.93 2.092 . . . . 0.0 107.925 -172.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tp -106.43 143.27 34.78 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.23 1.012 . . . . 0.0 108.984 -171.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -158.95 136.88 10.39 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.199 0.6 . . . . 0.0 109.461 -167.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -137.48 127.36 25.64 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 128.278 2.631 . . . . 0.0 106.062 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.257 1.494 0 C-N-CA 128.987 2.915 . . . . 0.0 104.888 153.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.783 0 N-CA-C 105.959 -2.857 . . . . 0.0 105.959 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -150.63 122.58 8.18 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 -150.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -144.71 108.21 4.63 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 104.054 -2.573 . . . . 0.0 104.054 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -152.57 147.25 25.96 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.914 1.286 . . . . 0.0 108.596 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -154.02 61.88 3.58 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.837 1.255 . . . . 0.0 109.437 -175.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -62.94 154.85 64.06 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.826 1.684 . . . . 0.0 111.93 -173.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.43 112.58 0.55 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 -169.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -142.87 -129.97 2.4 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 125.72 1.629 . . . . 0.0 109.804 173.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -150.85 158.92 44.74 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.09 1.445 . . . . 0.0 109.214 -174.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.466 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . 167.52 -148.91 13.59 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 128.714 3.054 . . . . 0.0 108.471 171.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.52 165.44 17.81 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.544 0.738 . . . . 0.0 112.291 -163.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.2 mtp -116.02 170.15 8.72 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 144.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -173.71 160.8 3.78 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 131.131 3.773 . . . . 0.0 106.902 -178.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -153.43 112.24 3.72 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.58 158.35 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.173 0.989 . . . . 0.0 109.169 175.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 p -136.43 160.27 39.25 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 160.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.7 tp -130.04 143.69 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 126.479 1.912 . . . . 0.0 106.031 173.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -131.63 139.18 49.06 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 126.944 2.098 . . . . 0.0 106.671 170.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -104.13 144.85 31.03 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.441 1.496 . . . . 0.0 107.975 176.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.3 t -154.38 170.7 20.72 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.816 1.246 . . . . 0.0 108.76 -176.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 54.66 -147.46 24.35 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.564 1.078 . . . . 0.0 110.646 -165.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -84.22 95.87 8.8 Favored 'General case' 0 C--O 1.222 -0.357 0 O-C-N 121.622 -0.928 . . . . 0.0 110.451 175.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -96.52 8.18 44.73 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 120.344 -1.473 . . . . 0.0 112.73 -175.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -94.92 -5.6 44.45 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -157.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.5 t -127.13 23.45 6.49 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.11 0.868 . . . . 0.0 110.972 -165.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -135.99 118.29 15.63 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.082 0.953 . . . . 0.0 110.908 -164.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.7 mt -66.63 108.44 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -80.75 149.93 29.46 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.547 1.139 . . . . 0.0 109.237 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 m -150.85 138.21 19.46 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 169.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.4 t -136.41 139.48 45.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.1 t -106.19 132.16 54.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 128.321 2.649 . . . . 0.0 108.695 169.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.4 p -126.56 166.29 23.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 126.613 1.965 . . . . 0.0 109.219 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.1 p -139.4 165.0 23.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 158.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.29 100.13 3.82 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 162.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -66.26 106.44 1.68 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.38 6.7 58.56 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 117.974 -1.459 . . . . 0.0 115.71 166.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 t -155.14 -174.39 4.96 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.913 1.856 . . . . 0.0 109.473 167.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -92.14 164.4 13.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.687 1.195 . . . . 0.0 111.703 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.5 tp -90.13 163.12 14.97 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.781 1.232 . . . . 0.0 108.426 172.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -125.2 117.66 24.34 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.357 1.463 . . . . 0.0 107.204 174.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -75.97 114.73 14.93 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.514 1.133 . . . . 0.0 109.166 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.91 0.68 35.97 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-O 118.524 -1.153 . . . . 0.0 114.283 -173.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.25 -40.6 81.89 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 119.837 1.819 . . . . 0.0 111.427 170.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.94 -18.97 1.17 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.001 0.92 . . . . 0.0 113.006 -169.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.23 19.43 57.21 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 119.25 -0.75 . . . . 0.0 111.936 -170.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -71.19 128.82 37.2 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.574 1.187 . . . . 0.0 109.171 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.65 133.21 50.64 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 126.334 1.854 . . . . 0.0 110.043 169.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 30.6 mt -128.93 152.22 48.8 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.612 1.165 . . . . 0.0 111.048 176.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.63 91.67 5.87 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.718 1.207 . . . . 0.0 110.156 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.81 153.46 42.58 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.643 0.777 . . . . 0.0 111.672 173.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.02 128.73 15.2 Favored 'Cis proline' 0 C--N 1.349 0.599 0 CA-C-N 120.229 1.117 . . . . 0.0 111.709 -8.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.8 t -96.42 155.71 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 172.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 18.2 mm -114.12 120.53 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 105.234 -2.135 . . . . 0.0 105.234 166.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.69 163.37 26.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 122.123 0.963 . . . . 0.0 109.017 172.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.511 ' H ' ' HG2' ' A' ' 58' ' ' GLU . 4.9 m -129.32 -153.79 0.59 Allowed 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 127.95 2.5 . . . . 0.0 109.106 -169.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.01 -29.69 13.99 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.774 1.63 . . . . 0.0 110.935 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -67.05 -40.27 87.07 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 125.221 1.409 . . . . 0.0 110.516 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.511 ' HG2' ' H ' ' A' ' 55' ' ' SER . 1.8 pp20? -62.31 -29.83 70.72 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 123.92 0.888 . . . . 0.0 112.265 -177.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.9 mt -89.14 27.9 1.31 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.401 2.281 . . . . 0.0 111.457 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.46 17.36 2.19 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.616 -1.303 . . . . 0.0 114.163 -172.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.9 m -123.93 -163.84 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 120.74 1.609 . . . . 0.0 108.337 166.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -76.02 -30.64 58.55 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 169.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -153.3 131.54 11.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 117.217 -1.373 . . . . 0.0 111.808 -162.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.86 165.31 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 119.618 1.099 . . . . 0.0 108.85 176.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.4 m -134.83 127.72 31.33 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 128.081 2.552 . . . . 0.0 106.386 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -129.52 133.2 47.12 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 121.218 1.826 . . . . 0.0 108.255 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.6 t -135.26 176.18 8.91 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.308 -0.87 . . . . 0.0 108.867 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.6 p -90.09 153.73 20.33 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 166.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.7 p -76.21 -13.36 60.18 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.859 -0.525 . . . . 0.0 112.311 173.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.63 -168.12 18.17 Favored Glycine 0 N--CA 1.449 -0.491 0 O-C-N 120.875 -1.141 . . . . 0.0 110.903 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.466 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 5.0 ttpt -60.26 139.02 57.82 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 170.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -135.16 177.81 7.52 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 168.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.2 mm -115.5 -11.04 12.11 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 118.087 -0.959 . . . . 0.0 111.017 -177.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -152.39 155.33 37.36 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 120.568 1.531 . . . . 0.0 110.556 172.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -141.45 107.43 5.17 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.369 1.468 . . . . 0.0 109.565 170.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.91 153.98 21.18 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.643 1.111 . . . . 0.0 110.45 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.8 t -146.53 95.72 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 173.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.7 m -131.19 159.83 36.58 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.581 -0.699 . . . . 0.0 109.404 174.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.92 -179.58 19.77 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-N 119.206 0.912 . . . . 0.0 113.267 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.43 -160.38 24.08 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 123.92 0.771 . . . . 0.0 111.308 -169.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.35 119.04 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 126.04 1.736 . . . . 0.0 110.822 -176.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.38 170.86 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.473 0 O-C-N 121.185 -0.947 . . . . 0.0 111.084 164.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -146.93 109.55 4.6 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.463 1.105 . . . . 0.0 109.125 158.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.43 2.65 84.65 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.255 -1.303 . . . . 0.0 113.083 174.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -89.51 140.94 29.03 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 120.058 1.929 . . . . 0.0 109.145 172.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -144.87 1.93 1.02 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.481 1.112 . . . . 0.0 111.628 175.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.34 28.58 4.25 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 126.681 2.086 . . . . 0.0 112.346 -177.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.8 p -144.51 130.98 15.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 125.377 1.471 . . . . 0.0 107.25 171.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.99 145.68 12.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -143.98 -165.66 2.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.481 1.112 . . . . 0.0 109.074 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -125.27 163.88 35.43 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 126.006 1.722 . . . . 0.0 109.635 168.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.42 175.07 9.29 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.74 2.293 . . . . 0.0 112.683 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 6.9 ptm -137.26 173.64 11.47 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.658 0.783 . . . . 0.0 110.291 -172.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -138.85 147.78 42.88 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.47 1.108 . . . . 0.0 108.763 170.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -117.61 133.11 56.31 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 170.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.1 t -128.16 111.7 24.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 -177.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.6 t -134.38 121.18 35.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 -160.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.6 m -110.87 159.8 17.35 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -173.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.9 t -125.61 129.4 72.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 162.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -97.04 134.91 39.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 104.74 -2.319 . . . . 0.0 104.74 163.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.3 tptm -91.56 -173.33 3.52 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 172.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.35 74.21 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.047 2.139 . . . . 0.0 109.581 167.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 157.33 -72.32 0.24 Allowed Glycine 0 CA--C 1.523 0.545 0 C-N-CA 126.72 2.105 . . . . 0.0 111.64 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.45 -177.15 6.35 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.291 1.436 . . . . 0.0 111.024 -171.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.16 144.06 7.57 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.452 1.501 . . . . 0.0 109.846 173.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.6 pt -133.41 -27.41 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 123.897 0.879 . . . . 0.0 111.624 168.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -148.21 151.44 35.51 Favored 'General case' 0 N--CA 1.461 0.082 0 CA-C-N 119.746 1.157 . . . . 0.0 111.517 -162.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -151.59 68.49 0.9 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.124 1.769 . . . . 0.0 110.453 -159.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.429 ' HE2' HD12 ' A' ' 126' ' ' LEU . 6.0 mmmt -86.25 118.76 25.91 Favored 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 120.539 -1.35 . . . . 0.0 109.225 176.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.54 139.46 52.3 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 125.064 1.345 . . . . 0.0 110.087 178.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mp -131.44 -178.37 4.82 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.484 2.314 . . . . 0.0 109.564 -177.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.7 p -154.08 44.79 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 124.793 1.237 . . . . 0.0 112.204 -162.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -72.44 169.2 16.9 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.407 -0.808 . . . . 0.0 112.53 -173.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.5 mtm-85 -147.39 175.1 11.07 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.207 1.003 . . . . 0.0 111.574 -168.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -61.31 160.29 10.92 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 131.191 3.796 . . . . 0.0 115.237 172.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 122.63 -42.87 1.54 Allowed Glycine 0 C--N 1.34 0.769 0 C-N-CA 125.637 1.589 . . . . 0.0 116.02 157.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.36 179.55 6.72 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 120.051 1.925 . . . . 0.0 110.527 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -107.36 137.07 46.07 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 125.975 1.71 . . . . 0.0 108.199 -176.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.5 pp -147.0 168.29 5.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 126.205 1.802 . . . . 0.0 107.252 175.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.18 17.4 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 175.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.35 -1.19 1.2 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 -161.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -142.82 62.81 1.4 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 122.691 1.234 . . . . 0.0 109.193 163.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -121.21 -82.75 0.65 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 127.936 2.495 . . . . 0.0 107.982 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.5 tp -138.25 121.71 17.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -167.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -141.26 80.86 1.76 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 169.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.429 HD12 ' HE2' ' A' ' 109' ' ' LYS . 1.4 tp -109.07 151.38 26.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -152.72 126.86 9.12 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -178.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -117.83 161.78 19.17 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.61 1.564 . . . . 0.0 110.521 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.39 0 C-N-CA 128.283 2.633 . . . . 0.0 106.849 164.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.782 0 N-CA-C 106.622 -2.591 . . . . 0.0 106.622 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -155.8 145.65 21.31 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 102.882 -3.007 . . . . 0.0 102.882 -158.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -109.0 15.28 23.5 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 127.537 2.335 . . . . 0.0 110.992 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -135.57 161.27 35.98 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.463 2.305 . . . . 0.0 108.723 173.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -153.56 85.86 4.03 Favored Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 167.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -81.05 -172.31 1.48 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.932 2.422 . . . . 0.0 110.412 -174.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.43 -10.04 73.17 Favored Glycine 0 CA--C 1.527 0.797 0 O-C-N 120.913 -1.117 . . . . 0.0 113.125 171.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.15 -126.21 7.85 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 178.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -148.9 161.12 42.49 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 173.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.58 -119.05 1.01 Allowed Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 154.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.18 -162.2 1.19 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.31 1.044 . . . . 0.0 108.324 -164.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.1 mtp -137.1 161.42 36.15 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 127.894 2.478 . . . . 0.0 105.332 161.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -136.65 148.89 47.67 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 173.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -143.6 138.05 28.77 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 103.676 -2.712 . . . . 0.0 103.676 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.2 157.5 38.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 169.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 p -124.83 154.09 41.54 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 164.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.402 HD11 ' CD2' ' A' ' 95' ' ' TRP . 7.1 tt -120.65 156.95 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 C-N-CA 122.44 0.296 . . . . 0.0 110.514 155.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -139.98 131.96 27.78 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 166.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -117.12 109.04 16.44 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.801 2.04 . . . . 0.0 107.13 -165.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.5 p -139.27 179.88 6.27 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 175.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.26 -157.96 17.69 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -152.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -85.15 106.93 16.96 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.176 0.988 . . . . 0.0 112.604 -168.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -113.79 -4.57 13.34 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 121.402 1.91 . . . . 0.0 115.299 -172.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.97 34.0 1.43 Allowed 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.316 -0.865 . . . . 0.0 111.159 -171.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.8 m -143.67 7.0 1.46 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.4 1.08 . . . . 0.0 112.317 -165.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -140.97 152.44 44.96 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 120.404 1.456 . . . . 0.0 111.346 -159.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 84.9 mt -84.95 95.29 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 174.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.64 148.32 22.39 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 172.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.8 t -142.6 157.55 44.59 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.409 1.884 . . . . 0.0 108.158 -175.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -143.48 160.03 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 165.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -128.69 141.45 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 126.713 2.005 . . . . 0.0 106.182 160.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.9 t -137.87 130.98 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.6 t -140.23 138.59 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.81 89.88 2.29 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.57 1.077 . . . . 0.0 111.896 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.539 ' H ' ' HB2' ' A' ' 74' ' ' GLU . 39.3 t-20 -58.16 105.26 0.26 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.223 1.409 . . . . 0.0 112.689 -174.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.44 -1.25 27.9 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 118.602 -1.11 . . . . 0.0 114.185 164.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.3 t -154.18 -168.1 2.84 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.054 1.427 . . . . 0.0 110.236 -169.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -116.75 159.51 22.18 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.017 1.727 . . . . 0.0 109.484 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.2 164.16 17.37 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 124.289 1.035 . . . . 0.0 108.693 176.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -133.06 123.16 25.27 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 173.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -79.9 117.19 20.54 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 166.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.83 -17.82 55.44 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.625 -1.097 . . . . 0.0 114.339 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.85 -39.11 87.86 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 119.855 1.827 . . . . 0.0 110.205 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.06 -10.58 1.13 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -169.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.1 29.36 64.76 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -171.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -69.13 115.31 8.27 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 170.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.78 103.69 11.64 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.5 mt -91.24 -173.7 3.71 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.156 0.983 . . . . 0.0 108.923 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.52 94.24 3.61 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -177.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.52 162.31 27.66 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.596 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.32 143.81 66.04 Favored 'Cis proline' 0 N--CA 1.459 -0.519 0 CA-C-N 120.142 1.086 . . . . 0.0 112.696 -1.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.7 t -142.07 149.11 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.28 1.432 . . . . 0.0 108.818 -169.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.8 mm -135.89 97.72 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 126.61 1.964 . . . . 0.0 107.124 -159.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -82.5 140.94 33.05 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.076 0.95 . . . . 0.0 108.913 -174.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.4 p -110.24 -166.23 1.07 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.22 1.008 . . . . 0.0 110.477 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -64.09 -48.28 76.75 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.684 1.994 . . . . 0.0 111.782 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -61.23 -27.44 68.44 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 125.04 1.336 . . . . 0.0 110.797 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -95.1 -11.9 27.44 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.317 0.647 . . . . 0.0 110.344 -169.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -96.98 17.77 16.18 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.862 2.065 . . . . 0.0 112.673 176.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.15 39.69 0.15 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.174 1.789 . . . . 0.0 113.378 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.1 m -136.46 162.48 35.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 126.281 1.832 . . . . 0.0 108.778 -170.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -85.5 -17.06 37.51 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.293 -0.88 . . . . 0.0 113.04 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -155.14 151.67 28.52 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 125.196 1.398 . . . . 0.0 107.911 -166.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.2 t -143.77 140.9 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 164.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.3 m -118.07 135.09 54.41 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 168.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.5 mt -140.0 146.04 38.58 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.6 169.25 22.01 Favored 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 121.649 -0.657 . . . . 0.0 110.148 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.3 p -95.44 155.97 16.52 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 117.801 0.273 . . . . 0.0 111.163 174.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.4 p -82.3 -3.38 55.17 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.524 -0.735 . . . . 0.0 112.015 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.72 -156.88 15.68 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -176.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.414 ' HE2' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -60.93 137.13 58.24 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 117.483 0.641 . . . . 0.0 110.218 -168.446 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -129.33 141.63 51.03 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 176.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.414 HD13 ' HE2' ' A' ' 71' ' ' LYS . 0.8 OUTLIER -133.94 21.5 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 C-N-CA 123.723 0.809 . . . . 0.0 110.254 174.718 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.539 ' HB2' ' H ' ' A' ' 35' ' ' ASN . 40.3 mt-10 -142.77 147.33 35.37 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 168.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -154.56 86.11 1.13 Allowed 'General case' 0 C--O 1.232 0.164 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 157.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.4 145.9 39.04 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.164 175.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.2 t -143.92 108.7 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.105 1.362 . . . . 0.0 107.712 166.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.6 t -109.38 173.67 6.22 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 152.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 150.55 -166.07 30.14 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 -170.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 146.21 166.77 12.28 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.513 1.054 . . . . 0.0 110.822 174.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.9 m -142.88 114.17 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 174.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.7 m -86.11 177.44 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -159.64 90.73 0.95 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 166.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -121.32 27.82 6.23 Favored Glycine 0 N--CA 1.465 0.615 0 C-N-CA 124.049 0.833 . . . . 0.0 111.213 -172.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.75 157.94 20.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.447 1.499 . . . . 0.0 109.407 -160.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -119.94 0.41 10.8 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.026 0.931 . . . . 0.0 112.489 -173.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -110.65 -44.96 0.93 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 125.086 1.327 . . . . 0.0 110.228 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.6 t -89.56 71.21 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 118.056 0.928 . . . . 0.0 109.569 -174.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.9 p -61.6 142.67 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 164.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.55 -166.6 2.28 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 170.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -87.22 164.08 37.26 Favored Pre-proline 0 CA--C 1.541 0.617 0 O-C-N 121.45 -0.781 . . . . 0.0 109.505 159.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -76.73 175.33 11.51 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.058 2.505 . . . . 0.0 112.913 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.3 ptm -139.94 164.0 31.16 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.722 1.209 . . . . 0.0 111.646 -173.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -140.26 156.52 46.44 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.208 1.403 . . . . 0.0 109.66 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.402 ' CD2' HD11 ' A' ' 17' ' ' ILE . 1.5 m0 -127.19 124.69 39.58 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 176.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 t -95.68 121.23 46.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 162.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.6 p -127.54 137.41 57.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 170.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.9 m -148.22 142.61 26.31 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.438 ' H ' ' HB3' ' A' ' 107' ' ' GLU . 3.4 t -117.01 145.31 22.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 124.209 1.004 . . . . 0.0 108.399 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -128.77 130.77 47.49 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 128.034 2.534 . . . . 0.0 106.103 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -84.45 -163.71 0.84 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.13 77.45 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.313 1.045 . . . . 0.0 109.261 166.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 151.87 -56.81 0.44 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.162 -1.355 . . . . 0.0 114.428 168.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.71 -176.84 5.96 Favored 'General case' 0 C--N 1.34 0.196 0 CA-C-N 119.958 1.879 . . . . 0.0 110.966 176.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -44.78 138.32 3.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 130.034 3.334 . . . . 0.0 111.935 176.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.8 pt -139.07 -2.03 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.95 1.7 . . . . 0.0 112.226 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.438 ' HB3' ' H ' ' A' ' 99' ' ' VAL . 0.0 OUTLIER -127.02 170.89 11.83 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.358 1.463 . . . . 0.0 107.43 -176.762 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.6 tttm -159.62 21.47 0.18 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.262 1.425 . . . . 0.0 111.628 175.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.41 87.9 1.57 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.388 -1.445 . . . . 0.0 110.54 -174.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 p -73.15 161.97 29.98 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.3 1.04 . . . . 0.0 110.441 170.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.2 mt -140.39 138.21 34.6 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.338 1.455 . . . . 0.0 108.417 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.5 p -142.61 81.69 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 122.489 1.138 . . . . 0.0 110.11 -172.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -73.13 167.17 21.7 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.423 1.489 . . . . 0.0 110.399 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -139.36 162.32 35.3 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 123.634 0.774 . . . . 0.0 110.173 -175.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -75.28 149.05 38.9 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.882 0.873 . . . . 0.0 108.838 167.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.21 36.14 13.43 Favored Glycine 0 C--O 1.239 0.437 0 CA-C-O 117.35 -1.806 . . . . 0.0 115.346 153.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.07 117.0 3.47 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 120.785 2.292 . . . . 0.0 114.99 -172.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.62 119.36 5.17 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.69 0.677 . . . . 0.0 110.461 169.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.9 pp -143.42 163.9 15.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 125.898 1.679 . . . . 0.0 110.342 174.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.7 p -164.35 8.73 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 116.87 2.174 . . . . 0.0 116.87 177.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.5 p -146.95 9.85 1.01 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 116.215 1.932 . . . . 0.0 116.215 -156.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -140.94 70.33 1.35 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.707 1.14 . . . . 0.0 108.134 167.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -122.19 -85.77 0.65 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-O 117.732 -1.127 . . . . 0.0 110.916 173.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 37.0 mt -142.25 101.22 3.87 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 120.16 1.345 . . . . 0.0 110.456 -165.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -130.01 51.53 2.08 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.174 2.189 . . . . 0.0 107.402 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 mp -107.55 139.17 42.5 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.801 1.24 . . . . 0.0 108.916 177.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -151.32 91.2 1.65 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -83.68 153.46 24.21 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.283 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 177.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.79 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -153.83 102.2 2.5 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 169.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.6 t0 174.45 127.79 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -144.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -158.67 122.95 4.05 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.897 1.279 . . . . 0.0 108.802 -169.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -153.57 85.45 4.08 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 124.496 1.118 . . . . 0.0 109.403 -172.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -86.81 142.55 6.75 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.401 2.067 . . . . 0.0 111.92 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -110.07 75.27 0.21 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 170.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 149.23 -168.05 29.58 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 124.495 1.045 . . . . 0.0 111.333 176.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.495 ' HG2' ' H ' ' A' ' 10' ' ' GLY . 26.3 tttm -123.97 166.92 14.86 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 159.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.495 ' H ' ' HG2' ' A' ' 9' ' ' LYS . . . -164.61 -148.6 5.51 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 127.803 2.621 . . . . 0.0 107.79 166.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.88 179.03 6.62 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.079 0.952 . . . . 0.0 109.991 -168.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.2 mtp -107.96 166.21 10.89 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 155.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.439 ' HB3' ' CD2' ' A' ' 75' ' ' PHE . 71.0 m-85 -147.65 139.99 24.47 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -142.4 120.93 12.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -178.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p -105.36 161.69 5.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 123.002 1.382 . . . . 0.0 109.063 176.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 p -132.86 148.7 52.3 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.519 1.528 . . . . 0.0 106.977 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.4 tp -139.51 132.65 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 174.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -132.95 123.73 26.47 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 127.133 2.173 . . . . 0.0 106.563 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -103.86 137.54 41.72 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.031 0.932 . . . . 0.0 109.291 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 m -135.99 172.15 13.44 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.295 -0.878 . . . . 0.0 110.707 170.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.88 -150.54 32.66 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-O 121.642 0.579 . . . . 0.0 111.987 173.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -72.89 98.09 2.39 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 159.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -113.71 23.59 12.94 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.146 0.498 . . . . 0.0 110.65 170.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.2 mtt180 -102.92 -29.32 11.5 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 118.498 -0.763 . . . . 0.0 111.693 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.8 m -114.55 22.44 13.62 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -152.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -128.41 144.83 51.19 Favored 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 121.476 -0.765 . . . . 0.0 109.251 -173.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.2 mp -76.03 89.11 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 171.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -89.64 146.99 24.16 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.006 1.322 . . . . 0.0 108.953 -177.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.3 t -138.69 148.91 44.55 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.457 1.503 . . . . 0.0 108.536 -174.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.4 t -136.87 106.79 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 161.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.3 t -65.73 117.01 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 160.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 91.8 t -116.72 123.62 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 175.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.72 156.76 42.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 162.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.29 120.91 9.79 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.969 1.708 . . . . 0.0 107.42 165.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -75.1 109.31 8.47 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 118.039 -0.981 . . . . 0.0 108.707 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.43 10.66 50.35 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 116.844 1.498 . . . . 0.0 116.844 161.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.8 t -157.0 -174.8 5.09 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 119.536 1.668 . . . . 0.0 107.969 164.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -106.46 165.27 11.39 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 122.309 1.052 . . . . 0.0 113.699 168.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.15 169.07 13.43 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 112.272 -2.24 . . . . 0.0 109.772 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -144.15 123.5 13.08 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.301 1.441 . . . . 0.0 109.215 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -71.93 131.77 43.43 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.301 1.04 . . . . 0.0 110.341 -177.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.07 -18.41 72.83 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.31 -1.272 . . . . 0.0 113.904 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.0 -60.38 3.96 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 119.057 1.428 . . . . 0.0 109.367 174.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.28 0.61 1.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -157.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.04 12.35 83.44 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-O 119.854 -0.414 . . . . 0.0 112.371 174.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -65.12 130.43 43.34 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.3 m -68.82 125.01 25.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 175.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.7 mt -112.71 128.92 56.54 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -174.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -95.81 88.36 4.93 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.303 1.041 . . . . 0.0 109.088 -170.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.7 m -51.15 156.67 1.76 Allowed Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 128.423 2.689 . . . . 0.0 112.128 172.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -73.42 154.22 99.49 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 N-CA-C 109.435 -1.025 . . . . 0.0 109.435 -8.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.2 t -138.55 144.21 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.0 mm -120.68 81.35 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 28.4 mt -63.1 136.19 57.64 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 m -110.27 175.74 5.32 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 125.902 1.681 . . . . 0.0 110.088 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -46.9 -48.04 21.34 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 127.306 2.243 . . . . 0.0 113.744 -175.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -69.6 -40.53 76.6 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.512 0.596 . . . . 0.0 110.89 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -68.4 -10.88 58.14 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.064 0.945 . . . . 0.0 111.081 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.9 mt -121.29 10.49 10.61 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.179 2.191 . . . . 0.0 111.141 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.92 11.97 0.46 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.067 1.347 . . . . 0.0 112.662 171.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.1 m -66.44 -168.5 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 126.054 1.742 . . . . 0.0 111.135 164.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -110.91 -36.24 5.73 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.909 1.684 . . . . 0.0 111.466 168.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.18 143.03 26.78 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 127.327 2.251 . . . . 0.0 105.941 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.2 p -146.63 102.6 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 120.363 1.438 . . . . 0.0 112.436 161.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m -66.04 134.48 52.96 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.434 -1.417 . . . . 0.0 109.933 172.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 mt -132.99 146.52 51.85 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 124.307 1.043 . . . . 0.0 108.455 -175.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.4 t -162.7 160.12 25.16 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -161.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -86.85 151.23 23.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.422 0.629 . . . . 0.0 112.466 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.2 p -82.75 -20.91 35.01 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.614 1.566 . . . . 0.0 112.165 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -146.55 -163.87 10.67 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 125.873 1.702 . . . . 0.0 108.871 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.414 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 16.1 ttpt -77.47 141.91 39.44 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 175.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -132.95 175.52 9.29 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.957 0.903 . . . . 0.0 109.833 171.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 mm -121.6 -13.53 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.409 1.084 . . . . 0.0 110.205 -167.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -151.51 162.2 41.37 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.614 1.166 . . . . 0.0 108.828 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.439 ' CD2' ' HB3' ' A' ' 13' ' ' TYR . 3.0 t80 -155.58 85.91 1.06 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.695 0.798 . . . . 0.0 109.202 173.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.16 149.72 28.99 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.998 -0.439 . . . . 0.0 110.73 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 t -142.65 124.25 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 125.248 1.419 . . . . 0.0 108.368 171.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.09 169.76 17.24 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 158.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.35 -125.74 0.88 Allowed Glycine 0 CA--C 1.52 0.394 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 173.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.32 173.03 13.48 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 123.614 0.626 . . . . 0.0 112.203 173.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.2 m -146.47 129.53 9.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 125.232 1.413 . . . . 0.0 109.175 173.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.86 159.1 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 123.896 0.878 . . . . 0.0 108.703 157.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -69.54 150.45 47.12 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.403 168.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -115.41 28.43 7.88 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 126.012 1.768 . . . . 0.0 112.628 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -128.65 -164.29 1.37 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.713 1.756 . . . . 0.0 108.039 171.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -143.09 110.63 5.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 105.807 -1.924 . . . . 0.0 105.807 169.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.27 18.04 58.02 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-O 119.166 -0.797 . . . . 0.0 113.417 174.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.2 p -59.66 156.49 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.988 0.899 . . . . 0.0 109.912 169.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.9 t -124.84 88.72 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -115.02 -154.34 0.54 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.986 1.715 . . . . 0.0 108.346 173.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -129.4 164.46 39.42 Favored Pre-proline 0 C--N 1.333 -0.127 0 O-C-N 120.551 -1.343 . . . . 0.0 111.614 176.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -73.0 175.19 10.8 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.485 1.457 . . . . 0.0 111.976 176.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -138.16 168.72 19.13 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.068 0.947 . . . . 0.0 110.414 177.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -135.98 157.04 47.79 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 169.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 33.2 m0 -123.46 133.82 54.0 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 168.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.1 t -90.28 135.57 26.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 151.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.7 130.68 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 172.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 m -135.94 147.63 48.17 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -176.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.2 t -118.07 131.2 71.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -116.1 166.92 11.46 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 128.682 2.793 . . . . 0.0 107.988 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.447 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 33.1 tttt -118.67 -154.3 0.56 Allowed 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 129.224 3.01 . . . . 0.0 107.616 -171.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.447 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 2.6 p30 -69.34 85.43 0.4 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 162.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.75 16.64 69.96 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 117.98 -1.456 . . . . 0.0 115.258 164.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.7 167.49 28.02 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 120.785 2.293 . . . . 0.0 112.116 172.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -90.21 141.05 29.08 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.09 1.356 . . . . 0.0 109.16 -174.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.8 pt -129.02 -19.81 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 119.124 0.874 . . . . 0.0 113.357 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -132.42 160.5 36.2 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -157.79 87.16 0.93 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 176.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.33 164.05 24.4 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 171.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.5 t -138.93 163.33 32.61 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 24.2 mt -126.14 157.49 37.98 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 123.61 0.764 . . . . 0.0 109.013 -177.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.3 p -147.2 114.68 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 -173.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -123.55 171.6 9.4 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 44.9 mtp85 -136.82 159.79 40.79 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.466 0.65 . . . . 0.0 110.285 174.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -65.59 158.24 27.68 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 127.095 2.158 . . . . 0.0 111.473 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.09 -73.58 0.28 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.302 1.429 . . . . 0.0 113.512 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -158.99 29.47 0.21 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 118.604 2.816 . . . . 0.0 118.604 -148.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -144.21 84.59 1.77 Allowed 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.206 -1.559 . . . . 0.0 113.666 -175.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.1 pp -144.8 -174.62 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 127.063 2.145 . . . . 0.0 109.767 174.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.3 t -153.24 148.04 26.39 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 121.364 -0.835 . . . . 0.0 110.078 168.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.0 p -69.45 30.0 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 129.862 3.265 . . . . 0.0 114.138 -175.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -126.86 56.56 1.49 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 158.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -56.46 10.24 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.75 143.49 50.78 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.884 1.274 . . . . 0.0 108.834 174.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -153.1 25.17 0.55 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.779 1.632 . . . . 0.0 111.586 -157.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 88.3 mt -97.15 124.41 41.18 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.71 1.604 . . . . 0.0 107.829 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -139.89 46.64 1.86 Allowed 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.542 0.737 . . . . 0.0 109.019 -170.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -55.26 137.67 46.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.85 -168.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.086 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 167.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.696 0 N-CA-C 107.524 -2.23 . . . . 0.0 107.524 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -149.38 -64.8 0.22 Allowed 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -157.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -171.11 155.79 4.54 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 129.329 3.052 . . . . 0.0 104.33 -164.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -141.16 99.11 3.51 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -172.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -152.82 57.17 1.96 Allowed Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.659 1.184 . . . . 0.0 110.329 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.42 111.01 2.18 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.356 2.038 . . . . 0.0 111.593 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.81 13.34 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.036 -0.984 . . . . 0.0 113.538 -156.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 173.89 -160.69 30.78 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -175.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.83 130.71 54.48 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.615 1.166 . . . . 0.0 109.107 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.433 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . -159.75 -126.3 0.84 Allowed Glycine 0 C--N 1.317 -0.485 0 C-N-CA 127.534 2.492 . . . . 0.0 107.137 164.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.64 161.4 35.23 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.724 0.81 . . . . 0.0 110.86 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 7.8 mtp -91.89 153.62 19.39 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 158.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.444 ' CD1' ' HB2' ' A' ' 75' ' ' PHE . 8.6 m-85 -143.65 114.66 7.81 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 126.282 1.833 . . . . 0.0 106.448 -170.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -127.29 144.76 50.99 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.743 2.017 . . . . 0.0 106.885 172.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.42 132.94 38.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 127.133 2.173 . . . . 0.0 108.89 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.5 p -96.0 163.56 13.08 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.749 0.785 . . . . 0.0 109.913 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 tp -140.75 112.6 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 167.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -114.29 135.97 53.48 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -176.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -122.19 115.4 22.33 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 124.287 1.035 . . . . 0.0 108.732 -161.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 m -120.92 -179.01 3.88 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.17 -99.29 0.56 Allowed Glycine 0 C--N 1.338 0.651 0 C-N-CA 127.301 2.382 . . . . 0.0 110.417 176.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.6 113.39 9.11 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -117.53 11.02 13.69 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -170.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -102.57 -1.06 31.09 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.079 1.352 . . . . 0.0 113.941 -168.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.1 m -143.45 95.12 2.7 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 164.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -176.94 110.83 0.08 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 128.08 2.552 . . . . 0.0 106.433 174.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.3 pt -66.39 86.8 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 127.221 2.208 . . . . 0.0 112.36 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.42 144.68 55.63 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 121.113 -0.992 . . . . 0.0 109.942 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.9 m -148.36 130.03 15.03 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 170.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.8 t -140.39 165.77 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 175.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.0 t -141.13 52.42 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 125.786 1.635 . . . . 0.0 110.806 -157.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.7 p -65.91 135.85 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 O-C-N 119.248 -2.157 . . . . 0.0 111.215 -170.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.6 t -117.56 148.12 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 171.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.32 133.74 20.77 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.93 0.892 . . . . 0.0 108.615 171.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -102.7 85.83 2.64 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.186 1.394 . . . . 0.0 109.022 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.09 -78.76 0.29 Allowed Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 162.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.8 t -76.55 179.51 5.9 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.106 0.963 . . . . 0.0 109.914 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -96.67 168.05 10.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.833 1.253 . . . . 0.0 111.232 174.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.59 168.31 15.48 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.38 1.472 . . . . 0.0 109.38 176.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -137.01 128.14 27.83 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.795 1.638 . . . . 0.0 109.524 172.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -92.2 110.32 21.71 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.547 1.939 . . . . 0.0 109.45 -165.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -57.69 -23.12 49.06 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 118.989 0.813 . . . . 0.0 114.553 -169.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.87 -56.97 15.32 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.325 1.45 . . . . 0.0 112.032 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.5 p -125.67 0.15 7.46 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.608 1.563 . . . . 0.0 111.144 -164.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.78 22.56 54.04 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 125.395 1.474 . . . . 0.0 112.171 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.32 158.2 26.17 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 118.24 1.02 . . . . 0.0 109.358 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.4 m -117.4 106.15 12.9 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 122.391 1.091 . . . . 0.0 110.207 -167.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 45.3 mt -93.59 159.47 15.21 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 125.109 1.364 . . . . 0.0 111.874 -164.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.86 95.69 9.67 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.926 2.09 . . . . 0.0 108.763 -172.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.2 p -58.74 167.72 1.73 Allowed Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.053 0.941 . . . . 0.0 111.468 172.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.72 145.38 79.18 Favored 'Cis proline' 0 CA--C 1.537 0.629 0 N-CA-C 109.733 -0.91 . . . . 0.0 109.733 -19.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.6 p -135.19 156.93 39.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 O-C-N 121.242 -0.911 . . . . 0.0 109.939 -170.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.5 mm -114.02 126.83 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 175.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.8 mt -92.43 164.83 13.33 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 128.154 2.582 . . . . 0.0 110.327 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.495 ' H ' ' HG2' ' A' ' 58' ' ' GLU . 57.4 p -132.64 -163.35 1.33 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.417 2.287 . . . . 0.0 111.126 -165.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -88.08 -21.01 24.96 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 126.565 1.946 . . . . 0.0 110.292 175.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.32 -36.52 61.05 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.286 1.434 . . . . 0.0 111.973 -177.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.495 ' HG2' ' H ' ' A' ' 55' ' ' SER . 2.3 pp20? -75.95 -32.09 59.37 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.262 1.825 . . . . 0.0 111.776 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.6 mt -95.99 24.16 5.78 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.5 1.12 . . . . 0.0 112.655 -176.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -77.41 33.24 0.16 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.629 1.972 . . . . 0.0 113.467 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.6 m -130.45 -167.83 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.511 1.924 . . . . 0.0 109.871 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -98.57 -24.08 15.25 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.335 1.454 . . . . 0.0 113.246 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -159.64 148.89 18.04 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 117.838 -1.077 . . . . 0.0 108.927 171.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.26 165.22 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 165.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 83.3 m -134.59 124.06 24.83 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 128.553 2.741 . . . . 0.0 105.685 171.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.6 140.51 49.54 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 174.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.1 t -145.42 -177.08 5.38 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.284 0.634 . . . . 0.0 110.405 -174.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.92 136.01 53.05 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 128.339 2.656 . . . . 0.0 110.306 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.9 p -75.24 -43.21 52.83 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 118.752 -1.179 . . . . 0.0 109.647 -171.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -107.98 -98.71 2.57 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.433 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -147.23 147.64 30.66 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.959 1.703 . . . . 0.0 109.964 174.235 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.23 -178.56 4.48 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.345 1.058 . . . . 0.0 109.088 170.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.84 -0.03 6.52 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.598 0 CA-C-O 117.664 -1.16 . . . . 0.0 110.814 176.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -149.63 158.0 43.77 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 120.561 1.528 . . . . 0.0 110.435 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.444 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -153.53 117.52 4.79 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 166.045 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -121.95 135.32 54.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.2 t -137.53 112.94 10.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -172.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.3 m -136.06 178.4 7.08 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.226 0.61 . . . . 0.0 110.134 173.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.01 -85.17 0.13 Allowed Glycine 0 C--N 1.333 0.39 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 155.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.34 179.12 18.98 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 127.37 2.414 . . . . 0.0 108.328 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.6 p -155.67 156.55 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 118.577 1.189 . . . . 0.0 109.379 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.6 t -135.27 170.1 19.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 127.826 2.451 . . . . 0.0 106.326 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -123.18 101.28 7.3 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 163.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.11 13.19 67.67 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.678 1.608 . . . . 0.0 113.865 -171.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.84 173.65 1.28 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.04 1.736 . . . . 0.0 110.709 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -165.63 125.69 1.78 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.84 -6.16 32.86 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 123.97 0.795 . . . . 0.0 113.506 174.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.0 p -146.72 140.44 20.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 171.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.71 136.04 27.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 169.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -109.14 -162.61 0.82 Allowed 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 170.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -124.23 165.83 22.41 Favored Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 120.906 1.685 . . . . 0.0 112.082 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.55 174.38 11.9 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.959 2.44 . . . . 0.0 113.547 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.7 ptp -148.0 -176.01 5.11 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.998 0.919 . . . . 0.0 111.131 -168.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -141.15 161.34 38.1 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 128.143 2.577 . . . . 0.0 106.616 169.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.4 m0 -130.68 112.28 12.97 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 104.972 -2.233 . . . . 0.0 104.972 173.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.02 127.3 45.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 168.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 m -139.39 104.45 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -167.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.3 m -118.63 153.29 34.54 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -169.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.93 124.89 51.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -174.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -121.14 121.06 37.02 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.962 1.705 . . . . 0.0 108.246 -172.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.521 ' CG ' ' H ' ' A' ' 102' ' ' ASN . 15.6 tttm -73.05 -166.52 0.31 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.594 1.958 . . . . 0.0 109.771 174.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.521 ' H ' ' CG ' ' A' ' 101' ' ' LYS . 7.7 p30 -58.66 90.44 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 163.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.4 29.58 75.57 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.535 2.017 . . . . 0.0 115.771 171.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -145.06 176.44 9.5 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 120.016 1.908 . . . . 0.0 109.746 165.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -98.1 154.33 17.81 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.97 1.708 . . . . 0.0 108.278 170.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 43.1 pt -132.17 -13.44 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.698 1.199 . . . . 0.0 112.753 168.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -140.91 150.12 42.77 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 119.776 1.171 . . . . 0.0 108.101 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -146.55 52.67 1.11 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.698 1.199 . . . . 0.0 108.076 170.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -75.85 169.7 17.64 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 122.23 1.014 . . . . 0.0 109.888 174.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.8 t -152.02 164.99 36.05 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.095 1.758 . . . . 0.0 106.455 171.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 37.6 mt -135.32 174.48 10.57 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.105 2.162 . . . . 0.0 109.033 176.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 p -152.9 68.05 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.394 1.077 . . . . 0.0 109.169 -175.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -66.71 123.39 19.97 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.033 1.333 . . . . 0.0 109.517 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -136.15 167.17 21.77 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.727 1.211 . . . . 0.0 109.995 176.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 50.98 86.68 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 129.729 3.211 . . . . 0.0 111.325 169.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -49.99 69.27 0.0 OUTLIER Glycine 0 C--N 1.338 0.668 0 C-N-CA 129.847 3.594 . . . . 0.0 115.422 166.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -123.12 174.79 7.01 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.423 1.889 . . . . 0.0 109.745 171.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -64.39 107.89 1.47 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.4 pp -141.77 165.63 17.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 126.804 2.042 . . . . 0.0 108.844 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.5 p -154.16 140.31 18.45 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.467 1.507 . . . . 0.0 107.284 161.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.3 p -144.0 163.17 34.26 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.145 0.978 . . . . 0.0 109.515 169.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -89.56 40.18 0.98 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 169.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.86 -42.56 65.33 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.847 2.059 . . . . 0.0 111.74 -178.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.47 106.27 16.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 176.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -161.86 87.11 0.65 Allowed 'General case' 0 C--O 1.234 0.286 0 O-C-N 123.479 0.487 . . . . 0.0 111.024 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.7 mt -133.67 150.15 51.54 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.171 1.388 . . . . 0.0 109.511 -172.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -143.23 146.86 34.02 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.843 1.657 . . . . 0.0 109.397 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -145.78 155.08 42.7 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.414 1.486 . . . . 0.0 109.069 172.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--O 1.249 1.065 0 C-N-CA 126.569 1.948 . . . . 0.0 106.663 173.37 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.601 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -82.81 -83.97 0.13 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -155.14 129.3 8.87 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -167.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -135.55 -86.15 0.37 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -169.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -162.41 75.22 2.14 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 127.101 2.161 . . . . 0.0 106.292 -176.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -76.12 171.95 17.17 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.546 2.164 . . . . 0.0 110.707 171.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.19 82.66 0.05 OUTLIER Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 175.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -158.57 166.92 34.49 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 177.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -110.7 121.64 45.84 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.419 1.088 . . . . 0.0 109.629 -173.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.86 -124.08 0.72 Allowed Glycine 0 CA--C 1.53 1.031 0 C-N-CA 128.641 3.02 . . . . 0.0 108.127 163.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.21 168.62 26.55 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.526 1.663 . . . . 0.0 109.767 -174.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.6 mtp -107.86 164.58 12.14 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.484 1.114 . . . . 0.0 111.82 162.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -177.36 153.78 0.96 Allowed 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 131.132 3.773 . . . . 0.0 110.054 -169.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -145.1 147.84 32.98 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.601 2.76 . . . . 0.0 105.137 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -124.06 146.74 29.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 125.83 1.652 . . . . 0.0 108.438 175.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 p -130.01 116.35 18.44 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 176.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -79.09 143.81 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 117.532 -1.667 . . . . 0.0 106.9 160.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -124.0 117.94 25.89 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 104.167 -2.531 . . . . 0.0 104.167 158.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -94.53 110.19 22.02 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 173.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 m -84.35 158.39 21.16 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 123.343 0.402 . . . . 0.0 110.184 172.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.97 -145.26 25.66 Favored Glycine 0 C--O 1.241 0.59 0 O-C-N 123.784 0.677 . . . . 0.0 112.684 168.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -82.67 128.91 34.79 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 168.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -132.64 17.94 4.3 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.681 1.192 . . . . 0.0 111.091 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -120.95 35.23 4.95 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.088 1.355 . . . . 0.0 110.402 -168.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.1 t -145.57 -6.33 0.62 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.245 1.418 . . . . 0.0 110.835 -173.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.416 ' HB3' ' CG2' ' A' ' 81' ' ' VAL . 20.7 m-85 -101.98 170.55 8.05 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 120.699 -1.25 . . . . 0.0 108.2 -153.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.2 mp -137.53 96.76 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -169.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.8 tptt 174.32 -162.03 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.739 2.015 . . . . 0.0 110.81 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.3 m -155.65 174.42 15.31 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.683 1.993 . . . . 0.0 110.569 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 t -115.97 144.69 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.026 1.331 . . . . 0.0 107.426 170.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.7 t -99.62 150.48 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 126.454 1.902 . . . . 0.0 108.247 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -145.33 145.32 20.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 124.073 0.949 . . . . 0.0 110.542 163.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.3 t -135.97 137.82 48.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 165.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.7 107.41 5.91 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.318 1.047 . . . . 0.0 108.517 173.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -59.85 112.0 1.68 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.071 1.349 . . . . 0.0 109.737 -177.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.25 32.76 27.72 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-O 118.395 -1.225 . . . . 0.0 114.743 165.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.4 t -156.51 -170.5 3.36 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.137 1.469 . . . . 0.0 110.103 175.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -111.87 164.64 12.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.941 1.696 . . . . 0.0 110.506 159.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.55 168.67 10.22 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 127.973 2.509 . . . . 0.0 108.255 176.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -130.23 132.24 45.89 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.328 1.851 . . . . 0.0 106.642 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -82.57 116.71 22.1 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 164.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.59 -10.02 62.9 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 118.573 -1.126 . . . . 0.0 114.476 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.16 -52.49 58.78 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 118.912 1.356 . . . . 0.0 109.922 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.33 -9.48 5.79 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.053 1.341 . . . . 0.0 111.47 -170.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.73 56.28 5.52 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -176.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -102.29 129.59 48.77 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 38.1 t -71.89 145.38 48.56 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.014 0.824 . . . . 0.0 109.069 172.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 24.1 mt -137.66 130.05 29.45 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 124.842 1.257 . . . . 0.0 110.089 -170.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -86.36 87.64 7.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.912 -177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.43 156.7 40.16 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-O 117.864 -1.065 . . . . 0.0 110.679 170.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.4 144.17 79.66 Favored 'Cis proline' 0 C--N 1.348 0.546 0 CA-C-N 120.305 1.144 . . . . 0.0 111.268 -2.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.8 p -157.57 162.14 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.229 1.011 . . . . 0.0 111.168 -170.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.8 mm -129.99 107.98 15.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 126.623 1.969 . . . . 0.0 108.494 -169.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.2 mt -70.62 125.3 26.43 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.337 0.655 . . . . 0.0 109.812 175.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.47 -172.11 3.88 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.48 2.312 . . . . 0.0 110.589 -176.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -61.18 -42.55 98.77 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.502 -1.374 . . . . 0.0 112.72 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -51.42 -45.3 62.55 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.065 0.946 . . . . 0.0 110.798 -176.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -68.59 -40.02 80.68 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.293 1.437 . . . . 0.0 109.704 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -89.02 11.7 17.58 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.35 1.86 . . . . 0.0 112.258 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.19 16.87 0.21 Allowed 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.046 -1.659 . . . . 0.0 113.03 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.1 m -131.62 163.75 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 126.319 1.847 . . . . 0.0 111.252 -172.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -65.62 -27.32 68.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.122 1.369 . . . . 0.0 112.75 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -152.48 126.54 9.11 Favored 'General case' 0 CA--C 1.511 -0.555 0 O-C-N 121.088 -1.008 . . . . 0.0 109.962 -173.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.3 t -120.54 140.68 43.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 173.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.5 m -138.0 106.89 5.96 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.071 1.348 . . . . 0.0 108.446 -163.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.2 mt -124.0 139.3 54.08 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -167.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.6 t -145.45 159.99 42.25 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.5 p -72.84 140.95 47.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.733 168.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.5 p -71.85 -53.0 14.61 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.093 174.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -112.54 170.58 13.55 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 124.992 1.282 . . . . 0.0 110.014 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.46 134.56 56.77 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.111 0.964 . . . . 0.0 109.646 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.97 179.76 3.99 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 125.678 1.591 . . . . 0.0 107.541 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.1 mm -117.19 -10.63 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.503 0.721 . . . . 0.0 111.163 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -148.05 165.14 31.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 167.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -144.33 107.31 4.5 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.683 1.593 . . . . 0.0 107.716 168.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.66 153.09 19.71 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.391 0.676 . . . . 0.0 109.958 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.5 t -144.98 115.35 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 127.274 2.23 . . . . 0.0 105.84 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 95.4 p -154.63 -172.73 4.3 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 120.688 -1.258 . . . . 0.0 111.162 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.48 -161.34 12.77 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -170.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.6 175.22 36.63 Favored Glycine 0 N--CA 1.464 0.531 0 N-CA-C 106.752 -2.539 . . . . 0.0 106.752 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.416 ' CG2' ' HB3' ' A' ' 26' ' ' PHE . 1.8 p -157.42 163.58 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 120.697 2.249 . . . . 0.0 109.79 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.9 p -151.94 160.16 3.61 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 160.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -87.81 129.92 35.04 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 171.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -95.19 -3.55 61.63 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 117.325 -1.819 . . . . 0.0 112.497 176.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -63.03 120.32 11.19 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 119.367 1.583 . . . . 0.0 108.18 167.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -126.86 37.95 4.19 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 170.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -131.81 -22.18 0.95 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.155 1.36 . . . . 0.0 113.007 -175.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.9 p -107.34 143.39 18.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 125.517 1.527 . . . . 0.0 107.479 174.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.4 p -83.28 126.99 40.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 166.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -126.1 -168.64 1.88 Allowed 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -115.76 154.92 48.12 Favored Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 155.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -80.47 -166.95 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.849 3.033 . . . . 0.0 112.288 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.4 ptm -145.62 167.44 23.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.638 0.732 . . . . 0.0 111.923 -171.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -132.61 131.52 41.51 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 168.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -79.9 105.0 10.86 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 156.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.3 t -79.59 135.89 24.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 149.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.9 t -138.76 91.21 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 172.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.22 152.02 38.39 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.013 1.325 . . . . 0.0 108.415 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 t -134.81 131.7 53.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 175.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -102.91 159.24 15.67 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 128.208 2.603 . . . . 0.0 107.634 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -129.21 -172.1 2.65 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 127.848 2.459 . . . . 0.0 105.41 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -54.1 50.12 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 130.166 3.386 . . . . 0.0 115.387 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 169.03 -58.2 0.2 Allowed Glycine 0 CA--C 1.524 0.622 0 O-C-N 119.541 -1.974 . . . . 0.0 112.145 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.76 -175.32 5.08 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.217 1.407 . . . . 0.0 111.339 -171.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -55.15 141.18 35.87 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.625 1.57 . . . . 0.0 108.923 175.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 15.9 pt -121.39 -34.05 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 125.57 1.548 . . . . 0.0 111.066 167.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -133.34 149.99 51.87 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 120.241 1.382 . . . . 0.0 109.723 -175.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.7 pttt -155.46 42.29 0.43 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.249 2.219 . . . . 0.0 108.857 -153.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.53 149.3 31.59 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.655 0.782 . . . . 0.0 110.744 -172.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.0 t -142.06 162.34 35.73 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.22 1.408 . . . . 0.0 109.341 -169.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.61 -163.71 1.2 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.618 1.967 . . . . 0.0 106.409 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.57 144.89 15.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 127.641 2.377 . . . . 0.0 107.331 168.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -130.29 146.83 51.94 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 106.503 -1.665 . . . . 0.0 106.503 170.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 48.1 mtm105 -134.07 158.57 43.26 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.113 0.965 . . . . 0.0 108.613 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.99 162.07 26.21 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 126.982 2.113 . . . . 0.0 109.403 -153.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.29 35.46 60.28 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 124.281 0.943 . . . . 0.0 114.016 168.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.6 mmtt -139.14 172.35 12.96 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.673 1.237 . . . . 0.0 110.08 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.42 98.72 3.3 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 120.743 -1.223 . . . . 0.0 109.198 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.3 pp -127.54 163.79 30.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 123.982 0.913 . . . . 0.0 110.141 -172.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.45 36.26 0.16 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.819 1.247 . . . . 0.0 110.064 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.428 ' C ' ' H ' ' A' ' 123' ' ' ASP . 5.2 p -63.11 163.18 10.44 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 120.795 -1.191 . . . . 0.0 110.66 167.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -65.83 49.4 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 129.457 3.103 . . . . 0.0 110.08 164.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.428 ' H ' ' C ' ' A' ' 121' ' ' THR . 0.4 OUTLIER -55.32 -29.84 59.07 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.323 1.449 . . . . 0.0 111.633 169.495 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.0 tp -138.17 146.4 42.68 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.427 0.632 . . . . 0.0 109.38 169.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -176.48 76.67 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.811 2.044 . . . . 0.0 105.966 -171.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.7 tp -126.12 137.34 53.59 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.919 0.888 . . . . 0.0 109.214 -168.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -140.45 144.52 36.13 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.019 1.328 . . . . 0.0 109.697 -176.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -140.18 155.54 46.9 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.485 1.514 . . . . 0.0 109.108 171.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.0 p30 . . . . . 0 C--O 1.25 1.097 0 C-N-CA 127.591 2.356 . . . . 0.0 105.906 158.308 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.204 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -158.53 66.57 0.44 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 164.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -157.47 128.45 6.64 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.635 -1.166 . . . . 0.0 107.883 -150.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -166.51 175.9 7.73 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 131.127 3.771 . . . . 0.0 105.139 -173.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.47 75.28 6.47 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 176.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -71.86 161.51 44.75 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.059 1.84 . . . . 0.0 110.846 -166.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.35 47.7 2.99 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.341 0.972 . . . . 0.0 111.694 175.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.84 136.79 4.42 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 119.641 1.72 . . . . 0.0 112.509 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -138.35 165.09 27.63 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 126.827 2.051 . . . . 0.0 107.496 166.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.563 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . 156.72 -160.36 30.24 Favored Glycine 0 CA--C 1.525 0.686 1 C-N-CA 131.601 4.429 . . . . 0.0 107.736 -178.762 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.18 167.88 20.17 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.787 0.835 . . . . 0.0 112.009 -167.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.9 mtp -86.41 153.26 22.04 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 161.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -147.55 130.39 16.14 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 125.834 1.959 . . . . 0.0 108.578 -175.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -140.96 149.75 42.21 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.217 2.207 . . . . 0.0 106.814 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.2 p -144.86 158.95 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 C-N-CA 124.833 1.253 . . . . 0.0 109.686 177.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.2 124.88 14.95 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 -165.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.1 tp -119.51 109.24 25.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -171.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -108.96 122.66 47.7 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.743 2.017 . . . . 0.0 109.537 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -105.45 139.69 39.69 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.179 -0.95 . . . . 0.0 109.982 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.5 m -143.46 166.99 23.26 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.781 0.832 . . . . 0.0 111.321 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.83 -156.32 28.33 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -168.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -76.59 92.0 3.44 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 121.39 -1.065 . . . . 0.0 108.801 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -97.5 14.76 25.35 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -173.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.38 9.05 10.27 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -158.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.0 m -141.17 40.17 1.77 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.08 2.152 . . . . 0.0 108.749 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.404 ' O ' ' HE2' ' A' ' 28' ' ' LYS . 46.7 m-85 -136.23 130.18 32.71 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 124.999 1.319 . . . . 0.0 109.36 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.9 mt -72.76 90.35 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 26' ' ' PHE . 27.0 mtmt -79.78 162.0 25.38 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.815 1.246 . . . . 0.0 110.252 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.4 t -146.72 154.18 41.12 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.902 0.881 . . . . 0.0 110.302 165.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 69.9 t -142.73 109.45 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 127.208 2.203 . . . . 0.0 105.676 164.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.9 p -73.02 147.5 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 149.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 p -131.58 137.71 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 126.202 1.801 . . . . 0.0 106.52 167.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 t -119.59 163.31 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 123.878 0.871 . . . . 0.0 108.923 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.56 153.42 40.35 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.844 1.258 . . . . 0.0 109.906 169.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -129.16 105.45 8.17 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 169.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.42 29.24 50.06 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 118.598 -1.112 . . . . 0.0 114.618 165.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -164.3 -164.72 0.88 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.21 1.804 . . . . 0.0 106.698 158.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -123.89 170.69 10.33 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.125 1.37 . . . . 0.0 109.974 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.41 166.01 12.28 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.904 1.281 . . . . 0.0 109.789 -175.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -134.52 116.79 15.49 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 125.338 1.455 . . . . 0.0 107.827 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -82.84 132.04 35.18 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 124.982 1.313 . . . . 0.0 109.167 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.28 -22.47 50.61 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 118.842 -0.977 . . . . 0.0 113.854 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.24 -52.31 16.36 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 127.572 2.349 . . . . 0.0 111.746 -177.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 t -148.17 -4.84 0.46 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.759 -0.638 . . . . 0.0 111.379 175.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.41 27.96 8.84 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 119.863 1.21 . . . . 0.0 111.668 -160.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -64.13 124.28 21.25 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.63 110.81 20.66 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.184 1.794 . . . . 0.0 111.029 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.9 mt -114.12 145.78 41.17 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 122.375 1.083 . . . . 0.0 112.631 -163.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.14 67.91 5.09 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.05 1.34 . . . . 0.0 112.153 -171.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.2 m -52.83 156.2 3.54 Favored Pre-proline 0 CA--C 1.543 0.692 0 O-C-N 121.054 -1.029 . . . . 0.0 113.097 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.9 144.85 75.85 Favored 'Cis proline' 0 CA--C 1.536 0.606 0 CA-C-N 119.071 0.704 . . . . 0.0 112.495 -5.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.6 t -140.73 155.38 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 126.134 1.774 . . . . 0.0 107.815 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.3 mm -116.59 144.74 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 125.575 1.55 . . . . 0.0 106.857 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.4 mt -120.97 115.89 24.06 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.983 1.313 . . . . 0.0 107.686 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 m -72.16 174.41 7.21 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 124.753 1.283 . . . . 0.0 110.389 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.65 -31.77 68.46 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.822 1.649 . . . . 0.0 113.074 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -63.82 -42.46 97.65 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 121.355 -0.84 . . . . 0.0 110.478 174.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -75.6 -32.12 60.19 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -175.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.8 mt -85.63 27.36 0.85 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.673 1.989 . . . . 0.0 111.792 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.05 1.4 27.9 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 176.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.8 m -88.76 149.12 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 119.427 1.012 . . . . 0.0 111.498 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -57.25 -37.01 71.68 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.451 1.101 . . . . 0.0 112.76 172.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -165.39 149.09 8.28 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -176.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.5 p -149.99 167.29 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 166.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.1 t -121.92 158.97 27.85 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 167.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 mt -135.89 155.03 50.92 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 173.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.4 t -164.44 158.03 17.98 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.5 p -78.34 158.17 28.89 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 122.858 0.463 . . . . 0.0 110.551 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.3 p -75.4 -13.67 60.41 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.349 -0.844 . . . . 0.0 111.722 171.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -167.37 -167.51 28.16 Favored Glycine 0 C--N 1.336 0.535 0 O-C-N 120.662 -1.274 . . . . 0.0 111.559 -175.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.563 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 2.6 ttpt -52.01 130.85 30.79 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 168.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -134.59 176.63 8.45 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.306 1.442 . . . . 0.0 107.629 173.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.61 9.29 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 118.707 -0.663 . . . . 0.0 109.705 176.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -146.46 151.76 37.93 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 120.191 1.36 . . . . 0.0 113.115 168.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.58 66.41 0.94 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.454 2.302 . . . . 0.0 108.888 165.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.87 138.91 33.73 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.244 -0.91 . . . . 0.0 109.705 174.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 69.1 t -138.58 124.19 23.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 125.689 1.595 . . . . 0.0 107.598 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.3 t -142.69 170.46 15.65 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.61 -88.66 0.12 Allowed Glycine 0 C--N 1.332 0.335 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.89 -165.51 16.26 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -176.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.43 152.17 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 106.347 -1.724 . . . . 0.0 106.347 159.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.5 p -124.15 152.23 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 159.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -77.73 149.59 34.54 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 171.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.99 21.22 3.0 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 125.911 1.72 . . . . 0.0 109.15 166.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.29 6.0 pt-20 -120.86 160.91 22.46 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.608 1.204 . . . . 0.0 110.146 170.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -168.3 87.96 0.23 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.912 2.085 . . . . 0.0 106.263 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.69 -28.3 2.87 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.246 1.403 . . . . 0.0 113.778 174.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.0 p -77.99 135.49 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 119.327 1.564 . . . . 0.0 108.477 174.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.6 t -105.78 81.72 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -177.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -77.76 174.79 10.6 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.658 1.183 . . . . 0.0 110.618 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -79.51 157.4 74.93 Favored Pre-proline 0 CA--C 1.533 0.313 0 O-C-N 120.511 -1.368 . . . . 0.0 109.568 157.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -82.94 -177.86 3.57 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.633 2.889 . . . . 0.0 112.179 -178.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 13.0 ptm -141.38 171.36 14.16 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.279 0.632 . . . . 0.0 112.249 -171.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -144.86 165.4 28.21 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.041 1.336 . . . . 0.0 109.445 166.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -128.42 136.29 50.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 170.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.2 t -115.86 129.35 72.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 161.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.9 t -114.54 151.67 16.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 103.895 -2.631 . . . . 0.0 103.895 166.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.3 m -135.94 136.7 40.64 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.3 t -116.5 141.61 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -123.67 148.03 46.88 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.046 1.738 . . . . 0.0 107.185 174.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.542 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 4.0 ttpm? -111.96 -159.29 0.68 Allowed 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.355 1.062 . . . . 0.0 108.295 178.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.542 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 3.3 p30 -60.96 81.65 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.029 1.332 . . . . 0.0 107.961 159.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 152.46 -74.83 0.25 Allowed Glycine 0 N--CA 1.45 -0.376 0 O-C-N 121.12 -0.987 . . . . 0.0 112.577 169.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.23 -171.45 3.87 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.076 1.75 . . . . 0.0 110.127 -173.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -46.1 141.27 3.37 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.829 2.052 . . . . 0.0 109.727 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.1 pt -141.95 -11.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 124.225 1.01 . . . . 0.0 113.492 178.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -142.16 149.27 39.54 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.663 1.12 . . . . 0.0 108.354 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -144.68 93.61 2.44 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.011 0.924 . . . . 0.0 109.124 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.69 151.48 43.09 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.772 0.796 . . . . 0.0 112.246 163.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.52 155.59 42.63 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 127.162 2.185 . . . . 0.0 107.785 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.404 ' HB3' ' H ' ' A' ' 112' ' ' VAL . 0.2 OUTLIER -133.33 -174.22 3.43 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 123.804 1.764 . . . . 0.0 107.139 -172.47 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.404 ' H ' ' HB3' ' A' ' 111' ' ' LEU . 9.9 p -154.02 146.9 13.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 C-N-CA 127.085 2.154 . . . . 0.0 109.88 -177.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -146.29 155.57 42.75 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 165.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -146.72 15.82 1.24 Allowed 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 75.76 163.99 0.26 Allowed 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 128.145 2.578 . . . . 0.0 113.205 -173.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 173.62 -72.56 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 CA-C-O 118.922 -0.932 . . . . 0.0 111.473 172.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -169.31 164.62 10.84 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 127.204 2.202 . . . . 0.0 107.404 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -60.05 149.89 30.95 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.211 0.604 . . . . 0.0 111.93 175.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.6 pp -153.25 -176.49 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 127.927 2.491 . . . . 0.0 109.863 -170.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.5 p -145.29 118.75 9.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 157.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.4 p -134.31 125.77 28.34 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.337 1.055 . . . . 0.0 108.287 -176.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -76.11 49.59 0.57 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.719 1.607 . . . . 0.0 109.577 171.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -62.93 -23.96 67.63 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.352 1.461 . . . . 0.0 111.429 173.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 tp -126.72 111.08 13.84 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -159.38 71.24 0.5 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.792 0.837 . . . . 0.0 109.624 166.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 mp -82.72 149.86 27.05 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.584 1.154 . . . . 0.0 109.637 170.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -137.65 125.81 23.03 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 127.427 2.291 . . . . 0.0 106.536 171.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -127.39 145.12 50.93 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 164.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 C--O 1.257 1.461 0 C-N-CA 127.17 2.188 . . . . 0.0 108.355 -168.971 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.914 0 N-CA-C 104.786 -3.326 . . . . 0.0 104.786 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.56 45.22 1.62 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -147.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -150.94 99.65 2.72 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.351 -145.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.85 -176.13 0.47 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 128.207 2.603 . . . . 0.0 112.559 -169.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.51 73.48 7.42 Favored Pre-proline 0 CA--C 1.54 0.59 0 O-C-N 120.783 -1.198 . . . . 0.0 109.002 162.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.44 124.78 11.12 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.717 2.278 . . . . 0.0 109.478 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 169.22 122.26 0.62 Allowed Glycine 0 CA--C 1.53 1.02 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -176.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.18 -48.22 11.54 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 117.822 0.811 . . . . 0.0 113.554 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -171.48 165.51 6.94 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.069 1.748 . . . . 0.0 107.92 175.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -160.62 -133.23 1.45 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 126.49 1.995 . . . . 0.0 108.548 165.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.24 -175.24 4.18 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.372 1.869 . . . . 0.0 107.626 167.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.2 mmm -97.14 163.1 13.07 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 144.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -146.8 154.41 41.34 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 125.233 1.413 . . . . 0.0 109.609 171.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -152.49 134.76 15.06 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 127.594 2.357 . . . . 0.0 106.359 -175.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 p -125.61 152.91 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 125.446 1.498 . . . . 0.0 110.144 174.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.4 p -120.48 157.7 28.84 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.108 0.963 . . . . 0.0 110.002 171.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.8 tp -143.08 110.46 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 174.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -107.92 132.33 53.58 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -116.76 120.96 40.2 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.286 1.034 . . . . 0.0 109.64 -169.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 m -134.5 172.39 12.98 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.418 0.687 . . . . 0.0 110.593 174.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.6 -163.76 46.28 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -163.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -86.0 59.18 5.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.744 0.783 . . . . 0.0 111.021 -160.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -63.0 21.7 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.782 2.433 . . . . 0.0 115.825 -178.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -115.62 12.04 15.96 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.125 1.77 . . . . 0.0 109.009 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.4 m -143.39 -0.74 1.08 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -157.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -137.49 126.48 24.27 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.69 1.196 . . . . 0.0 109.73 -168.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.4 mt -61.87 89.82 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.488 1.115 . . . . 0.0 110.511 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -74.66 163.45 27.7 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.996 0.903 . . . . 0.0 109.083 176.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.8 p -158.99 137.56 10.89 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.14 1.776 . . . . 0.0 108.965 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 t -138.45 98.1 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 119.454 1.024 . . . . 0.0 108.353 172.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.4 t -68.09 127.3 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 163.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.0 t -139.11 127.82 28.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 119.694 1.134 . . . . 0.0 109.114 171.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.4 t -109.8 154.79 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.491 1.516 . . . . 0.0 108.743 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.08 103.19 3.71 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.943 0.897 . . . . 0.0 109.917 165.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -58.76 100.87 0.07 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.549 1.54 . . . . 0.0 109.12 168.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.44 7.97 50.54 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 117.219 -1.878 . . . . 0.0 117.74 158.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 t -165.14 178.45 6.98 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 121.016 2.408 . . . . 0.0 108.615 162.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -94.8 161.47 14.16 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.281 1.032 . . . . 0.0 110.785 -175.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.46 169.03 11.4 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.928 1.291 . . . . 0.0 109.288 -178.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -137.09 119.92 16.31 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 124.741 1.216 . . . . 0.0 107.892 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -75.64 148.44 38.74 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.606 0.717 . . . . 0.0 109.755 176.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.1 -25.26 67.93 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 118.399 -1.223 . . . . 0.0 112.636 167.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.21 -60.48 2.92 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 126.609 1.963 . . . . 0.0 111.164 -171.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 t -144.74 8.43 1.3 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.182 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.4 24.7 56.21 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 118.969 0.804 . . . . 0.0 111.136 -165.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -55.86 118.73 4.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.713 1.205 . . . . 0.0 108.507 174.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 m -78.78 122.17 25.71 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 174.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 76.6 mt -113.03 134.19 54.63 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.76 1.224 . . . . 0.0 110.881 -170.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.36 73.92 1.36 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.85 2.06 . . . . 0.0 113.144 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.1 150.97 37.63 Favored Pre-proline 0 CA--C 1.545 0.785 0 O-C-N 120.979 -1.075 . . . . 0.0 111.151 171.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.52 155.74 85.92 Favored 'Cis proline' 0 C--N 1.348 0.509 0 CA-C-N 119.504 0.859 . . . . 0.0 110.785 -12.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.4 p -144.46 161.34 14.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 175.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.6 mm -108.69 99.24 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 166.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.83 104.94 3.05 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.384 -1.709 . . . . 0.0 106.384 168.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.9 m -74.05 175.15 7.7 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.64 0.733 . . . . 0.0 109.443 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -49.72 -37.98 31.47 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.794 1.637 . . . . 0.0 110.601 175.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -69.23 -32.16 71.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.484 1.913 . . . . 0.0 112.621 -175.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -76.61 -32.27 57.97 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.31 1.044 . . . . 0.0 108.93 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -90.13 16.28 8.75 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.701 1.6 . . . . 0.0 112.708 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.71 45.1 0.18 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.714 2.005 . . . . 0.0 112.295 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.0 m -140.85 162.92 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 128.434 2.694 . . . . 0.0 108.668 -173.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -75.19 -26.83 59.33 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.294 -0.879 . . . . 0.0 113.003 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.39 147.05 10.55 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.214 1.006 . . . . 0.0 109.436 -174.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -132.59 161.14 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.95 0.881 . . . . 0.0 109.81 163.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 m -128.5 116.28 19.45 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 130.029 3.331 . . . . 0.0 104.968 172.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -119.9 132.12 55.44 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 119.506 1.048 . . . . 0.0 108.342 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.43 166.49 24.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.02 -170.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 p -80.62 142.97 33.49 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.913 1.685 . . . . 0.0 110.125 -178.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.8 p -80.33 -51.22 9.14 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.503 -0.748 . . . . 0.0 110.74 172.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -106.6 -80.74 1.35 Allowed Glycine 0 C--N 1.335 0.486 0 O-C-N 121.534 -0.729 . . . . 0.0 112.407 -162.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.0 tttt -168.84 135.69 1.86 Allowed 'General case' 0 C--O 1.239 0.516 1 C-N-CA 131.849 4.06 . . . . 0.0 104.12 170.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -133.37 165.47 24.76 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 123.163 0.585 . . . . 0.0 110.066 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.23 -0.89 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 123.308 0.643 . . . . 0.0 110.673 -165.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -153.02 156.12 38.21 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.039 -1.038 . . . . 0.0 108.282 168.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.08 109.44 5.61 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 166.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.52 127.68 54.76 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.5 t -129.66 118.09 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 -174.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.0 157.94 45.09 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -169.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 154.85 -167.57 32.71 Favored Glycine 0 C--N 1.331 0.284 0 O-C-N 121.87 -0.519 . . . . 0.0 112.037 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.82 179.88 43.08 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.407 1.004 . . . . 0.0 112.155 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -132.62 -170.9 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 126.396 1.878 . . . . 0.0 108.463 171.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.8 p -120.04 167.9 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 128.501 2.721 . . . . 0.0 107.534 167.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -137.37 17.76 2.94 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.419 1.888 . . . . 0.0 110.219 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.9 12.63 68.37 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 125.73 1.634 . . . . 0.0 114.763 -156.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -68.14 135.78 52.66 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.195 1.398 . . . . 0.0 109.32 -168.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -137.69 -6.65 1.7 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.778 1.631 . . . . 0.0 112.221 -169.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -105.3 -4.16 40.99 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.769 1.652 . . . . 0.0 113.355 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.2 p -146.94 178.81 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 124.992 1.317 . . . . 0.0 108.679 -172.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.0 p -122.51 96.1 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 171.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -95.9 169.08 10.24 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.747 0.819 . . . . 0.0 109.002 172.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.94 160.96 31.33 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 159.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -84.35 -179.03 3.67 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.248 1.966 . . . . 0.0 111.5 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.498 ' CE ' ' HE1' ' A' ' 95' ' ' TRP . 4.6 ptm -131.31 160.28 35.43 Favored 'General case' 0 C--O 1.231 0.109 0 O-C-N 121.154 -0.966 . . . . 0.0 112.977 -176.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -142.01 143.31 33.11 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.536 1.134 . . . . 0.0 108.94 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.498 ' HE1' ' CE ' ' A' ' 93' ' ' MET . 54.4 m0 -116.9 139.46 50.61 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.23 1.012 . . . . 0.0 108.366 174.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.16 141.08 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 153.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.5 m -141.62 160.33 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 C-N-CA 127.074 2.149 . . . . 0.0 106.443 -177.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.8 m -152.59 142.94 22.55 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 174.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.36 136.59 48.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 169.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -123.19 113.69 19.29 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.698 2.399 . . . . 0.0 106.862 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -68.02 171.51 6.75 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 161.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -44.19 83.2 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.561 2.344 . . . . 0.0 114.128 -175.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 62.46 43.69 98.68 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.273 1.416 . . . . 0.0 113.465 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.0 mmtt -155.55 141.26 18.0 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.815 1.807 . . . . 0.0 109.463 155.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -68.31 143.83 55.05 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 125.932 1.693 . . . . 0.0 108.507 170.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.95 -13.94 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 120.218 1.372 . . . . 0.0 113.234 172.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -142.88 162.04 36.53 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.66 1.584 . . . . 0.0 107.085 -167.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.4 pttt -162.78 37.8 0.1 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.152 0.887 . . . . 0.0 112.637 -175.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -73.55 166.8 22.59 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.219 -1.55 . . . . 0.0 110.373 -176.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.7 t -151.59 160.08 43.81 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 127.168 2.187 . . . . 0.0 106.234 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 94.3 mt -132.6 141.49 48.7 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.924 0.89 . . . . 0.0 109.238 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.4 p -135.87 114.77 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 126.196 1.798 . . . . 0.0 107.319 174.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -108.79 122.6 47.51 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 166.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -149.35 104.18 3.36 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 175.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.5 t70 53.92 89.53 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 125.88 1.672 . . . . 0.0 109.918 -171.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -112.47 -81.9 1.15 Allowed Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 172.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm 174.47 172.23 0.22 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 128.391 2.677 . . . . 0.0 108.692 -165.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -72.62 106.55 4.7 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 153.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.6 pp -136.23 164.17 32.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 129.857 3.263 . . . . 0.0 105.953 173.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.6 m -159.12 6.99 0.11 Allowed 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.0 t -161.48 50.29 0.23 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.177 0.991 . . . . 0.0 111.61 -172.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -143.52 17.9 1.85 Allowed 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.067 -1.02 . . . . 0.0 112.031 174.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -93.79 -77.24 0.46 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.687 1.195 . . . . 0.0 111.312 -173.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.92 124.6 47.47 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.669 0.788 . . . . 0.0 109.314 -155.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -148.96 32.67 0.76 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.985 2.114 . . . . 0.0 111.802 -157.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.2 mp -80.77 148.58 30.0 Favored 'General case' 0 C--O 1.24 0.566 0 O-C-N 121.45 -0.781 . . . . 0.0 110.559 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -159.51 136.09 9.19 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.978 2.111 . . . . 0.0 109.963 173.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -142.17 158.66 43.48 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.078 2.151 . . . . 0.0 110.297 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.3 p30 . . . . . 0 C--O 1.249 1.035 0 C-N-CA 126.816 2.046 . . . . 0.0 109.3 177.926 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.087 0 CA-C-O 119.179 -0.79 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . 0.354 0.0 OUTLIER 76.71 -78.27 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 116.252 -1.832 . . . . 0.0 109.708 -113.572 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -144.79 104.29 4.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 121.288 1.858 . . . . 0.0 108.864 -162.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -159.54 86.39 0.8 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.658 0.783 . . . . 0.0 109.983 -165.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -154.26 86.13 3.74 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 123.954 0.902 . . . . 0.0 109.472 177.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -86.45 140.05 6.15 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.559 2.172 . . . . 0.0 112.224 173.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.55 78.28 0.36 Allowed Glycine 0 CA--C 1.526 0.722 0 O-C-N 121.701 -0.624 . . . . 0.0 112.196 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.6 -165.17 11.7 Favored Glycine 0 CA--C 1.52 0.379 0 O-C-N 121.372 -1.075 . . . . 0.0 111.468 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.6 pttm -144.75 165.4 28.18 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 126.766 2.026 . . . . 0.0 107.898 164.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.483 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . 157.01 -152.04 23.39 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 128.064 2.745 . . . . 0.0 107.697 -174.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.66 -172.61 2.96 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.158 0.979 . . . . 0.0 112.667 -162.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.1 mtp -113.69 158.77 20.47 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 147.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -144.77 143.2 30.55 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 125.256 1.597 . . . . 0.0 108.951 174.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -142.94 143.81 32.14 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.619 2.368 . . . . 0.0 105.065 172.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p -122.07 155.11 26.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 124.557 1.143 . . . . 0.0 109.108 171.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.04 151.11 52.07 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 173.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.6 tp -133.2 114.42 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.11 138.02 41.21 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 126.361 1.864 . . . . 0.0 107.45 176.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -128.46 122.34 31.04 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.453 1.101 . . . . 0.0 108.96 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.97 165.31 11.67 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.296 1.038 . . . . 0.0 108.772 172.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.49 -154.07 52.12 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 176.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -75.67 75.38 2.66 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 123.733 1.73 . . . . 0.0 113.108 -170.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -81.49 17.33 1.42 Allowed 'General case' 0 C--N 1.324 -0.536 0 O-C-N 119.715 -1.866 . . . . 0.0 114.116 -171.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 ptt-85 -137.64 28.34 2.7 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.559 1.527 . . . . 0.0 113.123 -170.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.4 m -127.97 17.29 6.74 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -171.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -134.81 -169.18 2.3 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.9 1.227 . . . . 0.0 112.556 -165.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.7 mm -114.91 87.88 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 106.104 -1.814 . . . . 0.0 106.104 163.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.16 160.22 19.97 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.246 0.93 . . . . 0.0 110.588 168.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.34 156.67 42.81 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.065 0.946 . . . . 0.0 108.565 169.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.1 t -138.02 104.02 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.198 1.399 . . . . 0.0 107.334 170.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.9 t -69.07 135.37 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 163.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.9 t -138.19 138.41 43.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.5 t -135.18 150.14 29.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.08 141.98 49.37 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.265 1.826 . . . . 0.0 109.955 168.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -118.27 103.61 9.98 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 130.158 3.383 . . . . 0.0 106.481 -178.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.47 0.98 32.9 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 125.163 1.364 . . . . 0.0 113.205 172.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 t -165.74 -174.44 3.08 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.582 1.191 . . . . 0.0 109.23 -174.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.408 ' HB2' ' HG1' ' A' ' 69' ' ' THR . 10.1 mt-30 -109.73 -175.75 2.83 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.871 1.668 . . . . 0.0 109.702 178.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.5 mt -119.18 165.58 14.03 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.313 1.445 . . . . 0.0 109.677 -177.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -138.26 122.6 18.26 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.095 0.958 . . . . 0.0 110.113 -170.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -70.08 135.29 49.09 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.755 0.822 . . . . 0.0 109.977 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.84 0.34 86.35 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-O 117.867 -1.518 . . . . 0.0 115.29 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.14 -51.35 15.88 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 120.196 1.998 . . . . 0.0 108.331 174.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.57 -22.8 3.56 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.836 1.254 . . . . 0.0 111.413 -167.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.94 20.55 28.06 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 118.444 -1.198 . . . . 0.0 112.24 -172.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -57.89 136.87 57.09 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 118.978 1.389 . . . . 0.0 109.42 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.13 138.77 49.93 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.268 1.027 . . . . 0.0 108.573 167.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.8 mt -126.91 -171.2 2.35 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.167 1.387 . . . . 0.0 109.306 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -143.03 117.94 9.98 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.685 1.994 . . . . 0.0 106.588 173.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.52 172.0 10.53 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.137 177.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.81 157.99 94.53 Favored 'Cis proline' 0 C--O 1.239 0.567 0 N-CA-C 108.525 -1.375 . . . . 0.0 108.525 -5.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 p -144.8 147.47 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 O-C-N 121.534 -0.728 . . . . 0.0 109.084 -171.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 18.0 mm -120.13 114.18 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 175.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.68 128.01 36.02 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 169.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.4 m -95.72 -175.69 3.51 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.93 1.692 . . . . 0.0 110.884 -174.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.93 -37.71 85.72 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 123.769 0.828 . . . . 0.0 111.848 -170.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -66.76 -36.4 82.35 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.072 0.949 . . . . 0.0 111.212 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -66.73 -36.49 82.59 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 122.44 1.114 . . . . 0.0 110.073 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.8 10.47 32.95 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.581 1.952 . . . . 0.0 112.874 -174.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.17 31.07 0.06 Allowed 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 120.392 1.451 . . . . 0.0 114.111 -174.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.7 m -131.37 167.27 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.504 1.522 . . . . 0.0 111.691 -169.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -59.38 -34.15 72.07 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.471 1.508 . . . . 0.0 113.415 175.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -157.95 147.28 19.68 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-O 117.116 -1.421 . . . . 0.0 109.913 -177.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 t -129.58 163.02 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 119.106 0.866 . . . . 0.0 108.74 163.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.3 m -139.29 109.39 6.41 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.702 2.801 . . . . 0.0 107.791 -172.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -122.4 131.58 53.95 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 121.053 1.751 . . . . 0.0 109.618 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.49 176.29 8.75 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.244 0.618 . . . . 0.0 111.455 -168.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 p -101.95 148.48 25.29 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.812 0.845 . . . . 0.0 109.954 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.408 ' HG1' ' HB2' ' A' ' 38' ' ' GLN . 30.3 p -84.27 -0.7 53.37 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.61 -0.681 . . . . 0.0 112.442 176.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.64 -172.73 37.95 Favored Glycine 0 N--CA 1.448 -0.525 0 O-C-N 119.877 -1.764 . . . . 0.0 109.498 -171.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.483 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 7.1 ttpt -70.43 129.35 39.05 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -126.4 169.69 12.71 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.121 0.568 . . . . 0.0 110.536 176.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -119.46 -2.69 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -175.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -141.65 172.48 12.62 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.836 1.198 . . . . 0.0 110.605 -177.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -164.61 89.75 0.52 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 120.073 1.306 . . . . 0.0 111.312 166.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.77 150.4 25.82 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.584 0.354 . . . . 0.0 110.766 176.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 t -140.76 123.6 15.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 126.207 1.803 . . . . 0.0 106.241 164.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 m -140.59 156.62 46.23 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 174.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.4 -153.35 23.46 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -167.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.38 -168.96 31.56 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -175.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.32 -179.94 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.178 1.391 . . . . 0.0 109.323 165.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.3 m -134.16 169.62 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 129.921 3.288 . . . . 0.0 107.024 168.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -155.15 100.96 2.21 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 168.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -142.48 48.81 0.76 Allowed Glycine 0 N--CA 1.452 -0.237 0 N-CA-C 108.834 -1.707 . . . . 0.0 108.834 -174.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -118.67 133.59 55.74 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.943 0.877 . . . . 0.0 111.406 -174.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -117.62 88.89 3.0 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 -172.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 135.11 -34.39 2.32 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.725 1.155 . . . . 0.0 112.604 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.5 t -86.03 66.28 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 118.428 1.114 . . . . 0.0 108.371 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.81 116.12 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -123.16 168.78 11.97 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.006 1.722 . . . . 0.0 108.973 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -75.51 157.82 84.02 Favored Pre-proline 0 CA--C 1.532 0.263 0 O-C-N 121.986 -0.446 . . . . 0.0 111.155 173.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -72.37 169.21 22.22 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 121.083 1.188 . . . . 0.0 111.722 171.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.4 ptm -139.59 172.53 12.66 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 125.046 1.338 . . . . 0.0 110.33 -174.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -143.91 153.3 42.16 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.23 1.012 . . . . 0.0 109.422 -177.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -127.59 140.75 51.91 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.518 1.527 . . . . 0.0 108.982 176.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.9 t -132.8 110.75 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 164.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 m -92.07 143.07 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 163.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 m -129.59 142.12 50.81 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.8 t -122.14 126.1 73.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -113.57 119.0 35.99 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 175.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.469 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 2.2 ttpt -80.01 -156.91 0.13 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 175.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.469 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 4.6 p30 -66.02 83.34 0.08 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 163.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 139.2 -43.48 1.16 Allowed Glycine 0 CA--C 1.524 0.615 0 CA-C-O 118.03 -1.428 . . . . 0.0 115.2 156.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -151.93 -174.98 5.04 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 119.66 1.73 . . . . 0.0 111.309 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -55.74 143.44 30.79 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 171.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 6.7 pt -128.14 -24.85 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-O 117.674 -1.155 . . . . 0.0 112.706 168.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -150.94 148.9 28.97 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 120.631 1.559 . . . . 0.0 108.319 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -148.67 54.79 1.0 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.107 1.363 . . . . 0.0 107.97 -169.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.17 113.02 2.35 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.72 135.0 50.54 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.955 1.302 . . . . 0.0 108.014 -169.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.12 -172.8 3.03 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 122.275 1.036 . . . . 0.0 109.85 -170.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 78.3 t -148.09 111.46 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 127.554 2.342 . . . . 0.0 106.481 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -81.31 169.63 17.03 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 169.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.6 169.94 19.22 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -74.0 128.34 35.26 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.171 1.789 . . . . 0.0 110.942 177.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.11 53.0 7.26 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 124.691 1.139 . . . . 0.0 112.685 170.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.6 mmtm -137.03 103.85 5.27 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 119.577 1.689 . . . . 0.0 112.151 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -82.5 98.38 8.91 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 122.889 1.328 . . . . 0.0 108.212 177.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.5 pp -127.11 164.55 27.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 127.621 2.369 . . . . 0.0 106.176 173.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.4 t -159.73 9.85 0.11 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.3 1.04 . . . . 0.0 112.36 166.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 63.2 p -132.83 21.29 4.19 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.258 1.423 . . . . 0.0 111.284 -164.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -149.89 26.66 0.81 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.675 -163.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -128.52 -82.94 0.58 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.325 0.65 . . . . 0.0 111.305 -177.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.1 tp -104.93 104.47 14.23 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -156.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.73 66.67 0.93 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -166.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 mp -119.58 141.78 48.97 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -161.19 111.39 1.69 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -97.64 146.57 25.19 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.204 1.002 . . . . 0.0 109.618 169.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.267 0 C-N-CA 126.868 2.067 . . . . 0.0 109.431 171.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.441 ' H1 ' ' CG ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.467 0.745 0 N-CA-C 105.692 -2.963 . . . . 0.0 105.692 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.441 ' CG ' ' H1 ' ' A' ' 1' ' ' GLY . 0.0 OUTLIER 73.99 58.46 0.09 Allowed 'General case' 0 CA--C 1.534 0.346 0 O-C-N 125.89 1.583 . . . . 0.0 109.115 142.322 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -152.3 78.54 1.22 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.793 1.637 . . . . 0.0 106.804 -149.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -160.73 126.71 3.96 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.056 0.942 . . . . 0.0 112.045 -165.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -155.14 85.73 3.47 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 125.646 1.579 . . . . 0.0 108.933 158.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.41 156.88 41.26 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.049 2.499 . . . . 0.0 111.228 -179.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.21 -138.39 9.64 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 122.206 0.892 . . . . 0.0 112.815 -171.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.94 14.53 82.23 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 127.438 2.447 . . . . 0.0 113.209 -170.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -84.54 105.48 15.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.461 ' H ' ' HD2' ' A' ' 71' ' ' LYS . . . -73.07 -85.51 0.23 Allowed Glycine 0 CA--C 1.522 0.471 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -147.3 152.41 38.21 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 117.499 0.65 . . . . 0.0 112.57 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.5 mtp -83.51 154.4 23.9 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.477 1.111 . . . . 0.0 108.685 158.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -137.88 152.71 49.31 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.607 1.163 . . . . 0.0 109.026 168.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -141.32 134.42 29.25 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 165.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.65 145.87 31.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 125.262 1.425 . . . . 0.0 107.854 -173.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.2 p -123.24 152.78 40.97 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -175.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.4 tp -136.31 92.87 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 170.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -72.74 139.52 47.21 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 165.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -124.02 126.25 45.95 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 173.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -136.47 176.72 8.44 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.037 0.935 . . . . 0.0 111.73 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.55 -83.46 1.62 Allowed Glycine 0 C--N 1.334 0.431 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 -175.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -149.78 158.9 44.61 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.336 1.855 . . . . 0.0 106.482 172.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -146.44 71.9 1.26 Allowed 'General case' 0 C--N 1.327 -0.375 0 O-C-N 119.739 -1.85 . . . . 0.0 109.355 164.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -133.45 -0.75 3.22 Favored 'General case' 0 C--N 1.332 -0.155 0 O-C-N 120.782 -1.198 . . . . 0.0 112.872 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.4 t -152.5 53.08 0.78 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.999 1.272 . . . . 0.0 110.304 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -148.02 116.56 6.63 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 116.675 -1.631 . . . . 0.0 109.729 -178.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.0 mt -55.14 98.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 125.333 1.453 . . . . 0.0 108.969 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.6 mtmm -82.86 136.73 34.53 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 170.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t -142.46 144.2 32.94 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 172.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.8 t -135.05 155.79 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 167.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 p -119.22 147.39 22.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 103.967 -2.605 . . . . 0.0 103.967 156.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.7 p -148.81 131.11 6.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 171.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.5 t -128.65 164.34 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.916 0.886 . . . . 0.0 108.798 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.58 107.1 4.07 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 166.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -65.22 89.55 0.09 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.248 1.023 . . . . 0.0 110.217 172.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.38 -79.63 0.34 Allowed Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 169.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -81.19 -165.02 0.84 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.255 1.022 . . . . 0.0 111.017 -174.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -110.29 162.28 14.78 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.916 1.686 . . . . 0.0 111.156 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -84.41 156.31 21.86 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.764 1.626 . . . . 0.0 109.651 167.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -128.63 114.46 16.7 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 127.275 2.23 . . . . 0.0 107.308 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.74 119.31 17.79 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.657 1.983 . . . . 0.0 109.088 -176.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.91 -3.39 50.99 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.56 1.076 . . . . 0.0 113.74 176.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.45 -51.91 67.51 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.933 1.293 . . . . 0.0 110.098 169.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.3 p -152.39 9.3 0.48 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.454 1.502 . . . . 0.0 112.394 -161.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.32 13.82 79.58 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 120.486 -1.384 . . . . 0.0 112.617 -175.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -65.65 124.19 21.71 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.772 1.229 . . . . 0.0 111.092 -171.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.2 m -74.2 127.28 32.55 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 169.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 75.8 mt -119.76 176.64 5.3 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.397 1.079 . . . . 0.0 109.925 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.99 110.13 12.23 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.043 1.337 . . . . 0.0 109.553 -173.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.0 p -77.12 170.37 16.67 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.284 1.434 . . . . 0.0 112.175 -172.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.66 146.41 76.73 Favored 'Cis proline' 0 CA--C 1.535 0.526 0 N-CA-C 109.287 -1.082 . . . . 0.0 109.287 -19.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.8 p -137.13 147.15 27.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 118.439 0.563 . . . . 0.0 110.842 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.7 mm -114.08 127.29 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 127.543 2.337 . . . . 0.0 107.044 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -103.33 140.41 37.46 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.666 0.787 . . . . 0.0 109.414 172.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.3 m -81.0 172.48 13.68 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.846 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.77 -24.96 67.98 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.418 2.287 . . . . 0.0 112.547 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -72.57 -37.03 68.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 118.465 -0.779 . . . . 0.0 111.519 172.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -74.21 -44.16 54.29 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -173.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.76 8.09 2.65 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.968 1.307 . . . . 0.0 114.357 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.66 41.39 0.09 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.221 2.208 . . . . 0.0 113.581 -174.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.6 m -133.1 159.1 43.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 126.013 1.725 . . . . 0.0 111.087 -171.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -67.05 -27.19 67.18 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.278 1.431 . . . . 0.0 113.546 -175.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -158.62 137.39 11.16 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 -172.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -123.04 150.67 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 158.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.5 m -133.65 134.52 43.26 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 173.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 31.4 mt -134.2 147.78 50.78 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -170.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.5 t -157.71 165.91 34.18 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -173.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.78 141.55 28.32 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.248 1.419 . . . . 0.0 109.659 -177.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 58.2 p -80.34 -1.0 39.22 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 175.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -158.94 -99.32 0.15 Allowed Glycine 0 C--N 1.339 0.743 0 O-C-N 120.61 -1.306 . . . . 0.0 112.851 -174.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.461 ' HD2' ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -134.69 152.06 51.48 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 126.67 1.988 . . . . 0.0 108.655 166.3 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.13 -178.71 4.05 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 158.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.424 HD11 ' HZ2' ' A' ' 71' ' ' LYS . 7.9 mm -111.44 -14.01 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.582 0.706 . . . . 0.0 109.746 173.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -148.9 163.2 38.13 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 126.521 1.928 . . . . 0.0 107.262 -163.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -154.34 96.22 1.9 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 128.991 2.917 . . . . 0.0 105.818 168.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -91.63 114.93 27.6 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.328 0.651 . . . . 0.0 110.433 177.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 52.7 t -129.1 115.57 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.913 1.285 . . . . 0.0 108.654 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.7 t -139.71 168.54 19.59 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.933 2.093 . . . . 0.0 108.255 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.65 -156.57 27.75 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 127.075 2.274 . . . . 0.0 108.299 -162.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 139.27 123.97 2.14 Favored Glycine 0 N--CA 1.473 1.141 0 CA-C-N 119.171 1.485 . . . . 0.0 112.554 174.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.98 104.96 17.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 121.767 0.794 . . . . 0.0 110.038 -169.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.7 p -82.88 143.91 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 122.06 0.933 . . . . 0.0 109.413 174.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -80.27 94.09 6.03 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 127.202 2.201 . . . . 0.0 109.29 170.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.99 51.77 3.55 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.6 1.571 . . . . 0.0 110.473 167.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.88 -163.32 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.833 1.653 . . . . 0.0 110.975 164.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 50.0 t0 66.49 34.17 6.29 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 123.054 1.407 . . . . 0.0 109.309 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.09 -12.95 0.03 OUTLIER Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.562 1.077 . . . . 0.0 114.826 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.66 147.61 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 120.168 1.984 . . . . 0.0 112.763 -170.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.2 p -112.12 96.75 4.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 171.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -138.93 -175.03 4.01 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 127.088 2.155 . . . . 0.0 107.902 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -105.29 160.7 25.13 Favored Pre-proline 0 C--N 1.328 -0.36 0 C-N-CA 123.641 0.776 . . . . 0.0 110.59 171.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -78.5 178.24 7.79 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.769 2.98 . . . . 0.0 111.784 173.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.3 ptm -138.12 169.53 17.62 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 122.558 1.17 . . . . 0.0 111.197 -172.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -140.54 151.26 44.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.823 2.049 . . . . 0.0 106.325 175.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -118.11 151.19 38.03 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 168.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.7 t -125.89 134.23 67.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 161.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.7 t -144.31 124.25 7.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 -168.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.4 m -141.43 150.7 42.66 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 -163.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 37.1 t -124.47 135.52 63.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.59 0.709 . . . . 0.0 111.002 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -118.35 158.66 24.83 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 128.467 2.707 . . . . 0.0 107.938 173.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.4 tptt -124.88 -153.44 0.56 Allowed 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 127.573 2.349 . . . . 0.0 107.402 -168.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -55.86 68.47 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.895 2.078 . . . . 0.0 110.633 160.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 64.14 58.98 9.09 Favored Glycine 0 CA--C 1.531 1.061 0 O-C-N 120.106 -1.621 . . . . 0.0 113.172 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -179.61 153.3 0.55 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 128.546 2.738 . . . . 0.0 107.595 162.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -64.84 155.85 32.7 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.358 1.463 . . . . 0.0 109.659 167.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.0 pt -136.18 -17.4 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 125.032 1.333 . . . . 0.0 113.949 167.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -150.7 129.1 12.09 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -170.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -136.98 106.98 6.28 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -175.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.2 pttt -145.58 173.18 12.27 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.817 0.818 . . . . 0.0 112.724 169.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.55 171.94 13.73 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 127.702 2.401 . . . . 0.0 109.79 173.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.3 mt -138.85 151.61 47.13 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.7 p -129.93 138.68 53.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -125.55 163.42 22.76 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -140.41 -164.6 1.75 Allowed 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.848 0.859 . . . . 0.0 109.693 -167.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.27 128.84 51.58 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 128.063 2.545 . . . . 0.0 104.37 164.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -177.49 -26.41 0.04 OUTLIER Glycine 0 CA--C 1.527 0.803 0 CA-C-O 116.585 -2.231 . . . . 0.0 116.755 166.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 174.13 176.44 0.14 Allowed 'General case' 0 C--N 1.343 0.299 0 C-N-CA 129.462 3.105 . . . . 0.0 108.307 156.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -57.09 136.33 56.36 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.817 -0.552 . . . . 0.0 109.902 168.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.43 -179.91 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 127.174 2.19 . . . . 0.0 109.443 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 62.3 p -151.91 106.15 3.18 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.996 1.319 . . . . 0.0 108.14 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.9 p -127.8 154.0 45.92 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.66 0.784 . . . . 0.0 109.49 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -83.68 13.01 5.03 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.839 1.256 . . . . 0.0 112.267 -171.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -43.25 -43.77 5.0 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 129.999 3.32 . . . . 0.0 114.749 -153.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.07 78.58 6.64 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -116.32 58.36 0.75 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.046 1.739 . . . . 0.0 109.25 -172.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 63.5 mt -124.83 107.95 11.43 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -177.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -132.54 81.92 1.98 Allowed 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -175.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -70.81 132.17 44.91 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 165.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 . . . . . 0 C--O 1.25 1.105 0 C-N-CA 128.315 2.646 . . . . 0.0 109.093 174.468 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.872 0 N-CA-C 106.007 -2.837 . . . . 0.0 106.007 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.39 108.42 3.55 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 102.545 -3.131 . . . . 0.0 102.545 -137.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -151.09 80.19 1.31 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.711 0.804 . . . . 0.0 109.014 -159.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.58 143.38 11.55 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.975 0.91 . . . . 0.0 110.767 173.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -153.95 54.7 1.16 Allowed Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.274 1.03 . . . . 0.0 111.372 176.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.11 119.16 6.12 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 O-C-N 118.163 -1.546 . . . . 0.0 111.624 -173.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.42 -101.23 0.77 Allowed Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.134 -169.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.69 178.87 49.0 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 175.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -124.66 135.14 52.81 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -173.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.449 ' CA ' ' HE2' ' A' ' 71' ' ' LYS . . . 167.05 -156.83 28.95 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 127.189 2.328 . . . . 0.0 109.901 177.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -148.13 -164.14 1.94 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.205 1.802 . . . . 0.0 111.163 -162.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.4 mtp -120.87 163.67 17.83 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 125.584 1.554 . . . . 0.0 108.101 147.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -143.13 143.87 31.99 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 125.91 2.006 . . . . 0.0 110.845 -178.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -150.65 145.09 25.63 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.939 1.696 . . . . 0.0 107.355 174.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.47 144.5 32.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 126.657 1.983 . . . . 0.0 107.936 176.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.7 127.98 54.95 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 167.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 tp -100.29 154.15 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 163.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.644 ' CD ' ' H ' ' A' ' 96' ' ' VAL . 0.0 OUTLIER -152.83 -174.63 4.99 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 127.801 2.44 . . . . 0.0 106.941 176.941 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -148.27 166.32 28.35 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 168.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -141.81 165.85 26.33 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 124.141 0.976 . . . . 0.0 110.381 171.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.69 -147.66 39.9 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -75.22 111.91 10.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.394 0.616 . . . . 0.0 110.274 177.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -113.15 33.38 5.11 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.32 1.048 . . . . 0.0 109.679 173.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -124.95 0.5 7.97 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.435 1.494 . . . . 0.0 110.363 -166.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.11 28.67 0.59 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.182 1.393 . . . . 0.0 112.837 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -122.64 116.7 24.26 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 120.72 -1.238 . . . . 0.0 107.773 172.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.7 mm -65.63 121.97 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 175.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -90.69 160.65 15.74 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.155 0.982 . . . . 0.0 110.345 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.4 m -152.48 136.69 16.57 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.373 1.869 . . . . 0.0 107.569 158.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.3 t -137.84 147.18 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 170.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 82.1 t -117.19 128.21 74.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 126.874 2.069 . . . . 0.0 105.851 170.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.33 147.63 19.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 167.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.9 t -128.69 147.73 33.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 170.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.76 91.75 1.91 Allowed 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 173.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -65.06 127.28 30.98 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 172.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.69 -14.66 19.89 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-O 118.735 -1.036 . . . . 0.0 114.503 153.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 t -161.07 -168.49 2.07 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -101.44 160.86 14.07 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.797 0.839 . . . . 0.0 111.302 173.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 tp -74.86 165.23 25.58 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 170.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -133.67 129.96 37.54 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 171.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -84.01 129.51 34.91 Favored 'General case' 0 CA--C 1.52 -0.211 0 O-C-N 123.719 0.637 . . . . 0.0 109.545 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.47 -23.16 70.13 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 118.107 -1.385 . . . . 0.0 112.986 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.72 -61.25 2.56 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.019 1.41 . . . . 0.0 111.116 -176.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.03 10.84 7.61 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.139 0.975 . . . . 0.0 111.029 -177.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.24 23.99 77.47 Favored Glycine 0 N--CA 1.446 -0.639 0 O-C-N 121.141 -0.974 . . . . 0.0 111.544 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -74.98 125.35 28.71 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -171.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.2 m -64.42 129.27 39.24 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 165.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 34.2 mt -107.42 -164.18 0.96 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.801 1.64 . . . . 0.0 108.247 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.67 98.26 3.37 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.693 -0.63 . . . . 0.0 110.55 173.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.5 m -73.48 168.37 26.09 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 122.705 0.402 . . . . 0.0 111.798 177.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -61.26 149.27 52.92 Favored 'Cis proline' 0 CA--C 1.538 0.691 0 N-CA-C 110.366 -0.667 . . . . 0.0 110.366 -16.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.6 t -127.48 151.48 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 18.0 mm -113.95 132.52 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 169.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.9 153.93 21.27 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 122.293 1.044 . . . . 0.0 108.899 170.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.72 -177.94 4.58 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.822 2.449 . . . . 0.0 107.601 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -61.19 -43.95 98.07 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -172.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -62.35 -31.26 71.88 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 123.546 0.738 . . . . 0.0 110.8 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -83.21 -17.98 40.9 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 118.755 -0.64 . . . . 0.0 110.202 -173.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 mt -114.25 6.09 16.06 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.897 1.679 . . . . 0.0 113.921 -168.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.57 34.21 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 128.429 2.692 . . . . 0.0 114.428 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.5 m -100.94 175.38 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 127.777 2.431 . . . . 0.0 110.346 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -95.3 -31.01 13.66 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 118.394 -0.812 . . . . 0.0 111.672 164.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 18' ' ' GLU . 71.7 tttt -157.43 139.12 14.02 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 125.223 1.409 . . . . 0.0 109.189 176.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.0 t -135.73 130.65 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 119.415 1.007 . . . . 0.0 108.53 162.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.8 m -78.27 138.54 38.66 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 121.079 -1.013 . . . . 0.0 108.418 158.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.8 mt -125.51 137.82 53.96 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 167.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.93 -174.59 4.12 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -172.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.83 146.68 37.24 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.329 1.061 . . . . 0.0 110.932 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.3 p -73.59 -22.91 59.9 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.136 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.21 -165.22 13.89 Favored Glycine 0 N--CA 1.449 -0.497 0 O-C-N 121.192 -0.943 . . . . 0.0 110.798 -170.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.449 ' HE2' ' CA ' ' A' ' 10' ' ' GLY . 47.7 tttt -57.86 135.81 56.91 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 168.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -137.03 161.47 35.97 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 174.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.34 -7.94 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 123.51 0.724 . . . . 0.0 109.945 -164.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -144.67 150.63 37.67 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -137.56 156.33 48.22 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 155.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -158.13 152.41 24.38 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 121.014 -1.054 . . . . 0.0 108.785 174.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.8 t -142.39 106.32 1.37 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.2 t -116.39 169.48 9.28 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.734 1.214 . . . . 0.0 107.888 156.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.22 -165.3 30.32 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 125.173 1.368 . . . . 0.0 110.277 -172.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.54 175.48 38.11 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 108.088 -2.005 . . . . 0.0 108.088 172.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.5 m -125.59 173.33 11.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.296 1.038 . . . . 0.0 108.446 169.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.443 ' C ' ' H ' ' A' ' 84' ' ' GLY . 3.9 p -139.61 142.32 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 162.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -65.84 24.81 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 131.026 3.731 . . . . 0.0 113.448 170.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 82' ' ' VAL . . . 76.36 -49.55 2.66 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 125.626 1.584 . . . . 0.0 110.161 -176.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 176.05 165.28 0.4 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.229 1.811 . . . . 0.0 112.649 -173.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -64.65 -13.32 53.33 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.429 1.892 . . . . 0.0 115.098 -174.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -117.94 12.13 13.23 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 126.523 2.011 . . . . 0.0 112.844 -175.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 72.4 t -75.68 167.9 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 118.89 1.345 . . . . 0.0 109.969 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.6 p -141.81 94.36 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 126.396 1.878 . . . . 0.0 108.617 -169.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -141.6 -154.56 0.52 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.172 0.989 . . . . 0.0 109.114 -174.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.79 166.48 10.68 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 126.69 1.996 . . . . 0.0 109.711 152.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -84.37 -177.0 2.77 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.564 2.842 . . . . 0.0 111.954 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.5 ptp -141.67 163.46 32.85 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 172.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -138.99 150.19 45.56 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 126.018 1.727 . . . . 0.0 108.976 173.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 20.7 m0 -125.3 151.05 46.51 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.547 1.539 . . . . 0.0 108.689 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.644 ' H ' ' CD ' ' A' ' 18' ' ' GLU . 13.7 p -136.45 81.04 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 126.85 2.06 . . . . 0.0 108.766 169.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 p -83.98 89.12 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.64 145.29 31.74 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 176.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.99 140.66 46.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -126.7 145.6 50.52 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 128.417 2.687 . . . . 0.0 107.883 -172.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.54 -174.69 2.51 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.03 1.332 . . . . 0.0 107.553 170.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -52.32 69.09 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.708 2.803 . . . . 0.0 113.053 176.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.53 -15.96 3.6 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 115.957 -2.58 . . . . 0.0 116.326 171.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.54 177.79 0.18 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 121.714 2.757 . . . . 0.0 111.918 175.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -50.99 150.81 2.85 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 128.724 2.81 . . . . 0.0 110.913 175.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.47 -20.44 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.638 1.175 . . . . 0.0 111.572 162.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -152.65 151.79 31.0 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 120.315 1.416 . . . . 0.0 110.739 -170.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -141.17 22.69 2.22 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 125.494 1.518 . . . . 0.0 112.842 -161.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -60.95 142.54 56.38 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.612 0.72 . . . . 0.0 110.106 -175.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.07 137.57 15.06 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 125.258 1.423 . . . . 0.0 109.703 -163.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.2 mp -126.85 177.87 6.31 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 123.413 1.578 . . . . 0.0 108.462 -166.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.2 p -149.93 146.8 16.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-N 111.438 -2.619 . . . . 0.0 110.945 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -141.45 151.4 43.36 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.571 1.948 . . . . 0.0 107.237 169.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 39.4 mtp180 -136.36 173.63 11.5 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 118.725 0.693 . . . . 0.0 111.753 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -60.62 134.17 56.81 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 128.299 2.64 . . . . 0.0 109.658 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.37 45.19 91.66 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 124.58 1.086 . . . . 0.0 113.151 165.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt -126.01 162.26 25.68 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 123.064 1.412 . . . . 0.0 113.496 -168.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -84.21 127.38 33.91 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.3 pp -132.81 173.56 14.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 126.169 1.788 . . . . 0.0 108.398 -176.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.3 m -152.07 150.93 30.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.0 0.92 . . . . 0.0 108.896 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.4 p -81.18 54.55 2.29 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.99 1.716 . . . . 0.0 109.76 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -148.38 -13.84 0.34 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -167.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.68 -15.96 23.21 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.283 1.433 . . . . 0.0 113.668 -170.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -120.93 120.7 36.24 Favored 'General case' 0 CA--C 1.517 -0.288 0 O-C-N 120.691 -1.256 . . . . 0.0 107.79 173.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -150.68 72.09 1.07 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 125.671 1.589 . . . . 0.0 110.522 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.5 mp -119.08 154.22 33.54 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.761 1.224 . . . . 0.0 110.727 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -145.83 148.89 33.38 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.31 2.244 . . . . 0.0 109.172 175.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -141.26 142.53 33.9 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.195 2.198 . . . . 0.0 107.813 177.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.5 p30 . . . . . 0 C--O 1.258 1.535 0 C-N-CA 128.202 2.601 . . . . 0.0 107.047 170.512 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.514 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . . . . . . 0 CA--C 1.525 0.657 0 N-CA-C 107.37 -2.292 . . . . 0.0 107.37 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.52 -162.49 1.32 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.037 1.735 . . . . 0.0 110.329 -164.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 33.5 mtp -128.59 165.08 21.48 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 128.551 2.741 . . . . 0.0 105.069 156.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -146.78 154.92 41.95 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.512 1.125 . . . . 0.0 110.733 177.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -146.62 120.96 9.6 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.744 2.018 . . . . 0.0 107.773 174.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.1 p -99.67 151.86 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.963 1.305 . . . . 0.0 109.465 170.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.415 HG23 HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -125.91 154.18 43.15 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.108 0.963 . . . . 0.0 110.089 168.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 tp -139.42 111.81 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 C-N-CA 126.034 1.734 . . . . 0.0 107.209 172.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.64 150.76 20.0 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 159.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -128.86 106.88 9.21 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.396 1.878 . . . . 0.0 107.524 -168.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 m -113.14 167.8 10.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.85 -172.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.6 -150.64 41.63 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -172.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -87.21 34.4 0.69 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -158.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -58.55 -6.09 0.65 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -165.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 54.5 mtt-85 -86.29 0.78 53.09 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.34 1.456 . . . . 0.0 113.424 -167.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.9 m -135.92 32.41 2.95 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.72 1.608 . . . . 0.0 110.149 -174.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.519 ' HB3' HG21 ' A' ' 81' ' ' VAL . 18.0 m-85 -143.27 102.33 3.96 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.867 1.267 . . . . 0.0 109.964 -166.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.1 mm -69.21 96.88 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 125.455 1.502 . . . . 0.0 110.732 -170.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? -110.39 160.79 16.27 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.441 1.096 . . . . 0.0 112.052 -164.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.2 m -145.52 126.29 14.35 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.271 0.628 . . . . 0.0 110.957 -158.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.4 t -135.64 155.74 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.218 1.007 . . . . 0.0 110.11 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 p -119.4 154.6 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 128.924 2.89 . . . . 0.0 107.964 173.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.474 HG11 HD21 ' A' ' 39' ' ' LEU . 1.7 t -145.61 127.25 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 168.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.2 t -127.79 125.5 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.17 112.17 17.37 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.107 0.963 . . . . 0.0 109.826 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -74.51 128.08 34.66 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.687 1.195 . . . . 0.0 108.902 170.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.41 1.08 74.55 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 115.698 1.039 . . . . 0.0 115.698 163.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -153.44 175.87 12.67 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 119.002 1.401 . . . . 0.0 110.387 175.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -100.0 161.01 13.88 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.675 1.19 . . . . 0.0 109.432 174.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.474 HD21 HG11 ' A' ' 32' ' ' VAL . 2.5 tp -89.9 171.62 9.46 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.31 0.644 . . . . 0.0 109.657 -178.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.405 ' HE2' ' HA2' ' A' ' 45' ' ' GLY . 82.4 tttt -137.74 139.54 40.17 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.101 0.96 . . . . 0.0 108.738 173.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -93.82 128.56 40.13 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.978 1.711 . . . . 0.0 109.986 -173.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.04 -21.59 76.96 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.811 -0.994 . . . . 0.0 114.277 -174.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.11 78.68 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.436 1.118 . . . . 0.0 112.03 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.3 p -145.56 -28.58 0.44 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.993 1.317 . . . . 0.0 111.511 -159.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.405 ' HA2' ' HE2' ' A' ' 40' ' ' LYS . . . 88.28 13.93 62.94 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.374 1.464 . . . . 0.0 112.888 -175.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -62.73 138.0 58.4 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.139 1.376 . . . . 0.0 107.296 171.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.1 m -68.7 150.78 47.52 Favored 'General case' 0 N--CA 1.426 -1.669 0 C-N-CA 125.804 1.642 . . . . 0.0 110.411 165.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.2 mt -136.32 142.05 43.84 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.315 1.046 . . . . 0.0 110.725 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.78 78.01 4.29 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.46 1.104 . . . . 0.0 111.144 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 p -54.68 156.28 6.65 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.171 0.988 . . . . 0.0 110.888 168.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -79.64 146.73 76.79 Favored 'Cis proline' 0 CA--C 1.537 0.639 0 CA-C-N 119.355 0.805 . . . . 0.0 111.69 2.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.8 t -140.26 159.14 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.63 1.172 . . . . 0.0 110.263 -171.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.1 mm -119.85 142.33 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 C-N-CA 129.023 2.929 . . . . 0.0 105.44 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -108.42 128.1 54.48 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 171.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.1 m -94.29 173.65 7.53 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.397 1.479 . . . . 0.0 109.404 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.2 -36.1 76.89 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -169.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -63.35 -36.94 85.37 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.593 0.757 . . . . 0.0 111.019 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -75.68 -36.77 59.98 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.8 mt -86.53 24.54 1.4 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.339 2.256 . . . . 0.0 110.73 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.16 -4.88 58.68 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.023 0.929 . . . . 0.0 112.618 174.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.1 m -82.76 163.22 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 118.807 0.73 . . . . 0.0 110.475 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -62.11 -34.85 77.11 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.542 1.137 . . . . 0.0 112.277 173.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -152.25 139.22 19.08 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -172.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -118.74 152.4 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 161.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.415 HG23 HG23 ' A' ' 16' ' ' THR . 19.7 m -129.82 131.29 46.1 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 103.512 -2.773 . . . . 0.0 103.512 164.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.0 mp -132.3 144.71 50.77 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 170.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.61 -173.05 3.67 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.098 -165.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 p -120.61 138.12 54.07 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.704 0.801 . . . . 0.0 110.917 -171.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 68.5 p -78.94 -12.0 60.02 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -168.32 -157.17 10.94 Favored Glycine 0 N--CA 1.447 -0.605 0 O-C-N 120.475 -1.39 . . . . 0.0 110.597 -167.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.514 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -73.36 91.68 1.76 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.39 1.476 . . . . 0.0 109.506 -168.356 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.91 155.52 21.64 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.831 1.252 . . . . 0.0 108.44 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.0 -5.88 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.867 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -148.92 159.19 44.42 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 119.726 1.148 . . . . 0.0 109.308 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.16 143.09 49.73 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 125.054 1.471 . . . . 0.0 107.831 151.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.27 129.3 27.09 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 166.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.2 t -139.85 100.59 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -168.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.2 t -120.11 158.8 26.13 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 178.08 171.53 41.55 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-O 121.571 0.539 . . . . 0.0 112.695 172.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.35 -172.67 40.44 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.971 1.748 . . . . 0.0 109.425 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.519 HG21 ' HB3' ' A' ' 26' ' ' PHE . 6.2 p . . . . . 0 C--O 1.236 0.374 0 C-N-CA 124.548 1.139 . . . . 0.0 109.196 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.79 -179.54 4.31 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 121.866 1.711 . . . . 0.0 113.618 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.8 ptm -138.01 174.3 10.72 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.945 0.898 . . . . 0.0 111.115 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -141.86 162.17 36.14 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.723 1.209 . . . . 0.0 109.729 175.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -128.47 108.64 10.71 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 126.485 1.914 . . . . 0.0 106.543 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.4 t -96.69 109.44 23.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.2 m -131.37 135.34 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.555 1.142 . . . . 0.0 109.25 -162.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.5 m -143.1 155.68 44.64 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -171.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.25 130.37 54.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -121.52 160.8 23.49 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 127.196 2.198 . . . . 0.0 109.396 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.43 -161.13 0.74 Allowed 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 127.334 2.254 . . . . 0.0 108.981 -172.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -62.83 20.84 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.386 1.874 . . . . 0.0 112.992 162.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 133.03 46.35 0.11 Allowed Glycine 0 C--N 1.34 0.759 0 O-C-N 120.187 -1.571 . . . . 0.0 113.725 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.403 ' HE2' ' O ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -170.3 154.92 5.02 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 125.769 1.627 . . . . 0.0 108.497 160.863 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.403 ' O ' ' HE2' ' A' ' 104' ' ' LYS . 33.7 tt0 -72.71 146.86 46.18 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.481 1.113 . . . . 0.0 108.271 165.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.32 -29.86 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 117.981 -1.009 . . . . 0.0 111.617 170.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -131.64 147.18 52.5 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 120.395 1.452 . . . . 0.0 109.278 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.6 ptmm? -148.99 91.1 1.82 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 -164.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -129.05 171.41 12.4 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 123.564 1.65 . . . . 0.0 111.762 -168.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.4 t -148.11 165.74 29.93 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 111.963 -2.38 . . . . 0.0 105.252 162.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.5 mt -144.06 160.58 40.63 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.902 2.081 . . . . 0.0 108.045 168.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 p -126.35 123.16 62.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 125.426 1.491 . . . . 0.0 108.205 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.426 ' CD1' HG12 ' A' ' 81' ' ' VAL . 95.0 m-85 . . . . . 0 CA--C 1.516 -0.332 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.3 t70 . . . . . 0 N--CA 1.468 0.431 0 CA-C-O 120.484 0.183 . . . . 0.0 111.474 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 16.2 tp -111.08 131.18 55.29 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 165.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.13 36.42 0.68 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.062 1.745 . . . . 0.0 110.935 -168.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.8 mt -83.65 155.15 23.33 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.293 1.037 . . . . 0.0 110.985 -171.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -160.36 156.79 26.79 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 126.674 1.989 . . . . 0.0 111.635 169.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -151.52 160.49 43.67 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 127.288 2.235 . . . . 0.0 110.04 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.4 p30 . . . . . 0 C--O 1.245 0.866 0 C-N-CA 123.288 0.635 . . . . 0.0 110.384 161.694 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.426 0 CA-C-O 119.021 -0.877 . . . . 0.0 112.736 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -118.09 128.67 54.97 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 160.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.419 ' H ' ' HB3' ' A' ' 102' ' ' ASN . 17.2 mtp -78.9 160.53 27.24 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 147.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -132.97 146.32 51.67 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 170.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -148.7 121.41 8.64 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.847 1.259 . . . . 0.0 107.713 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.3 p -101.49 151.16 5.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 125.351 1.46 . . . . 0.0 108.146 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.0 p -123.68 162.74 22.48 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 122.702 1.239 . . . . 0.0 109.448 165.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.487 HD11 ' CG ' ' A' ' 95' ' ' TRP . 6.0 tp -133.0 144.64 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 159.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -134.69 98.31 4.02 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 103.803 -2.666 . . . . 0.0 103.803 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -81.29 108.7 15.14 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -133.95 164.86 26.34 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 118.688 0.676 . . . . 0.0 112.469 172.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.76 -176.37 11.3 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -145.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -75.83 120.79 21.67 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.357 -1.084 . . . . 0.0 110.906 -168.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -109.78 19.08 19.52 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 120.049 1.295 . . . . 0.0 112.269 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -81.61 -10.54 59.4 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -172.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.4 p -128.14 25.86 5.82 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.757 1.623 . . . . 0.0 113.721 -169.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -125.62 168.18 14.07 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 119.312 -2.118 . . . . 0.0 110.076 -165.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.7 mp -120.62 89.01 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.516 ' HB3' HD13 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -71.67 147.26 47.65 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 120.971 -1.081 . . . . 0.0 109.55 -179.436 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.28 129.16 17.36 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.665 1.986 . . . . 0.0 105.909 170.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.8 t -131.15 126.5 59.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 160.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -91.85 130.07 41.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 167.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.264 12.6 p -134.27 150.67 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 120.243 1.383 . . . . 0.0 110.509 167.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.41 HG22 ' HB3' ' A' ' 51' ' ' PRO . 83.8 t -135.18 158.83 41.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 127.728 2.411 . . . . 0.0 104.524 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.73 127.77 20.75 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 156.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -77.85 115.8 17.87 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 171.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.02 -9.76 22.99 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 118.452 -1.193 . . . . 0.0 115.309 159.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.5 t -157.07 -173.15 4.31 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.252 1.526 . . . . 0.0 110.219 -176.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -96.2 177.03 5.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.882 1.273 . . . . 0.0 110.277 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -117.33 161.94 18.72 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 127.122 2.169 . . . . 0.0 107.897 -169.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -139.03 128.51 24.38 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -170.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -80.46 113.78 18.89 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.12 9.02 58.91 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.056 -0.858 . . . . 0.0 113.578 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.36 -64.44 0.92 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 119.664 1.732 . . . . 0.0 108.267 157.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.85 -20.12 3.2 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.31 0.644 . . . . 0.0 111.852 -156.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.98 46.83 2.36 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 124.692 1.139 . . . . 0.0 110.96 175.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -100.32 132.21 45.82 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 p -76.75 131.18 38.59 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.3 mt -121.63 168.63 11.55 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 126.464 1.905 . . . . 0.0 108.983 -176.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -123.47 109.57 14.0 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.652 1.981 . . . . 0.0 107.985 -167.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.8 165.11 28.03 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -174.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.41 ' HB3' HG22 ' A' ' 33' ' ' VAL . 64.1 Cg_endo -70.45 172.25 52.59 Favored 'Cis proline' 0 C--N 1.348 0.546 0 C-N-CA 124.694 -0.961 . . . . 0.0 110.027 -18.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.4 p -148.86 148.16 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 121.482 0.658 . . . . 0.0 109.77 -174.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.4 mm -116.74 112.27 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 104.767 -2.309 . . . . 0.0 104.767 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -76.34 99.86 4.95 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 162.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 75.6 m -91.7 -175.62 4.22 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 173.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -63.04 -24.92 68.14 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -166.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -64.93 -47.59 77.16 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.192 1.397 . . . . 0.0 109.878 173.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -74.11 -13.74 60.87 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.168 0.987 . . . . 0.0 111.027 -174.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.516 HD13 ' HB3' ' A' ' 28' ' ' LYS . 14.0 mt -116.79 19.55 14.4 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.991 1.716 . . . . 0.0 111.048 -175.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.73 13.54 0.36 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.006 1.722 . . . . 0.0 113.418 174.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.6 HG23 HG22 ' A' ' 64' ' ' VAL . 0.9 OUTLIER -131.29 160.17 42.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 127.338 2.255 . . . . 0.0 109.257 -162.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.79 -32.1 73.5 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.975 0.91 . . . . 0.0 113.032 -176.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -163.94 121.16 1.74 Allowed 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -158.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.6 HG22 HG23 ' A' ' 61' ' ' VAL . 1.8 t -132.1 93.17 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -170.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.3 m -82.35 130.2 35.05 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 175.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -130.95 146.48 52.37 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 176.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.4 t -145.75 171.46 14.73 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.342 0.657 . . . . 0.0 110.114 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.5 p -79.14 165.45 23.31 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.493 0.664 . . . . 0.0 110.165 168.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 61.1 p -89.85 1.17 56.51 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.522 -0.736 . . . . 0.0 111.439 166.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -172.53 -163.52 26.49 Favored Glycine 0 N--CA 1.444 -0.794 0 O-C-N 120.926 -1.109 . . . . 0.0 113.806 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.34 119.3 3.95 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 128.47 2.708 . . . . 0.0 109.663 171.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.494 ' C ' HD13 ' A' ' 73' ' ' ILE . . . -125.38 167.15 15.35 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.465 0.706 . . . . 0.0 110.455 175.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.494 HD13 ' C ' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -125.71 -3.06 5.32 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 C-N-CA 124.354 1.062 . . . . 0.0 110.861 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 129' ' ' ASN . 60.9 mt-10 -151.52 162.71 40.5 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 119.736 1.153 . . . . 0.0 109.823 171.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -161.47 72.3 0.41 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.347 1.459 . . . . 0.0 109.108 176.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.27 144.09 55.0 Favored 'General case' 0 C--N 1.333 -0.144 0 O-C-N 121.735 -0.603 . . . . 0.0 110.198 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 64.9 t -142.06 114.04 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 126.643 1.977 . . . . 0.0 106.526 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.9 m -129.13 158.85 37.82 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.003 0.921 . . . . 0.0 108.649 171.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 154.08 -172.44 32.72 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-N 118.569 0.622 . . . . 0.0 111.777 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.75 173.4 41.43 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.355 1.455 . . . . 0.0 111.375 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.537 0.444 0 C-N-CA 125.345 1.458 . . . . 0.0 110.651 172.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 . . . . . 0 C--O 1.224 -0.255 0 CA-C-O 118.77 -0.633 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -81.65 -179.35 4.82 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.342 2.028 . . . . 0.0 113.985 -172.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 6.5 ptm -133.82 168.6 18.45 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.221 1.01 . . . . 0.0 111.786 -166.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -140.56 153.51 46.16 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 126.702 2.001 . . . . 0.0 107.443 170.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.487 ' CG ' HD11 ' A' ' 17' ' ' ILE . 3.9 m0 -116.17 114.61 24.69 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 103.943 -2.614 . . . . 0.0 103.943 172.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.9 t -94.23 127.02 46.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 164.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 m -139.26 94.02 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 -163.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.7 m -95.57 164.94 12.58 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.8 t -135.61 122.86 35.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 164.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -96.05 156.81 16.18 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 125.93 1.692 . . . . 0.0 107.744 168.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -108.72 -162.48 0.82 Allowed 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.505 1.922 . . . . 0.0 106.956 171.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.419 ' HB3' ' H ' ' A' ' 12' ' ' MET . 9.7 p-10 -63.02 82.83 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.268 1.827 . . . . 0.0 109.396 170.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.34 16.31 59.13 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.459 1.504 . . . . 0.0 115.146 167.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -153.35 168.92 24.42 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.633 1.717 . . . . 0.0 111.368 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -97.91 135.25 39.9 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.426 1.491 . . . . 0.0 108.823 176.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.21 -14.52 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.72 1.145 . . . . 0.0 113.859 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -129.9 153.42 48.34 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 173.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.9 tttm -160.39 78.77 0.65 Allowed 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.4 169.4 11.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.566 0.698 . . . . 0.0 110.435 177.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.4 t -156.84 155.24 31.16 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.628 ' N ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -131.03 -174.56 3.41 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 125.906 1.682 . . . . 0.0 107.078 179.461 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.4 p -167.87 119.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 126.308 1.843 . . . . 0.0 108.515 -158.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.467 0.415 0 O-C-N 121.555 -0.716 . . . . 0.0 110.353 171.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.532 0.283 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 mt -113.15 128.02 56.36 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.304 1.042 . . . . 0.0 111.598 -175.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -139.75 82.84 1.9 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 128.473 2.709 . . . . 0.0 106.6 174.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.2 mp -120.01 128.57 53.66 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.854 1.262 . . . . 0.0 107.875 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.5 72.34 1.38 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -176.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -74.6 150.09 39.81 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.284 175.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 31.8 p-10 . . . . . 0 C--O 1.257 1.466 0 C-N-CA 126.738 2.015 . . . . 0.0 109.989 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.982 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.97 177.55 9.05 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.062 1.431 . . . . 0.0 111.335 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.11 150.96 21.83 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.366 1.866 . . . . 0.0 108.723 157.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.52 ' HE1' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -157.44 134.69 10.34 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 128.428 2.691 . . . . 0.0 109.664 178.339 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -127.33 137.58 52.83 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 128.199 2.599 . . . . 0.0 104.96 169.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.1 p -110.16 150.14 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 165.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.0 p -124.03 159.53 29.66 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 164.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 tp -129.1 135.23 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 C-N-CA 127.94 2.496 . . . . 0.0 105.645 168.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -111.03 138.7 47.11 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 155.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -121.67 116.53 24.72 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 m -143.76 171.76 13.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 118.335 0.516 . . . . 0.0 110.985 -172.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.71 -95.18 2.07 Favored Glycine 0 C--N 1.334 0.453 0 N-CA-C 105.066 -3.214 . . . . 0.0 105.066 -164.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -142.19 173.33 11.62 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.495 1.518 . . . . 0.0 107.448 165.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -157.71 8.33 0.16 Allowed 'General case' 0 C--N 1.328 -0.361 0 O-C-N 120.852 -1.155 . . . . 0.0 112.173 169.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -54.95 -41.74 71.48 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.478 1.111 . . . . 0.0 113.297 -172.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 m -128.37 51.89 1.95 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.623 1.169 . . . . 0.0 109.788 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.414 ' HB3' HG21 ' A' ' 81' ' ' VAL . 28.4 m-85 -122.85 107.97 12.47 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -176.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 51.3 mt -73.22 88.64 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 125.515 1.526 . . . . 0.0 108.481 -168.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.4 pttm -112.41 125.32 54.08 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.414 1.485 . . . . 0.0 110.351 -166.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.6 m -127.95 159.7 34.15 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.728 1.211 . . . . 0.0 109.317 168.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 85.8 t -140.45 133.68 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.4 t -84.88 135.79 24.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 125.731 1.612 . . . . 0.0 107.196 169.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.6 t -136.58 128.26 43.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 168.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.3 t -138.65 119.4 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.96 156.22 36.77 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 167.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -118.83 119.49 34.52 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.737 1.615 . . . . 0.0 109.613 -175.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.24 -6.81 56.27 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.769 1.176 . . . . 0.0 114.857 161.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.407 ' CG2' ' HB2' ' A' ' 72' ' ' ALA . 14.7 t -140.67 -164.14 1.67 Allowed 'General case' 0 C--O 1.242 0.695 0 C-N-CA 126.548 1.939 . . . . 0.0 107.813 -176.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -122.05 177.49 5.3 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 120.904 -1.123 . . . . 0.0 109.308 174.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.83 167.58 10.38 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 125.038 1.335 . . . . 0.0 109.013 -173.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -136.67 114.12 10.92 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.225 1.01 . . . . 0.0 108.53 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -69.23 127.05 31.69 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.62 -22.43 69.82 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-O 118.226 -1.319 . . . . 0.0 113.85 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.07 -51.7 68.59 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 119.505 1.653 . . . . 0.0 110.322 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.81 -9.35 1.6 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.955 0.902 . . . . 0.0 111.552 -160.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.6 13.22 80.51 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.262 0.934 . . . . 0.0 112.506 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -55.1 123.56 14.04 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.901 1.681 . . . . 0.0 108.699 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.83 104.35 12.14 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.8 mt -85.7 163.16 18.41 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.699 0.8 . . . . 0.0 109.483 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.95 109.92 17.64 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.604 1.962 . . . . 0.0 106.243 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 66.2 m -82.36 151.33 65.62 Favored Pre-proline 0 C--N 1.323 -0.55 0 C-N-CA 126.895 2.078 . . . . 0.0 111.913 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.61 163.87 89.43 Favored 'Cis proline' 0 CA--C 1.535 0.561 0 CA-C-N 119.13 0.725 . . . . 0.0 111.658 -1.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 p -156.61 157.87 3.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 123.607 0.763 . . . . 0.0 109.758 170.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.9 mm -116.15 116.37 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 125.896 1.678 . . . . 0.0 107.082 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.8 mt -71.94 145.29 48.54 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 165.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 m -108.59 176.77 5.0 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.24 171.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -58.39 -22.96 55.78 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.611 1.964 . . . . 0.0 112.665 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -66.18 -27.29 67.88 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.147 1.779 . . . . 0.0 112.47 175.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -100.76 -24.06 14.48 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.637 1.575 . . . . 0.0 110.463 -171.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.7 mt -97.72 15.82 22.47 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.673 1.989 . . . . 0.0 110.297 -175.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.46 14.57 0.17 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.907 1.683 . . . . 0.0 114.278 -175.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.7 m -128.03 170.91 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 126.919 2.088 . . . . 0.0 111.008 -162.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -76.36 -20.43 57.21 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.055 0.942 . . . . 0.0 112.651 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.14 133.78 16.68 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.599 1.56 . . . . 0.0 110.006 -168.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.5 t -140.04 82.37 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.415 0.626 . . . . 0.0 110.209 173.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 90.4 m -73.44 130.54 40.33 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.74 1.216 . . . . 0.0 109.436 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -132.4 129.56 39.5 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.548 1.067 . . . . 0.0 109.112 175.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.0 t -141.28 168.18 20.39 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.768 1.627 . . . . 0.0 108.481 175.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.33 153.77 18.99 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 123.961 0.904 . . . . 0.0 110.231 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.3 p -83.33 11.48 6.68 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.726 1.21 . . . . 0.0 112.063 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 173.34 -172.49 45.22 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 173.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.61 141.28 48.67 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.671 1.236 . . . . 0.0 109.165 174.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.52 ' HB3' ' HE1' ' A' ' 13' ' ' TYR . . . -124.75 178.38 5.5 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.496 1.118 . . . . 0.0 108.547 172.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.2 mm -116.13 -11.61 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.863 0.865 . . . . 0.0 111.113 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -143.89 156.2 44.36 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.366 1.066 . . . . 0.0 108.746 169.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -145.08 103.28 3.85 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 160.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.86 122.12 46.92 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.12 121.94 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 C-N-CA 127.752 2.421 . . . . 0.0 109.162 -171.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.1 t -147.56 153.16 39.1 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -169.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.76 -177.02 43.44 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 171.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.05 176.41 38.47 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 106.196 -2.762 . . . . 0.0 106.196 167.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.414 HG21 ' HB3' ' A' ' 26' ' ' PHE . 7.2 p . . . . . 0 C--N 1.323 -0.546 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 166.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 . . . . . 0 CA--C 1.535 0.372 0 CA-C-O 119.409 -0.329 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -84.6 -175.99 2.33 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.29 2.66 . . . . 0.0 112.792 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 19.5 ptm -148.03 176.19 10.39 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.339 -0.851 . . . . 0.0 113.254 -160.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -142.3 157.18 45.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.462 1.905 . . . . 0.0 108.39 169.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 21.9 m0 -116.23 122.07 43.91 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 162.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.274 7.1 p -116.69 103.92 15.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 168.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.0 m -97.53 168.91 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.46 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.2 m -156.2 147.37 22.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.7 t -121.46 132.04 71.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -119.31 117.01 27.42 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.868 1.667 . . . . 0.0 107.246 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.3 tptt -74.8 -164.73 0.31 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.414 1.886 . . . . 0.0 108.784 172.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.17 79.93 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.037 2.535 . . . . 0.0 108.769 173.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.16 36.77 50.33 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.178 1.371 . . . . 0.0 114.133 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -157.32 152.5 26.05 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 118.199 1.0 . . . . 0.0 109.651 164.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -77.98 140.28 39.19 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 166.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 3.0 pt -130.92 -17.43 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -148.92 144.32 26.77 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -174.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -148.14 39.27 0.91 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -174.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.04 148.52 41.88 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.683 -1.261 . . . . 0.0 111.964 -173.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.9 p -122.04 153.16 38.98 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 127.575 2.35 . . . . 0.0 109.138 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.0 mt -131.9 170.47 14.83 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.237 1.415 . . . . 0.0 109.3 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 t -146.44 146.8 18.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 124.719 1.208 . . . . 0.0 108.406 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 . . . . . 0 C--O 1.235 0.297 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 152.23 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.3 t0 . . . . . 0 C--O 1.234 0.249 0 CA-C-O 121.068 0.461 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.9 tt -89.74 115.45 27.11 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 162.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -139.6 113.36 8.61 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 167.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 62.9 mt -139.62 115.2 10.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -177.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -134.2 129.7 36.13 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -141.51 163.07 33.91 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.453 1.501 . . . . 0.0 108.549 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 117.013 -1.47 . . . . 0.0 111.071 -174.418 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.55 ' HA2' ' HE3' ' A' ' 71' ' ' LYS . . . . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 114.792 0.677 . . . . 0.0 114.792 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.51 122.32 36.25 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 163.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 35.3 mtp -75.18 175.01 8.68 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 145.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 75' ' ' PHE . 1.4 p90 -167.57 171.28 10.44 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 125.499 1.52 . . . . 0.0 110.88 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -161.21 105.9 1.33 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.974 1.31 . . . . 0.0 107.565 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.6 p -80.75 158.57 4.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 119.917 -1.739 . . . . 0.0 109.445 166.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.6 p -128.7 158.95 37.16 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.826 1.25 . . . . 0.0 108.132 168.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.54 HD11 ' CD2' ' A' ' 95' ' ' TRP . 3.0 tp -136.85 97.99 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 172.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -75.0 147.17 41.02 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 164.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -118.26 150.25 39.77 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 161.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.0 162.82 34.59 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.54 -153.81 39.58 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -173.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -83.89 76.87 9.99 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 124.9 1.28 . . . . 0.0 109.898 -169.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -75.18 13.07 0.76 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 116.716 -1.611 . . . . 0.0 113.73 -175.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.6 mtt-85 -106.28 5.29 29.6 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 121.465 1.939 . . . . 0.0 114.766 -164.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.0 m -144.48 53.93 1.26 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.822 1.192 . . . . 0.0 111.959 175.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -135.47 137.6 42.32 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.238 1.015 . . . . 0.0 109.746 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.8 mm -78.28 93.67 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.583 1.153 . . . . 0.0 108.812 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -89.87 151.11 21.91 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 121.146 -0.971 . . . . 0.0 109.24 -176.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.1 m -138.79 142.99 38.74 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.347 1.059 . . . . 0.0 109.448 174.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.4 t -138.92 128.04 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 166.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.1 t -107.91 105.83 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 171.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.5 p -117.61 128.93 74.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 125.796 1.639 . . . . 0.0 110.583 -171.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.4 t -133.53 138.24 51.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -175.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.38 107.49 9.55 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 164.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.576 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 24.6 t-20 -63.6 113.98 3.67 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 171.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.66 -12.71 64.46 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.264 1.411 . . . . 0.0 116.108 169.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.9 t -149.82 172.06 15.75 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.351 2.076 . . . . 0.0 110.996 -172.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -89.74 160.85 16.35 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 122.641 1.21 . . . . 0.0 110.525 173.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.91 162.37 16.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 112.894 -1.957 . . . . 0.0 108.145 169.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -123.9 124.76 43.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 171.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -74.48 120.59 20.25 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.13 -20.83 75.25 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 117.636 -1.647 . . . . 0.0 113.695 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.64 -42.1 74.71 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.713 1.756 . . . . 0.0 112.583 -170.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 p -126.97 0.57 6.58 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.121 0.873 . . . . 0.0 112.896 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.11 28.63 40.42 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 123.812 0.72 . . . . 0.0 111.471 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -77.72 172.35 13.56 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.12 1.368 . . . . 0.0 109.055 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.8 t -123.73 130.73 53.09 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.648 0.737 . . . . 0.0 110.084 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 49.8 mt -118.91 121.32 39.69 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.362 -1.745 . . . . 0.0 108.864 -163.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.95 92.19 1.61 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.5 p -73.5 165.11 55.9 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-O 118.332 -0.842 . . . . 0.0 109.995 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -60.74 149.61 50.16 Favored 'Cis proline' 0 N--CA 1.452 -0.958 0 CA-C-N 120.354 1.162 . . . . 0.0 110.673 -13.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.4 p -142.31 158.71 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.8 mm -114.83 117.11 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 104.215 -2.513 . . . . 0.0 104.215 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 64.3 mt -77.69 159.9 28.83 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 169.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.5 m -138.82 -173.52 3.59 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.523 1.529 . . . . 0.0 108.256 -176.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -55.85 -41.3 74.13 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.407 1.483 . . . . 0.0 113.138 -174.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -67.19 -39.33 86.35 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.234 1.014 . . . . 0.0 111.133 -176.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -67.68 -22.51 65.28 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.729 0.812 . . . . 0.0 110.281 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 16.6 mt -115.82 20.12 14.75 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.664 1.985 . . . . 0.0 111.259 -173.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.15 3.89 7.86 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.667 1.187 . . . . 0.0 113.584 -172.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.3 m -122.8 167.13 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.539 1.536 . . . . 0.0 111.105 -165.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -57.08 -23.09 44.3 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.64 134.68 5.37 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 117.157 -1.401 . . . . 0.0 108.92 -168.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.0 t -126.45 161.94 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 164.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.4 m -142.04 127.21 18.54 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.989 1.715 . . . . 0.0 106.901 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -128.75 132.21 47.92 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.6 t -148.41 164.5 33.93 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 126.346 1.859 . . . . 0.0 106.601 -169.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.5 p -97.37 157.74 15.82 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 122.976 1.369 . . . . 0.0 112.869 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.6 p -76.2 -25.24 54.95 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.326 171.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -152.17 -169.11 17.21 Favored Glycine 0 CA--C 1.531 1.074 0 O-C-N 120.879 -1.138 . . . . 0.0 112.025 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.585 ' HE2' ' CD1' ' A' ' 73' ' ' ILE . 71.8 tttt -48.17 139.34 8.5 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 168.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -125.04 178.48 5.51 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 161.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.585 ' CD1' ' HE2' ' A' ' 71' ' ' LYS . 5.1 mm -111.43 -15.16 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.722 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.576 ' HG2' ' HB2' ' A' ' 35' ' ' ASN . 7.6 pt-20 -156.82 159.42 38.22 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -174.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.42 ' HB2' ' CE2' ' A' ' 13' ' ' TYR . 11.6 t80 -146.88 104.58 3.72 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.044 1.738 . . . . 0.0 109.738 165.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.41 148.19 22.48 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 118.548 -0.739 . . . . 0.0 109.724 176.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 t -149.17 112.65 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 124.97 1.308 . . . . 0.0 108.719 176.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.4 p -131.63 171.36 13.55 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 120.047 -1.658 . . . . 0.0 110.2 167.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 164.88 -99.05 0.16 Allowed Glycine 0 C--N 1.333 0.401 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 168.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.17 -175.3 15.7 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.371 0.986 . . . . 0.0 111.1 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.516 -0.345 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 CA--C 1.535 0.399 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -82.67 174.01 9.98 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.615 2.21 . . . . 0.0 112.637 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.3 ptm -143.9 163.25 33.97 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.574 0.749 . . . . 0.0 112.365 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -133.64 162.06 32.96 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.116 1.766 . . . . 0.0 109.617 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.54 ' CD2' HD11 ' A' ' 17' ' ' ILE . 2.4 m0 -127.52 150.42 49.69 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 125.922 1.689 . . . . 0.0 107.523 171.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.3 t -128.21 134.77 64.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 159.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 m -135.84 70.29 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -168.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.6 m -85.49 138.4 32.24 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -173.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.6 t -113.1 120.62 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -103.84 157.17 17.27 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 122.944 1.354 . . . . 0.0 108.325 168.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -116.34 176.62 5.02 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 130.127 3.371 . . . . 0.0 105.955 172.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -47.96 87.68 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 129.395 3.078 . . . . 0.0 108.941 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.4 58.64 10.5 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.133 1.349 . . . . 0.0 114.604 -171.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.83 154.09 6.2 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.045 1.922 . . . . 0.0 109.893 150.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -73.12 143.02 47.5 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.573 1.149 . . . . 0.0 108.906 165.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.1 pt -135.48 5.28 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 119.092 0.86 . . . . 0.0 113.065 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -152.73 160.15 43.13 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 120.548 -1.345 . . . . 0.0 108.522 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.9 tttm -158.09 86.71 0.9 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.176 0.898 . . . . 0.0 110.941 168.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.08 158.04 34.79 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 121.452 -0.78 . . . . 0.0 110.849 168.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.18 160.05 42.05 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 129.517 3.127 . . . . 0.0 107.46 177.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.9 mt -126.09 154.73 42.67 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.241 1.016 . . . . 0.0 108.297 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.5 p -136.31 130.57 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 . . . . . 0 N--CA 1.446 -0.664 0 C-N-CA 124.239 1.015 . . . . 0.0 108.715 176.838 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 C--O 1.235 0.319 0 N-CA-C 111.461 0.171 . . . . 0.0 111.461 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.46 91.82 2.58 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -153.65 81.72 1.16 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.866 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mp -114.85 146.87 40.61 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 126.692 1.997 . . . . 0.0 110.54 -173.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.99 110.25 3.73 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 177.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -115.16 117.19 29.82 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--O 1.246 0.883 0 C-N-CA 124.293 1.037 . . . . 0.0 110.039 -179.608 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.769 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -154.02 -157.01 0.73 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.696 1.198 . . . . 0.0 109.659 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 37.3 mtp -121.61 161.5 22.32 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 154.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -133.9 152.02 51.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 123.836 0.71 . . . . 0.0 109.477 167.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -147.63 121.47 9.32 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.7 p -123.05 145.95 29.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 124.854 1.262 . . . . 0.0 108.868 -168.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 73.3 p -118.0 162.67 17.78 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 122.186 0.993 . . . . 0.0 110.647 174.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.1 tp -144.73 90.92 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 165.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.532 ' HB2' HG13 ' A' ' 96' ' ' VAL . 31.5 mt-10 -75.56 132.97 41.05 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 162.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -112.43 111.26 21.99 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.705 2.002 . . . . 0.0 106.864 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -87.56 177.95 6.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.836 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.85 -134.2 52.07 Favored Glycine 0 C--N 1.335 0.485 0 C-N-CA 123.201 0.429 . . . . 0.0 112.756 163.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.74 38.78 1.15 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -162.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.432 ' HA ' ' SD ' ' A' ' 93' ' ' MET . 25.0 p90 -55.86 4.19 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 119.699 3.222 . . . . 0.0 119.699 -162.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.67 13.61 17.41 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 126.349 1.859 . . . . 0.0 113.152 -155.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.7 m -150.87 23.19 0.77 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -169.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -135.26 129.89 34.31 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.323 1.049 . . . . 0.0 108.453 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -68.69 93.32 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 119.704 1.138 . . . . 0.0 110.553 -177.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.79 151.37 22.93 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.433 -0.792 . . . . 0.0 110.522 173.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.6 m -140.04 150.49 44.45 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.273 1.829 . . . . 0.0 107.066 170.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.4 t -140.69 115.05 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.89 150.9 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 164.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.8 p -136.1 133.51 50.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 158.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.4 t -114.55 153.15 16.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 170.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.48 159.56 44.39 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.099 0.96 . . . . 0.0 108.547 169.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -125.04 117.09 23.21 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 127.09 2.156 . . . . 0.0 107.075 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.05 -1.29 67.56 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-O 118.365 -1.241 . . . . 0.0 114.607 163.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.617 HG22 ' HB2' ' A' ' 72' ' ' ALA . 1.4 t -159.3 174.91 14.05 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.8 1.8 . . . . 0.0 109.153 174.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -97.75 176.08 5.94 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.263 1.025 . . . . 0.0 111.173 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.37 161.41 13.94 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.337 1.055 . . . . 0.0 109.14 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -133.54 131.61 39.96 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 125.704 1.601 . . . . 0.0 107.227 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -101.22 119.5 38.85 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 123.918 0.761 . . . . 0.0 109.943 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.84 -7.99 5.26 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 118.016 -1.435 . . . . 0.0 114.205 171.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.94 -45.73 82.55 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 120.462 2.131 . . . . 0.0 111.509 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.23 -11.38 0.12 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.821 1.248 . . . . 0.0 112.508 -167.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.3 2.02 55.71 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.507 1.051 . . . . 0.0 112.199 -166.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -63.15 119.27 9.22 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.849 1.324 . . . . 0.0 110.203 -173.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.76 134.82 35.48 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.648 1.579 . . . . 0.0 108.8 172.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.3 mt -129.71 169.81 14.62 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.884 1.273 . . . . 0.0 109.384 -173.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.03 101.88 7.96 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 126.36 1.864 . . . . 0.0 108.179 -166.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.4 168.59 23.55 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 125.33 1.452 . . . . 0.0 112.438 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -72.28 141.57 71.27 Favored 'Cis proline' 0 C--N 1.35 0.639 0 N-CA-C 109.559 -0.977 . . . . 0.0 109.559 -8.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.9 p -145.11 161.51 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 121.435 -0.79 . . . . 0.0 110.125 -175.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.4 mm -118.66 114.62 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -177.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -80.5 133.65 35.85 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 169.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.411 ' H ' ' HG2' ' A' ' 58' ' ' GLU . 6.9 m -101.88 -177.91 3.56 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.944 1.697 . . . . 0.0 110.082 -175.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -52.64 -46.3 67.06 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.423 1.489 . . . . 0.0 111.676 -173.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -74.19 -30.25 62.13 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.212 0.605 . . . . 0.0 112.627 -171.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.411 ' HG2' ' H ' ' A' ' 55' ' ' SER . 2.2 mm-40 -67.75 -32.9 73.82 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.266 0.626 . . . . 0.0 109.993 173.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.652 HD13 HG21 ' A' ' 64' ' ' VAL . 3.7 mm? -92.69 7.25 44.34 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.106 1.762 . . . . 0.0 112.373 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.85 45.02 0.68 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.857 1.663 . . . . 0.0 112.488 -170.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.0 m -138.52 170.0 17.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 127.978 2.511 . . . . 0.0 109.537 -175.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -72.57 -24.83 61.16 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.207 -0.933 . . . . 0.0 112.964 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -152.46 145.93 24.88 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.652 HG21 HD13 ' A' ' 59' ' ' LEU . 2.2 t -120.9 153.06 24.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 160.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.401 ' C ' HD22 ' A' ' 66' ' ' LEU . 93.0 m -149.2 135.84 19.51 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 120.148 -1.595 . . . . 0.0 108.551 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.401 HD22 ' C ' ' A' ' 65' ' ' THR . 3.0 mm? -134.8 164.05 28.42 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 125.24 1.416 . . . . 0.0 109.019 -172.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.0 t -152.86 158.53 42.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.783 0.833 . . . . 0.0 108.876 173.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.415 HG21 ' HB3' ' A' ' 72' ' ' ALA . 18.0 p -65.84 138.3 57.79 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.551 1.541 . . . . 0.0 109.205 163.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 74.3 p -75.29 -16.74 60.41 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 120.359 1.436 . . . . 0.0 113.449 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -156.83 -163.8 12.82 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 -174.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.35 115.7 7.29 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.617 ' HB2' HG22 ' A' ' 37' ' ' THR . . . -124.44 176.04 6.74 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.859 1.264 . . . . 0.0 111.312 -173.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.517 HD13 ' O ' ' A' ' 72' ' ' ALA . 0.7 OUTLIER -137.41 5.37 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -172.319 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -147.55 164.55 33.1 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 121.178 1.808 . . . . 0.0 111.982 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -156.41 86.44 1.01 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.324 1.45 . . . . 0.0 107.679 155.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.01 138.89 34.79 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 121.482 -0.761 . . . . 0.0 109.209 166.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.2 t -143.15 130.83 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.8 m -143.71 169.22 18.15 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.051 1.341 . . . . 0.0 108.059 166.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 164.69 -175.15 40.72 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -174.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.8 -175.27 41.46 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 176.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.533 0.304 0 C-N-CA 126.838 2.055 . . . . 0.0 108.415 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 CA--C 1.532 0.28 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -81.17 178.85 6.4 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.077 1.851 . . . . 0.0 112.436 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.432 ' SD ' ' HA ' ' A' ' 23' ' ' PHE . 15.7 ptm -146.28 163.27 36.01 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 122.008 0.908 . . . . 0.0 111.145 173.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -122.82 158.77 29.53 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.394 1.477 . . . . 0.0 107.715 177.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 21.0 m0 -126.64 132.93 51.11 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 176.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 18' ' ' GLU 0.273 2.1 p -130.03 106.97 14.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 179.063 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.0 m -117.75 106.05 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 125.779 1.632 . . . . 0.0 106.98 -166.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.2 m -88.38 160.42 17.59 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 174.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.5 t -125.73 138.38 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 159.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -116.03 151.4 35.57 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 126.904 2.082 . . . . 0.0 107.843 170.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -99.69 -172.54 2.26 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 128.986 2.914 . . . . 0.0 107.895 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -61.82 75.36 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.682 1.593 . . . . 0.0 110.547 167.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.43 42.44 6.95 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.711 1.624 . . . . 0.0 114.292 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -159.21 151.67 21.43 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.351 1.576 . . . . 0.0 108.448 165.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -76.17 137.73 40.23 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 159.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.7 pt -130.12 -18.39 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 118.295 -0.86 . . . . 0.0 113.262 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -143.7 139.23 29.4 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 120.156 1.344 . . . . 0.0 110.062 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -144.94 104.14 3.96 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -174.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -141.8 174.58 10.45 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 173.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.7 t -148.35 159.6 43.84 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.12 1.368 . . . . 0.0 109.271 174.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.3 mt -125.34 164.86 19.46 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.613 1.965 . . . . 0.0 109.001 -176.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.56 86.2 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 125.704 1.602 . . . . 0.0 108.828 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 . . . . . 0 C--O 1.234 0.274 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 168.227 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.539 0.534 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -132.18 134.65 45.62 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.814 1.643 . . . . 0.0 110.872 172.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.72 89.06 1.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 158.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 29.6 mt -110.15 140.43 44.26 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -153.64 73.93 0.98 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.729 1.612 . . . . 0.0 108.28 -176.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -73.39 148.31 43.48 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 121.661 -0.649 . . . . 0.0 109.843 170.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.5 p30 . . . . . 0 C--O 1.248 1.008 0 C-N-CA 127.116 2.166 . . . . 0.0 106.058 156.484 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.587 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -143.34 -160.52 1.12 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.764 1.226 . . . . 0.0 110.92 -171.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 30.4 mtp -135.27 167.06 21.72 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 128.58 2.752 . . . . 0.0 107.307 157.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -154.92 156.05 35.39 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.417 1.887 . . . . 0.0 108.87 -174.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -168.41 126.66 1.12 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.234 2.214 . . . . 0.0 106.23 -172.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.456 HG22 ' CE2' ' A' ' 75' ' ' PHE . 1.6 m -136.72 158.94 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 125.656 1.583 . . . . 0.0 110.177 -170.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.6 p -126.5 159.24 33.96 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.334 0.654 . . . . 0.0 111.062 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 tp -132.33 111.12 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 167.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -97.42 145.67 25.95 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 162.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -127.32 128.52 46.06 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.945 1.698 . . . . 0.0 107.717 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.1 m -149.85 178.88 8.5 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.524 1.53 . . . . 0.0 108.791 -167.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.52 -149.4 51.25 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -166.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -80.04 60.21 3.51 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.108 1.363 . . . . 0.0 111.691 -173.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.457 ' HA ' ' HE3' ' A' ' 93' ' ' MET . 52.1 p90 -76.44 30.57 0.12 Allowed 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.397 -1.439 . . . . 0.0 114.462 -174.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.9 mtt85 -106.83 -10.18 16.13 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -163.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.4 t -154.03 83.37 1.14 Allowed 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -145.95 165.85 27.75 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.975 0.91 . . . . 0.0 110.538 172.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.4 mt -132.11 88.47 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 125.473 1.509 . . . . 0.0 107.767 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.71 168.12 16.55 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.098 -1.002 . . . . 0.0 111.336 176.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.0 t -124.75 161.03 27.29 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 161.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -140.55 113.92 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 160.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.5 t -74.94 131.45 34.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 159.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.2 t -129.43 143.48 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 C-N-CA 124.541 1.136 . . . . 0.0 108.184 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 t -138.25 147.06 25.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.24 119.62 11.59 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.998 1.319 . . . . 0.0 108.111 169.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -76.78 127.39 32.67 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 118.166 -0.921 . . . . 0.0 109.859 173.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.82 0.05 69.36 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.085 1.326 . . . . 0.0 114.946 163.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.5 t -161.47 -179.43 7.34 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.621 1.21 . . . . 0.0 110.666 -170.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -104.42 169.94 8.18 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.073 1.349 . . . . 0.0 109.689 169.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.3 tp -101.77 164.43 11.74 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 127.274 2.23 . . . . 0.0 109.299 -174.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -130.11 114.21 15.46 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 126.144 1.777 . . . . 0.0 106.622 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -69.61 118.79 12.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 174.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.88 -7.24 55.31 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 117.671 -1.627 . . . . 0.0 113.52 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.2 -60.11 4.27 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 120.567 2.183 . . . . 0.0 110.067 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.98 3.09 3.7 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.304 1.841 . . . . 0.0 111.46 -167.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.57 17.73 67.76 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.843 1.211 . . . . 0.0 112.153 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -69.79 124.85 25.04 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.98 1.312 . . . . 0.0 109.854 -169.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.77 111.99 10.53 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.354 1.062 . . . . 0.0 109.933 173.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.4 mt -121.66 142.78 49.8 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 123.593 0.757 . . . . 0.0 109.44 -177.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.86 95.09 9.97 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.434 1.111 . . . . 0.0 108.6 175.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.3 p -51.24 154.51 2.82 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.199 157.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.76 130.57 20.85 Favored 'Cis proline' 0 N--CA 1.457 -0.648 0 CA-C-N 120.747 1.302 . . . . 0.0 111.159 -2.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.0 p -132.28 154.21 39.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 124.554 1.142 . . . . 0.0 108.618 -169.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.4 mm -117.55 120.14 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.1 mt -87.89 136.19 33.07 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.85 171.1 14.97 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.239 1.816 . . . . 0.0 108.932 171.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -61.23 -35.4 77.14 Favored 'General case' 0 C--O 1.22 -0.463 0 O-C-N 121.031 -1.043 . . . . 0.0 109.903 164.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -59.56 -25.69 64.76 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.707 1.203 . . . . 0.0 111.937 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -90.98 -28.55 17.95 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.768 1.227 . . . . 0.0 110.716 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.3 mt -113.08 5.08 16.96 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 124.376 1.07 . . . . 0.0 113.587 -169.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.03 45.66 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.387 2.675 . . . . 0.0 111.224 168.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.6 m -119.74 160.4 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 129.135 2.974 . . . . 0.0 108.303 173.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.64 -44.65 93.44 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 121.564 -0.71 . . . . 0.0 111.25 170.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.23 152.1 29.93 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 120.794 -1.191 . . . . 0.0 109.221 -175.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.9 p -142.19 165.4 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.419 0.628 . . . . 0.0 109.35 158.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.8 m -111.7 142.66 43.75 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 127.212 2.205 . . . . 0.0 105.993 170.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -123.33 133.27 54.15 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 169.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.47 177.89 8.14 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -174.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.1 p -119.19 147.29 44.38 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 118.894 0.77 . . . . 0.0 112.984 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.7 p -71.64 -12.63 61.44 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.634 1.173 . . . . 0.0 113.16 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -165.72 -169.73 29.71 Favored Glycine 0 N--CA 1.448 -0.562 0 O-C-N 120.596 -1.315 . . . . 0.0 110.522 -165.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.449 ' CE ' HD11 ' A' ' 73' ' ' ILE . 14.5 ttpt -55.46 115.6 2.39 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.624 1.57 . . . . 0.0 109.343 -176.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -111.33 145.42 38.87 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.449 HD11 ' CE ' ' A' ' 71' ' ' LYS . 1.3 mt -131.23 -11.23 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 118.878 -0.582 . . . . 0.0 112.02 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -144.4 137.87 27.36 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.456 ' CE2' HG22 ' A' ' 15' ' ' VAL . 0.9 OUTLIER -125.69 100.2 6.32 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 165.819 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.21 152.89 21.34 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 163.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.32 123.79 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 170.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.4 p -142.33 170.49 15.61 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.759 0.709 . . . . 0.0 111.027 164.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 142.41 -75.96 0.31 Allowed Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 176.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.559 ' H ' HD12 ' A' ' 124' ' ' LEU . . . 69.95 -152.38 51.22 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 CA--C 1.534 0.35 0 C-N-CA 124.315 1.046 . . . . 0.0 110.477 -176.765 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 . . . . . 0 CA--C 1.536 0.434 0 CA-C-O 119.661 -0.209 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -78.65 173.57 13.49 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.442 2.761 . . . . 0.0 112.741 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.53 ' CE ' ' HE1' ' A' ' 95' ' ' TRP . 2.7 ptm -125.2 162.23 25.13 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.355 -0.841 . . . . 0.0 111.508 176.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -142.8 144.81 32.72 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 124.992 1.317 . . . . 0.0 108.147 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.53 ' HE1' ' CE ' ' A' ' 93' ' ' MET . 52.7 m0 -123.35 156.92 34.43 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.2 t -133.26 117.92 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.7 m -128.54 123.85 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -165.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.2 m -121.75 156.96 32.04 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -173.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.9 t -131.65 131.56 62.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 123.808 0.843 . . . . 0.0 108.955 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -114.45 166.35 11.79 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.205 1.802 . . . . 0.0 109.099 170.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.02 -156.0 0.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.383 1.873 . . . . 0.0 108.094 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -65.76 68.7 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.563 1.145 . . . . 0.0 112.151 164.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.17 38.0 4.7 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.826 1.203 . . . . 0.0 113.428 166.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.54 152.72 12.35 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.555 1.177 . . . . 0.0 109.831 168.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -64.33 137.91 58.15 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 157.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.4 pt -123.86 -27.92 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 117.579 -1.201 . . . . 0.0 112.209 172.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -140.15 149.96 43.65 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.376 1.444 . . . . 0.0 109.39 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -152.83 108.94 3.36 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.663 1.985 . . . . 0.0 105.784 -174.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.68 154.09 39.17 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.175 170.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.87 157.83 27.91 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 125.593 1.557 . . . . 0.0 109.268 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 73.8 mt -129.82 147.64 51.62 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.432 1.093 . . . . 0.0 108.199 -163.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.9 p -129.82 100.87 5.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.62 0.724 . . . . 0.0 109.175 -171.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 N--CA 1.449 -0.505 0 CA-C-O 122.119 0.962 . . . . 0.0 108.488 167.555 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.274 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.559 HD12 ' H ' ' A' ' 80' ' ' GLY . 19.6 mt -111.16 96.18 5.98 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 -176.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -153.65 58.97 0.75 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.617 175.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 83.2 mt -107.91 145.36 33.88 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -153.18 72.19 0.93 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.002 0.906 . . . . 0.0 109.794 -176.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -65.15 133.53 51.76 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 171.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.3 p30 . . . . . 0 C--O 1.255 1.38 0 C-N-CA 125.363 1.465 . . . . 0.0 109.863 175.335 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.236 0 N-CA-C 106.899 -2.48 . . . . 0.0 106.899 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.64 174.58 11.3 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.238 1.019 . . . . 0.0 109.232 -176.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.8 mtp -84.39 -174.05 5.06 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 119.764 -1.835 . . . . 0.0 109.253 154.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -153.2 148.6 27.08 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.366 0.667 . . . . 0.0 110.487 152.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -142.06 144.63 33.68 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.898 2.079 . . . . 0.0 108.354 172.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 p -138.53 153.54 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 126.957 2.103 . . . . 0.0 110.105 175.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -114.31 153.84 29.06 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.465 1.506 . . . . 0.0 109.185 167.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.596 HG22 HG12 ' A' ' 64' ' ' VAL . 6.2 tp -105.34 148.4 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 155.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -139.92 115.25 9.88 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 167.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -104.59 128.65 52.65 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 126.014 1.726 . . . . 0.0 107.474 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -138.02 173.92 11.11 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 122.702 0.401 . . . . 0.0 110.666 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.64 -82.34 1.59 Allowed Glycine 0 CA--C 1.52 0.373 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -175.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.414 ' CG ' HH11 ' A' ' 24' ' ' ARG . 17.9 t0 -168.54 104.32 0.43 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 117.997 0.899 . . . . 0.0 112.927 175.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -96.25 24.61 5.57 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.515 -1.366 . . . . 0.0 112.363 -178.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.414 HH11 ' CG ' ' A' ' 22' ' ' ASP . 69.6 mtt85 -69.34 -47.23 64.98 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -172.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.4 m -127.26 69.15 1.28 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.807 1.185 . . . . 0.0 109.465 -177.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.526 ' HB3' HG21 ' A' ' 81' ' ' VAL . 65.9 m-85 -143.02 117.66 9.81 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -177.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.7 mm -84.62 79.06 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.567 ' H ' ' CD ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -79.44 145.41 33.32 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.209 1.403 . . . . 0.0 108.614 167.846 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.4 m -135.8 174.72 10.3 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 169.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.2 t -141.52 160.51 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 174.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.8 p -114.56 151.34 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 158.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.5 p -139.31 139.25 39.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 118.626 0.648 . . . . 0.0 110.413 162.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.5 t -126.47 144.81 35.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 126.49 1.916 . . . . 0.0 106.299 169.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.61 95.43 2.65 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.981 1.312 . . . . 0.0 109.048 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -62.56 100.3 0.18 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.314 1.446 . . . . 0.0 110.072 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.65 1.28 25.94 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 117.405 1.722 . . . . 0.0 117.405 159.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.422 HG22 ' HB2' ' A' ' 72' ' ' ALA . 2.6 t -157.78 179.11 9.52 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.934 2.367 . . . . 0.0 109.086 174.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -91.38 161.35 15.04 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.481 0.658 . . . . 0.0 110.471 175.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.3 mt -84.42 171.93 12.17 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.563 0.745 . . . . 0.0 109.731 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -135.74 129.09 32.07 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.779 1.232 . . . . 0.0 108.42 170.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.456 ' HA ' HD23 ' A' ' 66' ' ' LEU . 11.0 t0 -89.4 117.19 28.14 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.634 1.173 . . . . 0.0 109.808 173.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.96 11.72 5.86 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.079 1.323 . . . . 0.0 114.235 175.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.72 -48.16 56.01 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 120.123 1.962 . . . . 0.0 108.973 168.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.31 -9.71 0.57 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.686 1.194 . . . . 0.0 111.715 -167.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.86 13.4 55.01 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.244 1.878 . . . . 0.0 112.903 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -68.51 138.5 55.24 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -174.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.449 ' O ' HD23 ' A' ' 48' ' ' LEU . 4.7 m -71.54 147.23 47.89 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 170.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 47' ' ' SER . 2.4 mt -130.07 158.8 38.64 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 118.491 0.587 . . . . 0.0 109.56 171.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.48 103.59 10.25 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 126.77 2.028 . . . . 0.0 108.267 -173.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.95 165.54 52.38 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.233 169.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.98 140.05 64.91 Favored 'Cis proline' 0 N--CA 1.454 -0.813 0 N-CA-C 109.791 -0.888 . . . . 0.0 109.791 -8.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.2 p -143.37 160.05 17.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.03 0.932 . . . . 0.0 110.891 -177.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.0 mm -118.89 125.06 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 126.968 2.107 . . . . 0.0 107.111 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.3 mt -83.11 144.59 29.76 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 166.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.25 175.7 5.32 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.36 2.264 . . . . 0.0 109.544 176.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -59.39 -35.37 73.82 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.725 1.21 . . . . 0.0 113.428 -175.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -70.68 -28.48 64.8 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.962 0.801 . . . . 0.0 112.611 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -70.29 -52.98 18.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.434 ' O ' ' HE2' ' A' ' 28' ' ' LYS . 32.1 mt -77.28 24.61 0.18 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.786 2.034 . . . . 0.0 111.379 -175.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.07 -11.11 59.89 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.459 1.104 . . . . 0.0 112.155 175.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.9 m -84.1 148.61 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.442 1.097 . . . . 0.0 110.177 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -61.78 -33.24 73.75 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.638 -0.664 . . . . 0.0 112.19 173.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -154.4 141.05 18.96 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 -166.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.596 HG12 HG22 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -140.98 158.62 23.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -134.46 119.46 18.55 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -175.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 41' ' ' ASP . 17.7 mt -136.65 137.79 40.42 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 118.991 0.814 . . . . 0.0 109.626 -172.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -147.62 -168.23 3.01 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -168.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.22 147.54 42.41 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 127.369 2.268 . . . . 0.0 108.99 176.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 79.9 p -73.93 -20.84 60.26 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.515 -0.74 . . . . 0.0 111.302 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -156.59 -156.37 7.83 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 124.25 0.928 . . . . 0.0 111.05 -177.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -67.75 137.37 55.4 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.875 0.87 . . . . 0.0 109.793 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.422 ' HB2' HG22 ' A' ' 37' ' ' THR . . . -138.16 174.62 10.36 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.079 1.752 . . . . 0.0 109.783 172.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.73 21.07 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 123.544 0.738 . . . . 0.0 109.426 -174.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 129' ' ' ASN . 3.8 mt-10 -155.0 158.08 38.61 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 119.217 -2.177 . . . . 0.0 109.371 168.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.75 85.22 1.42 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.15 1.38 . . . . 0.0 107.547 160.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 127' ' ' TYR . . . -78.85 137.59 37.75 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 171.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.3 t -148.88 105.88 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 126.811 2.044 . . . . 0.0 106.445 -174.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.0 m -141.55 173.02 11.89 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.699 1.2 . . . . 0.0 111.082 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.66 -89.7 0.11 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 123.992 0.806 . . . . 0.0 111.361 167.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.01 133.43 7.94 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 108.796 -1.721 . . . . 0.0 108.796 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.526 HG21 ' HB3' ' A' ' 26' ' ' PHE . 9.4 p . . . . . 0 CA--C 1.532 0.26 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 . . . . . 0 N--CA 1.464 0.226 0 CA-C-O 118.823 -0.608 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -84.24 178.78 4.98 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.923 2.415 . . . . 0.0 112.312 176.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.5 ptm -148.37 171.2 16.41 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.287 -0.883 . . . . 0.0 112.164 -169.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -140.04 159.12 42.9 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 126.882 2.073 . . . . 0.0 107.547 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.0 m0 -128.3 141.58 51.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.018 1.327 . . . . 0.0 107.672 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -124.81 105.42 15.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 103.59 -2.745 . . . . 0.0 103.59 164.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.0 m -83.25 157.45 3.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 155.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 28.6 m -138.79 133.43 32.11 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 169.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.9 t -112.52 141.15 28.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -125.0 138.85 54.21 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.79 2.036 . . . . 0.0 108.529 -175.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -101.14 -174.79 2.69 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.341 1.457 . . . . 0.0 107.613 174.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -68.78 65.89 0.13 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.608 2.363 . . . . 0.0 109.031 -177.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 165.21 -68.81 0.2 Allowed Glycine 0 N--CA 1.448 -0.55 0 CA-C-O 118.675 -1.069 . . . . 0.0 112.278 -172.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -157.01 -176.59 6.07 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.534 1.133 . . . . 0.0 111.289 -174.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.86 139.03 14.03 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.899 1.68 . . . . 0.0 110.037 169.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.9 pt -129.12 -22.9 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 117.822 -1.085 . . . . 0.0 112.253 171.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -124.09 128.01 48.66 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 120.092 1.315 . . . . 0.0 110.411 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -126.6 90.89 3.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.052 1.741 . . . . 0.0 107.479 175.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -130.51 162.85 28.32 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 167.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.6 t -151.06 151.98 32.8 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.63 1.572 . . . . 0.0 107.026 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 36.9 mt -121.68 161.87 21.76 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.621 1.568 . . . . 0.0 109.112 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.0 p -137.75 132.82 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 N--CA 1.446 -0.654 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -174.39 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.6 t0 . . . . . 0 C--O 1.233 0.223 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.0 tp -122.55 114.98 21.39 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -154.28 53.71 0.68 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.345 1.458 . . . . 0.0 110.531 -159.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.3 mt -118.56 140.11 50.4 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -171.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 81.7 m-85 -151.71 67.65 0.88 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.968 1.307 . . . . 0.0 109.451 -168.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -64.89 159.76 22.03 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.003 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 3.8 t30 . . . . . 0 C--O 1.25 1.094 0 C-N-CA 128.408 2.683 . . . . 0.0 106.123 -176.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.843 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -152.02 -175.3 5.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.52 1.928 . . . . 0.0 108.694 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.446 ' H ' ' HB3' ' A' ' 102' ' ' ASN . 49.5 mtp -103.54 166.86 10.17 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 155.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -133.61 153.89 51.31 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.558 1.143 . . . . 0.0 108.033 169.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -148.36 145.19 27.98 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.29 133.76 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 127.195 2.198 . . . . 0.0 106.512 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 p -94.4 171.36 8.87 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 64' ' ' VAL . 11.3 tp -132.87 146.49 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 160.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -136.24 117.57 14.63 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 161.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -107.06 128.97 54.85 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 173.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.3 p -149.1 168.4 23.3 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 122.141 -0.35 . . . . 0.0 111.335 171.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.48 -114.53 3.96 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 107.284 -2.326 . . . . 0.0 107.284 -170.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -116.11 90.24 3.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 122.008 0.909 . . . . 0.0 110.709 -174.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -102.57 21.76 14.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.958 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.0 19.31 4.1 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.552 1.541 . . . . 0.0 112.311 -168.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.8 m -134.75 -1.27 2.77 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.302 1.441 . . . . 0.0 113.484 -173.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -119.24 -174.47 2.73 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.363 1.065 . . . . 0.0 108.328 -171.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.9 mp -129.87 80.8 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.48 ' HE2' ' OD2' ' A' ' 56' ' ' ASP . 2.3 pttt -81.1 162.42 23.71 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 121.835 -0.541 . . . . 0.0 110.091 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 m -145.35 158.06 43.91 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 171.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 74.4 t -142.28 105.77 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -68.49 149.11 11.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 159.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.04 142.23 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 124.982 1.313 . . . . 0.0 108.207 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.4 t -137.58 149.33 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 171.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.0 93.84 2.64 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 172.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -69.82 104.71 2.54 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.11 7.05 38.75 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.75 -1.028 . . . . 0.0 114.284 165.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.9 t -161.89 177.59 9.69 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.546 1.173 . . . . 0.0 109.024 -174.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -100.05 170.29 8.59 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.091 0.956 . . . . 0.0 108.739 171.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 tp -84.48 170.14 13.79 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.316 0.646 . . . . 0.0 109.396 164.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -134.67 120.19 19.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.898 1.279 . . . . 0.0 108.087 171.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -69.49 129.32 39.38 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.124 0.97 . . . . 0.0 109.37 176.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.69 -8.79 84.06 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 118.892 -0.949 . . . . 0.0 113.126 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.57 -46.75 86.9 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.128 1.464 . . . . 0.0 108.635 173.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.68 -16.04 1.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.688 0.795 . . . . 0.0 112.088 -160.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.38 63.27 2.82 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -173.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -123.48 140.11 53.33 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.481 1.112 . . . . 0.0 108.333 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.85 112.16 17.98 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -178.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.7 mt -97.09 128.23 43.82 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.75 0.786 . . . . 0.0 109.352 -174.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.16 79.54 6.7 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.35 1.46 . . . . 0.0 109.493 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.2 m -63.02 163.67 15.96 Favored Pre-proline 0 N--CA 1.444 -0.767 0 C-N-CA 123.724 0.809 . . . . 0.0 110.949 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -68.93 140.66 59.29 Favored 'Cis proline' 0 CA--C 1.536 0.617 0 CA-C-N 119.211 0.754 . . . . 0.0 110.625 -9.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.7 p -145.68 149.24 16.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 124.002 0.921 . . . . 0.0 109.651 -171.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.4 mm -125.47 98.24 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 124.032 0.933 . . . . 0.0 109.295 -173.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.2 mt -72.43 131.19 42.27 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 175.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.7 m -87.93 -177.05 5.68 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.11 1.364 . . . . 0.0 109.709 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.48 ' OD2' ' HE2' ' A' ' 28' ' ' LYS . 12.5 t70 -61.21 -43.89 98.16 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.902 0.881 . . . . 0.0 112.16 -172.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -67.83 -38.85 83.74 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -174.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.15 -32.55 73.96 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.33 20.33 0.15 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.919 1.688 . . . . 0.0 115.22 176.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.36 19.34 0.08 Allowed 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 120.691 1.587 . . . . 0.0 114.993 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.8 m -95.92 153.94 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 O-C-N 120.567 -1.333 . . . . 0.0 111.554 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -75.62 -41.43 54.31 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.561 -0.712 . . . . 0.0 111.853 175.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.72 107.36 0.87 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -166.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.52 ' H ' HG22 ' A' ' 17' ' ' ILE . 93.1 t -138.6 118.91 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 123.14 1.448 . . . . 0.0 111.239 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.9 m -69.26 125.53 26.97 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 128.231 2.613 . . . . 0.0 109.093 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.49 140.8 47.81 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.479 1.036 . . . . 0.0 108.225 170.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.4 t -150.69 178.17 9.36 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.08 1.352 . . . . 0.0 107.781 176.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.9 p -87.55 165.42 15.5 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.245 0.618 . . . . 0.0 110.484 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.8 p -80.41 -13.55 59.05 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.855 -0.528 . . . . 0.0 111.372 165.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -166.43 -170.73 31.71 Favored Glycine 0 CA--C 1.527 0.812 0 O-C-N 120.388 -1.445 . . . . 0.0 113.457 -167.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -63.02 132.43 51.96 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.432 1.093 . . . . 0.0 109.057 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.452 ' C ' HD13 ' A' ' 73' ' ' ILE . . . -133.61 160.66 36.83 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.624 1.17 . . . . 0.0 111.741 -175.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.452 HD13 ' C ' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -128.2 14.35 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 118.478 -0.772 . . . . 0.0 110.35 178.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -149.27 158.05 43.85 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.483 1.492 . . . . 0.0 110.701 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -161.48 99.33 1.15 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.197 1.399 . . . . 0.0 107.664 165.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.95 142.2 28.02 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.348 1.459 . . . . 0.0 110.949 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 t -145.63 107.84 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 124.526 1.13 . . . . 0.0 108.274 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.8 m -141.07 166.65 24.21 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 121.041 -1.037 . . . . 0.0 109.67 169.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.04 -65.22 0.3 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 167.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.65 176.22 25.04 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 121.123 0.29 . . . . 0.0 112.378 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 C--O 1.235 0.325 0 C-N-CA 126.006 1.722 . . . . 0.0 107.368 165.793 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -75.69 167.01 27.26 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.264 1.976 . . . . 0.0 112.36 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.0 ppp? -149.36 174.19 12.71 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.02 0.528 . . . . 0.0 111.11 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -135.1 156.4 49.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.138 1.375 . . . . 0.0 108.753 173.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -141.25 90.9 2.35 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -178.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.7 t -82.28 137.18 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 168.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 m -144.63 54.7 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 125.254 1.422 . . . . 0.0 108.67 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.0 m -65.93 140.23 58.32 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 120.703 -1.248 . . . . 0.0 108.206 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.9 m -103.83 154.63 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 CA-C-O 122.889 1.328 . . . . 0.0 109.693 172.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -127.26 172.84 10.24 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 126.889 2.076 . . . . 0.0 108.098 167.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -120.92 -162.13 0.94 Allowed 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 130.644 3.578 . . . . 0.0 105.234 -176.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.446 ' HB3' ' H ' ' A' ' 12' ' ' MET . 0.6 OUTLIER -67.99 72.72 0.18 Allowed 'General case' 0 CA--C 1.551 1.002 0 O-C-N 121.226 -0.921 . . . . 0.0 109.416 165.775 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.25 29.37 56.47 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 126.003 1.763 . . . . 0.0 115.067 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -136.04 178.64 6.9 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.744 1.772 . . . . 0.0 108.209 166.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -120.53 140.7 51.08 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 127.322 2.249 . . . . 0.0 106.705 170.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -117.09 -27.33 2.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 125.353 1.461 . . . . 0.0 111.768 175.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -149.82 143.54 25.42 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.253 0.933 . . . . 0.0 109.164 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.8 tttt -137.45 43.77 2.29 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.517 0.727 . . . . 0.0 110.359 -173.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -69.26 142.4 54.16 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.4 t -138.76 160.14 40.39 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.268 1.827 . . . . 0.0 107.828 168.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 31.3 mt -125.32 144.5 50.46 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.993 1.717 . . . . 0.0 107.984 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 98.7 t -135.27 126.82 46.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.315 1.446 . . . . 0.0 107.24 -175.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 . . . . . 0 CA--C 1.535 0.378 0 C-N-CA 124.324 1.049 . . . . 0.0 109.174 175.579 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.09 112.63 6.86 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 172.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -144.38 70.02 1.28 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -176.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.84 139.79 44.51 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.71 2.004 . . . . 0.0 107.224 -176.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -153.08 135.72 15.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 169.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -119.93 148.32 43.67 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.837 1.255 . . . . 0.0 109.09 171.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.3 p30 . . . . . 0 C--O 1.248 0.974 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 152.823 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.66 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.15 -178.06 6.28 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.7 0.8 . . . . 0.0 111.227 -170.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.9 mtp -107.39 156.15 19.24 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 160.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -133.94 137.52 44.92 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.843 0.857 . . . . 0.0 110.637 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 39.3 tt0 -133.93 133.54 41.53 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 127.984 2.514 . . . . 0.0 107.921 171.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.05 155.78 11.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 126.511 1.924 . . . . 0.0 108.094 168.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.32 143.92 36.07 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 172.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.441 HD11 ' CG ' ' A' ' 95' ' ' TRP . 1.5 tp -133.29 97.0 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.46 143.83 34.6 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 161.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -120.67 130.79 54.25 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 173.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 m -112.18 165.79 11.83 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 122.385 0.274 . . . . 0.0 110.388 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 62.19 -147.8 48.84 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -79.3 77.38 5.83 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-O 122.112 0.958 . . . . 0.0 110.34 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -83.8 -5.97 59.32 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.006 -1.059 . . . . 0.0 112.541 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 90.9 mtt-85 -70.14 -57.43 4.95 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.8 m -78.74 35.34 0.24 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.735 1.614 . . . . 0.0 113.272 -157.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.704 ' HB3' HG21 ' A' ' 81' ' ' VAL . 36.6 m-85 -154.49 113.77 3.71 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.788 1.235 . . . . 0.0 111.392 -158.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.6 pt -67.68 74.99 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 127.791 2.436 . . . . 0.0 112.649 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -77.85 160.62 28.19 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 128.181 2.592 . . . . 0.0 111.851 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.5 t -156.63 152.91 27.75 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.636 -0.665 . . . . 0.0 109.798 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.5 t -128.19 139.95 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 125.628 1.571 . . . . 0.0 108.4 175.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.4 t -106.15 129.05 60.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 127.878 2.471 . . . . 0.0 104.761 164.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.62 147.08 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 119.696 1.135 . . . . 0.0 110.234 176.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.9 t -140.87 150.56 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.2 100.52 3.29 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 170.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -68.67 118.36 11.57 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.012 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.19 -14.11 40.17 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 119.408 -0.662 . . . . 0.0 114.106 159.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.4 t -148.87 178.3 8.8 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.872 1.269 . . . . 0.0 110.052 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -89.8 155.03 19.45 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.462 0.705 . . . . 0.0 109.816 173.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.5 tp -77.47 166.96 22.42 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.423 1.089 . . . . 0.0 108.883 168.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -137.07 128.36 28.07 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.152 1.781 . . . . 0.0 107.209 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.423 ' HB2' HD11 ' A' ' 48' ' ' LEU . 8.7 t0 -84.67 121.32 27.49 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.93 -8.25 57.52 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-O 119.125 -0.819 . . . . 0.0 113.693 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.8 -26.52 40.53 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.047 1.423 . . . . 0.0 111.729 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 p -134.09 -43.91 0.79 Allowed 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 124.299 1.04 . . . . 0.0 110.808 -169.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.57 13.1 56.16 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.724 -1.042 . . . . 0.0 111.058 -163.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -67.29 156.9 35.22 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 118.705 1.252 . . . . 0.0 109.253 168.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.4 p -112.96 133.62 54.84 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.39 1.476 . . . . 0.0 108.962 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.423 HD11 ' HB2' ' A' ' 41' ' ' ASP . 44.9 mt -130.93 137.58 49.36 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.79 0.836 . . . . 0.0 109.515 -162.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -85.02 63.28 8.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.227 1.411 . . . . 0.0 111.059 -167.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.7 m -53.5 150.64 12.12 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-O 118.832 -0.604 . . . . 0.0 110.948 172.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.03 140.61 68.28 Favored 'Cis proline' 0 CA--C 1.535 0.541 0 CA-C-N 119.857 0.985 . . . . 0.0 113.359 2.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.0 t -144.7 165.48 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.384 1.873 . . . . 0.0 108.222 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.4 mm -114.69 138.96 43.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 C-N-CA 126.63 1.972 . . . . 0.0 107.001 172.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -115.71 125.98 53.52 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.53 174.04 12.0 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 126.018 1.727 . . . . 0.0 110.461 -172.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -51.38 -38.88 55.65 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.743 1.617 . . . . 0.0 112.705 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -70.2 -39.6 75.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.078 0.551 . . . . 0.0 110.876 -175.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -63.92 -40.18 95.87 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.06 11.92 10.66 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.605 1.962 . . . . 0.0 113.376 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.87 19.26 0.07 Allowed 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 122.21 2.277 . . . . 0.0 115.83 -172.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.7 m -124.97 169.76 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 120.185 -1.572 . . . . 0.0 112.795 -159.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -66.78 -30.22 70.37 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.201 -0.937 . . . . 0.0 112.193 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 23.7 tttp -154.32 151.35 28.98 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 119.475 1.034 . . . . 0.0 110.278 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -125.45 156.69 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 158.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.5 m -136.59 126.23 25.42 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 126.165 1.786 . . . . 0.0 106.529 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.9 mp -140.7 146.61 38.02 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 120.319 1.418 . . . . 0.0 110.695 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 20.9 t -132.4 -167.08 1.83 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.43 1.092 . . . . 0.0 109.743 -177.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.94 147.55 36.85 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.749 1.62 . . . . 0.0 108.609 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.1 p -77.47 -14.14 59.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.438 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.53 -167.21 20.73 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -173.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -66.36 133.08 49.77 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.1 153.76 38.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 173.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -113.61 -0.7 9.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 123.392 0.677 . . . . 0.0 109.473 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 129' ' ' ASN . 46.2 mt-10 -149.88 157.72 43.46 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 119.394 0.997 . . . . 0.0 108.487 173.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.5 157.23 44.96 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.513 1.925 . . . . 0.0 106.182 159.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.26 143.95 36.2 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 164.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.8 t -129.68 90.85 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 102.97 -2.974 . . . . 0.0 102.97 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.1 t -125.17 160.43 29.18 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.37 -152.35 21.49 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 -165.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.68 -165.39 24.81 Favored Glycine 0 C--O 1.239 0.451 0 N-CA-C 107.829 -2.109 . . . . 0.0 107.829 -167.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.704 HG21 ' HB3' ' A' ' 26' ' ' PHE . 14.9 p . . . . . 0 N--CA 1.443 -0.79 0 C-N-CA 123.74 0.816 . . . . 0.0 109.228 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 . . . . . 0 N--CA 1.465 0.285 0 CA-C-O 120.926 0.393 . . . . 0.0 111.606 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.18 175.36 10.01 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.896 1.731 . . . . 0.0 112.93 164.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.1 ptm -154.6 -179.27 7.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.903 1.681 . . . . 0.0 107.805 -172.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -169.25 165.66 10.83 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.093 1.357 . . . . 0.0 107.375 171.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.535 ' HB2' HD12 ' A' ' 111' ' ' LEU . 36.0 m0 -104.21 144.39 31.67 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 162.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 96.9 t -128.52 79.31 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 101.42 -3.548 . . . . 0.0 101.42 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.433 ' CG1' HD13 ' A' ' 17' ' ' ILE . 17.0 m -83.92 144.65 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.3 m -133.61 142.98 48.35 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.5 t -127.84 130.86 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -117.43 142.74 46.76 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.195 1.398 . . . . 0.0 109.127 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.431 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 18.5 ttpt -83.08 -162.33 0.59 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 163.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.431 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 3.1 p-10 -59.09 74.24 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.352 2.261 . . . . 0.0 110.043 167.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.38 40.16 24.34 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.864 1.221 . . . . 0.0 114.643 173.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.14 148.93 28.22 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.429 1.491 . . . . 0.0 107.765 167.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -77.7 146.58 35.92 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 169.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 39.7 pt -132.05 -21.9 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.849 1.26 . . . . 0.0 112.165 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -137.78 146.39 43.53 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.018 -1.051 . . . . 0.0 108.732 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 41.9 tttt -142.35 27.14 1.75 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.524 1.13 . . . . 0.0 110.584 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.476 ' HE2' HD21 ' A' ' 126' ' ' LEU . 33.4 ttpt -80.54 131.67 35.56 Favored 'General case' 0 CA--C 1.517 -0.29 0 O-C-N 121.538 -0.726 . . . . 0.0 110.239 -171.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 p -106.49 167.53 9.78 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 125.895 1.678 . . . . 0.0 109.021 177.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.535 HD12 ' HB2' ' A' ' 95' ' ' TRP . 45.9 mt -127.92 -177.2 4.03 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.466 1.507 . . . . 0.0 108.073 -174.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.9 p -151.21 146.86 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 175.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 . . . . . 0 C--O 1.238 0.483 0 C-N-CA 125.956 1.703 . . . . 0.0 108.18 162.649 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.402 ' OD2' HD13 ' A' ' 111' ' ' LEU . 27.0 t0 . . . . . 0 CA--C 1.523 -0.072 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.509 ' HG ' HD11 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -127.04 111.71 14.37 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -169.535 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -138.41 50.53 1.88 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.545 1.138 . . . . 0.0 109.757 -172.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.476 HD21 ' HE2' ' A' ' 109' ' ' LYS . 92.6 mt -101.68 144.75 30.0 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.055 -1.028 . . . . 0.0 108.614 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -156.71 149.57 23.8 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.736 1.614 . . . . 0.0 107.864 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -144.91 152.51 40.33 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.671 1.189 . . . . 0.0 109.247 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 4.6 p30 . . . . . 0 C--O 1.251 1.142 0 C-N-CA 125.479 1.511 . . . . 0.0 109.167 166.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.747 0 N-CA-C 106.158 -2.777 . . . . 0.0 106.158 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.78 145.59 38.42 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 118.716 1.258 . . . . 0.0 110.235 -172.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.1 mtp -63.03 147.0 51.98 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 154.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -135.18 148.63 49.74 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 164.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -143.77 110.36 5.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.338 1.855 . . . . 0.0 106.679 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 p -89.25 142.94 12.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 169.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.02 156.23 36.85 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 169.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.404 HD11 ' CG ' ' A' ' 95' ' ' TRP . 6.3 tp -138.16 143.2 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 169.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -129.89 97.06 4.37 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 172.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -83.78 125.46 31.95 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.6 t -151.43 167.73 27.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.5 -158.2 52.59 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -159.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -76.7 52.26 0.81 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.288 1.044 . . . . 0.0 113.779 -170.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -64.35 -8.5 13.32 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.336 -1.477 . . . . 0.0 114.427 -174.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -58.88 -60.73 3.39 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 119.25 0.932 . . . . 0.0 109.902 -174.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.9 m -79.1 28.38 0.23 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.183 1.793 . . . . 0.0 113.352 -167.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.407 ' O ' ' HE3' ' A' ' 28' ' ' LYS . 40.4 m-85 -123.95 123.1 39.66 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.075 0.95 . . . . 0.0 108.58 -172.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.4 mm -70.09 98.44 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -177.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.423 ' HD2' ' H ' ' A' ' 28' ' ' LYS . 2.2 mptt -75.29 131.35 40.25 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.639 0.776 . . . . 0.0 109.258 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.2 m -137.53 134.41 35.66 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.275 1.03 . . . . 0.0 108.603 169.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 89.8 t -137.34 113.91 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 165.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.5 p -70.24 132.75 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 158.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.94 143.69 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 126.33 1.852 . . . . 0.0 108.163 176.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.7 t -140.58 158.31 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.879 1.272 . . . . 0.0 107.739 -171.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.62 154.43 34.18 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.308 1.043 . . . . 0.0 108.809 168.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.441 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 18.2 t-20 -118.16 101.84 8.54 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 124.979 1.312 . . . . 0.0 109.587 178.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.17 -80.23 0.27 Allowed Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 106.186 -2.765 . . . . 0.0 106.186 171.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.9 t -70.79 174.76 5.64 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 125.31 1.444 . . . . 0.0 110.505 -175.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -110.32 172.82 6.64 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.149 0.98 . . . . 0.0 111.149 -175.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.26 164.49 11.93 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.1 1.36 . . . . 0.0 108.424 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -138.48 124.15 19.72 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.61 0.764 . . . . 0.0 109.66 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -73.78 126.78 31.14 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 123.956 0.785 . . . . 0.0 109.607 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.99 6.66 19.1 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 117.58 -1.678 . . . . 0.0 114.321 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.49 -62.07 1.7 Allowed 'General case' 0 C--O 1.23 0.066 0 CA-C-N 120.621 2.21 . . . . 0.0 109.065 171.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.93 7.62 4.73 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.68 1.192 . . . . 0.0 111.787 -170.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.19 32.19 83.11 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -65.9 126.78 29.62 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 175.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.94 104.78 17.33 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -170.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 68.7 mt -91.06 -175.01 4.18 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.424 1.489 . . . . 0.0 110.673 -165.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.15 109.27 5.78 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.064 1.346 . . . . 0.0 107.427 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.44 165.01 46.92 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.822 -0.549 . . . . 0.0 110.74 174.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.67 142.74 65.34 Favored 'Cis proline' 0 CA--C 1.537 0.673 0 CA-C-N 118.569 0.525 . . . . 0.0 111.722 -9.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.5 p -145.09 165.05 12.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 126.092 1.757 . . . . 0.0 111.12 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.4 mm -119.59 118.5 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 126.222 1.809 . . . . 0.0 107.361 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.2 mt -73.6 104.68 4.63 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 159.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.0 m -76.5 179.73 5.73 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.55 1.14 . . . . 0.0 110.479 168.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -50.96 -34.23 27.9 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.126 1.37 . . . . 0.0 112.32 170.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -66.84 -32.42 73.68 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.55 1.14 . . . . 0.0 112.169 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -86.84 -47.77 8.77 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.2 mt -76.04 21.56 0.17 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.614 1.966 . . . . 0.0 111.887 174.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.78 -4.87 37.32 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.104 1.362 . . . . 0.0 112.893 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.76 HG23 HG22 ' A' ' 64' ' ' VAL . 1.4 m -108.54 160.89 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 127.333 2.253 . . . . 0.0 110.875 -177.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -68.19 -33.12 73.85 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.289 1.036 . . . . 0.0 112.319 -176.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -143.77 126.31 15.91 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -165.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.76 HG22 HG23 ' A' ' 61' ' ' VAL . 1.7 t -136.17 90.44 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -172.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.2 m -81.58 114.86 20.57 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.787 0.835 . . . . 0.0 109.418 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -116.08 132.12 56.75 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 t -147.64 168.52 21.82 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.274 0.559 . . . . 0.0 109.569 -175.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.19 139.51 32.25 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.188 1.795 . . . . 0.0 111.133 -171.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.3 p -68.14 -28.93 67.73 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -175.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -132.81 -86.37 0.3 Allowed Glycine 0 C--N 1.338 0.672 0 CA-C-N 118.82 0.736 . . . . 0.0 112.891 -173.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.99 139.48 20.5 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 130.764 3.625 . . . . 0.0 107.614 162.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.423 ' HB1' ' H ' ' A' ' 35' ' ' ASN . . . -101.51 -169.13 1.65 Allowed 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 169.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.1 mm -115.32 -19.71 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.788 170.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.441 ' HG2' ' HB2' ' A' ' 35' ' ' ASN . 19.3 pt-20 -150.4 164.62 35.39 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.643 -1.286 . . . . 0.0 109.571 -160.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -164.52 124.03 1.92 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.66 1.584 . . . . 0.0 109.982 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.35 155.85 19.54 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 120.037 1.29 . . . . 0.0 109.73 167.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.7 t -150.16 92.76 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 127.501 2.32 . . . . 0.0 105.287 174.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.9 m -137.0 159.93 40.43 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.287 -0.883 . . . . 0.0 110.437 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.24 -97.3 0.18 Allowed Glycine 0 C--N 1.333 0.38 0 N-CA-C 106.978 -2.449 . . . . 0.0 106.978 176.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.9 -168.38 21.31 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -175.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.234 0.265 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 161.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.05 175.68 10.92 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.712 2.275 . . . . 0.0 111.129 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.0 ptm -146.61 168.86 20.23 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -142.87 160.08 41.01 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 122.295 1.045 . . . . 0.0 109.292 172.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.404 ' CG ' HD11 ' A' ' 17' ' ' ILE . 4.0 m0 -127.07 112.1 14.81 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 171.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.5 t -92.87 132.39 37.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 159.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.82 161.95 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 174.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.91 155.84 28.43 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.276 -1.749 . . . . 0.0 106.276 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 75.8 t -125.27 91.61 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 171.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -72.58 163.14 28.53 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 170.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -127.63 -154.33 0.63 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.478 2.311 . . . . 0.0 109.552 -168.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -62.17 61.34 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.719 2.007 . . . . 0.0 111.449 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.34 65.99 2.93 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 120.264 -1.522 . . . . 0.0 110.964 -169.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -165.74 165.13 18.76 Favored 'General case' 0 C--N 1.335 -0.059 0 C-N-CA 125.746 1.618 . . . . 0.0 107.999 150.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -77.83 147.75 35.04 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.925 1.69 . . . . 0.0 107.442 159.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 6.4 pt -134.51 -10.36 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.367 1.467 . . . . 0.0 112.553 166.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -145.97 159.35 43.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.237 1.815 . . . . 0.0 108.78 -165.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -153.69 25.76 0.51 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -173.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -47.67 128.16 12.47 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.94 0.896 . . . . 0.0 111.394 177.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.0 p -147.42 140.46 25.09 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.286 1.034 . . . . 0.0 109.469 -177.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.619 ' N ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -133.73 -173.45 3.24 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 123.256 1.503 . . . . 0.0 109.645 -174.933 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.7 p -159.83 141.34 4.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 128.96 2.904 . . . . 0.0 108.689 -177.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 . . . . . 0 C--O 1.238 0.449 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 172.016 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.7 tp -134.56 112.81 11.17 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -156.11 54.11 0.57 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 126.93 2.092 . . . . 0.0 107.925 -172.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tp -106.43 143.27 34.78 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.23 1.012 . . . . 0.0 108.984 -171.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -158.95 136.88 10.39 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.199 0.6 . . . . 0.0 109.461 -167.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -137.48 127.36 25.64 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 128.278 2.631 . . . . 0.0 106.062 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.257 1.494 0 C-N-CA 128.987 2.915 . . . . 0.0 104.888 153.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.471 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . . . . . . 0 CA--C 1.524 0.616 0 N-CA-C 108.471 -1.851 . . . . 0.0 108.471 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.52 165.44 17.81 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.544 0.738 . . . . 0.0 112.291 -163.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.461 ' H ' ' HB3' ' A' ' 102' ' ' ASN . 25.2 mtp -116.02 170.15 8.72 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 144.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -173.71 160.8 3.78 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 131.131 3.773 . . . . 0.0 106.902 -178.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -153.43 112.24 3.72 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.58 158.35 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.173 0.989 . . . . 0.0 109.169 175.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 p -136.43 160.27 39.25 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 160.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.7 tp -130.04 143.69 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 126.479 1.912 . . . . 0.0 106.031 173.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -131.63 139.18 49.06 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 126.944 2.098 . . . . 0.0 106.671 170.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -104.13 144.85 31.03 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.441 1.496 . . . . 0.0 107.975 176.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.3 t -154.38 170.7 20.72 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.816 1.246 . . . . 0.0 108.76 -176.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 54.66 -147.46 24.35 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.564 1.078 . . . . 0.0 110.646 -165.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -84.22 95.87 8.8 Favored 'General case' 0 C--O 1.222 -0.357 0 O-C-N 121.622 -0.928 . . . . 0.0 110.451 175.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -96.52 8.18 44.73 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 120.344 -1.473 . . . . 0.0 112.73 -175.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -94.92 -5.6 44.45 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -157.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.5 t -127.13 23.45 6.49 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.11 0.868 . . . . 0.0 110.972 -165.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -135.99 118.29 15.63 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.082 0.953 . . . . 0.0 110.908 -164.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.7 mt -66.63 108.44 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -80.75 149.93 29.46 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.547 1.139 . . . . 0.0 109.237 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 m -150.85 138.21 19.46 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 169.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.4 t -136.41 139.48 45.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.501 HG22 HD12 ' A' ' 53' ' ' ILE . 58.1 t -106.19 132.16 54.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 128.321 2.649 . . . . 0.0 108.695 169.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.4 p -126.56 166.29 23.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 126.613 1.965 . . . . 0.0 109.219 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.1 p -139.4 165.0 23.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 158.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.29 100.13 3.82 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 162.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -66.26 106.44 1.68 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.38 6.7 58.56 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 117.974 -1.459 . . . . 0.0 115.71 166.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.448 HG22 ' HB2' ' A' ' 72' ' ' ALA . 1.3 t -155.14 -174.39 4.96 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.913 1.856 . . . . 0.0 109.473 167.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -92.14 164.4 13.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.687 1.195 . . . . 0.0 111.703 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.5 tp -90.13 163.12 14.97 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.781 1.232 . . . . 0.0 108.426 172.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.416 ' HE2' ' HA2' ' A' ' 45' ' ' GLY . 77.8 tttt -125.2 117.66 24.34 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.357 1.463 . . . . 0.0 107.204 174.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -75.97 114.73 14.93 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.514 1.133 . . . . 0.0 109.166 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.91 0.68 35.97 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-O 118.524 -1.153 . . . . 0.0 114.283 -173.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.25 -40.6 81.89 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 119.837 1.819 . . . . 0.0 111.427 170.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.94 -18.97 1.17 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.001 0.92 . . . . 0.0 113.006 -169.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.416 ' HA2' ' HE2' ' A' ' 40' ' ' LYS . . . 86.23 19.43 57.21 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 119.25 -0.75 . . . . 0.0 111.936 -170.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -71.19 128.82 37.2 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.574 1.187 . . . . 0.0 109.171 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.65 133.21 50.64 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 126.334 1.854 . . . . 0.0 110.043 169.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 30.6 mt -128.93 152.22 48.8 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.612 1.165 . . . . 0.0 111.048 176.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.63 91.67 5.87 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.718 1.207 . . . . 0.0 110.156 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.81 153.46 42.58 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.643 0.777 . . . . 0.0 111.672 173.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.02 128.73 15.2 Favored 'Cis proline' 0 C--N 1.349 0.599 0 CA-C-N 120.229 1.117 . . . . 0.0 111.709 -8.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.419 ' O ' HD13 ' A' ' 53' ' ' ILE . 99.8 t -96.42 155.71 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 172.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.501 HD12 HG22 ' A' ' 31' ' ' VAL . 18.2 mm -114.12 120.53 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 105.234 -2.135 . . . . 0.0 105.234 166.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.69 163.37 26.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 122.123 0.963 . . . . 0.0 109.017 172.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.589 ' H ' ' HG2' ' A' ' 58' ' ' GLU . 4.9 m -129.32 -153.79 0.59 Allowed 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 127.95 2.5 . . . . 0.0 109.106 -169.018 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.01 -29.69 13.99 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.774 1.63 . . . . 0.0 110.935 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -67.05 -40.27 87.07 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 125.221 1.409 . . . . 0.0 110.516 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.589 ' HG2' ' H ' ' A' ' 55' ' ' SER . 1.8 pp20? -62.31 -29.83 70.72 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 123.92 0.888 . . . . 0.0 112.265 -177.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.9 mt -89.14 27.9 1.31 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.401 2.281 . . . . 0.0 111.457 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.46 17.36 2.19 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.616 -1.303 . . . . 0.0 114.163 -172.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.773 HG23 ' H ' ' A' ' 63' ' ' LYS . 13.9 m -123.93 -163.84 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 120.74 1.609 . . . . 0.0 108.337 166.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -76.02 -30.64 58.55 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 169.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.773 ' H ' HG23 ' A' ' 61' ' ' VAL . 2.2 tmtp? -153.3 131.54 11.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 117.217 -1.373 . . . . 0.0 111.808 -162.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.86 165.31 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 119.618 1.099 . . . . 0.0 108.85 176.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.4 m -134.83 127.72 31.33 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 128.081 2.552 . . . . 0.0 106.386 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -129.52 133.2 47.12 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 121.218 1.826 . . . . 0.0 108.255 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.6 t -135.26 176.18 8.91 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.308 -0.87 . . . . 0.0 108.867 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.6 p -90.09 153.73 20.33 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 166.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.7 p -76.21 -13.36 60.18 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.859 -0.525 . . . . 0.0 112.311 173.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.63 -168.12 18.17 Favored Glycine 0 N--CA 1.449 -0.491 0 O-C-N 120.875 -1.141 . . . . 0.0 110.903 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.471 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 5.0 ttpt -60.26 139.02 57.82 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 170.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.448 ' HB2' HG22 ' A' ' 37' ' ' THR . . . -135.16 177.81 7.52 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 168.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.2 mm -115.5 -11.04 12.11 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 118.087 -0.959 . . . . 0.0 111.017 -177.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -152.39 155.33 37.36 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 120.568 1.531 . . . . 0.0 110.556 172.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -141.45 107.43 5.17 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.369 1.468 . . . . 0.0 109.565 170.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.91 153.98 21.18 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.643 1.111 . . . . 0.0 110.45 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.8 t -146.53 95.72 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 173.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.7 m -131.19 159.83 36.58 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.581 -0.699 . . . . 0.0 109.404 174.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.92 -179.58 19.77 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-N 119.206 0.912 . . . . 0.0 113.267 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.43 -160.38 24.08 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 123.92 0.771 . . . . 0.0 111.308 -169.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.463 0 C-N-CA 126.04 1.736 . . . . 0.0 110.822 -176.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.42 175.07 9.29 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.74 2.293 . . . . 0.0 112.683 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 6.9 ptm -137.26 173.64 11.47 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.658 0.783 . . . . 0.0 110.291 -172.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -138.85 147.78 42.88 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.47 1.108 . . . . 0.0 108.763 170.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -117.61 133.11 56.31 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 170.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.1 t -128.16 111.7 24.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 -177.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.6 t -134.38 121.18 35.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 -160.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.6 m -110.87 159.8 17.35 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -173.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.9 t -125.61 129.4 72.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 162.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -97.04 134.91 39.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 104.74 -2.319 . . . . 0.0 104.74 163.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.3 tptm -91.56 -173.33 3.52 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 172.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.461 ' HB3' ' H ' ' A' ' 12' ' ' MET . 0.7 OUTLIER -59.35 74.21 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.047 2.139 . . . . 0.0 109.581 167.922 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 157.33 -72.32 0.24 Allowed Glycine 0 CA--C 1.523 0.545 0 C-N-CA 126.72 2.105 . . . . 0.0 111.64 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.45 -177.15 6.35 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.291 1.436 . . . . 0.0 111.024 -171.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.16 144.06 7.57 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.452 1.501 . . . . 0.0 109.846 173.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.6 pt -133.41 -27.41 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 123.897 0.879 . . . . 0.0 111.624 168.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -148.21 151.44 35.51 Favored 'General case' 0 N--CA 1.461 0.082 0 CA-C-N 119.746 1.157 . . . . 0.0 111.517 -162.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -151.59 68.49 0.9 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.124 1.769 . . . . 0.0 110.453 -159.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.444 ' HE2' HD13 ' A' ' 126' ' ' LEU . 6.0 mmmt -86.25 118.76 25.91 Favored 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 120.539 -1.35 . . . . 0.0 109.225 176.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.54 139.46 52.3 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 125.064 1.345 . . . . 0.0 110.087 178.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 111' ' ' LEU . 1.2 mp -131.44 -178.37 4.82 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.484 2.314 . . . . 0.0 109.564 -177.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.7 p -154.08 44.79 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 124.793 1.237 . . . . 0.0 112.204 -162.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.536 0.429 0 O-C-N 121.407 -0.808 . . . . 0.0 112.53 -173.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 p30 . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.5 tp -138.25 121.71 17.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -167.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -141.26 80.86 1.76 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 169.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.444 HD13 ' HE2' ' A' ' 109' ' ' LYS . 1.4 tp -109.07 151.38 26.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -152.72 126.86 9.12 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -178.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -117.83 161.78 19.17 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.61 1.564 . . . . 0.0 110.521 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.39 0 C-N-CA 128.283 2.633 . . . . 0.0 106.849 164.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.18 -162.2 1.19 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.31 1.044 . . . . 0.0 108.324 -164.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.1 mtp -137.1 161.42 36.15 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 127.894 2.478 . . . . 0.0 105.332 161.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -136.65 148.89 47.67 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 173.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -143.6 138.05 28.77 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 103.676 -2.712 . . . . 0.0 103.676 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.2 157.5 38.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 169.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 p -124.83 154.09 41.54 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 164.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.459 HD11 ' CD2' ' A' ' 95' ' ' TRP . 7.1 tt -120.65 156.95 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 C-N-CA 122.44 0.296 . . . . 0.0 110.514 155.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -139.98 131.96 27.78 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 166.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -117.12 109.04 16.44 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.801 2.04 . . . . 0.0 107.13 -165.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.5 p -139.27 179.88 6.27 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 175.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 93' ' ' MET . . . 58.26 -157.96 17.69 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -152.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -85.15 106.93 16.96 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.176 0.988 . . . . 0.0 112.604 -168.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -113.79 -4.57 13.34 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 121.402 1.91 . . . . 0.0 115.299 -172.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.97 34.0 1.43 Allowed 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.316 -0.865 . . . . 0.0 111.159 -171.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.8 m -143.67 7.0 1.46 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.4 1.08 . . . . 0.0 112.317 -165.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -140.97 152.44 44.96 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 120.404 1.456 . . . . 0.0 111.346 -159.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 84.9 mt -84.95 95.29 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 174.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.64 148.32 22.39 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 172.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.8 t -142.6 157.55 44.59 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.409 1.884 . . . . 0.0 108.158 -175.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -143.48 160.03 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 165.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.485 ' CG1' ' H ' ' A' ' 78' ' ' SER . 2.4 p -128.69 141.45 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 126.713 2.005 . . . . 0.0 106.182 160.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.9 t -137.87 130.98 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.6 t -140.23 138.59 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.81 89.88 2.29 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.57 1.077 . . . . 0.0 111.896 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.472 ' H ' ' HB2' ' A' ' 74' ' ' GLU . 39.3 t-20 -58.16 105.26 0.26 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.223 1.409 . . . . 0.0 112.689 -174.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.44 -1.25 27.9 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 118.602 -1.11 . . . . 0.0 114.185 164.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.3 t -154.18 -168.1 2.84 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.054 1.427 . . . . 0.0 110.236 -169.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -116.75 159.51 22.18 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.017 1.727 . . . . 0.0 109.484 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.2 164.16 17.37 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 124.289 1.035 . . . . 0.0 108.693 176.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -133.06 123.16 25.27 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 173.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -79.9 117.19 20.54 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 166.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.83 -17.82 55.44 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.625 -1.097 . . . . 0.0 114.339 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.85 -39.11 87.86 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 119.855 1.827 . . . . 0.0 110.205 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.06 -10.58 1.13 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -169.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.1 29.36 64.76 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -171.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -69.13 115.31 8.27 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 170.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.78 103.69 11.64 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.5 mt -91.24 -173.7 3.71 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.156 0.983 . . . . 0.0 108.923 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.52 94.24 3.61 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -177.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.52 162.31 27.66 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.596 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.32 143.81 66.04 Favored 'Cis proline' 0 N--CA 1.459 -0.519 0 CA-C-N 120.142 1.086 . . . . 0.0 112.696 -1.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.7 t -142.07 149.11 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.28 1.432 . . . . 0.0 108.818 -169.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.8 mm -135.89 97.72 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 126.61 1.964 . . . . 0.0 107.124 -159.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -82.5 140.94 33.05 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.076 0.95 . . . . 0.0 108.913 -174.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.4 p -110.24 -166.23 1.07 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.22 1.008 . . . . 0.0 110.477 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -64.09 -48.28 76.75 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.684 1.994 . . . . 0.0 111.782 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -61.23 -27.44 68.44 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 125.04 1.336 . . . . 0.0 110.797 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -95.1 -11.9 27.44 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.317 0.647 . . . . 0.0 110.344 -169.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -96.98 17.77 16.18 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.862 2.065 . . . . 0.0 112.673 176.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.15 39.69 0.15 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.174 1.789 . . . . 0.0 113.378 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.1 m -136.46 162.48 35.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 126.281 1.832 . . . . 0.0 108.778 -170.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -85.5 -17.06 37.51 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.293 -0.88 . . . . 0.0 113.04 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -155.14 151.67 28.52 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 125.196 1.398 . . . . 0.0 107.911 -166.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.446 ' HB ' HG22 ' A' ' 17' ' ' ILE . 11.2 t -143.77 140.9 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 164.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.3 m -118.07 135.09 54.41 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 168.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.5 mt -140.0 146.04 38.58 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.6 169.25 22.01 Favored 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 121.649 -0.657 . . . . 0.0 110.148 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.427 HG21 ' HB2' ' A' ' 72' ' ' ALA . 3.3 p -95.44 155.97 16.52 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 117.801 0.273 . . . . 0.0 111.163 174.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.4 p -82.3 -3.38 55.17 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.524 -0.735 . . . . 0.0 112.015 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.72 -156.88 15.68 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -176.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.488 ' HE2' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -60.93 137.13 58.24 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 117.483 0.641 . . . . 0.0 110.218 -168.446 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.427 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -129.33 141.63 51.03 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 176.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.488 HD11 ' HE2' ' A' ' 71' ' ' LYS . 0.8 OUTLIER -133.94 21.5 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 C-N-CA 123.723 0.809 . . . . 0.0 110.254 174.718 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 129' ' ' ASN . 40.3 mt-10 -142.77 147.33 35.37 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 168.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -154.56 86.11 1.13 Allowed 'General case' 0 C--O 1.232 0.164 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 157.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 127' ' ' TYR . . . -76.4 145.9 39.04 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.164 175.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.2 t -143.92 108.7 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.105 1.362 . . . . 0.0 107.712 166.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.485 ' H ' ' CG1' ' A' ' 31' ' ' VAL . 1.6 t -109.38 173.67 6.22 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 152.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 150.55 -166.07 30.14 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 -170.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 146.21 166.77 12.28 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.513 1.054 . . . . 0.0 110.822 174.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.464 0.254 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 174.331 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 . . . . . 0 CA--C 1.541 0.617 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -76.73 175.33 11.51 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.058 2.505 . . . . 0.0 112.913 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.403 ' HA ' ' HA3' ' A' ' 21' ' ' GLY . 14.3 ptm -139.94 164.0 31.16 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.722 1.209 . . . . 0.0 111.646 -173.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -140.26 156.52 46.44 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.208 1.403 . . . . 0.0 109.66 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.459 ' CD2' HD11 ' A' ' 17' ' ' ILE . 1.5 m0 -127.19 124.69 39.58 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 176.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 t -95.68 121.23 46.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 162.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.6 p -127.54 137.41 57.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 170.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.9 m -148.22 142.61 26.31 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.457 ' H ' ' HB3' ' A' ' 107' ' ' GLU . 3.4 t -117.01 145.31 22.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 124.209 1.004 . . . . 0.0 108.399 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -128.77 130.77 47.49 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 128.034 2.534 . . . . 0.0 106.103 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -84.45 -163.71 0.84 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.13 77.45 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.313 1.045 . . . . 0.0 109.261 166.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 151.87 -56.81 0.44 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.162 -1.355 . . . . 0.0 114.428 168.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.71 -176.84 5.96 Favored 'General case' 0 C--N 1.34 0.196 0 CA-C-N 119.958 1.879 . . . . 0.0 110.966 176.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -44.78 138.32 3.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 130.034 3.334 . . . . 0.0 111.935 176.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.8 pt -139.07 -2.03 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.95 1.7 . . . . 0.0 112.226 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.457 ' HB3' ' H ' ' A' ' 99' ' ' VAL . 0.0 OUTLIER -127.02 170.89 11.83 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.358 1.463 . . . . 0.0 107.43 -176.762 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.6 tttm -159.62 21.47 0.18 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.262 1.425 . . . . 0.0 111.628 175.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.41 87.9 1.57 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.388 -1.445 . . . . 0.0 110.54 -174.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 p -73.15 161.97 29.98 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.3 1.04 . . . . 0.0 110.441 170.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.2 mt -140.39 138.21 34.6 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.338 1.455 . . . . 0.0 108.417 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.5 p -142.61 81.69 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 122.489 1.138 . . . . 0.0 110.11 -172.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 . . . . . 0 C--O 1.238 0.465 0 C-N-CA 125.423 1.489 . . . . 0.0 110.399 178.864 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.6 p30 . . . . . 0 C--O 1.233 0.209 0 CA-C-O 117.732 -1.127 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 37.0 mt -142.25 101.22 3.87 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 120.16 1.345 . . . . 0.0 110.456 -165.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -130.01 51.53 2.08 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.174 2.189 . . . . 0.0 107.402 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 mp -107.55 139.17 42.5 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.801 1.24 . . . . 0.0 108.916 177.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 59.5 t80 -151.32 91.2 1.65 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -178.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -83.68 153.46 24.21 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.283 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 177.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.425 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . . . . . . 0 CA--C 1.523 0.549 0 N-CA-C 107.79 -2.124 . . . . 0.0 107.79 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.88 179.03 6.62 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.079 0.952 . . . . 0.0 109.991 -168.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.2 mtp -107.96 166.21 10.89 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 155.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.51 ' HB3' ' CD2' ' A' ' 75' ' ' PHE . 71.0 m-85 -147.65 139.99 24.47 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -142.4 120.93 12.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -178.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p -105.36 161.69 5.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 123.002 1.382 . . . . 0.0 109.063 176.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 p -132.86 148.7 52.3 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.519 1.528 . . . . 0.0 106.977 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.4 tp -139.51 132.65 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 174.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -132.95 123.73 26.47 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 127.133 2.173 . . . . 0.0 106.563 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -103.86 137.54 41.72 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.031 0.932 . . . . 0.0 109.291 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 m -135.99 172.15 13.44 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.295 -0.878 . . . . 0.0 110.707 170.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.88 -150.54 32.66 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-O 121.642 0.579 . . . . 0.0 111.987 173.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -72.89 98.09 2.39 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 159.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -113.71 23.59 12.94 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.146 0.498 . . . . 0.0 110.65 170.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.2 mtt180 -102.92 -29.32 11.5 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 118.498 -0.763 . . . . 0.0 111.693 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.8 m -114.55 22.44 13.62 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -152.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -128.41 144.83 51.19 Favored 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 121.476 -0.765 . . . . 0.0 109.251 -173.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.2 mp -76.03 89.11 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 171.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -89.64 146.99 24.16 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.006 1.322 . . . . 0.0 108.953 -177.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.3 t -138.69 148.91 44.55 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.457 1.503 . . . . 0.0 108.536 -174.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.4 t -136.87 106.79 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 161.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.3 t -65.73 117.01 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 160.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 91.8 t -116.72 123.62 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 175.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.454 HG22 ' HB3' ' A' ' 51' ' ' PRO . 16.8 t -129.72 156.76 42.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 162.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.29 120.91 9.79 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.969 1.708 . . . . 0.0 107.42 165.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -75.1 109.31 8.47 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 118.039 -0.981 . . . . 0.0 108.707 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.43 10.66 50.35 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 116.844 1.498 . . . . 0.0 116.844 161.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.854 HG22 ' HB2' ' A' ' 72' ' ' ALA . 14.8 t -157.0 -174.8 5.09 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 119.536 1.668 . . . . 0.0 107.969 164.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -106.46 165.27 11.39 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 122.309 1.052 . . . . 0.0 113.699 168.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.15 169.07 13.43 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 112.272 -2.24 . . . . 0.0 109.772 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -144.15 123.5 13.08 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.301 1.441 . . . . 0.0 109.215 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -71.93 131.77 43.43 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.301 1.04 . . . . 0.0 110.341 -177.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.07 -18.41 72.83 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.31 -1.272 . . . . 0.0 113.904 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.0 -60.38 3.96 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 119.057 1.428 . . . . 0.0 109.367 174.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.28 0.61 1.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -157.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.04 12.35 83.44 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-O 119.854 -0.414 . . . . 0.0 112.371 174.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -65.12 130.43 43.34 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.3 m -68.82 125.01 25.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 175.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.7 mt -112.71 128.92 56.54 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -174.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -95.81 88.36 4.93 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.303 1.041 . . . . 0.0 109.088 -170.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.7 m -51.15 156.67 1.76 Allowed Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 128.423 2.689 . . . . 0.0 112.128 172.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.454 ' HB3' HG22 ' A' ' 33' ' ' VAL . 66.7 Cg_endo -73.42 154.22 99.49 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 N-CA-C 109.435 -1.025 . . . . 0.0 109.435 -8.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.2 t -138.55 144.21 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.0 mm -120.68 81.35 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 28.4 mt -63.1 136.19 57.64 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 m -110.27 175.74 5.32 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 125.902 1.681 . . . . 0.0 110.088 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -46.9 -48.04 21.34 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 127.306 2.243 . . . . 0.0 113.744 -175.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -69.6 -40.53 76.6 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.512 0.596 . . . . 0.0 110.89 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -68.4 -10.88 58.14 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.064 0.945 . . . . 0.0 111.081 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.9 mt -121.29 10.49 10.61 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.179 2.191 . . . . 0.0 111.141 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.92 11.97 0.46 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.067 1.347 . . . . 0.0 112.662 171.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.1 m -66.44 -168.5 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 126.054 1.742 . . . . 0.0 111.135 164.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -110.91 -36.24 5.73 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.909 1.684 . . . . 0.0 111.466 168.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.18 143.03 26.78 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 127.327 2.251 . . . . 0.0 105.941 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.2 p -146.63 102.6 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 120.363 1.438 . . . . 0.0 112.436 161.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m -66.04 134.48 52.96 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.434 -1.417 . . . . 0.0 109.933 172.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 mt -132.99 146.52 51.85 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 124.307 1.043 . . . . 0.0 108.455 -175.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.4 t -162.7 160.12 25.16 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -161.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -86.85 151.23 23.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.422 0.629 . . . . 0.0 112.466 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.2 p -82.75 -20.91 35.01 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.614 1.566 . . . . 0.0 112.165 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -146.55 -163.87 10.67 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 125.873 1.702 . . . . 0.0 108.871 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.425 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 16.1 ttpt -77.47 141.91 39.44 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 175.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.854 ' HB2' HG22 ' A' ' 37' ' ' THR . . . -132.95 175.52 9.29 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.957 0.903 . . . . 0.0 109.833 171.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 mm -121.6 -13.53 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.409 1.084 . . . . 0.0 110.205 -167.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -151.51 162.2 41.37 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.614 1.166 . . . . 0.0 108.828 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.51 ' CD2' ' HB3' ' A' ' 13' ' ' TYR . 3.0 t80 -155.58 85.91 1.06 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.695 0.798 . . . . 0.0 109.202 173.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.16 149.72 28.99 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.998 -0.439 . . . . 0.0 110.73 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 t -142.65 124.25 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 125.248 1.419 . . . . 0.0 108.368 171.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.09 169.76 17.24 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 158.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.35 -125.74 0.88 Allowed Glycine 0 CA--C 1.52 0.394 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 173.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.32 173.03 13.48 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 123.614 0.626 . . . . 0.0 112.203 173.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.2 m . . . . . 0 C--N 1.33 -0.255 0 C-N-CA 125.232 1.413 . . . . 0.0 109.175 173.994 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 . . . . . 0 CA--C 1.523 -0.08 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -73.0 175.19 10.8 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.485 1.457 . . . . 0.0 111.976 176.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -138.16 168.72 19.13 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.068 0.947 . . . . 0.0 110.414 177.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -135.98 157.04 47.79 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 169.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.539 ' CE3' HD12 ' A' ' 111' ' ' LEU . 33.2 m0 -123.46 133.82 54.0 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 168.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.1 t -90.28 135.57 26.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 151.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.7 130.68 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 172.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 m -135.94 147.63 48.17 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -176.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.2 t -118.07 131.2 71.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -116.1 166.92 11.46 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 128.682 2.793 . . . . 0.0 107.988 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -118.67 -154.3 0.56 Allowed 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 129.224 3.01 . . . . 0.0 107.616 -171.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -69.34 85.43 0.4 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 162.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.75 16.64 69.96 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 117.98 -1.456 . . . . 0.0 115.258 164.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.7 167.49 28.02 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 120.785 2.293 . . . . 0.0 112.116 172.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -90.21 141.05 29.08 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.09 1.356 . . . . 0.0 109.16 -174.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.8 pt -129.02 -19.81 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 119.124 0.874 . . . . 0.0 113.357 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -132.42 160.5 36.2 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -157.79 87.16 0.93 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 176.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.33 164.05 24.4 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 171.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.5 t -138.93 163.33 32.61 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.539 HD12 ' CE3' ' A' ' 95' ' ' TRP . 24.2 mt -126.14 157.49 37.98 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 123.61 0.764 . . . . 0.0 109.013 -177.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.3 p -147.2 114.68 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 -173.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 . . . . . 0 C--O 1.237 0.438 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.445 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.146 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.75 143.49 50.78 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.884 1.274 . . . . 0.0 108.834 174.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -153.1 25.17 0.55 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.779 1.632 . . . . 0.0 111.586 -157.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 88.3 mt -97.15 124.41 41.18 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.71 1.604 . . . . 0.0 107.829 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -139.89 46.64 1.86 Allowed 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.542 0.737 . . . . 0.0 109.019 -170.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -55.26 137.67 46.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.85 -168.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.086 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 167.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.41 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . . . . . . 0 CA--C 1.52 0.383 0 N-CA-C 107.137 -2.385 . . . . 0.0 107.137 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.64 161.4 35.23 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.724 0.81 . . . . 0.0 110.86 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 7.8 mtp -91.89 153.62 19.39 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 158.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.489 ' CD1' ' HB2' ' A' ' 75' ' ' PHE . 8.6 m-85 -143.65 114.66 7.81 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 126.282 1.833 . . . . 0.0 106.448 -170.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -127.29 144.76 50.99 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.743 2.017 . . . . 0.0 106.885 172.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.42 132.94 38.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 127.133 2.173 . . . . 0.0 108.89 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.5 p -96.0 163.56 13.08 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.749 0.785 . . . . 0.0 109.913 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.426 HD11 ' CD2' ' A' ' 95' ' ' TRP . 4.0 tp -140.75 112.6 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 167.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -114.29 135.97 53.48 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -176.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -122.19 115.4 22.33 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 124.287 1.035 . . . . 0.0 108.732 -161.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 m -120.92 -179.01 3.88 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.17 -99.29 0.56 Allowed Glycine 0 C--N 1.338 0.651 0 C-N-CA 127.301 2.382 . . . . 0.0 110.417 176.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.6 113.39 9.11 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -117.53 11.02 13.69 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -170.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -102.57 -1.06 31.09 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.079 1.352 . . . . 0.0 113.941 -168.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.1 m -143.45 95.12 2.7 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 164.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -176.94 110.83 0.08 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 128.08 2.552 . . . . 0.0 106.433 174.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.3 pt -66.39 86.8 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 127.221 2.208 . . . . 0.0 112.36 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.42 144.68 55.63 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 121.113 -0.992 . . . . 0.0 109.942 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.9 m -148.36 130.03 15.03 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 170.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.8 t -140.39 165.77 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 175.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.647 HG13 ' CD1' ' A' ' 53' ' ' ILE . 30.0 t -141.13 52.42 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 125.786 1.635 . . . . 0.0 110.806 -157.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.7 p -65.91 135.85 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 O-C-N 119.248 -2.157 . . . . 0.0 111.215 -170.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.6 t -117.56 148.12 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 171.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.32 133.74 20.77 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.93 0.892 . . . . 0.0 108.615 171.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -102.7 85.83 2.64 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.186 1.394 . . . . 0.0 109.022 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.09 -78.76 0.29 Allowed Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 162.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.8 t -76.55 179.51 5.9 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.106 0.963 . . . . 0.0 109.914 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -96.67 168.05 10.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.833 1.253 . . . . 0.0 111.232 174.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.59 168.31 15.48 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.38 1.472 . . . . 0.0 109.38 176.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -137.01 128.14 27.83 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.795 1.638 . . . . 0.0 109.524 172.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -92.2 110.32 21.71 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.547 1.939 . . . . 0.0 109.45 -165.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -57.69 -23.12 49.06 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 118.989 0.813 . . . . 0.0 114.553 -169.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.87 -56.97 15.32 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.325 1.45 . . . . 0.0 112.032 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.5 p -125.67 0.15 7.46 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.608 1.563 . . . . 0.0 111.144 -164.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.78 22.56 54.04 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 125.395 1.474 . . . . 0.0 112.171 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.32 158.2 26.17 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 118.24 1.02 . . . . 0.0 109.358 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.4 m -117.4 106.15 12.9 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 122.391 1.091 . . . . 0.0 110.207 -167.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 45.3 mt -93.59 159.47 15.21 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 125.109 1.364 . . . . 0.0 111.874 -164.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.86 95.69 9.67 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.926 2.09 . . . . 0.0 108.763 -172.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.2 p -58.74 167.72 1.73 Allowed Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.053 0.941 . . . . 0.0 111.468 172.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.72 145.38 79.18 Favored 'Cis proline' 0 CA--C 1.537 0.629 0 N-CA-C 109.733 -0.91 . . . . 0.0 109.733 -19.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.6 p -135.19 156.93 39.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 O-C-N 121.242 -0.911 . . . . 0.0 109.939 -170.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.647 ' CD1' HG13 ' A' ' 31' ' ' VAL . 30.5 mm -114.02 126.83 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 175.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.8 mt -92.43 164.83 13.33 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 128.154 2.582 . . . . 0.0 110.327 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.571 ' H ' ' HG2' ' A' ' 58' ' ' GLU . 57.4 p -132.64 -163.35 1.33 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.417 2.287 . . . . 0.0 111.126 -165.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -88.08 -21.01 24.96 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 126.565 1.946 . . . . 0.0 110.292 175.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.32 -36.52 61.05 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.286 1.434 . . . . 0.0 111.973 -177.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.571 ' HG2' ' H ' ' A' ' 55' ' ' SER . 2.3 pp20? -75.95 -32.09 59.37 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.262 1.825 . . . . 0.0 111.776 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.6 mt -95.99 24.16 5.78 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.5 1.12 . . . . 0.0 112.655 -176.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -77.41 33.24 0.16 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.629 1.972 . . . . 0.0 113.467 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.6 m -130.45 -167.83 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.511 1.924 . . . . 0.0 109.871 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -98.57 -24.08 15.25 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.335 1.454 . . . . 0.0 113.246 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -159.64 148.89 18.04 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 117.838 -1.077 . . . . 0.0 108.927 171.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.26 165.22 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 165.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 83.3 m -134.59 124.06 24.83 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 128.553 2.741 . . . . 0.0 105.685 171.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.6 140.51 49.54 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 174.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.1 t -145.42 -177.08 5.38 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.284 0.634 . . . . 0.0 110.405 -174.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.92 136.01 53.05 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 128.339 2.656 . . . . 0.0 110.306 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.9 p -75.24 -43.21 52.83 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 118.752 -1.179 . . . . 0.0 109.647 -171.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -107.98 -98.71 2.57 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.41 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -147.23 147.64 30.66 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.959 1.703 . . . . 0.0 109.964 174.235 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.468 ' C ' HD13 ' A' ' 73' ' ' ILE . . . -127.23 -178.56 4.48 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.345 1.058 . . . . 0.0 109.088 170.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.468 HD13 ' C ' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -122.84 -0.03 6.52 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.598 0 CA-C-O 117.664 -1.16 . . . . 0.0 110.814 176.413 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -149.63 158.0 43.77 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 120.561 1.528 . . . . 0.0 110.435 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.489 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -153.53 117.52 4.79 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 166.045 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -121.95 135.32 54.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.2 t -137.53 112.94 10.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -172.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.3 m -136.06 178.4 7.08 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.226 0.61 . . . . 0.0 110.134 173.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.01 -85.17 0.13 Allowed Glycine 0 C--N 1.333 0.39 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 155.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.34 179.12 18.98 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 127.37 2.414 . . . . 0.0 108.328 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.6 p . . . . . 0 CA--C 1.531 0.218 0 CA-C-N 118.577 1.189 . . . . 0.0 109.379 178.205 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 N--CA 1.468 0.443 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.55 174.38 11.9 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.959 2.44 . . . . 0.0 113.547 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.7 ptp -148.0 -176.01 5.11 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.998 0.919 . . . . 0.0 111.131 -168.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -141.15 161.34 38.1 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 128.143 2.577 . . . . 0.0 106.616 169.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.426 ' CD2' HD11 ' A' ' 17' ' ' ILE . 2.4 m0 -130.68 112.28 12.97 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 104.972 -2.233 . . . . 0.0 104.972 173.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.02 127.3 45.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 168.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 m -139.39 104.45 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -167.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.3 m -118.63 153.29 34.54 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -169.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.93 124.89 51.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -174.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -121.14 121.06 37.02 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.962 1.705 . . . . 0.0 108.246 -172.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -73.05 -166.52 0.31 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.594 1.958 . . . . 0.0 109.771 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -58.66 90.44 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 163.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.4 29.58 75.57 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.535 2.017 . . . . 0.0 115.771 171.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -145.06 176.44 9.5 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 120.016 1.908 . . . . 0.0 109.746 165.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -98.1 154.33 17.81 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.97 1.708 . . . . 0.0 108.278 170.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 43.1 pt -132.17 -13.44 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.698 1.199 . . . . 0.0 112.753 168.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -140.91 150.12 42.77 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 119.776 1.171 . . . . 0.0 108.101 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -146.55 52.67 1.11 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.698 1.199 . . . . 0.0 108.076 170.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -75.85 169.7 17.64 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 122.23 1.014 . . . . 0.0 109.888 174.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.8 t -152.02 164.99 36.05 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.095 1.758 . . . . 0.0 106.455 171.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 37.6 mt -135.32 174.48 10.57 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.105 2.162 . . . . 0.0 109.033 176.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 p -152.9 68.05 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.394 1.077 . . . . 0.0 109.169 -175.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 . . . . . 0 C--O 1.236 0.357 0 C-N-CA 125.033 1.333 . . . . 0.0 109.517 178.944 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.395 0 CA-C-O 120.853 0.359 . . . . 0.0 111.74 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.47 106.27 16.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 176.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -161.86 87.11 0.65 Allowed 'General case' 0 C--O 1.234 0.286 0 O-C-N 123.479 0.487 . . . . 0.0 111.024 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.7 mt -133.67 150.15 51.54 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.171 1.388 . . . . 0.0 109.511 -172.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -143.23 146.86 34.02 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.843 1.657 . . . . 0.0 109.397 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -145.78 155.08 42.7 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.414 1.486 . . . . 0.0 109.069 172.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--O 1.249 1.065 0 C-N-CA 126.569 1.948 . . . . 0.0 106.663 173.37 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.031 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.21 168.62 26.55 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.526 1.663 . . . . 0.0 109.767 -174.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.6 mtp -107.86 164.58 12.14 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.484 1.114 . . . . 0.0 111.82 162.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -177.36 153.78 0.96 Allowed 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 131.132 3.773 . . . . 0.0 110.054 -169.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -145.1 147.84 32.98 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.601 2.76 . . . . 0.0 105.137 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -124.06 146.74 29.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 125.83 1.652 . . . . 0.0 108.438 175.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.449 ' CG2' HG23 ' A' ' 65' ' ' THR . 1.3 p -130.01 116.35 18.44 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.477 HG22 ' HB ' ' A' ' 64' ' ' VAL . 0.7 OUTLIER -79.09 143.81 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 117.532 -1.667 . . . . 0.0 106.9 160.334 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -124.0 117.94 25.89 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 104.167 -2.531 . . . . 0.0 104.167 158.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -94.53 110.19 22.02 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 173.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 m -84.35 158.39 21.16 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 123.343 0.402 . . . . 0.0 110.184 172.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.97 -145.26 25.66 Favored Glycine 0 C--O 1.241 0.59 0 O-C-N 123.784 0.677 . . . . 0.0 112.684 168.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -82.67 128.91 34.79 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 168.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -132.64 17.94 4.3 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.681 1.192 . . . . 0.0 111.091 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -120.95 35.23 4.95 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.088 1.355 . . . . 0.0 110.402 -168.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.1 t -145.57 -6.33 0.62 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.245 1.418 . . . . 0.0 110.835 -173.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.439 ' HB3' ' CG2' ' A' ' 81' ' ' VAL . 20.7 m-85 -101.98 170.55 8.05 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 120.699 -1.25 . . . . 0.0 108.2 -153.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.2 mp -137.53 96.76 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -169.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.8 tptt 174.32 -162.03 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.739 2.015 . . . . 0.0 110.81 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.3 m -155.65 174.42 15.31 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.683 1.993 . . . . 0.0 110.569 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 t -115.97 144.69 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.026 1.331 . . . . 0.0 107.426 170.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.7 t -99.62 150.48 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 126.454 1.902 . . . . 0.0 108.247 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -145.33 145.32 20.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 124.073 0.949 . . . . 0.0 110.542 163.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.3 t -135.97 137.82 48.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 165.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.7 107.41 5.91 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.318 1.047 . . . . 0.0 108.517 173.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -59.85 112.0 1.68 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.071 1.349 . . . . 0.0 109.737 -177.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.25 32.76 27.72 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-O 118.395 -1.225 . . . . 0.0 114.743 165.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.532 ' CG2' ' HB2' ' A' ' 72' ' ' ALA . 11.4 t -156.51 -170.5 3.36 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.137 1.469 . . . . 0.0 110.103 175.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -111.87 164.64 12.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.941 1.696 . . . . 0.0 110.506 159.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.55 168.67 10.22 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 127.973 2.509 . . . . 0.0 108.255 176.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -130.23 132.24 45.89 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.328 1.851 . . . . 0.0 106.642 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -82.57 116.71 22.1 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 164.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.59 -10.02 62.9 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 118.573 -1.126 . . . . 0.0 114.476 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.16 -52.49 58.78 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 118.912 1.356 . . . . 0.0 109.922 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.33 -9.48 5.79 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.053 1.341 . . . . 0.0 111.47 -170.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.73 56.28 5.52 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -176.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -102.29 129.59 48.77 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 38.1 t -71.89 145.38 48.56 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.014 0.824 . . . . 0.0 109.069 172.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 24.1 mt -137.66 130.05 29.45 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 124.842 1.257 . . . . 0.0 110.089 -170.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -86.36 87.64 7.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.912 -177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.43 156.7 40.16 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-O 117.864 -1.065 . . . . 0.0 110.679 170.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.4 144.17 79.66 Favored 'Cis proline' 0 C--N 1.348 0.546 0 CA-C-N 120.305 1.144 . . . . 0.0 111.268 -2.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.8 p -157.57 162.14 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.229 1.011 . . . . 0.0 111.168 -170.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.8 mm -129.99 107.98 15.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 126.623 1.969 . . . . 0.0 108.494 -169.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.2 mt -70.62 125.3 26.43 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.337 0.655 . . . . 0.0 109.812 175.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.47 -172.11 3.88 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.48 2.312 . . . . 0.0 110.589 -176.016 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -61.18 -42.55 98.77 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.502 -1.374 . . . . 0.0 112.72 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -51.42 -45.3 62.55 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.065 0.946 . . . . 0.0 110.798 -176.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.404 ' H ' ' HG2' ' A' ' 58' ' ' GLU . 2.3 mm-40 -68.59 -40.02 80.68 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.293 1.437 . . . . 0.0 109.704 -175.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -89.02 11.7 17.58 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.35 1.86 . . . . 0.0 112.258 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.19 16.87 0.21 Allowed 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.046 -1.659 . . . . 0.0 113.03 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.1 m -131.62 163.75 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 126.319 1.847 . . . . 0.0 111.252 -172.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -65.62 -27.32 68.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.122 1.369 . . . . 0.0 112.75 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -152.48 126.54 9.11 Favored 'General case' 0 CA--C 1.511 -0.555 0 O-C-N 121.088 -1.008 . . . . 0.0 109.962 -173.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.477 ' HB ' HG22 ' A' ' 17' ' ' ILE . 23.3 t -120.54 140.68 43.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 173.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.449 HG23 ' CG2' ' A' ' 16' ' ' THR . 25.5 m -138.0 106.89 5.96 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.071 1.348 . . . . 0.0 108.446 -163.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.2 mt -124.0 139.3 54.08 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -167.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.6 t -145.45 159.99 42.25 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.5 p -72.84 140.95 47.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.733 168.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.5 p -71.85 -53.0 14.61 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.093 174.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -112.54 170.58 13.55 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 124.992 1.282 . . . . 0.0 110.014 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.46 134.56 56.77 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.111 0.964 . . . . 0.0 109.646 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.532 ' HB2' ' CG2' ' A' ' 37' ' ' THR . . . -117.97 179.76 3.99 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 125.678 1.591 . . . . 0.0 107.541 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.526 HD13 ' C ' ' A' ' 72' ' ' ALA . 1.1 mm -117.19 -10.63 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.503 0.721 . . . . 0.0 111.163 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -148.05 165.14 31.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 167.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -144.33 107.31 4.5 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.683 1.593 . . . . 0.0 107.716 168.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.66 153.09 19.71 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.391 0.676 . . . . 0.0 109.958 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.5 t -144.98 115.35 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 127.274 2.23 . . . . 0.0 105.84 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 95.4 p -154.63 -172.73 4.3 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 120.688 -1.258 . . . . 0.0 111.162 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.48 -161.34 12.77 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -170.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.6 175.22 36.63 Favored Glycine 0 N--CA 1.464 0.531 0 N-CA-C 106.752 -2.539 . . . . 0.0 106.752 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.447 HG12 ' CZ2' ' A' ' 95' ' ' TRP . 1.8 p . . . . . 0 N--CA 1.465 0.313 0 CA-C-N 120.697 2.249 . . . . 0.0 109.79 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -80.47 -166.95 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.849 3.033 . . . . 0.0 112.288 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.4 ptm -145.62 167.44 23.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.638 0.732 . . . . 0.0 111.923 -171.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -132.61 131.52 41.51 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 168.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.447 ' CZ2' HG12 ' A' ' 81' ' ' VAL . 13.2 m0 -79.9 105.0 10.86 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 156.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.3 t -79.59 135.89 24.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 149.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.9 t -138.76 91.21 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 172.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.22 152.02 38.39 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.013 1.325 . . . . 0.0 108.415 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 t -134.81 131.7 53.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 175.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -102.91 159.24 15.67 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 128.208 2.603 . . . . 0.0 107.634 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.414 ' HG3' ' H ' ' A' ' 102' ' ' ASN . 22.0 tptm -129.21 -172.1 2.65 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 127.848 2.459 . . . . 0.0 105.41 177.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.414 ' H ' ' HG3' ' A' ' 101' ' ' LYS . 11.6 p30 -54.1 50.12 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 130.166 3.386 . . . . 0.0 115.387 177.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 169.03 -58.2 0.2 Allowed Glycine 0 CA--C 1.524 0.622 0 O-C-N 119.541 -1.974 . . . . 0.0 112.145 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.76 -175.32 5.08 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.217 1.407 . . . . 0.0 111.339 -171.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -55.15 141.18 35.87 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.625 1.57 . . . . 0.0 108.923 175.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 15.9 pt -121.39 -34.05 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 125.57 1.548 . . . . 0.0 111.066 167.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -133.34 149.99 51.87 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 120.241 1.382 . . . . 0.0 109.723 -175.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.7 pttt -155.46 42.29 0.43 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.249 2.219 . . . . 0.0 108.857 -153.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.57 ' HE2' HD11 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -111.53 149.3 31.59 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.655 0.782 . . . . 0.0 110.744 -172.883 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.0 t -142.06 162.34 35.73 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.22 1.408 . . . . 0.0 109.341 -169.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.536 ' N ' HD12 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -124.61 -163.71 1.2 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.618 1.967 . . . . 0.0 106.409 -179.817 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.57 144.89 15.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 127.641 2.377 . . . . 0.0 107.331 168.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 . . . . . 0 C--O 1.232 0.162 0 N-CA-C 106.503 -1.665 . . . . 0.0 106.503 170.9 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.465 0.308 0 N-CA-C 111.633 0.234 . . . . 0.0 111.633 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.57 HD11 ' HE2' ' A' ' 109' ' ' LYS . 8.0 tp -138.17 146.4 42.68 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.427 0.632 . . . . 0.0 109.38 169.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -176.48 76.67 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.811 2.044 . . . . 0.0 105.966 -171.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.7 tp -126.12 137.34 53.59 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.919 0.888 . . . . 0.0 109.214 -168.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -140.45 144.52 36.13 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.019 1.328 . . . . 0.0 109.697 -176.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -140.18 155.54 46.9 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.485 1.514 . . . . 0.0 109.108 171.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.0 p30 . . . . . 0 C--O 1.25 1.097 0 C-N-CA 127.591 2.356 . . . . 0.0 105.906 158.308 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.593 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . . . . . . 0 CA--C 1.525 0.686 0 N-CA-C 107.736 -2.146 . . . . 0.0 107.736 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.18 167.88 20.17 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.787 0.835 . . . . 0.0 112.009 -167.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.9 mtp -86.41 153.26 22.04 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 161.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -147.55 130.39 16.14 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 125.834 1.959 . . . . 0.0 108.578 -175.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -140.96 149.75 42.21 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.217 2.207 . . . . 0.0 106.814 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.404 HG23 HG22 ' A' ' 99' ' ' VAL . 11.2 p -144.86 158.95 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 C-N-CA 124.833 1.253 . . . . 0.0 109.686 177.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.2 124.88 14.95 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 -165.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.1 tp -119.51 109.24 25.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -171.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -108.96 122.66 47.7 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.743 2.017 . . . . 0.0 109.537 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -105.45 139.69 39.69 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.179 -0.95 . . . . 0.0 109.982 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.5 m -143.46 166.99 23.26 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.781 0.832 . . . . 0.0 111.321 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.83 -156.32 28.33 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -168.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -76.59 92.0 3.44 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 121.39 -1.065 . . . . 0.0 108.801 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -97.5 14.76 25.35 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -173.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.38 9.05 10.27 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -158.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.0 m -141.17 40.17 1.77 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.08 2.152 . . . . 0.0 108.749 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.42 ' O ' ' HE2' ' A' ' 28' ' ' LYS . 46.7 m-85 -136.23 130.18 32.71 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 124.999 1.319 . . . . 0.0 109.36 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.9 mt -72.76 90.35 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.42 ' HE2' ' O ' ' A' ' 26' ' ' PHE . 27.0 mtmt -79.78 162.0 25.38 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.815 1.246 . . . . 0.0 110.252 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.4 t -146.72 154.18 41.12 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.902 0.881 . . . . 0.0 110.302 165.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 69.9 t -142.73 109.45 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 127.208 2.203 . . . . 0.0 105.676 164.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.9 p -73.02 147.5 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 149.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 p -131.58 137.71 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 126.202 1.801 . . . . 0.0 106.52 167.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 t -119.59 163.31 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 123.878 0.871 . . . . 0.0 108.923 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.56 153.42 40.35 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.844 1.258 . . . . 0.0 109.906 169.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -129.16 105.45 8.17 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 169.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.42 29.24 50.06 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 118.598 -1.112 . . . . 0.0 114.618 165.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.582 HG22 ' HB2' ' A' ' 72' ' ' ALA . 5.0 t -164.3 -164.72 0.88 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.21 1.804 . . . . 0.0 106.698 158.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -123.89 170.69 10.33 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.125 1.37 . . . . 0.0 109.974 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.41 166.01 12.28 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.904 1.281 . . . . 0.0 109.789 -175.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -134.52 116.79 15.49 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 125.338 1.455 . . . . 0.0 107.827 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -82.84 132.04 35.18 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 124.982 1.313 . . . . 0.0 109.167 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.28 -22.47 50.61 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 118.842 -0.977 . . . . 0.0 113.854 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.24 -52.31 16.36 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 127.572 2.349 . . . . 0.0 111.746 -177.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 t -148.17 -4.84 0.46 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.759 -0.638 . . . . 0.0 111.379 175.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.41 27.96 8.84 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 119.863 1.21 . . . . 0.0 111.668 -160.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -64.13 124.28 21.25 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.63 110.81 20.66 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.184 1.794 . . . . 0.0 111.029 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.9 mt -114.12 145.78 41.17 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 122.375 1.083 . . . . 0.0 112.631 -163.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.14 67.91 5.09 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.05 1.34 . . . . 0.0 112.153 -171.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.2 m -52.83 156.2 3.54 Favored Pre-proline 0 CA--C 1.543 0.692 0 O-C-N 121.054 -1.029 . . . . 0.0 113.097 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.9 144.85 75.85 Favored 'Cis proline' 0 CA--C 1.536 0.606 0 CA-C-N 119.071 0.704 . . . . 0.0 112.495 -5.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.6 t -140.73 155.38 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 126.134 1.774 . . . . 0.0 107.815 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.3 mm -116.59 144.74 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 125.575 1.55 . . . . 0.0 106.857 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.4 mt -120.97 115.89 24.06 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.983 1.313 . . . . 0.0 107.686 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 m -72.16 174.41 7.21 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 124.753 1.283 . . . . 0.0 110.389 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.65 -31.77 68.46 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.822 1.649 . . . . 0.0 113.074 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -63.82 -42.46 97.65 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 121.355 -0.84 . . . . 0.0 110.478 174.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -75.6 -32.12 60.19 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -175.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.8 mt -85.63 27.36 0.85 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.673 1.989 . . . . 0.0 111.792 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.05 1.4 27.9 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 176.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.8 m -88.76 149.12 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 119.427 1.012 . . . . 0.0 111.498 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -57.25 -37.01 71.68 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.451 1.101 . . . . 0.0 112.76 172.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -165.39 149.09 8.28 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -176.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.5 p -149.99 167.29 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 166.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.1 t -121.92 158.97 27.85 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 167.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 mt -135.89 155.03 50.92 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 173.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.4 t -164.44 158.03 17.98 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.5 p -78.34 158.17 28.89 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 122.858 0.463 . . . . 0.0 110.551 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.3 p -75.4 -13.67 60.41 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.349 -0.844 . . . . 0.0 111.722 171.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -167.37 -167.51 28.16 Favored Glycine 0 C--N 1.336 0.535 0 O-C-N 120.662 -1.274 . . . . 0.0 111.559 -175.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.593 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 2.6 ttpt -52.01 130.85 30.79 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 168.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.582 ' HB2' HG22 ' A' ' 37' ' ' THR . . . -134.59 176.63 8.45 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.306 1.442 . . . . 0.0 107.629 173.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.61 9.29 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 118.707 -0.663 . . . . 0.0 109.705 176.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -146.46 151.76 37.93 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 120.191 1.36 . . . . 0.0 113.115 168.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.58 66.41 0.94 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.454 2.302 . . . . 0.0 108.888 165.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.87 138.91 33.73 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.244 -0.91 . . . . 0.0 109.705 174.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 69.1 t -138.58 124.19 23.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 125.689 1.595 . . . . 0.0 107.598 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.3 t -142.69 170.46 15.65 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.61 -88.66 0.12 Allowed Glycine 0 C--N 1.332 0.335 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.89 -165.51 16.26 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -176.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.408 0 N-CA-C 106.347 -1.724 . . . . 0.0 106.347 159.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 118.592 -0.718 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -82.94 -177.86 3.57 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.633 2.889 . . . . 0.0 112.179 -178.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 13.0 ptm -141.38 171.36 14.16 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.279 0.632 . . . . 0.0 112.249 -171.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -144.86 165.4 28.21 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.041 1.336 . . . . 0.0 109.445 166.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -128.42 136.29 50.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 170.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.2 t -115.86 129.35 72.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 161.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.9 t -114.54 151.67 16.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 103.895 -2.631 . . . . 0.0 103.895 166.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.3 m -135.94 136.7 40.64 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.404 HG22 HG23 ' A' ' 15' ' ' VAL . 19.3 t -116.5 141.61 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 176.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -123.67 148.03 46.88 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.046 1.738 . . . . 0.0 107.185 174.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.454 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 4.0 ttpm? -111.96 -159.29 0.68 Allowed 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.355 1.062 . . . . 0.0 108.295 178.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.454 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 3.3 p30 -60.96 81.65 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.029 1.332 . . . . 0.0 107.961 159.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 152.46 -74.83 0.25 Allowed Glycine 0 N--CA 1.45 -0.376 0 O-C-N 121.12 -0.987 . . . . 0.0 112.577 169.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.23 -171.45 3.87 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.076 1.75 . . . . 0.0 110.127 -173.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -46.1 141.27 3.37 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.829 2.052 . . . . 0.0 109.727 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.1 pt -141.95 -11.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 124.225 1.01 . . . . 0.0 113.492 178.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -142.16 149.27 39.54 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.663 1.12 . . . . 0.0 108.354 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -144.68 93.61 2.44 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.011 0.924 . . . . 0.0 109.124 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.69 151.48 43.09 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.772 0.796 . . . . 0.0 112.246 163.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.443 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -146.52 155.59 42.63 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 127.162 2.185 . . . . 0.0 107.785 179.102 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -133.33 -174.22 3.43 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 123.804 1.764 . . . . 0.0 107.139 -172.47 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.9 p -154.02 146.9 13.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 C-N-CA 127.085 2.154 . . . . 0.0 109.88 -177.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.1 t80 . . . . . 0 C--O 1.237 0.4 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 165.741 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 t0 . . . . . 0 N--CA 1.474 0.743 0 CA-C-O 121.671 0.748 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 tp -126.72 111.08 13.84 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -159.38 71.24 0.5 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.792 0.837 . . . . 0.0 109.624 166.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 mp -82.72 149.86 27.05 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.584 1.154 . . . . 0.0 109.637 170.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -137.65 125.81 23.03 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 127.427 2.291 . . . . 0.0 106.536 171.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -127.39 145.12 50.93 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 164.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 C--O 1.257 1.461 0 C-N-CA 127.17 2.188 . . . . 0.0 108.355 -168.971 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.77 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.24 -175.24 4.18 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.372 1.869 . . . . 0.0 107.626 167.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.2 mmm -97.14 163.1 13.07 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 144.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -146.8 154.41 41.34 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 125.233 1.413 . . . . 0.0 109.609 171.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -152.49 134.76 15.06 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 127.594 2.357 . . . . 0.0 106.359 -175.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 p -125.61 152.91 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 125.446 1.498 . . . . 0.0 110.144 174.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.4 p -120.48 157.7 28.84 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.108 0.963 . . . . 0.0 110.002 171.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.8 tp -143.08 110.46 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 174.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -107.92 132.33 53.58 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -116.76 120.96 40.2 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.286 1.034 . . . . 0.0 109.64 -169.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 m -134.5 172.39 12.98 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.418 0.687 . . . . 0.0 110.593 174.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.6 -163.76 46.28 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -163.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -86.0 59.18 5.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.744 0.783 . . . . 0.0 111.021 -160.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -63.0 21.7 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.782 2.433 . . . . 0.0 115.825 -178.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -115.62 12.04 15.96 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.125 1.77 . . . . 0.0 109.009 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.4 m -143.39 -0.74 1.08 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -157.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -137.49 126.48 24.27 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.69 1.196 . . . . 0.0 109.73 -168.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.4 mt -61.87 89.82 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.488 1.115 . . . . 0.0 110.511 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -74.66 163.45 27.7 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.996 0.903 . . . . 0.0 109.083 176.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.8 p -158.99 137.56 10.89 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.14 1.776 . . . . 0.0 108.965 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 t -138.45 98.1 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 119.454 1.024 . . . . 0.0 108.353 172.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.4 t -68.09 127.3 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 163.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.0 t -139.11 127.82 28.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 119.694 1.134 . . . . 0.0 109.114 171.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.4 t -109.8 154.79 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.491 1.516 . . . . 0.0 108.743 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.08 103.19 3.71 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.943 0.897 . . . . 0.0 109.917 165.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -58.76 100.87 0.07 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.549 1.54 . . . . 0.0 109.12 168.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.44 7.97 50.54 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 117.219 -1.878 . . . . 0.0 117.74 158.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.548 HG21 ' H ' ' A' ' 70' ' ' GLY . 2.0 t -165.14 178.45 6.98 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 121.016 2.408 . . . . 0.0 108.615 162.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -94.8 161.47 14.16 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.281 1.032 . . . . 0.0 110.785 -175.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.57 HD12 HD12 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -90.46 169.03 11.4 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.928 1.291 . . . . 0.0 109.288 -178.92 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -137.09 119.92 16.31 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 124.741 1.216 . . . . 0.0 107.892 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -75.64 148.44 38.74 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.606 0.717 . . . . 0.0 109.755 176.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.1 -25.26 67.93 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 118.399 -1.223 . . . . 0.0 112.636 167.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.21 -60.48 2.92 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 126.609 1.963 . . . . 0.0 111.164 -171.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.666 HG22 ' HG3' ' A' ' 46' ' ' GLU . 1.3 t -144.74 8.43 1.3 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.182 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.4 24.7 56.21 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 118.969 0.804 . . . . 0.0 111.136 -165.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.666 ' HG3' HG22 ' A' ' 44' ' ' THR . 74.7 mt-10 -55.86 118.73 4.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.713 1.205 . . . . 0.0 108.507 174.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 m -78.78 122.17 25.71 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 174.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 76.6 mt -113.03 134.19 54.63 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.76 1.224 . . . . 0.0 110.881 -170.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.36 73.92 1.36 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.85 2.06 . . . . 0.0 113.144 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.1 150.97 37.63 Favored Pre-proline 0 CA--C 1.545 0.785 0 O-C-N 120.979 -1.075 . . . . 0.0 111.151 171.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.52 155.74 85.92 Favored 'Cis proline' 0 C--N 1.348 0.509 0 CA-C-N 119.504 0.859 . . . . 0.0 110.785 -12.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.4 p -144.46 161.34 14.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 175.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.6 mm -108.69 99.24 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 166.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.83 104.94 3.05 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.384 -1.709 . . . . 0.0 106.384 168.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.9 m -74.05 175.15 7.7 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.64 0.733 . . . . 0.0 109.443 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -49.72 -37.98 31.47 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.794 1.637 . . . . 0.0 110.601 175.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -69.23 -32.16 71.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.484 1.913 . . . . 0.0 112.621 -175.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -76.61 -32.27 57.97 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.31 1.044 . . . . 0.0 108.93 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -90.13 16.28 8.75 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.701 1.6 . . . . 0.0 112.708 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.71 45.1 0.18 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.714 2.005 . . . . 0.0 112.295 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.0 m -140.85 162.92 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 128.434 2.694 . . . . 0.0 108.668 -173.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -75.19 -26.83 59.33 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.294 -0.879 . . . . 0.0 113.003 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.39 147.05 10.55 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.214 1.006 . . . . 0.0 109.436 -174.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -132.59 161.14 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.95 0.881 . . . . 0.0 109.81 163.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 m -128.5 116.28 19.45 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 130.029 3.331 . . . . 0.0 104.968 172.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.57 HD12 HD12 ' A' ' 39' ' ' LEU . 4.3 mm? -119.9 132.12 55.44 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 119.506 1.048 . . . . 0.0 108.342 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.43 166.49 24.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.02 -170.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 p -80.62 142.97 33.49 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.913 1.685 . . . . 0.0 110.125 -178.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.8 p -80.33 -51.22 9.14 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.503 -0.748 . . . . 0.0 110.74 172.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.548 ' H ' HG21 ' A' ' 37' ' ' THR . . . -106.6 -80.74 1.35 Allowed Glycine 0 C--N 1.335 0.486 0 O-C-N 121.534 -0.729 . . . . 0.0 112.407 -162.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.0 tttt -168.84 135.69 1.86 Allowed 'General case' 0 C--O 1.239 0.516 1 C-N-CA 131.849 4.06 . . . . 0.0 104.12 170.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -133.37 165.47 24.76 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 123.163 0.585 . . . . 0.0 110.066 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.23 -0.89 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 123.308 0.643 . . . . 0.0 110.673 -165.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -153.02 156.12 38.21 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.039 -1.038 . . . . 0.0 108.282 168.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.08 109.44 5.61 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 166.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.52 127.68 54.76 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.5 t -129.66 118.09 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 -174.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.0 157.94 45.09 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -169.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 154.85 -167.57 32.71 Favored Glycine 0 C--N 1.331 0.284 0 O-C-N 121.87 -0.519 . . . . 0.0 112.037 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.82 179.88 43.08 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.407 1.004 . . . . 0.0 112.155 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.54 0.584 0 C-N-CA 126.396 1.878 . . . . 0.0 108.463 171.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.534 0.328 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -84.35 -179.03 3.67 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.248 1.966 . . . . 0.0 111.5 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.406 ' CE ' ' HE1' ' A' ' 95' ' ' TRP . 4.6 ptm -131.31 160.28 35.43 Favored 'General case' 0 C--O 1.231 0.109 0 O-C-N 121.154 -0.966 . . . . 0.0 112.977 -176.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -142.01 143.31 33.11 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.536 1.134 . . . . 0.0 108.94 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.406 ' HE1' ' CE ' ' A' ' 93' ' ' MET . 54.4 m0 -116.9 139.46 50.61 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.23 1.012 . . . . 0.0 108.366 174.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.16 141.08 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 153.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.5 m -141.62 160.33 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 C-N-CA 127.074 2.149 . . . . 0.0 106.443 -177.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.8 m -152.59 142.94 22.55 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 174.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.36 136.59 48.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 169.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -123.19 113.69 19.29 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.698 2.399 . . . . 0.0 106.862 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -68.02 171.51 6.75 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 161.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -44.19 83.2 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.561 2.344 . . . . 0.0 114.128 -175.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 62.46 43.69 98.68 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.273 1.416 . . . . 0.0 113.465 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.0 mmtt -155.55 141.26 18.0 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.815 1.807 . . . . 0.0 109.463 155.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -68.31 143.83 55.05 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 125.932 1.693 . . . . 0.0 108.507 170.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.95 -13.94 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 120.218 1.372 . . . . 0.0 113.234 172.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -142.88 162.04 36.53 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.66 1.584 . . . . 0.0 107.085 -167.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.4 pttt -162.78 37.8 0.1 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.152 0.887 . . . . 0.0 112.637 -175.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -73.55 166.8 22.59 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.219 -1.55 . . . . 0.0 110.373 -176.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.7 t -151.59 160.08 43.81 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 127.168 2.187 . . . . 0.0 106.234 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 94.3 mt -132.6 141.49 48.7 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.924 0.89 . . . . 0.0 109.238 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.4 p -135.87 114.77 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 126.196 1.798 . . . . 0.0 107.319 174.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.51 -0.569 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 166.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 . . . . . 0 N--CA 1.466 0.341 0 N-CA-C 111.312 0.116 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.92 124.6 47.47 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.669 0.788 . . . . 0.0 109.314 -155.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -148.96 32.67 0.76 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.985 2.114 . . . . 0.0 111.802 -157.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.2 mp -80.77 148.58 30.0 Favored 'General case' 0 C--O 1.24 0.566 0 O-C-N 121.45 -0.781 . . . . 0.0 110.559 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -159.51 136.09 9.19 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.978 2.111 . . . . 0.0 109.963 173.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -142.17 158.66 43.48 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.078 2.151 . . . . 0.0 110.297 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.3 p30 . . . . . 0 C--O 1.249 1.035 0 C-N-CA 126.816 2.046 . . . . 0.0 109.3 177.926 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.502 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . . . . . . 0 CA--C 1.527 0.786 0 N-CA-C 107.697 -2.161 . . . . 0.0 107.697 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.66 -172.61 2.96 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.158 0.979 . . . . 0.0 112.667 -162.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.1 mtp -113.69 158.77 20.47 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 147.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -144.77 143.2 30.55 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 125.256 1.597 . . . . 0.0 108.951 174.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -142.94 143.81 32.14 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.619 2.368 . . . . 0.0 105.065 172.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p -122.07 155.11 26.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 124.557 1.143 . . . . 0.0 109.108 171.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.04 151.11 52.07 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 173.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.6 tp -133.2 114.42 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.11 138.02 41.21 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 126.361 1.864 . . . . 0.0 107.45 176.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -128.46 122.34 31.04 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.453 1.101 . . . . 0.0 108.96 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.97 165.31 11.67 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.296 1.038 . . . . 0.0 108.772 172.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.49 -154.07 52.12 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 176.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -75.67 75.38 2.66 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 123.733 1.73 . . . . 0.0 113.108 -170.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -81.49 17.33 1.42 Allowed 'General case' 0 C--N 1.324 -0.536 0 O-C-N 119.715 -1.866 . . . . 0.0 114.116 -171.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 ptt-85 -137.64 28.34 2.7 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.559 1.527 . . . . 0.0 113.123 -170.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.4 m -127.97 17.29 6.74 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -171.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -134.81 -169.18 2.3 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.9 1.227 . . . . 0.0 112.556 -165.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.7 mm -114.91 87.88 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 106.104 -1.814 . . . . 0.0 106.104 163.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.409 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 0.4 OUTLIER -85.16 160.22 19.97 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.246 0.93 . . . . 0.0 110.588 168.394 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.34 156.67 42.81 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.065 0.946 . . . . 0.0 108.565 169.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.1 t -138.02 104.02 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.198 1.399 . . . . 0.0 107.334 170.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.711 HG22 HD12 ' A' ' 53' ' ' ILE . 84.9 t -69.07 135.37 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 163.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.9 t -138.19 138.41 43.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.5 t -135.18 150.14 29.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.08 141.98 49.37 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.265 1.826 . . . . 0.0 109.955 168.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -118.27 103.61 9.98 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 130.158 3.383 . . . . 0.0 106.481 -178.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.47 0.98 32.9 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 125.163 1.364 . . . . 0.0 113.205 172.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.537 HG22 ' HB2' ' A' ' 72' ' ' ALA . 15.0 t -165.74 -174.44 3.08 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.582 1.191 . . . . 0.0 109.23 -174.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -109.73 -175.75 2.83 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.871 1.668 . . . . 0.0 109.702 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.5 mt -119.18 165.58 14.03 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.313 1.445 . . . . 0.0 109.677 -177.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -138.26 122.6 18.26 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.095 0.958 . . . . 0.0 110.113 -170.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -70.08 135.29 49.09 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.755 0.822 . . . . 0.0 109.977 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.84 0.34 86.35 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-O 117.867 -1.518 . . . . 0.0 115.29 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.14 -51.35 15.88 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 120.196 1.998 . . . . 0.0 108.331 174.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.57 -22.8 3.56 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.836 1.254 . . . . 0.0 111.413 -167.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.94 20.55 28.06 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 118.444 -1.198 . . . . 0.0 112.24 -172.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -57.89 136.87 57.09 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 118.978 1.389 . . . . 0.0 109.42 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.13 138.77 49.93 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.268 1.027 . . . . 0.0 108.573 167.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.8 mt -126.91 -171.2 2.35 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.167 1.387 . . . . 0.0 109.306 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -143.03 117.94 9.98 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.685 1.994 . . . . 0.0 106.588 173.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.52 172.0 10.53 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.137 177.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.81 157.99 94.53 Favored 'Cis proline' 0 C--O 1.239 0.567 0 N-CA-C 108.525 -1.375 . . . . 0.0 108.525 -5.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 p -144.8 147.47 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 O-C-N 121.534 -0.728 . . . . 0.0 109.084 -171.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.711 HD12 HG22 ' A' ' 31' ' ' VAL . 18.0 mm -120.13 114.18 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 175.162 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.68 128.01 36.02 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 169.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.4 m -95.72 -175.69 3.51 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.93 1.692 . . . . 0.0 110.884 -174.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.409 ' HA ' ' HG2' ' A' ' 28' ' ' LYS . 29.5 t70 -61.93 -37.71 85.72 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 123.769 0.828 . . . . 0.0 111.848 -170.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -66.76 -36.4 82.35 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.072 0.949 . . . . 0.0 111.212 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -66.73 -36.49 82.59 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 122.44 1.114 . . . . 0.0 110.073 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.8 10.47 32.95 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.581 1.952 . . . . 0.0 112.874 -174.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.17 31.07 0.06 Allowed 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 120.392 1.451 . . . . 0.0 114.111 -174.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.7 m -131.37 167.27 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.504 1.522 . . . . 0.0 111.691 -169.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -59.38 -34.15 72.07 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.471 1.508 . . . . 0.0 113.415 175.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -157.95 147.28 19.68 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-O 117.116 -1.421 . . . . 0.0 109.913 -177.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 t -129.58 163.02 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 119.106 0.866 . . . . 0.0 108.74 163.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.3 m -139.29 109.39 6.41 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.702 2.801 . . . . 0.0 107.791 -172.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -122.4 131.58 53.95 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 121.053 1.751 . . . . 0.0 109.618 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.49 176.29 8.75 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.244 0.618 . . . . 0.0 111.455 -168.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 p -101.95 148.48 25.29 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.812 0.845 . . . . 0.0 109.954 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.3 p -84.27 -0.7 53.37 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.61 -0.681 . . . . 0.0 112.442 176.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.64 -172.73 37.95 Favored Glycine 0 N--CA 1.448 -0.525 0 O-C-N 119.877 -1.764 . . . . 0.0 109.498 -171.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.502 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 7.1 ttpt -70.43 129.35 39.05 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.537 ' HB2' HG22 ' A' ' 37' ' ' THR . . . -126.4 169.69 12.71 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.121 0.568 . . . . 0.0 110.536 176.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -119.46 -2.69 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -175.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -141.65 172.48 12.62 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.836 1.198 . . . . 0.0 110.605 -177.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -164.61 89.75 0.52 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 120.073 1.306 . . . . 0.0 111.312 166.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.77 150.4 25.82 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.584 0.354 . . . . 0.0 110.766 176.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 t -140.76 123.6 15.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 126.207 1.803 . . . . 0.0 106.241 164.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 m -140.59 156.62 46.23 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 174.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.4 -153.35 23.46 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -167.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.38 -168.96 31.56 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -175.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.538 HG23 ' CE1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 125.178 1.391 . . . . 0.0 109.323 165.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 . . . . . 0 CA--C 1.532 0.263 0 CA-C-O 119.725 -0.179 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -72.37 169.21 22.22 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 121.083 1.188 . . . . 0.0 111.722 171.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.4 ptm -139.59 172.53 12.66 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 125.046 1.338 . . . . 0.0 110.33 -174.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -143.91 153.3 42.16 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.23 1.012 . . . . 0.0 109.422 -177.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -127.59 140.75 51.91 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.518 1.527 . . . . 0.0 108.982 176.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.9 t -132.8 110.75 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 164.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 m -92.07 143.07 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 163.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 m -129.59 142.12 50.81 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.8 t -122.14 126.1 73.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -113.57 119.0 35.99 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 175.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.439 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 2.2 ttpt -80.01 -156.91 0.13 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 175.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.439 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 4.6 p30 -66.02 83.34 0.08 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 163.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 139.2 -43.48 1.16 Allowed Glycine 0 CA--C 1.524 0.615 0 CA-C-O 118.03 -1.428 . . . . 0.0 115.2 156.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -151.93 -174.98 5.04 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 119.66 1.73 . . . . 0.0 111.309 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -55.74 143.44 30.79 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 171.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 6.7 pt -128.14 -24.85 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-O 117.674 -1.155 . . . . 0.0 112.706 168.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -150.94 148.9 28.97 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 120.631 1.559 . . . . 0.0 108.319 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -148.67 54.79 1.0 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.107 1.363 . . . . 0.0 107.97 -169.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.17 113.02 2.35 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.72 135.0 50.54 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.955 1.302 . . . . 0.0 108.014 -169.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -133.12 -172.8 3.03 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 122.275 1.036 . . . . 0.0 109.85 -170.117 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 78.3 t -148.09 111.46 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 127.554 2.342 . . . . 0.0 106.481 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.538 ' CE1' HG23 ' A' ' 81' ' ' VAL . 1.8 t80 . . . . . 0 C--O 1.233 0.213 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 169.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 . . . . . 0 N--CA 1.467 0.421 0 CA-C-O 120.656 0.265 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.1 tp -104.93 104.47 14.23 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -156.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.73 66.67 0.93 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -166.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 mp -119.58 141.78 48.97 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -161.19 111.39 1.69 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -97.64 146.57 25.19 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.204 1.002 . . . . 0.0 109.618 169.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 . . . . . 0 C--O 1.253 1.267 0 C-N-CA 126.868 2.067 . . . . 0.0 109.431 171.074 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.471 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -147.3 152.41 38.21 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 117.499 0.65 . . . . 0.0 112.57 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.5 mtp -83.51 154.4 23.9 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.477 1.111 . . . . 0.0 108.685 158.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -137.88 152.71 49.31 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.607 1.163 . . . . 0.0 109.026 168.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -141.32 134.42 29.25 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 165.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.593 HG12 HG22 ' A' ' 99' ' ' VAL . 3.8 m -134.65 145.87 31.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 125.262 1.425 . . . . 0.0 107.854 -173.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.2 p -123.24 152.78 40.97 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -175.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.4 tp -136.31 92.87 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 170.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -72.74 139.52 47.21 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 165.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -124.02 126.25 45.95 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 173.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -136.47 176.72 8.44 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.037 0.935 . . . . 0.0 111.73 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.55 -83.46 1.62 Allowed Glycine 0 C--N 1.334 0.431 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 -175.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -149.78 158.9 44.61 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.336 1.855 . . . . 0.0 106.482 172.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -146.44 71.9 1.26 Allowed 'General case' 0 C--N 1.327 -0.375 0 O-C-N 119.739 -1.85 . . . . 0.0 109.355 164.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -133.45 -0.75 3.22 Favored 'General case' 0 C--N 1.332 -0.155 0 O-C-N 120.782 -1.198 . . . . 0.0 112.872 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.4 t -152.5 53.08 0.78 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.999 1.272 . . . . 0.0 110.304 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -148.02 116.56 6.63 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 116.675 -1.631 . . . . 0.0 109.729 -178.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.0 mt -55.14 98.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 125.333 1.453 . . . . 0.0 108.969 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.6 mtmm -82.86 136.73 34.53 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 170.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t -142.46 144.2 32.94 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 172.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.8 t -135.05 155.79 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 167.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 p -119.22 147.39 22.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 103.967 -2.605 . . . . 0.0 103.967 156.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.7 p -148.81 131.11 6.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 171.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.5 t -128.65 164.34 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.916 0.886 . . . . 0.0 108.798 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.58 107.1 4.07 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 166.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.526 ' H ' ' HG3' ' A' ' 74' ' ' GLU . 32.4 t-20 -65.22 89.55 0.09 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.248 1.023 . . . . 0.0 110.217 172.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.38 -79.63 0.34 Allowed Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 169.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -81.19 -165.02 0.84 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.255 1.022 . . . . 0.0 111.017 -174.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -110.29 162.28 14.78 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.916 1.686 . . . . 0.0 111.156 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -84.41 156.31 21.86 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.764 1.626 . . . . 0.0 109.651 167.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -128.63 114.46 16.7 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 127.275 2.23 . . . . 0.0 107.308 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.74 119.31 17.79 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.657 1.983 . . . . 0.0 109.088 -176.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.91 -3.39 50.99 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.56 1.076 . . . . 0.0 113.74 176.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.45 -51.91 67.51 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.933 1.293 . . . . 0.0 110.098 169.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.3 p -152.39 9.3 0.48 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.454 1.502 . . . . 0.0 112.394 -161.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.32 13.82 79.58 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 120.486 -1.384 . . . . 0.0 112.617 -175.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -65.65 124.19 21.71 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.772 1.229 . . . . 0.0 111.092 -171.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.2 m -74.2 127.28 32.55 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 169.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 75.8 mt -119.76 176.64 5.3 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.397 1.079 . . . . 0.0 109.925 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.99 110.13 12.23 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.043 1.337 . . . . 0.0 109.553 -173.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.0 p -77.12 170.37 16.67 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.284 1.434 . . . . 0.0 112.175 -172.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.66 146.41 76.73 Favored 'Cis proline' 0 CA--C 1.535 0.526 0 N-CA-C 109.287 -1.082 . . . . 0.0 109.287 -19.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.8 p -137.13 147.15 27.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 118.439 0.563 . . . . 0.0 110.842 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.7 mm -114.08 127.29 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 127.543 2.337 . . . . 0.0 107.044 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -103.33 140.41 37.46 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.666 0.787 . . . . 0.0 109.414 172.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.3 m -81.0 172.48 13.68 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.846 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.77 -24.96 67.98 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.418 2.287 . . . . 0.0 112.547 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -72.57 -37.03 68.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 118.465 -0.779 . . . . 0.0 111.519 172.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -74.21 -44.16 54.29 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -173.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.76 8.09 2.65 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.968 1.307 . . . . 0.0 114.357 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.66 41.39 0.09 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.221 2.208 . . . . 0.0 113.581 -174.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.6 m -133.1 159.1 43.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 126.013 1.725 . . . . 0.0 111.087 -171.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -67.05 -27.19 67.18 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.278 1.431 . . . . 0.0 113.546 -175.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -158.62 137.39 11.16 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 -172.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -123.04 150.67 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 158.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.5 m -133.65 134.52 43.26 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 173.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 31.4 mt -134.2 147.78 50.78 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -170.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.5 t -157.71 165.91 34.18 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -173.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.78 141.55 28.32 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.248 1.419 . . . . 0.0 109.659 -177.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 58.2 p -80.34 -1.0 39.22 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 175.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -158.94 -99.32 0.15 Allowed Glycine 0 C--N 1.339 0.743 0 O-C-N 120.61 -1.306 . . . . 0.0 112.851 -174.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.423 ' HE2' ' C ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -134.69 152.06 51.48 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 126.67 1.988 . . . . 0.0 108.655 166.3 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.13 -178.71 4.05 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 158.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.9 mm -111.44 -14.01 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.582 0.706 . . . . 0.0 109.746 173.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.526 ' HG3' ' H ' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -148.9 163.2 38.13 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 126.521 1.928 . . . . 0.0 107.262 -163.115 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.423 ' HD2' HG11 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -154.34 96.22 1.9 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 128.991 2.917 . . . . 0.0 105.818 168.813 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -91.63 114.93 27.6 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.328 0.651 . . . . 0.0 110.433 177.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 52.7 t -129.1 115.57 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.913 1.285 . . . . 0.0 108.654 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.457 ' HA ' ' HB3' ' A' ' 124' ' ' LEU . 46.7 t -139.71 168.54 19.59 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.933 2.093 . . . . 0.0 108.255 175.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.65 -156.57 27.75 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 127.075 2.274 . . . . 0.0 108.299 -162.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 139.27 123.97 2.14 Favored Glycine 0 N--CA 1.473 1.141 0 CA-C-N 119.171 1.485 . . . . 0.0 112.554 174.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.252 0 CA-C-O 121.767 0.794 . . . . 0.0 110.038 -169.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 . . . . . 0 CA--C 1.532 0.256 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.59 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -78.5 178.24 7.79 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.769 2.98 . . . . 0.0 111.784 173.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.3 ptm -138.12 169.53 17.62 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 122.558 1.17 . . . . 0.0 111.197 -172.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -140.54 151.26 44.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.823 2.049 . . . . 0.0 106.325 175.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -118.11 151.19 38.03 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 168.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.7 t -125.89 134.23 67.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 161.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.7 t -144.31 124.25 7.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 -168.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.4 m -141.43 150.7 42.66 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 -163.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.593 HG22 HG12 ' A' ' 15' ' ' VAL . 37.1 t -124.47 135.52 63.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.59 0.709 . . . . 0.0 111.002 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -118.35 158.66 24.83 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 128.467 2.707 . . . . 0.0 107.938 173.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.4 tptt -124.88 -153.44 0.56 Allowed 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 127.573 2.349 . . . . 0.0 107.402 -168.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -55.86 68.47 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.895 2.078 . . . . 0.0 110.633 160.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 64.14 58.98 9.09 Favored Glycine 0 CA--C 1.531 1.061 0 O-C-N 120.106 -1.621 . . . . 0.0 113.172 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -179.61 153.3 0.55 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 128.546 2.738 . . . . 0.0 107.595 162.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -64.84 155.85 32.7 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.358 1.463 . . . . 0.0 109.659 167.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.0 pt -136.18 -17.4 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 125.032 1.333 . . . . 0.0 113.949 167.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -150.7 129.1 12.09 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -170.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -136.98 106.98 6.28 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -175.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.492 ' HE2' HD21 ' A' ' 126' ' ' LEU . 32.2 pttt -145.58 173.18 12.27 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.817 0.818 . . . . 0.0 112.724 169.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.52 ' O ' HD23 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -135.55 171.94 13.73 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 127.702 2.401 . . . . 0.0 109.79 173.409 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.528 HD22 ' OD1' ' A' ' 123' ' ' ASP . 14.3 mt -138.85 151.61 47.13 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.7 p -129.93 138.68 53.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 . . . . . 0 N--CA 1.446 -0.64 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -178.877 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.528 ' OD1' HD22 ' A' ' 111' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.468 0.469 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' A' ' 123' ' ' ASP . 3.5 mm? -90.07 78.58 6.64 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -116.32 58.36 0.75 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.046 1.739 . . . . 0.0 109.25 -172.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.492 HD21 ' HE2' ' A' ' 109' ' ' LYS . 63.5 mt -124.83 107.95 11.43 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -177.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -132.54 81.92 1.98 Allowed 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -175.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -70.81 132.17 44.91 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 165.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.429 ' HA ' ' CB ' ' A' ' 74' ' ' GLU . 8.0 p-10 . . . . . 0 C--O 1.25 1.105 0 C-N-CA 128.315 2.646 . . . . 0.0 109.093 174.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.438 ' N ' ' HE2' ' A' ' 71' ' ' LYS . . . . . . . . 0 CA--C 1.528 0.877 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -148.13 -164.14 1.94 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.205 1.802 . . . . 0.0 111.163 -162.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.4 mtp -120.87 163.67 17.83 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 125.584 1.554 . . . . 0.0 108.101 147.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -143.13 143.87 31.99 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 125.91 2.006 . . . . 0.0 110.845 -178.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -150.65 145.09 25.63 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.939 1.696 . . . . 0.0 107.355 174.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.47 144.5 32.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 126.657 1.983 . . . . 0.0 107.936 176.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.7 127.98 54.95 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 167.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 tp -100.29 154.15 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 163.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.664 ' CD ' ' H ' ' A' ' 96' ' ' VAL . 0.0 OUTLIER -152.83 -174.63 4.99 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 127.801 2.44 . . . . 0.0 106.941 176.941 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -148.27 166.32 28.35 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 168.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -141.81 165.85 26.33 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 124.141 0.976 . . . . 0.0 110.381 171.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.69 -147.66 39.9 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -75.22 111.91 10.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.394 0.616 . . . . 0.0 110.274 177.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -113.15 33.38 5.11 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.32 1.048 . . . . 0.0 109.679 173.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -124.95 0.5 7.97 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.435 1.494 . . . . 0.0 110.363 -166.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.11 28.67 0.59 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.182 1.393 . . . . 0.0 112.837 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -122.64 116.7 24.26 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 120.72 -1.238 . . . . 0.0 107.773 172.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.7 mm -65.63 121.97 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 175.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -90.69 160.65 15.74 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.155 0.982 . . . . 0.0 110.345 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.4 m -152.48 136.69 16.57 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.373 1.869 . . . . 0.0 107.569 158.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.3 t -137.84 147.18 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 170.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.52 HG22 HD12 ' A' ' 53' ' ' ILE . 82.1 t -117.19 128.21 74.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 126.874 2.069 . . . . 0.0 105.851 170.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.33 147.63 19.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 167.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.9 t -128.69 147.73 33.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 170.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.76 91.75 1.91 Allowed 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 173.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -65.06 127.28 30.98 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 172.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.69 -14.66 19.89 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-O 118.735 -1.036 . . . . 0.0 114.503 153.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 t -161.07 -168.49 2.07 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -101.44 160.86 14.07 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.797 0.839 . . . . 0.0 111.302 173.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 tp -74.86 165.23 25.58 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 170.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -133.67 129.96 37.54 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 171.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.425 ' HA ' HD23 ' A' ' 66' ' ' LEU . 5.9 t70 -84.01 129.51 34.91 Favored 'General case' 0 CA--C 1.52 -0.211 0 O-C-N 123.719 0.637 . . . . 0.0 109.545 175.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.47 -23.16 70.13 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 118.107 -1.385 . . . . 0.0 112.986 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.72 -61.25 2.56 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.019 1.41 . . . . 0.0 111.116 -176.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.03 10.84 7.61 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.139 0.975 . . . . 0.0 111.029 -177.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.24 23.99 77.47 Favored Glycine 0 N--CA 1.446 -0.639 0 O-C-N 121.141 -0.974 . . . . 0.0 111.544 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -74.98 125.35 28.71 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -171.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.2 m -64.42 129.27 39.24 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 165.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 34.2 mt -107.42 -164.18 0.96 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.801 1.64 . . . . 0.0 108.247 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.67 98.26 3.37 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.693 -0.63 . . . . 0.0 110.55 173.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.425 ' HA ' HG23 ' A' ' 52' ' ' VAL . 4.5 m -73.48 168.37 26.09 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 122.705 0.402 . . . . 0.0 111.798 177.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -61.26 149.27 52.92 Favored 'Cis proline' 0 CA--C 1.538 0.691 0 N-CA-C 110.366 -0.667 . . . . 0.0 110.366 -16.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.425 HG23 ' HA ' ' A' ' 50' ' ' SER . 12.6 t -127.48 151.48 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.52 HD12 HG22 ' A' ' 31' ' ' VAL . 18.0 mm -113.95 132.52 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 169.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.9 153.93 21.27 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 122.293 1.044 . . . . 0.0 108.899 170.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.72 -177.94 4.58 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.822 2.449 . . . . 0.0 107.601 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -61.19 -43.95 98.07 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -172.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -62.35 -31.26 71.88 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 123.546 0.738 . . . . 0.0 110.8 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -83.21 -17.98 40.9 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 118.755 -0.64 . . . . 0.0 110.202 -173.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 mt -114.25 6.09 16.06 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.897 1.679 . . . . 0.0 113.921 -168.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.57 34.21 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 128.429 2.692 . . . . 0.0 114.428 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.5 m -100.94 175.38 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 127.777 2.431 . . . . 0.0 110.346 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -95.3 -31.01 13.66 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 118.394 -0.812 . . . . 0.0 111.672 164.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 18' ' ' GLU . 71.7 tttt -157.43 139.12 14.02 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 125.223 1.409 . . . . 0.0 109.189 176.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.0 t -135.73 130.65 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 119.415 1.007 . . . . 0.0 108.53 162.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.8 m -78.27 138.54 38.66 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 121.079 -1.013 . . . . 0.0 108.418 158.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 41' ' ' ASP . 77.8 mt -125.51 137.82 53.96 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 167.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.93 -174.59 4.12 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -172.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.83 146.68 37.24 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.329 1.061 . . . . 0.0 110.932 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.3 p -73.59 -22.91 59.9 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.136 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.21 -165.22 13.89 Favored Glycine 0 N--CA 1.449 -0.497 0 O-C-N 121.192 -0.943 . . . . 0.0 110.798 -170.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.438 ' HE2' ' N ' ' A' ' 10' ' ' GLY . 47.7 tttt -57.86 135.81 56.91 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 168.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -137.03 161.47 35.97 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 174.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.34 -7.94 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 123.51 0.724 . . . . 0.0 109.945 -164.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -144.67 150.63 37.67 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -137.56 156.33 48.22 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 155.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -158.13 152.41 24.38 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 121.014 -1.054 . . . . 0.0 108.785 174.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.8 t -142.39 106.32 1.37 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.2 t -116.39 169.48 9.28 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.734 1.214 . . . . 0.0 107.888 156.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.22 -165.3 30.32 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 125.173 1.368 . . . . 0.0 110.277 -172.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.54 175.48 38.11 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 108.088 -2.005 . . . . 0.0 108.088 172.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 C--O 1.235 0.339 0 C-N-CA 124.296 1.038 . . . . 0.0 108.446 169.243 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.538 0.495 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -84.37 -177.0 2.77 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.564 2.842 . . . . 0.0 111.954 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.5 ptp -141.67 163.46 32.85 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 172.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -138.99 150.19 45.56 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 126.018 1.727 . . . . 0.0 108.976 173.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 20.7 m0 -125.3 151.05 46.51 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.547 1.539 . . . . 0.0 108.689 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.664 ' H ' ' CD ' ' A' ' 18' ' ' GLU . 13.7 p -136.45 81.04 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 126.85 2.06 . . . . 0.0 108.766 169.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 p -83.98 89.12 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.64 145.29 31.74 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 176.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.99 140.66 46.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -126.7 145.6 50.52 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 128.417 2.687 . . . . 0.0 107.883 -172.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.54 -174.69 2.51 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.03 1.332 . . . . 0.0 107.553 170.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -52.32 69.09 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.708 2.803 . . . . 0.0 113.053 176.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.53 -15.96 3.6 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 115.957 -2.58 . . . . 0.0 116.326 171.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.54 177.79 0.18 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 121.714 2.757 . . . . 0.0 111.918 175.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -50.99 150.81 2.85 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 128.724 2.81 . . . . 0.0 110.913 175.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.47 -20.44 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.638 1.175 . . . . 0.0 111.572 162.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -152.65 151.79 31.0 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 120.315 1.416 . . . . 0.0 110.739 -170.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -141.17 22.69 2.22 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 125.494 1.518 . . . . 0.0 112.842 -161.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.412 ' HE3' HD13 ' A' ' 126' ' ' LEU . 1.7 ttpm? -60.95 142.54 56.38 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.612 0.72 . . . . 0.0 110.106 -175.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.439 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -155.07 137.57 15.06 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 125.258 1.423 . . . . 0.0 109.703 -163.968 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.548 ' N ' HD12 ' A' ' 111' ' ' LEU . 2.2 mp -126.85 177.87 6.31 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 123.413 1.578 . . . . 0.0 108.462 -166.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.2 p -149.93 146.8 16.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-N 111.438 -2.619 . . . . 0.0 110.945 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 . . . . . 0 C--O 1.234 0.243 0 C-N-CA 126.571 1.948 . . . . 0.0 107.237 169.128 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -120.93 120.7 36.24 Favored 'General case' 0 CA--C 1.517 -0.288 0 O-C-N 120.691 -1.256 . . . . 0.0 107.79 173.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -150.68 72.09 1.07 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 125.671 1.589 . . . . 0.0 110.522 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.412 HD13 ' HE3' ' A' ' 109' ' ' LYS . 4.5 mp -119.08 154.22 33.54 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.761 1.224 . . . . 0.0 110.727 178.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -145.83 148.89 33.38 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.31 2.244 . . . . 0.0 109.172 175.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -141.26 142.53 33.9 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.195 2.198 . . . . 0.0 107.813 177.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.5 p30 . . . . . 0 C--O 1.258 1.535 0 C-N-CA 128.202 2.601 . . . . 0.0 107.047 170.512 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.705 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 73.27 -80.85 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 126.663 1.985 . . . . 0.0 107.534 -170.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -164.47 155.18 14.88 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.139 1.776 . . . . 0.0 106.731 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -125.36 171.09 10.71 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 127.552 2.341 . . . . 0.0 109.282 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -154.8 85.57 3.61 Favored Pre-proline 0 N--CA 1.448 -0.554 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 -159.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.02 165.12 26.59 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.055 1.837 . . . . 0.0 109.926 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 121.21 110.88 2.19 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 -174.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 106.19 -176.91 22.12 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 123.935 0.779 . . . . 0.0 111.86 162.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -134.46 165.95 23.99 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 124.947 1.299 . . . . 0.0 108.83 -167.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.514 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . 158.7 -154.18 25.28 Favored Glycine 0 C--N 1.313 -0.697 0 C-N-CA 130.207 3.765 . . . . 0.0 107.37 175.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.52 -162.49 1.32 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.037 1.735 . . . . 0.0 110.329 -164.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 33.5 mtp -128.59 165.08 21.48 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 128.551 2.741 . . . . 0.0 105.069 156.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -146.78 154.92 41.95 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.512 1.125 . . . . 0.0 110.733 177.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -146.62 120.96 9.6 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.744 2.018 . . . . 0.0 107.773 174.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.1 p -99.67 151.86 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.963 1.305 . . . . 0.0 109.465 170.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.415 HG23 HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -125.91 154.18 43.15 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.108 0.963 . . . . 0.0 110.089 168.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 tp -139.42 111.81 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 C-N-CA 126.034 1.734 . . . . 0.0 107.209 172.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.64 150.76 20.0 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 159.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -128.86 106.88 9.21 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.396 1.878 . . . . 0.0 107.524 -168.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 m -113.14 167.8 10.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.85 -172.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.6 -150.64 41.63 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -172.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -87.21 34.4 0.69 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -158.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -58.55 -6.09 0.65 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -165.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 54.5 mtt-85 -86.29 0.78 53.09 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.34 1.456 . . . . 0.0 113.424 -167.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.9 m -135.92 32.41 2.95 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.72 1.608 . . . . 0.0 110.149 -174.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.519 ' HB3' HG21 ' A' ' 81' ' ' VAL . 18.0 m-85 -143.27 102.33 3.96 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.867 1.267 . . . . 0.0 109.964 -166.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.1 mm -69.21 96.88 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 125.455 1.502 . . . . 0.0 110.732 -170.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? -110.39 160.79 16.27 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.441 1.096 . . . . 0.0 112.052 -164.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.2 m -145.52 126.29 14.35 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.271 0.628 . . . . 0.0 110.957 -158.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.4 t -135.64 155.74 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.218 1.007 . . . . 0.0 110.11 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 p -119.4 154.6 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 128.924 2.89 . . . . 0.0 107.964 173.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.474 HG11 HD21 ' A' ' 39' ' ' LEU . 1.7 t -145.61 127.25 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 168.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.2 t -127.79 125.5 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.17 112.17 17.37 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.107 0.963 . . . . 0.0 109.826 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -74.51 128.08 34.66 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.687 1.195 . . . . 0.0 108.902 170.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.41 1.08 74.55 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 115.698 1.039 . . . . 0.0 115.698 163.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -153.44 175.87 12.67 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 119.002 1.401 . . . . 0.0 110.387 175.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -100.0 161.01 13.88 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.675 1.19 . . . . 0.0 109.432 174.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.474 HD21 HG11 ' A' ' 32' ' ' VAL . 2.5 tp -89.9 171.62 9.46 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.31 0.644 . . . . 0.0 109.657 -178.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.405 ' HE2' ' HA2' ' A' ' 45' ' ' GLY . 82.4 tttt -137.74 139.54 40.17 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.101 0.96 . . . . 0.0 108.738 173.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -93.82 128.56 40.13 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.978 1.711 . . . . 0.0 109.986 -173.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.04 -21.59 76.96 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.811 -0.994 . . . . 0.0 114.277 -174.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.11 78.68 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.436 1.118 . . . . 0.0 112.03 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.3 p -145.56 -28.58 0.44 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.993 1.317 . . . . 0.0 111.511 -159.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.405 ' HA2' ' HE2' ' A' ' 40' ' ' LYS . . . 88.28 13.93 62.94 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.374 1.464 . . . . 0.0 112.888 -175.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -62.73 138.0 58.4 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.139 1.376 . . . . 0.0 107.296 171.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.1 m -68.7 150.78 47.52 Favored 'General case' 0 N--CA 1.426 -1.669 0 C-N-CA 125.804 1.642 . . . . 0.0 110.411 165.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.2 mt -136.32 142.05 43.84 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.315 1.046 . . . . 0.0 110.725 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.78 78.01 4.29 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.46 1.104 . . . . 0.0 111.144 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 p -54.68 156.28 6.65 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.171 0.988 . . . . 0.0 110.888 168.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -79.64 146.73 76.79 Favored 'Cis proline' 0 CA--C 1.537 0.639 0 CA-C-N 119.355 0.805 . . . . 0.0 111.69 2.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.8 t -140.26 159.14 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.63 1.172 . . . . 0.0 110.263 -171.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.1 mm -119.85 142.33 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 C-N-CA 129.023 2.929 . . . . 0.0 105.44 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -108.42 128.1 54.48 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 171.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.1 m -94.29 173.65 7.53 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.397 1.479 . . . . 0.0 109.404 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.2 -36.1 76.89 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -169.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -63.35 -36.94 85.37 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.593 0.757 . . . . 0.0 111.019 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -75.68 -36.77 59.98 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.8 mt -86.53 24.54 1.4 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.339 2.256 . . . . 0.0 110.73 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.16 -4.88 58.68 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.023 0.929 . . . . 0.0 112.618 174.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.1 m -82.76 163.22 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 118.807 0.73 . . . . 0.0 110.475 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -62.11 -34.85 77.11 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.542 1.137 . . . . 0.0 112.277 173.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -152.25 139.22 19.08 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -172.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -118.74 152.4 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 161.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.415 HG23 HG23 ' A' ' 16' ' ' THR . 19.7 m -129.82 131.29 46.1 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 103.512 -2.773 . . . . 0.0 103.512 164.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.0 mp -132.3 144.71 50.77 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 170.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.61 -173.05 3.67 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.098 -165.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 p -120.61 138.12 54.07 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.704 0.801 . . . . 0.0 110.917 -171.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 68.5 p -78.94 -12.0 60.02 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -168.32 -157.17 10.94 Favored Glycine 0 N--CA 1.447 -0.605 0 O-C-N 120.475 -1.39 . . . . 0.0 110.597 -167.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.514 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -73.36 91.68 1.76 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.39 1.476 . . . . 0.0 109.506 -168.356 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.91 155.52 21.64 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.831 1.252 . . . . 0.0 108.44 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.0 -5.88 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.867 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -148.92 159.19 44.42 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 119.726 1.148 . . . . 0.0 109.308 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.16 143.09 49.73 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 125.054 1.471 . . . . 0.0 107.831 151.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.27 129.3 27.09 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 166.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.2 t -139.85 100.59 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -168.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.2 t -120.11 158.8 26.13 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 178.08 171.53 41.55 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-O 121.571 0.539 . . . . 0.0 112.695 172.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.35 -172.67 40.44 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.971 1.748 . . . . 0.0 109.425 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.561 HG22 ' H ' ' A' ' 82' ' ' VAL . 6.2 p -146.67 -174.94 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 124.548 1.139 . . . . 0.0 109.196 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.561 ' H ' HG22 ' A' ' 81' ' ' VAL . 25.3 m -133.81 -164.75 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 126.089 1.756 . . . . 0.0 109.675 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -148.57 100.51 3.13 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 160.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -151.1 22.22 0.98 Allowed Glycine 0 C--O 1.228 -0.266 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -170.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -82.19 57.45 3.58 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 122.771 1.272 . . . . 0.0 110.022 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.8 t0 45.42 36.32 2.35 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.309 2.244 . . . . 0.0 112.17 -173.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.22 14.59 78.64 Favored Glycine 0 C--N 1.337 0.587 0 CA-C-O 118.455 -1.192 . . . . 0.0 113.461 171.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.9 p -58.0 131.34 21.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 120.028 1.914 . . . . 0.0 109.117 173.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.7 t -90.71 138.05 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 171.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -145.04 -154.69 0.55 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.877 2.471 . . . . 0.0 106.341 -177.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -111.21 165.46 12.69 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 124.994 1.318 . . . . 0.0 108.743 168.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.79 -179.54 4.31 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 121.866 1.711 . . . . 0.0 113.618 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.8 ptm -138.01 174.3 10.72 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.945 0.898 . . . . 0.0 111.115 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -141.86 162.17 36.14 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.723 1.209 . . . . 0.0 109.729 175.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -128.47 108.64 10.71 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 126.485 1.914 . . . . 0.0 106.543 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.4 t -96.69 109.44 23.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.2 m -131.37 135.34 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.555 1.142 . . . . 0.0 109.25 -162.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.5 m -143.1 155.68 44.64 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -171.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.25 130.37 54.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -121.52 160.8 23.49 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 127.196 2.198 . . . . 0.0 109.396 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.43 -161.13 0.74 Allowed 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 127.334 2.254 . . . . 0.0 108.981 -172.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -62.83 20.84 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.386 1.874 . . . . 0.0 112.992 162.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 133.03 46.35 0.11 Allowed Glycine 0 C--N 1.34 0.759 0 O-C-N 120.187 -1.571 . . . . 0.0 113.725 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.403 ' HE2' ' O ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -170.3 154.92 5.02 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 125.769 1.627 . . . . 0.0 108.497 160.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.403 ' O ' ' HE2' ' A' ' 104' ' ' LYS . 33.7 tt0 -72.71 146.86 46.18 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.481 1.113 . . . . 0.0 108.271 165.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.32 -29.86 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 117.981 -1.009 . . . . 0.0 111.617 170.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -131.64 147.18 52.5 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 120.395 1.452 . . . . 0.0 109.278 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.6 ptmm? -148.99 91.1 1.82 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 -164.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -129.05 171.41 12.4 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 123.564 1.65 . . . . 0.0 111.762 -168.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.4 t -148.11 165.74 29.93 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 111.963 -2.38 . . . . 0.0 105.252 162.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.5 mt -144.06 160.58 40.63 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.902 2.081 . . . . 0.0 108.045 168.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 p -126.35 123.16 62.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 125.426 1.491 . . . . 0.0 108.205 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.426 ' CD1' HG12 ' A' ' 81' ' ' VAL . 95.0 m-85 -111.64 147.48 35.42 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 175.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.9 mtm105 -141.17 166.66 24.18 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.186 0.517 . . . . 0.0 110.932 -176.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -65.5 169.8 5.67 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 125.535 1.534 . . . . 0.0 111.873 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 151.2 -78.21 0.22 Allowed Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt -171.8 171.72 5.1 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 127.141 2.176 . . . . 0.0 110.069 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -51.14 138.78 19.51 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.661 1.985 . . . . 0.0 110.771 166.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.2 pp -154.12 -178.02 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 127.784 2.434 . . . . 0.0 107.312 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.6 p -133.47 103.63 6.02 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.106 1.762 . . . . 0.0 107.019 173.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 25.6 p -127.49 117.79 22.77 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.13 66.28 0.27 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 158.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -72.45 -28.43 62.93 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.347 -0.846 . . . . 0.0 111.474 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 16.2 tp -111.08 131.18 55.29 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 165.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.13 36.42 0.68 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.062 1.745 . . . . 0.0 110.935 -168.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.8 mt -83.65 155.15 23.33 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.293 1.037 . . . . 0.0 110.985 -171.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -160.36 156.79 26.79 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 126.674 1.989 . . . . 0.0 111.635 169.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -151.52 160.49 43.67 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 127.288 2.235 . . . . 0.0 110.04 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.4 p30 . . . . . 0 C--O 1.245 0.866 0 C-N-CA 123.288 0.635 . . . . 0.0 110.384 161.694 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.671 0 N-CA-C 104.729 -3.348 . . . . 0.0 104.729 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -140.64 60.01 1.54 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 103.194 -2.891 . . . . 0.0 103.194 -148.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -143.87 156.03 44.31 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.689 2.395 . . . . 0.0 104.545 -142.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -138.74 121.74 16.71 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 125.177 1.391 . . . . 0.0 111.797 -163.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.39 60.46 3.14 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 124.835 1.254 . . . . 0.0 111.383 -171.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -69.73 97.97 0.66 Allowed 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 121.601 1.534 . . . . 0.0 112.837 -172.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.1 13.42 58.79 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.522 -0.763 . . . . 0.0 114.187 -176.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -130.27 -49.67 0.12 Allowed Glycine 0 CA--C 1.526 0.739 0 CA-C-N 119.286 1.543 . . . . 0.0 113.368 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.6 mttt -124.09 109.77 13.89 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -163.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.38 84.08 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 CA-C-O 119.021 -0.877 . . . . 0.0 112.736 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -118.09 128.67 54.97 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 160.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.419 ' H ' ' HB3' ' A' ' 102' ' ' ASN . 17.2 mtp -78.9 160.53 27.24 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 147.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -132.97 146.32 51.67 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 170.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -148.7 121.41 8.64 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.847 1.259 . . . . 0.0 107.713 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.3 p -101.49 151.16 5.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 125.351 1.46 . . . . 0.0 108.146 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.0 p -123.68 162.74 22.48 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 122.702 1.239 . . . . 0.0 109.448 165.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.487 HD11 ' CG ' ' A' ' 95' ' ' TRP . 6.0 tp -133.0 144.64 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 159.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -134.69 98.31 4.02 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 103.803 -2.666 . . . . 0.0 103.803 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -81.29 108.7 15.14 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -133.95 164.86 26.34 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 118.688 0.676 . . . . 0.0 112.469 172.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.76 -176.37 11.3 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -145.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -75.83 120.79 21.67 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.357 -1.084 . . . . 0.0 110.906 -168.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -109.78 19.08 19.52 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 120.049 1.295 . . . . 0.0 112.269 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -81.61 -10.54 59.4 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -172.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.4 p -128.14 25.86 5.82 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.757 1.623 . . . . 0.0 113.721 -169.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -125.62 168.18 14.07 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 119.312 -2.118 . . . . 0.0 110.076 -165.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.7 mp -120.62 89.01 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.516 ' HB3' HD13 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -71.67 147.26 47.65 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 120.971 -1.081 . . . . 0.0 109.55 -179.436 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.28 129.16 17.36 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.665 1.986 . . . . 0.0 105.909 170.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.8 t -131.15 126.5 59.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 160.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -91.85 130.07 41.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 167.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.264 12.6 p -134.27 150.67 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 120.243 1.383 . . . . 0.0 110.509 167.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.41 HG22 ' HB3' ' A' ' 51' ' ' PRO . 83.8 t -135.18 158.83 41.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 127.728 2.411 . . . . 0.0 104.524 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.73 127.77 20.75 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 156.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -77.85 115.8 17.87 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 171.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.02 -9.76 22.99 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 118.452 -1.193 . . . . 0.0 115.309 159.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.5 t -157.07 -173.15 4.31 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.252 1.526 . . . . 0.0 110.219 -176.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -96.2 177.03 5.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.882 1.273 . . . . 0.0 110.277 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -117.33 161.94 18.72 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 127.122 2.169 . . . . 0.0 107.897 -169.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -139.03 128.51 24.38 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -170.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -80.46 113.78 18.89 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.12 9.02 58.91 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.056 -0.858 . . . . 0.0 113.578 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.36 -64.44 0.92 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 119.664 1.732 . . . . 0.0 108.267 157.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.85 -20.12 3.2 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.31 0.644 . . . . 0.0 111.852 -156.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.98 46.83 2.36 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 124.692 1.139 . . . . 0.0 110.96 175.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -100.32 132.21 45.82 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 p -76.75 131.18 38.59 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.3 mt -121.63 168.63 11.55 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 126.464 1.905 . . . . 0.0 108.983 -176.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -123.47 109.57 14.0 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.652 1.981 . . . . 0.0 107.985 -167.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.8 165.11 28.03 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -174.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.41 ' HB3' HG22 ' A' ' 33' ' ' VAL . 64.1 Cg_endo -70.45 172.25 52.59 Favored 'Cis proline' 0 C--N 1.348 0.546 0 C-N-CA 124.694 -0.961 . . . . 0.0 110.027 -18.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.4 p -148.86 148.16 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 121.482 0.658 . . . . 0.0 109.77 -174.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.4 mm -116.74 112.27 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 104.767 -2.309 . . . . 0.0 104.767 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -76.34 99.86 4.95 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 162.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 75.6 m -91.7 -175.62 4.22 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 173.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -63.04 -24.92 68.14 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -166.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -64.93 -47.59 77.16 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.192 1.397 . . . . 0.0 109.878 173.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -74.11 -13.74 60.87 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.168 0.987 . . . . 0.0 111.027 -174.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.516 HD13 ' HB3' ' A' ' 28' ' ' LYS . 14.0 mt -116.79 19.55 14.4 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.991 1.716 . . . . 0.0 111.048 -175.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.73 13.54 0.36 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.006 1.722 . . . . 0.0 113.418 174.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.6 HG23 HG22 ' A' ' 64' ' ' VAL . 0.9 OUTLIER -131.29 160.17 42.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 127.338 2.255 . . . . 0.0 109.257 -162.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.79 -32.1 73.5 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.975 0.91 . . . . 0.0 113.032 -176.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -163.94 121.16 1.74 Allowed 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -158.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.6 HG22 HG23 ' A' ' 61' ' ' VAL . 1.8 t -132.1 93.17 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -170.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.3 m -82.35 130.2 35.05 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 175.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -130.95 146.48 52.37 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 176.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.4 t -145.75 171.46 14.73 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.342 0.657 . . . . 0.0 110.114 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.5 p -79.14 165.45 23.31 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.493 0.664 . . . . 0.0 110.165 168.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 61.1 p -89.85 1.17 56.51 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.522 -0.736 . . . . 0.0 111.439 166.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -172.53 -163.52 26.49 Favored Glycine 0 N--CA 1.444 -0.794 0 O-C-N 120.926 -1.109 . . . . 0.0 113.806 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.34 119.3 3.95 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 128.47 2.708 . . . . 0.0 109.663 171.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.494 ' C ' HD13 ' A' ' 73' ' ' ILE . . . -125.38 167.15 15.35 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.465 0.706 . . . . 0.0 110.455 175.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.494 HD13 ' C ' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -125.71 -3.06 5.32 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 C-N-CA 124.354 1.062 . . . . 0.0 110.861 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 129' ' ' ASN . 60.9 mt-10 -151.52 162.71 40.5 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 119.736 1.153 . . . . 0.0 109.823 171.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -161.47 72.3 0.41 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.347 1.459 . . . . 0.0 109.108 176.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.27 144.09 55.0 Favored 'General case' 0 C--N 1.333 -0.144 0 O-C-N 121.735 -0.603 . . . . 0.0 110.198 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 64.9 t -142.06 114.04 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 126.643 1.977 . . . . 0.0 106.526 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.9 m -129.13 158.85 37.82 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.003 0.921 . . . . 0.0 108.649 171.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 154.08 -172.44 32.72 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-N 118.569 0.622 . . . . 0.0 111.777 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.75 173.4 41.43 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.355 1.455 . . . . 0.0 111.375 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -147.92 134.34 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.345 1.458 . . . . 0.0 110.651 172.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.419 HG21 HG13 ' A' ' 119' ' ' ILE . 0.6 OUTLIER -141.23 155.06 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 126.342 1.857 . . . . 0.0 110.387 159.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -53.91 121.87 8.88 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 127.907 2.483 . . . . 0.0 108.133 -174.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.83 -4.72 85.92 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 118.47 -1.183 . . . . 0.0 113.61 -173.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -135.38 172.26 13.26 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.184 1.492 . . . . 0.0 112.115 -162.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -138.32 32.52 2.33 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 127.28 2.232 . . . . 0.0 108.908 -175.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -151.24 -6.02 0.16 Allowed Glycine 0 CA--C 1.52 0.35 0 CA-C-O 118.375 -1.236 . . . . 0.0 113.822 -170.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.4 t -129.81 83.41 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 CA-C-N 120.023 1.912 . . . . 0.0 106.773 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.8 t -59.96 98.96 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.796 1.238 . . . . 0.0 107.738 176.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -112.98 161.29 17.2 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 126.872 2.069 . . . . 0.0 109.841 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -74.32 152.1 87.9 Favored Pre-proline 0 C--O 1.224 -0.255 0 CA-C-O 118.77 -0.633 . . . . 0.0 109.453 169.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -81.65 -179.35 4.82 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.342 2.028 . . . . 0.0 113.985 -172.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 6.5 ptm -133.82 168.6 18.45 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.221 1.01 . . . . 0.0 111.786 -166.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -140.56 153.51 46.16 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 126.702 2.001 . . . . 0.0 107.443 170.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.487 ' CG ' HD11 ' A' ' 17' ' ' ILE . 3.9 m0 -116.17 114.61 24.69 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 103.943 -2.614 . . . . 0.0 103.943 172.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.9 t -94.23 127.02 46.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 164.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 m -139.26 94.02 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 -163.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.7 m -95.57 164.94 12.58 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.8 t -135.61 122.86 35.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 164.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -96.05 156.81 16.18 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 125.93 1.692 . . . . 0.0 107.744 168.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -108.72 -162.48 0.82 Allowed 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.505 1.922 . . . . 0.0 106.956 171.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.419 ' HB3' ' H ' ' A' ' 12' ' ' MET . 9.7 p-10 -63.02 82.83 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.268 1.827 . . . . 0.0 109.396 170.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.34 16.31 59.13 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.459 1.504 . . . . 0.0 115.146 167.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -153.35 168.92 24.42 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.633 1.717 . . . . 0.0 111.368 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -97.91 135.25 39.9 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.426 1.491 . . . . 0.0 108.823 176.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.21 -14.52 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.72 1.145 . . . . 0.0 113.859 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -129.9 153.42 48.34 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 173.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.9 tttm -160.39 78.77 0.65 Allowed 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.4 169.4 11.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.566 0.698 . . . . 0.0 110.435 177.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.4 t -156.84 155.24 31.16 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.628 ' N ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -131.03 -174.56 3.41 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 125.906 1.682 . . . . 0.0 107.078 179.461 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.4 p -167.87 119.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 126.308 1.843 . . . . 0.0 108.515 -158.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.411 ' CE2' HD11 ' A' ' 119' ' ' ILE . 0.3 OUTLIER -143.4 167.96 20.95 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.555 -0.716 . . . . 0.0 110.353 171.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -144.26 173.83 11.42 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.23 1.412 . . . . 0.0 108.704 -173.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.26 141.6 4.51 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 126.949 2.1 . . . . 0.0 111.233 164.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 108.6 8.66 28.17 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-O 118.525 -1.153 . . . . 0.0 115.331 157.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -138.63 93.22 2.7 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 119.651 1.725 . . . . 0.0 111.715 -174.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -64.34 100.12 0.33 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.779 0.832 . . . . 0.0 111.624 169.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.419 HG13 HG21 ' A' ' 82' ' ' VAL . 2.5 pp -145.57 174.58 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 128.105 2.562 . . . . 0.0 107.696 -178.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -168.78 7.24 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 168.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.0 p -135.78 30.47 3.11 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 125.097 1.359 . . . . 0.0 110.396 -166.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -153.12 56.94 0.78 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.39 -83.37 0.37 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -177.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 mt -113.15 128.02 56.36 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.304 1.042 . . . . 0.0 111.598 -175.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -139.75 82.84 1.9 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 128.473 2.709 . . . . 0.0 106.6 174.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.2 mp -120.01 128.57 53.66 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.854 1.262 . . . . 0.0 107.875 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.5 72.34 1.38 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -176.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -74.6 150.09 39.81 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.284 175.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 31.8 p-10 . . . . . 0 C--O 1.257 1.466 0 C-N-CA 126.738 2.015 . . . . 0.0 109.989 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.676 0 N-CA-C 108.033 -2.027 . . . . 0.0 108.033 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.0 t70 74.19 108.82 0.07 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 104.017 -2.586 . . . . 0.0 104.017 -131.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -143.53 154.26 43.44 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 -157.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -145.7 155.77 43.2 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 125.858 1.663 . . . . 0.0 107.755 -158.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -157.15 86.6 2.76 Favored Pre-proline 0 C--O 1.237 0.412 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -64.46 149.15 90.51 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 120.693 0.929 . . . . 0.0 109.898 173.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 162.33 62.45 0.02 OUTLIER Glycine 0 C--N 1.333 0.373 0 N-CA-C 115.949 1.14 . . . . 0.0 115.949 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.68 -102.77 0.18 Allowed Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 164.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -162.97 154.32 17.44 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.026 1.731 . . . . 0.0 107.207 -175.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.66 -147.0 4.96 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.384 1.945 . . . . 0.0 109.28 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.97 177.55 9.05 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.062 1.431 . . . . 0.0 111.335 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.11 150.96 21.83 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.366 1.866 . . . . 0.0 108.723 157.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.52 ' HE1' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -157.44 134.69 10.34 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 128.428 2.691 . . . . 0.0 109.664 178.339 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -127.33 137.58 52.83 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 128.199 2.599 . . . . 0.0 104.96 169.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.1 p -110.16 150.14 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 165.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.0 p -124.03 159.53 29.66 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 164.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 tp -129.1 135.23 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 C-N-CA 127.94 2.496 . . . . 0.0 105.645 168.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -111.03 138.7 47.11 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 155.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -121.67 116.53 24.72 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 m -143.76 171.76 13.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 118.335 0.516 . . . . 0.0 110.985 -172.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.71 -95.18 2.07 Favored Glycine 0 C--N 1.334 0.453 0 N-CA-C 105.066 -3.214 . . . . 0.0 105.066 -164.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -142.19 173.33 11.62 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.495 1.518 . . . . 0.0 107.448 165.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -157.71 8.33 0.16 Allowed 'General case' 0 C--N 1.328 -0.361 0 O-C-N 120.852 -1.155 . . . . 0.0 112.173 169.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -54.95 -41.74 71.48 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.478 1.111 . . . . 0.0 113.297 -172.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 m -128.37 51.89 1.95 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.623 1.169 . . . . 0.0 109.788 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.414 ' HB3' HG21 ' A' ' 81' ' ' VAL . 28.4 m-85 -122.85 107.97 12.47 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -176.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 51.3 mt -73.22 88.64 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 125.515 1.526 . . . . 0.0 108.481 -168.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.4 pttm -112.41 125.32 54.08 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.414 1.485 . . . . 0.0 110.351 -166.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.6 m -127.95 159.7 34.15 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.728 1.211 . . . . 0.0 109.317 168.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 85.8 t -140.45 133.68 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.4 t -84.88 135.79 24.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 125.731 1.612 . . . . 0.0 107.196 169.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.6 t -136.58 128.26 43.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 168.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.3 t -138.65 119.4 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.96 156.22 36.77 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 167.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -118.83 119.49 34.52 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.737 1.615 . . . . 0.0 109.613 -175.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.24 -6.81 56.27 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.769 1.176 . . . . 0.0 114.857 161.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.407 ' CG2' ' HB2' ' A' ' 72' ' ' ALA . 14.7 t -140.67 -164.14 1.67 Allowed 'General case' 0 C--O 1.242 0.695 0 C-N-CA 126.548 1.939 . . . . 0.0 107.813 -176.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -122.05 177.49 5.3 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 120.904 -1.123 . . . . 0.0 109.308 174.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.83 167.58 10.38 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 125.038 1.335 . . . . 0.0 109.013 -173.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -136.67 114.12 10.92 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.225 1.01 . . . . 0.0 108.53 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -69.23 127.05 31.69 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.62 -22.43 69.82 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-O 118.226 -1.319 . . . . 0.0 113.85 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.07 -51.7 68.59 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 119.505 1.653 . . . . 0.0 110.322 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.81 -9.35 1.6 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.955 0.902 . . . . 0.0 111.552 -160.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.6 13.22 80.51 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.262 0.934 . . . . 0.0 112.506 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -55.1 123.56 14.04 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.901 1.681 . . . . 0.0 108.699 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.83 104.35 12.14 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.8 mt -85.7 163.16 18.41 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.699 0.8 . . . . 0.0 109.483 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.95 109.92 17.64 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.604 1.962 . . . . 0.0 106.243 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 66.2 m -82.36 151.33 65.62 Favored Pre-proline 0 C--N 1.323 -0.55 0 C-N-CA 126.895 2.078 . . . . 0.0 111.913 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.61 163.87 89.43 Favored 'Cis proline' 0 CA--C 1.535 0.561 0 CA-C-N 119.13 0.725 . . . . 0.0 111.658 -1.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 p -156.61 157.87 3.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 123.607 0.763 . . . . 0.0 109.758 170.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.9 mm -116.15 116.37 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 125.896 1.678 . . . . 0.0 107.082 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.8 mt -71.94 145.29 48.54 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 165.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 m -108.59 176.77 5.0 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.24 171.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -58.39 -22.96 55.78 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.611 1.964 . . . . 0.0 112.665 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -66.18 -27.29 67.88 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.147 1.779 . . . . 0.0 112.47 175.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -100.76 -24.06 14.48 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.637 1.575 . . . . 0.0 110.463 -171.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.7 mt -97.72 15.82 22.47 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.673 1.989 . . . . 0.0 110.297 -175.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.46 14.57 0.17 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.907 1.683 . . . . 0.0 114.278 -175.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.7 m -128.03 170.91 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 126.919 2.088 . . . . 0.0 111.008 -162.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -76.36 -20.43 57.21 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.055 0.942 . . . . 0.0 112.651 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.14 133.78 16.68 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.599 1.56 . . . . 0.0 110.006 -168.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.5 t -140.04 82.37 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.415 0.626 . . . . 0.0 110.209 173.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 90.4 m -73.44 130.54 40.33 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.74 1.216 . . . . 0.0 109.436 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -132.4 129.56 39.5 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.548 1.067 . . . . 0.0 109.112 175.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.0 t -141.28 168.18 20.39 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.768 1.627 . . . . 0.0 108.481 175.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.33 153.77 18.99 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 123.961 0.904 . . . . 0.0 110.231 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.3 p -83.33 11.48 6.68 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.726 1.21 . . . . 0.0 112.063 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 173.34 -172.49 45.22 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 173.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.61 141.28 48.67 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.671 1.236 . . . . 0.0 109.165 174.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.52 ' HB3' ' HE1' ' A' ' 13' ' ' TYR . . . -124.75 178.38 5.5 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.496 1.118 . . . . 0.0 108.547 172.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.2 mm -116.13 -11.61 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.863 0.865 . . . . 0.0 111.113 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -143.89 156.2 44.36 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.366 1.066 . . . . 0.0 108.746 169.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -145.08 103.28 3.85 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 160.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.86 122.12 46.92 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.12 121.94 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 C-N-CA 127.752 2.421 . . . . 0.0 109.162 -171.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.1 t -147.56 153.16 39.1 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -169.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.76 -177.02 43.44 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 171.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.05 176.41 38.47 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 106.196 -2.762 . . . . 0.0 106.196 167.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.414 HG21 ' HB3' ' A' ' 26' ' ' PHE . 7.2 p -156.37 155.92 5.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 166.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.01 172.93 10.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 125.613 1.565 . . . . 0.0 107.635 168.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.91 136.44 47.19 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 160.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -107.2 -12.53 23.4 Favored Glycine 0 C--N 1.322 -0.214 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 170.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -93.37 162.03 14.15 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -159.69 66.69 0.38 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 173.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 160.33 -13.7 0.18 Allowed Glycine 0 CA--C 1.531 1.065 0 N-CA-C 115.474 0.95 . . . . 0.0 115.474 -167.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.0 p -122.36 136.4 59.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-N 119.782 1.791 . . . . 0.0 107.495 165.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.99 119.5 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 124.48 1.112 . . . . 0.0 108.402 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -139.36 138.36 36.53 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 171.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.75 154.46 94.3 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 119.409 -0.329 . . . . 0.0 110.117 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -84.6 -175.99 2.33 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.29 2.66 . . . . 0.0 112.792 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 19.5 ptm -148.03 176.19 10.39 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.339 -0.851 . . . . 0.0 113.254 -160.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -142.3 157.18 45.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.462 1.905 . . . . 0.0 108.39 169.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 21.9 m0 -116.23 122.07 43.91 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 162.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.274 7.1 p -116.69 103.92 15.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 168.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.0 m -97.53 168.91 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.46 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.2 m -156.2 147.37 22.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.7 t -121.46 132.04 71.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -119.31 117.01 27.42 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.868 1.667 . . . . 0.0 107.246 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.3 tptt -74.8 -164.73 0.31 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.414 1.886 . . . . 0.0 108.784 172.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.17 79.93 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.037 2.535 . . . . 0.0 108.769 173.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.16 36.77 50.33 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.178 1.371 . . . . 0.0 114.133 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -157.32 152.5 26.05 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 118.199 1.0 . . . . 0.0 109.651 164.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -77.98 140.28 39.19 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 166.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 3.0 pt -130.92 -17.43 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -148.92 144.32 26.77 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -174.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -148.14 39.27 0.91 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -174.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.04 148.52 41.88 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.683 -1.261 . . . . 0.0 111.964 -173.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.9 p -122.04 153.16 38.98 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 127.575 2.35 . . . . 0.0 109.138 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.0 mt -131.9 170.47 14.83 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.237 1.415 . . . . 0.0 109.3 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 t -146.44 146.8 18.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 124.719 1.208 . . . . 0.0 108.406 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.409 ' CE2' HG21 ' A' ' 121' ' ' THR . 12.2 m-85 -139.5 145.19 38.44 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 152.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -140.79 103.89 4.59 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 172.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 14.9 t0 58.59 -175.9 0.08 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.259 1.424 . . . . 0.0 111.405 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 137.45 -63.85 0.57 Allowed Glycine 0 CA--C 1.5 -0.902 0 C-N-CA 126.328 1.918 . . . . 0.0 109.728 160.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.19 169.79 0.22 Allowed 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 129.066 2.947 . . . . 0.0 108.059 167.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.453 ' O ' HG23 ' A' ' 119' ' ' ILE . 0.0 OUTLIER -56.32 141.72 40.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 125.168 1.387 . . . . 0.0 110.774 156.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 118' ' ' GLU . 2.1 pp -165.37 -172.83 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 129.925 3.29 . . . . 0.0 105.377 173.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.5 p -114.43 156.69 24.05 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 154.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.409 HG21 ' CE2' ' A' ' 113' ' ' PHE . 14.6 t -153.01 150.76 29.53 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -116.07 30.43 7.35 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 125.281 1.432 . . . . 0.0 108.085 -169.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -61.68 -36.19 80.16 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 128.124 2.57 . . . . 0.0 111.387 -168.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.9 tt -89.74 115.45 27.11 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 162.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -139.6 113.36 8.61 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 167.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 62.9 mt -139.62 115.2 10.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -177.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -134.2 129.7 36.13 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -141.51 163.07 33.91 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.453 1.501 . . . . 0.0 108.549 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 117.013 -1.47 . . . . 0.0 111.071 -174.418 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.212 0 N-CA-C 107.849 -2.1 . . . . 0.0 107.849 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.2 t0 61.21 90.37 0.07 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 -111.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -150.67 112.68 4.56 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 128.358 2.663 . . . . 0.0 103.962 -168.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -158.78 125.35 4.67 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 120.352 1.433 . . . . 0.0 108.249 170.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -153.82 85.38 4.0 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 127.214 2.206 . . . . 0.0 106.457 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -81.01 176.19 9.16 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.197 2.598 . . . . 0.0 110.103 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -153.7 -127.58 1.19 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 107.516 -2.234 . . . . 0.0 107.516 163.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -106.84 28.1 14.23 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-O 118.796 -1.002 . . . . 0.0 114.37 -174.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -108.74 93.97 4.8 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.932 1.366 . . . . 0.0 110.1 171.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.55 ' HA2' ' HE3' ' A' ' 71' ' ' LYS . . . 118.77 130.44 4.15 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 124.275 0.941 . . . . 0.0 114.792 155.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.51 122.32 36.25 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 163.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 35.3 mtp -75.18 175.01 8.68 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 145.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 75' ' ' PHE . 1.4 p90 -167.57 171.28 10.44 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 125.499 1.52 . . . . 0.0 110.88 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -161.21 105.9 1.33 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.974 1.31 . . . . 0.0 107.565 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.6 p -80.75 158.57 4.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 119.917 -1.739 . . . . 0.0 109.445 166.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.6 p -128.7 158.95 37.16 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.826 1.25 . . . . 0.0 108.132 168.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.54 HD11 ' CD2' ' A' ' 95' ' ' TRP . 3.0 tp -136.85 97.99 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 172.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -75.0 147.17 41.02 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 164.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -118.26 150.25 39.77 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 161.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.0 162.82 34.59 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.54 -153.81 39.58 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -173.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -83.89 76.87 9.99 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 124.9 1.28 . . . . 0.0 109.898 -169.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -75.18 13.07 0.76 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 116.716 -1.611 . . . . 0.0 113.73 -175.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.6 mtt-85 -106.28 5.29 29.6 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 121.465 1.939 . . . . 0.0 114.766 -164.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.0 m -144.48 53.93 1.26 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.822 1.192 . . . . 0.0 111.959 175.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -135.47 137.6 42.32 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.238 1.015 . . . . 0.0 109.746 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.8 mm -78.28 93.67 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.583 1.153 . . . . 0.0 108.812 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -89.87 151.11 21.91 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 121.146 -0.971 . . . . 0.0 109.24 -176.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.1 m -138.79 142.99 38.74 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.347 1.059 . . . . 0.0 109.448 174.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.4 t -138.92 128.04 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 166.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.1 t -107.91 105.83 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 171.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.5 p -117.61 128.93 74.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 125.796 1.639 . . . . 0.0 110.583 -171.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.4 t -133.53 138.24 51.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -175.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.38 107.49 9.55 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 164.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.576 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 24.6 t-20 -63.6 113.98 3.67 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 171.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.66 -12.71 64.46 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.264 1.411 . . . . 0.0 116.108 169.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.9 t -149.82 172.06 15.75 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.351 2.076 . . . . 0.0 110.996 -172.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -89.74 160.85 16.35 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 122.641 1.21 . . . . 0.0 110.525 173.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.91 162.37 16.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 112.894 -1.957 . . . . 0.0 108.145 169.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -123.9 124.76 43.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 171.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -74.48 120.59 20.25 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.13 -20.83 75.25 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 117.636 -1.647 . . . . 0.0 113.695 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.64 -42.1 74.71 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.713 1.756 . . . . 0.0 112.583 -170.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 p -126.97 0.57 6.58 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.121 0.873 . . . . 0.0 112.896 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.11 28.63 40.42 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 123.812 0.72 . . . . 0.0 111.471 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -77.72 172.35 13.56 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.12 1.368 . . . . 0.0 109.055 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.8 t -123.73 130.73 53.09 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.648 0.737 . . . . 0.0 110.084 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 49.8 mt -118.91 121.32 39.69 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.362 -1.745 . . . . 0.0 108.864 -163.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.95 92.19 1.61 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.5 p -73.5 165.11 55.9 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-O 118.332 -0.842 . . . . 0.0 109.995 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -60.74 149.61 50.16 Favored 'Cis proline' 0 N--CA 1.452 -0.958 0 CA-C-N 120.354 1.162 . . . . 0.0 110.673 -13.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.4 p -142.31 158.71 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.8 mm -114.83 117.11 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 104.215 -2.513 . . . . 0.0 104.215 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 64.3 mt -77.69 159.9 28.83 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 169.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.5 m -138.82 -173.52 3.59 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.523 1.529 . . . . 0.0 108.256 -176.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -55.85 -41.3 74.13 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.407 1.483 . . . . 0.0 113.138 -174.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -67.19 -39.33 86.35 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.234 1.014 . . . . 0.0 111.133 -176.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -67.68 -22.51 65.28 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.729 0.812 . . . . 0.0 110.281 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 16.6 mt -115.82 20.12 14.75 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.664 1.985 . . . . 0.0 111.259 -173.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.15 3.89 7.86 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.667 1.187 . . . . 0.0 113.584 -172.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.3 m -122.8 167.13 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.539 1.536 . . . . 0.0 111.105 -165.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -57.08 -23.09 44.3 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.64 134.68 5.37 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 117.157 -1.401 . . . . 0.0 108.92 -168.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.0 t -126.45 161.94 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 164.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.4 m -142.04 127.21 18.54 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.989 1.715 . . . . 0.0 106.901 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -128.75 132.21 47.92 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.6 t -148.41 164.5 33.93 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 126.346 1.859 . . . . 0.0 106.601 -169.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.5 p -97.37 157.74 15.82 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 122.976 1.369 . . . . 0.0 112.869 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.6 p -76.2 -25.24 54.95 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.326 171.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -152.17 -169.11 17.21 Favored Glycine 0 CA--C 1.531 1.074 0 O-C-N 120.879 -1.138 . . . . 0.0 112.025 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.585 ' HE2' ' CD1' ' A' ' 73' ' ' ILE . 71.8 tttt -48.17 139.34 8.5 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 168.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -125.04 178.48 5.51 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 161.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.585 ' CD1' ' HE2' ' A' ' 71' ' ' LYS . 5.1 mm -111.43 -15.16 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.722 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.576 ' HG2' ' HB2' ' A' ' 35' ' ' ASN . 7.6 pt-20 -156.82 159.42 38.22 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -174.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.42 ' HB2' ' CE2' ' A' ' 13' ' ' TYR . 11.6 t80 -146.88 104.58 3.72 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.044 1.738 . . . . 0.0 109.738 165.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.41 148.19 22.48 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 118.548 -0.739 . . . . 0.0 109.724 176.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 t -149.17 112.65 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 124.97 1.308 . . . . 0.0 108.719 176.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.4 p -131.63 171.36 13.55 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 120.047 -1.658 . . . . 0.0 110.2 167.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 164.88 -99.05 0.16 Allowed Glycine 0 C--N 1.333 0.401 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 168.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.17 -175.3 15.7 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.371 0.986 . . . . 0.0 111.1 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.98 93.39 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.0 p -75.29 148.78 7.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 161.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.17 153.7 17.95 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.926 1.69 . . . . 0.0 107.601 166.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -125.48 13.2 7.39 Favored Glycine 0 N--CA 1.457 0.096 0 CA-C-O 117.724 -1.598 . . . . 0.0 112.99 -172.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -126.9 -179.17 4.69 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 118.834 1.317 . . . . 0.0 110.645 -176.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -169.26 125.53 0.9 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 125.999 1.72 . . . . 0.0 106.903 -169.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.86 -8.52 69.34 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.234 -0.759 . . . . 0.0 113.102 173.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.9 m -58.56 165.46 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.463 1.105 . . . . 0.0 110.052 168.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.3 t -124.95 78.62 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -102.42 179.31 4.34 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 125.332 1.453 . . . . 0.0 109.98 -170.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -109.2 162.96 18.14 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 123.482 0.713 . . . . 0.0 109.707 162.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -82.67 174.01 9.98 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.615 2.21 . . . . 0.0 112.637 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.3 ptm -143.9 163.25 33.97 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.574 0.749 . . . . 0.0 112.365 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -133.64 162.06 32.96 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.116 1.766 . . . . 0.0 109.617 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.54 ' CD2' HD11 ' A' ' 17' ' ' ILE . 2.4 m0 -127.52 150.42 49.69 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 125.922 1.689 . . . . 0.0 107.523 171.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.3 t -128.21 134.77 64.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 159.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 m -135.84 70.29 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -168.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.6 m -85.49 138.4 32.24 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -173.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.6 t -113.1 120.62 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -103.84 157.17 17.27 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 122.944 1.354 . . . . 0.0 108.325 168.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -116.34 176.62 5.02 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 130.127 3.371 . . . . 0.0 105.955 172.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -47.96 87.68 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 129.395 3.078 . . . . 0.0 108.941 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.4 58.64 10.5 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.133 1.349 . . . . 0.0 114.604 -171.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.83 154.09 6.2 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.045 1.922 . . . . 0.0 109.893 150.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -73.12 143.02 47.5 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.573 1.149 . . . . 0.0 108.906 165.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.1 pt -135.48 5.28 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 119.092 0.86 . . . . 0.0 113.065 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -152.73 160.15 43.13 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 120.548 -1.345 . . . . 0.0 108.522 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.9 tttm -158.09 86.71 0.9 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.176 0.898 . . . . 0.0 110.941 168.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.08 158.04 34.79 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 121.452 -0.78 . . . . 0.0 110.849 168.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.18 160.05 42.05 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 129.517 3.127 . . . . 0.0 107.46 177.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.9 mt -126.09 154.73 42.67 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.241 1.016 . . . . 0.0 108.297 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.5 p -136.31 130.57 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -129.66 173.6 10.47 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.239 1.015 . . . . 0.0 108.715 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 12.5 mtm180 -136.64 12.26 3.19 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.506 1.922 . . . . 0.0 111.739 -166.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.9 t70 63.49 170.61 0.16 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.228 2.211 . . . . 0.0 111.636 -163.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 51.58 54.83 22.81 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 127.813 2.625 . . . . 0.0 115.579 170.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.8 mmtt -154.59 125.74 7.28 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 118.995 1.398 . . . . 0.0 112.255 -176.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -56.47 159.86 3.47 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.964 1.706 . . . . 0.0 111.101 159.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.74 159.5 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 125.247 1.419 . . . . 0.0 109.307 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.72 28.55 0.05 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.505 1.122 . . . . 0.0 111.074 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 20.9 p -104.43 171.32 7.4 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.14 1.376 . . . . 0.0 110.089 -170.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -83.08 28.77 0.5 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.427 1.091 . . . . 0.0 110.576 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -52.52 -40.03 61.99 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.796 1.638 . . . . 0.0 111.461 -170.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.46 91.82 2.58 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -153.65 81.72 1.16 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.866 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mp -114.85 146.87 40.61 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 126.692 1.997 . . . . 0.0 110.54 -173.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.99 110.25 3.73 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 177.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -115.16 117.19 29.82 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--O 1.246 0.883 0 C-N-CA 124.293 1.037 . . . . 0.0 110.039 -179.608 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.809 0 N-CA-C 106.412 -2.675 . . . . 0.0 106.412 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -145.31 115.94 7.68 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 -169.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -153.4 80.46 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 -163.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -159.38 147.24 17.41 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.535 1.534 . . . . 0.0 107.649 -159.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -154.21 69.37 6.13 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 124.146 0.978 . . . . 0.0 109.805 167.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.44 132.72 32.17 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.815 1.677 . . . . 0.0 112.826 -174.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.31 -98.65 0.15 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.738 1.637 . . . . 0.0 110.36 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 103.26 157.08 24.95 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 124.85 1.214 . . . . 0.0 111.525 166.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -132.23 137.07 47.41 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -177.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.56 -130.72 2.19 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 128.114 2.768 . . . . 0.0 108.185 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -154.02 -157.01 0.73 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.696 1.198 . . . . 0.0 109.659 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 37.3 mtp -121.61 161.5 22.32 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 154.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -133.9 152.02 51.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 123.836 0.71 . . . . 0.0 109.477 167.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -147.63 121.47 9.32 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.7 p -123.05 145.95 29.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 124.854 1.262 . . . . 0.0 108.868 -168.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 73.3 p -118.0 162.67 17.78 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 122.186 0.993 . . . . 0.0 110.647 174.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.1 tp -144.73 90.92 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 165.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.532 ' HB2' HG13 ' A' ' 96' ' ' VAL . 31.5 mt-10 -75.56 132.97 41.05 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 162.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -112.43 111.26 21.99 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.705 2.002 . . . . 0.0 106.864 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -87.56 177.95 6.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.836 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.85 -134.2 52.07 Favored Glycine 0 C--N 1.335 0.485 0 C-N-CA 123.201 0.429 . . . . 0.0 112.756 163.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.74 38.78 1.15 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -162.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.432 ' HA ' ' SD ' ' A' ' 93' ' ' MET . 25.0 p90 -55.86 4.19 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 119.699 3.222 . . . . 0.0 119.699 -162.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.67 13.61 17.41 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 126.349 1.859 . . . . 0.0 113.152 -155.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.7 m -150.87 23.19 0.77 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -169.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -135.26 129.89 34.31 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.323 1.049 . . . . 0.0 108.453 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -68.69 93.32 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 119.704 1.138 . . . . 0.0 110.553 -177.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.79 151.37 22.93 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.433 -0.792 . . . . 0.0 110.522 173.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.6 m -140.04 150.49 44.45 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.273 1.829 . . . . 0.0 107.066 170.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.4 t -140.69 115.05 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.89 150.9 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 164.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.8 p -136.1 133.51 50.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 158.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.4 t -114.55 153.15 16.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 170.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.48 159.56 44.39 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.099 0.96 . . . . 0.0 108.547 169.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -125.04 117.09 23.21 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 127.09 2.156 . . . . 0.0 107.075 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.05 -1.29 67.56 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-O 118.365 -1.241 . . . . 0.0 114.607 163.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.617 HG22 ' HB2' ' A' ' 72' ' ' ALA . 1.4 t -159.3 174.91 14.05 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.8 1.8 . . . . 0.0 109.153 174.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -97.75 176.08 5.94 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.263 1.025 . . . . 0.0 111.173 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.37 161.41 13.94 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.337 1.055 . . . . 0.0 109.14 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -133.54 131.61 39.96 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 125.704 1.601 . . . . 0.0 107.227 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -101.22 119.5 38.85 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 123.918 0.761 . . . . 0.0 109.943 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.84 -7.99 5.26 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 118.016 -1.435 . . . . 0.0 114.205 171.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.94 -45.73 82.55 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 120.462 2.131 . . . . 0.0 111.509 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.23 -11.38 0.12 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.821 1.248 . . . . 0.0 112.508 -167.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.3 2.02 55.71 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.507 1.051 . . . . 0.0 112.199 -166.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -63.15 119.27 9.22 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.849 1.324 . . . . 0.0 110.203 -173.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.76 134.82 35.48 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.648 1.579 . . . . 0.0 108.8 172.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.3 mt -129.71 169.81 14.62 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.884 1.273 . . . . 0.0 109.384 -173.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.03 101.88 7.96 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 126.36 1.864 . . . . 0.0 108.179 -166.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.4 168.59 23.55 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 125.33 1.452 . . . . 0.0 112.438 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -72.28 141.57 71.27 Favored 'Cis proline' 0 C--N 1.35 0.639 0 N-CA-C 109.559 -0.977 . . . . 0.0 109.559 -8.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.9 p -145.11 161.51 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 121.435 -0.79 . . . . 0.0 110.125 -175.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.4 mm -118.66 114.62 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -177.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -80.5 133.65 35.85 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 169.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.411 ' H ' ' HG2' ' A' ' 58' ' ' GLU . 6.9 m -101.88 -177.91 3.56 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.944 1.697 . . . . 0.0 110.082 -175.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -52.64 -46.3 67.06 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.423 1.489 . . . . 0.0 111.676 -173.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -74.19 -30.25 62.13 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.212 0.605 . . . . 0.0 112.627 -171.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.411 ' HG2' ' H ' ' A' ' 55' ' ' SER . 2.2 mm-40 -67.75 -32.9 73.82 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.266 0.626 . . . . 0.0 109.993 173.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.652 HD13 HG21 ' A' ' 64' ' ' VAL . 3.7 mm? -92.69 7.25 44.34 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.106 1.762 . . . . 0.0 112.373 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.85 45.02 0.68 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.857 1.663 . . . . 0.0 112.488 -170.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.0 m -138.52 170.0 17.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 127.978 2.511 . . . . 0.0 109.537 -175.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -72.57 -24.83 61.16 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.207 -0.933 . . . . 0.0 112.964 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -152.46 145.93 24.88 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.652 HG21 HD13 ' A' ' 59' ' ' LEU . 2.2 t -120.9 153.06 24.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 160.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.401 ' C ' HD22 ' A' ' 66' ' ' LEU . 93.0 m -149.2 135.84 19.51 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 120.148 -1.595 . . . . 0.0 108.551 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.401 HD22 ' C ' ' A' ' 65' ' ' THR . 3.0 mm? -134.8 164.05 28.42 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 125.24 1.416 . . . . 0.0 109.019 -172.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.0 t -152.86 158.53 42.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.783 0.833 . . . . 0.0 108.876 173.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.415 HG21 ' HB3' ' A' ' 72' ' ' ALA . 18.0 p -65.84 138.3 57.79 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.551 1.541 . . . . 0.0 109.205 163.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 74.3 p -75.29 -16.74 60.41 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 120.359 1.436 . . . . 0.0 113.449 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -156.83 -163.8 12.82 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 -174.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.35 115.7 7.29 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.617 ' HB2' HG22 ' A' ' 37' ' ' THR . . . -124.44 176.04 6.74 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.859 1.264 . . . . 0.0 111.312 -173.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.517 HD13 ' O ' ' A' ' 72' ' ' ALA . 0.7 OUTLIER -137.41 5.37 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -172.319 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -147.55 164.55 33.1 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 121.178 1.808 . . . . 0.0 111.982 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -156.41 86.44 1.01 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.324 1.45 . . . . 0.0 107.679 155.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.01 138.89 34.79 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 121.482 -0.761 . . . . 0.0 109.209 166.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.2 t -143.15 130.83 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.8 m -143.71 169.22 18.15 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.051 1.341 . . . . 0.0 108.059 166.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 164.69 -175.15 40.72 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -174.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.8 -175.27 41.46 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 176.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -148.31 162.99 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 126.838 2.055 . . . . 0.0 108.415 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.2 m -119.1 167.25 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 C-N-CA 126.405 1.882 . . . . 0.0 107.671 158.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -114.2 148.59 37.08 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 112.539 -2.119 . . . . 0.0 105.668 138.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -143.96 36.94 1.47 Allowed Glycine 0 C--N 1.318 -0.458 0 C-N-CA 125.505 1.526 . . . . 0.0 111.269 176.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -108.94 149.72 28.78 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.423 0.63 . . . . 0.0 109.468 177.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -148.12 95.18 2.43 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -166.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 121.11 22.22 2.96 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 123.745 0.688 . . . . 0.0 113.337 -171.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.0 m -124.89 -179.66 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.003 1.721 . . . . 0.0 109.064 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.3 t -137.59 86.84 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 174.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -78.09 -178.43 5.58 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.675 1.19 . . . . 0.0 109.494 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -120.77 160.72 43.36 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 125.144 1.378 . . . . 0.0 107.784 157.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -81.17 178.85 6.4 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.077 1.851 . . . . 0.0 112.436 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.432 ' SD ' ' HA ' ' A' ' 23' ' ' PHE . 15.7 ptm -146.28 163.27 36.01 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 122.008 0.908 . . . . 0.0 111.145 173.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -122.82 158.77 29.53 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.394 1.477 . . . . 0.0 107.715 177.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 21.0 m0 -126.64 132.93 51.11 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 176.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 18' ' ' GLU 0.273 2.1 p -130.03 106.97 14.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 179.063 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.0 m -117.75 106.05 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 125.779 1.632 . . . . 0.0 106.98 -166.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.2 m -88.38 160.42 17.59 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 174.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.5 t -125.73 138.38 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 159.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -116.03 151.4 35.57 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 126.904 2.082 . . . . 0.0 107.843 170.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -99.69 -172.54 2.26 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 128.986 2.914 . . . . 0.0 107.895 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -61.82 75.36 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.682 1.593 . . . . 0.0 110.547 167.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.43 42.44 6.95 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.711 1.624 . . . . 0.0 114.292 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -159.21 151.67 21.43 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.351 1.576 . . . . 0.0 108.448 165.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -76.17 137.73 40.23 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 159.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.7 pt -130.12 -18.39 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 118.295 -0.86 . . . . 0.0 113.262 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -143.7 139.23 29.4 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 120.156 1.344 . . . . 0.0 110.062 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -144.94 104.14 3.96 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -174.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -141.8 174.58 10.45 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 173.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.7 t -148.35 159.6 43.84 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.12 1.368 . . . . 0.0 109.271 174.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.3 mt -125.34 164.86 19.46 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.613 1.965 . . . . 0.0 109.001 -176.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.56 86.2 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 125.704 1.602 . . . . 0.0 108.828 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -72.14 173.11 8.98 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 168.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -139.42 171.92 13.57 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 123.039 1.4 . . . . 0.0 110.409 176.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -109.55 164.69 12.29 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 130.154 3.381 . . . . 0.0 110.791 -166.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.38 -76.12 0.79 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 126.701 2.096 . . . . 0.0 110.85 -170.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . 0.292 0.0 OUTLIER -164.76 16.32 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -152.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -131.18 108.24 9.58 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.4 pp -151.8 168.05 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.684 0 C-N-CA 127.829 2.452 . . . . 0.0 108.862 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.7 p -114.48 160.28 19.38 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 122.217 1.008 . . . . 0.0 108.931 162.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 17.2 p -83.57 -7.96 59.42 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.293 1.037 . . . . 0.0 112.434 171.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 50.3 p30 -114.43 15.28 17.94 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -159.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.41 -18.83 64.13 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -172.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -132.18 134.65 45.62 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.814 1.643 . . . . 0.0 110.872 172.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.72 89.06 1.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 158.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 29.6 mt -110.15 140.43 44.26 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -153.64 73.93 0.98 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.729 1.612 . . . . 0.0 108.28 -176.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -73.39 148.31 43.48 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 121.661 -0.649 . . . . 0.0 109.843 170.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.5 p30 . . . . . 0 C--O 1.248 1.008 0 C-N-CA 127.116 2.166 . . . . 0.0 106.058 156.484 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.084 0 N-CA-C 105.767 -2.933 . . . . 0.0 105.767 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -151.84 109.32 3.61 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 103.013 -2.958 . . . . 0.0 103.013 -136.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -159.32 125.58 4.45 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 127.422 2.289 . . . . 0.0 105.425 -164.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -155.42 166.69 32.76 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.413 1.006 . . . . 0.0 112.102 -176.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -154.27 87.14 3.59 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 125.766 1.626 . . . . 0.0 107.518 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -80.49 63.75 8.8 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.359 2.706 . . . . 0.0 110.863 -167.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.81 1.76 78.79 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.126 -1.035 . . . . 0.0 115.144 -148.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.57 154.49 16.5 Favored Glycine 0 C--O 1.24 0.508 0 C-N-CA 124.532 1.063 . . . . 0.0 110.529 -172.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -153.1 166.4 32.6 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 128.608 2.763 . . . . 0.0 105.571 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -160.53 -131.76 1.27 Allowed Glycine 0 CA--C 1.523 0.587 0 C-N-CA 124.235 0.921 . . . . 0.0 111.204 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -143.34 -160.52 1.12 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.764 1.226 . . . . 0.0 110.92 -171.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 30.4 mtp -135.27 167.06 21.72 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 128.58 2.752 . . . . 0.0 107.307 157.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -154.92 156.05 35.39 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.417 1.887 . . . . 0.0 108.87 -174.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -168.41 126.66 1.12 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.234 2.214 . . . . 0.0 106.23 -172.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.456 HG22 ' CE2' ' A' ' 75' ' ' PHE . 1.6 m -136.72 158.94 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 125.656 1.583 . . . . 0.0 110.177 -170.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.6 p -126.5 159.24 33.96 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.334 0.654 . . . . 0.0 111.062 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 tp -132.33 111.12 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 167.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -97.42 145.67 25.95 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 162.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -127.32 128.52 46.06 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.945 1.698 . . . . 0.0 107.717 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.1 m -149.85 178.88 8.5 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.524 1.53 . . . . 0.0 108.791 -167.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.52 -149.4 51.25 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -166.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -80.04 60.21 3.51 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.108 1.363 . . . . 0.0 111.691 -173.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.457 ' HA ' ' HE3' ' A' ' 93' ' ' MET . 52.1 p90 -76.44 30.57 0.12 Allowed 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.397 -1.439 . . . . 0.0 114.462 -174.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.9 mtt85 -106.83 -10.18 16.13 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -163.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.4 t -154.03 83.37 1.14 Allowed 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -145.95 165.85 27.75 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.975 0.91 . . . . 0.0 110.538 172.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.4 mt -132.11 88.47 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 125.473 1.509 . . . . 0.0 107.767 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.71 168.12 16.55 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.098 -1.002 . . . . 0.0 111.336 176.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.0 t -124.75 161.03 27.29 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 161.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -140.55 113.92 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 160.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.5 t -74.94 131.45 34.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 159.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.2 t -129.43 143.48 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 C-N-CA 124.541 1.136 . . . . 0.0 108.184 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 t -138.25 147.06 25.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.24 119.62 11.59 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.998 1.319 . . . . 0.0 108.111 169.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -76.78 127.39 32.67 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 118.166 -0.921 . . . . 0.0 109.859 173.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.82 0.05 69.36 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.085 1.326 . . . . 0.0 114.946 163.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.5 t -161.47 -179.43 7.34 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.621 1.21 . . . . 0.0 110.666 -170.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -104.42 169.94 8.18 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.073 1.349 . . . . 0.0 109.689 169.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.3 tp -101.77 164.43 11.74 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 127.274 2.23 . . . . 0.0 109.299 -174.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -130.11 114.21 15.46 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 126.144 1.777 . . . . 0.0 106.622 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -69.61 118.79 12.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 174.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.88 -7.24 55.31 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 117.671 -1.627 . . . . 0.0 113.52 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.2 -60.11 4.27 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 120.567 2.183 . . . . 0.0 110.067 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.98 3.09 3.7 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.304 1.841 . . . . 0.0 111.46 -167.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.57 17.73 67.76 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.843 1.211 . . . . 0.0 112.153 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -69.79 124.85 25.04 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.98 1.312 . . . . 0.0 109.854 -169.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.77 111.99 10.53 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.354 1.062 . . . . 0.0 109.933 173.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.4 mt -121.66 142.78 49.8 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 123.593 0.757 . . . . 0.0 109.44 -177.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.86 95.09 9.97 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.434 1.111 . . . . 0.0 108.6 175.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.3 p -51.24 154.51 2.82 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.199 157.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.76 130.57 20.85 Favored 'Cis proline' 0 N--CA 1.457 -0.648 0 CA-C-N 120.747 1.302 . . . . 0.0 111.159 -2.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.0 p -132.28 154.21 39.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 124.554 1.142 . . . . 0.0 108.618 -169.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.4 mm -117.55 120.14 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.1 mt -87.89 136.19 33.07 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.85 171.1 14.97 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.239 1.816 . . . . 0.0 108.932 171.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -61.23 -35.4 77.14 Favored 'General case' 0 C--O 1.22 -0.463 0 O-C-N 121.031 -1.043 . . . . 0.0 109.903 164.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -59.56 -25.69 64.76 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.707 1.203 . . . . 0.0 111.937 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -90.98 -28.55 17.95 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.768 1.227 . . . . 0.0 110.716 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.3 mt -113.08 5.08 16.96 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 124.376 1.07 . . . . 0.0 113.587 -169.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.03 45.66 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.387 2.675 . . . . 0.0 111.224 168.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.6 m -119.74 160.4 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 129.135 2.974 . . . . 0.0 108.303 173.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.64 -44.65 93.44 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 121.564 -0.71 . . . . 0.0 111.25 170.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.23 152.1 29.93 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 120.794 -1.191 . . . . 0.0 109.221 -175.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.9 p -142.19 165.4 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.419 0.628 . . . . 0.0 109.35 158.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.8 m -111.7 142.66 43.75 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 127.212 2.205 . . . . 0.0 105.993 170.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -123.33 133.27 54.15 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 169.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.47 177.89 8.14 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -174.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.1 p -119.19 147.29 44.38 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 118.894 0.77 . . . . 0.0 112.984 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.7 p -71.64 -12.63 61.44 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.634 1.173 . . . . 0.0 113.16 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -165.72 -169.73 29.71 Favored Glycine 0 N--CA 1.448 -0.562 0 O-C-N 120.596 -1.315 . . . . 0.0 110.522 -165.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.449 ' CE ' HD11 ' A' ' 73' ' ' ILE . 14.5 ttpt -55.46 115.6 2.39 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.624 1.57 . . . . 0.0 109.343 -176.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -111.33 145.42 38.87 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.449 HD11 ' CE ' ' A' ' 71' ' ' LYS . 1.3 mt -131.23 -11.23 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 118.878 -0.582 . . . . 0.0 112.02 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -144.4 137.87 27.36 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.456 ' CE2' HG22 ' A' ' 15' ' ' VAL . 0.9 OUTLIER -125.69 100.2 6.32 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 165.819 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.21 152.89 21.34 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 163.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.32 123.79 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 170.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.4 p -142.33 170.49 15.61 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.759 0.709 . . . . 0.0 111.027 164.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 142.41 -75.96 0.31 Allowed Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 176.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.559 ' H ' HD12 ' A' ' 124' ' ' LEU . . . 69.95 -152.38 51.22 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.9 p -159.13 157.27 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.315 1.046 . . . . 0.0 110.477 -176.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.8 p -143.24 170.14 10.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 128.131 2.573 . . . . 0.0 104.727 156.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -106.9 144.04 34.11 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 118.597 0.635 . . . . 0.0 109.343 165.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.89 -21.96 34.66 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-O 119.279 -0.734 . . . . 0.0 112.142 -176.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -68.76 150.61 47.67 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 118.393 1.097 . . . . 0.0 109.195 -170.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.88 10.32 7.64 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.387 1.075 . . . . 0.0 110.662 -174.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.82 19.07 3.54 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 127.23 2.348 . . . . 0.0 112.316 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.6 t -133.91 137.07 52.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.7 p -134.94 147.89 29.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.9 1.68 . . . . 0.0 106.644 173.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -150.0 -168.87 3.23 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 123.438 0.695 . . . . 0.0 109.414 -164.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -87.84 165.74 28.15 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 123.768 0.827 . . . . 0.0 110.895 158.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -78.65 173.57 13.49 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.442 2.761 . . . . 0.0 112.741 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.53 ' CE ' ' HE1' ' A' ' 95' ' ' TRP . 2.7 ptm -125.2 162.23 25.13 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.355 -0.841 . . . . 0.0 111.508 176.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -142.8 144.81 32.72 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 124.992 1.317 . . . . 0.0 108.147 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.53 ' HE1' ' CE ' ' A' ' 93' ' ' MET . 52.7 m0 -123.35 156.92 34.43 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.2 t -133.26 117.92 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.7 m -128.54 123.85 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -165.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.2 m -121.75 156.96 32.04 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -173.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.9 t -131.65 131.56 62.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 123.808 0.843 . . . . 0.0 108.955 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -114.45 166.35 11.79 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.205 1.802 . . . . 0.0 109.099 170.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.02 -156.0 0.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.383 1.873 . . . . 0.0 108.094 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -65.76 68.7 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.563 1.145 . . . . 0.0 112.151 164.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.17 38.0 4.7 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.826 1.203 . . . . 0.0 113.428 166.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.54 152.72 12.35 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.555 1.177 . . . . 0.0 109.831 168.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -64.33 137.91 58.15 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 157.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.4 pt -123.86 -27.92 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 117.579 -1.201 . . . . 0.0 112.209 172.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -140.15 149.96 43.65 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.376 1.444 . . . . 0.0 109.39 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -152.83 108.94 3.36 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.663 1.985 . . . . 0.0 105.784 -174.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.68 154.09 39.17 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.175 170.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.87 157.83 27.91 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 125.593 1.557 . . . . 0.0 109.268 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 73.8 mt -129.82 147.64 51.62 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.432 1.093 . . . . 0.0 108.199 -163.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.9 p -129.82 100.87 5.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.62 0.724 . . . . 0.0 109.175 -171.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -92.32 179.56 5.51 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 122.119 0.962 . . . . 0.0 108.488 167.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 48.0 mtm180 -134.23 -164.36 1.49 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.918 2.087 . . . . 0.0 106.833 -168.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -47.05 146.95 1.54 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.213 1.005 . . . . 0.0 108.888 164.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -55.81 -34.18 60.84 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-O 119.485 -0.62 . . . . 0.0 113.376 -173.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -89.64 19.4 4.66 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 -169.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -160.38 91.92 0.95 Allowed 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 127.892 2.477 . . . . 0.0 111.979 -161.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.8 pp -142.43 159.59 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 O-C-N 118.729 -2.482 . . . . 0.0 111.391 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.8 p 179.87 82.32 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.582 1.553 . . . . 0.0 111.343 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.63 151.71 46.21 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 -170.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.73 56.49 1.16 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 158.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.28 -82.65 0.03 OUTLIER 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.838 1.255 . . . . 0.0 110.429 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.559 HD12 ' H ' ' A' ' 80' ' ' GLY . 19.6 mt -111.16 96.18 5.98 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 -176.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -153.65 58.97 0.75 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.617 175.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 83.2 mt -107.91 145.36 33.88 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -153.18 72.19 0.93 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.002 0.906 . . . . 0.0 109.794 -176.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -65.15 133.53 51.76 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 171.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.3 p30 . . . . . 0 C--O 1.255 1.38 0 C-N-CA 125.363 1.465 . . . . 0.0 109.863 175.335 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.76 0 N-CA-C 105.053 -3.219 . . . . 0.0 105.053 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 75.1 68.55 0.08 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 163.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -153.38 149.44 27.81 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 129.004 2.922 . . . . 0.0 106.281 -134.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -171.18 164.55 7.31 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 128.257 2.623 . . . . 0.0 106.979 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -153.64 85.19 4.1 Favored Pre-proline 0 C--O 1.237 0.397 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -79.35 161.18 25.79 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.406 2.071 . . . . 0.0 110.837 176.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.38 32.79 0.64 Allowed Glycine 0 CA--C 1.525 0.713 0 O-C-N 121.273 -0.892 . . . . 0.0 111.512 -173.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.87 -174.92 14.31 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 125.229 1.395 . . . . 0.0 111.077 -171.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -146.27 166.05 27.42 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.06 -135.42 2.19 Favored Glycine 0 C--N 1.317 -0.484 0 C-N-CA 127.842 2.639 . . . . 0.0 106.899 177.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.64 174.58 11.3 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.238 1.019 . . . . 0.0 109.232 -176.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.8 mtp -84.39 -174.05 5.06 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 119.764 -1.835 . . . . 0.0 109.253 154.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -153.2 148.6 27.08 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.366 0.667 . . . . 0.0 110.487 152.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -142.06 144.63 33.68 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.898 2.079 . . . . 0.0 108.354 172.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 p -138.53 153.54 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 126.957 2.103 . . . . 0.0 110.105 175.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -114.31 153.84 29.06 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.465 1.506 . . . . 0.0 109.185 167.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.596 HG22 HG12 ' A' ' 64' ' ' VAL . 6.2 tp -105.34 148.4 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 155.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -139.92 115.25 9.88 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 167.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -104.59 128.65 52.65 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 126.014 1.726 . . . . 0.0 107.474 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -138.02 173.92 11.11 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 122.702 0.401 . . . . 0.0 110.666 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.64 -82.34 1.59 Allowed Glycine 0 CA--C 1.52 0.373 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -175.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.414 ' CG ' HH11 ' A' ' 24' ' ' ARG . 17.9 t0 -168.54 104.32 0.43 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 117.997 0.899 . . . . 0.0 112.927 175.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -96.25 24.61 5.57 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.515 -1.366 . . . . 0.0 112.363 -178.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.414 HH11 ' CG ' ' A' ' 22' ' ' ASP . 69.6 mtt85 -69.34 -47.23 64.98 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -172.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.4 m -127.26 69.15 1.28 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.807 1.185 . . . . 0.0 109.465 -177.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.526 ' HB3' HG21 ' A' ' 81' ' ' VAL . 65.9 m-85 -143.02 117.66 9.81 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -177.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.7 mm -84.62 79.06 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.567 ' H ' ' CD ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -79.44 145.41 33.32 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.209 1.403 . . . . 0.0 108.614 167.846 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.4 m -135.8 174.72 10.3 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 169.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.2 t -141.52 160.51 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 174.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.8 p -114.56 151.34 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 158.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.5 p -139.31 139.25 39.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 118.626 0.648 . . . . 0.0 110.413 162.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.5 t -126.47 144.81 35.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 126.49 1.916 . . . . 0.0 106.299 169.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.61 95.43 2.65 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.981 1.312 . . . . 0.0 109.048 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -62.56 100.3 0.18 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.314 1.446 . . . . 0.0 110.072 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.65 1.28 25.94 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 117.405 1.722 . . . . 0.0 117.405 159.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.422 HG22 ' HB2' ' A' ' 72' ' ' ALA . 2.6 t -157.78 179.11 9.52 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.934 2.367 . . . . 0.0 109.086 174.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -91.38 161.35 15.04 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.481 0.658 . . . . 0.0 110.471 175.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.3 mt -84.42 171.93 12.17 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.563 0.745 . . . . 0.0 109.731 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -135.74 129.09 32.07 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.779 1.232 . . . . 0.0 108.42 170.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.456 ' HA ' HD23 ' A' ' 66' ' ' LEU . 11.0 t0 -89.4 117.19 28.14 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.634 1.173 . . . . 0.0 109.808 173.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.96 11.72 5.86 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.079 1.323 . . . . 0.0 114.235 175.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.72 -48.16 56.01 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 120.123 1.962 . . . . 0.0 108.973 168.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.31 -9.71 0.57 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.686 1.194 . . . . 0.0 111.715 -167.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.86 13.4 55.01 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.244 1.878 . . . . 0.0 112.903 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -68.51 138.5 55.24 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -174.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.449 ' O ' HD23 ' A' ' 48' ' ' LEU . 4.7 m -71.54 147.23 47.89 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 170.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 47' ' ' SER . 2.4 mt -130.07 158.8 38.64 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 118.491 0.587 . . . . 0.0 109.56 171.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.48 103.59 10.25 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 126.77 2.028 . . . . 0.0 108.267 -173.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.95 165.54 52.38 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.233 169.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.98 140.05 64.91 Favored 'Cis proline' 0 N--CA 1.454 -0.813 0 N-CA-C 109.791 -0.888 . . . . 0.0 109.791 -8.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.2 p -143.37 160.05 17.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.03 0.932 . . . . 0.0 110.891 -177.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.0 mm -118.89 125.06 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 126.968 2.107 . . . . 0.0 107.111 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.3 mt -83.11 144.59 29.76 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 166.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.25 175.7 5.32 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.36 2.264 . . . . 0.0 109.544 176.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -59.39 -35.37 73.82 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.725 1.21 . . . . 0.0 113.428 -175.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -70.68 -28.48 64.8 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.962 0.801 . . . . 0.0 112.611 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -70.29 -52.98 18.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.434 ' O ' ' HE2' ' A' ' 28' ' ' LYS . 32.1 mt -77.28 24.61 0.18 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.786 2.034 . . . . 0.0 111.379 -175.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.07 -11.11 59.89 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.459 1.104 . . . . 0.0 112.155 175.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.9 m -84.1 148.61 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.442 1.097 . . . . 0.0 110.177 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -61.78 -33.24 73.75 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.638 -0.664 . . . . 0.0 112.19 173.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -154.4 141.05 18.96 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 -166.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.596 HG12 HG22 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -140.98 158.62 23.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -134.46 119.46 18.55 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -175.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 41' ' ' ASP . 17.7 mt -136.65 137.79 40.42 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 118.991 0.814 . . . . 0.0 109.626 -172.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -147.62 -168.23 3.01 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -168.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.22 147.54 42.41 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 127.369 2.268 . . . . 0.0 108.99 176.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 79.9 p -73.93 -20.84 60.26 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.515 -0.74 . . . . 0.0 111.302 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -156.59 -156.37 7.83 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 124.25 0.928 . . . . 0.0 111.05 -177.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -67.75 137.37 55.4 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.875 0.87 . . . . 0.0 109.793 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.422 ' HB2' HG22 ' A' ' 37' ' ' THR . . . -138.16 174.62 10.36 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.079 1.752 . . . . 0.0 109.783 172.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.73 21.07 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 123.544 0.738 . . . . 0.0 109.426 -174.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 129' ' ' ASN . 3.8 mt-10 -155.0 158.08 38.61 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 119.217 -2.177 . . . . 0.0 109.371 168.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.75 85.22 1.42 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.15 1.38 . . . . 0.0 107.547 160.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 127' ' ' TYR . . . -78.85 137.59 37.75 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 171.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.3 t -148.88 105.88 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 126.811 2.044 . . . . 0.0 106.445 -174.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.0 m -141.55 173.02 11.89 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.699 1.2 . . . . 0.0 111.082 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.66 -89.7 0.11 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 123.992 0.806 . . . . 0.0 111.361 167.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.01 133.43 7.94 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 108.796 -1.721 . . . . 0.0 108.796 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.526 HG21 ' HB3' ' A' ' 26' ' ' PHE . 9.4 p -96.07 168.86 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.8 p -125.74 -177.96 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 175.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -112.18 105.03 13.27 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -94.99 7.99 70.08 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 124.484 1.04 . . . . 0.0 112.741 -165.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -122.3 176.79 5.67 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.557 1.543 . . . . 0.0 107.308 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -167.08 125.51 1.33 Allowed 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.06 1.744 . . . . 0.0 106.406 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.64 30.7 66.04 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.538 1.066 . . . . 0.0 112.188 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.6 m -102.62 -164.6 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 125.771 1.628 . . . . 0.0 109.901 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.28 110.65 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 160.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -141.11 -179.38 6.06 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.947 1.699 . . . . 0.0 107.251 165.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -119.71 160.2 43.3 Favored Pre-proline 0 C--N 1.33 -0.271 0 C-N-CA 124.646 1.179 . . . . 0.0 109.424 172.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -84.24 178.78 4.98 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.923 2.415 . . . . 0.0 112.312 176.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.5 ptm -148.37 171.2 16.41 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.287 -0.883 . . . . 0.0 112.164 -169.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -140.04 159.12 42.9 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 126.882 2.073 . . . . 0.0 107.547 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.0 m0 -128.3 141.58 51.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.018 1.327 . . . . 0.0 107.672 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -124.81 105.42 15.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 103.59 -2.745 . . . . 0.0 103.59 164.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.0 m -83.25 157.45 3.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 155.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 28.6 m -138.79 133.43 32.11 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 169.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.9 t -112.52 141.15 28.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -125.0 138.85 54.21 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.79 2.036 . . . . 0.0 108.529 -175.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -101.14 -174.79 2.69 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.341 1.457 . . . . 0.0 107.613 174.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -68.78 65.89 0.13 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.608 2.363 . . . . 0.0 109.031 -177.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 165.21 -68.81 0.2 Allowed Glycine 0 N--CA 1.448 -0.55 0 CA-C-O 118.675 -1.069 . . . . 0.0 112.278 -172.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -157.01 -176.59 6.07 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.534 1.133 . . . . 0.0 111.289 -174.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.86 139.03 14.03 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.899 1.68 . . . . 0.0 110.037 169.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.9 pt -129.12 -22.9 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 117.822 -1.085 . . . . 0.0 112.253 171.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -124.09 128.01 48.66 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 120.092 1.315 . . . . 0.0 110.411 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -126.6 90.89 3.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.052 1.741 . . . . 0.0 107.479 175.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -130.51 162.85 28.32 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 167.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.6 t -151.06 151.98 32.8 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.63 1.572 . . . . 0.0 107.026 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 36.9 mt -121.68 161.87 21.76 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.621 1.568 . . . . 0.0 109.112 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.0 p -137.75 132.82 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -120.96 106.44 11.61 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -147.39 104.37 3.64 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -169.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -169.72 -166.86 0.61 Allowed 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 127.491 2.317 . . . . 0.0 106.894 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.76 14.6 0.34 Allowed Glycine 0 CA--C 1.525 0.713 0 CA-C-O 118.931 -0.927 . . . . 0.0 112.242 169.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -141.62 174.74 10.28 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.817 1.308 . . . . 0.0 109.17 -170.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -60.39 133.27 55.94 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 173.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.9 pp -150.99 176.6 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 126.801 2.04 . . . . 0.0 107.488 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.1 m -157.83 90.11 1.05 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.411 1.484 . . . . 0.0 107.661 166.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.56 164.57 24.56 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 122.203 1.001 . . . . 0.0 109.251 156.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -116.94 60.22 0.75 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 162.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -68.07 -15.8 63.75 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -173.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.0 tp -122.55 114.98 21.39 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -154.28 53.71 0.68 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.345 1.458 . . . . 0.0 110.531 -159.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.3 mt -118.56 140.11 50.4 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -171.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 81.7 m-85 -151.71 67.65 0.88 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.968 1.307 . . . . 0.0 109.451 -168.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -64.89 159.76 22.03 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.003 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 3.8 t30 . . . . . 0 C--O 1.25 1.094 0 C-N-CA 128.408 2.683 . . . . 0.0 106.123 -176.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.635 0 N-CA-C 105.915 -2.874 . . . . 0.0 105.915 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -175.12 128.64 0.28 Allowed 'General case' 0 C--O 1.245 0.86 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 -155.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -136.49 -12.11 1.83 Allowed 'General case' 0 C--O 1.236 0.365 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -156.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -85.29 106.22 16.53 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.935 1.698 . . . . 0.0 109.63 169.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -154.26 82.52 4.33 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 162.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -78.52 142.43 18.43 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.95 2.433 . . . . 0.0 110.222 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -109.37 -61.15 0.52 Allowed Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.67 -149.04 21.14 Favored Glycine 0 C--N 1.333 0.413 0 O-C-N 121.352 -1.087 . . . . 0.0 110.845 -168.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.2 pttt -129.76 150.7 50.96 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 125.8 1.64 . . . . 0.0 108.995 -174.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.26 -126.55 1.14 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 129.684 3.516 . . . . 0.0 107.688 172.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -152.02 -175.3 5.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.52 1.928 . . . . 0.0 108.694 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.446 ' H ' ' HB3' ' A' ' 102' ' ' ASN . 49.5 mtp -103.54 166.86 10.17 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 155.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -133.61 153.89 51.31 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.558 1.143 . . . . 0.0 108.033 169.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -148.36 145.19 27.98 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.29 133.76 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 127.195 2.198 . . . . 0.0 106.512 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 p -94.4 171.36 8.87 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 64' ' ' VAL . 11.3 tp -132.87 146.49 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 160.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -136.24 117.57 14.63 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 161.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -107.06 128.97 54.85 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 173.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.3 p -149.1 168.4 23.3 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 122.141 -0.35 . . . . 0.0 111.335 171.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.48 -114.53 3.96 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 107.284 -2.326 . . . . 0.0 107.284 -170.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -116.11 90.24 3.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 122.008 0.909 . . . . 0.0 110.709 -174.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -102.57 21.76 14.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.958 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.0 19.31 4.1 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.552 1.541 . . . . 0.0 112.311 -168.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.8 m -134.75 -1.27 2.77 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.302 1.441 . . . . 0.0 113.484 -173.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -119.24 -174.47 2.73 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.363 1.065 . . . . 0.0 108.328 -171.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.9 mp -129.87 80.8 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.48 ' HE2' ' OD2' ' A' ' 56' ' ' ASP . 2.3 pttt -81.1 162.42 23.71 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 121.835 -0.541 . . . . 0.0 110.091 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 m -145.35 158.06 43.91 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 171.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 74.4 t -142.28 105.77 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -68.49 149.11 11.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 159.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.04 142.23 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 124.982 1.313 . . . . 0.0 108.207 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.4 t -137.58 149.33 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 171.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.0 93.84 2.64 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 172.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -69.82 104.71 2.54 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.11 7.05 38.75 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.75 -1.028 . . . . 0.0 114.284 165.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.9 t -161.89 177.59 9.69 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.546 1.173 . . . . 0.0 109.024 -174.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -100.05 170.29 8.59 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.091 0.956 . . . . 0.0 108.739 171.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 tp -84.48 170.14 13.79 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.316 0.646 . . . . 0.0 109.396 164.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -134.67 120.19 19.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.898 1.279 . . . . 0.0 108.087 171.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -69.49 129.32 39.38 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.124 0.97 . . . . 0.0 109.37 176.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.69 -8.79 84.06 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 118.892 -0.949 . . . . 0.0 113.126 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.57 -46.75 86.9 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.128 1.464 . . . . 0.0 108.635 173.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.68 -16.04 1.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.688 0.795 . . . . 0.0 112.088 -160.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.38 63.27 2.82 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -173.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -123.48 140.11 53.33 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.481 1.112 . . . . 0.0 108.333 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.85 112.16 17.98 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -178.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.7 mt -97.09 128.23 43.82 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.75 0.786 . . . . 0.0 109.352 -174.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.16 79.54 6.7 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.35 1.46 . . . . 0.0 109.493 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.2 m -63.02 163.67 15.96 Favored Pre-proline 0 N--CA 1.444 -0.767 0 C-N-CA 123.724 0.809 . . . . 0.0 110.949 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -68.93 140.66 59.29 Favored 'Cis proline' 0 CA--C 1.536 0.617 0 CA-C-N 119.211 0.754 . . . . 0.0 110.625 -9.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.7 p -145.68 149.24 16.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 124.002 0.921 . . . . 0.0 109.651 -171.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.4 mm -125.47 98.24 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 124.032 0.933 . . . . 0.0 109.295 -173.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.2 mt -72.43 131.19 42.27 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 175.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.7 m -87.93 -177.05 5.68 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.11 1.364 . . . . 0.0 109.709 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.48 ' OD2' ' HE2' ' A' ' 28' ' ' LYS . 12.5 t70 -61.21 -43.89 98.16 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.902 0.881 . . . . 0.0 112.16 -172.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -67.83 -38.85 83.74 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -174.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.15 -32.55 73.96 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.33 20.33 0.15 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.919 1.688 . . . . 0.0 115.22 176.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.36 19.34 0.08 Allowed 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 120.691 1.587 . . . . 0.0 114.993 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.8 m -95.92 153.94 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 O-C-N 120.567 -1.333 . . . . 0.0 111.554 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -75.62 -41.43 54.31 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.561 -0.712 . . . . 0.0 111.853 175.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.72 107.36 0.87 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -166.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.52 ' H ' HG22 ' A' ' 17' ' ' ILE . 93.1 t -138.6 118.91 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 123.14 1.448 . . . . 0.0 111.239 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.9 m -69.26 125.53 26.97 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 128.231 2.613 . . . . 0.0 109.093 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.49 140.8 47.81 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.479 1.036 . . . . 0.0 108.225 170.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.4 t -150.69 178.17 9.36 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.08 1.352 . . . . 0.0 107.781 176.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.9 p -87.55 165.42 15.5 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.245 0.618 . . . . 0.0 110.484 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.8 p -80.41 -13.55 59.05 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.855 -0.528 . . . . 0.0 111.372 165.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -166.43 -170.73 31.71 Favored Glycine 0 CA--C 1.527 0.812 0 O-C-N 120.388 -1.445 . . . . 0.0 113.457 -167.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -63.02 132.43 51.96 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.432 1.093 . . . . 0.0 109.057 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.452 ' C ' HD13 ' A' ' 73' ' ' ILE . . . -133.61 160.66 36.83 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.624 1.17 . . . . 0.0 111.741 -175.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.452 HD13 ' C ' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -128.2 14.35 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 118.478 -0.772 . . . . 0.0 110.35 178.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -149.27 158.05 43.85 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.483 1.492 . . . . 0.0 110.701 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -161.48 99.33 1.15 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.197 1.399 . . . . 0.0 107.664 165.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.95 142.2 28.02 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.348 1.459 . . . . 0.0 110.949 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 t -145.63 107.84 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 124.526 1.13 . . . . 0.0 108.274 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.8 m -141.07 166.65 24.21 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 121.041 -1.037 . . . . 0.0 109.67 169.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.04 -65.22 0.3 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 167.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.65 176.22 25.04 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 121.123 0.29 . . . . 0.0 112.378 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.5 m -128.86 158.97 41.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 126.006 1.722 . . . . 0.0 107.368 165.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.2 p -114.68 158.9 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 169.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -98.4 8.01 45.43 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.104 0.962 . . . . 0.0 111.344 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.15 23.27 1.83 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.745 1.64 . . . . 0.0 116.178 -158.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -54.87 146.66 16.9 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 118.766 1.283 . . . . 0.0 108.444 167.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -148.95 89.05 1.64 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 137.82 -6.58 3.5 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.93 1.252 . . . . 0.0 113.206 -170.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.4 p -143.13 166.69 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 126.42 1.888 . . . . 0.0 107.653 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.6 p -116.35 159.42 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 171.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -129.73 163.12 26.87 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 174.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -82.16 165.5 42.51 Favored Pre-proline 0 CA--C 1.538 0.518 0 O-C-N 121.502 -0.749 . . . . 0.0 110.192 164.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -75.69 167.01 27.26 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.264 1.976 . . . . 0.0 112.36 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.0 ppp? -149.36 174.19 12.71 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.02 0.528 . . . . 0.0 111.11 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -135.1 156.4 49.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.138 1.375 . . . . 0.0 108.753 173.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -141.25 90.9 2.35 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -178.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.7 t -82.28 137.18 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 168.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 m -144.63 54.7 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 125.254 1.422 . . . . 0.0 108.67 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.0 m -65.93 140.23 58.32 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 120.703 -1.248 . . . . 0.0 108.206 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.9 m -103.83 154.63 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 CA-C-O 122.889 1.328 . . . . 0.0 109.693 172.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -127.26 172.84 10.24 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 126.889 2.076 . . . . 0.0 108.098 167.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -120.92 -162.13 0.94 Allowed 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 130.644 3.578 . . . . 0.0 105.234 -176.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.446 ' HB3' ' H ' ' A' ' 12' ' ' MET . 0.6 OUTLIER -67.99 72.72 0.18 Allowed 'General case' 0 CA--C 1.551 1.002 0 O-C-N 121.226 -0.921 . . . . 0.0 109.416 165.775 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.25 29.37 56.47 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 126.003 1.763 . . . . 0.0 115.067 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -136.04 178.64 6.9 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.744 1.772 . . . . 0.0 108.209 166.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -120.53 140.7 51.08 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 127.322 2.249 . . . . 0.0 106.705 170.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -117.09 -27.33 2.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 125.353 1.461 . . . . 0.0 111.768 175.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -149.82 143.54 25.42 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.253 0.933 . . . . 0.0 109.164 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.8 tttt -137.45 43.77 2.29 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.517 0.727 . . . . 0.0 110.359 -173.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -69.26 142.4 54.16 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.4 t -138.76 160.14 40.39 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.268 1.827 . . . . 0.0 107.828 168.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 31.3 mt -125.32 144.5 50.46 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.993 1.717 . . . . 0.0 107.984 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 98.7 t -135.27 126.82 46.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.315 1.446 . . . . 0.0 107.24 -175.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -116.58 166.37 12.18 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.324 1.049 . . . . 0.0 109.174 175.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 30.7 mtt-85 -136.81 -2.04 2.17 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 117.322 -1.323 . . . . 0.0 114.168 -168.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 61.98 133.84 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.748 1.219 . . . . 0.0 110.198 -152.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.35 60.22 4.88 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.554 1.074 . . . . 0.0 112.442 172.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -129.87 139.34 51.2 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.715 -1.462 . . . . 0.0 112.997 -173.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -78.77 112.2 15.66 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 126.005 1.722 . . . . 0.0 108.718 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.2 pp -131.96 169.88 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.804 2.041 . . . . 0.0 109.814 176.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.7 t -146.92 -179.6 6.91 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.006 0.922 . . . . 0.0 108.909 168.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.0 p -72.86 37.03 0.08 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 128.078 2.551 . . . . 0.0 115.101 -162.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -134.62 20.72 3.6 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.464 1.506 . . . . 0.0 109.997 174.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.15 -39.12 66.22 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.193 1.397 . . . . 0.0 112.519 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.09 112.63 6.86 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 172.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -144.38 70.02 1.28 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -176.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.84 139.79 44.51 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.71 2.004 . . . . 0.0 107.224 -176.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -153.08 135.72 15.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 169.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -119.93 148.32 43.67 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.837 1.255 . . . . 0.0 109.09 171.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.3 p30 . . . . . 0 C--O 1.248 0.974 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 152.823 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.483 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 t0 66.97 74.88 0.32 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 127.82 2.448 . . . . 0.0 106.777 -172.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -101.09 62.71 0.98 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 112.265 -2.243 . . . . 0.0 107.023 -138.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.43 ' CG ' ' H ' ' A' ' 5' ' ' GLU . 10.3 t70 58.15 -178.89 0.07 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.079 2.152 . . . . 0.0 110.985 -146.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.43 ' H ' ' CG ' ' A' ' 4' ' ' ASP . 5.5 pt-20 -168.5 66.42 0.68 Allowed Pre-proline 0 CA--C 1.548 0.897 0 O-C-N 120.257 -1.527 . . . . 0.0 108.962 -167.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.1 176.37 10.21 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.269 2.646 . . . . 0.0 112.278 -173.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.41 -67.9 0.28 Allowed Glycine 0 C--N 1.337 0.595 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.65 167.78 39.42 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 173.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -137.73 153.24 49.77 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.623 1.169 . . . . 0.0 108.937 -171.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.37 -137.68 4.55 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 127.119 2.295 . . . . 0.0 108.523 172.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.15 -178.06 6.28 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.7 0.8 . . . . 0.0 111.227 -170.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.9 mtp -107.39 156.15 19.24 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 160.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -133.94 137.52 44.92 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.843 0.857 . . . . 0.0 110.637 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 39.3 tt0 -133.93 133.54 41.53 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 127.984 2.514 . . . . 0.0 107.921 171.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.05 155.78 11.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 126.511 1.924 . . . . 0.0 108.094 168.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.32 143.92 36.07 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 172.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.441 HD11 ' CG ' ' A' ' 95' ' ' TRP . 1.5 tp -133.29 97.0 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.46 143.83 34.6 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 161.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -120.67 130.79 54.25 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 173.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 m -112.18 165.79 11.83 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 122.385 0.274 . . . . 0.0 110.388 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 62.19 -147.8 48.84 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -79.3 77.38 5.83 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-O 122.112 0.958 . . . . 0.0 110.34 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -83.8 -5.97 59.32 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.006 -1.059 . . . . 0.0 112.541 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 90.9 mtt-85 -70.14 -57.43 4.95 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.8 m -78.74 35.34 0.24 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.735 1.614 . . . . 0.0 113.272 -157.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.704 ' HB3' HG21 ' A' ' 81' ' ' VAL . 36.6 m-85 -154.49 113.77 3.71 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.788 1.235 . . . . 0.0 111.392 -158.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.6 pt -67.68 74.99 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 127.791 2.436 . . . . 0.0 112.649 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -77.85 160.62 28.19 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 128.181 2.592 . . . . 0.0 111.851 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.5 t -156.63 152.91 27.75 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.636 -0.665 . . . . 0.0 109.798 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.5 t -128.19 139.95 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 125.628 1.571 . . . . 0.0 108.4 175.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.4 t -106.15 129.05 60.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 127.878 2.471 . . . . 0.0 104.761 164.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.62 147.08 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 119.696 1.135 . . . . 0.0 110.234 176.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.9 t -140.87 150.56 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.2 100.52 3.29 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 170.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -68.67 118.36 11.57 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.012 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.19 -14.11 40.17 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 119.408 -0.662 . . . . 0.0 114.106 159.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.4 t -148.87 178.3 8.8 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.872 1.269 . . . . 0.0 110.052 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -89.8 155.03 19.45 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.462 0.705 . . . . 0.0 109.816 173.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.5 tp -77.47 166.96 22.42 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.423 1.089 . . . . 0.0 108.883 168.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -137.07 128.36 28.07 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.152 1.781 . . . . 0.0 107.209 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.423 ' HB2' HD11 ' A' ' 48' ' ' LEU . 8.7 t0 -84.67 121.32 27.49 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.93 -8.25 57.52 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-O 119.125 -0.819 . . . . 0.0 113.693 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.8 -26.52 40.53 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.047 1.423 . . . . 0.0 111.729 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 p -134.09 -43.91 0.79 Allowed 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 124.299 1.04 . . . . 0.0 110.808 -169.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.57 13.1 56.16 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.724 -1.042 . . . . 0.0 111.058 -163.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -67.29 156.9 35.22 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 118.705 1.252 . . . . 0.0 109.253 168.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.4 p -112.96 133.62 54.84 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.39 1.476 . . . . 0.0 108.962 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.423 HD11 ' HB2' ' A' ' 41' ' ' ASP . 44.9 mt -130.93 137.58 49.36 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.79 0.836 . . . . 0.0 109.515 -162.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -85.02 63.28 8.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.227 1.411 . . . . 0.0 111.059 -167.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.7 m -53.5 150.64 12.12 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-O 118.832 -0.604 . . . . 0.0 110.948 172.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.03 140.61 68.28 Favored 'Cis proline' 0 CA--C 1.535 0.541 0 CA-C-N 119.857 0.985 . . . . 0.0 113.359 2.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.0 t -144.7 165.48 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.384 1.873 . . . . 0.0 108.222 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.4 mm -114.69 138.96 43.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 C-N-CA 126.63 1.972 . . . . 0.0 107.001 172.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -115.71 125.98 53.52 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.53 174.04 12.0 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 126.018 1.727 . . . . 0.0 110.461 -172.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -51.38 -38.88 55.65 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.743 1.617 . . . . 0.0 112.705 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -70.2 -39.6 75.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.078 0.551 . . . . 0.0 110.876 -175.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -63.92 -40.18 95.87 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.06 11.92 10.66 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.605 1.962 . . . . 0.0 113.376 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.87 19.26 0.07 Allowed 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 122.21 2.277 . . . . 0.0 115.83 -172.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.7 m -124.97 169.76 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 120.185 -1.572 . . . . 0.0 112.795 -159.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -66.78 -30.22 70.37 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.201 -0.937 . . . . 0.0 112.193 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 23.7 tttp -154.32 151.35 28.98 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 119.475 1.034 . . . . 0.0 110.278 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -125.45 156.69 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 158.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.5 m -136.59 126.23 25.42 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 126.165 1.786 . . . . 0.0 106.529 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.9 mp -140.7 146.61 38.02 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 120.319 1.418 . . . . 0.0 110.695 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 20.9 t -132.4 -167.08 1.83 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.43 1.092 . . . . 0.0 109.743 -177.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.94 147.55 36.85 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.749 1.62 . . . . 0.0 108.609 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.1 p -77.47 -14.14 59.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.438 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.53 -167.21 20.73 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -173.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -66.36 133.08 49.77 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.1 153.76 38.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 173.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -113.61 -0.7 9.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 123.392 0.677 . . . . 0.0 109.473 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 129' ' ' ASN . 46.2 mt-10 -149.88 157.72 43.46 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 119.394 0.997 . . . . 0.0 108.487 173.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.5 157.23 44.96 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.513 1.925 . . . . 0.0 106.182 159.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.26 143.95 36.2 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 164.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.8 t -129.68 90.85 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 102.97 -2.974 . . . . 0.0 102.97 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.1 t -125.17 160.43 29.18 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.37 -152.35 21.49 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 -165.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.68 -165.39 24.81 Favored Glycine 0 C--O 1.239 0.451 0 N-CA-C 107.829 -2.109 . . . . 0.0 107.829 -167.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.704 HG21 ' HB3' ' A' ' 26' ' ' PHE . 14.9 p -146.6 163.78 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 C-N-CA 123.74 0.816 . . . . 0.0 109.228 177.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 p -133.7 155.88 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 167.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -86.24 127.16 34.71 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -95.91 3.41 64.85 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.893 1.711 . . . . 0.0 112.868 173.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -121.64 172.67 7.95 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.673 1.989 . . . . 0.0 109.28 -176.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -177.45 101.03 0.05 OUTLIER 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.111 2.165 . . . . 0.0 106.149 168.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 145.17 -38.44 1.25 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 125.096 1.331 . . . . 0.0 111.584 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.3 p -81.6 82.94 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 118.743 1.272 . . . . 0.0 109.178 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.0 t -60.99 95.82 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 124.776 1.23 . . . . 0.0 109.664 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -107.8 -156.98 0.6 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.148 1.779 . . . . 0.0 108.977 -173.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -96.89 164.71 17.37 Favored Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 120.856 1.662 . . . . 0.0 111.606 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.18 175.36 10.01 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.896 1.731 . . . . 0.0 112.93 164.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.1 ptm -154.6 -179.27 7.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.903 1.681 . . . . 0.0 107.805 -172.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -169.25 165.66 10.83 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.093 1.357 . . . . 0.0 107.375 171.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.535 ' HB2' HD12 ' A' ' 111' ' ' LEU . 36.0 m0 -104.21 144.39 31.67 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 162.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 96.9 t -128.52 79.31 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 101.42 -3.548 . . . . 0.0 101.42 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.433 ' CG1' HD13 ' A' ' 17' ' ' ILE . 17.0 m -83.92 144.65 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.3 m -133.61 142.98 48.35 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.5 t -127.84 130.86 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -117.43 142.74 46.76 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.195 1.398 . . . . 0.0 109.127 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.431 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 18.5 ttpt -83.08 -162.33 0.59 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 163.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.431 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 3.1 p-10 -59.09 74.24 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.352 2.261 . . . . 0.0 110.043 167.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.38 40.16 24.34 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.864 1.221 . . . . 0.0 114.643 173.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.14 148.93 28.22 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.429 1.491 . . . . 0.0 107.765 167.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -77.7 146.58 35.92 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 169.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 39.7 pt -132.05 -21.9 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.849 1.26 . . . . 0.0 112.165 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -137.78 146.39 43.53 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.018 -1.051 . . . . 0.0 108.732 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 41.9 tttt -142.35 27.14 1.75 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.524 1.13 . . . . 0.0 110.584 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.476 ' HE2' HD21 ' A' ' 126' ' ' LEU . 33.4 ttpt -80.54 131.67 35.56 Favored 'General case' 0 CA--C 1.517 -0.29 0 O-C-N 121.538 -0.726 . . . . 0.0 110.239 -171.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 p -106.49 167.53 9.78 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 125.895 1.678 . . . . 0.0 109.021 177.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.535 HD12 ' HB2' ' A' ' 95' ' ' TRP . 45.9 mt -127.92 -177.2 4.03 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.466 1.507 . . . . 0.0 108.073 -174.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.9 p -151.21 146.86 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 175.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -157.11 172.37 18.79 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.956 1.703 . . . . 0.0 108.18 162.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 12.6 mtm180 -138.97 174.22 10.75 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.454 1.102 . . . . 0.0 111.099 168.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -55.55 145.59 22.72 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 129.394 3.078 . . . . 0.0 112.361 167.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 47.67 51.51 17.19 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 127.323 2.392 . . . . 0.0 112.635 164.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 30.2 mmtt -143.89 166.4 25.04 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.319 1.059 . . . . 0.0 111.9 -170.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -46.54 143.29 2.7 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.36 1.464 . . . . 0.0 110.513 160.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.4 pp -142.57 167.34 14.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 127.867 2.467 . . . . 0.0 104.829 170.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.3 m -133.3 149.96 51.91 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 168.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.18 59.34 1.34 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.416 1.486 . . . . 0.0 108.334 168.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.6 p30 -143.28 -1.27 1.06 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.497 1.519 . . . . 0.0 113.981 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.402 ' OD2' HD13 ' A' ' 111' ' ' LEU . 27.0 t0 -64.57 -38.16 90.04 Favored 'General case' 0 CA--C 1.523 -0.072 0 C-N-CA 124.033 0.933 . . . . 0.0 111.918 -162.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.509 ' HG ' HD11 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -127.04 111.71 14.37 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -169.535 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -138.41 50.53 1.88 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.545 1.138 . . . . 0.0 109.757 -172.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.476 HD21 ' HE2' ' A' ' 109' ' ' LYS . 92.6 mt -101.68 144.75 30.0 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.055 -1.028 . . . . 0.0 108.614 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -156.71 149.57 23.8 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.736 1.614 . . . . 0.0 107.864 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -144.91 152.51 40.33 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.671 1.189 . . . . 0.0 109.247 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 4.6 p30 . . . . . 0 C--O 1.251 1.142 0 C-N-CA 125.479 1.511 . . . . 0.0 109.167 166.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.582 0 N-CA-C 107.592 -2.203 . . . . 0.0 107.592 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 175.55 145.17 0.07 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 128.387 2.675 . . . . 0.0 103.831 -155.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.95 14.54 0.72 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.634 0.773 . . . . 0.0 112.461 175.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -68.14 158.25 33.55 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.079 0.952 . . . . 0.0 110.534 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -161.9 60.57 1.15 Allowed Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 124.571 1.148 . . . . 0.0 110.743 -175.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.08 146.85 25.93 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.398 2.065 . . . . 0.0 111.655 -172.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -162.63 -81.67 0.04 OUTLIER Glycine 0 C--N 1.335 0.479 0 N-CA-C 110.464 -1.055 . . . . 0.0 110.464 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.39 -152.58 9.48 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 117.79 0.795 . . . . 0.0 113.048 -175.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -134.25 114.82 13.44 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.965 0.906 . . . . 0.0 110.255 -169.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.489 ' H ' ' HD2' ' A' ' 71' ' ' LYS . . . -149.98 -130.51 1.8 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 106.158 -2.777 . . . . 0.0 106.158 169.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.78 145.59 38.42 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 118.716 1.258 . . . . 0.0 110.235 -172.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.1 mtp -63.03 147.0 51.98 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 154.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -135.18 148.63 49.74 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 164.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -143.77 110.36 5.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.338 1.855 . . . . 0.0 106.679 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 p -89.25 142.94 12.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 169.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.02 156.23 36.85 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 169.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.404 HD11 ' CG ' ' A' ' 95' ' ' TRP . 6.3 tp -138.16 143.2 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 169.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -129.89 97.06 4.37 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 172.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -83.78 125.46 31.95 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.6 t -151.43 167.73 27.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.5 -158.2 52.59 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -159.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -76.7 52.26 0.81 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.288 1.044 . . . . 0.0 113.779 -170.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -64.35 -8.5 13.32 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.336 -1.477 . . . . 0.0 114.427 -174.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -58.88 -60.73 3.39 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 119.25 0.932 . . . . 0.0 109.902 -174.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.9 m -79.1 28.38 0.23 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.183 1.793 . . . . 0.0 113.352 -167.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.407 ' O ' ' HE3' ' A' ' 28' ' ' LYS . 40.4 m-85 -123.95 123.1 39.66 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.075 0.95 . . . . 0.0 108.58 -172.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.4 mm -70.09 98.44 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -177.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.423 ' HD2' ' H ' ' A' ' 28' ' ' LYS . 2.2 mptt -75.29 131.35 40.25 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.639 0.776 . . . . 0.0 109.258 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.2 m -137.53 134.41 35.66 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.275 1.03 . . . . 0.0 108.603 169.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 89.8 t -137.34 113.91 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 165.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.5 p -70.24 132.75 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 158.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.94 143.69 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 126.33 1.852 . . . . 0.0 108.163 176.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.7 t -140.58 158.31 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.879 1.272 . . . . 0.0 107.739 -171.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.62 154.43 34.18 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.308 1.043 . . . . 0.0 108.809 168.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.441 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 18.2 t-20 -118.16 101.84 8.54 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 124.979 1.312 . . . . 0.0 109.587 178.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.17 -80.23 0.27 Allowed Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 106.186 -2.765 . . . . 0.0 106.186 171.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.9 t -70.79 174.76 5.64 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 125.31 1.444 . . . . 0.0 110.505 -175.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -110.32 172.82 6.64 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.149 0.98 . . . . 0.0 111.149 -175.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.26 164.49 11.93 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.1 1.36 . . . . 0.0 108.424 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -138.48 124.15 19.72 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.61 0.764 . . . . 0.0 109.66 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -73.78 126.78 31.14 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 123.956 0.785 . . . . 0.0 109.607 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.99 6.66 19.1 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 117.58 -1.678 . . . . 0.0 114.321 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.49 -62.07 1.7 Allowed 'General case' 0 C--O 1.23 0.066 0 CA-C-N 120.621 2.21 . . . . 0.0 109.065 171.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.93 7.62 4.73 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.68 1.192 . . . . 0.0 111.787 -170.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.19 32.19 83.11 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -65.9 126.78 29.62 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 175.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.94 104.78 17.33 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -170.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 68.7 mt -91.06 -175.01 4.18 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.424 1.489 . . . . 0.0 110.673 -165.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.15 109.27 5.78 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.064 1.346 . . . . 0.0 107.427 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.44 165.01 46.92 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.822 -0.549 . . . . 0.0 110.74 174.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.67 142.74 65.34 Favored 'Cis proline' 0 CA--C 1.537 0.673 0 CA-C-N 118.569 0.525 . . . . 0.0 111.722 -9.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.5 p -145.09 165.05 12.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 126.092 1.757 . . . . 0.0 111.12 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.4 mm -119.59 118.5 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 126.222 1.809 . . . . 0.0 107.361 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.2 mt -73.6 104.68 4.63 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 159.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.0 m -76.5 179.73 5.73 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.55 1.14 . . . . 0.0 110.479 168.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -50.96 -34.23 27.9 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.126 1.37 . . . . 0.0 112.32 170.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -66.84 -32.42 73.68 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.55 1.14 . . . . 0.0 112.169 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -86.84 -47.77 8.77 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.2 mt -76.04 21.56 0.17 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.614 1.966 . . . . 0.0 111.887 174.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.78 -4.87 37.32 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.104 1.362 . . . . 0.0 112.893 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.76 HG23 HG22 ' A' ' 64' ' ' VAL . 1.4 m -108.54 160.89 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 127.333 2.253 . . . . 0.0 110.875 -177.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -68.19 -33.12 73.85 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.289 1.036 . . . . 0.0 112.319 -176.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -143.77 126.31 15.91 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -165.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.76 HG22 HG23 ' A' ' 61' ' ' VAL . 1.7 t -136.17 90.44 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -172.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.2 m -81.58 114.86 20.57 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.787 0.835 . . . . 0.0 109.418 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -116.08 132.12 56.75 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 t -147.64 168.52 21.82 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.274 0.559 . . . . 0.0 109.569 -175.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.19 139.51 32.25 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.188 1.795 . . . . 0.0 111.133 -171.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.3 p -68.14 -28.93 67.73 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -175.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -132.81 -86.37 0.3 Allowed Glycine 0 C--N 1.338 0.672 0 CA-C-N 118.82 0.736 . . . . 0.0 112.891 -173.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.489 ' HD2' ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -150.99 139.48 20.5 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 130.764 3.625 . . . . 0.0 107.614 162.044 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.423 ' HB1' ' H ' ' A' ' 35' ' ' ASN . . . -101.51 -169.13 1.65 Allowed 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 169.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.1 mm -115.32 -19.71 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.788 170.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.441 ' HG2' ' HB2' ' A' ' 35' ' ' ASN . 19.3 pt-20 -150.4 164.62 35.39 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.643 -1.286 . . . . 0.0 109.571 -160.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -164.52 124.03 1.92 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.66 1.584 . . . . 0.0 109.982 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.35 155.85 19.54 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 120.037 1.29 . . . . 0.0 109.73 167.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.7 t -150.16 92.76 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 127.501 2.32 . . . . 0.0 105.287 174.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.9 m -137.0 159.93 40.43 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.287 -0.883 . . . . 0.0 110.437 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.24 -97.3 0.18 Allowed Glycine 0 C--N 1.333 0.38 0 N-CA-C 106.978 -2.449 . . . . 0.0 106.978 176.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.9 -168.38 21.31 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -175.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -138.64 161.21 30.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 161.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.6 p -143.24 139.74 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 171.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -65.38 146.6 54.7 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.55 1.14 . . . . 0.0 110.077 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.6 -7.92 85.46 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.897 1.236 . . . . 0.0 111.835 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -147.77 154.21 40.22 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 122.017 0.913 . . . . 0.0 112.138 -171.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -146.3 102.06 3.56 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 159.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 144.0 5.12 0.66 Allowed Glycine 0 CA--C 1.536 1.406 0 N-CA-C 115.992 1.157 . . . . 0.0 115.992 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.9 m -117.62 179.86 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 119.806 1.803 . . . . 0.0 109.637 173.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.47 98.94 7.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.463 1.105 . . . . 0.0 108.134 175.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -113.12 -163.88 0.88 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.229 1.812 . . . . 0.0 106.944 176.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -123.37 163.5 33.82 Favored Pre-proline 0 CA--C 1.533 0.322 0 O-C-N 121.331 -0.856 . . . . 0.0 108.938 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.05 175.68 10.92 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.712 2.275 . . . . 0.0 111.129 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.0 ptm -146.61 168.86 20.23 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -142.87 160.08 41.01 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 122.295 1.045 . . . . 0.0 109.292 172.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.404 ' CG ' HD11 ' A' ' 17' ' ' ILE . 4.0 m0 -127.07 112.1 14.81 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 171.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.5 t -92.87 132.39 37.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 159.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.82 161.95 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 174.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.91 155.84 28.43 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.276 -1.749 . . . . 0.0 106.276 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 75.8 t -125.27 91.61 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 171.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -72.58 163.14 28.53 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 170.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -127.63 -154.33 0.63 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.478 2.311 . . . . 0.0 109.552 -168.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -62.17 61.34 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.719 2.007 . . . . 0.0 111.449 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.34 65.99 2.93 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 120.264 -1.522 . . . . 0.0 110.964 -169.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -165.74 165.13 18.76 Favored 'General case' 0 C--N 1.335 -0.059 0 C-N-CA 125.746 1.618 . . . . 0.0 107.999 150.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -77.83 147.75 35.04 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.925 1.69 . . . . 0.0 107.442 159.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 6.4 pt -134.51 -10.36 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.367 1.467 . . . . 0.0 112.553 166.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -145.97 159.35 43.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.237 1.815 . . . . 0.0 108.78 -165.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -153.69 25.76 0.51 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -173.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -47.67 128.16 12.47 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.94 0.896 . . . . 0.0 111.394 177.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.0 p -147.42 140.46 25.09 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.286 1.034 . . . . 0.0 109.469 -177.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.619 ' N ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -133.73 -173.45 3.24 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 123.256 1.503 . . . . 0.0 109.645 -174.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.7 p -159.83 141.34 4.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 128.96 2.904 . . . . 0.0 108.689 -177.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -138.97 171.38 14.41 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 172.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -133.11 162.23 32.28 Favored 'General case' 0 CA--C 1.513 -0.481 0 O-C-N 121.699 -0.626 . . . . 0.0 111.325 -162.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -61.5 116.73 4.94 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 124.153 0.908 . . . . 0.0 109.224 164.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.36 55.3 3.49 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 160.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -145.13 99.29 3.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 117.156 0.478 . . . . 0.0 110.413 174.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -62.0 145.79 52.03 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 158.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.7 pp -150.52 -177.44 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 127.066 2.147 . . . . 0.0 107.52 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.5 m -160.33 118.19 2.56 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.087 1.755 . . . . 0.0 106.345 155.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 16.2 p -148.46 152.29 36.67 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.661 1.184 . . . . 0.0 109.96 -172.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.16 31.1 0.1 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.103 1.761 . . . . 0.0 110.679 175.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.43 -17.04 41.7 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.238 1.415 . . . . 0.0 113.111 -166.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.7 tp -134.56 112.81 11.17 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -156.11 54.11 0.57 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 126.93 2.092 . . . . 0.0 107.925 -172.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tp -106.43 143.27 34.78 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.23 1.012 . . . . 0.0 108.984 -171.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -158.95 136.88 10.39 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.199 0.6 . . . . 0.0 109.461 -167.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -137.48 127.36 25.64 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 128.278 2.631 . . . . 0.0 106.062 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.257 1.494 0 C-N-CA 128.987 2.915 . . . . 0.0 104.888 153.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.783 0 N-CA-C 105.959 -2.857 . . . . 0.0 105.959 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -150.63 122.58 8.18 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 -150.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -144.71 108.21 4.63 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 104.054 -2.573 . . . . 0.0 104.054 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -152.57 147.25 25.96 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.914 1.286 . . . . 0.0 108.596 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -154.02 61.88 3.58 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.837 1.255 . . . . 0.0 109.437 -175.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -62.94 154.85 64.06 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.826 1.684 . . . . 0.0 111.93 -173.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.43 112.58 0.55 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 -169.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -142.87 -129.97 2.4 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 125.72 1.629 . . . . 0.0 109.804 173.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -150.85 158.92 44.74 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.09 1.445 . . . . 0.0 109.214 -174.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.471 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . 167.52 -148.91 13.59 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 128.714 3.054 . . . . 0.0 108.471 171.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.52 165.44 17.81 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.544 0.738 . . . . 0.0 112.291 -163.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.461 ' H ' ' HB3' ' A' ' 102' ' ' ASN . 25.2 mtp -116.02 170.15 8.72 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 144.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -173.71 160.8 3.78 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 131.131 3.773 . . . . 0.0 106.902 -178.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -153.43 112.24 3.72 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.58 158.35 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.173 0.989 . . . . 0.0 109.169 175.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 p -136.43 160.27 39.25 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 160.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.7 tp -130.04 143.69 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 126.479 1.912 . . . . 0.0 106.031 173.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -131.63 139.18 49.06 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 126.944 2.098 . . . . 0.0 106.671 170.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -104.13 144.85 31.03 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.441 1.496 . . . . 0.0 107.975 176.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.3 t -154.38 170.7 20.72 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.816 1.246 . . . . 0.0 108.76 -176.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 54.66 -147.46 24.35 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.564 1.078 . . . . 0.0 110.646 -165.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -84.22 95.87 8.8 Favored 'General case' 0 C--O 1.222 -0.357 0 O-C-N 121.622 -0.928 . . . . 0.0 110.451 175.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -96.52 8.18 44.73 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 120.344 -1.473 . . . . 0.0 112.73 -175.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -94.92 -5.6 44.45 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -157.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.5 t -127.13 23.45 6.49 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.11 0.868 . . . . 0.0 110.972 -165.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -135.99 118.29 15.63 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.082 0.953 . . . . 0.0 110.908 -164.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.7 mt -66.63 108.44 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -80.75 149.93 29.46 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.547 1.139 . . . . 0.0 109.237 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 m -150.85 138.21 19.46 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 169.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.4 t -136.41 139.48 45.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.501 HG22 HD12 ' A' ' 53' ' ' ILE . 58.1 t -106.19 132.16 54.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 128.321 2.649 . . . . 0.0 108.695 169.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.4 p -126.56 166.29 23.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 126.613 1.965 . . . . 0.0 109.219 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.1 p -139.4 165.0 23.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 158.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.29 100.13 3.82 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 162.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -66.26 106.44 1.68 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.38 6.7 58.56 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 117.974 -1.459 . . . . 0.0 115.71 166.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.448 HG22 ' HB2' ' A' ' 72' ' ' ALA . 1.3 t -155.14 -174.39 4.96 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.913 1.856 . . . . 0.0 109.473 167.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -92.14 164.4 13.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.687 1.195 . . . . 0.0 111.703 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.5 tp -90.13 163.12 14.97 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.781 1.232 . . . . 0.0 108.426 172.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.416 ' HE2' ' HA2' ' A' ' 45' ' ' GLY . 77.8 tttt -125.2 117.66 24.34 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.357 1.463 . . . . 0.0 107.204 174.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -75.97 114.73 14.93 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.514 1.133 . . . . 0.0 109.166 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.91 0.68 35.97 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-O 118.524 -1.153 . . . . 0.0 114.283 -173.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.25 -40.6 81.89 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 119.837 1.819 . . . . 0.0 111.427 170.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.94 -18.97 1.17 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.001 0.92 . . . . 0.0 113.006 -169.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.416 ' HA2' ' HE2' ' A' ' 40' ' ' LYS . . . 86.23 19.43 57.21 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 119.25 -0.75 . . . . 0.0 111.936 -170.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -71.19 128.82 37.2 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.574 1.187 . . . . 0.0 109.171 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.65 133.21 50.64 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 126.334 1.854 . . . . 0.0 110.043 169.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 30.6 mt -128.93 152.22 48.8 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.612 1.165 . . . . 0.0 111.048 176.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.63 91.67 5.87 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.718 1.207 . . . . 0.0 110.156 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.81 153.46 42.58 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.643 0.777 . . . . 0.0 111.672 173.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.02 128.73 15.2 Favored 'Cis proline' 0 C--N 1.349 0.599 0 CA-C-N 120.229 1.117 . . . . 0.0 111.709 -8.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.419 ' O ' HD13 ' A' ' 53' ' ' ILE . 99.8 t -96.42 155.71 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 172.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.501 HD12 HG22 ' A' ' 31' ' ' VAL . 18.2 mm -114.12 120.53 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 105.234 -2.135 . . . . 0.0 105.234 166.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.69 163.37 26.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 122.123 0.963 . . . . 0.0 109.017 172.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.589 ' H ' ' HG2' ' A' ' 58' ' ' GLU . 4.9 m -129.32 -153.79 0.59 Allowed 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 127.95 2.5 . . . . 0.0 109.106 -169.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.01 -29.69 13.99 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.774 1.63 . . . . 0.0 110.935 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -67.05 -40.27 87.07 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 125.221 1.409 . . . . 0.0 110.516 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.589 ' HG2' ' H ' ' A' ' 55' ' ' SER . 1.8 pp20? -62.31 -29.83 70.72 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 123.92 0.888 . . . . 0.0 112.265 -177.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.9 mt -89.14 27.9 1.31 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.401 2.281 . . . . 0.0 111.457 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.46 17.36 2.19 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.616 -1.303 . . . . 0.0 114.163 -172.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.773 HG23 ' H ' ' A' ' 63' ' ' LYS . 13.9 m -123.93 -163.84 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 120.74 1.609 . . . . 0.0 108.337 166.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -76.02 -30.64 58.55 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 169.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.773 ' H ' HG23 ' A' ' 61' ' ' VAL . 2.2 tmtp? -153.3 131.54 11.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 117.217 -1.373 . . . . 0.0 111.808 -162.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.86 165.31 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 119.618 1.099 . . . . 0.0 108.85 176.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.4 m -134.83 127.72 31.33 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 128.081 2.552 . . . . 0.0 106.386 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -129.52 133.2 47.12 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 121.218 1.826 . . . . 0.0 108.255 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.6 t -135.26 176.18 8.91 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.308 -0.87 . . . . 0.0 108.867 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.6 p -90.09 153.73 20.33 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 166.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.7 p -76.21 -13.36 60.18 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.859 -0.525 . . . . 0.0 112.311 173.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.63 -168.12 18.17 Favored Glycine 0 N--CA 1.449 -0.491 0 O-C-N 120.875 -1.141 . . . . 0.0 110.903 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.471 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 5.0 ttpt -60.26 139.02 57.82 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 170.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.448 ' HB2' HG22 ' A' ' 37' ' ' THR . . . -135.16 177.81 7.52 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 168.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.2 mm -115.5 -11.04 12.11 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 118.087 -0.959 . . . . 0.0 111.017 -177.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -152.39 155.33 37.36 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 120.568 1.531 . . . . 0.0 110.556 172.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -141.45 107.43 5.17 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.369 1.468 . . . . 0.0 109.565 170.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.91 153.98 21.18 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.643 1.111 . . . . 0.0 110.45 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.8 t -146.53 95.72 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 173.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.7 m -131.19 159.83 36.58 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.581 -0.699 . . . . 0.0 109.404 174.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.92 -179.58 19.77 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-N 119.206 0.912 . . . . 0.0 113.267 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.43 -160.38 24.08 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 123.92 0.771 . . . . 0.0 111.308 -169.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.35 119.04 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 126.04 1.736 . . . . 0.0 110.822 -176.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.38 170.86 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.473 0 O-C-N 121.185 -0.947 . . . . 0.0 111.084 164.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -146.93 109.55 4.6 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.463 1.105 . . . . 0.0 109.125 158.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.43 2.65 84.65 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.255 -1.303 . . . . 0.0 113.083 174.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -89.51 140.94 29.03 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 120.058 1.929 . . . . 0.0 109.145 172.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -144.87 1.93 1.02 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.481 1.112 . . . . 0.0 111.628 175.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.34 28.58 4.25 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 126.681 2.086 . . . . 0.0 112.346 -177.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.8 p -144.51 130.98 15.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 125.377 1.471 . . . . 0.0 107.25 171.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.99 145.68 12.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -143.98 -165.66 2.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.481 1.112 . . . . 0.0 109.074 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -125.27 163.88 35.43 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 126.006 1.722 . . . . 0.0 109.635 168.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.42 175.07 9.29 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.74 2.293 . . . . 0.0 112.683 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 6.9 ptm -137.26 173.64 11.47 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.658 0.783 . . . . 0.0 110.291 -172.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -138.85 147.78 42.88 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.47 1.108 . . . . 0.0 108.763 170.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -117.61 133.11 56.31 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 170.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.1 t -128.16 111.7 24.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 -177.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.6 t -134.38 121.18 35.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 -160.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.6 m -110.87 159.8 17.35 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -173.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.9 t -125.61 129.4 72.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 162.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -97.04 134.91 39.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 104.74 -2.319 . . . . 0.0 104.74 163.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.3 tptm -91.56 -173.33 3.52 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 172.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.461 ' HB3' ' H ' ' A' ' 12' ' ' MET . 0.7 OUTLIER -59.35 74.21 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.047 2.139 . . . . 0.0 109.581 167.922 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 157.33 -72.32 0.24 Allowed Glycine 0 CA--C 1.523 0.545 0 C-N-CA 126.72 2.105 . . . . 0.0 111.64 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.45 -177.15 6.35 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.291 1.436 . . . . 0.0 111.024 -171.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.16 144.06 7.57 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.452 1.501 . . . . 0.0 109.846 173.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.6 pt -133.41 -27.41 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 123.897 0.879 . . . . 0.0 111.624 168.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -148.21 151.44 35.51 Favored 'General case' 0 N--CA 1.461 0.082 0 CA-C-N 119.746 1.157 . . . . 0.0 111.517 -162.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -151.59 68.49 0.9 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.124 1.769 . . . . 0.0 110.453 -159.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.444 ' HE2' HD13 ' A' ' 126' ' ' LEU . 6.0 mmmt -86.25 118.76 25.91 Favored 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 120.539 -1.35 . . . . 0.0 109.225 176.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.54 139.46 52.3 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 125.064 1.345 . . . . 0.0 110.087 178.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 111' ' ' LEU . 1.2 mp -131.44 -178.37 4.82 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.484 2.314 . . . . 0.0 109.564 -177.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.7 p -154.08 44.79 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 124.793 1.237 . . . . 0.0 112.204 -162.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -72.44 169.2 16.9 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.407 -0.808 . . . . 0.0 112.53 -173.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.5 mtm-85 -147.39 175.1 11.07 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.207 1.003 . . . . 0.0 111.574 -168.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -61.31 160.29 10.92 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 131.191 3.796 . . . . 0.0 115.237 172.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 122.63 -42.87 1.54 Allowed Glycine 0 C--N 1.34 0.769 0 C-N-CA 125.637 1.589 . . . . 0.0 116.02 157.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.36 179.55 6.72 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 120.051 1.925 . . . . 0.0 110.527 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -107.36 137.07 46.07 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 125.975 1.71 . . . . 0.0 108.199 -176.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.441 ' C ' HD12 ' A' ' 119' ' ' ILE . 2.5 pp -147.0 168.29 5.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 126.205 1.802 . . . . 0.0 107.252 175.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.18 17.4 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 175.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.35 -1.19 1.2 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 -161.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -142.82 62.81 1.4 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 122.691 1.234 . . . . 0.0 109.193 163.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -121.21 -82.75 0.65 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 127.936 2.495 . . . . 0.0 107.982 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.5 tp -138.25 121.71 17.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -167.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -141.26 80.86 1.76 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 169.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.444 HD13 ' HE2' ' A' ' 109' ' ' LYS . 1.4 tp -109.07 151.38 26.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -152.72 126.86 9.12 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -178.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -117.83 161.78 19.17 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.61 1.564 . . . . 0.0 110.521 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.39 0 C-N-CA 128.283 2.633 . . . . 0.0 106.849 164.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.782 0 N-CA-C 106.622 -2.591 . . . . 0.0 106.622 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -155.8 145.65 21.31 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 102.882 -3.007 . . . . 0.0 102.882 -158.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -109.0 15.28 23.5 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 127.537 2.335 . . . . 0.0 110.992 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -135.57 161.27 35.98 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.463 2.305 . . . . 0.0 108.723 173.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -153.56 85.86 4.03 Favored Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 167.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -81.05 -172.31 1.48 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.932 2.422 . . . . 0.0 110.412 -174.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.43 -10.04 73.17 Favored Glycine 0 CA--C 1.527 0.797 0 O-C-N 120.913 -1.117 . . . . 0.0 113.125 171.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.15 -126.21 7.85 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 178.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -148.9 161.12 42.49 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 173.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.58 -119.05 1.01 Allowed Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 154.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.18 -162.2 1.19 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.31 1.044 . . . . 0.0 108.324 -164.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.1 mtp -137.1 161.42 36.15 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 127.894 2.478 . . . . 0.0 105.332 161.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -136.65 148.89 47.67 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 173.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -143.6 138.05 28.77 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 103.676 -2.712 . . . . 0.0 103.676 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.2 157.5 38.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 169.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 p -124.83 154.09 41.54 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 164.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.459 HD11 ' CD2' ' A' ' 95' ' ' TRP . 7.1 tt -120.65 156.95 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 C-N-CA 122.44 0.296 . . . . 0.0 110.514 155.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -139.98 131.96 27.78 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 166.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -117.12 109.04 16.44 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.801 2.04 . . . . 0.0 107.13 -165.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.5 p -139.27 179.88 6.27 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 175.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 93' ' ' MET . . . 58.26 -157.96 17.69 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -152.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -85.15 106.93 16.96 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.176 0.988 . . . . 0.0 112.604 -168.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -113.79 -4.57 13.34 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 121.402 1.91 . . . . 0.0 115.299 -172.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.97 34.0 1.43 Allowed 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.316 -0.865 . . . . 0.0 111.159 -171.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.8 m -143.67 7.0 1.46 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.4 1.08 . . . . 0.0 112.317 -165.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -140.97 152.44 44.96 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 120.404 1.456 . . . . 0.0 111.346 -159.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 84.9 mt -84.95 95.29 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 174.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.64 148.32 22.39 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 172.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.8 t -142.6 157.55 44.59 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.409 1.884 . . . . 0.0 108.158 -175.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -143.48 160.03 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 165.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.485 ' CG1' ' H ' ' A' ' 78' ' ' SER . 2.4 p -128.69 141.45 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 126.713 2.005 . . . . 0.0 106.182 160.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.9 t -137.87 130.98 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.6 t -140.23 138.59 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.81 89.88 2.29 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.57 1.077 . . . . 0.0 111.896 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.472 ' H ' ' HB2' ' A' ' 74' ' ' GLU . 39.3 t-20 -58.16 105.26 0.26 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.223 1.409 . . . . 0.0 112.689 -174.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.44 -1.25 27.9 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 118.602 -1.11 . . . . 0.0 114.185 164.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.3 t -154.18 -168.1 2.84 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.054 1.427 . . . . 0.0 110.236 -169.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -116.75 159.51 22.18 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.017 1.727 . . . . 0.0 109.484 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.2 164.16 17.37 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 124.289 1.035 . . . . 0.0 108.693 176.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -133.06 123.16 25.27 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 173.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -79.9 117.19 20.54 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 166.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.83 -17.82 55.44 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.625 -1.097 . . . . 0.0 114.339 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.85 -39.11 87.86 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 119.855 1.827 . . . . 0.0 110.205 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.06 -10.58 1.13 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -169.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.1 29.36 64.76 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -171.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -69.13 115.31 8.27 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 170.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.78 103.69 11.64 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.5 mt -91.24 -173.7 3.71 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.156 0.983 . . . . 0.0 108.923 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.52 94.24 3.61 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -177.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.52 162.31 27.66 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.596 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.32 143.81 66.04 Favored 'Cis proline' 0 N--CA 1.459 -0.519 0 CA-C-N 120.142 1.086 . . . . 0.0 112.696 -1.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.7 t -142.07 149.11 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.28 1.432 . . . . 0.0 108.818 -169.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.8 mm -135.89 97.72 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 126.61 1.964 . . . . 0.0 107.124 -159.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -82.5 140.94 33.05 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.076 0.95 . . . . 0.0 108.913 -174.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.4 p -110.24 -166.23 1.07 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.22 1.008 . . . . 0.0 110.477 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -64.09 -48.28 76.75 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.684 1.994 . . . . 0.0 111.782 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -61.23 -27.44 68.44 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 125.04 1.336 . . . . 0.0 110.797 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -95.1 -11.9 27.44 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.317 0.647 . . . . 0.0 110.344 -169.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -96.98 17.77 16.18 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.862 2.065 . . . . 0.0 112.673 176.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.15 39.69 0.15 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.174 1.789 . . . . 0.0 113.378 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.1 m -136.46 162.48 35.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 126.281 1.832 . . . . 0.0 108.778 -170.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -85.5 -17.06 37.51 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.293 -0.88 . . . . 0.0 113.04 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -155.14 151.67 28.52 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 125.196 1.398 . . . . 0.0 107.911 -166.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.446 ' HB ' HG22 ' A' ' 17' ' ' ILE . 11.2 t -143.77 140.9 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 164.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.3 m -118.07 135.09 54.41 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 168.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.5 mt -140.0 146.04 38.58 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.6 169.25 22.01 Favored 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 121.649 -0.657 . . . . 0.0 110.148 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.427 HG21 ' HB2' ' A' ' 72' ' ' ALA . 3.3 p -95.44 155.97 16.52 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 117.801 0.273 . . . . 0.0 111.163 174.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.4 p -82.3 -3.38 55.17 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.524 -0.735 . . . . 0.0 112.015 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.72 -156.88 15.68 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -176.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.488 ' HE2' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -60.93 137.13 58.24 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 117.483 0.641 . . . . 0.0 110.218 -168.446 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.427 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -129.33 141.63 51.03 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 176.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.488 HD11 ' HE2' ' A' ' 71' ' ' LYS . 0.8 OUTLIER -133.94 21.5 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 C-N-CA 123.723 0.809 . . . . 0.0 110.254 174.718 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 129' ' ' ASN . 40.3 mt-10 -142.77 147.33 35.37 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 168.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -154.56 86.11 1.13 Allowed 'General case' 0 C--O 1.232 0.164 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 157.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 127' ' ' TYR . . . -76.4 145.9 39.04 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.164 175.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.2 t -143.92 108.7 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.105 1.362 . . . . 0.0 107.712 166.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.485 ' H ' ' CG1' ' A' ' 31' ' ' VAL . 1.6 t -109.38 173.67 6.22 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 152.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 150.55 -166.07 30.14 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 -170.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 146.21 166.77 12.28 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.513 1.054 . . . . 0.0 110.822 174.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.9 m -142.88 114.17 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 174.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.7 m -86.11 177.44 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -159.64 90.73 0.95 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 166.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -121.32 27.82 6.23 Favored Glycine 0 N--CA 1.465 0.615 0 C-N-CA 124.049 0.833 . . . . 0.0 111.213 -172.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.75 157.94 20.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.447 1.499 . . . . 0.0 109.407 -160.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -119.94 0.41 10.8 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.026 0.931 . . . . 0.0 112.489 -173.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -110.65 -44.96 0.93 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 125.086 1.327 . . . . 0.0 110.228 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.6 t -89.56 71.21 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 118.056 0.928 . . . . 0.0 109.569 -174.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.9 p -61.6 142.67 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 164.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.55 -166.6 2.28 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 170.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -87.22 164.08 37.26 Favored Pre-proline 0 CA--C 1.541 0.617 0 O-C-N 121.45 -0.781 . . . . 0.0 109.505 159.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -76.73 175.33 11.51 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.058 2.505 . . . . 0.0 112.913 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.403 ' HA ' ' HA3' ' A' ' 21' ' ' GLY . 14.3 ptm -139.94 164.0 31.16 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.722 1.209 . . . . 0.0 111.646 -173.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -140.26 156.52 46.44 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.208 1.403 . . . . 0.0 109.66 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.459 ' CD2' HD11 ' A' ' 17' ' ' ILE . 1.5 m0 -127.19 124.69 39.58 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 176.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 t -95.68 121.23 46.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 162.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.6 p -127.54 137.41 57.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 170.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.9 m -148.22 142.61 26.31 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.457 ' H ' ' HB3' ' A' ' 107' ' ' GLU . 3.4 t -117.01 145.31 22.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 124.209 1.004 . . . . 0.0 108.399 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -128.77 130.77 47.49 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 128.034 2.534 . . . . 0.0 106.103 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -84.45 -163.71 0.84 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.13 77.45 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.313 1.045 . . . . 0.0 109.261 166.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 151.87 -56.81 0.44 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.162 -1.355 . . . . 0.0 114.428 168.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.71 -176.84 5.96 Favored 'General case' 0 C--N 1.34 0.196 0 CA-C-N 119.958 1.879 . . . . 0.0 110.966 176.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -44.78 138.32 3.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 130.034 3.334 . . . . 0.0 111.935 176.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.8 pt -139.07 -2.03 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.95 1.7 . . . . 0.0 112.226 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.457 ' HB3' ' H ' ' A' ' 99' ' ' VAL . 0.0 OUTLIER -127.02 170.89 11.83 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.358 1.463 . . . . 0.0 107.43 -176.762 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.6 tttm -159.62 21.47 0.18 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.262 1.425 . . . . 0.0 111.628 175.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.41 87.9 1.57 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.388 -1.445 . . . . 0.0 110.54 -174.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 p -73.15 161.97 29.98 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.3 1.04 . . . . 0.0 110.441 170.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.2 mt -140.39 138.21 34.6 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.338 1.455 . . . . 0.0 108.417 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.5 p -142.61 81.69 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 122.489 1.138 . . . . 0.0 110.11 -172.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -73.13 167.17 21.7 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.423 1.489 . . . . 0.0 110.399 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -139.36 162.32 35.3 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 123.634 0.774 . . . . 0.0 110.173 -175.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -75.28 149.05 38.9 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.882 0.873 . . . . 0.0 108.838 167.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.21 36.14 13.43 Favored Glycine 0 C--O 1.239 0.437 0 CA-C-O 117.35 -1.806 . . . . 0.0 115.346 153.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.07 117.0 3.47 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 120.785 2.292 . . . . 0.0 114.99 -172.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.62 119.36 5.17 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.69 0.677 . . . . 0.0 110.461 169.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.9 pp -143.42 163.9 15.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 125.898 1.679 . . . . 0.0 110.342 174.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.7 p -164.35 8.73 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 116.87 2.174 . . . . 0.0 116.87 177.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.5 p -146.95 9.85 1.01 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 116.215 1.932 . . . . 0.0 116.215 -156.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -140.94 70.33 1.35 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.707 1.14 . . . . 0.0 108.134 167.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -122.19 -85.77 0.65 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-O 117.732 -1.127 . . . . 0.0 110.916 173.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 37.0 mt -142.25 101.22 3.87 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 120.16 1.345 . . . . 0.0 110.456 -165.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -130.01 51.53 2.08 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.174 2.189 . . . . 0.0 107.402 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 mp -107.55 139.17 42.5 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.801 1.24 . . . . 0.0 108.916 177.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 59.5 t80 -151.32 91.2 1.65 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -178.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -83.68 153.46 24.21 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.283 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 177.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.79 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -153.83 102.2 2.5 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 169.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.6 t0 174.45 127.79 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -144.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -158.67 122.95 4.05 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.897 1.279 . . . . 0.0 108.802 -169.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -153.57 85.45 4.08 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 124.496 1.118 . . . . 0.0 109.403 -172.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -86.81 142.55 6.75 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.401 2.067 . . . . 0.0 111.92 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -110.07 75.27 0.21 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 170.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 149.23 -168.05 29.58 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 124.495 1.045 . . . . 0.0 111.333 176.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.3 tttm -123.97 166.92 14.86 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 159.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . -164.61 -148.6 5.51 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 127.803 2.621 . . . . 0.0 107.79 166.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.88 179.03 6.62 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.079 0.952 . . . . 0.0 109.991 -168.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.2 mtp -107.96 166.21 10.89 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 155.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.51 ' HB3' ' CD2' ' A' ' 75' ' ' PHE . 71.0 m-85 -147.65 139.99 24.47 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -142.4 120.93 12.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -178.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p -105.36 161.69 5.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 123.002 1.382 . . . . 0.0 109.063 176.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 p -132.86 148.7 52.3 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.519 1.528 . . . . 0.0 106.977 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.4 tp -139.51 132.65 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 174.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -132.95 123.73 26.47 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 127.133 2.173 . . . . 0.0 106.563 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -103.86 137.54 41.72 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.031 0.932 . . . . 0.0 109.291 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 m -135.99 172.15 13.44 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.295 -0.878 . . . . 0.0 110.707 170.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.88 -150.54 32.66 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-O 121.642 0.579 . . . . 0.0 111.987 173.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -72.89 98.09 2.39 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 159.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -113.71 23.59 12.94 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.146 0.498 . . . . 0.0 110.65 170.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.2 mtt180 -102.92 -29.32 11.5 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 118.498 -0.763 . . . . 0.0 111.693 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.8 m -114.55 22.44 13.62 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -152.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -128.41 144.83 51.19 Favored 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 121.476 -0.765 . . . . 0.0 109.251 -173.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.2 mp -76.03 89.11 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 171.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -89.64 146.99 24.16 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.006 1.322 . . . . 0.0 108.953 -177.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.3 t -138.69 148.91 44.55 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.457 1.503 . . . . 0.0 108.536 -174.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.4 t -136.87 106.79 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 161.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.3 t -65.73 117.01 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 160.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 91.8 t -116.72 123.62 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 175.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.454 HG22 ' HB3' ' A' ' 51' ' ' PRO . 16.8 t -129.72 156.76 42.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 162.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.29 120.91 9.79 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.969 1.708 . . . . 0.0 107.42 165.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -75.1 109.31 8.47 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 118.039 -0.981 . . . . 0.0 108.707 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.43 10.66 50.35 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 116.844 1.498 . . . . 0.0 116.844 161.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.854 HG22 ' HB2' ' A' ' 72' ' ' ALA . 14.8 t -157.0 -174.8 5.09 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 119.536 1.668 . . . . 0.0 107.969 164.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -106.46 165.27 11.39 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 122.309 1.052 . . . . 0.0 113.699 168.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.15 169.07 13.43 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 112.272 -2.24 . . . . 0.0 109.772 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -144.15 123.5 13.08 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.301 1.441 . . . . 0.0 109.215 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -71.93 131.77 43.43 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.301 1.04 . . . . 0.0 110.341 -177.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.07 -18.41 72.83 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.31 -1.272 . . . . 0.0 113.904 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.0 -60.38 3.96 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 119.057 1.428 . . . . 0.0 109.367 174.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.28 0.61 1.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -157.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.04 12.35 83.44 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-O 119.854 -0.414 . . . . 0.0 112.371 174.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -65.12 130.43 43.34 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.3 m -68.82 125.01 25.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 175.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.7 mt -112.71 128.92 56.54 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -174.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -95.81 88.36 4.93 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.303 1.041 . . . . 0.0 109.088 -170.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.7 m -51.15 156.67 1.76 Allowed Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 128.423 2.689 . . . . 0.0 112.128 172.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.454 ' HB3' HG22 ' A' ' 33' ' ' VAL . 66.7 Cg_endo -73.42 154.22 99.49 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 N-CA-C 109.435 -1.025 . . . . 0.0 109.435 -8.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.2 t -138.55 144.21 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.0 mm -120.68 81.35 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 28.4 mt -63.1 136.19 57.64 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 m -110.27 175.74 5.32 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 125.902 1.681 . . . . 0.0 110.088 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -46.9 -48.04 21.34 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 127.306 2.243 . . . . 0.0 113.744 -175.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -69.6 -40.53 76.6 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.512 0.596 . . . . 0.0 110.89 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -68.4 -10.88 58.14 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.064 0.945 . . . . 0.0 111.081 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.9 mt -121.29 10.49 10.61 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.179 2.191 . . . . 0.0 111.141 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.92 11.97 0.46 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.067 1.347 . . . . 0.0 112.662 171.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.1 m -66.44 -168.5 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 126.054 1.742 . . . . 0.0 111.135 164.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -110.91 -36.24 5.73 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.909 1.684 . . . . 0.0 111.466 168.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.18 143.03 26.78 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 127.327 2.251 . . . . 0.0 105.941 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.2 p -146.63 102.6 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 120.363 1.438 . . . . 0.0 112.436 161.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m -66.04 134.48 52.96 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.434 -1.417 . . . . 0.0 109.933 172.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 mt -132.99 146.52 51.85 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 124.307 1.043 . . . . 0.0 108.455 -175.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.4 t -162.7 160.12 25.16 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -161.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -86.85 151.23 23.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.422 0.629 . . . . 0.0 112.466 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.2 p -82.75 -20.91 35.01 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.614 1.566 . . . . 0.0 112.165 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -146.55 -163.87 10.67 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 125.873 1.702 . . . . 0.0 108.871 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.425 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 16.1 ttpt -77.47 141.91 39.44 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 175.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.854 ' HB2' HG22 ' A' ' 37' ' ' THR . . . -132.95 175.52 9.29 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.957 0.903 . . . . 0.0 109.833 171.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 mm -121.6 -13.53 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.409 1.084 . . . . 0.0 110.205 -167.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -151.51 162.2 41.37 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.614 1.166 . . . . 0.0 108.828 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.51 ' CD2' ' HB3' ' A' ' 13' ' ' TYR . 3.0 t80 -155.58 85.91 1.06 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.695 0.798 . . . . 0.0 109.202 173.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.16 149.72 28.99 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.998 -0.439 . . . . 0.0 110.73 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 t -142.65 124.25 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 125.248 1.419 . . . . 0.0 108.368 171.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.09 169.76 17.24 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 158.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.35 -125.74 0.88 Allowed Glycine 0 CA--C 1.52 0.394 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 173.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.32 173.03 13.48 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 123.614 0.626 . . . . 0.0 112.203 173.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.2 m -146.47 129.53 9.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 125.232 1.413 . . . . 0.0 109.175 173.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.86 159.1 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 123.896 0.878 . . . . 0.0 108.703 157.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -69.54 150.45 47.12 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.403 168.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -115.41 28.43 7.88 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 126.012 1.768 . . . . 0.0 112.628 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -128.65 -164.29 1.37 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.713 1.756 . . . . 0.0 108.039 171.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -143.09 110.63 5.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 105.807 -1.924 . . . . 0.0 105.807 169.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.27 18.04 58.02 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-O 119.166 -0.797 . . . . 0.0 113.417 174.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.2 p -59.66 156.49 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.988 0.899 . . . . 0.0 109.912 169.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.9 t -124.84 88.72 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -115.02 -154.34 0.54 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.986 1.715 . . . . 0.0 108.346 173.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -129.4 164.46 39.42 Favored Pre-proline 0 C--N 1.333 -0.127 0 O-C-N 120.551 -1.343 . . . . 0.0 111.614 176.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -73.0 175.19 10.8 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.485 1.457 . . . . 0.0 111.976 176.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -138.16 168.72 19.13 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.068 0.947 . . . . 0.0 110.414 177.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -135.98 157.04 47.79 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 169.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.539 ' CE3' HD12 ' A' ' 111' ' ' LEU . 33.2 m0 -123.46 133.82 54.0 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 168.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.1 t -90.28 135.57 26.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 151.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.7 130.68 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 172.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 m -135.94 147.63 48.17 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -176.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.2 t -118.07 131.2 71.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -116.1 166.92 11.46 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 128.682 2.793 . . . . 0.0 107.988 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -118.67 -154.3 0.56 Allowed 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 129.224 3.01 . . . . 0.0 107.616 -171.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -69.34 85.43 0.4 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 162.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.75 16.64 69.96 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 117.98 -1.456 . . . . 0.0 115.258 164.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.7 167.49 28.02 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 120.785 2.293 . . . . 0.0 112.116 172.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -90.21 141.05 29.08 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.09 1.356 . . . . 0.0 109.16 -174.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.8 pt -129.02 -19.81 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 119.124 0.874 . . . . 0.0 113.357 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -132.42 160.5 36.2 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -157.79 87.16 0.93 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 176.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.33 164.05 24.4 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 171.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.5 t -138.93 163.33 32.61 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.539 HD12 ' CE3' ' A' ' 95' ' ' TRP . 24.2 mt -126.14 157.49 37.98 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 123.61 0.764 . . . . 0.0 109.013 -177.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.3 p -147.2 114.68 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 -173.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -123.55 171.6 9.4 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 44.9 mtp85 -136.82 159.79 40.79 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.466 0.65 . . . . 0.0 110.285 174.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -65.59 158.24 27.68 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 127.095 2.158 . . . . 0.0 111.473 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.09 -73.58 0.28 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.302 1.429 . . . . 0.0 113.512 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -158.99 29.47 0.21 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 118.604 2.816 . . . . 0.0 118.604 -148.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -144.21 84.59 1.77 Allowed 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.206 -1.559 . . . . 0.0 113.666 -175.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.1 pp -144.8 -174.62 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 127.063 2.145 . . . . 0.0 109.767 174.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.3 t -153.24 148.04 26.39 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 121.364 -0.835 . . . . 0.0 110.078 168.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.0 p -69.45 30.0 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 129.862 3.265 . . . . 0.0 114.138 -175.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -126.86 56.56 1.49 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 158.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -56.46 10.24 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.75 143.49 50.78 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.884 1.274 . . . . 0.0 108.834 174.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -153.1 25.17 0.55 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.779 1.632 . . . . 0.0 111.586 -157.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 88.3 mt -97.15 124.41 41.18 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.71 1.604 . . . . 0.0 107.829 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -139.89 46.64 1.86 Allowed 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.542 0.737 . . . . 0.0 109.019 -170.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -55.26 137.67 46.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.85 -168.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.086 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 167.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.696 0 N-CA-C 107.524 -2.23 . . . . 0.0 107.524 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -149.38 -64.8 0.22 Allowed 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -157.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -171.11 155.79 4.54 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 129.329 3.052 . . . . 0.0 104.33 -164.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -141.16 99.11 3.51 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -172.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -152.82 57.17 1.96 Allowed Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.659 1.184 . . . . 0.0 110.329 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.42 111.01 2.18 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.356 2.038 . . . . 0.0 111.593 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.81 13.34 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.036 -0.984 . . . . 0.0 113.538 -156.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 173.89 -160.69 30.78 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -175.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.83 130.71 54.48 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.615 1.166 . . . . 0.0 109.107 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.41 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . -159.75 -126.3 0.84 Allowed Glycine 0 C--N 1.317 -0.485 0 C-N-CA 127.534 2.492 . . . . 0.0 107.137 164.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.64 161.4 35.23 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.724 0.81 . . . . 0.0 110.86 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 7.8 mtp -91.89 153.62 19.39 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 158.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.489 ' CD1' ' HB2' ' A' ' 75' ' ' PHE . 8.6 m-85 -143.65 114.66 7.81 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 126.282 1.833 . . . . 0.0 106.448 -170.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -127.29 144.76 50.99 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.743 2.017 . . . . 0.0 106.885 172.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.42 132.94 38.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 127.133 2.173 . . . . 0.0 108.89 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.5 p -96.0 163.56 13.08 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.749 0.785 . . . . 0.0 109.913 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.426 HD11 ' CD2' ' A' ' 95' ' ' TRP . 4.0 tp -140.75 112.6 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 167.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -114.29 135.97 53.48 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -176.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -122.19 115.4 22.33 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 124.287 1.035 . . . . 0.0 108.732 -161.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 m -120.92 -179.01 3.88 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.17 -99.29 0.56 Allowed Glycine 0 C--N 1.338 0.651 0 C-N-CA 127.301 2.382 . . . . 0.0 110.417 176.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.6 113.39 9.11 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -117.53 11.02 13.69 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -170.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -102.57 -1.06 31.09 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.079 1.352 . . . . 0.0 113.941 -168.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.1 m -143.45 95.12 2.7 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 164.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -176.94 110.83 0.08 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 128.08 2.552 . . . . 0.0 106.433 174.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.3 pt -66.39 86.8 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 127.221 2.208 . . . . 0.0 112.36 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.42 144.68 55.63 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 121.113 -0.992 . . . . 0.0 109.942 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.9 m -148.36 130.03 15.03 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 170.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.8 t -140.39 165.77 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 175.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.647 HG13 ' CD1' ' A' ' 53' ' ' ILE . 30.0 t -141.13 52.42 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 125.786 1.635 . . . . 0.0 110.806 -157.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.7 p -65.91 135.85 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 O-C-N 119.248 -2.157 . . . . 0.0 111.215 -170.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.6 t -117.56 148.12 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 171.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.32 133.74 20.77 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.93 0.892 . . . . 0.0 108.615 171.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -102.7 85.83 2.64 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.186 1.394 . . . . 0.0 109.022 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.09 -78.76 0.29 Allowed Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 162.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.8 t -76.55 179.51 5.9 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.106 0.963 . . . . 0.0 109.914 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -96.67 168.05 10.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.833 1.253 . . . . 0.0 111.232 174.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.59 168.31 15.48 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.38 1.472 . . . . 0.0 109.38 176.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -137.01 128.14 27.83 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.795 1.638 . . . . 0.0 109.524 172.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -92.2 110.32 21.71 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.547 1.939 . . . . 0.0 109.45 -165.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -57.69 -23.12 49.06 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 118.989 0.813 . . . . 0.0 114.553 -169.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.87 -56.97 15.32 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.325 1.45 . . . . 0.0 112.032 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.5 p -125.67 0.15 7.46 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.608 1.563 . . . . 0.0 111.144 -164.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.78 22.56 54.04 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 125.395 1.474 . . . . 0.0 112.171 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.32 158.2 26.17 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 118.24 1.02 . . . . 0.0 109.358 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.4 m -117.4 106.15 12.9 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 122.391 1.091 . . . . 0.0 110.207 -167.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 45.3 mt -93.59 159.47 15.21 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 125.109 1.364 . . . . 0.0 111.874 -164.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.86 95.69 9.67 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.926 2.09 . . . . 0.0 108.763 -172.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.2 p -58.74 167.72 1.73 Allowed Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.053 0.941 . . . . 0.0 111.468 172.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.72 145.38 79.18 Favored 'Cis proline' 0 CA--C 1.537 0.629 0 N-CA-C 109.733 -0.91 . . . . 0.0 109.733 -19.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.6 p -135.19 156.93 39.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 O-C-N 121.242 -0.911 . . . . 0.0 109.939 -170.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.647 ' CD1' HG13 ' A' ' 31' ' ' VAL . 30.5 mm -114.02 126.83 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 175.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.8 mt -92.43 164.83 13.33 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 128.154 2.582 . . . . 0.0 110.327 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.571 ' H ' ' HG2' ' A' ' 58' ' ' GLU . 57.4 p -132.64 -163.35 1.33 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.417 2.287 . . . . 0.0 111.126 -165.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -88.08 -21.01 24.96 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 126.565 1.946 . . . . 0.0 110.292 175.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.32 -36.52 61.05 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.286 1.434 . . . . 0.0 111.973 -177.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.571 ' HG2' ' H ' ' A' ' 55' ' ' SER . 2.3 pp20? -75.95 -32.09 59.37 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.262 1.825 . . . . 0.0 111.776 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.6 mt -95.99 24.16 5.78 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.5 1.12 . . . . 0.0 112.655 -176.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -77.41 33.24 0.16 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.629 1.972 . . . . 0.0 113.467 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.6 m -130.45 -167.83 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.511 1.924 . . . . 0.0 109.871 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -98.57 -24.08 15.25 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.335 1.454 . . . . 0.0 113.246 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -159.64 148.89 18.04 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 117.838 -1.077 . . . . 0.0 108.927 171.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.26 165.22 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 165.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 83.3 m -134.59 124.06 24.83 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 128.553 2.741 . . . . 0.0 105.685 171.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.6 140.51 49.54 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 174.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.1 t -145.42 -177.08 5.38 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.284 0.634 . . . . 0.0 110.405 -174.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.92 136.01 53.05 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 128.339 2.656 . . . . 0.0 110.306 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.9 p -75.24 -43.21 52.83 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 118.752 -1.179 . . . . 0.0 109.647 -171.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -107.98 -98.71 2.57 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.41 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -147.23 147.64 30.66 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.959 1.703 . . . . 0.0 109.964 174.235 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.468 ' C ' HD13 ' A' ' 73' ' ' ILE . . . -127.23 -178.56 4.48 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.345 1.058 . . . . 0.0 109.088 170.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.468 HD13 ' C ' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -122.84 -0.03 6.52 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.598 0 CA-C-O 117.664 -1.16 . . . . 0.0 110.814 176.413 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -149.63 158.0 43.77 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 120.561 1.528 . . . . 0.0 110.435 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.489 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -153.53 117.52 4.79 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 166.045 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -121.95 135.32 54.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.2 t -137.53 112.94 10.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -172.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.3 m -136.06 178.4 7.08 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.226 0.61 . . . . 0.0 110.134 173.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.01 -85.17 0.13 Allowed Glycine 0 C--N 1.333 0.39 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 155.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.34 179.12 18.98 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 127.37 2.414 . . . . 0.0 108.328 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.6 p -155.67 156.55 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 118.577 1.189 . . . . 0.0 109.379 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.6 t -135.27 170.1 19.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 127.826 2.451 . . . . 0.0 106.326 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.446 ' HB3' ' HA3' ' A' ' 116' ' ' GLY . 21.5 t0 -123.18 101.28 7.3 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 163.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.11 13.19 67.67 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.678 1.608 . . . . 0.0 113.865 -171.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.84 173.65 1.28 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.04 1.736 . . . . 0.0 110.709 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -165.63 125.69 1.78 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.84 -6.16 32.86 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 123.97 0.795 . . . . 0.0 113.506 174.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.0 p -146.72 140.44 20.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 171.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.71 136.04 27.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 169.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -109.14 -162.61 0.82 Allowed 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 170.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -124.23 165.83 22.41 Favored Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 120.906 1.685 . . . . 0.0 112.082 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.55 174.38 11.9 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.959 2.44 . . . . 0.0 113.547 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.7 ptp -148.0 -176.01 5.11 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.998 0.919 . . . . 0.0 111.131 -168.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -141.15 161.34 38.1 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 128.143 2.577 . . . . 0.0 106.616 169.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.426 ' CD2' HD11 ' A' ' 17' ' ' ILE . 2.4 m0 -130.68 112.28 12.97 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 104.972 -2.233 . . . . 0.0 104.972 173.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.02 127.3 45.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 168.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 m -139.39 104.45 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -167.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.3 m -118.63 153.29 34.54 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -169.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.93 124.89 51.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -174.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -121.14 121.06 37.02 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.962 1.705 . . . . 0.0 108.246 -172.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -73.05 -166.52 0.31 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.594 1.958 . . . . 0.0 109.771 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -58.66 90.44 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 163.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.4 29.58 75.57 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.535 2.017 . . . . 0.0 115.771 171.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -145.06 176.44 9.5 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 120.016 1.908 . . . . 0.0 109.746 165.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -98.1 154.33 17.81 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.97 1.708 . . . . 0.0 108.278 170.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 43.1 pt -132.17 -13.44 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.698 1.199 . . . . 0.0 112.753 168.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -140.91 150.12 42.77 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 119.776 1.171 . . . . 0.0 108.101 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -146.55 52.67 1.11 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.698 1.199 . . . . 0.0 108.076 170.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -75.85 169.7 17.64 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 122.23 1.014 . . . . 0.0 109.888 174.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.8 t -152.02 164.99 36.05 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.095 1.758 . . . . 0.0 106.455 171.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 37.6 mt -135.32 174.48 10.57 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.105 2.162 . . . . 0.0 109.033 176.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 p -152.9 68.05 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.394 1.077 . . . . 0.0 109.169 -175.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -66.71 123.39 19.97 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.033 1.333 . . . . 0.0 109.517 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -136.15 167.17 21.77 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.727 1.211 . . . . 0.0 109.995 176.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 50.98 86.68 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 129.729 3.211 . . . . 0.0 111.325 169.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.446 ' HA3' ' HB3' ' A' ' 83' ' ' ASP . . . -49.99 69.27 0.0 OUTLIER Glycine 0 C--N 1.338 0.668 0 C-N-CA 129.847 3.594 . . . . 0.0 115.422 166.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -123.12 174.79 7.01 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.423 1.889 . . . . 0.0 109.745 171.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -64.39 107.89 1.47 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.4 pp -141.77 165.63 17.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 126.804 2.042 . . . . 0.0 108.844 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.5 p -154.16 140.31 18.45 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.467 1.507 . . . . 0.0 107.284 161.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.3 p -144.0 163.17 34.26 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.145 0.978 . . . . 0.0 109.515 169.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -89.56 40.18 0.98 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 169.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.86 -42.56 65.33 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.847 2.059 . . . . 0.0 111.74 -178.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.47 106.27 16.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 176.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -161.86 87.11 0.65 Allowed 'General case' 0 C--O 1.234 0.286 0 O-C-N 123.479 0.487 . . . . 0.0 111.024 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.7 mt -133.67 150.15 51.54 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.171 1.388 . . . . 0.0 109.511 -172.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -143.23 146.86 34.02 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.843 1.657 . . . . 0.0 109.397 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -145.78 155.08 42.7 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.414 1.486 . . . . 0.0 109.069 172.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--O 1.249 1.065 0 C-N-CA 126.569 1.948 . . . . 0.0 106.663 173.37 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.601 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -82.81 -83.97 0.13 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -155.14 129.3 8.87 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -167.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -135.55 -86.15 0.37 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -169.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -162.41 75.22 2.14 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 127.101 2.161 . . . . 0.0 106.292 -176.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -76.12 171.95 17.17 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.546 2.164 . . . . 0.0 110.707 171.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.19 82.66 0.05 OUTLIER Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 175.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -158.57 166.92 34.49 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 177.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -110.7 121.64 45.84 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.419 1.088 . . . . 0.0 109.629 -173.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.86 -124.08 0.72 Allowed Glycine 0 CA--C 1.53 1.031 0 C-N-CA 128.641 3.02 . . . . 0.0 108.127 163.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.21 168.62 26.55 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.526 1.663 . . . . 0.0 109.767 -174.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.6 mtp -107.86 164.58 12.14 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.484 1.114 . . . . 0.0 111.82 162.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -177.36 153.78 0.96 Allowed 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 131.132 3.773 . . . . 0.0 110.054 -169.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -145.1 147.84 32.98 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.601 2.76 . . . . 0.0 105.137 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -124.06 146.74 29.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 125.83 1.652 . . . . 0.0 108.438 175.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.449 ' CG2' HG23 ' A' ' 65' ' ' THR . 1.3 p -130.01 116.35 18.44 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.477 HG22 ' HB ' ' A' ' 64' ' ' VAL . 0.7 OUTLIER -79.09 143.81 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 117.532 -1.667 . . . . 0.0 106.9 160.334 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -124.0 117.94 25.89 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 104.167 -2.531 . . . . 0.0 104.167 158.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -94.53 110.19 22.02 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 173.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 m -84.35 158.39 21.16 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 123.343 0.402 . . . . 0.0 110.184 172.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.97 -145.26 25.66 Favored Glycine 0 C--O 1.241 0.59 0 O-C-N 123.784 0.677 . . . . 0.0 112.684 168.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -82.67 128.91 34.79 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 168.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -132.64 17.94 4.3 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.681 1.192 . . . . 0.0 111.091 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -120.95 35.23 4.95 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.088 1.355 . . . . 0.0 110.402 -168.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.1 t -145.57 -6.33 0.62 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.245 1.418 . . . . 0.0 110.835 -173.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.439 ' HB3' ' CG2' ' A' ' 81' ' ' VAL . 20.7 m-85 -101.98 170.55 8.05 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 120.699 -1.25 . . . . 0.0 108.2 -153.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.2 mp -137.53 96.76 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -169.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.8 tptt 174.32 -162.03 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.739 2.015 . . . . 0.0 110.81 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.3 m -155.65 174.42 15.31 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.683 1.993 . . . . 0.0 110.569 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 t -115.97 144.69 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.026 1.331 . . . . 0.0 107.426 170.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.7 t -99.62 150.48 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 126.454 1.902 . . . . 0.0 108.247 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -145.33 145.32 20.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 124.073 0.949 . . . . 0.0 110.542 163.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.3 t -135.97 137.82 48.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 165.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.7 107.41 5.91 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.318 1.047 . . . . 0.0 108.517 173.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -59.85 112.0 1.68 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.071 1.349 . . . . 0.0 109.737 -177.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.25 32.76 27.72 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-O 118.395 -1.225 . . . . 0.0 114.743 165.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.532 ' CG2' ' HB2' ' A' ' 72' ' ' ALA . 11.4 t -156.51 -170.5 3.36 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.137 1.469 . . . . 0.0 110.103 175.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -111.87 164.64 12.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.941 1.696 . . . . 0.0 110.506 159.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.55 168.67 10.22 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 127.973 2.509 . . . . 0.0 108.255 176.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -130.23 132.24 45.89 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.328 1.851 . . . . 0.0 106.642 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -82.57 116.71 22.1 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 164.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.59 -10.02 62.9 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 118.573 -1.126 . . . . 0.0 114.476 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.16 -52.49 58.78 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 118.912 1.356 . . . . 0.0 109.922 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.33 -9.48 5.79 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.053 1.341 . . . . 0.0 111.47 -170.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.73 56.28 5.52 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -176.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -102.29 129.59 48.77 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 38.1 t -71.89 145.38 48.56 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.014 0.824 . . . . 0.0 109.069 172.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 24.1 mt -137.66 130.05 29.45 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 124.842 1.257 . . . . 0.0 110.089 -170.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -86.36 87.64 7.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.912 -177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.43 156.7 40.16 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-O 117.864 -1.065 . . . . 0.0 110.679 170.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.4 144.17 79.66 Favored 'Cis proline' 0 C--N 1.348 0.546 0 CA-C-N 120.305 1.144 . . . . 0.0 111.268 -2.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.8 p -157.57 162.14 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.229 1.011 . . . . 0.0 111.168 -170.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.8 mm -129.99 107.98 15.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 126.623 1.969 . . . . 0.0 108.494 -169.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.2 mt -70.62 125.3 26.43 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.337 0.655 . . . . 0.0 109.812 175.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.47 -172.11 3.88 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.48 2.312 . . . . 0.0 110.589 -176.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -61.18 -42.55 98.77 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.502 -1.374 . . . . 0.0 112.72 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -51.42 -45.3 62.55 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.065 0.946 . . . . 0.0 110.798 -176.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.404 ' H ' ' HG2' ' A' ' 58' ' ' GLU . 2.3 mm-40 -68.59 -40.02 80.68 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.293 1.437 . . . . 0.0 109.704 -175.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -89.02 11.7 17.58 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.35 1.86 . . . . 0.0 112.258 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.19 16.87 0.21 Allowed 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.046 -1.659 . . . . 0.0 113.03 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.1 m -131.62 163.75 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 126.319 1.847 . . . . 0.0 111.252 -172.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -65.62 -27.32 68.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.122 1.369 . . . . 0.0 112.75 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -152.48 126.54 9.11 Favored 'General case' 0 CA--C 1.511 -0.555 0 O-C-N 121.088 -1.008 . . . . 0.0 109.962 -173.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.477 ' HB ' HG22 ' A' ' 17' ' ' ILE . 23.3 t -120.54 140.68 43.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 173.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.449 HG23 ' CG2' ' A' ' 16' ' ' THR . 25.5 m -138.0 106.89 5.96 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.071 1.348 . . . . 0.0 108.446 -163.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.2 mt -124.0 139.3 54.08 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -167.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.6 t -145.45 159.99 42.25 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.5 p -72.84 140.95 47.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.733 168.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.5 p -71.85 -53.0 14.61 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.093 174.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -112.54 170.58 13.55 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 124.992 1.282 . . . . 0.0 110.014 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.46 134.56 56.77 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.111 0.964 . . . . 0.0 109.646 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.532 ' HB2' ' CG2' ' A' ' 37' ' ' THR . . . -117.97 179.76 3.99 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 125.678 1.591 . . . . 0.0 107.541 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.526 HD13 ' C ' ' A' ' 72' ' ' ALA . 1.1 mm -117.19 -10.63 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.503 0.721 . . . . 0.0 111.163 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -148.05 165.14 31.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 167.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -144.33 107.31 4.5 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.683 1.593 . . . . 0.0 107.716 168.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.66 153.09 19.71 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.391 0.676 . . . . 0.0 109.958 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.5 t -144.98 115.35 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 127.274 2.23 . . . . 0.0 105.84 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 95.4 p -154.63 -172.73 4.3 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 120.688 -1.258 . . . . 0.0 111.162 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.48 -161.34 12.77 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -170.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.6 175.22 36.63 Favored Glycine 0 N--CA 1.464 0.531 0 N-CA-C 106.752 -2.539 . . . . 0.0 106.752 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.447 HG12 ' CZ2' ' A' ' 95' ' ' TRP . 1.8 p -157.42 163.58 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 120.697 2.249 . . . . 0.0 109.79 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.9 p -151.94 160.16 3.61 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 160.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -87.81 129.92 35.04 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 171.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -95.19 -3.55 61.63 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 117.325 -1.819 . . . . 0.0 112.497 176.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -63.03 120.32 11.19 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 119.367 1.583 . . . . 0.0 108.18 167.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -126.86 37.95 4.19 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 170.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -131.81 -22.18 0.95 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.155 1.36 . . . . 0.0 113.007 -175.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.9 p -107.34 143.39 18.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 125.517 1.527 . . . . 0.0 107.479 174.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.4 p -83.28 126.99 40.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 166.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -126.1 -168.64 1.88 Allowed 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -115.76 154.92 48.12 Favored Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 155.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -80.47 -166.95 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.849 3.033 . . . . 0.0 112.288 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.4 ptm -145.62 167.44 23.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.638 0.732 . . . . 0.0 111.923 -171.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -132.61 131.52 41.51 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 168.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.447 ' CZ2' HG12 ' A' ' 81' ' ' VAL . 13.2 m0 -79.9 105.0 10.86 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 156.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.3 t -79.59 135.89 24.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 149.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.9 t -138.76 91.21 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 172.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.22 152.02 38.39 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.013 1.325 . . . . 0.0 108.415 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 t -134.81 131.7 53.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 175.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -102.91 159.24 15.67 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 128.208 2.603 . . . . 0.0 107.634 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.414 ' HG3' ' H ' ' A' ' 102' ' ' ASN . 22.0 tptm -129.21 -172.1 2.65 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 127.848 2.459 . . . . 0.0 105.41 177.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.414 ' H ' ' HG3' ' A' ' 101' ' ' LYS . 11.6 p30 -54.1 50.12 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 130.166 3.386 . . . . 0.0 115.387 177.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 169.03 -58.2 0.2 Allowed Glycine 0 CA--C 1.524 0.622 0 O-C-N 119.541 -1.974 . . . . 0.0 112.145 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.76 -175.32 5.08 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.217 1.407 . . . . 0.0 111.339 -171.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -55.15 141.18 35.87 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.625 1.57 . . . . 0.0 108.923 175.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 15.9 pt -121.39 -34.05 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 125.57 1.548 . . . . 0.0 111.066 167.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -133.34 149.99 51.87 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 120.241 1.382 . . . . 0.0 109.723 -175.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.7 pttt -155.46 42.29 0.43 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.249 2.219 . . . . 0.0 108.857 -153.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.57 ' HE2' HD11 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -111.53 149.3 31.59 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.655 0.782 . . . . 0.0 110.744 -172.883 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.0 t -142.06 162.34 35.73 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.22 1.408 . . . . 0.0 109.341 -169.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.536 ' N ' HD12 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -124.61 -163.71 1.2 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.618 1.967 . . . . 0.0 106.409 -179.817 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.57 144.89 15.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 127.641 2.377 . . . . 0.0 107.331 168.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -130.29 146.83 51.94 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 106.503 -1.665 . . . . 0.0 106.503 170.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 48.1 mtm105 -134.07 158.57 43.26 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.113 0.965 . . . . 0.0 108.613 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.99 162.07 26.21 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 126.982 2.113 . . . . 0.0 109.403 -153.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.29 35.46 60.28 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 124.281 0.943 . . . . 0.0 114.016 168.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.6 mmtt -139.14 172.35 12.96 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.673 1.237 . . . . 0.0 110.08 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.42 98.72 3.3 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 120.743 -1.223 . . . . 0.0 109.198 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.3 pp -127.54 163.79 30.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 123.982 0.913 . . . . 0.0 110.141 -172.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.45 36.26 0.16 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.819 1.247 . . . . 0.0 110.064 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.2 p -63.11 163.18 10.44 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 120.795 -1.191 . . . . 0.0 110.66 167.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -65.83 49.4 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 129.457 3.103 . . . . 0.0 110.08 164.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.32 -29.84 59.07 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.323 1.449 . . . . 0.0 111.633 169.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.57 HD11 ' HE2' ' A' ' 109' ' ' LYS . 8.0 tp -138.17 146.4 42.68 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.427 0.632 . . . . 0.0 109.38 169.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -176.48 76.67 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.811 2.044 . . . . 0.0 105.966 -171.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.7 tp -126.12 137.34 53.59 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.919 0.888 . . . . 0.0 109.214 -168.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -140.45 144.52 36.13 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.019 1.328 . . . . 0.0 109.697 -176.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -140.18 155.54 46.9 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.485 1.514 . . . . 0.0 109.108 171.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.0 p30 . . . . . 0 C--O 1.25 1.097 0 C-N-CA 127.591 2.356 . . . . 0.0 105.906 158.308 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.204 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -158.53 66.57 0.44 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 164.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -157.47 128.45 6.64 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.635 -1.166 . . . . 0.0 107.883 -150.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -166.51 175.9 7.73 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 131.127 3.771 . . . . 0.0 105.139 -173.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.47 75.28 6.47 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 176.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -71.86 161.51 44.75 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.059 1.84 . . . . 0.0 110.846 -166.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.35 47.7 2.99 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.341 0.972 . . . . 0.0 111.694 175.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.84 136.79 4.42 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 119.641 1.72 . . . . 0.0 112.509 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -138.35 165.09 27.63 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 126.827 2.051 . . . . 0.0 107.496 166.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.593 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . 156.72 -160.36 30.24 Favored Glycine 0 CA--C 1.525 0.686 1 C-N-CA 131.601 4.429 . . . . 0.0 107.736 -178.762 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.18 167.88 20.17 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.787 0.835 . . . . 0.0 112.009 -167.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.9 mtp -86.41 153.26 22.04 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 161.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -147.55 130.39 16.14 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 125.834 1.959 . . . . 0.0 108.578 -175.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -140.96 149.75 42.21 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.217 2.207 . . . . 0.0 106.814 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.404 HG23 HG22 ' A' ' 99' ' ' VAL . 11.2 p -144.86 158.95 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 C-N-CA 124.833 1.253 . . . . 0.0 109.686 177.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.2 124.88 14.95 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 -165.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.1 tp -119.51 109.24 25.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -171.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -108.96 122.66 47.7 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.743 2.017 . . . . 0.0 109.537 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -105.45 139.69 39.69 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.179 -0.95 . . . . 0.0 109.982 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.5 m -143.46 166.99 23.26 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.781 0.832 . . . . 0.0 111.321 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.83 -156.32 28.33 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -168.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -76.59 92.0 3.44 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 121.39 -1.065 . . . . 0.0 108.801 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -97.5 14.76 25.35 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -173.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.38 9.05 10.27 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -158.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.0 m -141.17 40.17 1.77 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.08 2.152 . . . . 0.0 108.749 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.42 ' O ' ' HE2' ' A' ' 28' ' ' LYS . 46.7 m-85 -136.23 130.18 32.71 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 124.999 1.319 . . . . 0.0 109.36 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.9 mt -72.76 90.35 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.42 ' HE2' ' O ' ' A' ' 26' ' ' PHE . 27.0 mtmt -79.78 162.0 25.38 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.815 1.246 . . . . 0.0 110.252 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.4 t -146.72 154.18 41.12 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.902 0.881 . . . . 0.0 110.302 165.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 69.9 t -142.73 109.45 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 127.208 2.203 . . . . 0.0 105.676 164.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.9 p -73.02 147.5 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 149.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 p -131.58 137.71 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 126.202 1.801 . . . . 0.0 106.52 167.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 t -119.59 163.31 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 123.878 0.871 . . . . 0.0 108.923 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.56 153.42 40.35 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.844 1.258 . . . . 0.0 109.906 169.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -129.16 105.45 8.17 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 169.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.42 29.24 50.06 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 118.598 -1.112 . . . . 0.0 114.618 165.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.582 HG22 ' HB2' ' A' ' 72' ' ' ALA . 5.0 t -164.3 -164.72 0.88 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.21 1.804 . . . . 0.0 106.698 158.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -123.89 170.69 10.33 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.125 1.37 . . . . 0.0 109.974 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.41 166.01 12.28 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.904 1.281 . . . . 0.0 109.789 -175.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -134.52 116.79 15.49 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 125.338 1.455 . . . . 0.0 107.827 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -82.84 132.04 35.18 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 124.982 1.313 . . . . 0.0 109.167 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.28 -22.47 50.61 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 118.842 -0.977 . . . . 0.0 113.854 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.24 -52.31 16.36 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 127.572 2.349 . . . . 0.0 111.746 -177.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 t -148.17 -4.84 0.46 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.759 -0.638 . . . . 0.0 111.379 175.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.41 27.96 8.84 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 119.863 1.21 . . . . 0.0 111.668 -160.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -64.13 124.28 21.25 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.63 110.81 20.66 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.184 1.794 . . . . 0.0 111.029 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.9 mt -114.12 145.78 41.17 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 122.375 1.083 . . . . 0.0 112.631 -163.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.14 67.91 5.09 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.05 1.34 . . . . 0.0 112.153 -171.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.2 m -52.83 156.2 3.54 Favored Pre-proline 0 CA--C 1.543 0.692 0 O-C-N 121.054 -1.029 . . . . 0.0 113.097 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.9 144.85 75.85 Favored 'Cis proline' 0 CA--C 1.536 0.606 0 CA-C-N 119.071 0.704 . . . . 0.0 112.495 -5.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.6 t -140.73 155.38 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 126.134 1.774 . . . . 0.0 107.815 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.3 mm -116.59 144.74 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 125.575 1.55 . . . . 0.0 106.857 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.4 mt -120.97 115.89 24.06 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.983 1.313 . . . . 0.0 107.686 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 m -72.16 174.41 7.21 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 124.753 1.283 . . . . 0.0 110.389 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.65 -31.77 68.46 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.822 1.649 . . . . 0.0 113.074 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -63.82 -42.46 97.65 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 121.355 -0.84 . . . . 0.0 110.478 174.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -75.6 -32.12 60.19 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -175.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.8 mt -85.63 27.36 0.85 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.673 1.989 . . . . 0.0 111.792 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.05 1.4 27.9 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 176.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.8 m -88.76 149.12 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 119.427 1.012 . . . . 0.0 111.498 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -57.25 -37.01 71.68 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.451 1.101 . . . . 0.0 112.76 172.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -165.39 149.09 8.28 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -176.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.5 p -149.99 167.29 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 166.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.1 t -121.92 158.97 27.85 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 167.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 mt -135.89 155.03 50.92 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 173.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.4 t -164.44 158.03 17.98 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.5 p -78.34 158.17 28.89 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 122.858 0.463 . . . . 0.0 110.551 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.3 p -75.4 -13.67 60.41 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.349 -0.844 . . . . 0.0 111.722 171.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -167.37 -167.51 28.16 Favored Glycine 0 C--N 1.336 0.535 0 O-C-N 120.662 -1.274 . . . . 0.0 111.559 -175.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.593 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 2.6 ttpt -52.01 130.85 30.79 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 168.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.582 ' HB2' HG22 ' A' ' 37' ' ' THR . . . -134.59 176.63 8.45 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.306 1.442 . . . . 0.0 107.629 173.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.61 9.29 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 118.707 -0.663 . . . . 0.0 109.705 176.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -146.46 151.76 37.93 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 120.191 1.36 . . . . 0.0 113.115 168.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.58 66.41 0.94 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.454 2.302 . . . . 0.0 108.888 165.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.87 138.91 33.73 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.244 -0.91 . . . . 0.0 109.705 174.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 69.1 t -138.58 124.19 23.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 125.689 1.595 . . . . 0.0 107.598 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.3 t -142.69 170.46 15.65 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.61 -88.66 0.12 Allowed Glycine 0 C--N 1.332 0.335 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.89 -165.51 16.26 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -176.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.43 152.17 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 106.347 -1.724 . . . . 0.0 106.347 159.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.441 HG23 ' H ' ' A' ' 119' ' ' ILE . 12.5 p -124.15 152.23 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 159.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -77.73 149.59 34.54 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 171.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.99 21.22 3.0 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 125.911 1.72 . . . . 0.0 109.15 166.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.29 6.0 pt-20 -120.86 160.91 22.46 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.608 1.204 . . . . 0.0 110.146 170.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -168.3 87.96 0.23 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.912 2.085 . . . . 0.0 106.263 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.69 -28.3 2.87 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.246 1.403 . . . . 0.0 113.778 174.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.0 p -77.99 135.49 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 119.327 1.564 . . . . 0.0 108.477 174.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.6 t -105.78 81.72 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -177.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -77.76 174.79 10.6 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.658 1.183 . . . . 0.0 110.618 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -79.51 157.4 74.93 Favored Pre-proline 0 CA--C 1.533 0.313 0 O-C-N 120.511 -1.368 . . . . 0.0 109.568 157.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -82.94 -177.86 3.57 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.633 2.889 . . . . 0.0 112.179 -178.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 13.0 ptm -141.38 171.36 14.16 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.279 0.632 . . . . 0.0 112.249 -171.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -144.86 165.4 28.21 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.041 1.336 . . . . 0.0 109.445 166.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -128.42 136.29 50.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 170.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.2 t -115.86 129.35 72.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 161.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.9 t -114.54 151.67 16.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 103.895 -2.631 . . . . 0.0 103.895 166.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.3 m -135.94 136.7 40.64 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.404 HG22 HG23 ' A' ' 15' ' ' VAL . 19.3 t -116.5 141.61 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 176.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -123.67 148.03 46.88 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.046 1.738 . . . . 0.0 107.185 174.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.454 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 4.0 ttpm? -111.96 -159.29 0.68 Allowed 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.355 1.062 . . . . 0.0 108.295 178.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.454 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 3.3 p30 -60.96 81.65 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.029 1.332 . . . . 0.0 107.961 159.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 152.46 -74.83 0.25 Allowed Glycine 0 N--CA 1.45 -0.376 0 O-C-N 121.12 -0.987 . . . . 0.0 112.577 169.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.23 -171.45 3.87 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.076 1.75 . . . . 0.0 110.127 -173.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -46.1 141.27 3.37 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.829 2.052 . . . . 0.0 109.727 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.1 pt -141.95 -11.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 124.225 1.01 . . . . 0.0 113.492 178.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -142.16 149.27 39.54 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.663 1.12 . . . . 0.0 108.354 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -144.68 93.61 2.44 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.011 0.924 . . . . 0.0 109.124 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.69 151.48 43.09 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.772 0.796 . . . . 0.0 112.246 163.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.443 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -146.52 155.59 42.63 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 127.162 2.185 . . . . 0.0 107.785 179.102 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -133.33 -174.22 3.43 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 123.804 1.764 . . . . 0.0 107.139 -172.47 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.9 p -154.02 146.9 13.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 C-N-CA 127.085 2.154 . . . . 0.0 109.88 -177.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -146.29 155.57 42.75 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 165.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -146.72 15.82 1.24 Allowed 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 75.76 163.99 0.26 Allowed 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 128.145 2.578 . . . . 0.0 113.205 -173.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 173.62 -72.56 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 CA-C-O 118.922 -0.932 . . . . 0.0 111.473 172.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -169.31 164.62 10.84 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 127.204 2.202 . . . . 0.0 107.404 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -60.05 149.89 30.95 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.211 0.604 . . . . 0.0 111.93 175.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.441 ' H ' HG23 ' A' ' 82' ' ' VAL . 2.6 pp -153.25 -176.49 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 127.927 2.491 . . . . 0.0 109.863 -170.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.5 p -145.29 118.75 9.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 157.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.4 p -134.31 125.77 28.34 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.337 1.055 . . . . 0.0 108.287 -176.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -76.11 49.59 0.57 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.719 1.607 . . . . 0.0 109.577 171.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -62.93 -23.96 67.63 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.352 1.461 . . . . 0.0 111.429 173.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 tp -126.72 111.08 13.84 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -159.38 71.24 0.5 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.792 0.837 . . . . 0.0 109.624 166.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 mp -82.72 149.86 27.05 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.584 1.154 . . . . 0.0 109.637 170.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -137.65 125.81 23.03 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 127.427 2.291 . . . . 0.0 106.536 171.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -127.39 145.12 50.93 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 164.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 C--O 1.257 1.461 0 C-N-CA 127.17 2.188 . . . . 0.0 108.355 -168.971 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.914 0 N-CA-C 104.786 -3.326 . . . . 0.0 104.786 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.56 45.22 1.62 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -147.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -150.94 99.65 2.72 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.351 -145.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.85 -176.13 0.47 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 128.207 2.603 . . . . 0.0 112.559 -169.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.51 73.48 7.42 Favored Pre-proline 0 CA--C 1.54 0.59 0 O-C-N 120.783 -1.198 . . . . 0.0 109.002 162.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.44 124.78 11.12 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.717 2.278 . . . . 0.0 109.478 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 169.22 122.26 0.62 Allowed Glycine 0 CA--C 1.53 1.02 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -176.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.18 -48.22 11.54 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 117.822 0.811 . . . . 0.0 113.554 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -171.48 165.51 6.94 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.069 1.748 . . . . 0.0 107.92 175.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -160.62 -133.23 1.45 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 126.49 1.995 . . . . 0.0 108.548 165.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.24 -175.24 4.18 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.372 1.869 . . . . 0.0 107.626 167.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.2 mmm -97.14 163.1 13.07 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 144.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -146.8 154.41 41.34 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 125.233 1.413 . . . . 0.0 109.609 171.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -152.49 134.76 15.06 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 127.594 2.357 . . . . 0.0 106.359 -175.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 p -125.61 152.91 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 125.446 1.498 . . . . 0.0 110.144 174.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.4 p -120.48 157.7 28.84 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.108 0.963 . . . . 0.0 110.002 171.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.8 tp -143.08 110.46 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 174.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -107.92 132.33 53.58 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -116.76 120.96 40.2 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.286 1.034 . . . . 0.0 109.64 -169.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 m -134.5 172.39 12.98 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.418 0.687 . . . . 0.0 110.593 174.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.6 -163.76 46.28 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -163.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -86.0 59.18 5.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.744 0.783 . . . . 0.0 111.021 -160.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -63.0 21.7 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.782 2.433 . . . . 0.0 115.825 -178.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -115.62 12.04 15.96 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.125 1.77 . . . . 0.0 109.009 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.4 m -143.39 -0.74 1.08 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -157.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -137.49 126.48 24.27 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.69 1.196 . . . . 0.0 109.73 -168.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.4 mt -61.87 89.82 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.488 1.115 . . . . 0.0 110.511 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -74.66 163.45 27.7 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.996 0.903 . . . . 0.0 109.083 176.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.8 p -158.99 137.56 10.89 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.14 1.776 . . . . 0.0 108.965 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 t -138.45 98.1 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 119.454 1.024 . . . . 0.0 108.353 172.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.4 t -68.09 127.3 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 163.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.0 t -139.11 127.82 28.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 119.694 1.134 . . . . 0.0 109.114 171.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.4 t -109.8 154.79 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.491 1.516 . . . . 0.0 108.743 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.08 103.19 3.71 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.943 0.897 . . . . 0.0 109.917 165.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -58.76 100.87 0.07 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.549 1.54 . . . . 0.0 109.12 168.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.44 7.97 50.54 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 117.219 -1.878 . . . . 0.0 117.74 158.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.548 HG21 ' H ' ' A' ' 70' ' ' GLY . 2.0 t -165.14 178.45 6.98 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 121.016 2.408 . . . . 0.0 108.615 162.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -94.8 161.47 14.16 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.281 1.032 . . . . 0.0 110.785 -175.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.57 HD12 HD12 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -90.46 169.03 11.4 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.928 1.291 . . . . 0.0 109.288 -178.92 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -137.09 119.92 16.31 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 124.741 1.216 . . . . 0.0 107.892 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -75.64 148.44 38.74 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.606 0.717 . . . . 0.0 109.755 176.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.1 -25.26 67.93 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 118.399 -1.223 . . . . 0.0 112.636 167.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.21 -60.48 2.92 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 126.609 1.963 . . . . 0.0 111.164 -171.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.666 HG22 ' HG3' ' A' ' 46' ' ' GLU . 1.3 t -144.74 8.43 1.3 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.182 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.4 24.7 56.21 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 118.969 0.804 . . . . 0.0 111.136 -165.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.666 ' HG3' HG22 ' A' ' 44' ' ' THR . 74.7 mt-10 -55.86 118.73 4.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.713 1.205 . . . . 0.0 108.507 174.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 m -78.78 122.17 25.71 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 174.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 76.6 mt -113.03 134.19 54.63 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.76 1.224 . . . . 0.0 110.881 -170.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.36 73.92 1.36 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.85 2.06 . . . . 0.0 113.144 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.1 150.97 37.63 Favored Pre-proline 0 CA--C 1.545 0.785 0 O-C-N 120.979 -1.075 . . . . 0.0 111.151 171.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.52 155.74 85.92 Favored 'Cis proline' 0 C--N 1.348 0.509 0 CA-C-N 119.504 0.859 . . . . 0.0 110.785 -12.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.4 p -144.46 161.34 14.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 175.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.6 mm -108.69 99.24 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 166.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.83 104.94 3.05 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.384 -1.709 . . . . 0.0 106.384 168.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.9 m -74.05 175.15 7.7 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.64 0.733 . . . . 0.0 109.443 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -49.72 -37.98 31.47 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.794 1.637 . . . . 0.0 110.601 175.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -69.23 -32.16 71.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.484 1.913 . . . . 0.0 112.621 -175.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -76.61 -32.27 57.97 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.31 1.044 . . . . 0.0 108.93 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -90.13 16.28 8.75 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.701 1.6 . . . . 0.0 112.708 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.71 45.1 0.18 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.714 2.005 . . . . 0.0 112.295 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.0 m -140.85 162.92 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 128.434 2.694 . . . . 0.0 108.668 -173.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -75.19 -26.83 59.33 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.294 -0.879 . . . . 0.0 113.003 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.39 147.05 10.55 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.214 1.006 . . . . 0.0 109.436 -174.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -132.59 161.14 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.95 0.881 . . . . 0.0 109.81 163.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 m -128.5 116.28 19.45 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 130.029 3.331 . . . . 0.0 104.968 172.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.57 HD12 HD12 ' A' ' 39' ' ' LEU . 4.3 mm? -119.9 132.12 55.44 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 119.506 1.048 . . . . 0.0 108.342 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.43 166.49 24.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.02 -170.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 p -80.62 142.97 33.49 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.913 1.685 . . . . 0.0 110.125 -178.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.8 p -80.33 -51.22 9.14 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.503 -0.748 . . . . 0.0 110.74 172.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.548 ' H ' HG21 ' A' ' 37' ' ' THR . . . -106.6 -80.74 1.35 Allowed Glycine 0 C--N 1.335 0.486 0 O-C-N 121.534 -0.729 . . . . 0.0 112.407 -162.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.0 tttt -168.84 135.69 1.86 Allowed 'General case' 0 C--O 1.239 0.516 1 C-N-CA 131.849 4.06 . . . . 0.0 104.12 170.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -133.37 165.47 24.76 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 123.163 0.585 . . . . 0.0 110.066 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.23 -0.89 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 123.308 0.643 . . . . 0.0 110.673 -165.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -153.02 156.12 38.21 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.039 -1.038 . . . . 0.0 108.282 168.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.08 109.44 5.61 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 166.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.52 127.68 54.76 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.5 t -129.66 118.09 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 -174.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.0 157.94 45.09 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -169.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 154.85 -167.57 32.71 Favored Glycine 0 C--N 1.331 0.284 0 O-C-N 121.87 -0.519 . . . . 0.0 112.037 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.82 179.88 43.08 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.407 1.004 . . . . 0.0 112.155 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -132.62 -170.9 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 126.396 1.878 . . . . 0.0 108.463 171.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.491 HG22 ' H ' ' A' ' 84' ' ' GLY . 7.8 p -120.04 167.9 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 128.501 2.721 . . . . 0.0 107.534 167.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -137.37 17.76 2.94 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.419 1.888 . . . . 0.0 110.219 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.491 ' H ' HG22 ' A' ' 82' ' ' VAL . . . -90.9 12.63 68.37 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 125.73 1.634 . . . . 0.0 114.763 -156.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -68.14 135.78 52.66 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.195 1.398 . . . . 0.0 109.32 -168.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -137.69 -6.65 1.7 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.778 1.631 . . . . 0.0 112.221 -169.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -105.3 -4.16 40.99 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.769 1.652 . . . . 0.0 113.355 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.2 p -146.94 178.81 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 124.992 1.317 . . . . 0.0 108.679 -172.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.0 p -122.51 96.1 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 171.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -95.9 169.08 10.24 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.747 0.819 . . . . 0.0 109.002 172.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.94 160.96 31.33 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 159.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -84.35 -179.03 3.67 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.248 1.966 . . . . 0.0 111.5 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.406 ' CE ' ' HE1' ' A' ' 95' ' ' TRP . 4.6 ptm -131.31 160.28 35.43 Favored 'General case' 0 C--O 1.231 0.109 0 O-C-N 121.154 -0.966 . . . . 0.0 112.977 -176.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -142.01 143.31 33.11 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.536 1.134 . . . . 0.0 108.94 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.406 ' HE1' ' CE ' ' A' ' 93' ' ' MET . 54.4 m0 -116.9 139.46 50.61 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.23 1.012 . . . . 0.0 108.366 174.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.16 141.08 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 153.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.5 m -141.62 160.33 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 C-N-CA 127.074 2.149 . . . . 0.0 106.443 -177.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.8 m -152.59 142.94 22.55 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 174.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.36 136.59 48.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 169.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -123.19 113.69 19.29 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.698 2.399 . . . . 0.0 106.862 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -68.02 171.51 6.75 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 161.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -44.19 83.2 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.561 2.344 . . . . 0.0 114.128 -175.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 62.46 43.69 98.68 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.273 1.416 . . . . 0.0 113.465 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.0 mmtt -155.55 141.26 18.0 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.815 1.807 . . . . 0.0 109.463 155.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -68.31 143.83 55.05 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 125.932 1.693 . . . . 0.0 108.507 170.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.95 -13.94 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 120.218 1.372 . . . . 0.0 113.234 172.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -142.88 162.04 36.53 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.66 1.584 . . . . 0.0 107.085 -167.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.4 pttt -162.78 37.8 0.1 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.152 0.887 . . . . 0.0 112.637 -175.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -73.55 166.8 22.59 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.219 -1.55 . . . . 0.0 110.373 -176.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.7 t -151.59 160.08 43.81 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 127.168 2.187 . . . . 0.0 106.234 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 94.3 mt -132.6 141.49 48.7 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.924 0.89 . . . . 0.0 109.238 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.4 p -135.87 114.77 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 126.196 1.798 . . . . 0.0 107.319 174.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -108.79 122.6 47.51 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 166.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -149.35 104.18 3.36 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 175.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.5 t70 53.92 89.53 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 125.88 1.672 . . . . 0.0 109.918 -171.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -112.47 -81.9 1.15 Allowed Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 172.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm 174.47 172.23 0.22 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 128.391 2.677 . . . . 0.0 108.692 -165.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -72.62 106.55 4.7 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 153.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.6 pp -136.23 164.17 32.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 129.857 3.263 . . . . 0.0 105.953 173.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.6 m -159.12 6.99 0.11 Allowed 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.0 t -161.48 50.29 0.23 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.177 0.991 . . . . 0.0 111.61 -172.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -143.52 17.9 1.85 Allowed 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.067 -1.02 . . . . 0.0 112.031 174.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -93.79 -77.24 0.46 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.687 1.195 . . . . 0.0 111.312 -173.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.92 124.6 47.47 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.669 0.788 . . . . 0.0 109.314 -155.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -148.96 32.67 0.76 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.985 2.114 . . . . 0.0 111.802 -157.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.2 mp -80.77 148.58 30.0 Favored 'General case' 0 C--O 1.24 0.566 0 O-C-N 121.45 -0.781 . . . . 0.0 110.559 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -159.51 136.09 9.19 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.978 2.111 . . . . 0.0 109.963 173.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -142.17 158.66 43.48 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.078 2.151 . . . . 0.0 110.297 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.3 p30 . . . . . 0 C--O 1.249 1.035 0 C-N-CA 126.816 2.046 . . . . 0.0 109.3 177.926 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.087 0 CA-C-O 119.179 -0.79 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . 0.354 0.0 OUTLIER 76.71 -78.27 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 116.252 -1.832 . . . . 0.0 109.708 -113.572 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -144.79 104.29 4.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 121.288 1.858 . . . . 0.0 108.864 -162.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -159.54 86.39 0.8 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.658 0.783 . . . . 0.0 109.983 -165.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -154.26 86.13 3.74 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 123.954 0.902 . . . . 0.0 109.472 177.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -86.45 140.05 6.15 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.559 2.172 . . . . 0.0 112.224 173.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.55 78.28 0.36 Allowed Glycine 0 CA--C 1.526 0.722 0 O-C-N 121.701 -0.624 . . . . 0.0 112.196 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.6 -165.17 11.7 Favored Glycine 0 CA--C 1.52 0.379 0 O-C-N 121.372 -1.075 . . . . 0.0 111.468 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.6 pttm -144.75 165.4 28.18 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 126.766 2.026 . . . . 0.0 107.898 164.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.502 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . 157.01 -152.04 23.39 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 128.064 2.745 . . . . 0.0 107.697 -174.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.66 -172.61 2.96 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.158 0.979 . . . . 0.0 112.667 -162.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.1 mtp -113.69 158.77 20.47 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 147.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -144.77 143.2 30.55 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 125.256 1.597 . . . . 0.0 108.951 174.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -142.94 143.81 32.14 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.619 2.368 . . . . 0.0 105.065 172.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p -122.07 155.11 26.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 124.557 1.143 . . . . 0.0 109.108 171.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.04 151.11 52.07 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 173.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.6 tp -133.2 114.42 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.11 138.02 41.21 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 126.361 1.864 . . . . 0.0 107.45 176.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -128.46 122.34 31.04 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.453 1.101 . . . . 0.0 108.96 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.97 165.31 11.67 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.296 1.038 . . . . 0.0 108.772 172.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.49 -154.07 52.12 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 176.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -75.67 75.38 2.66 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 123.733 1.73 . . . . 0.0 113.108 -170.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -81.49 17.33 1.42 Allowed 'General case' 0 C--N 1.324 -0.536 0 O-C-N 119.715 -1.866 . . . . 0.0 114.116 -171.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 ptt-85 -137.64 28.34 2.7 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.559 1.527 . . . . 0.0 113.123 -170.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.4 m -127.97 17.29 6.74 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -171.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -134.81 -169.18 2.3 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.9 1.227 . . . . 0.0 112.556 -165.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.7 mm -114.91 87.88 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 106.104 -1.814 . . . . 0.0 106.104 163.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.409 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 0.4 OUTLIER -85.16 160.22 19.97 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.246 0.93 . . . . 0.0 110.588 168.394 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.34 156.67 42.81 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.065 0.946 . . . . 0.0 108.565 169.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.1 t -138.02 104.02 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.198 1.399 . . . . 0.0 107.334 170.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.711 HG22 HD12 ' A' ' 53' ' ' ILE . 84.9 t -69.07 135.37 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 163.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.9 t -138.19 138.41 43.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.5 t -135.18 150.14 29.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.08 141.98 49.37 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.265 1.826 . . . . 0.0 109.955 168.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -118.27 103.61 9.98 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 130.158 3.383 . . . . 0.0 106.481 -178.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.47 0.98 32.9 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 125.163 1.364 . . . . 0.0 113.205 172.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.537 HG22 ' HB2' ' A' ' 72' ' ' ALA . 15.0 t -165.74 -174.44 3.08 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.582 1.191 . . . . 0.0 109.23 -174.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -109.73 -175.75 2.83 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.871 1.668 . . . . 0.0 109.702 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.5 mt -119.18 165.58 14.03 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.313 1.445 . . . . 0.0 109.677 -177.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -138.26 122.6 18.26 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.095 0.958 . . . . 0.0 110.113 -170.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -70.08 135.29 49.09 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.755 0.822 . . . . 0.0 109.977 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.84 0.34 86.35 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-O 117.867 -1.518 . . . . 0.0 115.29 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.14 -51.35 15.88 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 120.196 1.998 . . . . 0.0 108.331 174.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.57 -22.8 3.56 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.836 1.254 . . . . 0.0 111.413 -167.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.94 20.55 28.06 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 118.444 -1.198 . . . . 0.0 112.24 -172.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -57.89 136.87 57.09 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 118.978 1.389 . . . . 0.0 109.42 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.13 138.77 49.93 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.268 1.027 . . . . 0.0 108.573 167.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.8 mt -126.91 -171.2 2.35 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.167 1.387 . . . . 0.0 109.306 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -143.03 117.94 9.98 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.685 1.994 . . . . 0.0 106.588 173.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.52 172.0 10.53 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.137 177.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.81 157.99 94.53 Favored 'Cis proline' 0 C--O 1.239 0.567 0 N-CA-C 108.525 -1.375 . . . . 0.0 108.525 -5.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 p -144.8 147.47 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 O-C-N 121.534 -0.728 . . . . 0.0 109.084 -171.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.711 HD12 HG22 ' A' ' 31' ' ' VAL . 18.0 mm -120.13 114.18 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 175.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.68 128.01 36.02 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 169.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.4 m -95.72 -175.69 3.51 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.93 1.692 . . . . 0.0 110.884 -174.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.409 ' HA ' ' HG2' ' A' ' 28' ' ' LYS . 29.5 t70 -61.93 -37.71 85.72 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 123.769 0.828 . . . . 0.0 111.848 -170.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -66.76 -36.4 82.35 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.072 0.949 . . . . 0.0 111.212 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -66.73 -36.49 82.59 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 122.44 1.114 . . . . 0.0 110.073 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.8 10.47 32.95 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.581 1.952 . . . . 0.0 112.874 -174.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.17 31.07 0.06 Allowed 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 120.392 1.451 . . . . 0.0 114.111 -174.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.7 m -131.37 167.27 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.504 1.522 . . . . 0.0 111.691 -169.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -59.38 -34.15 72.07 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.471 1.508 . . . . 0.0 113.415 175.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -157.95 147.28 19.68 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-O 117.116 -1.421 . . . . 0.0 109.913 -177.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 t -129.58 163.02 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 119.106 0.866 . . . . 0.0 108.74 163.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.3 m -139.29 109.39 6.41 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.702 2.801 . . . . 0.0 107.791 -172.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -122.4 131.58 53.95 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 121.053 1.751 . . . . 0.0 109.618 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.49 176.29 8.75 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.244 0.618 . . . . 0.0 111.455 -168.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 p -101.95 148.48 25.29 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.812 0.845 . . . . 0.0 109.954 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.3 p -84.27 -0.7 53.37 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.61 -0.681 . . . . 0.0 112.442 176.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.64 -172.73 37.95 Favored Glycine 0 N--CA 1.448 -0.525 0 O-C-N 119.877 -1.764 . . . . 0.0 109.498 -171.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.502 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 7.1 ttpt -70.43 129.35 39.05 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.537 ' HB2' HG22 ' A' ' 37' ' ' THR . . . -126.4 169.69 12.71 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.121 0.568 . . . . 0.0 110.536 176.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -119.46 -2.69 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -175.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -141.65 172.48 12.62 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.836 1.198 . . . . 0.0 110.605 -177.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -164.61 89.75 0.52 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 120.073 1.306 . . . . 0.0 111.312 166.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.77 150.4 25.82 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.584 0.354 . . . . 0.0 110.766 176.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 t -140.76 123.6 15.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 126.207 1.803 . . . . 0.0 106.241 164.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 m -140.59 156.62 46.23 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 174.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.4 -153.35 23.46 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -167.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.38 -168.96 31.56 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -175.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.538 HG23 ' CE1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -125.32 -179.94 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.178 1.391 . . . . 0.0 109.323 165.718 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.3 m -134.16 169.62 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 129.921 3.288 . . . . 0.0 107.024 168.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.406 ' HB3' ' H ' ' A' ' 117' ' ' LYS . 22.9 t0 -155.15 100.96 2.21 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 168.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -142.48 48.81 0.76 Allowed Glycine 0 N--CA 1.452 -0.237 0 N-CA-C 108.834 -1.707 . . . . 0.0 108.834 -174.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -118.67 133.59 55.74 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.943 0.877 . . . . 0.0 111.406 -174.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -117.62 88.89 3.0 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 -172.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 135.11 -34.39 2.32 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.725 1.155 . . . . 0.0 112.604 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.5 t -86.03 66.28 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 118.428 1.114 . . . . 0.0 108.371 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.81 116.12 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -123.16 168.78 11.97 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.006 1.722 . . . . 0.0 108.973 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -75.51 157.82 84.02 Favored Pre-proline 0 CA--C 1.532 0.263 0 O-C-N 121.986 -0.446 . . . . 0.0 111.155 173.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -72.37 169.21 22.22 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 121.083 1.188 . . . . 0.0 111.722 171.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.4 ptm -139.59 172.53 12.66 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 125.046 1.338 . . . . 0.0 110.33 -174.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -143.91 153.3 42.16 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.23 1.012 . . . . 0.0 109.422 -177.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -127.59 140.75 51.91 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.518 1.527 . . . . 0.0 108.982 176.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.9 t -132.8 110.75 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 164.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 m -92.07 143.07 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 163.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 m -129.59 142.12 50.81 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.8 t -122.14 126.1 73.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -113.57 119.0 35.99 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 175.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.439 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 2.2 ttpt -80.01 -156.91 0.13 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 175.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.439 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 4.6 p30 -66.02 83.34 0.08 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 163.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 139.2 -43.48 1.16 Allowed Glycine 0 CA--C 1.524 0.615 0 CA-C-O 118.03 -1.428 . . . . 0.0 115.2 156.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -151.93 -174.98 5.04 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 119.66 1.73 . . . . 0.0 111.309 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -55.74 143.44 30.79 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 171.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 6.7 pt -128.14 -24.85 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-O 117.674 -1.155 . . . . 0.0 112.706 168.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -150.94 148.9 28.97 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 120.631 1.559 . . . . 0.0 108.319 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -148.67 54.79 1.0 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.107 1.363 . . . . 0.0 107.97 -169.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.17 113.02 2.35 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.72 135.0 50.54 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.955 1.302 . . . . 0.0 108.014 -169.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -133.12 -172.8 3.03 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 122.275 1.036 . . . . 0.0 109.85 -170.117 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 78.3 t -148.09 111.46 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 127.554 2.342 . . . . 0.0 106.481 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.538 ' CE1' HG23 ' A' ' 81' ' ' VAL . 1.8 t80 -81.31 169.63 17.03 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 169.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.6 169.94 19.22 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -74.0 128.34 35.26 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.171 1.789 . . . . 0.0 110.942 177.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.11 53.0 7.26 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 124.691 1.139 . . . . 0.0 112.685 170.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.406 ' H ' ' HB3' ' A' ' 83' ' ' ASP . 6.6 mmtm -137.03 103.85 5.27 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 119.577 1.689 . . . . 0.0 112.151 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -82.5 98.38 8.91 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 122.889 1.328 . . . . 0.0 108.212 177.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.5 pp -127.11 164.55 27.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 127.621 2.369 . . . . 0.0 106.176 173.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.4 t -159.73 9.85 0.11 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.3 1.04 . . . . 0.0 112.36 166.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 63.2 p -132.83 21.29 4.19 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.258 1.423 . . . . 0.0 111.284 -164.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -149.89 26.66 0.81 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.675 -163.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -128.52 -82.94 0.58 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.325 0.65 . . . . 0.0 111.305 -177.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.1 tp -104.93 104.47 14.23 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -156.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.73 66.67 0.93 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -166.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 mp -119.58 141.78 48.97 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -161.19 111.39 1.69 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -97.64 146.57 25.19 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.204 1.002 . . . . 0.0 109.618 169.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 . . . . . 0 C--O 1.253 1.267 0 C-N-CA 126.868 2.067 . . . . 0.0 109.431 171.074 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.745 0 N-CA-C 105.692 -2.963 . . . . 0.0 105.692 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 73.99 58.46 0.09 Allowed 'General case' 0 CA--C 1.534 0.346 0 O-C-N 125.89 1.583 . . . . 0.0 109.115 142.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -152.3 78.54 1.22 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.793 1.637 . . . . 0.0 106.804 -149.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -160.73 126.71 3.96 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.056 0.942 . . . . 0.0 112.045 -165.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -155.14 85.73 3.47 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 125.646 1.579 . . . . 0.0 108.933 158.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.41 156.88 41.26 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.049 2.499 . . . . 0.0 111.228 -179.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.21 -138.39 9.64 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 122.206 0.892 . . . . 0.0 112.815 -171.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.94 14.53 82.23 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 127.438 2.447 . . . . 0.0 113.209 -170.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -84.54 105.48 15.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.446 ' H ' ' HD2' ' A' ' 71' ' ' LYS . . . -73.07 -85.51 0.23 Allowed Glycine 0 CA--C 1.522 0.471 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -147.3 152.41 38.21 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 117.499 0.65 . . . . 0.0 112.57 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.5 mtp -83.51 154.4 23.9 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.477 1.111 . . . . 0.0 108.685 158.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -137.88 152.71 49.31 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.607 1.163 . . . . 0.0 109.026 168.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -141.32 134.42 29.25 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 165.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.593 HG12 HG22 ' A' ' 99' ' ' VAL . 3.8 m -134.65 145.87 31.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 125.262 1.425 . . . . 0.0 107.854 -173.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.2 p -123.24 152.78 40.97 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -175.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.4 tp -136.31 92.87 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 170.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -72.74 139.52 47.21 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 165.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -124.02 126.25 45.95 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 173.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -136.47 176.72 8.44 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.037 0.935 . . . . 0.0 111.73 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.55 -83.46 1.62 Allowed Glycine 0 C--N 1.334 0.431 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 -175.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -149.78 158.9 44.61 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.336 1.855 . . . . 0.0 106.482 172.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -146.44 71.9 1.26 Allowed 'General case' 0 C--N 1.327 -0.375 0 O-C-N 119.739 -1.85 . . . . 0.0 109.355 164.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -133.45 -0.75 3.22 Favored 'General case' 0 C--N 1.332 -0.155 0 O-C-N 120.782 -1.198 . . . . 0.0 112.872 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.4 t -152.5 53.08 0.78 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.999 1.272 . . . . 0.0 110.304 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -148.02 116.56 6.63 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 116.675 -1.631 . . . . 0.0 109.729 -178.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.0 mt -55.14 98.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 125.333 1.453 . . . . 0.0 108.969 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.6 mtmm -82.86 136.73 34.53 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 170.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t -142.46 144.2 32.94 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 172.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.8 t -135.05 155.79 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 167.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 p -119.22 147.39 22.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 103.967 -2.605 . . . . 0.0 103.967 156.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.7 p -148.81 131.11 6.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 171.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.5 t -128.65 164.34 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.916 0.886 . . . . 0.0 108.798 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.58 107.1 4.07 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 166.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.526 ' H ' ' HG3' ' A' ' 74' ' ' GLU . 32.4 t-20 -65.22 89.55 0.09 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.248 1.023 . . . . 0.0 110.217 172.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.38 -79.63 0.34 Allowed Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 169.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -81.19 -165.02 0.84 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.255 1.022 . . . . 0.0 111.017 -174.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -110.29 162.28 14.78 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.916 1.686 . . . . 0.0 111.156 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -84.41 156.31 21.86 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.764 1.626 . . . . 0.0 109.651 167.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -128.63 114.46 16.7 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 127.275 2.23 . . . . 0.0 107.308 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.74 119.31 17.79 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.657 1.983 . . . . 0.0 109.088 -176.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.91 -3.39 50.99 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.56 1.076 . . . . 0.0 113.74 176.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.45 -51.91 67.51 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.933 1.293 . . . . 0.0 110.098 169.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.3 p -152.39 9.3 0.48 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.454 1.502 . . . . 0.0 112.394 -161.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.32 13.82 79.58 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 120.486 -1.384 . . . . 0.0 112.617 -175.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -65.65 124.19 21.71 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.772 1.229 . . . . 0.0 111.092 -171.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.2 m -74.2 127.28 32.55 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 169.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 75.8 mt -119.76 176.64 5.3 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.397 1.079 . . . . 0.0 109.925 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.99 110.13 12.23 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.043 1.337 . . . . 0.0 109.553 -173.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.0 p -77.12 170.37 16.67 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.284 1.434 . . . . 0.0 112.175 -172.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.66 146.41 76.73 Favored 'Cis proline' 0 CA--C 1.535 0.526 0 N-CA-C 109.287 -1.082 . . . . 0.0 109.287 -19.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.8 p -137.13 147.15 27.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 118.439 0.563 . . . . 0.0 110.842 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.7 mm -114.08 127.29 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 127.543 2.337 . . . . 0.0 107.044 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -103.33 140.41 37.46 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.666 0.787 . . . . 0.0 109.414 172.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.3 m -81.0 172.48 13.68 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.846 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.77 -24.96 67.98 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.418 2.287 . . . . 0.0 112.547 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -72.57 -37.03 68.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 118.465 -0.779 . . . . 0.0 111.519 172.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -74.21 -44.16 54.29 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -173.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.76 8.09 2.65 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.968 1.307 . . . . 0.0 114.357 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.66 41.39 0.09 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.221 2.208 . . . . 0.0 113.581 -174.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.6 m -133.1 159.1 43.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 126.013 1.725 . . . . 0.0 111.087 -171.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -67.05 -27.19 67.18 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.278 1.431 . . . . 0.0 113.546 -175.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -158.62 137.39 11.16 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 -172.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -123.04 150.67 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 158.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.5 m -133.65 134.52 43.26 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 173.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 31.4 mt -134.2 147.78 50.78 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -170.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.5 t -157.71 165.91 34.18 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -173.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.78 141.55 28.32 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.248 1.419 . . . . 0.0 109.659 -177.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 58.2 p -80.34 -1.0 39.22 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 175.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -158.94 -99.32 0.15 Allowed Glycine 0 C--N 1.339 0.743 0 O-C-N 120.61 -1.306 . . . . 0.0 112.851 -174.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.446 ' HD2' ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -134.69 152.06 51.48 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 126.67 1.988 . . . . 0.0 108.655 166.3 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.13 -178.71 4.05 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 158.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.9 mm -111.44 -14.01 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.582 0.706 . . . . 0.0 109.746 173.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.526 ' HG3' ' H ' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -148.9 163.2 38.13 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 126.521 1.928 . . . . 0.0 107.262 -163.115 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.423 ' HD2' HG11 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -154.34 96.22 1.9 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 128.991 2.917 . . . . 0.0 105.818 168.813 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -91.63 114.93 27.6 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.328 0.651 . . . . 0.0 110.433 177.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 52.7 t -129.1 115.57 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.913 1.285 . . . . 0.0 108.654 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.457 ' HA ' ' HB3' ' A' ' 124' ' ' LEU . 46.7 t -139.71 168.54 19.59 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.933 2.093 . . . . 0.0 108.255 175.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.65 -156.57 27.75 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 127.075 2.274 . . . . 0.0 108.299 -162.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 139.27 123.97 2.14 Favored Glycine 0 N--CA 1.473 1.141 0 CA-C-N 119.171 1.485 . . . . 0.0 112.554 174.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.98 104.96 17.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 121.767 0.794 . . . . 0.0 110.038 -169.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.469 HG23 ' H ' ' A' ' 119' ' ' ILE . 7.7 p -82.88 143.91 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 122.06 0.933 . . . . 0.0 109.413 174.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -80.27 94.09 6.03 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 127.202 2.201 . . . . 0.0 109.29 170.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.99 51.77 3.55 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.6 1.571 . . . . 0.0 110.473 167.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.88 -163.32 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.833 1.653 . . . . 0.0 110.975 164.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 50.0 t0 66.49 34.17 6.29 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 123.054 1.407 . . . . 0.0 109.309 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.09 -12.95 0.03 OUTLIER Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.562 1.077 . . . . 0.0 114.826 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.66 147.61 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 120.168 1.984 . . . . 0.0 112.763 -170.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.2 p -112.12 96.75 4.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 171.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -138.93 -175.03 4.01 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 127.088 2.155 . . . . 0.0 107.902 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -105.29 160.7 25.13 Favored Pre-proline 0 C--N 1.328 -0.36 0 C-N-CA 123.641 0.776 . . . . 0.0 110.59 171.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -78.5 178.24 7.79 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.769 2.98 . . . . 0.0 111.784 173.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.3 ptm -138.12 169.53 17.62 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 122.558 1.17 . . . . 0.0 111.197 -172.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -140.54 151.26 44.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.823 2.049 . . . . 0.0 106.325 175.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -118.11 151.19 38.03 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 168.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.7 t -125.89 134.23 67.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 161.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.7 t -144.31 124.25 7.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 -168.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.4 m -141.43 150.7 42.66 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 -163.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.593 HG22 HG12 ' A' ' 15' ' ' VAL . 37.1 t -124.47 135.52 63.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.59 0.709 . . . . 0.0 111.002 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -118.35 158.66 24.83 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 128.467 2.707 . . . . 0.0 107.938 173.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.4 tptt -124.88 -153.44 0.56 Allowed 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 127.573 2.349 . . . . 0.0 107.402 -168.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -55.86 68.47 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.895 2.078 . . . . 0.0 110.633 160.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 64.14 58.98 9.09 Favored Glycine 0 CA--C 1.531 1.061 0 O-C-N 120.106 -1.621 . . . . 0.0 113.172 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -179.61 153.3 0.55 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 128.546 2.738 . . . . 0.0 107.595 162.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -64.84 155.85 32.7 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.358 1.463 . . . . 0.0 109.659 167.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.0 pt -136.18 -17.4 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 125.032 1.333 . . . . 0.0 113.949 167.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -150.7 129.1 12.09 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -170.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -136.98 106.98 6.28 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -175.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.492 ' HE2' HD21 ' A' ' 126' ' ' LEU . 32.2 pttt -145.58 173.18 12.27 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.817 0.818 . . . . 0.0 112.724 169.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.52 ' O ' HD23 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -135.55 171.94 13.73 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 127.702 2.401 . . . . 0.0 109.79 173.409 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.528 HD22 ' OD1' ' A' ' 123' ' ' ASP . 14.3 mt -138.85 151.61 47.13 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.7 p -129.93 138.68 53.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -125.55 163.42 22.76 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -140.41 -164.6 1.75 Allowed 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.848 0.859 . . . . 0.0 109.693 -167.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.27 128.84 51.58 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 128.063 2.545 . . . . 0.0 104.37 164.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -177.49 -26.41 0.04 OUTLIER Glycine 0 CA--C 1.527 0.803 0 CA-C-O 116.585 -2.231 . . . . 0.0 116.755 166.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 174.13 176.44 0.14 Allowed 'General case' 0 C--N 1.343 0.299 0 C-N-CA 129.462 3.105 . . . . 0.0 108.307 156.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -57.09 136.33 56.36 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.817 -0.552 . . . . 0.0 109.902 168.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.469 ' H ' HG23 ' A' ' 82' ' ' VAL . 2.4 pp -139.43 -179.91 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 127.174 2.19 . . . . 0.0 109.443 -177.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 62.3 p -151.91 106.15 3.18 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.996 1.319 . . . . 0.0 108.14 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.9 p -127.8 154.0 45.92 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.66 0.784 . . . . 0.0 109.49 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -83.68 13.01 5.03 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.839 1.256 . . . . 0.0 112.267 -171.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.528 ' OD1' HD22 ' A' ' 111' ' ' LEU . 0.8 OUTLIER -43.25 -43.77 5.0 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 129.999 3.32 . . . . 0.0 114.749 -153.723 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' A' ' 123' ' ' ASP . 3.5 mm? -90.07 78.58 6.64 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -116.32 58.36 0.75 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.046 1.739 . . . . 0.0 109.25 -172.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.492 HD21 ' HE2' ' A' ' 109' ' ' LYS . 63.5 mt -124.83 107.95 11.43 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -177.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -132.54 81.92 1.98 Allowed 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -175.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -70.81 132.17 44.91 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 165.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.429 ' HA ' ' CB ' ' A' ' 74' ' ' GLU . 8.0 p-10 . . . . . 0 C--O 1.25 1.105 0 C-N-CA 128.315 2.646 . . . . 0.0 109.093 174.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.872 0 N-CA-C 106.007 -2.837 . . . . 0.0 106.007 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.39 108.42 3.55 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 102.545 -3.131 . . . . 0.0 102.545 -137.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -151.09 80.19 1.31 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.711 0.804 . . . . 0.0 109.014 -159.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.58 143.38 11.55 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.975 0.91 . . . . 0.0 110.767 173.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -153.95 54.7 1.16 Allowed Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.274 1.03 . . . . 0.0 111.372 176.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.11 119.16 6.12 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 O-C-N 118.163 -1.546 . . . . 0.0 111.624 -173.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.42 -101.23 0.77 Allowed Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.134 -169.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.69 178.87 49.0 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 175.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -124.66 135.14 52.81 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -173.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.438 ' N ' ' HE2' ' A' ' 71' ' ' LYS . . . 167.05 -156.83 28.95 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 127.189 2.328 . . . . 0.0 109.901 177.018 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -148.13 -164.14 1.94 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.205 1.802 . . . . 0.0 111.163 -162.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.4 mtp -120.87 163.67 17.83 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 125.584 1.554 . . . . 0.0 108.101 147.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -143.13 143.87 31.99 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 125.91 2.006 . . . . 0.0 110.845 -178.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -150.65 145.09 25.63 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.939 1.696 . . . . 0.0 107.355 174.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.47 144.5 32.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 126.657 1.983 . . . . 0.0 107.936 176.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.7 127.98 54.95 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 167.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 tp -100.29 154.15 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 163.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.664 ' CD ' ' H ' ' A' ' 96' ' ' VAL . 0.0 OUTLIER -152.83 -174.63 4.99 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 127.801 2.44 . . . . 0.0 106.941 176.941 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -148.27 166.32 28.35 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 168.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -141.81 165.85 26.33 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 124.141 0.976 . . . . 0.0 110.381 171.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.69 -147.66 39.9 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -75.22 111.91 10.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.394 0.616 . . . . 0.0 110.274 177.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -113.15 33.38 5.11 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.32 1.048 . . . . 0.0 109.679 173.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -124.95 0.5 7.97 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.435 1.494 . . . . 0.0 110.363 -166.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.11 28.67 0.59 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.182 1.393 . . . . 0.0 112.837 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -122.64 116.7 24.26 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 120.72 -1.238 . . . . 0.0 107.773 172.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.7 mm -65.63 121.97 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 175.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -90.69 160.65 15.74 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.155 0.982 . . . . 0.0 110.345 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.4 m -152.48 136.69 16.57 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.373 1.869 . . . . 0.0 107.569 158.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.3 t -137.84 147.18 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 170.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.52 HG22 HD12 ' A' ' 53' ' ' ILE . 82.1 t -117.19 128.21 74.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 126.874 2.069 . . . . 0.0 105.851 170.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.33 147.63 19.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 167.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.9 t -128.69 147.73 33.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 170.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.76 91.75 1.91 Allowed 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 173.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -65.06 127.28 30.98 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 172.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.69 -14.66 19.89 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-O 118.735 -1.036 . . . . 0.0 114.503 153.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 t -161.07 -168.49 2.07 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -101.44 160.86 14.07 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.797 0.839 . . . . 0.0 111.302 173.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 tp -74.86 165.23 25.58 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 170.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -133.67 129.96 37.54 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 171.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.425 ' HA ' HD23 ' A' ' 66' ' ' LEU . 5.9 t70 -84.01 129.51 34.91 Favored 'General case' 0 CA--C 1.52 -0.211 0 O-C-N 123.719 0.637 . . . . 0.0 109.545 175.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.47 -23.16 70.13 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 118.107 -1.385 . . . . 0.0 112.986 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.72 -61.25 2.56 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.019 1.41 . . . . 0.0 111.116 -176.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.03 10.84 7.61 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.139 0.975 . . . . 0.0 111.029 -177.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.24 23.99 77.47 Favored Glycine 0 N--CA 1.446 -0.639 0 O-C-N 121.141 -0.974 . . . . 0.0 111.544 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -74.98 125.35 28.71 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -171.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.2 m -64.42 129.27 39.24 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 165.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 34.2 mt -107.42 -164.18 0.96 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.801 1.64 . . . . 0.0 108.247 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.67 98.26 3.37 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.693 -0.63 . . . . 0.0 110.55 173.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.425 ' HA ' HG23 ' A' ' 52' ' ' VAL . 4.5 m -73.48 168.37 26.09 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 122.705 0.402 . . . . 0.0 111.798 177.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -61.26 149.27 52.92 Favored 'Cis proline' 0 CA--C 1.538 0.691 0 N-CA-C 110.366 -0.667 . . . . 0.0 110.366 -16.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.425 HG23 ' HA ' ' A' ' 50' ' ' SER . 12.6 t -127.48 151.48 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.52 HD12 HG22 ' A' ' 31' ' ' VAL . 18.0 mm -113.95 132.52 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 169.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.9 153.93 21.27 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 122.293 1.044 . . . . 0.0 108.899 170.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.72 -177.94 4.58 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.822 2.449 . . . . 0.0 107.601 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -61.19 -43.95 98.07 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -172.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -62.35 -31.26 71.88 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 123.546 0.738 . . . . 0.0 110.8 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -83.21 -17.98 40.9 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 118.755 -0.64 . . . . 0.0 110.202 -173.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 mt -114.25 6.09 16.06 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.897 1.679 . . . . 0.0 113.921 -168.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.57 34.21 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 128.429 2.692 . . . . 0.0 114.428 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.5 m -100.94 175.38 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 127.777 2.431 . . . . 0.0 110.346 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -95.3 -31.01 13.66 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 118.394 -0.812 . . . . 0.0 111.672 164.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 18' ' ' GLU . 71.7 tttt -157.43 139.12 14.02 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 125.223 1.409 . . . . 0.0 109.189 176.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.0 t -135.73 130.65 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 119.415 1.007 . . . . 0.0 108.53 162.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.8 m -78.27 138.54 38.66 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 121.079 -1.013 . . . . 0.0 108.418 158.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 41' ' ' ASP . 77.8 mt -125.51 137.82 53.96 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 167.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.93 -174.59 4.12 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -172.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.83 146.68 37.24 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.329 1.061 . . . . 0.0 110.932 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.3 p -73.59 -22.91 59.9 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.136 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.21 -165.22 13.89 Favored Glycine 0 N--CA 1.449 -0.497 0 O-C-N 121.192 -0.943 . . . . 0.0 110.798 -170.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.438 ' HE2' ' N ' ' A' ' 10' ' ' GLY . 47.7 tttt -57.86 135.81 56.91 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 168.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -137.03 161.47 35.97 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 174.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.34 -7.94 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 123.51 0.724 . . . . 0.0 109.945 -164.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -144.67 150.63 37.67 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -137.56 156.33 48.22 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 155.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -158.13 152.41 24.38 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 121.014 -1.054 . . . . 0.0 108.785 174.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.8 t -142.39 106.32 1.37 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.2 t -116.39 169.48 9.28 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.734 1.214 . . . . 0.0 107.888 156.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.22 -165.3 30.32 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 125.173 1.368 . . . . 0.0 110.277 -172.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.54 175.48 38.11 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 108.088 -2.005 . . . . 0.0 108.088 172.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.5 m -125.59 173.33 11.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.296 1.038 . . . . 0.0 108.446 169.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.9 p -139.61 142.32 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 162.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -65.84 24.81 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 131.026 3.731 . . . . 0.0 113.448 170.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.36 -49.55 2.66 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 125.626 1.584 . . . . 0.0 110.161 -176.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 176.05 165.28 0.4 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.229 1.811 . . . . 0.0 112.649 -173.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -64.65 -13.32 53.33 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.429 1.892 . . . . 0.0 115.098 -174.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -117.94 12.13 13.23 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 126.523 2.011 . . . . 0.0 112.844 -175.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 72.4 t -75.68 167.9 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 118.89 1.345 . . . . 0.0 109.969 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.6 p -141.81 94.36 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 126.396 1.878 . . . . 0.0 108.617 -169.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -141.6 -154.56 0.52 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.172 0.989 . . . . 0.0 109.114 -174.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.79 166.48 10.68 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 126.69 1.996 . . . . 0.0 109.711 152.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -84.37 -177.0 2.77 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.564 2.842 . . . . 0.0 111.954 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.5 ptp -141.67 163.46 32.85 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 172.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -138.99 150.19 45.56 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 126.018 1.727 . . . . 0.0 108.976 173.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 20.7 m0 -125.3 151.05 46.51 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.547 1.539 . . . . 0.0 108.689 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.664 ' H ' ' CD ' ' A' ' 18' ' ' GLU . 13.7 p -136.45 81.04 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 126.85 2.06 . . . . 0.0 108.766 169.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 p -83.98 89.12 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.64 145.29 31.74 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 176.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.99 140.66 46.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -126.7 145.6 50.52 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 128.417 2.687 . . . . 0.0 107.883 -172.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.54 -174.69 2.51 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.03 1.332 . . . . 0.0 107.553 170.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -52.32 69.09 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.708 2.803 . . . . 0.0 113.053 176.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.53 -15.96 3.6 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 115.957 -2.58 . . . . 0.0 116.326 171.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.54 177.79 0.18 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 121.714 2.757 . . . . 0.0 111.918 175.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -50.99 150.81 2.85 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 128.724 2.81 . . . . 0.0 110.913 175.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.47 -20.44 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.638 1.175 . . . . 0.0 111.572 162.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -152.65 151.79 31.0 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 120.315 1.416 . . . . 0.0 110.739 -170.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -141.17 22.69 2.22 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 125.494 1.518 . . . . 0.0 112.842 -161.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.412 ' HE3' HD13 ' A' ' 126' ' ' LEU . 1.7 ttpm? -60.95 142.54 56.38 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.612 0.72 . . . . 0.0 110.106 -175.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.439 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -155.07 137.57 15.06 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 125.258 1.423 . . . . 0.0 109.703 -163.968 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.548 ' N ' HD12 ' A' ' 111' ' ' LEU . 2.2 mp -126.85 177.87 6.31 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 123.413 1.578 . . . . 0.0 108.462 -166.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.2 p -149.93 146.8 16.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-N 111.438 -2.619 . . . . 0.0 110.945 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -141.45 151.4 43.36 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.571 1.948 . . . . 0.0 107.237 169.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 39.4 mtp180 -136.36 173.63 11.5 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 118.725 0.693 . . . . 0.0 111.753 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -60.62 134.17 56.81 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 128.299 2.64 . . . . 0.0 109.658 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.37 45.19 91.66 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 124.58 1.086 . . . . 0.0 113.151 165.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt -126.01 162.26 25.68 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 123.064 1.412 . . . . 0.0 113.496 -168.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -84.21 127.38 33.91 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.3 pp -132.81 173.56 14.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 126.169 1.788 . . . . 0.0 108.398 -176.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.3 m -152.07 150.93 30.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.0 0.92 . . . . 0.0 108.896 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.4 p -81.18 54.55 2.29 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.99 1.716 . . . . 0.0 109.76 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -148.38 -13.84 0.34 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -167.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.68 -15.96 23.21 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.283 1.433 . . . . 0.0 113.668 -170.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -120.93 120.7 36.24 Favored 'General case' 0 CA--C 1.517 -0.288 0 O-C-N 120.691 -1.256 . . . . 0.0 107.79 173.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -150.68 72.09 1.07 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 125.671 1.589 . . . . 0.0 110.522 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.412 HD13 ' HE3' ' A' ' 109' ' ' LYS . 4.5 mp -119.08 154.22 33.54 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.761 1.224 . . . . 0.0 110.727 178.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -145.83 148.89 33.38 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.31 2.244 . . . . 0.0 109.172 175.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -141.26 142.53 33.9 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.195 2.198 . . . . 0.0 107.813 177.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.5 p30 . . . . . 0 C--O 1.258 1.535 0 C-N-CA 128.202 2.601 . . . . 0.0 107.047 170.512 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.514 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . . . . . . 0 CA--C 1.525 0.657 0 N-CA-C 107.37 -2.292 . . . . 0.0 107.37 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.52 -162.49 1.32 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.037 1.735 . . . . 0.0 110.329 -164.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 33.5 mtp -128.59 165.08 21.48 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 128.551 2.741 . . . . 0.0 105.069 156.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -146.78 154.92 41.95 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.512 1.125 . . . . 0.0 110.733 177.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -146.62 120.96 9.6 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.744 2.018 . . . . 0.0 107.773 174.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.1 p -99.67 151.86 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.963 1.305 . . . . 0.0 109.465 170.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.415 HG23 HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -125.91 154.18 43.15 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.108 0.963 . . . . 0.0 110.089 168.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 tp -139.42 111.81 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 C-N-CA 126.034 1.734 . . . . 0.0 107.209 172.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.64 150.76 20.0 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 159.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -128.86 106.88 9.21 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.396 1.878 . . . . 0.0 107.524 -168.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 m -113.14 167.8 10.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.85 -172.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.6 -150.64 41.63 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -172.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -87.21 34.4 0.69 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -158.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -58.55 -6.09 0.65 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -165.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 54.5 mtt-85 -86.29 0.78 53.09 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.34 1.456 . . . . 0.0 113.424 -167.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.9 m -135.92 32.41 2.95 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.72 1.608 . . . . 0.0 110.149 -174.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.519 ' HB3' HG21 ' A' ' 81' ' ' VAL . 18.0 m-85 -143.27 102.33 3.96 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.867 1.267 . . . . 0.0 109.964 -166.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.1 mm -69.21 96.88 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 125.455 1.502 . . . . 0.0 110.732 -170.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? -110.39 160.79 16.27 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.441 1.096 . . . . 0.0 112.052 -164.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.2 m -145.52 126.29 14.35 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.271 0.628 . . . . 0.0 110.957 -158.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.4 t -135.64 155.74 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.218 1.007 . . . . 0.0 110.11 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 p -119.4 154.6 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 128.924 2.89 . . . . 0.0 107.964 173.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.474 HG11 HD21 ' A' ' 39' ' ' LEU . 1.7 t -145.61 127.25 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 168.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.2 t -127.79 125.5 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.17 112.17 17.37 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.107 0.963 . . . . 0.0 109.826 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -74.51 128.08 34.66 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.687 1.195 . . . . 0.0 108.902 170.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.41 1.08 74.55 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 115.698 1.039 . . . . 0.0 115.698 163.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -153.44 175.87 12.67 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 119.002 1.401 . . . . 0.0 110.387 175.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -100.0 161.01 13.88 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.675 1.19 . . . . 0.0 109.432 174.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.474 HD21 HG11 ' A' ' 32' ' ' VAL . 2.5 tp -89.9 171.62 9.46 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.31 0.644 . . . . 0.0 109.657 -178.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.405 ' HE2' ' HA2' ' A' ' 45' ' ' GLY . 82.4 tttt -137.74 139.54 40.17 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.101 0.96 . . . . 0.0 108.738 173.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -93.82 128.56 40.13 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.978 1.711 . . . . 0.0 109.986 -173.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.04 -21.59 76.96 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.811 -0.994 . . . . 0.0 114.277 -174.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.11 78.68 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.436 1.118 . . . . 0.0 112.03 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.3 p -145.56 -28.58 0.44 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.993 1.317 . . . . 0.0 111.511 -159.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.405 ' HA2' ' HE2' ' A' ' 40' ' ' LYS . . . 88.28 13.93 62.94 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.374 1.464 . . . . 0.0 112.888 -175.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -62.73 138.0 58.4 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.139 1.376 . . . . 0.0 107.296 171.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.1 m -68.7 150.78 47.52 Favored 'General case' 0 N--CA 1.426 -1.669 0 C-N-CA 125.804 1.642 . . . . 0.0 110.411 165.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.2 mt -136.32 142.05 43.84 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.315 1.046 . . . . 0.0 110.725 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.78 78.01 4.29 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.46 1.104 . . . . 0.0 111.144 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 p -54.68 156.28 6.65 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.171 0.988 . . . . 0.0 110.888 168.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -79.64 146.73 76.79 Favored 'Cis proline' 0 CA--C 1.537 0.639 0 CA-C-N 119.355 0.805 . . . . 0.0 111.69 2.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.8 t -140.26 159.14 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.63 1.172 . . . . 0.0 110.263 -171.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.1 mm -119.85 142.33 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 C-N-CA 129.023 2.929 . . . . 0.0 105.44 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -108.42 128.1 54.48 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 171.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.1 m -94.29 173.65 7.53 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.397 1.479 . . . . 0.0 109.404 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.2 -36.1 76.89 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -169.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -63.35 -36.94 85.37 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.593 0.757 . . . . 0.0 111.019 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -75.68 -36.77 59.98 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.8 mt -86.53 24.54 1.4 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.339 2.256 . . . . 0.0 110.73 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.16 -4.88 58.68 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.023 0.929 . . . . 0.0 112.618 174.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.1 m -82.76 163.22 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 118.807 0.73 . . . . 0.0 110.475 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -62.11 -34.85 77.11 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.542 1.137 . . . . 0.0 112.277 173.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -152.25 139.22 19.08 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -172.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -118.74 152.4 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 161.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.415 HG23 HG23 ' A' ' 16' ' ' THR . 19.7 m -129.82 131.29 46.1 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 103.512 -2.773 . . . . 0.0 103.512 164.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.0 mp -132.3 144.71 50.77 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 170.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.61 -173.05 3.67 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.098 -165.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 p -120.61 138.12 54.07 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.704 0.801 . . . . 0.0 110.917 -171.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 68.5 p -78.94 -12.0 60.02 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -168.32 -157.17 10.94 Favored Glycine 0 N--CA 1.447 -0.605 0 O-C-N 120.475 -1.39 . . . . 0.0 110.597 -167.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.514 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -73.36 91.68 1.76 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.39 1.476 . . . . 0.0 109.506 -168.356 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.91 155.52 21.64 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.831 1.252 . . . . 0.0 108.44 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.0 -5.88 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.867 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -148.92 159.19 44.42 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 119.726 1.148 . . . . 0.0 109.308 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.16 143.09 49.73 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 125.054 1.471 . . . . 0.0 107.831 151.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.27 129.3 27.09 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 166.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.2 t -139.85 100.59 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -168.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.2 t -120.11 158.8 26.13 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 178.08 171.53 41.55 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-O 121.571 0.539 . . . . 0.0 112.695 172.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.35 -172.67 40.44 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.971 1.748 . . . . 0.0 109.425 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.519 HG21 ' HB3' ' A' ' 26' ' ' PHE . 6.2 p . . . . . 0 C--O 1.236 0.374 0 C-N-CA 124.548 1.139 . . . . 0.0 109.196 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.79 -179.54 4.31 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 121.866 1.711 . . . . 0.0 113.618 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.8 ptm -138.01 174.3 10.72 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.945 0.898 . . . . 0.0 111.115 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -141.86 162.17 36.14 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.723 1.209 . . . . 0.0 109.729 175.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -128.47 108.64 10.71 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 126.485 1.914 . . . . 0.0 106.543 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.4 t -96.69 109.44 23.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.2 m -131.37 135.34 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.555 1.142 . . . . 0.0 109.25 -162.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.5 m -143.1 155.68 44.64 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -171.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.25 130.37 54.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -121.52 160.8 23.49 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 127.196 2.198 . . . . 0.0 109.396 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.43 -161.13 0.74 Allowed 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 127.334 2.254 . . . . 0.0 108.981 -172.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -62.83 20.84 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.386 1.874 . . . . 0.0 112.992 162.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 133.03 46.35 0.11 Allowed Glycine 0 C--N 1.34 0.759 0 O-C-N 120.187 -1.571 . . . . 0.0 113.725 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.403 ' HE2' ' O ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -170.3 154.92 5.02 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 125.769 1.627 . . . . 0.0 108.497 160.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.403 ' O ' ' HE2' ' A' ' 104' ' ' LYS . 33.7 tt0 -72.71 146.86 46.18 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.481 1.113 . . . . 0.0 108.271 165.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.32 -29.86 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 117.981 -1.009 . . . . 0.0 111.617 170.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -131.64 147.18 52.5 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 120.395 1.452 . . . . 0.0 109.278 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.6 ptmm? -148.99 91.1 1.82 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 -164.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -129.05 171.41 12.4 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 123.564 1.65 . . . . 0.0 111.762 -168.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.4 t -148.11 165.74 29.93 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 111.963 -2.38 . . . . 0.0 105.252 162.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.5 mt -144.06 160.58 40.63 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.902 2.081 . . . . 0.0 108.045 168.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 p -126.35 123.16 62.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 125.426 1.491 . . . . 0.0 108.205 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.426 ' CD1' HG12 ' A' ' 81' ' ' VAL . 95.0 m-85 . . . . . 0 CA--C 1.516 -0.332 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.3 t70 . . . . . 0 N--CA 1.468 0.431 0 CA-C-O 120.484 0.183 . . . . 0.0 111.474 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 16.2 tp -111.08 131.18 55.29 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 165.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.13 36.42 0.68 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.062 1.745 . . . . 0.0 110.935 -168.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.8 mt -83.65 155.15 23.33 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.293 1.037 . . . . 0.0 110.985 -171.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -160.36 156.79 26.79 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 126.674 1.989 . . . . 0.0 111.635 169.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -151.52 160.49 43.67 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 127.288 2.235 . . . . 0.0 110.04 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.4 p30 . . . . . 0 C--O 1.245 0.866 0 C-N-CA 123.288 0.635 . . . . 0.0 110.384 161.694 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.426 0 CA-C-O 119.021 -0.877 . . . . 0.0 112.736 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -118.09 128.67 54.97 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 160.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.419 ' H ' ' HB3' ' A' ' 102' ' ' ASN . 17.2 mtp -78.9 160.53 27.24 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 147.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -132.97 146.32 51.67 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 170.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -148.7 121.41 8.64 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.847 1.259 . . . . 0.0 107.713 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.3 p -101.49 151.16 5.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 125.351 1.46 . . . . 0.0 108.146 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.0 p -123.68 162.74 22.48 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 122.702 1.239 . . . . 0.0 109.448 165.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.487 HD11 ' CG ' ' A' ' 95' ' ' TRP . 6.0 tp -133.0 144.64 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 159.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -134.69 98.31 4.02 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 103.803 -2.666 . . . . 0.0 103.803 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -81.29 108.7 15.14 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -133.95 164.86 26.34 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 118.688 0.676 . . . . 0.0 112.469 172.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.76 -176.37 11.3 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -145.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -75.83 120.79 21.67 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.357 -1.084 . . . . 0.0 110.906 -168.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -109.78 19.08 19.52 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 120.049 1.295 . . . . 0.0 112.269 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -81.61 -10.54 59.4 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -172.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.4 p -128.14 25.86 5.82 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.757 1.623 . . . . 0.0 113.721 -169.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -125.62 168.18 14.07 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 119.312 -2.118 . . . . 0.0 110.076 -165.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.7 mp -120.62 89.01 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.516 ' HB3' HD13 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -71.67 147.26 47.65 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 120.971 -1.081 . . . . 0.0 109.55 -179.436 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.28 129.16 17.36 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.665 1.986 . . . . 0.0 105.909 170.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.8 t -131.15 126.5 59.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 160.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -91.85 130.07 41.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 167.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.264 12.6 p -134.27 150.67 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 120.243 1.383 . . . . 0.0 110.509 167.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.41 HG22 ' HB3' ' A' ' 51' ' ' PRO . 83.8 t -135.18 158.83 41.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 127.728 2.411 . . . . 0.0 104.524 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.73 127.77 20.75 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 156.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -77.85 115.8 17.87 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 171.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.02 -9.76 22.99 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 118.452 -1.193 . . . . 0.0 115.309 159.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.5 t -157.07 -173.15 4.31 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.252 1.526 . . . . 0.0 110.219 -176.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -96.2 177.03 5.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.882 1.273 . . . . 0.0 110.277 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -117.33 161.94 18.72 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 127.122 2.169 . . . . 0.0 107.897 -169.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -139.03 128.51 24.38 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -170.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -80.46 113.78 18.89 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.12 9.02 58.91 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.056 -0.858 . . . . 0.0 113.578 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.36 -64.44 0.92 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 119.664 1.732 . . . . 0.0 108.267 157.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.85 -20.12 3.2 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.31 0.644 . . . . 0.0 111.852 -156.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.98 46.83 2.36 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 124.692 1.139 . . . . 0.0 110.96 175.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -100.32 132.21 45.82 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 p -76.75 131.18 38.59 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.3 mt -121.63 168.63 11.55 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 126.464 1.905 . . . . 0.0 108.983 -176.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -123.47 109.57 14.0 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.652 1.981 . . . . 0.0 107.985 -167.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.8 165.11 28.03 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -174.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.41 ' HB3' HG22 ' A' ' 33' ' ' VAL . 64.1 Cg_endo -70.45 172.25 52.59 Favored 'Cis proline' 0 C--N 1.348 0.546 0 C-N-CA 124.694 -0.961 . . . . 0.0 110.027 -18.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.4 p -148.86 148.16 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 121.482 0.658 . . . . 0.0 109.77 -174.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.4 mm -116.74 112.27 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 104.767 -2.309 . . . . 0.0 104.767 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -76.34 99.86 4.95 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 162.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 75.6 m -91.7 -175.62 4.22 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 173.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -63.04 -24.92 68.14 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -166.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -64.93 -47.59 77.16 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.192 1.397 . . . . 0.0 109.878 173.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -74.11 -13.74 60.87 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.168 0.987 . . . . 0.0 111.027 -174.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.516 HD13 ' HB3' ' A' ' 28' ' ' LYS . 14.0 mt -116.79 19.55 14.4 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.991 1.716 . . . . 0.0 111.048 -175.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.73 13.54 0.36 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.006 1.722 . . . . 0.0 113.418 174.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.6 HG23 HG22 ' A' ' 64' ' ' VAL . 0.9 OUTLIER -131.29 160.17 42.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 127.338 2.255 . . . . 0.0 109.257 -162.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.79 -32.1 73.5 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.975 0.91 . . . . 0.0 113.032 -176.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -163.94 121.16 1.74 Allowed 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -158.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.6 HG22 HG23 ' A' ' 61' ' ' VAL . 1.8 t -132.1 93.17 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -170.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.3 m -82.35 130.2 35.05 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 175.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -130.95 146.48 52.37 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 176.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.4 t -145.75 171.46 14.73 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.342 0.657 . . . . 0.0 110.114 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.5 p -79.14 165.45 23.31 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.493 0.664 . . . . 0.0 110.165 168.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 61.1 p -89.85 1.17 56.51 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.522 -0.736 . . . . 0.0 111.439 166.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -172.53 -163.52 26.49 Favored Glycine 0 N--CA 1.444 -0.794 0 O-C-N 120.926 -1.109 . . . . 0.0 113.806 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.34 119.3 3.95 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 128.47 2.708 . . . . 0.0 109.663 171.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.494 ' C ' HD13 ' A' ' 73' ' ' ILE . . . -125.38 167.15 15.35 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.465 0.706 . . . . 0.0 110.455 175.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.494 HD13 ' C ' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -125.71 -3.06 5.32 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 C-N-CA 124.354 1.062 . . . . 0.0 110.861 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 129' ' ' ASN . 60.9 mt-10 -151.52 162.71 40.5 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 119.736 1.153 . . . . 0.0 109.823 171.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -161.47 72.3 0.41 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.347 1.459 . . . . 0.0 109.108 176.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.27 144.09 55.0 Favored 'General case' 0 C--N 1.333 -0.144 0 O-C-N 121.735 -0.603 . . . . 0.0 110.198 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 64.9 t -142.06 114.04 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 126.643 1.977 . . . . 0.0 106.526 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.9 m -129.13 158.85 37.82 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.003 0.921 . . . . 0.0 108.649 171.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 154.08 -172.44 32.72 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-N 118.569 0.622 . . . . 0.0 111.777 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.75 173.4 41.43 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.355 1.455 . . . . 0.0 111.375 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.537 0.444 0 C-N-CA 125.345 1.458 . . . . 0.0 110.651 172.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 . . . . . 0 C--O 1.224 -0.255 0 CA-C-O 118.77 -0.633 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -81.65 -179.35 4.82 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.342 2.028 . . . . 0.0 113.985 -172.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 6.5 ptm -133.82 168.6 18.45 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.221 1.01 . . . . 0.0 111.786 -166.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -140.56 153.51 46.16 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 126.702 2.001 . . . . 0.0 107.443 170.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.487 ' CG ' HD11 ' A' ' 17' ' ' ILE . 3.9 m0 -116.17 114.61 24.69 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 103.943 -2.614 . . . . 0.0 103.943 172.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.9 t -94.23 127.02 46.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 164.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 m -139.26 94.02 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 -163.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.7 m -95.57 164.94 12.58 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.8 t -135.61 122.86 35.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 164.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -96.05 156.81 16.18 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 125.93 1.692 . . . . 0.0 107.744 168.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.465 ' HG2' HD22 ' A' ' 102' ' ' ASN . 31.4 tttt -108.72 -162.48 0.82 Allowed 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.505 1.922 . . . . 0.0 106.956 171.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.465 HD22 ' HG2' ' A' ' 101' ' ' LYS . 0.9 OUTLIER -63.02 82.83 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.268 1.827 . . . . 0.0 109.396 170.425 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.34 16.31 59.13 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.459 1.504 . . . . 0.0 115.146 167.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -153.35 168.92 24.42 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.633 1.717 . . . . 0.0 111.368 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -97.91 135.25 39.9 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.426 1.491 . . . . 0.0 108.823 176.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.21 -14.52 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.72 1.145 . . . . 0.0 113.859 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -129.9 153.42 48.34 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 173.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.9 tttm -160.39 78.77 0.65 Allowed 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.4 169.4 11.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.566 0.698 . . . . 0.0 110.435 177.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.4 t -156.84 155.24 31.16 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.628 ' N ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -131.03 -174.56 3.41 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 125.906 1.682 . . . . 0.0 107.078 179.461 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.4 p -167.87 119.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 126.308 1.843 . . . . 0.0 108.515 -158.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.467 0.415 0 O-C-N 121.555 -0.716 . . . . 0.0 110.353 171.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.532 0.283 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 mt -113.15 128.02 56.36 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.304 1.042 . . . . 0.0 111.598 -175.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -139.75 82.84 1.9 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 128.473 2.709 . . . . 0.0 106.6 174.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.2 mp -120.01 128.57 53.66 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.854 1.262 . . . . 0.0 107.875 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.5 72.34 1.38 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -176.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -74.6 150.09 39.81 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.284 175.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 31.8 p-10 . . . . . 0 C--O 1.257 1.466 0 C-N-CA 126.738 2.015 . . . . 0.0 109.989 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.982 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.97 177.55 9.05 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.062 1.431 . . . . 0.0 111.335 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.11 150.96 21.83 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.366 1.866 . . . . 0.0 108.723 157.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.52 ' HE1' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -157.44 134.69 10.34 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 128.428 2.691 . . . . 0.0 109.664 178.339 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -127.33 137.58 52.83 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 128.199 2.599 . . . . 0.0 104.96 169.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.1 p -110.16 150.14 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 165.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.0 p -124.03 159.53 29.66 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 164.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 tp -129.1 135.23 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 C-N-CA 127.94 2.496 . . . . 0.0 105.645 168.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -111.03 138.7 47.11 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 155.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -121.67 116.53 24.72 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 m -143.76 171.76 13.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 118.335 0.516 . . . . 0.0 110.985 -172.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.71 -95.18 2.07 Favored Glycine 0 C--N 1.334 0.453 0 N-CA-C 105.066 -3.214 . . . . 0.0 105.066 -164.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -142.19 173.33 11.62 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.495 1.518 . . . . 0.0 107.448 165.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -157.71 8.33 0.16 Allowed 'General case' 0 C--N 1.328 -0.361 0 O-C-N 120.852 -1.155 . . . . 0.0 112.173 169.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -54.95 -41.74 71.48 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.478 1.111 . . . . 0.0 113.297 -172.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 m -128.37 51.89 1.95 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.623 1.169 . . . . 0.0 109.788 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.414 ' HB3' HG21 ' A' ' 81' ' ' VAL . 28.4 m-85 -122.85 107.97 12.47 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -176.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 51.3 mt -73.22 88.64 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 125.515 1.526 . . . . 0.0 108.481 -168.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.4 pttm -112.41 125.32 54.08 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.414 1.485 . . . . 0.0 110.351 -166.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.6 m -127.95 159.7 34.15 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.728 1.211 . . . . 0.0 109.317 168.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 85.8 t -140.45 133.68 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.4 t -84.88 135.79 24.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 125.731 1.612 . . . . 0.0 107.196 169.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.6 t -136.58 128.26 43.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 168.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.3 t -138.65 119.4 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.96 156.22 36.77 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 167.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -118.83 119.49 34.52 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.737 1.615 . . . . 0.0 109.613 -175.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.24 -6.81 56.27 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.769 1.176 . . . . 0.0 114.857 161.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.407 ' CG2' ' HB2' ' A' ' 72' ' ' ALA . 14.7 t -140.67 -164.14 1.67 Allowed 'General case' 0 C--O 1.242 0.695 0 C-N-CA 126.548 1.939 . . . . 0.0 107.813 -176.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -122.05 177.49 5.3 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 120.904 -1.123 . . . . 0.0 109.308 174.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.83 167.58 10.38 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 125.038 1.335 . . . . 0.0 109.013 -173.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -136.67 114.12 10.92 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.225 1.01 . . . . 0.0 108.53 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -69.23 127.05 31.69 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.62 -22.43 69.82 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-O 118.226 -1.319 . . . . 0.0 113.85 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.07 -51.7 68.59 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 119.505 1.653 . . . . 0.0 110.322 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.81 -9.35 1.6 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.955 0.902 . . . . 0.0 111.552 -160.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.6 13.22 80.51 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.262 0.934 . . . . 0.0 112.506 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -55.1 123.56 14.04 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.901 1.681 . . . . 0.0 108.699 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.83 104.35 12.14 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.8 mt -85.7 163.16 18.41 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.699 0.8 . . . . 0.0 109.483 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.95 109.92 17.64 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.604 1.962 . . . . 0.0 106.243 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 66.2 m -82.36 151.33 65.62 Favored Pre-proline 0 C--N 1.323 -0.55 0 C-N-CA 126.895 2.078 . . . . 0.0 111.913 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.61 163.87 89.43 Favored 'Cis proline' 0 CA--C 1.535 0.561 0 CA-C-N 119.13 0.725 . . . . 0.0 111.658 -1.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 p -156.61 157.87 3.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 123.607 0.763 . . . . 0.0 109.758 170.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.9 mm -116.15 116.37 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 125.896 1.678 . . . . 0.0 107.082 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.8 mt -71.94 145.29 48.54 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 165.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 m -108.59 176.77 5.0 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.24 171.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -58.39 -22.96 55.78 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.611 1.964 . . . . 0.0 112.665 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -66.18 -27.29 67.88 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.147 1.779 . . . . 0.0 112.47 175.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -100.76 -24.06 14.48 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.637 1.575 . . . . 0.0 110.463 -171.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.7 mt -97.72 15.82 22.47 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.673 1.989 . . . . 0.0 110.297 -175.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.46 14.57 0.17 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.907 1.683 . . . . 0.0 114.278 -175.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.7 m -128.03 170.91 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 126.919 2.088 . . . . 0.0 111.008 -162.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -76.36 -20.43 57.21 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.055 0.942 . . . . 0.0 112.651 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.14 133.78 16.68 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.599 1.56 . . . . 0.0 110.006 -168.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.5 t -140.04 82.37 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.415 0.626 . . . . 0.0 110.209 173.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 90.4 m -73.44 130.54 40.33 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.74 1.216 . . . . 0.0 109.436 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -132.4 129.56 39.5 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.548 1.067 . . . . 0.0 109.112 175.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.0 t -141.28 168.18 20.39 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.768 1.627 . . . . 0.0 108.481 175.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.33 153.77 18.99 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 123.961 0.904 . . . . 0.0 110.231 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.3 p -83.33 11.48 6.68 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.726 1.21 . . . . 0.0 112.063 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 173.34 -172.49 45.22 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 173.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.61 141.28 48.67 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.671 1.236 . . . . 0.0 109.165 174.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.52 ' HB3' ' HE1' ' A' ' 13' ' ' TYR . . . -124.75 178.38 5.5 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.496 1.118 . . . . 0.0 108.547 172.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.2 mm -116.13 -11.61 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.863 0.865 . . . . 0.0 111.113 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -143.89 156.2 44.36 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.366 1.066 . . . . 0.0 108.746 169.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -145.08 103.28 3.85 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 160.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.86 122.12 46.92 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.12 121.94 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 C-N-CA 127.752 2.421 . . . . 0.0 109.162 -171.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.1 t -147.56 153.16 39.1 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -169.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.76 -177.02 43.44 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 171.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.05 176.41 38.47 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 106.196 -2.762 . . . . 0.0 106.196 167.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.414 HG21 ' HB3' ' A' ' 26' ' ' PHE . 7.2 p . . . . . 0 C--N 1.323 -0.546 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 166.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 . . . . . 0 CA--C 1.535 0.372 0 CA-C-O 119.409 -0.329 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -84.6 -175.99 2.33 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.29 2.66 . . . . 0.0 112.792 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 19.5 ptm -148.03 176.19 10.39 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.339 -0.851 . . . . 0.0 113.254 -160.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -142.3 157.18 45.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.462 1.905 . . . . 0.0 108.39 169.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 21.9 m0 -116.23 122.07 43.91 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 162.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.274 7.1 p -116.69 103.92 15.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 168.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.0 m -97.53 168.91 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.46 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.2 m -156.2 147.37 22.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.7 t -121.46 132.04 71.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -119.31 117.01 27.42 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.868 1.667 . . . . 0.0 107.246 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.3 tptt -74.8 -164.73 0.31 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.414 1.886 . . . . 0.0 108.784 172.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.17 79.93 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.037 2.535 . . . . 0.0 108.769 173.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.16 36.77 50.33 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.178 1.371 . . . . 0.0 114.133 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -157.32 152.5 26.05 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 118.199 1.0 . . . . 0.0 109.651 164.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -77.98 140.28 39.19 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 166.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 3.0 pt -130.92 -17.43 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -148.92 144.32 26.77 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -174.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -148.14 39.27 0.91 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -174.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.04 148.52 41.88 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.683 -1.261 . . . . 0.0 111.964 -173.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.9 p -122.04 153.16 38.98 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 127.575 2.35 . . . . 0.0 109.138 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.0 mt -131.9 170.47 14.83 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.237 1.415 . . . . 0.0 109.3 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 t -146.44 146.8 18.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 124.719 1.208 . . . . 0.0 108.406 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 . . . . . 0 C--O 1.235 0.297 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 152.23 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.3 t0 . . . . . 0 C--O 1.234 0.249 0 CA-C-O 121.068 0.461 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.9 tt -89.74 115.45 27.11 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 162.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -139.6 113.36 8.61 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 167.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 62.9 mt -139.62 115.2 10.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -177.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -134.2 129.7 36.13 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -141.51 163.07 33.91 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.453 1.501 . . . . 0.0 108.549 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 117.013 -1.47 . . . . 0.0 111.071 -174.418 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.55 ' HA2' ' HE3' ' A' ' 71' ' ' LYS . . . . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 114.792 0.677 . . . . 0.0 114.792 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.51 122.32 36.25 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 163.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 35.3 mtp -75.18 175.01 8.68 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 145.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 75' ' ' PHE . 1.4 p90 -167.57 171.28 10.44 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 125.499 1.52 . . . . 0.0 110.88 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -161.21 105.9 1.33 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.974 1.31 . . . . 0.0 107.565 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.6 p -80.75 158.57 4.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 119.917 -1.739 . . . . 0.0 109.445 166.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.6 p -128.7 158.95 37.16 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.826 1.25 . . . . 0.0 108.132 168.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.54 HD11 ' CD2' ' A' ' 95' ' ' TRP . 3.0 tp -136.85 97.99 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 172.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -75.0 147.17 41.02 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 164.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -118.26 150.25 39.77 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 161.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.0 162.82 34.59 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.54 -153.81 39.58 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -173.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -83.89 76.87 9.99 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 124.9 1.28 . . . . 0.0 109.898 -169.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -75.18 13.07 0.76 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 116.716 -1.611 . . . . 0.0 113.73 -175.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.6 mtt-85 -106.28 5.29 29.6 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 121.465 1.939 . . . . 0.0 114.766 -164.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.0 m -144.48 53.93 1.26 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.822 1.192 . . . . 0.0 111.959 175.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -135.47 137.6 42.32 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.238 1.015 . . . . 0.0 109.746 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.8 mm -78.28 93.67 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.583 1.153 . . . . 0.0 108.812 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -89.87 151.11 21.91 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 121.146 -0.971 . . . . 0.0 109.24 -176.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.1 m -138.79 142.99 38.74 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.347 1.059 . . . . 0.0 109.448 174.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.4 t -138.92 128.04 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 166.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.1 t -107.91 105.83 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 171.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.5 p -117.61 128.93 74.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 125.796 1.639 . . . . 0.0 110.583 -171.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.4 t -133.53 138.24 51.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -175.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.38 107.49 9.55 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 164.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.576 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 24.6 t-20 -63.6 113.98 3.67 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 171.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.66 -12.71 64.46 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.264 1.411 . . . . 0.0 116.108 169.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.9 t -149.82 172.06 15.75 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.351 2.076 . . . . 0.0 110.996 -172.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -89.74 160.85 16.35 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 122.641 1.21 . . . . 0.0 110.525 173.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.91 162.37 16.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 112.894 -1.957 . . . . 0.0 108.145 169.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -123.9 124.76 43.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 171.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -74.48 120.59 20.25 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.13 -20.83 75.25 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 117.636 -1.647 . . . . 0.0 113.695 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.64 -42.1 74.71 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.713 1.756 . . . . 0.0 112.583 -170.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 p -126.97 0.57 6.58 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.121 0.873 . . . . 0.0 112.896 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.11 28.63 40.42 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 123.812 0.72 . . . . 0.0 111.471 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -77.72 172.35 13.56 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.12 1.368 . . . . 0.0 109.055 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.8 t -123.73 130.73 53.09 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.648 0.737 . . . . 0.0 110.084 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 49.8 mt -118.91 121.32 39.69 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.362 -1.745 . . . . 0.0 108.864 -163.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.95 92.19 1.61 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.5 p -73.5 165.11 55.9 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-O 118.332 -0.842 . . . . 0.0 109.995 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -60.74 149.61 50.16 Favored 'Cis proline' 0 N--CA 1.452 -0.958 0 CA-C-N 120.354 1.162 . . . . 0.0 110.673 -13.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.4 p -142.31 158.71 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.8 mm -114.83 117.11 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 104.215 -2.513 . . . . 0.0 104.215 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 64.3 mt -77.69 159.9 28.83 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 169.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.5 m -138.82 -173.52 3.59 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.523 1.529 . . . . 0.0 108.256 -176.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -55.85 -41.3 74.13 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.407 1.483 . . . . 0.0 113.138 -174.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -67.19 -39.33 86.35 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.234 1.014 . . . . 0.0 111.133 -176.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -67.68 -22.51 65.28 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.729 0.812 . . . . 0.0 110.281 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 16.6 mt -115.82 20.12 14.75 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.664 1.985 . . . . 0.0 111.259 -173.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.15 3.89 7.86 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.667 1.187 . . . . 0.0 113.584 -172.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.3 m -122.8 167.13 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.539 1.536 . . . . 0.0 111.105 -165.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -57.08 -23.09 44.3 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.64 134.68 5.37 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 117.157 -1.401 . . . . 0.0 108.92 -168.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.0 t -126.45 161.94 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 164.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.4 m -142.04 127.21 18.54 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.989 1.715 . . . . 0.0 106.901 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -128.75 132.21 47.92 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.6 t -148.41 164.5 33.93 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 126.346 1.859 . . . . 0.0 106.601 -169.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.5 p -97.37 157.74 15.82 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 122.976 1.369 . . . . 0.0 112.869 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.6 p -76.2 -25.24 54.95 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.326 171.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -152.17 -169.11 17.21 Favored Glycine 0 CA--C 1.531 1.074 0 O-C-N 120.879 -1.138 . . . . 0.0 112.025 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.585 ' HE2' ' CD1' ' A' ' 73' ' ' ILE . 71.8 tttt -48.17 139.34 8.5 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 168.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -125.04 178.48 5.51 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 161.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.585 ' CD1' ' HE2' ' A' ' 71' ' ' LYS . 5.1 mm -111.43 -15.16 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.722 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.576 ' HG2' ' HB2' ' A' ' 35' ' ' ASN . 7.6 pt-20 -156.82 159.42 38.22 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -174.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.42 ' HB2' ' CE2' ' A' ' 13' ' ' TYR . 11.6 t80 -146.88 104.58 3.72 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.044 1.738 . . . . 0.0 109.738 165.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.41 148.19 22.48 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 118.548 -0.739 . . . . 0.0 109.724 176.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 t -149.17 112.65 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 124.97 1.308 . . . . 0.0 108.719 176.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.4 p -131.63 171.36 13.55 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 120.047 -1.658 . . . . 0.0 110.2 167.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 164.88 -99.05 0.16 Allowed Glycine 0 C--N 1.333 0.401 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 168.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.17 -175.3 15.7 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.371 0.986 . . . . 0.0 111.1 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.516 -0.345 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 CA--C 1.535 0.399 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -82.67 174.01 9.98 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.615 2.21 . . . . 0.0 112.637 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.3 ptm -143.9 163.25 33.97 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.574 0.749 . . . . 0.0 112.365 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -133.64 162.06 32.96 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.116 1.766 . . . . 0.0 109.617 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.54 ' CD2' HD11 ' A' ' 17' ' ' ILE . 2.4 m0 -127.52 150.42 49.69 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 125.922 1.689 . . . . 0.0 107.523 171.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.3 t -128.21 134.77 64.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 159.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 m -135.84 70.29 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -168.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.6 m -85.49 138.4 32.24 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -173.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.6 t -113.1 120.62 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -103.84 157.17 17.27 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 122.944 1.354 . . . . 0.0 108.325 168.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -116.34 176.62 5.02 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 130.127 3.371 . . . . 0.0 105.955 172.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -47.96 87.68 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 129.395 3.078 . . . . 0.0 108.941 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.4 58.64 10.5 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.133 1.349 . . . . 0.0 114.604 -171.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.83 154.09 6.2 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.045 1.922 . . . . 0.0 109.893 150.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -73.12 143.02 47.5 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.573 1.149 . . . . 0.0 108.906 165.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.1 pt -135.48 5.28 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 119.092 0.86 . . . . 0.0 113.065 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -152.73 160.15 43.13 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 120.548 -1.345 . . . . 0.0 108.522 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.9 tttm -158.09 86.71 0.9 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.176 0.898 . . . . 0.0 110.941 168.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.08 158.04 34.79 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 121.452 -0.78 . . . . 0.0 110.849 168.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.18 160.05 42.05 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 129.517 3.127 . . . . 0.0 107.46 177.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.9 mt -126.09 154.73 42.67 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.241 1.016 . . . . 0.0 108.297 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.5 p -136.31 130.57 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 . . . . . 0 N--CA 1.446 -0.664 0 C-N-CA 124.239 1.015 . . . . 0.0 108.715 176.838 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 C--O 1.235 0.319 0 N-CA-C 111.461 0.171 . . . . 0.0 111.461 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.46 91.82 2.58 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -153.65 81.72 1.16 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.866 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mp -114.85 146.87 40.61 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 126.692 1.997 . . . . 0.0 110.54 -173.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.99 110.25 3.73 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 177.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -115.16 117.19 29.82 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--O 1.246 0.883 0 C-N-CA 124.293 1.037 . . . . 0.0 110.039 -179.608 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.769 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -154.02 -157.01 0.73 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.696 1.198 . . . . 0.0 109.659 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 37.3 mtp -121.61 161.5 22.32 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 154.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -133.9 152.02 51.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 123.836 0.71 . . . . 0.0 109.477 167.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -147.63 121.47 9.32 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.7 p -123.05 145.95 29.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 124.854 1.262 . . . . 0.0 108.868 -168.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 73.3 p -118.0 162.67 17.78 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 122.186 0.993 . . . . 0.0 110.647 174.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.1 tp -144.73 90.92 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 165.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.532 ' HB2' HG13 ' A' ' 96' ' ' VAL . 31.5 mt-10 -75.56 132.97 41.05 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 162.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -112.43 111.26 21.99 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.705 2.002 . . . . 0.0 106.864 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -87.56 177.95 6.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.836 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.85 -134.2 52.07 Favored Glycine 0 C--N 1.335 0.485 0 C-N-CA 123.201 0.429 . . . . 0.0 112.756 163.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.74 38.78 1.15 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -162.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.432 ' HA ' ' SD ' ' A' ' 93' ' ' MET . 25.0 p90 -55.86 4.19 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 119.699 3.222 . . . . 0.0 119.699 -162.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.67 13.61 17.41 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 126.349 1.859 . . . . 0.0 113.152 -155.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.7 m -150.87 23.19 0.77 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -169.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -135.26 129.89 34.31 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.323 1.049 . . . . 0.0 108.453 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -68.69 93.32 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 119.704 1.138 . . . . 0.0 110.553 -177.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.79 151.37 22.93 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.433 -0.792 . . . . 0.0 110.522 173.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.6 m -140.04 150.49 44.45 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.273 1.829 . . . . 0.0 107.066 170.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.4 t -140.69 115.05 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.89 150.9 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 164.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.8 p -136.1 133.51 50.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 158.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.4 t -114.55 153.15 16.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 170.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.48 159.56 44.39 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.099 0.96 . . . . 0.0 108.547 169.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -125.04 117.09 23.21 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 127.09 2.156 . . . . 0.0 107.075 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.05 -1.29 67.56 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-O 118.365 -1.241 . . . . 0.0 114.607 163.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.617 HG22 ' HB2' ' A' ' 72' ' ' ALA . 1.4 t -159.3 174.91 14.05 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.8 1.8 . . . . 0.0 109.153 174.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -97.75 176.08 5.94 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.263 1.025 . . . . 0.0 111.173 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.37 161.41 13.94 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.337 1.055 . . . . 0.0 109.14 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -133.54 131.61 39.96 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 125.704 1.601 . . . . 0.0 107.227 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -101.22 119.5 38.85 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 123.918 0.761 . . . . 0.0 109.943 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.84 -7.99 5.26 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 118.016 -1.435 . . . . 0.0 114.205 171.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.94 -45.73 82.55 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 120.462 2.131 . . . . 0.0 111.509 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.23 -11.38 0.12 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.821 1.248 . . . . 0.0 112.508 -167.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.3 2.02 55.71 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.507 1.051 . . . . 0.0 112.199 -166.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -63.15 119.27 9.22 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.849 1.324 . . . . 0.0 110.203 -173.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.76 134.82 35.48 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.648 1.579 . . . . 0.0 108.8 172.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.3 mt -129.71 169.81 14.62 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.884 1.273 . . . . 0.0 109.384 -173.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.03 101.88 7.96 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 126.36 1.864 . . . . 0.0 108.179 -166.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.4 168.59 23.55 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 125.33 1.452 . . . . 0.0 112.438 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -72.28 141.57 71.27 Favored 'Cis proline' 0 C--N 1.35 0.639 0 N-CA-C 109.559 -0.977 . . . . 0.0 109.559 -8.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.9 p -145.11 161.51 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 121.435 -0.79 . . . . 0.0 110.125 -175.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.4 mm -118.66 114.62 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -177.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -80.5 133.65 35.85 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 169.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.411 ' H ' ' HG2' ' A' ' 58' ' ' GLU . 6.9 m -101.88 -177.91 3.56 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.944 1.697 . . . . 0.0 110.082 -175.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -52.64 -46.3 67.06 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.423 1.489 . . . . 0.0 111.676 -173.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -74.19 -30.25 62.13 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.212 0.605 . . . . 0.0 112.627 -171.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.411 ' HG2' ' H ' ' A' ' 55' ' ' SER . 2.2 mm-40 -67.75 -32.9 73.82 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.266 0.626 . . . . 0.0 109.993 173.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.652 HD13 HG21 ' A' ' 64' ' ' VAL . 3.7 mm? -92.69 7.25 44.34 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.106 1.762 . . . . 0.0 112.373 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.85 45.02 0.68 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.857 1.663 . . . . 0.0 112.488 -170.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.0 m -138.52 170.0 17.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 127.978 2.511 . . . . 0.0 109.537 -175.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -72.57 -24.83 61.16 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.207 -0.933 . . . . 0.0 112.964 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -152.46 145.93 24.88 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.652 HG21 HD13 ' A' ' 59' ' ' LEU . 2.2 t -120.9 153.06 24.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 160.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.401 ' C ' HD22 ' A' ' 66' ' ' LEU . 93.0 m -149.2 135.84 19.51 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 120.148 -1.595 . . . . 0.0 108.551 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.401 HD22 ' C ' ' A' ' 65' ' ' THR . 3.0 mm? -134.8 164.05 28.42 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 125.24 1.416 . . . . 0.0 109.019 -172.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.0 t -152.86 158.53 42.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.783 0.833 . . . . 0.0 108.876 173.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.415 HG21 ' HB3' ' A' ' 72' ' ' ALA . 18.0 p -65.84 138.3 57.79 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.551 1.541 . . . . 0.0 109.205 163.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 74.3 p -75.29 -16.74 60.41 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 120.359 1.436 . . . . 0.0 113.449 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -156.83 -163.8 12.82 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 -174.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.35 115.7 7.29 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.617 ' HB2' HG22 ' A' ' 37' ' ' THR . . . -124.44 176.04 6.74 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.859 1.264 . . . . 0.0 111.312 -173.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.517 HD13 ' O ' ' A' ' 72' ' ' ALA . 0.7 OUTLIER -137.41 5.37 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -172.319 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -147.55 164.55 33.1 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 121.178 1.808 . . . . 0.0 111.982 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -156.41 86.44 1.01 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.324 1.45 . . . . 0.0 107.679 155.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.01 138.89 34.79 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 121.482 -0.761 . . . . 0.0 109.209 166.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.2 t -143.15 130.83 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.8 m -143.71 169.22 18.15 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.051 1.341 . . . . 0.0 108.059 166.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 164.69 -175.15 40.72 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -174.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.8 -175.27 41.46 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 176.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.533 0.304 0 C-N-CA 126.838 2.055 . . . . 0.0 108.415 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 CA--C 1.532 0.28 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -81.17 178.85 6.4 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.077 1.851 . . . . 0.0 112.436 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.432 ' SD ' ' HA ' ' A' ' 23' ' ' PHE . 15.7 ptm -146.28 163.27 36.01 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 122.008 0.908 . . . . 0.0 111.145 173.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -122.82 158.77 29.53 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.394 1.477 . . . . 0.0 107.715 177.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 21.0 m0 -126.64 132.93 51.11 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 176.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 18' ' ' GLU 0.273 2.1 p -130.03 106.97 14.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 179.063 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.0 m -117.75 106.05 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 125.779 1.632 . . . . 0.0 106.98 -166.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.2 m -88.38 160.42 17.59 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 174.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.5 t -125.73 138.38 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 159.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -116.03 151.4 35.57 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 126.904 2.082 . . . . 0.0 107.843 170.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.476 ' HG2' HD22 ' A' ' 102' ' ' ASN . 15.3 tttm -99.69 -172.54 2.26 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 128.986 2.914 . . . . 0.0 107.895 174.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.476 HD22 ' HG2' ' A' ' 101' ' ' LYS . 0.1 OUTLIER -61.82 75.36 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.682 1.593 . . . . 0.0 110.547 167.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.43 42.44 6.95 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.711 1.624 . . . . 0.0 114.292 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -159.21 151.67 21.43 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.351 1.576 . . . . 0.0 108.448 165.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -76.17 137.73 40.23 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 159.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.7 pt -130.12 -18.39 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 118.295 -0.86 . . . . 0.0 113.262 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -143.7 139.23 29.4 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 120.156 1.344 . . . . 0.0 110.062 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -144.94 104.14 3.96 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -174.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -141.8 174.58 10.45 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 173.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.7 t -148.35 159.6 43.84 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.12 1.368 . . . . 0.0 109.271 174.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.3 mt -125.34 164.86 19.46 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.613 1.965 . . . . 0.0 109.001 -176.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.56 86.2 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 125.704 1.602 . . . . 0.0 108.828 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 . . . . . 0 C--O 1.234 0.274 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 168.227 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.539 0.534 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -132.18 134.65 45.62 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.814 1.643 . . . . 0.0 110.872 172.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.72 89.06 1.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 158.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 29.6 mt -110.15 140.43 44.26 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -153.64 73.93 0.98 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.729 1.612 . . . . 0.0 108.28 -176.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -73.39 148.31 43.48 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 121.661 -0.649 . . . . 0.0 109.843 170.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.5 p30 . . . . . 0 C--O 1.248 1.008 0 C-N-CA 127.116 2.166 . . . . 0.0 106.058 156.484 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.587 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -143.34 -160.52 1.12 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.764 1.226 . . . . 0.0 110.92 -171.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 30.4 mtp -135.27 167.06 21.72 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 128.58 2.752 . . . . 0.0 107.307 157.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -154.92 156.05 35.39 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.417 1.887 . . . . 0.0 108.87 -174.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -168.41 126.66 1.12 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.234 2.214 . . . . 0.0 106.23 -172.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.456 HG22 ' CE2' ' A' ' 75' ' ' PHE . 1.6 m -136.72 158.94 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 125.656 1.583 . . . . 0.0 110.177 -170.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.6 p -126.5 159.24 33.96 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.334 0.654 . . . . 0.0 111.062 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 tp -132.33 111.12 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 167.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -97.42 145.67 25.95 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 162.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -127.32 128.52 46.06 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.945 1.698 . . . . 0.0 107.717 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.1 m -149.85 178.88 8.5 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.524 1.53 . . . . 0.0 108.791 -167.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.52 -149.4 51.25 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -166.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -80.04 60.21 3.51 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.108 1.363 . . . . 0.0 111.691 -173.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.457 ' HA ' ' HE3' ' A' ' 93' ' ' MET . 52.1 p90 -76.44 30.57 0.12 Allowed 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.397 -1.439 . . . . 0.0 114.462 -174.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.9 mtt85 -106.83 -10.18 16.13 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -163.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.4 t -154.03 83.37 1.14 Allowed 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -145.95 165.85 27.75 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.975 0.91 . . . . 0.0 110.538 172.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.4 mt -132.11 88.47 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 125.473 1.509 . . . . 0.0 107.767 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.71 168.12 16.55 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.098 -1.002 . . . . 0.0 111.336 176.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.0 t -124.75 161.03 27.29 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 161.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -140.55 113.92 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 160.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.5 t -74.94 131.45 34.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 159.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.2 t -129.43 143.48 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 C-N-CA 124.541 1.136 . . . . 0.0 108.184 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 t -138.25 147.06 25.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.24 119.62 11.59 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.998 1.319 . . . . 0.0 108.111 169.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -76.78 127.39 32.67 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 118.166 -0.921 . . . . 0.0 109.859 173.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.82 0.05 69.36 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.085 1.326 . . . . 0.0 114.946 163.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.5 t -161.47 -179.43 7.34 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.621 1.21 . . . . 0.0 110.666 -170.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -104.42 169.94 8.18 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.073 1.349 . . . . 0.0 109.689 169.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.3 tp -101.77 164.43 11.74 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 127.274 2.23 . . . . 0.0 109.299 -174.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -130.11 114.21 15.46 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 126.144 1.777 . . . . 0.0 106.622 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -69.61 118.79 12.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 174.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.88 -7.24 55.31 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 117.671 -1.627 . . . . 0.0 113.52 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.2 -60.11 4.27 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 120.567 2.183 . . . . 0.0 110.067 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.98 3.09 3.7 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.304 1.841 . . . . 0.0 111.46 -167.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.57 17.73 67.76 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.843 1.211 . . . . 0.0 112.153 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -69.79 124.85 25.04 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.98 1.312 . . . . 0.0 109.854 -169.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.77 111.99 10.53 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.354 1.062 . . . . 0.0 109.933 173.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.4 mt -121.66 142.78 49.8 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 123.593 0.757 . . . . 0.0 109.44 -177.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.86 95.09 9.97 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.434 1.111 . . . . 0.0 108.6 175.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.3 p -51.24 154.51 2.82 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.199 157.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.76 130.57 20.85 Favored 'Cis proline' 0 N--CA 1.457 -0.648 0 CA-C-N 120.747 1.302 . . . . 0.0 111.159 -2.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.0 p -132.28 154.21 39.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 124.554 1.142 . . . . 0.0 108.618 -169.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.4 mm -117.55 120.14 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.1 mt -87.89 136.19 33.07 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.85 171.1 14.97 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.239 1.816 . . . . 0.0 108.932 171.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -61.23 -35.4 77.14 Favored 'General case' 0 C--O 1.22 -0.463 0 O-C-N 121.031 -1.043 . . . . 0.0 109.903 164.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -59.56 -25.69 64.76 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.707 1.203 . . . . 0.0 111.937 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -90.98 -28.55 17.95 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.768 1.227 . . . . 0.0 110.716 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.3 mt -113.08 5.08 16.96 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 124.376 1.07 . . . . 0.0 113.587 -169.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.03 45.66 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.387 2.675 . . . . 0.0 111.224 168.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.6 m -119.74 160.4 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 129.135 2.974 . . . . 0.0 108.303 173.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.64 -44.65 93.44 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 121.564 -0.71 . . . . 0.0 111.25 170.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.23 152.1 29.93 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 120.794 -1.191 . . . . 0.0 109.221 -175.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.9 p -142.19 165.4 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.419 0.628 . . . . 0.0 109.35 158.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.8 m -111.7 142.66 43.75 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 127.212 2.205 . . . . 0.0 105.993 170.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -123.33 133.27 54.15 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 169.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.47 177.89 8.14 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -174.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.1 p -119.19 147.29 44.38 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 118.894 0.77 . . . . 0.0 112.984 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.7 p -71.64 -12.63 61.44 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.634 1.173 . . . . 0.0 113.16 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -165.72 -169.73 29.71 Favored Glycine 0 N--CA 1.448 -0.562 0 O-C-N 120.596 -1.315 . . . . 0.0 110.522 -165.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.449 ' CE ' HD11 ' A' ' 73' ' ' ILE . 14.5 ttpt -55.46 115.6 2.39 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.624 1.57 . . . . 0.0 109.343 -176.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -111.33 145.42 38.87 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.449 HD11 ' CE ' ' A' ' 71' ' ' LYS . 1.3 mt -131.23 -11.23 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 118.878 -0.582 . . . . 0.0 112.02 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -144.4 137.87 27.36 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.456 ' CE2' HG22 ' A' ' 15' ' ' VAL . 0.9 OUTLIER -125.69 100.2 6.32 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 165.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.21 152.89 21.34 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 163.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.32 123.79 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 170.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.4 p -142.33 170.49 15.61 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.759 0.709 . . . . 0.0 111.027 164.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 142.41 -75.96 0.31 Allowed Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 176.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.559 ' H ' HD12 ' A' ' 124' ' ' LEU . . . 69.95 -152.38 51.22 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 CA--C 1.534 0.35 0 C-N-CA 124.315 1.046 . . . . 0.0 110.477 -176.765 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 . . . . . 0 CA--C 1.536 0.434 0 CA-C-O 119.661 -0.209 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -78.65 173.57 13.49 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.442 2.761 . . . . 0.0 112.741 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.53 ' CE ' ' HE1' ' A' ' 95' ' ' TRP . 2.7 ptm -125.2 162.23 25.13 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.355 -0.841 . . . . 0.0 111.508 176.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -142.8 144.81 32.72 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 124.992 1.317 . . . . 0.0 108.147 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.53 ' HE1' ' CE ' ' A' ' 93' ' ' MET . 52.7 m0 -123.35 156.92 34.43 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.2 t -133.26 117.92 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.7 m -128.54 123.85 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -165.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.2 m -121.75 156.96 32.04 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -173.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.9 t -131.65 131.56 62.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 123.808 0.843 . . . . 0.0 108.955 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -114.45 166.35 11.79 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.205 1.802 . . . . 0.0 109.099 170.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.02 -156.0 0.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.383 1.873 . . . . 0.0 108.094 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -65.76 68.7 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.563 1.145 . . . . 0.0 112.151 164.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.17 38.0 4.7 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.826 1.203 . . . . 0.0 113.428 166.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.54 152.72 12.35 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.555 1.177 . . . . 0.0 109.831 168.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -64.33 137.91 58.15 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 157.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.4 pt -123.86 -27.92 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 117.579 -1.201 . . . . 0.0 112.209 172.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -140.15 149.96 43.65 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.376 1.444 . . . . 0.0 109.39 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -152.83 108.94 3.36 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.663 1.985 . . . . 0.0 105.784 -174.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.68 154.09 39.17 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.175 170.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.87 157.83 27.91 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 125.593 1.557 . . . . 0.0 109.268 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 73.8 mt -129.82 147.64 51.62 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.432 1.093 . . . . 0.0 108.199 -163.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.9 p -129.82 100.87 5.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.62 0.724 . . . . 0.0 109.175 -171.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 N--CA 1.449 -0.505 0 CA-C-O 122.119 0.962 . . . . 0.0 108.488 167.555 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.274 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.559 HD12 ' H ' ' A' ' 80' ' ' GLY . 19.6 mt -111.16 96.18 5.98 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 -176.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -153.65 58.97 0.75 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.617 175.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 83.2 mt -107.91 145.36 33.88 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -153.18 72.19 0.93 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.002 0.906 . . . . 0.0 109.794 -176.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -65.15 133.53 51.76 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 171.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.3 p30 . . . . . 0 C--O 1.255 1.38 0 C-N-CA 125.363 1.465 . . . . 0.0 109.863 175.335 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.236 0 N-CA-C 106.899 -2.48 . . . . 0.0 106.899 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.64 174.58 11.3 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.238 1.019 . . . . 0.0 109.232 -176.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.8 mtp -84.39 -174.05 5.06 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 119.764 -1.835 . . . . 0.0 109.253 154.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -153.2 148.6 27.08 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.366 0.667 . . . . 0.0 110.487 152.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -142.06 144.63 33.68 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.898 2.079 . . . . 0.0 108.354 172.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 p -138.53 153.54 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 126.957 2.103 . . . . 0.0 110.105 175.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -114.31 153.84 29.06 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.465 1.506 . . . . 0.0 109.185 167.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.596 HG22 HG12 ' A' ' 64' ' ' VAL . 6.2 tp -105.34 148.4 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 155.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -139.92 115.25 9.88 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 167.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -104.59 128.65 52.65 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 126.014 1.726 . . . . 0.0 107.474 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -138.02 173.92 11.11 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 122.702 0.401 . . . . 0.0 110.666 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.64 -82.34 1.59 Allowed Glycine 0 CA--C 1.52 0.373 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -175.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.414 ' CG ' HH11 ' A' ' 24' ' ' ARG . 17.9 t0 -168.54 104.32 0.43 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 117.997 0.899 . . . . 0.0 112.927 175.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -96.25 24.61 5.57 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.515 -1.366 . . . . 0.0 112.363 -178.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.414 HH11 ' CG ' ' A' ' 22' ' ' ASP . 69.6 mtt85 -69.34 -47.23 64.98 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -172.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.4 m -127.26 69.15 1.28 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.807 1.185 . . . . 0.0 109.465 -177.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.526 ' HB3' HG21 ' A' ' 81' ' ' VAL . 65.9 m-85 -143.02 117.66 9.81 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -177.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.7 mm -84.62 79.06 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.567 ' H ' ' CD ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -79.44 145.41 33.32 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.209 1.403 . . . . 0.0 108.614 167.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.4 m -135.8 174.72 10.3 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 169.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.2 t -141.52 160.51 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 174.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.8 p -114.56 151.34 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 158.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.5 p -139.31 139.25 39.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 118.626 0.648 . . . . 0.0 110.413 162.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.5 t -126.47 144.81 35.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 126.49 1.916 . . . . 0.0 106.299 169.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.61 95.43 2.65 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.981 1.312 . . . . 0.0 109.048 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -62.56 100.3 0.18 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.314 1.446 . . . . 0.0 110.072 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.65 1.28 25.94 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 117.405 1.722 . . . . 0.0 117.405 159.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.422 HG22 ' HB2' ' A' ' 72' ' ' ALA . 2.6 t -157.78 179.11 9.52 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.934 2.367 . . . . 0.0 109.086 174.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -91.38 161.35 15.04 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.481 0.658 . . . . 0.0 110.471 175.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.3 mt -84.42 171.93 12.17 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.563 0.745 . . . . 0.0 109.731 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -135.74 129.09 32.07 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.779 1.232 . . . . 0.0 108.42 170.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.456 ' HA ' HD23 ' A' ' 66' ' ' LEU . 11.0 t0 -89.4 117.19 28.14 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.634 1.173 . . . . 0.0 109.808 173.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.96 11.72 5.86 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.079 1.323 . . . . 0.0 114.235 175.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.72 -48.16 56.01 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 120.123 1.962 . . . . 0.0 108.973 168.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.31 -9.71 0.57 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.686 1.194 . . . . 0.0 111.715 -167.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.86 13.4 55.01 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.244 1.878 . . . . 0.0 112.903 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -68.51 138.5 55.24 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -174.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.449 ' O ' HD23 ' A' ' 48' ' ' LEU . 4.7 m -71.54 147.23 47.89 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 170.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 47' ' ' SER . 2.4 mt -130.07 158.8 38.64 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 118.491 0.587 . . . . 0.0 109.56 171.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.48 103.59 10.25 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 126.77 2.028 . . . . 0.0 108.267 -173.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.95 165.54 52.38 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.233 169.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.98 140.05 64.91 Favored 'Cis proline' 0 N--CA 1.454 -0.813 0 N-CA-C 109.791 -0.888 . . . . 0.0 109.791 -8.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.2 p -143.37 160.05 17.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.03 0.932 . . . . 0.0 110.891 -177.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.0 mm -118.89 125.06 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 126.968 2.107 . . . . 0.0 107.111 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.3 mt -83.11 144.59 29.76 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 166.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.25 175.7 5.32 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.36 2.264 . . . . 0.0 109.544 176.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -59.39 -35.37 73.82 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.725 1.21 . . . . 0.0 113.428 -175.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -70.68 -28.48 64.8 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.962 0.801 . . . . 0.0 112.611 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -70.29 -52.98 18.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.434 ' O ' ' HE2' ' A' ' 28' ' ' LYS . 32.1 mt -77.28 24.61 0.18 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.786 2.034 . . . . 0.0 111.379 -175.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.07 -11.11 59.89 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.459 1.104 . . . . 0.0 112.155 175.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.9 m -84.1 148.61 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.442 1.097 . . . . 0.0 110.177 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -61.78 -33.24 73.75 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.638 -0.664 . . . . 0.0 112.19 173.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -154.4 141.05 18.96 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 -166.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.596 HG12 HG22 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -140.98 158.62 23.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -134.46 119.46 18.55 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -175.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 41' ' ' ASP . 17.7 mt -136.65 137.79 40.42 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 118.991 0.814 . . . . 0.0 109.626 -172.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -147.62 -168.23 3.01 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -168.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.22 147.54 42.41 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 127.369 2.268 . . . . 0.0 108.99 176.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 79.9 p -73.93 -20.84 60.26 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.515 -0.74 . . . . 0.0 111.302 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -156.59 -156.37 7.83 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 124.25 0.928 . . . . 0.0 111.05 -177.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -67.75 137.37 55.4 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.875 0.87 . . . . 0.0 109.793 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.422 ' HB2' HG22 ' A' ' 37' ' ' THR . . . -138.16 174.62 10.36 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.079 1.752 . . . . 0.0 109.783 172.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.73 21.07 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 123.544 0.738 . . . . 0.0 109.426 -174.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 129' ' ' ASN . 3.8 mt-10 -155.0 158.08 38.61 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 119.217 -2.177 . . . . 0.0 109.371 168.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.75 85.22 1.42 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.15 1.38 . . . . 0.0 107.547 160.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 127' ' ' TYR . . . -78.85 137.59 37.75 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 171.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.3 t -148.88 105.88 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 126.811 2.044 . . . . 0.0 106.445 -174.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.0 m -141.55 173.02 11.89 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.699 1.2 . . . . 0.0 111.082 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.66 -89.7 0.11 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 123.992 0.806 . . . . 0.0 111.361 167.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.01 133.43 7.94 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 108.796 -1.721 . . . . 0.0 108.796 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.526 HG21 ' HB3' ' A' ' 26' ' ' PHE . 9.4 p . . . . . 0 CA--C 1.532 0.26 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 . . . . . 0 N--CA 1.464 0.226 0 CA-C-O 118.823 -0.608 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -84.24 178.78 4.98 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.923 2.415 . . . . 0.0 112.312 176.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.5 ptm -148.37 171.2 16.41 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.287 -0.883 . . . . 0.0 112.164 -169.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -140.04 159.12 42.9 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 126.882 2.073 . . . . 0.0 107.547 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.0 m0 -128.3 141.58 51.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.018 1.327 . . . . 0.0 107.672 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -124.81 105.42 15.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 103.59 -2.745 . . . . 0.0 103.59 164.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.0 m -83.25 157.45 3.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 155.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 28.6 m -138.79 133.43 32.11 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 169.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.9 t -112.52 141.15 28.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -125.0 138.85 54.21 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.79 2.036 . . . . 0.0 108.529 -175.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -101.14 -174.79 2.69 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.341 1.457 . . . . 0.0 107.613 174.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -68.78 65.89 0.13 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.608 2.363 . . . . 0.0 109.031 -177.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 165.21 -68.81 0.2 Allowed Glycine 0 N--CA 1.448 -0.55 0 CA-C-O 118.675 -1.069 . . . . 0.0 112.278 -172.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -157.01 -176.59 6.07 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.534 1.133 . . . . 0.0 111.289 -174.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.86 139.03 14.03 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.899 1.68 . . . . 0.0 110.037 169.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.9 pt -129.12 -22.9 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 117.822 -1.085 . . . . 0.0 112.253 171.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -124.09 128.01 48.66 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 120.092 1.315 . . . . 0.0 110.411 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -126.6 90.89 3.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.052 1.741 . . . . 0.0 107.479 175.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -130.51 162.85 28.32 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 167.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.6 t -151.06 151.98 32.8 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.63 1.572 . . . . 0.0 107.026 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 36.9 mt -121.68 161.87 21.76 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.621 1.568 . . . . 0.0 109.112 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.0 p -137.75 132.82 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 N--CA 1.446 -0.654 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -174.39 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.6 t0 . . . . . 0 C--O 1.233 0.223 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.0 tp -122.55 114.98 21.39 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -154.28 53.71 0.68 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.345 1.458 . . . . 0.0 110.531 -159.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.3 mt -118.56 140.11 50.4 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -171.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 81.7 m-85 -151.71 67.65 0.88 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.968 1.307 . . . . 0.0 109.451 -168.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -64.89 159.76 22.03 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.003 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 3.8 t30 . . . . . 0 C--O 1.25 1.094 0 C-N-CA 128.408 2.683 . . . . 0.0 106.123 -176.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.843 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -152.02 -175.3 5.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.52 1.928 . . . . 0.0 108.694 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.446 ' H ' ' HB3' ' A' ' 102' ' ' ASN . 49.5 mtp -103.54 166.86 10.17 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 155.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -133.61 153.89 51.31 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.558 1.143 . . . . 0.0 108.033 169.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -148.36 145.19 27.98 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.29 133.76 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 127.195 2.198 . . . . 0.0 106.512 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 p -94.4 171.36 8.87 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 64' ' ' VAL . 11.3 tp -132.87 146.49 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 160.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -136.24 117.57 14.63 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 161.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -107.06 128.97 54.85 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 173.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.3 p -149.1 168.4 23.3 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 122.141 -0.35 . . . . 0.0 111.335 171.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.48 -114.53 3.96 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 107.284 -2.326 . . . . 0.0 107.284 -170.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -116.11 90.24 3.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 122.008 0.909 . . . . 0.0 110.709 -174.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -102.57 21.76 14.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.958 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.0 19.31 4.1 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.552 1.541 . . . . 0.0 112.311 -168.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.8 m -134.75 -1.27 2.77 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.302 1.441 . . . . 0.0 113.484 -173.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -119.24 -174.47 2.73 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.363 1.065 . . . . 0.0 108.328 -171.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.9 mp -129.87 80.8 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.48 ' HE2' ' OD2' ' A' ' 56' ' ' ASP . 2.3 pttt -81.1 162.42 23.71 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 121.835 -0.541 . . . . 0.0 110.091 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 m -145.35 158.06 43.91 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 171.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 74.4 t -142.28 105.77 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -68.49 149.11 11.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 159.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.04 142.23 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 124.982 1.313 . . . . 0.0 108.207 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.4 t -137.58 149.33 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 171.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.0 93.84 2.64 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 172.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -69.82 104.71 2.54 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.11 7.05 38.75 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.75 -1.028 . . . . 0.0 114.284 165.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.9 t -161.89 177.59 9.69 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.546 1.173 . . . . 0.0 109.024 -174.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -100.05 170.29 8.59 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.091 0.956 . . . . 0.0 108.739 171.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 tp -84.48 170.14 13.79 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.316 0.646 . . . . 0.0 109.396 164.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -134.67 120.19 19.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.898 1.279 . . . . 0.0 108.087 171.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -69.49 129.32 39.38 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.124 0.97 . . . . 0.0 109.37 176.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.69 -8.79 84.06 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 118.892 -0.949 . . . . 0.0 113.126 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.57 -46.75 86.9 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.128 1.464 . . . . 0.0 108.635 173.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.68 -16.04 1.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.688 0.795 . . . . 0.0 112.088 -160.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.38 63.27 2.82 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -173.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -123.48 140.11 53.33 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.481 1.112 . . . . 0.0 108.333 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.85 112.16 17.98 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -178.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.7 mt -97.09 128.23 43.82 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.75 0.786 . . . . 0.0 109.352 -174.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.16 79.54 6.7 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.35 1.46 . . . . 0.0 109.493 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.2 m -63.02 163.67 15.96 Favored Pre-proline 0 N--CA 1.444 -0.767 0 C-N-CA 123.724 0.809 . . . . 0.0 110.949 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -68.93 140.66 59.29 Favored 'Cis proline' 0 CA--C 1.536 0.617 0 CA-C-N 119.211 0.754 . . . . 0.0 110.625 -9.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.7 p -145.68 149.24 16.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 124.002 0.921 . . . . 0.0 109.651 -171.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.4 mm -125.47 98.24 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 124.032 0.933 . . . . 0.0 109.295 -173.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.2 mt -72.43 131.19 42.27 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 175.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.7 m -87.93 -177.05 5.68 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.11 1.364 . . . . 0.0 109.709 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.48 ' OD2' ' HE2' ' A' ' 28' ' ' LYS . 12.5 t70 -61.21 -43.89 98.16 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.902 0.881 . . . . 0.0 112.16 -172.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -67.83 -38.85 83.74 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -174.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.15 -32.55 73.96 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.33 20.33 0.15 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.919 1.688 . . . . 0.0 115.22 176.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.36 19.34 0.08 Allowed 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 120.691 1.587 . . . . 0.0 114.993 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.8 m -95.92 153.94 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 O-C-N 120.567 -1.333 . . . . 0.0 111.554 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -75.62 -41.43 54.31 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.561 -0.712 . . . . 0.0 111.853 175.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.72 107.36 0.87 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -166.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.52 ' H ' HG22 ' A' ' 17' ' ' ILE . 93.1 t -138.6 118.91 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 123.14 1.448 . . . . 0.0 111.239 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.9 m -69.26 125.53 26.97 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 128.231 2.613 . . . . 0.0 109.093 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.49 140.8 47.81 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.479 1.036 . . . . 0.0 108.225 170.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.4 t -150.69 178.17 9.36 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.08 1.352 . . . . 0.0 107.781 176.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.9 p -87.55 165.42 15.5 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.245 0.618 . . . . 0.0 110.484 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.8 p -80.41 -13.55 59.05 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.855 -0.528 . . . . 0.0 111.372 165.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -166.43 -170.73 31.71 Favored Glycine 0 CA--C 1.527 0.812 0 O-C-N 120.388 -1.445 . . . . 0.0 113.457 -167.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -63.02 132.43 51.96 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.432 1.093 . . . . 0.0 109.057 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.452 ' C ' HD13 ' A' ' 73' ' ' ILE . . . -133.61 160.66 36.83 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.624 1.17 . . . . 0.0 111.741 -175.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.452 HD13 ' C ' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -128.2 14.35 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 118.478 -0.772 . . . . 0.0 110.35 178.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -149.27 158.05 43.85 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.483 1.492 . . . . 0.0 110.701 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -161.48 99.33 1.15 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.197 1.399 . . . . 0.0 107.664 165.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.95 142.2 28.02 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.348 1.459 . . . . 0.0 110.949 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 t -145.63 107.84 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 124.526 1.13 . . . . 0.0 108.274 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.8 m -141.07 166.65 24.21 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 121.041 -1.037 . . . . 0.0 109.67 169.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.04 -65.22 0.3 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 167.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.65 176.22 25.04 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 121.123 0.29 . . . . 0.0 112.378 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 C--O 1.235 0.325 0 C-N-CA 126.006 1.722 . . . . 0.0 107.368 165.793 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -75.69 167.01 27.26 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.264 1.976 . . . . 0.0 112.36 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.0 ppp? -149.36 174.19 12.71 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.02 0.528 . . . . 0.0 111.11 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -135.1 156.4 49.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.138 1.375 . . . . 0.0 108.753 173.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -141.25 90.9 2.35 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -178.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.7 t -82.28 137.18 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 168.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 m -144.63 54.7 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 125.254 1.422 . . . . 0.0 108.67 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.0 m -65.93 140.23 58.32 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 120.703 -1.248 . . . . 0.0 108.206 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.9 m -103.83 154.63 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 CA-C-O 122.889 1.328 . . . . 0.0 109.693 172.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -127.26 172.84 10.24 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 126.889 2.076 . . . . 0.0 108.098 167.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -120.92 -162.13 0.94 Allowed 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 130.644 3.578 . . . . 0.0 105.234 -176.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.446 ' HB3' ' H ' ' A' ' 12' ' ' MET . 0.6 OUTLIER -67.99 72.72 0.18 Allowed 'General case' 0 CA--C 1.551 1.002 0 O-C-N 121.226 -0.921 . . . . 0.0 109.416 165.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.25 29.37 56.47 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 126.003 1.763 . . . . 0.0 115.067 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -136.04 178.64 6.9 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.744 1.772 . . . . 0.0 108.209 166.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -120.53 140.7 51.08 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 127.322 2.249 . . . . 0.0 106.705 170.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -117.09 -27.33 2.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 125.353 1.461 . . . . 0.0 111.768 175.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -149.82 143.54 25.42 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.253 0.933 . . . . 0.0 109.164 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.8 tttt -137.45 43.77 2.29 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.517 0.727 . . . . 0.0 110.359 -173.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -69.26 142.4 54.16 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.4 t -138.76 160.14 40.39 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.268 1.827 . . . . 0.0 107.828 168.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 31.3 mt -125.32 144.5 50.46 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.993 1.717 . . . . 0.0 107.984 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 98.7 t -135.27 126.82 46.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.315 1.446 . . . . 0.0 107.24 -175.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 . . . . . 0 CA--C 1.535 0.378 0 C-N-CA 124.324 1.049 . . . . 0.0 109.174 175.579 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.09 112.63 6.86 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 172.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -144.38 70.02 1.28 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -176.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.84 139.79 44.51 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.71 2.004 . . . . 0.0 107.224 -176.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -153.08 135.72 15.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 169.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -119.93 148.32 43.67 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.837 1.255 . . . . 0.0 109.09 171.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.3 p30 . . . . . 0 C--O 1.248 0.974 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 152.823 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.66 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.15 -178.06 6.28 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.7 0.8 . . . . 0.0 111.227 -170.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.9 mtp -107.39 156.15 19.24 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 160.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -133.94 137.52 44.92 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.843 0.857 . . . . 0.0 110.637 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 39.3 tt0 -133.93 133.54 41.53 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 127.984 2.514 . . . . 0.0 107.921 171.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.05 155.78 11.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 126.511 1.924 . . . . 0.0 108.094 168.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.32 143.92 36.07 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 172.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.441 HD11 ' CG ' ' A' ' 95' ' ' TRP . 1.5 tp -133.29 97.0 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.46 143.83 34.6 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 161.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -120.67 130.79 54.25 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 173.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 m -112.18 165.79 11.83 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 122.385 0.274 . . . . 0.0 110.388 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 62.19 -147.8 48.84 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -79.3 77.38 5.83 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-O 122.112 0.958 . . . . 0.0 110.34 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -83.8 -5.97 59.32 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.006 -1.059 . . . . 0.0 112.541 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 90.9 mtt-85 -70.14 -57.43 4.95 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.8 m -78.74 35.34 0.24 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.735 1.614 . . . . 0.0 113.272 -157.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.704 ' HB3' HG21 ' A' ' 81' ' ' VAL . 36.6 m-85 -154.49 113.77 3.71 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.788 1.235 . . . . 0.0 111.392 -158.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.6 pt -67.68 74.99 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 127.791 2.436 . . . . 0.0 112.649 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -77.85 160.62 28.19 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 128.181 2.592 . . . . 0.0 111.851 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.5 t -156.63 152.91 27.75 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.636 -0.665 . . . . 0.0 109.798 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.5 t -128.19 139.95 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 125.628 1.571 . . . . 0.0 108.4 175.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.4 t -106.15 129.05 60.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 127.878 2.471 . . . . 0.0 104.761 164.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.62 147.08 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 119.696 1.135 . . . . 0.0 110.234 176.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.9 t -140.87 150.56 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.2 100.52 3.29 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 170.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -68.67 118.36 11.57 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.012 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.19 -14.11 40.17 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 119.408 -0.662 . . . . 0.0 114.106 159.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.4 t -148.87 178.3 8.8 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.872 1.269 . . . . 0.0 110.052 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -89.8 155.03 19.45 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.462 0.705 . . . . 0.0 109.816 173.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.5 tp -77.47 166.96 22.42 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.423 1.089 . . . . 0.0 108.883 168.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -137.07 128.36 28.07 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.152 1.781 . . . . 0.0 107.209 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.423 ' HB2' HD11 ' A' ' 48' ' ' LEU . 8.7 t0 -84.67 121.32 27.49 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.93 -8.25 57.52 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-O 119.125 -0.819 . . . . 0.0 113.693 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.8 -26.52 40.53 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.047 1.423 . . . . 0.0 111.729 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 p -134.09 -43.91 0.79 Allowed 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 124.299 1.04 . . . . 0.0 110.808 -169.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.57 13.1 56.16 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.724 -1.042 . . . . 0.0 111.058 -163.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -67.29 156.9 35.22 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 118.705 1.252 . . . . 0.0 109.253 168.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.4 p -112.96 133.62 54.84 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.39 1.476 . . . . 0.0 108.962 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.423 HD11 ' HB2' ' A' ' 41' ' ' ASP . 44.9 mt -130.93 137.58 49.36 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.79 0.836 . . . . 0.0 109.515 -162.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -85.02 63.28 8.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.227 1.411 . . . . 0.0 111.059 -167.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.7 m -53.5 150.64 12.12 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-O 118.832 -0.604 . . . . 0.0 110.948 172.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.03 140.61 68.28 Favored 'Cis proline' 0 CA--C 1.535 0.541 0 CA-C-N 119.857 0.985 . . . . 0.0 113.359 2.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.0 t -144.7 165.48 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.384 1.873 . . . . 0.0 108.222 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.4 mm -114.69 138.96 43.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 C-N-CA 126.63 1.972 . . . . 0.0 107.001 172.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -115.71 125.98 53.52 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.53 174.04 12.0 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 126.018 1.727 . . . . 0.0 110.461 -172.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -51.38 -38.88 55.65 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.743 1.617 . . . . 0.0 112.705 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -70.2 -39.6 75.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.078 0.551 . . . . 0.0 110.876 -175.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -63.92 -40.18 95.87 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.06 11.92 10.66 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.605 1.962 . . . . 0.0 113.376 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.87 19.26 0.07 Allowed 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 122.21 2.277 . . . . 0.0 115.83 -172.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.7 m -124.97 169.76 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 120.185 -1.572 . . . . 0.0 112.795 -159.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -66.78 -30.22 70.37 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.201 -0.937 . . . . 0.0 112.193 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 23.7 tttp -154.32 151.35 28.98 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 119.475 1.034 . . . . 0.0 110.278 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -125.45 156.69 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 158.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.5 m -136.59 126.23 25.42 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 126.165 1.786 . . . . 0.0 106.529 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.9 mp -140.7 146.61 38.02 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 120.319 1.418 . . . . 0.0 110.695 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 20.9 t -132.4 -167.08 1.83 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.43 1.092 . . . . 0.0 109.743 -177.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.94 147.55 36.85 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.749 1.62 . . . . 0.0 108.609 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.1 p -77.47 -14.14 59.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.438 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.53 -167.21 20.73 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -173.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -66.36 133.08 49.77 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.1 153.76 38.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 173.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -113.61 -0.7 9.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 123.392 0.677 . . . . 0.0 109.473 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 129' ' ' ASN . 46.2 mt-10 -149.88 157.72 43.46 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 119.394 0.997 . . . . 0.0 108.487 173.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.5 157.23 44.96 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.513 1.925 . . . . 0.0 106.182 159.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.26 143.95 36.2 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 164.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.8 t -129.68 90.85 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 102.97 -2.974 . . . . 0.0 102.97 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.1 t -125.17 160.43 29.18 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.37 -152.35 21.49 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 -165.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.68 -165.39 24.81 Favored Glycine 0 C--O 1.239 0.451 0 N-CA-C 107.829 -2.109 . . . . 0.0 107.829 -167.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.704 HG21 ' HB3' ' A' ' 26' ' ' PHE . 14.9 p . . . . . 0 N--CA 1.443 -0.79 0 C-N-CA 123.74 0.816 . . . . 0.0 109.228 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 . . . . . 0 N--CA 1.465 0.285 0 CA-C-O 120.926 0.393 . . . . 0.0 111.606 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.18 175.36 10.01 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.896 1.731 . . . . 0.0 112.93 164.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.1 ptm -154.6 -179.27 7.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.903 1.681 . . . . 0.0 107.805 -172.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -169.25 165.66 10.83 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.093 1.357 . . . . 0.0 107.375 171.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.535 ' HB2' HD12 ' A' ' 111' ' ' LEU . 36.0 m0 -104.21 144.39 31.67 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 162.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 96.9 t -128.52 79.31 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 101.42 -3.548 . . . . 0.0 101.42 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.433 ' CG1' HD13 ' A' ' 17' ' ' ILE . 17.0 m -83.92 144.65 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.3 m -133.61 142.98 48.35 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.5 t -127.84 130.86 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -117.43 142.74 46.76 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.195 1.398 . . . . 0.0 109.127 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.431 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 18.5 ttpt -83.08 -162.33 0.59 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 163.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.431 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 7.1 p30 -59.09 74.24 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.352 2.261 . . . . 0.0 110.043 167.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.38 40.16 24.34 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.864 1.221 . . . . 0.0 114.643 173.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.14 148.93 28.22 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.429 1.491 . . . . 0.0 107.765 167.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -77.7 146.58 35.92 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 169.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 39.7 pt -132.05 -21.9 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.849 1.26 . . . . 0.0 112.165 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -137.78 146.39 43.53 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.018 -1.051 . . . . 0.0 108.732 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 41.9 tttt -142.35 27.14 1.75 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.524 1.13 . . . . 0.0 110.584 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.476 ' HE2' HD21 ' A' ' 126' ' ' LEU . 33.4 ttpt -80.54 131.67 35.56 Favored 'General case' 0 CA--C 1.517 -0.29 0 O-C-N 121.538 -0.726 . . . . 0.0 110.239 -171.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 p -106.49 167.53 9.78 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 125.895 1.678 . . . . 0.0 109.021 177.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.535 HD12 ' HB2' ' A' ' 95' ' ' TRP . 45.9 mt -127.92 -177.2 4.03 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.466 1.507 . . . . 0.0 108.073 -174.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.9 p -151.21 146.86 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 175.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 . . . . . 0 C--O 1.238 0.483 0 C-N-CA 125.956 1.703 . . . . 0.0 108.18 162.649 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.402 ' OD2' HD13 ' A' ' 111' ' ' LEU . 27.0 t0 . . . . . 0 CA--C 1.523 -0.072 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.509 ' HG ' HD11 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -127.04 111.71 14.37 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -169.535 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -138.41 50.53 1.88 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.545 1.138 . . . . 0.0 109.757 -172.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.476 HD21 ' HE2' ' A' ' 109' ' ' LYS . 92.6 mt -101.68 144.75 30.0 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.055 -1.028 . . . . 0.0 108.614 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -156.71 149.57 23.8 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.736 1.614 . . . . 0.0 107.864 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -144.91 152.51 40.33 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.671 1.189 . . . . 0.0 109.247 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 4.6 p30 . . . . . 0 C--O 1.251 1.142 0 C-N-CA 125.479 1.511 . . . . 0.0 109.167 166.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.747 0 N-CA-C 106.158 -2.777 . . . . 0.0 106.158 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.78 145.59 38.42 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 118.716 1.258 . . . . 0.0 110.235 -172.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.1 mtp -63.03 147.0 51.98 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 154.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -135.18 148.63 49.74 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 164.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -143.77 110.36 5.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.338 1.855 . . . . 0.0 106.679 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 p -89.25 142.94 12.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 169.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.02 156.23 36.85 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 169.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.404 HD11 ' CG ' ' A' ' 95' ' ' TRP . 6.3 tp -138.16 143.2 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 169.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -129.89 97.06 4.37 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 172.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -83.78 125.46 31.95 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.6 t -151.43 167.73 27.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.5 -158.2 52.59 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -159.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -76.7 52.26 0.81 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.288 1.044 . . . . 0.0 113.779 -170.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -64.35 -8.5 13.32 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.336 -1.477 . . . . 0.0 114.427 -174.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -58.88 -60.73 3.39 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 119.25 0.932 . . . . 0.0 109.902 -174.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.9 m -79.1 28.38 0.23 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.183 1.793 . . . . 0.0 113.352 -167.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.407 ' O ' ' HE3' ' A' ' 28' ' ' LYS . 40.4 m-85 -123.95 123.1 39.66 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.075 0.95 . . . . 0.0 108.58 -172.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.4 mm -70.09 98.44 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -177.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.423 ' HD2' ' H ' ' A' ' 28' ' ' LYS . 2.2 mptt -75.29 131.35 40.25 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.639 0.776 . . . . 0.0 109.258 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.2 m -137.53 134.41 35.66 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.275 1.03 . . . . 0.0 108.603 169.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 89.8 t -137.34 113.91 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 165.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.5 p -70.24 132.75 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 158.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.94 143.69 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 126.33 1.852 . . . . 0.0 108.163 176.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.7 t -140.58 158.31 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.879 1.272 . . . . 0.0 107.739 -171.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.62 154.43 34.18 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.308 1.043 . . . . 0.0 108.809 168.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.441 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 18.2 t-20 -118.16 101.84 8.54 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 124.979 1.312 . . . . 0.0 109.587 178.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.17 -80.23 0.27 Allowed Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 106.186 -2.765 . . . . 0.0 106.186 171.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.9 t -70.79 174.76 5.64 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 125.31 1.444 . . . . 0.0 110.505 -175.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -110.32 172.82 6.64 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.149 0.98 . . . . 0.0 111.149 -175.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.26 164.49 11.93 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.1 1.36 . . . . 0.0 108.424 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -138.48 124.15 19.72 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.61 0.764 . . . . 0.0 109.66 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -73.78 126.78 31.14 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 123.956 0.785 . . . . 0.0 109.607 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.99 6.66 19.1 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 117.58 -1.678 . . . . 0.0 114.321 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.49 -62.07 1.7 Allowed 'General case' 0 C--O 1.23 0.066 0 CA-C-N 120.621 2.21 . . . . 0.0 109.065 171.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.93 7.62 4.73 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.68 1.192 . . . . 0.0 111.787 -170.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.19 32.19 83.11 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -65.9 126.78 29.62 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 175.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.94 104.78 17.33 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -170.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 68.7 mt -91.06 -175.01 4.18 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.424 1.489 . . . . 0.0 110.673 -165.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.15 109.27 5.78 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.064 1.346 . . . . 0.0 107.427 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.44 165.01 46.92 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.822 -0.549 . . . . 0.0 110.74 174.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.67 142.74 65.34 Favored 'Cis proline' 0 CA--C 1.537 0.673 0 CA-C-N 118.569 0.525 . . . . 0.0 111.722 -9.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.5 p -145.09 165.05 12.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 126.092 1.757 . . . . 0.0 111.12 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.4 mm -119.59 118.5 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 126.222 1.809 . . . . 0.0 107.361 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.2 mt -73.6 104.68 4.63 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 159.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.0 m -76.5 179.73 5.73 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.55 1.14 . . . . 0.0 110.479 168.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -50.96 -34.23 27.9 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.126 1.37 . . . . 0.0 112.32 170.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -66.84 -32.42 73.68 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.55 1.14 . . . . 0.0 112.169 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -86.84 -47.77 8.77 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.2 mt -76.04 21.56 0.17 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.614 1.966 . . . . 0.0 111.887 174.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.78 -4.87 37.32 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.104 1.362 . . . . 0.0 112.893 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.76 HG23 HG22 ' A' ' 64' ' ' VAL . 1.4 m -108.54 160.89 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 127.333 2.253 . . . . 0.0 110.875 -177.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -68.19 -33.12 73.85 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.289 1.036 . . . . 0.0 112.319 -176.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -143.77 126.31 15.91 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -165.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.76 HG22 HG23 ' A' ' 61' ' ' VAL . 1.7 t -136.17 90.44 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -172.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.2 m -81.58 114.86 20.57 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.787 0.835 . . . . 0.0 109.418 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -116.08 132.12 56.75 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 t -147.64 168.52 21.82 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.274 0.559 . . . . 0.0 109.569 -175.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.19 139.51 32.25 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.188 1.795 . . . . 0.0 111.133 -171.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.3 p -68.14 -28.93 67.73 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -175.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -132.81 -86.37 0.3 Allowed Glycine 0 C--N 1.338 0.672 0 CA-C-N 118.82 0.736 . . . . 0.0 112.891 -173.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.99 139.48 20.5 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 130.764 3.625 . . . . 0.0 107.614 162.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.423 ' HB1' ' H ' ' A' ' 35' ' ' ASN . . . -101.51 -169.13 1.65 Allowed 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 169.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.1 mm -115.32 -19.71 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.788 170.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.441 ' HG2' ' HB2' ' A' ' 35' ' ' ASN . 19.3 pt-20 -150.4 164.62 35.39 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.643 -1.286 . . . . 0.0 109.571 -160.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -164.52 124.03 1.92 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.66 1.584 . . . . 0.0 109.982 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.35 155.85 19.54 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 120.037 1.29 . . . . 0.0 109.73 167.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.7 t -150.16 92.76 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 127.501 2.32 . . . . 0.0 105.287 174.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.9 m -137.0 159.93 40.43 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.287 -0.883 . . . . 0.0 110.437 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.24 -97.3 0.18 Allowed Glycine 0 C--N 1.333 0.38 0 N-CA-C 106.978 -2.449 . . . . 0.0 106.978 176.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.9 -168.38 21.31 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -175.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.234 0.265 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 161.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.05 175.68 10.92 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.712 2.275 . . . . 0.0 111.129 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.0 ptm -146.61 168.86 20.23 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -142.87 160.08 41.01 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 122.295 1.045 . . . . 0.0 109.292 172.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.404 ' CG ' HD11 ' A' ' 17' ' ' ILE . 4.0 m0 -127.07 112.1 14.81 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 171.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.5 t -92.87 132.39 37.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 159.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.82 161.95 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 174.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.91 155.84 28.43 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.276 -1.749 . . . . 0.0 106.276 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 75.8 t -125.27 91.61 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 171.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -72.58 163.14 28.53 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 170.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -127.63 -154.33 0.63 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.478 2.311 . . . . 0.0 109.552 -168.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -62.17 61.34 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.719 2.007 . . . . 0.0 111.449 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.34 65.99 2.93 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 120.264 -1.522 . . . . 0.0 110.964 -169.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -165.74 165.13 18.76 Favored 'General case' 0 C--N 1.335 -0.059 0 C-N-CA 125.746 1.618 . . . . 0.0 107.999 150.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -77.83 147.75 35.04 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.925 1.69 . . . . 0.0 107.442 159.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 6.4 pt -134.51 -10.36 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.367 1.467 . . . . 0.0 112.553 166.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -145.97 159.35 43.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.237 1.815 . . . . 0.0 108.78 -165.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -153.69 25.76 0.51 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -173.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -47.67 128.16 12.47 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.94 0.896 . . . . 0.0 111.394 177.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.0 p -147.42 140.46 25.09 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.286 1.034 . . . . 0.0 109.469 -177.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.619 ' N ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -133.73 -173.45 3.24 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 123.256 1.503 . . . . 0.0 109.645 -174.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.7 p -159.83 141.34 4.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 128.96 2.904 . . . . 0.0 108.689 -177.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 . . . . . 0 C--O 1.238 0.449 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 172.016 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.7 tp -134.56 112.81 11.17 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -156.11 54.11 0.57 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 126.93 2.092 . . . . 0.0 107.925 -172.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tp -106.43 143.27 34.78 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.23 1.012 . . . . 0.0 108.984 -171.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -158.95 136.88 10.39 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.199 0.6 . . . . 0.0 109.461 -167.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -137.48 127.36 25.64 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 128.278 2.631 . . . . 0.0 106.062 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.257 1.494 0 C-N-CA 128.987 2.915 . . . . 0.0 104.888 153.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.471 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . . . . . . 0 CA--C 1.524 0.616 0 N-CA-C 108.471 -1.851 . . . . 0.0 108.471 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.52 165.44 17.81 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.544 0.738 . . . . 0.0 112.291 -163.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.461 ' H ' ' HB3' ' A' ' 102' ' ' ASN . 25.2 mtp -116.02 170.15 8.72 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 144.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -173.71 160.8 3.78 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 131.131 3.773 . . . . 0.0 106.902 -178.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -153.43 112.24 3.72 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.58 158.35 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.173 0.989 . . . . 0.0 109.169 175.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 p -136.43 160.27 39.25 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 160.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.7 tp -130.04 143.69 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 126.479 1.912 . . . . 0.0 106.031 173.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -131.63 139.18 49.06 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 126.944 2.098 . . . . 0.0 106.671 170.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -104.13 144.85 31.03 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.441 1.496 . . . . 0.0 107.975 176.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.3 t -154.38 170.7 20.72 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.816 1.246 . . . . 0.0 108.76 -176.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 54.66 -147.46 24.35 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.564 1.078 . . . . 0.0 110.646 -165.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -84.22 95.87 8.8 Favored 'General case' 0 C--O 1.222 -0.357 0 O-C-N 121.622 -0.928 . . . . 0.0 110.451 175.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -96.52 8.18 44.73 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 120.344 -1.473 . . . . 0.0 112.73 -175.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -94.92 -5.6 44.45 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -157.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.5 t -127.13 23.45 6.49 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.11 0.868 . . . . 0.0 110.972 -165.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -135.99 118.29 15.63 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.082 0.953 . . . . 0.0 110.908 -164.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.7 mt -66.63 108.44 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -80.75 149.93 29.46 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.547 1.139 . . . . 0.0 109.237 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 m -150.85 138.21 19.46 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 169.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.4 t -136.41 139.48 45.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.501 HG22 HD12 ' A' ' 53' ' ' ILE . 58.1 t -106.19 132.16 54.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 128.321 2.649 . . . . 0.0 108.695 169.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.4 p -126.56 166.29 23.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 126.613 1.965 . . . . 0.0 109.219 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.1 p -139.4 165.0 23.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 158.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.29 100.13 3.82 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 162.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -66.26 106.44 1.68 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.38 6.7 58.56 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 117.974 -1.459 . . . . 0.0 115.71 166.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.448 HG22 ' HB2' ' A' ' 72' ' ' ALA . 1.3 t -155.14 -174.39 4.96 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.913 1.856 . . . . 0.0 109.473 167.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -92.14 164.4 13.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.687 1.195 . . . . 0.0 111.703 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.5 tp -90.13 163.12 14.97 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.781 1.232 . . . . 0.0 108.426 172.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.416 ' HE2' ' HA2' ' A' ' 45' ' ' GLY . 77.8 tttt -125.2 117.66 24.34 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.357 1.463 . . . . 0.0 107.204 174.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -75.97 114.73 14.93 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.514 1.133 . . . . 0.0 109.166 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.91 0.68 35.97 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-O 118.524 -1.153 . . . . 0.0 114.283 -173.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.25 -40.6 81.89 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 119.837 1.819 . . . . 0.0 111.427 170.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.94 -18.97 1.17 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.001 0.92 . . . . 0.0 113.006 -169.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.416 ' HA2' ' HE2' ' A' ' 40' ' ' LYS . . . 86.23 19.43 57.21 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 119.25 -0.75 . . . . 0.0 111.936 -170.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -71.19 128.82 37.2 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.574 1.187 . . . . 0.0 109.171 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.65 133.21 50.64 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 126.334 1.854 . . . . 0.0 110.043 169.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 30.6 mt -128.93 152.22 48.8 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.612 1.165 . . . . 0.0 111.048 176.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.63 91.67 5.87 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.718 1.207 . . . . 0.0 110.156 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.81 153.46 42.58 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.643 0.777 . . . . 0.0 111.672 173.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.02 128.73 15.2 Favored 'Cis proline' 0 C--N 1.349 0.599 0 CA-C-N 120.229 1.117 . . . . 0.0 111.709 -8.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.419 ' O ' HD13 ' A' ' 53' ' ' ILE . 99.8 t -96.42 155.71 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 172.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.501 HD12 HG22 ' A' ' 31' ' ' VAL . 18.2 mm -114.12 120.53 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 105.234 -2.135 . . . . 0.0 105.234 166.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.69 163.37 26.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 122.123 0.963 . . . . 0.0 109.017 172.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.589 ' H ' ' HG2' ' A' ' 58' ' ' GLU . 4.9 m -129.32 -153.79 0.59 Allowed 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 127.95 2.5 . . . . 0.0 109.106 -169.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.01 -29.69 13.99 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.774 1.63 . . . . 0.0 110.935 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -67.05 -40.27 87.07 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 125.221 1.409 . . . . 0.0 110.516 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.589 ' HG2' ' H ' ' A' ' 55' ' ' SER . 1.8 pp20? -62.31 -29.83 70.72 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 123.92 0.888 . . . . 0.0 112.265 -177.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.9 mt -89.14 27.9 1.31 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.401 2.281 . . . . 0.0 111.457 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.46 17.36 2.19 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.616 -1.303 . . . . 0.0 114.163 -172.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.773 HG23 ' H ' ' A' ' 63' ' ' LYS . 13.9 m -123.93 -163.84 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 120.74 1.609 . . . . 0.0 108.337 166.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -76.02 -30.64 58.55 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 169.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.773 ' H ' HG23 ' A' ' 61' ' ' VAL . 2.2 tmtp? -153.3 131.54 11.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 117.217 -1.373 . . . . 0.0 111.808 -162.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.86 165.31 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 119.618 1.099 . . . . 0.0 108.85 176.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.4 m -134.83 127.72 31.33 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 128.081 2.552 . . . . 0.0 106.386 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -129.52 133.2 47.12 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 121.218 1.826 . . . . 0.0 108.255 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.6 t -135.26 176.18 8.91 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.308 -0.87 . . . . 0.0 108.867 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.6 p -90.09 153.73 20.33 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 166.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.7 p -76.21 -13.36 60.18 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.859 -0.525 . . . . 0.0 112.311 173.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.63 -168.12 18.17 Favored Glycine 0 N--CA 1.449 -0.491 0 O-C-N 120.875 -1.141 . . . . 0.0 110.903 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.471 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 5.0 ttpt -60.26 139.02 57.82 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 170.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.448 ' HB2' HG22 ' A' ' 37' ' ' THR . . . -135.16 177.81 7.52 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 168.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.2 mm -115.5 -11.04 12.11 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 118.087 -0.959 . . . . 0.0 111.017 -177.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -152.39 155.33 37.36 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 120.568 1.531 . . . . 0.0 110.556 172.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -141.45 107.43 5.17 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.369 1.468 . . . . 0.0 109.565 170.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.91 153.98 21.18 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.643 1.111 . . . . 0.0 110.45 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.8 t -146.53 95.72 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 173.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.7 m -131.19 159.83 36.58 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.581 -0.699 . . . . 0.0 109.404 174.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.92 -179.58 19.77 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-N 119.206 0.912 . . . . 0.0 113.267 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.43 -160.38 24.08 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 123.92 0.771 . . . . 0.0 111.308 -169.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.463 0 C-N-CA 126.04 1.736 . . . . 0.0 110.822 -176.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.42 175.07 9.29 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.74 2.293 . . . . 0.0 112.683 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 6.9 ptm -137.26 173.64 11.47 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.658 0.783 . . . . 0.0 110.291 -172.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -138.85 147.78 42.88 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.47 1.108 . . . . 0.0 108.763 170.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -117.61 133.11 56.31 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 170.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.1 t -128.16 111.7 24.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 -177.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.6 t -134.38 121.18 35.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 -160.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.6 m -110.87 159.8 17.35 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -173.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.9 t -125.61 129.4 72.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 162.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -97.04 134.91 39.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 104.74 -2.319 . . . . 0.0 104.74 163.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.3 tptm -91.56 -173.33 3.52 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 172.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.461 ' HB3' ' H ' ' A' ' 12' ' ' MET . 0.7 OUTLIER -59.35 74.21 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.047 2.139 . . . . 0.0 109.581 167.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 157.33 -72.32 0.24 Allowed Glycine 0 CA--C 1.523 0.545 0 C-N-CA 126.72 2.105 . . . . 0.0 111.64 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.45 -177.15 6.35 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.291 1.436 . . . . 0.0 111.024 -171.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.16 144.06 7.57 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.452 1.501 . . . . 0.0 109.846 173.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.6 pt -133.41 -27.41 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 123.897 0.879 . . . . 0.0 111.624 168.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -148.21 151.44 35.51 Favored 'General case' 0 N--CA 1.461 0.082 0 CA-C-N 119.746 1.157 . . . . 0.0 111.517 -162.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -151.59 68.49 0.9 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.124 1.769 . . . . 0.0 110.453 -159.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.444 ' HE2' HD13 ' A' ' 126' ' ' LEU . 6.0 mmmt -86.25 118.76 25.91 Favored 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 120.539 -1.35 . . . . 0.0 109.225 176.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.54 139.46 52.3 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 125.064 1.345 . . . . 0.0 110.087 178.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 111' ' ' LEU . 1.2 mp -131.44 -178.37 4.82 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.484 2.314 . . . . 0.0 109.564 -177.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.7 p -154.08 44.79 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 124.793 1.237 . . . . 0.0 112.204 -162.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.536 0.429 0 O-C-N 121.407 -0.808 . . . . 0.0 112.53 -173.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 p30 . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.5 tp -138.25 121.71 17.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -167.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -141.26 80.86 1.76 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 169.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.444 HD13 ' HE2' ' A' ' 109' ' ' LYS . 1.4 tp -109.07 151.38 26.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -152.72 126.86 9.12 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -178.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -117.83 161.78 19.17 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.61 1.564 . . . . 0.0 110.521 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.39 0 C-N-CA 128.283 2.633 . . . . 0.0 106.849 164.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.18 -162.2 1.19 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.31 1.044 . . . . 0.0 108.324 -164.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.1 mtp -137.1 161.42 36.15 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 127.894 2.478 . . . . 0.0 105.332 161.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -136.65 148.89 47.67 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 173.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -143.6 138.05 28.77 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 103.676 -2.712 . . . . 0.0 103.676 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.2 157.5 38.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 169.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 p -124.83 154.09 41.54 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 164.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.459 HD11 ' CD2' ' A' ' 95' ' ' TRP . 7.1 tt -120.65 156.95 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 C-N-CA 122.44 0.296 . . . . 0.0 110.514 155.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -139.98 131.96 27.78 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 166.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -117.12 109.04 16.44 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.801 2.04 . . . . 0.0 107.13 -165.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.5 p -139.27 179.88 6.27 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 175.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 93' ' ' MET . . . 58.26 -157.96 17.69 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -152.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -85.15 106.93 16.96 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.176 0.988 . . . . 0.0 112.604 -168.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -113.79 -4.57 13.34 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 121.402 1.91 . . . . 0.0 115.299 -172.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.97 34.0 1.43 Allowed 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.316 -0.865 . . . . 0.0 111.159 -171.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.8 m -143.67 7.0 1.46 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.4 1.08 . . . . 0.0 112.317 -165.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -140.97 152.44 44.96 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 120.404 1.456 . . . . 0.0 111.346 -159.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 84.9 mt -84.95 95.29 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 174.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.64 148.32 22.39 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 172.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.8 t -142.6 157.55 44.59 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.409 1.884 . . . . 0.0 108.158 -175.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -143.48 160.03 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 165.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.485 ' CG1' ' H ' ' A' ' 78' ' ' SER . 2.4 p -128.69 141.45 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 126.713 2.005 . . . . 0.0 106.182 160.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.9 t -137.87 130.98 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.6 t -140.23 138.59 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.81 89.88 2.29 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.57 1.077 . . . . 0.0 111.896 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.472 ' H ' ' HB2' ' A' ' 74' ' ' GLU . 39.3 t-20 -58.16 105.26 0.26 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.223 1.409 . . . . 0.0 112.689 -174.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.44 -1.25 27.9 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 118.602 -1.11 . . . . 0.0 114.185 164.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.3 t -154.18 -168.1 2.84 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.054 1.427 . . . . 0.0 110.236 -169.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -116.75 159.51 22.18 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.017 1.727 . . . . 0.0 109.484 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.2 164.16 17.37 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 124.289 1.035 . . . . 0.0 108.693 176.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -133.06 123.16 25.27 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 173.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -79.9 117.19 20.54 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 166.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.83 -17.82 55.44 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.625 -1.097 . . . . 0.0 114.339 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.85 -39.11 87.86 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 119.855 1.827 . . . . 0.0 110.205 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.06 -10.58 1.13 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -169.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.1 29.36 64.76 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -171.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -69.13 115.31 8.27 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 170.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.78 103.69 11.64 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.5 mt -91.24 -173.7 3.71 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.156 0.983 . . . . 0.0 108.923 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.52 94.24 3.61 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -177.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.52 162.31 27.66 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.596 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.32 143.81 66.04 Favored 'Cis proline' 0 N--CA 1.459 -0.519 0 CA-C-N 120.142 1.086 . . . . 0.0 112.696 -1.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.7 t -142.07 149.11 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.28 1.432 . . . . 0.0 108.818 -169.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.8 mm -135.89 97.72 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 126.61 1.964 . . . . 0.0 107.124 -159.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -82.5 140.94 33.05 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.076 0.95 . . . . 0.0 108.913 -174.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.4 p -110.24 -166.23 1.07 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.22 1.008 . . . . 0.0 110.477 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -64.09 -48.28 76.75 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.684 1.994 . . . . 0.0 111.782 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -61.23 -27.44 68.44 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 125.04 1.336 . . . . 0.0 110.797 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -95.1 -11.9 27.44 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.317 0.647 . . . . 0.0 110.344 -169.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -96.98 17.77 16.18 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.862 2.065 . . . . 0.0 112.673 176.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.15 39.69 0.15 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.174 1.789 . . . . 0.0 113.378 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.1 m -136.46 162.48 35.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 126.281 1.832 . . . . 0.0 108.778 -170.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -85.5 -17.06 37.51 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.293 -0.88 . . . . 0.0 113.04 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -155.14 151.67 28.52 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 125.196 1.398 . . . . 0.0 107.911 -166.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.446 ' HB ' HG22 ' A' ' 17' ' ' ILE . 11.2 t -143.77 140.9 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 164.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.3 m -118.07 135.09 54.41 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 168.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.5 mt -140.0 146.04 38.58 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.6 169.25 22.01 Favored 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 121.649 -0.657 . . . . 0.0 110.148 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.427 HG21 ' HB2' ' A' ' 72' ' ' ALA . 3.3 p -95.44 155.97 16.52 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 117.801 0.273 . . . . 0.0 111.163 174.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.4 p -82.3 -3.38 55.17 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.524 -0.735 . . . . 0.0 112.015 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.72 -156.88 15.68 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -176.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.488 ' HE2' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -60.93 137.13 58.24 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 117.483 0.641 . . . . 0.0 110.218 -168.446 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.427 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -129.33 141.63 51.03 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 176.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.488 HD11 ' HE2' ' A' ' 71' ' ' LYS . 0.8 OUTLIER -133.94 21.5 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 C-N-CA 123.723 0.809 . . . . 0.0 110.254 174.718 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 129' ' ' ASN . 40.3 mt-10 -142.77 147.33 35.37 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 168.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -154.56 86.11 1.13 Allowed 'General case' 0 C--O 1.232 0.164 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 157.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 127' ' ' TYR . . . -76.4 145.9 39.04 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.164 175.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.2 t -143.92 108.7 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.105 1.362 . . . . 0.0 107.712 166.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.485 ' H ' ' CG1' ' A' ' 31' ' ' VAL . 1.6 t -109.38 173.67 6.22 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 152.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 150.55 -166.07 30.14 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 -170.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 146.21 166.77 12.28 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.513 1.054 . . . . 0.0 110.822 174.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.464 0.254 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 174.331 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 . . . . . 0 CA--C 1.541 0.617 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -76.73 175.33 11.51 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.058 2.505 . . . . 0.0 112.913 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.403 ' HA ' ' HA3' ' A' ' 21' ' ' GLY . 14.3 ptm -139.94 164.0 31.16 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.722 1.209 . . . . 0.0 111.646 -173.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -140.26 156.52 46.44 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.208 1.403 . . . . 0.0 109.66 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.459 ' CD2' HD11 ' A' ' 17' ' ' ILE . 1.5 m0 -127.19 124.69 39.58 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 176.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 t -95.68 121.23 46.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 162.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.6 p -127.54 137.41 57.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 170.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.9 m -148.22 142.61 26.31 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.457 ' H ' ' HB3' ' A' ' 107' ' ' GLU . 3.4 t -117.01 145.31 22.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 124.209 1.004 . . . . 0.0 108.399 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -128.77 130.77 47.49 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 128.034 2.534 . . . . 0.0 106.103 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -84.45 -163.71 0.84 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.13 77.45 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.313 1.045 . . . . 0.0 109.261 166.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 151.87 -56.81 0.44 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.162 -1.355 . . . . 0.0 114.428 168.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.71 -176.84 5.96 Favored 'General case' 0 C--N 1.34 0.196 0 CA-C-N 119.958 1.879 . . . . 0.0 110.966 176.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -44.78 138.32 3.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 130.034 3.334 . . . . 0.0 111.935 176.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.8 pt -139.07 -2.03 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.95 1.7 . . . . 0.0 112.226 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.457 ' HB3' ' H ' ' A' ' 99' ' ' VAL . 0.0 OUTLIER -127.02 170.89 11.83 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.358 1.463 . . . . 0.0 107.43 -176.762 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.6 tttm -159.62 21.47 0.18 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.262 1.425 . . . . 0.0 111.628 175.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.41 87.9 1.57 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.388 -1.445 . . . . 0.0 110.54 -174.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 p -73.15 161.97 29.98 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.3 1.04 . . . . 0.0 110.441 170.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.2 mt -140.39 138.21 34.6 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.338 1.455 . . . . 0.0 108.417 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.5 p -142.61 81.69 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 122.489 1.138 . . . . 0.0 110.11 -172.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 . . . . . 0 C--O 1.238 0.465 0 C-N-CA 125.423 1.489 . . . . 0.0 110.399 178.864 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.6 p30 . . . . . 0 C--O 1.233 0.209 0 CA-C-O 117.732 -1.127 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 37.0 mt -142.25 101.22 3.87 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 120.16 1.345 . . . . 0.0 110.456 -165.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -130.01 51.53 2.08 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.174 2.189 . . . . 0.0 107.402 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 mp -107.55 139.17 42.5 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.801 1.24 . . . . 0.0 108.916 177.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 59.5 t80 -151.32 91.2 1.65 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -178.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -83.68 153.46 24.21 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.283 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 177.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.425 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . . . . . . 0 CA--C 1.523 0.549 0 N-CA-C 107.79 -2.124 . . . . 0.0 107.79 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.88 179.03 6.62 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.079 0.952 . . . . 0.0 109.991 -168.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.2 mtp -107.96 166.21 10.89 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 155.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.51 ' HB3' ' CD2' ' A' ' 75' ' ' PHE . 71.0 m-85 -147.65 139.99 24.47 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -142.4 120.93 12.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -178.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p -105.36 161.69 5.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 123.002 1.382 . . . . 0.0 109.063 176.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 p -132.86 148.7 52.3 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.519 1.528 . . . . 0.0 106.977 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.4 tp -139.51 132.65 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 174.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -132.95 123.73 26.47 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 127.133 2.173 . . . . 0.0 106.563 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -103.86 137.54 41.72 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.031 0.932 . . . . 0.0 109.291 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 m -135.99 172.15 13.44 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.295 -0.878 . . . . 0.0 110.707 170.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.88 -150.54 32.66 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-O 121.642 0.579 . . . . 0.0 111.987 173.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -72.89 98.09 2.39 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 159.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -113.71 23.59 12.94 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.146 0.498 . . . . 0.0 110.65 170.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.2 mtt180 -102.92 -29.32 11.5 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 118.498 -0.763 . . . . 0.0 111.693 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.8 m -114.55 22.44 13.62 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -152.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -128.41 144.83 51.19 Favored 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 121.476 -0.765 . . . . 0.0 109.251 -173.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.2 mp -76.03 89.11 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 171.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -89.64 146.99 24.16 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.006 1.322 . . . . 0.0 108.953 -177.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.3 t -138.69 148.91 44.55 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.457 1.503 . . . . 0.0 108.536 -174.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.4 t -136.87 106.79 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 161.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.3 t -65.73 117.01 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 160.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 91.8 t -116.72 123.62 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 175.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.454 HG22 ' HB3' ' A' ' 51' ' ' PRO . 16.8 t -129.72 156.76 42.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 162.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.29 120.91 9.79 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.969 1.708 . . . . 0.0 107.42 165.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -75.1 109.31 8.47 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 118.039 -0.981 . . . . 0.0 108.707 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.43 10.66 50.35 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 116.844 1.498 . . . . 0.0 116.844 161.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.854 HG22 ' HB2' ' A' ' 72' ' ' ALA . 14.8 t -157.0 -174.8 5.09 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 119.536 1.668 . . . . 0.0 107.969 164.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -106.46 165.27 11.39 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 122.309 1.052 . . . . 0.0 113.699 168.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.15 169.07 13.43 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 112.272 -2.24 . . . . 0.0 109.772 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -144.15 123.5 13.08 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.301 1.441 . . . . 0.0 109.215 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -71.93 131.77 43.43 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.301 1.04 . . . . 0.0 110.341 -177.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.07 -18.41 72.83 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.31 -1.272 . . . . 0.0 113.904 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.0 -60.38 3.96 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 119.057 1.428 . . . . 0.0 109.367 174.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.28 0.61 1.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -157.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.04 12.35 83.44 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-O 119.854 -0.414 . . . . 0.0 112.371 174.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -65.12 130.43 43.34 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.3 m -68.82 125.01 25.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 175.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.7 mt -112.71 128.92 56.54 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -174.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -95.81 88.36 4.93 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.303 1.041 . . . . 0.0 109.088 -170.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.7 m -51.15 156.67 1.76 Allowed Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 128.423 2.689 . . . . 0.0 112.128 172.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.454 ' HB3' HG22 ' A' ' 33' ' ' VAL . 66.7 Cg_endo -73.42 154.22 99.49 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 N-CA-C 109.435 -1.025 . . . . 0.0 109.435 -8.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.2 t -138.55 144.21 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.0 mm -120.68 81.35 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 28.4 mt -63.1 136.19 57.64 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 m -110.27 175.74 5.32 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 125.902 1.681 . . . . 0.0 110.088 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -46.9 -48.04 21.34 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 127.306 2.243 . . . . 0.0 113.744 -175.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -69.6 -40.53 76.6 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.512 0.596 . . . . 0.0 110.89 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -68.4 -10.88 58.14 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.064 0.945 . . . . 0.0 111.081 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.9 mt -121.29 10.49 10.61 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.179 2.191 . . . . 0.0 111.141 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.92 11.97 0.46 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.067 1.347 . . . . 0.0 112.662 171.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.1 m -66.44 -168.5 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 126.054 1.742 . . . . 0.0 111.135 164.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -110.91 -36.24 5.73 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.909 1.684 . . . . 0.0 111.466 168.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.18 143.03 26.78 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 127.327 2.251 . . . . 0.0 105.941 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.2 p -146.63 102.6 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 120.363 1.438 . . . . 0.0 112.436 161.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m -66.04 134.48 52.96 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.434 -1.417 . . . . 0.0 109.933 172.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 mt -132.99 146.52 51.85 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 124.307 1.043 . . . . 0.0 108.455 -175.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.4 t -162.7 160.12 25.16 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -161.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -86.85 151.23 23.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.422 0.629 . . . . 0.0 112.466 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.2 p -82.75 -20.91 35.01 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.614 1.566 . . . . 0.0 112.165 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -146.55 -163.87 10.67 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 125.873 1.702 . . . . 0.0 108.871 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.425 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 16.1 ttpt -77.47 141.91 39.44 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 175.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.854 ' HB2' HG22 ' A' ' 37' ' ' THR . . . -132.95 175.52 9.29 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.957 0.903 . . . . 0.0 109.833 171.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 mm -121.6 -13.53 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.409 1.084 . . . . 0.0 110.205 -167.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -151.51 162.2 41.37 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.614 1.166 . . . . 0.0 108.828 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.51 ' CD2' ' HB3' ' A' ' 13' ' ' TYR . 3.0 t80 -155.58 85.91 1.06 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.695 0.798 . . . . 0.0 109.202 173.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.16 149.72 28.99 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.998 -0.439 . . . . 0.0 110.73 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 t -142.65 124.25 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 125.248 1.419 . . . . 0.0 108.368 171.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.09 169.76 17.24 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 158.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.35 -125.74 0.88 Allowed Glycine 0 CA--C 1.52 0.394 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 173.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.32 173.03 13.48 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 123.614 0.626 . . . . 0.0 112.203 173.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.2 m . . . . . 0 C--N 1.33 -0.255 0 C-N-CA 125.232 1.413 . . . . 0.0 109.175 173.994 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 . . . . . 0 CA--C 1.523 -0.08 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -73.0 175.19 10.8 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.485 1.457 . . . . 0.0 111.976 176.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -138.16 168.72 19.13 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.068 0.947 . . . . 0.0 110.414 177.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -135.98 157.04 47.79 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 169.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.539 ' CE3' HD12 ' A' ' 111' ' ' LEU . 33.2 m0 -123.46 133.82 54.0 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 168.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.1 t -90.28 135.57 26.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 151.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.7 130.68 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 172.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 m -135.94 147.63 48.17 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -176.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.2 t -118.07 131.2 71.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -116.1 166.92 11.46 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 128.682 2.793 . . . . 0.0 107.988 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -118.67 -154.3 0.56 Allowed 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 129.224 3.01 . . . . 0.0 107.616 -171.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -69.34 85.43 0.4 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 162.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.75 16.64 69.96 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 117.98 -1.456 . . . . 0.0 115.258 164.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.7 167.49 28.02 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 120.785 2.293 . . . . 0.0 112.116 172.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -90.21 141.05 29.08 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.09 1.356 . . . . 0.0 109.16 -174.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.8 pt -129.02 -19.81 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 119.124 0.874 . . . . 0.0 113.357 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -132.42 160.5 36.2 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -157.79 87.16 0.93 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 176.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.33 164.05 24.4 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 171.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.5 t -138.93 163.33 32.61 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.539 HD12 ' CE3' ' A' ' 95' ' ' TRP . 24.2 mt -126.14 157.49 37.98 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 123.61 0.764 . . . . 0.0 109.013 -177.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.3 p -147.2 114.68 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 -173.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 . . . . . 0 C--O 1.237 0.438 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.445 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.146 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.75 143.49 50.78 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.884 1.274 . . . . 0.0 108.834 174.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -153.1 25.17 0.55 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.779 1.632 . . . . 0.0 111.586 -157.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 88.3 mt -97.15 124.41 41.18 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.71 1.604 . . . . 0.0 107.829 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -139.89 46.64 1.86 Allowed 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.542 0.737 . . . . 0.0 109.019 -170.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -55.26 137.67 46.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.85 -168.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.086 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 167.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.41 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . . . . . . 0 CA--C 1.52 0.383 0 N-CA-C 107.137 -2.385 . . . . 0.0 107.137 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.64 161.4 35.23 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.724 0.81 . . . . 0.0 110.86 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 7.8 mtp -91.89 153.62 19.39 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 158.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.489 ' CD1' ' HB2' ' A' ' 75' ' ' PHE . 8.6 m-85 -143.65 114.66 7.81 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 126.282 1.833 . . . . 0.0 106.448 -170.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -127.29 144.76 50.99 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.743 2.017 . . . . 0.0 106.885 172.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.42 132.94 38.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 127.133 2.173 . . . . 0.0 108.89 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.5 p -96.0 163.56 13.08 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.749 0.785 . . . . 0.0 109.913 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.426 HD11 ' CD2' ' A' ' 95' ' ' TRP . 4.0 tp -140.75 112.6 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 167.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -114.29 135.97 53.48 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -176.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -122.19 115.4 22.33 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 124.287 1.035 . . . . 0.0 108.732 -161.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 m -120.92 -179.01 3.88 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.17 -99.29 0.56 Allowed Glycine 0 C--N 1.338 0.651 0 C-N-CA 127.301 2.382 . . . . 0.0 110.417 176.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.6 113.39 9.11 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -117.53 11.02 13.69 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -170.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -102.57 -1.06 31.09 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.079 1.352 . . . . 0.0 113.941 -168.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.1 m -143.45 95.12 2.7 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 164.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -176.94 110.83 0.08 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 128.08 2.552 . . . . 0.0 106.433 174.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.3 pt -66.39 86.8 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 127.221 2.208 . . . . 0.0 112.36 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.42 144.68 55.63 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 121.113 -0.992 . . . . 0.0 109.942 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.9 m -148.36 130.03 15.03 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 170.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.8 t -140.39 165.77 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 175.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.647 HG13 ' CD1' ' A' ' 53' ' ' ILE . 30.0 t -141.13 52.42 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 125.786 1.635 . . . . 0.0 110.806 -157.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.7 p -65.91 135.85 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 O-C-N 119.248 -2.157 . . . . 0.0 111.215 -170.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.6 t -117.56 148.12 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 171.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.32 133.74 20.77 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.93 0.892 . . . . 0.0 108.615 171.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -102.7 85.83 2.64 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.186 1.394 . . . . 0.0 109.022 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.09 -78.76 0.29 Allowed Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 162.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.8 t -76.55 179.51 5.9 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.106 0.963 . . . . 0.0 109.914 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -96.67 168.05 10.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.833 1.253 . . . . 0.0 111.232 174.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.59 168.31 15.48 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.38 1.472 . . . . 0.0 109.38 176.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -137.01 128.14 27.83 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.795 1.638 . . . . 0.0 109.524 172.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -92.2 110.32 21.71 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.547 1.939 . . . . 0.0 109.45 -165.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -57.69 -23.12 49.06 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 118.989 0.813 . . . . 0.0 114.553 -169.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.87 -56.97 15.32 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.325 1.45 . . . . 0.0 112.032 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.5 p -125.67 0.15 7.46 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.608 1.563 . . . . 0.0 111.144 -164.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.78 22.56 54.04 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 125.395 1.474 . . . . 0.0 112.171 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.32 158.2 26.17 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 118.24 1.02 . . . . 0.0 109.358 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.4 m -117.4 106.15 12.9 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 122.391 1.091 . . . . 0.0 110.207 -167.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 45.3 mt -93.59 159.47 15.21 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 125.109 1.364 . . . . 0.0 111.874 -164.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.86 95.69 9.67 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.926 2.09 . . . . 0.0 108.763 -172.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.2 p -58.74 167.72 1.73 Allowed Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.053 0.941 . . . . 0.0 111.468 172.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.72 145.38 79.18 Favored 'Cis proline' 0 CA--C 1.537 0.629 0 N-CA-C 109.733 -0.91 . . . . 0.0 109.733 -19.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.6 p -135.19 156.93 39.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 O-C-N 121.242 -0.911 . . . . 0.0 109.939 -170.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.647 ' CD1' HG13 ' A' ' 31' ' ' VAL . 30.5 mm -114.02 126.83 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 175.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.8 mt -92.43 164.83 13.33 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 128.154 2.582 . . . . 0.0 110.327 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.571 ' H ' ' HG2' ' A' ' 58' ' ' GLU . 57.4 p -132.64 -163.35 1.33 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.417 2.287 . . . . 0.0 111.126 -165.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -88.08 -21.01 24.96 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 126.565 1.946 . . . . 0.0 110.292 175.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.32 -36.52 61.05 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.286 1.434 . . . . 0.0 111.973 -177.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.571 ' HG2' ' H ' ' A' ' 55' ' ' SER . 2.3 pp20? -75.95 -32.09 59.37 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.262 1.825 . . . . 0.0 111.776 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.6 mt -95.99 24.16 5.78 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.5 1.12 . . . . 0.0 112.655 -176.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -77.41 33.24 0.16 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.629 1.972 . . . . 0.0 113.467 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.6 m -130.45 -167.83 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.511 1.924 . . . . 0.0 109.871 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -98.57 -24.08 15.25 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.335 1.454 . . . . 0.0 113.246 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -159.64 148.89 18.04 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 117.838 -1.077 . . . . 0.0 108.927 171.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.26 165.22 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 165.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 83.3 m -134.59 124.06 24.83 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 128.553 2.741 . . . . 0.0 105.685 171.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.6 140.51 49.54 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 174.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.1 t -145.42 -177.08 5.38 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.284 0.634 . . . . 0.0 110.405 -174.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.92 136.01 53.05 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 128.339 2.656 . . . . 0.0 110.306 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.9 p -75.24 -43.21 52.83 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 118.752 -1.179 . . . . 0.0 109.647 -171.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -107.98 -98.71 2.57 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.41 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -147.23 147.64 30.66 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.959 1.703 . . . . 0.0 109.964 174.235 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.468 ' C ' HD13 ' A' ' 73' ' ' ILE . . . -127.23 -178.56 4.48 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.345 1.058 . . . . 0.0 109.088 170.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.468 HD13 ' C ' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -122.84 -0.03 6.52 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.598 0 CA-C-O 117.664 -1.16 . . . . 0.0 110.814 176.413 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -149.63 158.0 43.77 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 120.561 1.528 . . . . 0.0 110.435 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.489 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -153.53 117.52 4.79 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 166.045 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -121.95 135.32 54.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.2 t -137.53 112.94 10.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -172.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.3 m -136.06 178.4 7.08 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.226 0.61 . . . . 0.0 110.134 173.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.01 -85.17 0.13 Allowed Glycine 0 C--N 1.333 0.39 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 155.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.34 179.12 18.98 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 127.37 2.414 . . . . 0.0 108.328 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.6 p . . . . . 0 CA--C 1.531 0.218 0 CA-C-N 118.577 1.189 . . . . 0.0 109.379 178.205 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 N--CA 1.468 0.443 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.55 174.38 11.9 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.959 2.44 . . . . 0.0 113.547 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.7 ptp -148.0 -176.01 5.11 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.998 0.919 . . . . 0.0 111.131 -168.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -141.15 161.34 38.1 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 128.143 2.577 . . . . 0.0 106.616 169.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.426 ' CD2' HD11 ' A' ' 17' ' ' ILE . 2.4 m0 -130.68 112.28 12.97 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 104.972 -2.233 . . . . 0.0 104.972 173.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.02 127.3 45.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 168.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 m -139.39 104.45 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -167.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.3 m -118.63 153.29 34.54 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -169.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.93 124.89 51.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -174.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -121.14 121.06 37.02 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.962 1.705 . . . . 0.0 108.246 -172.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -73.05 -166.52 0.31 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.594 1.958 . . . . 0.0 109.771 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -58.66 90.44 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 163.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.4 29.58 75.57 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.535 2.017 . . . . 0.0 115.771 171.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -145.06 176.44 9.5 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 120.016 1.908 . . . . 0.0 109.746 165.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -98.1 154.33 17.81 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.97 1.708 . . . . 0.0 108.278 170.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 43.1 pt -132.17 -13.44 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.698 1.199 . . . . 0.0 112.753 168.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -140.91 150.12 42.77 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 119.776 1.171 . . . . 0.0 108.101 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -146.55 52.67 1.11 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.698 1.199 . . . . 0.0 108.076 170.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -75.85 169.7 17.64 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 122.23 1.014 . . . . 0.0 109.888 174.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.8 t -152.02 164.99 36.05 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.095 1.758 . . . . 0.0 106.455 171.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 37.6 mt -135.32 174.48 10.57 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.105 2.162 . . . . 0.0 109.033 176.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 p -152.9 68.05 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.394 1.077 . . . . 0.0 109.169 -175.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 . . . . . 0 C--O 1.236 0.357 0 C-N-CA 125.033 1.333 . . . . 0.0 109.517 178.944 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.395 0 CA-C-O 120.853 0.359 . . . . 0.0 111.74 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.47 106.27 16.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 176.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -161.86 87.11 0.65 Allowed 'General case' 0 C--O 1.234 0.286 0 O-C-N 123.479 0.487 . . . . 0.0 111.024 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.7 mt -133.67 150.15 51.54 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.171 1.388 . . . . 0.0 109.511 -172.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -143.23 146.86 34.02 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.843 1.657 . . . . 0.0 109.397 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -145.78 155.08 42.7 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.414 1.486 . . . . 0.0 109.069 172.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--O 1.249 1.065 0 C-N-CA 126.569 1.948 . . . . 0.0 106.663 173.37 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.031 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.21 168.62 26.55 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.526 1.663 . . . . 0.0 109.767 -174.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.6 mtp -107.86 164.58 12.14 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.484 1.114 . . . . 0.0 111.82 162.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -177.36 153.78 0.96 Allowed 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 131.132 3.773 . . . . 0.0 110.054 -169.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -145.1 147.84 32.98 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.601 2.76 . . . . 0.0 105.137 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -124.06 146.74 29.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 125.83 1.652 . . . . 0.0 108.438 175.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.449 ' CG2' HG23 ' A' ' 65' ' ' THR . 1.3 p -130.01 116.35 18.44 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.477 HG22 ' HB ' ' A' ' 64' ' ' VAL . 0.7 OUTLIER -79.09 143.81 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 117.532 -1.667 . . . . 0.0 106.9 160.334 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -124.0 117.94 25.89 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 104.167 -2.531 . . . . 0.0 104.167 158.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -94.53 110.19 22.02 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 173.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 m -84.35 158.39 21.16 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 123.343 0.402 . . . . 0.0 110.184 172.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.97 -145.26 25.66 Favored Glycine 0 C--O 1.241 0.59 0 O-C-N 123.784 0.677 . . . . 0.0 112.684 168.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -82.67 128.91 34.79 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 168.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -132.64 17.94 4.3 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.681 1.192 . . . . 0.0 111.091 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -120.95 35.23 4.95 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.088 1.355 . . . . 0.0 110.402 -168.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.1 t -145.57 -6.33 0.62 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.245 1.418 . . . . 0.0 110.835 -173.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.439 ' HB3' ' CG2' ' A' ' 81' ' ' VAL . 20.7 m-85 -101.98 170.55 8.05 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 120.699 -1.25 . . . . 0.0 108.2 -153.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.2 mp -137.53 96.76 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -169.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.8 tptt 174.32 -162.03 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.739 2.015 . . . . 0.0 110.81 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.3 m -155.65 174.42 15.31 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.683 1.993 . . . . 0.0 110.569 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 t -115.97 144.69 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.026 1.331 . . . . 0.0 107.426 170.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.7 t -99.62 150.48 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 126.454 1.902 . . . . 0.0 108.247 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -145.33 145.32 20.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 124.073 0.949 . . . . 0.0 110.542 163.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.3 t -135.97 137.82 48.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 165.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.7 107.41 5.91 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.318 1.047 . . . . 0.0 108.517 173.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -59.85 112.0 1.68 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.071 1.349 . . . . 0.0 109.737 -177.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.25 32.76 27.72 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-O 118.395 -1.225 . . . . 0.0 114.743 165.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.532 ' CG2' ' HB2' ' A' ' 72' ' ' ALA . 11.4 t -156.51 -170.5 3.36 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.137 1.469 . . . . 0.0 110.103 175.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -111.87 164.64 12.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.941 1.696 . . . . 0.0 110.506 159.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.55 168.67 10.22 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 127.973 2.509 . . . . 0.0 108.255 176.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -130.23 132.24 45.89 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.328 1.851 . . . . 0.0 106.642 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -82.57 116.71 22.1 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 164.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.59 -10.02 62.9 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 118.573 -1.126 . . . . 0.0 114.476 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.16 -52.49 58.78 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 118.912 1.356 . . . . 0.0 109.922 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.33 -9.48 5.79 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.053 1.341 . . . . 0.0 111.47 -170.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.73 56.28 5.52 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -176.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -102.29 129.59 48.77 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 38.1 t -71.89 145.38 48.56 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.014 0.824 . . . . 0.0 109.069 172.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 24.1 mt -137.66 130.05 29.45 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 124.842 1.257 . . . . 0.0 110.089 -170.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -86.36 87.64 7.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.912 -177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.43 156.7 40.16 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-O 117.864 -1.065 . . . . 0.0 110.679 170.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.4 144.17 79.66 Favored 'Cis proline' 0 C--N 1.348 0.546 0 CA-C-N 120.305 1.144 . . . . 0.0 111.268 -2.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.8 p -157.57 162.14 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.229 1.011 . . . . 0.0 111.168 -170.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.8 mm -129.99 107.98 15.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 126.623 1.969 . . . . 0.0 108.494 -169.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.2 mt -70.62 125.3 26.43 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.337 0.655 . . . . 0.0 109.812 175.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.47 -172.11 3.88 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.48 2.312 . . . . 0.0 110.589 -176.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -61.18 -42.55 98.77 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.502 -1.374 . . . . 0.0 112.72 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -51.42 -45.3 62.55 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.065 0.946 . . . . 0.0 110.798 -176.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.404 ' H ' ' HG2' ' A' ' 58' ' ' GLU . 2.3 mm-40 -68.59 -40.02 80.68 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.293 1.437 . . . . 0.0 109.704 -175.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -89.02 11.7 17.58 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.35 1.86 . . . . 0.0 112.258 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.19 16.87 0.21 Allowed 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.046 -1.659 . . . . 0.0 113.03 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.1 m -131.62 163.75 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 126.319 1.847 . . . . 0.0 111.252 -172.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -65.62 -27.32 68.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.122 1.369 . . . . 0.0 112.75 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -152.48 126.54 9.11 Favored 'General case' 0 CA--C 1.511 -0.555 0 O-C-N 121.088 -1.008 . . . . 0.0 109.962 -173.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.477 ' HB ' HG22 ' A' ' 17' ' ' ILE . 23.3 t -120.54 140.68 43.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 173.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.449 HG23 ' CG2' ' A' ' 16' ' ' THR . 25.5 m -138.0 106.89 5.96 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.071 1.348 . . . . 0.0 108.446 -163.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.2 mt -124.0 139.3 54.08 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -167.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.6 t -145.45 159.99 42.25 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.5 p -72.84 140.95 47.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.733 168.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.5 p -71.85 -53.0 14.61 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.093 174.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -112.54 170.58 13.55 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 124.992 1.282 . . . . 0.0 110.014 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.46 134.56 56.77 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.111 0.964 . . . . 0.0 109.646 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.532 ' HB2' ' CG2' ' A' ' 37' ' ' THR . . . -117.97 179.76 3.99 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 125.678 1.591 . . . . 0.0 107.541 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.526 HD13 ' C ' ' A' ' 72' ' ' ALA . 1.1 mm -117.19 -10.63 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.503 0.721 . . . . 0.0 111.163 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -148.05 165.14 31.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 167.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -144.33 107.31 4.5 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.683 1.593 . . . . 0.0 107.716 168.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.66 153.09 19.71 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.391 0.676 . . . . 0.0 109.958 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.5 t -144.98 115.35 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 127.274 2.23 . . . . 0.0 105.84 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 95.4 p -154.63 -172.73 4.3 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 120.688 -1.258 . . . . 0.0 111.162 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.48 -161.34 12.77 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -170.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.6 175.22 36.63 Favored Glycine 0 N--CA 1.464 0.531 0 N-CA-C 106.752 -2.539 . . . . 0.0 106.752 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.447 HG12 ' CZ2' ' A' ' 95' ' ' TRP . 1.8 p . . . . . 0 N--CA 1.465 0.313 0 CA-C-N 120.697 2.249 . . . . 0.0 109.79 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -80.47 -166.95 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.849 3.033 . . . . 0.0 112.288 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.4 ptm -145.62 167.44 23.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.638 0.732 . . . . 0.0 111.923 -171.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -132.61 131.52 41.51 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 168.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.447 ' CZ2' HG12 ' A' ' 81' ' ' VAL . 13.2 m0 -79.9 105.0 10.86 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 156.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.3 t -79.59 135.89 24.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 149.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.9 t -138.76 91.21 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 172.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.22 152.02 38.39 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.013 1.325 . . . . 0.0 108.415 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 t -134.81 131.7 53.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 175.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -102.91 159.24 15.67 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 128.208 2.603 . . . . 0.0 107.634 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.414 ' HG3' ' H ' ' A' ' 102' ' ' ASN . 22.0 tptm -129.21 -172.1 2.65 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 127.848 2.459 . . . . 0.0 105.41 177.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.414 ' H ' ' HG3' ' A' ' 101' ' ' LYS . 11.6 p30 -54.1 50.12 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 130.166 3.386 . . . . 0.0 115.387 177.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 169.03 -58.2 0.2 Allowed Glycine 0 CA--C 1.524 0.622 0 O-C-N 119.541 -1.974 . . . . 0.0 112.145 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.76 -175.32 5.08 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.217 1.407 . . . . 0.0 111.339 -171.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -55.15 141.18 35.87 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.625 1.57 . . . . 0.0 108.923 175.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 15.9 pt -121.39 -34.05 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 125.57 1.548 . . . . 0.0 111.066 167.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -133.34 149.99 51.87 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 120.241 1.382 . . . . 0.0 109.723 -175.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.7 pttt -155.46 42.29 0.43 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.249 2.219 . . . . 0.0 108.857 -153.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.57 ' HE2' HD11 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -111.53 149.3 31.59 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.655 0.782 . . . . 0.0 110.744 -172.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.0 t -142.06 162.34 35.73 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.22 1.408 . . . . 0.0 109.341 -169.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.536 ' N ' HD12 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -124.61 -163.71 1.2 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.618 1.967 . . . . 0.0 106.409 -179.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.57 144.89 15.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 127.641 2.377 . . . . 0.0 107.331 168.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 . . . . . 0 C--O 1.232 0.162 0 N-CA-C 106.503 -1.665 . . . . 0.0 106.503 170.9 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.465 0.308 0 N-CA-C 111.633 0.234 . . . . 0.0 111.633 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.57 HD11 ' HE2' ' A' ' 109' ' ' LYS . 8.0 tp -138.17 146.4 42.68 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.427 0.632 . . . . 0.0 109.38 169.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -176.48 76.67 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.811 2.044 . . . . 0.0 105.966 -171.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.7 tp -126.12 137.34 53.59 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.919 0.888 . . . . 0.0 109.214 -168.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -140.45 144.52 36.13 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.019 1.328 . . . . 0.0 109.697 -176.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -140.18 155.54 46.9 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.485 1.514 . . . . 0.0 109.108 171.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.0 p30 . . . . . 0 C--O 1.25 1.097 0 C-N-CA 127.591 2.356 . . . . 0.0 105.906 158.308 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.593 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . . . . . . 0 CA--C 1.525 0.686 0 N-CA-C 107.736 -2.146 . . . . 0.0 107.736 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.18 167.88 20.17 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.787 0.835 . . . . 0.0 112.009 -167.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.9 mtp -86.41 153.26 22.04 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 161.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -147.55 130.39 16.14 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 125.834 1.959 . . . . 0.0 108.578 -175.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -140.96 149.75 42.21 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.217 2.207 . . . . 0.0 106.814 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.404 HG23 HG22 ' A' ' 99' ' ' VAL . 11.2 p -144.86 158.95 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 C-N-CA 124.833 1.253 . . . . 0.0 109.686 177.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.2 124.88 14.95 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 -165.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.1 tp -119.51 109.24 25.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -171.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -108.96 122.66 47.7 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.743 2.017 . . . . 0.0 109.537 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -105.45 139.69 39.69 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.179 -0.95 . . . . 0.0 109.982 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.5 m -143.46 166.99 23.26 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.781 0.832 . . . . 0.0 111.321 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.83 -156.32 28.33 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -168.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -76.59 92.0 3.44 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 121.39 -1.065 . . . . 0.0 108.801 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -97.5 14.76 25.35 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -173.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.38 9.05 10.27 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -158.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.0 m -141.17 40.17 1.77 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.08 2.152 . . . . 0.0 108.749 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.42 ' O ' ' HE2' ' A' ' 28' ' ' LYS . 46.7 m-85 -136.23 130.18 32.71 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 124.999 1.319 . . . . 0.0 109.36 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.9 mt -72.76 90.35 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.42 ' HE2' ' O ' ' A' ' 26' ' ' PHE . 27.0 mtmt -79.78 162.0 25.38 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.815 1.246 . . . . 0.0 110.252 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.4 t -146.72 154.18 41.12 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.902 0.881 . . . . 0.0 110.302 165.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 69.9 t -142.73 109.45 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 127.208 2.203 . . . . 0.0 105.676 164.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.9 p -73.02 147.5 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 149.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 p -131.58 137.71 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 126.202 1.801 . . . . 0.0 106.52 167.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 t -119.59 163.31 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 123.878 0.871 . . . . 0.0 108.923 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.56 153.42 40.35 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.844 1.258 . . . . 0.0 109.906 169.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -129.16 105.45 8.17 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 169.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.42 29.24 50.06 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 118.598 -1.112 . . . . 0.0 114.618 165.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.582 HG22 ' HB2' ' A' ' 72' ' ' ALA . 5.0 t -164.3 -164.72 0.88 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.21 1.804 . . . . 0.0 106.698 158.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -123.89 170.69 10.33 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.125 1.37 . . . . 0.0 109.974 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.41 166.01 12.28 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.904 1.281 . . . . 0.0 109.789 -175.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -134.52 116.79 15.49 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 125.338 1.455 . . . . 0.0 107.827 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -82.84 132.04 35.18 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 124.982 1.313 . . . . 0.0 109.167 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.28 -22.47 50.61 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 118.842 -0.977 . . . . 0.0 113.854 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.24 -52.31 16.36 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 127.572 2.349 . . . . 0.0 111.746 -177.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 t -148.17 -4.84 0.46 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.759 -0.638 . . . . 0.0 111.379 175.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.41 27.96 8.84 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 119.863 1.21 . . . . 0.0 111.668 -160.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -64.13 124.28 21.25 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.63 110.81 20.66 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.184 1.794 . . . . 0.0 111.029 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.9 mt -114.12 145.78 41.17 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 122.375 1.083 . . . . 0.0 112.631 -163.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.14 67.91 5.09 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.05 1.34 . . . . 0.0 112.153 -171.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.2 m -52.83 156.2 3.54 Favored Pre-proline 0 CA--C 1.543 0.692 0 O-C-N 121.054 -1.029 . . . . 0.0 113.097 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.9 144.85 75.85 Favored 'Cis proline' 0 CA--C 1.536 0.606 0 CA-C-N 119.071 0.704 . . . . 0.0 112.495 -5.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.6 t -140.73 155.38 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 126.134 1.774 . . . . 0.0 107.815 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.3 mm -116.59 144.74 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 125.575 1.55 . . . . 0.0 106.857 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.4 mt -120.97 115.89 24.06 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.983 1.313 . . . . 0.0 107.686 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 m -72.16 174.41 7.21 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 124.753 1.283 . . . . 0.0 110.389 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.65 -31.77 68.46 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.822 1.649 . . . . 0.0 113.074 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -63.82 -42.46 97.65 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 121.355 -0.84 . . . . 0.0 110.478 174.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -75.6 -32.12 60.19 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -175.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.8 mt -85.63 27.36 0.85 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.673 1.989 . . . . 0.0 111.792 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.05 1.4 27.9 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 176.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.8 m -88.76 149.12 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 119.427 1.012 . . . . 0.0 111.498 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -57.25 -37.01 71.68 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.451 1.101 . . . . 0.0 112.76 172.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -165.39 149.09 8.28 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -176.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.5 p -149.99 167.29 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 166.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.1 t -121.92 158.97 27.85 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 167.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 mt -135.89 155.03 50.92 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 173.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.4 t -164.44 158.03 17.98 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.5 p -78.34 158.17 28.89 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 122.858 0.463 . . . . 0.0 110.551 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.3 p -75.4 -13.67 60.41 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.349 -0.844 . . . . 0.0 111.722 171.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -167.37 -167.51 28.16 Favored Glycine 0 C--N 1.336 0.535 0 O-C-N 120.662 -1.274 . . . . 0.0 111.559 -175.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.593 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 2.6 ttpt -52.01 130.85 30.79 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 168.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.582 ' HB2' HG22 ' A' ' 37' ' ' THR . . . -134.59 176.63 8.45 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.306 1.442 . . . . 0.0 107.629 173.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.61 9.29 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 118.707 -0.663 . . . . 0.0 109.705 176.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -146.46 151.76 37.93 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 120.191 1.36 . . . . 0.0 113.115 168.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.58 66.41 0.94 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.454 2.302 . . . . 0.0 108.888 165.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.87 138.91 33.73 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.244 -0.91 . . . . 0.0 109.705 174.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 69.1 t -138.58 124.19 23.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 125.689 1.595 . . . . 0.0 107.598 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.3 t -142.69 170.46 15.65 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.61 -88.66 0.12 Allowed Glycine 0 C--N 1.332 0.335 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.89 -165.51 16.26 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -176.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.408 0 N-CA-C 106.347 -1.724 . . . . 0.0 106.347 159.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 118.592 -0.718 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -82.94 -177.86 3.57 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.633 2.889 . . . . 0.0 112.179 -178.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 13.0 ptm -141.38 171.36 14.16 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.279 0.632 . . . . 0.0 112.249 -171.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -144.86 165.4 28.21 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.041 1.336 . . . . 0.0 109.445 166.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -128.42 136.29 50.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 170.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.2 t -115.86 129.35 72.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 161.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.9 t -114.54 151.67 16.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 103.895 -2.631 . . . . 0.0 103.895 166.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.3 m -135.94 136.7 40.64 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.404 HG22 HG23 ' A' ' 15' ' ' VAL . 19.3 t -116.5 141.61 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 176.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -123.67 148.03 46.88 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.046 1.738 . . . . 0.0 107.185 174.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.454 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 4.0 ttpm? -111.96 -159.29 0.68 Allowed 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.355 1.062 . . . . 0.0 108.295 178.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.454 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 3.3 p30 -60.96 81.65 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.029 1.332 . . . . 0.0 107.961 159.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 152.46 -74.83 0.25 Allowed Glycine 0 N--CA 1.45 -0.376 0 O-C-N 121.12 -0.987 . . . . 0.0 112.577 169.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.23 -171.45 3.87 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.076 1.75 . . . . 0.0 110.127 -173.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -46.1 141.27 3.37 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.829 2.052 . . . . 0.0 109.727 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.1 pt -141.95 -11.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 124.225 1.01 . . . . 0.0 113.492 178.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -142.16 149.27 39.54 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.663 1.12 . . . . 0.0 108.354 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -144.68 93.61 2.44 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.011 0.924 . . . . 0.0 109.124 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.69 151.48 43.09 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.772 0.796 . . . . 0.0 112.246 163.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.443 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -146.52 155.59 42.63 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 127.162 2.185 . . . . 0.0 107.785 179.102 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -133.33 -174.22 3.43 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 123.804 1.764 . . . . 0.0 107.139 -172.47 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.9 p -154.02 146.9 13.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 C-N-CA 127.085 2.154 . . . . 0.0 109.88 -177.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.1 t80 . . . . . 0 C--O 1.237 0.4 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 165.741 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 t0 . . . . . 0 N--CA 1.474 0.743 0 CA-C-O 121.671 0.748 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 tp -126.72 111.08 13.84 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -159.38 71.24 0.5 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.792 0.837 . . . . 0.0 109.624 166.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 mp -82.72 149.86 27.05 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.584 1.154 . . . . 0.0 109.637 170.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -137.65 125.81 23.03 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 127.427 2.291 . . . . 0.0 106.536 171.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -127.39 145.12 50.93 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 164.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 C--O 1.257 1.461 0 C-N-CA 127.17 2.188 . . . . 0.0 108.355 -168.971 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.77 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.24 -175.24 4.18 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.372 1.869 . . . . 0.0 107.626 167.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.2 mmm -97.14 163.1 13.07 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 144.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -146.8 154.41 41.34 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 125.233 1.413 . . . . 0.0 109.609 171.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -152.49 134.76 15.06 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 127.594 2.357 . . . . 0.0 106.359 -175.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 p -125.61 152.91 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 125.446 1.498 . . . . 0.0 110.144 174.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.4 p -120.48 157.7 28.84 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.108 0.963 . . . . 0.0 110.002 171.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.8 tp -143.08 110.46 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 174.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -107.92 132.33 53.58 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -116.76 120.96 40.2 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.286 1.034 . . . . 0.0 109.64 -169.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 m -134.5 172.39 12.98 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.418 0.687 . . . . 0.0 110.593 174.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.6 -163.76 46.28 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -163.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -86.0 59.18 5.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.744 0.783 . . . . 0.0 111.021 -160.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -63.0 21.7 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.782 2.433 . . . . 0.0 115.825 -178.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -115.62 12.04 15.96 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.125 1.77 . . . . 0.0 109.009 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.4 m -143.39 -0.74 1.08 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -157.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -137.49 126.48 24.27 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.69 1.196 . . . . 0.0 109.73 -168.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.4 mt -61.87 89.82 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.488 1.115 . . . . 0.0 110.511 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -74.66 163.45 27.7 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.996 0.903 . . . . 0.0 109.083 176.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.8 p -158.99 137.56 10.89 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.14 1.776 . . . . 0.0 108.965 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 t -138.45 98.1 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 119.454 1.024 . . . . 0.0 108.353 172.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.4 t -68.09 127.3 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 163.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.0 t -139.11 127.82 28.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 119.694 1.134 . . . . 0.0 109.114 171.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.4 t -109.8 154.79 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.491 1.516 . . . . 0.0 108.743 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.08 103.19 3.71 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.943 0.897 . . . . 0.0 109.917 165.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -58.76 100.87 0.07 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.549 1.54 . . . . 0.0 109.12 168.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.44 7.97 50.54 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 117.219 -1.878 . . . . 0.0 117.74 158.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.548 HG21 ' H ' ' A' ' 70' ' ' GLY . 2.0 t -165.14 178.45 6.98 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 121.016 2.408 . . . . 0.0 108.615 162.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -94.8 161.47 14.16 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.281 1.032 . . . . 0.0 110.785 -175.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.57 HD12 HD12 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -90.46 169.03 11.4 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.928 1.291 . . . . 0.0 109.288 -178.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -137.09 119.92 16.31 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 124.741 1.216 . . . . 0.0 107.892 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -75.64 148.44 38.74 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.606 0.717 . . . . 0.0 109.755 176.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.1 -25.26 67.93 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 118.399 -1.223 . . . . 0.0 112.636 167.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.21 -60.48 2.92 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 126.609 1.963 . . . . 0.0 111.164 -171.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.666 HG22 ' HG3' ' A' ' 46' ' ' GLU . 1.3 t -144.74 8.43 1.3 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.182 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.4 24.7 56.21 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 118.969 0.804 . . . . 0.0 111.136 -165.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.666 ' HG3' HG22 ' A' ' 44' ' ' THR . 74.7 mt-10 -55.86 118.73 4.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.713 1.205 . . . . 0.0 108.507 174.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 m -78.78 122.17 25.71 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 174.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 76.6 mt -113.03 134.19 54.63 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.76 1.224 . . . . 0.0 110.881 -170.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.36 73.92 1.36 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.85 2.06 . . . . 0.0 113.144 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.1 150.97 37.63 Favored Pre-proline 0 CA--C 1.545 0.785 0 O-C-N 120.979 -1.075 . . . . 0.0 111.151 171.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.52 155.74 85.92 Favored 'Cis proline' 0 C--N 1.348 0.509 0 CA-C-N 119.504 0.859 . . . . 0.0 110.785 -12.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.4 p -144.46 161.34 14.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 175.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.6 mm -108.69 99.24 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 166.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.83 104.94 3.05 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.384 -1.709 . . . . 0.0 106.384 168.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.9 m -74.05 175.15 7.7 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.64 0.733 . . . . 0.0 109.443 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -49.72 -37.98 31.47 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.794 1.637 . . . . 0.0 110.601 175.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -69.23 -32.16 71.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.484 1.913 . . . . 0.0 112.621 -175.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -76.61 -32.27 57.97 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.31 1.044 . . . . 0.0 108.93 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -90.13 16.28 8.75 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.701 1.6 . . . . 0.0 112.708 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.71 45.1 0.18 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.714 2.005 . . . . 0.0 112.295 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.0 m -140.85 162.92 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 128.434 2.694 . . . . 0.0 108.668 -173.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -75.19 -26.83 59.33 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.294 -0.879 . . . . 0.0 113.003 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.39 147.05 10.55 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.214 1.006 . . . . 0.0 109.436 -174.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -132.59 161.14 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.95 0.881 . . . . 0.0 109.81 163.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 m -128.5 116.28 19.45 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 130.029 3.331 . . . . 0.0 104.968 172.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.57 HD12 HD12 ' A' ' 39' ' ' LEU . 4.3 mm? -119.9 132.12 55.44 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 119.506 1.048 . . . . 0.0 108.342 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.43 166.49 24.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.02 -170.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 p -80.62 142.97 33.49 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.913 1.685 . . . . 0.0 110.125 -178.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.8 p -80.33 -51.22 9.14 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.503 -0.748 . . . . 0.0 110.74 172.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.548 ' H ' HG21 ' A' ' 37' ' ' THR . . . -106.6 -80.74 1.35 Allowed Glycine 0 C--N 1.335 0.486 0 O-C-N 121.534 -0.729 . . . . 0.0 112.407 -162.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.0 tttt -168.84 135.69 1.86 Allowed 'General case' 0 C--O 1.239 0.516 1 C-N-CA 131.849 4.06 . . . . 0.0 104.12 170.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -133.37 165.47 24.76 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 123.163 0.585 . . . . 0.0 110.066 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.23 -0.89 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 123.308 0.643 . . . . 0.0 110.673 -165.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -153.02 156.12 38.21 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.039 -1.038 . . . . 0.0 108.282 168.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.08 109.44 5.61 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 166.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.52 127.68 54.76 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.5 t -129.66 118.09 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 -174.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.0 157.94 45.09 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -169.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 154.85 -167.57 32.71 Favored Glycine 0 C--N 1.331 0.284 0 O-C-N 121.87 -0.519 . . . . 0.0 112.037 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.82 179.88 43.08 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.407 1.004 . . . . 0.0 112.155 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.54 0.584 0 C-N-CA 126.396 1.878 . . . . 0.0 108.463 171.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.534 0.328 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -84.35 -179.03 3.67 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.248 1.966 . . . . 0.0 111.5 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.406 ' CE ' ' HE1' ' A' ' 95' ' ' TRP . 4.6 ptm -131.31 160.28 35.43 Favored 'General case' 0 C--O 1.231 0.109 0 O-C-N 121.154 -0.966 . . . . 0.0 112.977 -176.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -142.01 143.31 33.11 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.536 1.134 . . . . 0.0 108.94 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.406 ' HE1' ' CE ' ' A' ' 93' ' ' MET . 54.4 m0 -116.9 139.46 50.61 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.23 1.012 . . . . 0.0 108.366 174.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.16 141.08 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 153.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.5 m -141.62 160.33 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 C-N-CA 127.074 2.149 . . . . 0.0 106.443 -177.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.8 m -152.59 142.94 22.55 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 174.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.36 136.59 48.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 169.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -123.19 113.69 19.29 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.698 2.399 . . . . 0.0 106.862 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -68.02 171.51 6.75 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 161.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -44.19 83.2 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.561 2.344 . . . . 0.0 114.128 -175.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 62.46 43.69 98.68 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.273 1.416 . . . . 0.0 113.465 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.0 mmtt -155.55 141.26 18.0 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.815 1.807 . . . . 0.0 109.463 155.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -68.31 143.83 55.05 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 125.932 1.693 . . . . 0.0 108.507 170.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.95 -13.94 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 120.218 1.372 . . . . 0.0 113.234 172.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -142.88 162.04 36.53 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.66 1.584 . . . . 0.0 107.085 -167.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.4 pttt -162.78 37.8 0.1 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.152 0.887 . . . . 0.0 112.637 -175.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -73.55 166.8 22.59 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.219 -1.55 . . . . 0.0 110.373 -176.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.7 t -151.59 160.08 43.81 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 127.168 2.187 . . . . 0.0 106.234 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 94.3 mt -132.6 141.49 48.7 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.924 0.89 . . . . 0.0 109.238 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.4 p -135.87 114.77 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 126.196 1.798 . . . . 0.0 107.319 174.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.51 -0.569 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 166.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 . . . . . 0 N--CA 1.466 0.341 0 N-CA-C 111.312 0.116 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.92 124.6 47.47 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.669 0.788 . . . . 0.0 109.314 -155.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -148.96 32.67 0.76 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.985 2.114 . . . . 0.0 111.802 -157.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.2 mp -80.77 148.58 30.0 Favored 'General case' 0 C--O 1.24 0.566 0 O-C-N 121.45 -0.781 . . . . 0.0 110.559 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -159.51 136.09 9.19 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.978 2.111 . . . . 0.0 109.963 173.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -142.17 158.66 43.48 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.078 2.151 . . . . 0.0 110.297 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.3 p30 . . . . . 0 C--O 1.249 1.035 0 C-N-CA 126.816 2.046 . . . . 0.0 109.3 177.926 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.502 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . . . . . . 0 CA--C 1.527 0.786 0 N-CA-C 107.697 -2.161 . . . . 0.0 107.697 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.66 -172.61 2.96 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.158 0.979 . . . . 0.0 112.667 -162.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.1 mtp -113.69 158.77 20.47 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 147.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -144.77 143.2 30.55 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 125.256 1.597 . . . . 0.0 108.951 174.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -142.94 143.81 32.14 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.619 2.368 . . . . 0.0 105.065 172.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p -122.07 155.11 26.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 124.557 1.143 . . . . 0.0 109.108 171.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.04 151.11 52.07 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 173.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.6 tp -133.2 114.42 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.11 138.02 41.21 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 126.361 1.864 . . . . 0.0 107.45 176.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -128.46 122.34 31.04 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.453 1.101 . . . . 0.0 108.96 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.97 165.31 11.67 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.296 1.038 . . . . 0.0 108.772 172.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.49 -154.07 52.12 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 176.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -75.67 75.38 2.66 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 123.733 1.73 . . . . 0.0 113.108 -170.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -81.49 17.33 1.42 Allowed 'General case' 0 C--N 1.324 -0.536 0 O-C-N 119.715 -1.866 . . . . 0.0 114.116 -171.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 ptt-85 -137.64 28.34 2.7 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.559 1.527 . . . . 0.0 113.123 -170.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.4 m -127.97 17.29 6.74 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -171.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -134.81 -169.18 2.3 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.9 1.227 . . . . 0.0 112.556 -165.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.7 mm -114.91 87.88 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 106.104 -1.814 . . . . 0.0 106.104 163.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.409 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 0.4 OUTLIER -85.16 160.22 19.97 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.246 0.93 . . . . 0.0 110.588 168.394 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.34 156.67 42.81 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.065 0.946 . . . . 0.0 108.565 169.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.1 t -138.02 104.02 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.198 1.399 . . . . 0.0 107.334 170.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.711 HG22 HD12 ' A' ' 53' ' ' ILE . 84.9 t -69.07 135.37 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 163.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.9 t -138.19 138.41 43.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.5 t -135.18 150.14 29.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.08 141.98 49.37 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.265 1.826 . . . . 0.0 109.955 168.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -118.27 103.61 9.98 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 130.158 3.383 . . . . 0.0 106.481 -178.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.47 0.98 32.9 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 125.163 1.364 . . . . 0.0 113.205 172.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.537 HG22 ' HB2' ' A' ' 72' ' ' ALA . 15.0 t -165.74 -174.44 3.08 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.582 1.191 . . . . 0.0 109.23 -174.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -109.73 -175.75 2.83 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.871 1.668 . . . . 0.0 109.702 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.5 mt -119.18 165.58 14.03 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.313 1.445 . . . . 0.0 109.677 -177.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -138.26 122.6 18.26 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.095 0.958 . . . . 0.0 110.113 -170.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -70.08 135.29 49.09 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.755 0.822 . . . . 0.0 109.977 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.84 0.34 86.35 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-O 117.867 -1.518 . . . . 0.0 115.29 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.14 -51.35 15.88 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 120.196 1.998 . . . . 0.0 108.331 174.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.57 -22.8 3.56 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.836 1.254 . . . . 0.0 111.413 -167.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.94 20.55 28.06 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 118.444 -1.198 . . . . 0.0 112.24 -172.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -57.89 136.87 57.09 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 118.978 1.389 . . . . 0.0 109.42 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.13 138.77 49.93 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.268 1.027 . . . . 0.0 108.573 167.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.8 mt -126.91 -171.2 2.35 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.167 1.387 . . . . 0.0 109.306 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -143.03 117.94 9.98 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.685 1.994 . . . . 0.0 106.588 173.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.52 172.0 10.53 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.137 177.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.81 157.99 94.53 Favored 'Cis proline' 0 C--O 1.239 0.567 0 N-CA-C 108.525 -1.375 . . . . 0.0 108.525 -5.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 p -144.8 147.47 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 O-C-N 121.534 -0.728 . . . . 0.0 109.084 -171.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.711 HD12 HG22 ' A' ' 31' ' ' VAL . 18.0 mm -120.13 114.18 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 175.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.68 128.01 36.02 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 169.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.4 m -95.72 -175.69 3.51 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.93 1.692 . . . . 0.0 110.884 -174.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.409 ' HA ' ' HG2' ' A' ' 28' ' ' LYS . 29.5 t70 -61.93 -37.71 85.72 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 123.769 0.828 . . . . 0.0 111.848 -170.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -66.76 -36.4 82.35 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.072 0.949 . . . . 0.0 111.212 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -66.73 -36.49 82.59 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 122.44 1.114 . . . . 0.0 110.073 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.8 10.47 32.95 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.581 1.952 . . . . 0.0 112.874 -174.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.17 31.07 0.06 Allowed 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 120.392 1.451 . . . . 0.0 114.111 -174.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.7 m -131.37 167.27 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.504 1.522 . . . . 0.0 111.691 -169.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -59.38 -34.15 72.07 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.471 1.508 . . . . 0.0 113.415 175.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -157.95 147.28 19.68 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-O 117.116 -1.421 . . . . 0.0 109.913 -177.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 t -129.58 163.02 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 119.106 0.866 . . . . 0.0 108.74 163.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.3 m -139.29 109.39 6.41 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.702 2.801 . . . . 0.0 107.791 -172.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -122.4 131.58 53.95 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 121.053 1.751 . . . . 0.0 109.618 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.49 176.29 8.75 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.244 0.618 . . . . 0.0 111.455 -168.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 p -101.95 148.48 25.29 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.812 0.845 . . . . 0.0 109.954 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.3 p -84.27 -0.7 53.37 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.61 -0.681 . . . . 0.0 112.442 176.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.64 -172.73 37.95 Favored Glycine 0 N--CA 1.448 -0.525 0 O-C-N 119.877 -1.764 . . . . 0.0 109.498 -171.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.502 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 7.1 ttpt -70.43 129.35 39.05 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.537 ' HB2' HG22 ' A' ' 37' ' ' THR . . . -126.4 169.69 12.71 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.121 0.568 . . . . 0.0 110.536 176.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -119.46 -2.69 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -175.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -141.65 172.48 12.62 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.836 1.198 . . . . 0.0 110.605 -177.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -164.61 89.75 0.52 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 120.073 1.306 . . . . 0.0 111.312 166.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.77 150.4 25.82 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.584 0.354 . . . . 0.0 110.766 176.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 t -140.76 123.6 15.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 126.207 1.803 . . . . 0.0 106.241 164.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 m -140.59 156.62 46.23 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 174.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.4 -153.35 23.46 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -167.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.38 -168.96 31.56 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -175.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.538 HG23 ' CE1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 125.178 1.391 . . . . 0.0 109.323 165.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 . . . . . 0 CA--C 1.532 0.263 0 CA-C-O 119.725 -0.179 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -72.37 169.21 22.22 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 121.083 1.188 . . . . 0.0 111.722 171.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.4 ptm -139.59 172.53 12.66 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 125.046 1.338 . . . . 0.0 110.33 -174.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -143.91 153.3 42.16 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.23 1.012 . . . . 0.0 109.422 -177.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -127.59 140.75 51.91 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.518 1.527 . . . . 0.0 108.982 176.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.9 t -132.8 110.75 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 164.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 m -92.07 143.07 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 163.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 m -129.59 142.12 50.81 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.8 t -122.14 126.1 73.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -113.57 119.0 35.99 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 175.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.439 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 2.2 ttpt -80.01 -156.91 0.13 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 175.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.439 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 4.6 p30 -66.02 83.34 0.08 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 163.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 139.2 -43.48 1.16 Allowed Glycine 0 CA--C 1.524 0.615 0 CA-C-O 118.03 -1.428 . . . . 0.0 115.2 156.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -151.93 -174.98 5.04 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 119.66 1.73 . . . . 0.0 111.309 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -55.74 143.44 30.79 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 171.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 6.7 pt -128.14 -24.85 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-O 117.674 -1.155 . . . . 0.0 112.706 168.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -150.94 148.9 28.97 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 120.631 1.559 . . . . 0.0 108.319 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -148.67 54.79 1.0 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.107 1.363 . . . . 0.0 107.97 -169.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.17 113.02 2.35 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.72 135.0 50.54 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.955 1.302 . . . . 0.0 108.014 -169.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -133.12 -172.8 3.03 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 122.275 1.036 . . . . 0.0 109.85 -170.117 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 78.3 t -148.09 111.46 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 127.554 2.342 . . . . 0.0 106.481 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.538 ' CE1' HG23 ' A' ' 81' ' ' VAL . 1.8 t80 . . . . . 0 C--O 1.233 0.213 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 169.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 . . . . . 0 N--CA 1.467 0.421 0 CA-C-O 120.656 0.265 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.1 tp -104.93 104.47 14.23 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -156.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.73 66.67 0.93 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -166.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 mp -119.58 141.78 48.97 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -161.19 111.39 1.69 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -97.64 146.57 25.19 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.204 1.002 . . . . 0.0 109.618 169.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.267 0 C-N-CA 126.868 2.067 . . . . 0.0 109.431 171.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.471 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -147.3 152.41 38.21 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 117.499 0.65 . . . . 0.0 112.57 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.5 mtp -83.51 154.4 23.9 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.477 1.111 . . . . 0.0 108.685 158.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -137.88 152.71 49.31 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.607 1.163 . . . . 0.0 109.026 168.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -141.32 134.42 29.25 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 165.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.593 HG12 HG22 ' A' ' 99' ' ' VAL . 3.8 m -134.65 145.87 31.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 125.262 1.425 . . . . 0.0 107.854 -173.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.2 p -123.24 152.78 40.97 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -175.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.4 tp -136.31 92.87 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 170.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -72.74 139.52 47.21 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 165.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -124.02 126.25 45.95 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 173.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -136.47 176.72 8.44 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.037 0.935 . . . . 0.0 111.73 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.55 -83.46 1.62 Allowed Glycine 0 C--N 1.334 0.431 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 -175.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -149.78 158.9 44.61 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.336 1.855 . . . . 0.0 106.482 172.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -146.44 71.9 1.26 Allowed 'General case' 0 C--N 1.327 -0.375 0 O-C-N 119.739 -1.85 . . . . 0.0 109.355 164.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -133.45 -0.75 3.22 Favored 'General case' 0 C--N 1.332 -0.155 0 O-C-N 120.782 -1.198 . . . . 0.0 112.872 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.4 t -152.5 53.08 0.78 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.999 1.272 . . . . 0.0 110.304 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -148.02 116.56 6.63 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 116.675 -1.631 . . . . 0.0 109.729 -178.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.0 mt -55.14 98.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 125.333 1.453 . . . . 0.0 108.969 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.6 mtmm -82.86 136.73 34.53 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 170.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t -142.46 144.2 32.94 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 172.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.8 t -135.05 155.79 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 167.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 p -119.22 147.39 22.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 103.967 -2.605 . . . . 0.0 103.967 156.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.7 p -148.81 131.11 6.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 171.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.5 t -128.65 164.34 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.916 0.886 . . . . 0.0 108.798 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.58 107.1 4.07 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 166.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.526 ' H ' ' HG3' ' A' ' 74' ' ' GLU . 32.4 t-20 -65.22 89.55 0.09 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.248 1.023 . . . . 0.0 110.217 172.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.38 -79.63 0.34 Allowed Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 169.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -81.19 -165.02 0.84 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.255 1.022 . . . . 0.0 111.017 -174.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -110.29 162.28 14.78 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.916 1.686 . . . . 0.0 111.156 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -84.41 156.31 21.86 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.764 1.626 . . . . 0.0 109.651 167.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -128.63 114.46 16.7 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 127.275 2.23 . . . . 0.0 107.308 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.74 119.31 17.79 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.657 1.983 . . . . 0.0 109.088 -176.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.91 -3.39 50.99 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.56 1.076 . . . . 0.0 113.74 176.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.45 -51.91 67.51 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.933 1.293 . . . . 0.0 110.098 169.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.3 p -152.39 9.3 0.48 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.454 1.502 . . . . 0.0 112.394 -161.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.32 13.82 79.58 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 120.486 -1.384 . . . . 0.0 112.617 -175.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -65.65 124.19 21.71 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.772 1.229 . . . . 0.0 111.092 -171.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.2 m -74.2 127.28 32.55 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 169.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 75.8 mt -119.76 176.64 5.3 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.397 1.079 . . . . 0.0 109.925 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.99 110.13 12.23 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.043 1.337 . . . . 0.0 109.553 -173.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.0 p -77.12 170.37 16.67 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.284 1.434 . . . . 0.0 112.175 -172.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.66 146.41 76.73 Favored 'Cis proline' 0 CA--C 1.535 0.526 0 N-CA-C 109.287 -1.082 . . . . 0.0 109.287 -19.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.8 p -137.13 147.15 27.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 118.439 0.563 . . . . 0.0 110.842 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.7 mm -114.08 127.29 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 127.543 2.337 . . . . 0.0 107.044 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -103.33 140.41 37.46 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.666 0.787 . . . . 0.0 109.414 172.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.3 m -81.0 172.48 13.68 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.846 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.77 -24.96 67.98 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.418 2.287 . . . . 0.0 112.547 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -72.57 -37.03 68.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 118.465 -0.779 . . . . 0.0 111.519 172.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -74.21 -44.16 54.29 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -173.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.76 8.09 2.65 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.968 1.307 . . . . 0.0 114.357 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.66 41.39 0.09 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.221 2.208 . . . . 0.0 113.581 -174.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.6 m -133.1 159.1 43.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 126.013 1.725 . . . . 0.0 111.087 -171.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -67.05 -27.19 67.18 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.278 1.431 . . . . 0.0 113.546 -175.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -158.62 137.39 11.16 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 -172.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -123.04 150.67 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 158.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.5 m -133.65 134.52 43.26 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 173.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 31.4 mt -134.2 147.78 50.78 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -170.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.5 t -157.71 165.91 34.18 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -173.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.78 141.55 28.32 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.248 1.419 . . . . 0.0 109.659 -177.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 58.2 p -80.34 -1.0 39.22 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 175.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -158.94 -99.32 0.15 Allowed Glycine 0 C--N 1.339 0.743 0 O-C-N 120.61 -1.306 . . . . 0.0 112.851 -174.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.423 ' HE2' ' C ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -134.69 152.06 51.48 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 126.67 1.988 . . . . 0.0 108.655 166.3 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.13 -178.71 4.05 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 158.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.9 mm -111.44 -14.01 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.582 0.706 . . . . 0.0 109.746 173.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.526 ' HG3' ' H ' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -148.9 163.2 38.13 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 126.521 1.928 . . . . 0.0 107.262 -163.115 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.423 ' HD2' HG11 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -154.34 96.22 1.9 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 128.991 2.917 . . . . 0.0 105.818 168.813 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -91.63 114.93 27.6 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.328 0.651 . . . . 0.0 110.433 177.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 52.7 t -129.1 115.57 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.913 1.285 . . . . 0.0 108.654 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.457 ' HA ' ' HB3' ' A' ' 124' ' ' LEU . 46.7 t -139.71 168.54 19.59 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.933 2.093 . . . . 0.0 108.255 175.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.65 -156.57 27.75 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 127.075 2.274 . . . . 0.0 108.299 -162.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 139.27 123.97 2.14 Favored Glycine 0 N--CA 1.473 1.141 0 CA-C-N 119.171 1.485 . . . . 0.0 112.554 174.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.252 0 CA-C-O 121.767 0.794 . . . . 0.0 110.038 -169.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 . . . . . 0 CA--C 1.532 0.256 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.59 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -78.5 178.24 7.79 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.769 2.98 . . . . 0.0 111.784 173.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.3 ptm -138.12 169.53 17.62 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 122.558 1.17 . . . . 0.0 111.197 -172.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -140.54 151.26 44.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.823 2.049 . . . . 0.0 106.325 175.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -118.11 151.19 38.03 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 168.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.7 t -125.89 134.23 67.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 161.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.7 t -144.31 124.25 7.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 -168.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.4 m -141.43 150.7 42.66 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 -163.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.593 HG22 HG12 ' A' ' 15' ' ' VAL . 37.1 t -124.47 135.52 63.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.59 0.709 . . . . 0.0 111.002 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -118.35 158.66 24.83 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 128.467 2.707 . . . . 0.0 107.938 173.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.4 tptt -124.88 -153.44 0.56 Allowed 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 127.573 2.349 . . . . 0.0 107.402 -168.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -55.86 68.47 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.895 2.078 . . . . 0.0 110.633 160.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 64.14 58.98 9.09 Favored Glycine 0 CA--C 1.531 1.061 0 O-C-N 120.106 -1.621 . . . . 0.0 113.172 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -179.61 153.3 0.55 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 128.546 2.738 . . . . 0.0 107.595 162.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -64.84 155.85 32.7 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.358 1.463 . . . . 0.0 109.659 167.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.0 pt -136.18 -17.4 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 125.032 1.333 . . . . 0.0 113.949 167.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -150.7 129.1 12.09 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -170.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -136.98 106.98 6.28 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -175.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.492 ' HE2' HD21 ' A' ' 126' ' ' LEU . 32.2 pttt -145.58 173.18 12.27 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.817 0.818 . . . . 0.0 112.724 169.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.52 ' O ' HD23 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -135.55 171.94 13.73 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 127.702 2.401 . . . . 0.0 109.79 173.409 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.528 HD22 ' OD1' ' A' ' 123' ' ' ASP . 14.3 mt -138.85 151.61 47.13 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.7 p -129.93 138.68 53.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 . . . . . 0 N--CA 1.446 -0.64 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -178.877 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.528 ' OD1' HD22 ' A' ' 111' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.468 0.469 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' A' ' 123' ' ' ASP . 3.5 mm? -90.07 78.58 6.64 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -116.32 58.36 0.75 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.046 1.739 . . . . 0.0 109.25 -172.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.492 HD21 ' HE2' ' A' ' 109' ' ' LYS . 63.5 mt -124.83 107.95 11.43 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -177.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -132.54 81.92 1.98 Allowed 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -175.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -70.81 132.17 44.91 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 165.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.429 ' HA ' ' CB ' ' A' ' 74' ' ' GLU . 8.0 p-10 . . . . . 0 C--O 1.25 1.105 0 C-N-CA 128.315 2.646 . . . . 0.0 109.093 174.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.438 ' N ' ' HE2' ' A' ' 71' ' ' LYS . . . . . . . . 0 CA--C 1.528 0.877 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -148.13 -164.14 1.94 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.205 1.802 . . . . 0.0 111.163 -162.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.4 mtp -120.87 163.67 17.83 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 125.584 1.554 . . . . 0.0 108.101 147.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -143.13 143.87 31.99 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 125.91 2.006 . . . . 0.0 110.845 -178.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -150.65 145.09 25.63 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.939 1.696 . . . . 0.0 107.355 174.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.47 144.5 32.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 126.657 1.983 . . . . 0.0 107.936 176.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.7 127.98 54.95 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 167.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 tp -100.29 154.15 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 163.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.664 ' CD ' ' H ' ' A' ' 96' ' ' VAL . 0.0 OUTLIER -152.83 -174.63 4.99 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 127.801 2.44 . . . . 0.0 106.941 176.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -148.27 166.32 28.35 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 168.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -141.81 165.85 26.33 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 124.141 0.976 . . . . 0.0 110.381 171.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.69 -147.66 39.9 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -75.22 111.91 10.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.394 0.616 . . . . 0.0 110.274 177.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -113.15 33.38 5.11 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.32 1.048 . . . . 0.0 109.679 173.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -124.95 0.5 7.97 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.435 1.494 . . . . 0.0 110.363 -166.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.11 28.67 0.59 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.182 1.393 . . . . 0.0 112.837 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -122.64 116.7 24.26 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 120.72 -1.238 . . . . 0.0 107.773 172.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.7 mm -65.63 121.97 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 175.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -90.69 160.65 15.74 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.155 0.982 . . . . 0.0 110.345 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.4 m -152.48 136.69 16.57 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.373 1.869 . . . . 0.0 107.569 158.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.3 t -137.84 147.18 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 170.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.52 HG22 HD12 ' A' ' 53' ' ' ILE . 82.1 t -117.19 128.21 74.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 126.874 2.069 . . . . 0.0 105.851 170.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.33 147.63 19.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 167.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.9 t -128.69 147.73 33.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 170.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.76 91.75 1.91 Allowed 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 173.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -65.06 127.28 30.98 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 172.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.69 -14.66 19.89 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-O 118.735 -1.036 . . . . 0.0 114.503 153.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 t -161.07 -168.49 2.07 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -101.44 160.86 14.07 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.797 0.839 . . . . 0.0 111.302 173.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 tp -74.86 165.23 25.58 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 170.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -133.67 129.96 37.54 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 171.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.425 ' HA ' HD23 ' A' ' 66' ' ' LEU . 5.9 t70 -84.01 129.51 34.91 Favored 'General case' 0 CA--C 1.52 -0.211 0 O-C-N 123.719 0.637 . . . . 0.0 109.545 175.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.47 -23.16 70.13 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 118.107 -1.385 . . . . 0.0 112.986 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.72 -61.25 2.56 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.019 1.41 . . . . 0.0 111.116 -176.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.03 10.84 7.61 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.139 0.975 . . . . 0.0 111.029 -177.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.24 23.99 77.47 Favored Glycine 0 N--CA 1.446 -0.639 0 O-C-N 121.141 -0.974 . . . . 0.0 111.544 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -74.98 125.35 28.71 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -171.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.2 m -64.42 129.27 39.24 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 165.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 34.2 mt -107.42 -164.18 0.96 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.801 1.64 . . . . 0.0 108.247 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.67 98.26 3.37 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.693 -0.63 . . . . 0.0 110.55 173.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.425 ' HA ' HG23 ' A' ' 52' ' ' VAL . 4.5 m -73.48 168.37 26.09 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 122.705 0.402 . . . . 0.0 111.798 177.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -61.26 149.27 52.92 Favored 'Cis proline' 0 CA--C 1.538 0.691 0 N-CA-C 110.366 -0.667 . . . . 0.0 110.366 -16.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.425 HG23 ' HA ' ' A' ' 50' ' ' SER . 12.6 t -127.48 151.48 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.52 HD12 HG22 ' A' ' 31' ' ' VAL . 18.0 mm -113.95 132.52 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 169.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.9 153.93 21.27 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 122.293 1.044 . . . . 0.0 108.899 170.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.72 -177.94 4.58 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.822 2.449 . . . . 0.0 107.601 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -61.19 -43.95 98.07 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -172.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -62.35 -31.26 71.88 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 123.546 0.738 . . . . 0.0 110.8 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -83.21 -17.98 40.9 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 118.755 -0.64 . . . . 0.0 110.202 -173.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 mt -114.25 6.09 16.06 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.897 1.679 . . . . 0.0 113.921 -168.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.57 34.21 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 128.429 2.692 . . . . 0.0 114.428 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.5 m -100.94 175.38 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 127.777 2.431 . . . . 0.0 110.346 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -95.3 -31.01 13.66 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 118.394 -0.812 . . . . 0.0 111.672 164.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 18' ' ' GLU . 71.7 tttt -157.43 139.12 14.02 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 125.223 1.409 . . . . 0.0 109.189 176.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.0 t -135.73 130.65 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 119.415 1.007 . . . . 0.0 108.53 162.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.8 m -78.27 138.54 38.66 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 121.079 -1.013 . . . . 0.0 108.418 158.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 41' ' ' ASP . 77.8 mt -125.51 137.82 53.96 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 167.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.93 -174.59 4.12 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -172.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.83 146.68 37.24 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.329 1.061 . . . . 0.0 110.932 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.3 p -73.59 -22.91 59.9 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.136 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.21 -165.22 13.89 Favored Glycine 0 N--CA 1.449 -0.497 0 O-C-N 121.192 -0.943 . . . . 0.0 110.798 -170.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.438 ' HE2' ' N ' ' A' ' 10' ' ' GLY . 47.7 tttt -57.86 135.81 56.91 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 168.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -137.03 161.47 35.97 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 174.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.34 -7.94 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 123.51 0.724 . . . . 0.0 109.945 -164.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -144.67 150.63 37.67 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -137.56 156.33 48.22 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 155.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -158.13 152.41 24.38 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 121.014 -1.054 . . . . 0.0 108.785 174.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.8 t -142.39 106.32 1.37 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.2 t -116.39 169.48 9.28 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.734 1.214 . . . . 0.0 107.888 156.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.22 -165.3 30.32 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 125.173 1.368 . . . . 0.0 110.277 -172.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.54 175.48 38.11 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 108.088 -2.005 . . . . 0.0 108.088 172.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 C--O 1.235 0.339 0 C-N-CA 124.296 1.038 . . . . 0.0 108.446 169.243 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.538 0.495 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -84.37 -177.0 2.77 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.564 2.842 . . . . 0.0 111.954 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.5 ptp -141.67 163.46 32.85 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 172.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -138.99 150.19 45.56 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 126.018 1.727 . . . . 0.0 108.976 173.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 20.7 m0 -125.3 151.05 46.51 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.547 1.539 . . . . 0.0 108.689 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.664 ' H ' ' CD ' ' A' ' 18' ' ' GLU . 13.7 p -136.45 81.04 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 126.85 2.06 . . . . 0.0 108.766 169.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 p -83.98 89.12 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.64 145.29 31.74 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 176.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.99 140.66 46.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -126.7 145.6 50.52 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 128.417 2.687 . . . . 0.0 107.883 -172.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.54 -174.69 2.51 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.03 1.332 . . . . 0.0 107.553 170.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -52.32 69.09 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.708 2.803 . . . . 0.0 113.053 176.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.53 -15.96 3.6 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 115.957 -2.58 . . . . 0.0 116.326 171.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.54 177.79 0.18 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 121.714 2.757 . . . . 0.0 111.918 175.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -50.99 150.81 2.85 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 128.724 2.81 . . . . 0.0 110.913 175.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.47 -20.44 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.638 1.175 . . . . 0.0 111.572 162.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -152.65 151.79 31.0 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 120.315 1.416 . . . . 0.0 110.739 -170.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -141.17 22.69 2.22 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 125.494 1.518 . . . . 0.0 112.842 -161.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.412 ' HE3' HD13 ' A' ' 126' ' ' LEU . 1.7 ttpm? -60.95 142.54 56.38 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.612 0.72 . . . . 0.0 110.106 -175.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.439 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -155.07 137.57 15.06 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 125.258 1.423 . . . . 0.0 109.703 -163.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.548 ' N ' HD12 ' A' ' 111' ' ' LEU . 2.2 mp -126.85 177.87 6.31 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 123.413 1.578 . . . . 0.0 108.462 -166.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.2 p -149.93 146.8 16.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-N 111.438 -2.619 . . . . 0.0 110.945 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 . . . . . 0 C--O 1.234 0.243 0 C-N-CA 126.571 1.948 . . . . 0.0 107.237 169.128 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -120.93 120.7 36.24 Favored 'General case' 0 CA--C 1.517 -0.288 0 O-C-N 120.691 -1.256 . . . . 0.0 107.79 173.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -150.68 72.09 1.07 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 125.671 1.589 . . . . 0.0 110.522 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.412 HD13 ' HE3' ' A' ' 109' ' ' LYS . 4.5 mp -119.08 154.22 33.54 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.761 1.224 . . . . 0.0 110.727 178.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -145.83 148.89 33.38 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.31 2.244 . . . . 0.0 109.172 175.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -141.26 142.53 33.9 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.195 2.198 . . . . 0.0 107.813 177.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.5 p30 . . . . . 0 C--O 1.258 1.535 0 C-N-CA 128.202 2.601 . . . . 0.0 107.047 170.512 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.705 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 73.27 -80.85 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 126.663 1.985 . . . . 0.0 107.534 -170.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -164.47 155.18 14.88 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.139 1.776 . . . . 0.0 106.731 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -125.36 171.09 10.71 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 127.552 2.341 . . . . 0.0 109.282 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -154.8 85.57 3.61 Favored Pre-proline 0 N--CA 1.448 -0.554 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 -159.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.02 165.12 26.59 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.055 1.837 . . . . 0.0 109.926 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 121.21 110.88 2.19 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 -174.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 106.19 -176.91 22.12 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 123.935 0.779 . . . . 0.0 111.86 162.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -134.46 165.95 23.99 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 124.947 1.299 . . . . 0.0 108.83 -167.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.514 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . 158.7 -154.18 25.28 Favored Glycine 0 C--N 1.313 -0.697 0 C-N-CA 130.207 3.765 . . . . 0.0 107.37 175.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.52 -162.49 1.32 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.037 1.735 . . . . 0.0 110.329 -164.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 33.5 mtp -128.59 165.08 21.48 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 128.551 2.741 . . . . 0.0 105.069 156.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -146.78 154.92 41.95 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.512 1.125 . . . . 0.0 110.733 177.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -146.62 120.96 9.6 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.744 2.018 . . . . 0.0 107.773 174.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.1 p -99.67 151.86 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.963 1.305 . . . . 0.0 109.465 170.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.415 HG23 HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -125.91 154.18 43.15 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.108 0.963 . . . . 0.0 110.089 168.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 tp -139.42 111.81 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 C-N-CA 126.034 1.734 . . . . 0.0 107.209 172.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.64 150.76 20.0 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 159.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -128.86 106.88 9.21 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.396 1.878 . . . . 0.0 107.524 -168.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 m -113.14 167.8 10.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.85 -172.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.6 -150.64 41.63 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -172.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -87.21 34.4 0.69 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -158.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -58.55 -6.09 0.65 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -165.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 54.5 mtt-85 -86.29 0.78 53.09 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.34 1.456 . . . . 0.0 113.424 -167.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.9 m -135.92 32.41 2.95 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.72 1.608 . . . . 0.0 110.149 -174.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.519 ' HB3' HG21 ' A' ' 81' ' ' VAL . 18.0 m-85 -143.27 102.33 3.96 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.867 1.267 . . . . 0.0 109.964 -166.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.1 mm -69.21 96.88 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 125.455 1.502 . . . . 0.0 110.732 -170.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? -110.39 160.79 16.27 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.441 1.096 . . . . 0.0 112.052 -164.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.2 m -145.52 126.29 14.35 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.271 0.628 . . . . 0.0 110.957 -158.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.4 t -135.64 155.74 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.218 1.007 . . . . 0.0 110.11 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 p -119.4 154.6 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 128.924 2.89 . . . . 0.0 107.964 173.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.474 HG11 HD21 ' A' ' 39' ' ' LEU . 1.7 t -145.61 127.25 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 168.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.2 t -127.79 125.5 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.17 112.17 17.37 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.107 0.963 . . . . 0.0 109.826 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -74.51 128.08 34.66 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.687 1.195 . . . . 0.0 108.902 170.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.41 1.08 74.55 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 115.698 1.039 . . . . 0.0 115.698 163.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -153.44 175.87 12.67 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 119.002 1.401 . . . . 0.0 110.387 175.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -100.0 161.01 13.88 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.675 1.19 . . . . 0.0 109.432 174.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.474 HD21 HG11 ' A' ' 32' ' ' VAL . 2.5 tp -89.9 171.62 9.46 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.31 0.644 . . . . 0.0 109.657 -178.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.405 ' HE2' ' HA2' ' A' ' 45' ' ' GLY . 82.4 tttt -137.74 139.54 40.17 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.101 0.96 . . . . 0.0 108.738 173.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -93.82 128.56 40.13 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.978 1.711 . . . . 0.0 109.986 -173.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.04 -21.59 76.96 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.811 -0.994 . . . . 0.0 114.277 -174.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.11 78.68 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.436 1.118 . . . . 0.0 112.03 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.3 p -145.56 -28.58 0.44 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.993 1.317 . . . . 0.0 111.511 -159.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.405 ' HA2' ' HE2' ' A' ' 40' ' ' LYS . . . 88.28 13.93 62.94 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.374 1.464 . . . . 0.0 112.888 -175.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -62.73 138.0 58.4 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.139 1.376 . . . . 0.0 107.296 171.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.1 m -68.7 150.78 47.52 Favored 'General case' 0 N--CA 1.426 -1.669 0 C-N-CA 125.804 1.642 . . . . 0.0 110.411 165.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.2 mt -136.32 142.05 43.84 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.315 1.046 . . . . 0.0 110.725 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.78 78.01 4.29 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.46 1.104 . . . . 0.0 111.144 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 p -54.68 156.28 6.65 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.171 0.988 . . . . 0.0 110.888 168.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -79.64 146.73 76.79 Favored 'Cis proline' 0 CA--C 1.537 0.639 0 CA-C-N 119.355 0.805 . . . . 0.0 111.69 2.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.8 t -140.26 159.14 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.63 1.172 . . . . 0.0 110.263 -171.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.1 mm -119.85 142.33 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 C-N-CA 129.023 2.929 . . . . 0.0 105.44 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -108.42 128.1 54.48 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 171.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.1 m -94.29 173.65 7.53 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.397 1.479 . . . . 0.0 109.404 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.2 -36.1 76.89 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -169.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -63.35 -36.94 85.37 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.593 0.757 . . . . 0.0 111.019 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -75.68 -36.77 59.98 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.8 mt -86.53 24.54 1.4 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.339 2.256 . . . . 0.0 110.73 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.16 -4.88 58.68 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.023 0.929 . . . . 0.0 112.618 174.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.1 m -82.76 163.22 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 118.807 0.73 . . . . 0.0 110.475 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -62.11 -34.85 77.11 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.542 1.137 . . . . 0.0 112.277 173.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -152.25 139.22 19.08 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -172.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -118.74 152.4 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 161.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.415 HG23 HG23 ' A' ' 16' ' ' THR . 19.7 m -129.82 131.29 46.1 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 103.512 -2.773 . . . . 0.0 103.512 164.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.0 mp -132.3 144.71 50.77 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 170.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.61 -173.05 3.67 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.098 -165.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 p -120.61 138.12 54.07 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.704 0.801 . . . . 0.0 110.917 -171.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 68.5 p -78.94 -12.0 60.02 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -168.32 -157.17 10.94 Favored Glycine 0 N--CA 1.447 -0.605 0 O-C-N 120.475 -1.39 . . . . 0.0 110.597 -167.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.514 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -73.36 91.68 1.76 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.39 1.476 . . . . 0.0 109.506 -168.356 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.91 155.52 21.64 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.831 1.252 . . . . 0.0 108.44 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.0 -5.88 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.867 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -148.92 159.19 44.42 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 119.726 1.148 . . . . 0.0 109.308 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.16 143.09 49.73 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 125.054 1.471 . . . . 0.0 107.831 151.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.27 129.3 27.09 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 166.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.2 t -139.85 100.59 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -168.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.2 t -120.11 158.8 26.13 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 178.08 171.53 41.55 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-O 121.571 0.539 . . . . 0.0 112.695 172.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.35 -172.67 40.44 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.971 1.748 . . . . 0.0 109.425 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.561 HG22 ' H ' ' A' ' 82' ' ' VAL . 6.2 p -146.67 -174.94 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 124.548 1.139 . . . . 0.0 109.196 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.561 ' H ' HG22 ' A' ' 81' ' ' VAL . 25.3 m -133.81 -164.75 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 126.089 1.756 . . . . 0.0 109.675 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -148.57 100.51 3.13 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 160.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -151.1 22.22 0.98 Allowed Glycine 0 C--O 1.228 -0.266 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -170.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -82.19 57.45 3.58 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 122.771 1.272 . . . . 0.0 110.022 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.8 t0 45.42 36.32 2.35 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.309 2.244 . . . . 0.0 112.17 -173.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.22 14.59 78.64 Favored Glycine 0 C--N 1.337 0.587 0 CA-C-O 118.455 -1.192 . . . . 0.0 113.461 171.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.9 p -58.0 131.34 21.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 120.028 1.914 . . . . 0.0 109.117 173.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.7 t -90.71 138.05 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 171.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -145.04 -154.69 0.55 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.877 2.471 . . . . 0.0 106.341 -177.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -111.21 165.46 12.69 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 124.994 1.318 . . . . 0.0 108.743 168.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.79 -179.54 4.31 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 121.866 1.711 . . . . 0.0 113.618 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.8 ptm -138.01 174.3 10.72 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.945 0.898 . . . . 0.0 111.115 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -141.86 162.17 36.14 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.723 1.209 . . . . 0.0 109.729 175.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -128.47 108.64 10.71 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 126.485 1.914 . . . . 0.0 106.543 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.4 t -96.69 109.44 23.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.2 m -131.37 135.34 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.555 1.142 . . . . 0.0 109.25 -162.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.5 m -143.1 155.68 44.64 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -171.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.25 130.37 54.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -121.52 160.8 23.49 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 127.196 2.198 . . . . 0.0 109.396 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.43 -161.13 0.74 Allowed 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 127.334 2.254 . . . . 0.0 108.981 -172.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -62.83 20.84 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.386 1.874 . . . . 0.0 112.992 162.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 133.03 46.35 0.11 Allowed Glycine 0 C--N 1.34 0.759 0 O-C-N 120.187 -1.571 . . . . 0.0 113.725 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.403 ' HE2' ' O ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -170.3 154.92 5.02 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 125.769 1.627 . . . . 0.0 108.497 160.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.403 ' O ' ' HE2' ' A' ' 104' ' ' LYS . 33.7 tt0 -72.71 146.86 46.18 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.481 1.113 . . . . 0.0 108.271 165.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.32 -29.86 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 117.981 -1.009 . . . . 0.0 111.617 170.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -131.64 147.18 52.5 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 120.395 1.452 . . . . 0.0 109.278 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.6 ptmm? -148.99 91.1 1.82 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 -164.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -129.05 171.41 12.4 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 123.564 1.65 . . . . 0.0 111.762 -168.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.4 t -148.11 165.74 29.93 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 111.963 -2.38 . . . . 0.0 105.252 162.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.5 mt -144.06 160.58 40.63 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.902 2.081 . . . . 0.0 108.045 168.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 p -126.35 123.16 62.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 125.426 1.491 . . . . 0.0 108.205 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.426 ' CD1' HG12 ' A' ' 81' ' ' VAL . 95.0 m-85 -111.64 147.48 35.42 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 175.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.9 mtm105 -141.17 166.66 24.18 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.186 0.517 . . . . 0.0 110.932 -176.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -65.5 169.8 5.67 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 125.535 1.534 . . . . 0.0 111.873 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 151.2 -78.21 0.22 Allowed Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt -171.8 171.72 5.1 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 127.141 2.176 . . . . 0.0 110.069 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -51.14 138.78 19.51 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.661 1.985 . . . . 0.0 110.771 166.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.2 pp -154.12 -178.02 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 127.784 2.434 . . . . 0.0 107.312 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.6 p -133.47 103.63 6.02 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.106 1.762 . . . . 0.0 107.019 173.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 25.6 p -127.49 117.79 22.77 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.13 66.28 0.27 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 158.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -72.45 -28.43 62.93 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.347 -0.846 . . . . 0.0 111.474 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 16.2 tp -111.08 131.18 55.29 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 165.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.13 36.42 0.68 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.062 1.745 . . . . 0.0 110.935 -168.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.8 mt -83.65 155.15 23.33 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.293 1.037 . . . . 0.0 110.985 -171.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -160.36 156.79 26.79 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 126.674 1.989 . . . . 0.0 111.635 169.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -151.52 160.49 43.67 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 127.288 2.235 . . . . 0.0 110.04 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.4 p30 . . . . . 0 C--O 1.245 0.866 0 C-N-CA 123.288 0.635 . . . . 0.0 110.384 161.694 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.671 0 N-CA-C 104.729 -3.348 . . . . 0.0 104.729 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -140.64 60.01 1.54 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 103.194 -2.891 . . . . 0.0 103.194 -148.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -143.87 156.03 44.31 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.689 2.395 . . . . 0.0 104.545 -142.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -138.74 121.74 16.71 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 125.177 1.391 . . . . 0.0 111.797 -163.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.39 60.46 3.14 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 124.835 1.254 . . . . 0.0 111.383 -171.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -69.73 97.97 0.66 Allowed 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 121.601 1.534 . . . . 0.0 112.837 -172.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.1 13.42 58.79 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.522 -0.763 . . . . 0.0 114.187 -176.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -130.27 -49.67 0.12 Allowed Glycine 0 CA--C 1.526 0.739 0 CA-C-N 119.286 1.543 . . . . 0.0 113.368 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.6 mttt -124.09 109.77 13.89 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -163.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.38 84.08 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 CA-C-O 119.021 -0.877 . . . . 0.0 112.736 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -118.09 128.67 54.97 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 160.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.419 ' H ' ' HB3' ' A' ' 102' ' ' ASN . 17.2 mtp -78.9 160.53 27.24 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 147.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -132.97 146.32 51.67 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 170.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -148.7 121.41 8.64 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.847 1.259 . . . . 0.0 107.713 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.3 p -101.49 151.16 5.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 125.351 1.46 . . . . 0.0 108.146 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.0 p -123.68 162.74 22.48 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 122.702 1.239 . . . . 0.0 109.448 165.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.487 HD11 ' CG ' ' A' ' 95' ' ' TRP . 6.0 tp -133.0 144.64 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 159.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -134.69 98.31 4.02 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 103.803 -2.666 . . . . 0.0 103.803 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -81.29 108.7 15.14 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -133.95 164.86 26.34 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 118.688 0.676 . . . . 0.0 112.469 172.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.76 -176.37 11.3 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -145.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -75.83 120.79 21.67 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.357 -1.084 . . . . 0.0 110.906 -168.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -109.78 19.08 19.52 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 120.049 1.295 . . . . 0.0 112.269 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -81.61 -10.54 59.4 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -172.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.4 p -128.14 25.86 5.82 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.757 1.623 . . . . 0.0 113.721 -169.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -125.62 168.18 14.07 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 119.312 -2.118 . . . . 0.0 110.076 -165.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.7 mp -120.62 89.01 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.516 ' HB3' HD13 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -71.67 147.26 47.65 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 120.971 -1.081 . . . . 0.0 109.55 -179.436 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.28 129.16 17.36 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.665 1.986 . . . . 0.0 105.909 170.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.8 t -131.15 126.5 59.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 160.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -91.85 130.07 41.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 167.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.264 12.6 p -134.27 150.67 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 120.243 1.383 . . . . 0.0 110.509 167.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.41 HG22 ' HB3' ' A' ' 51' ' ' PRO . 83.8 t -135.18 158.83 41.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 127.728 2.411 . . . . 0.0 104.524 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.73 127.77 20.75 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 156.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -77.85 115.8 17.87 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 171.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.02 -9.76 22.99 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 118.452 -1.193 . . . . 0.0 115.309 159.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.5 t -157.07 -173.15 4.31 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.252 1.526 . . . . 0.0 110.219 -176.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -96.2 177.03 5.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.882 1.273 . . . . 0.0 110.277 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -117.33 161.94 18.72 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 127.122 2.169 . . . . 0.0 107.897 -169.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -139.03 128.51 24.38 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -170.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -80.46 113.78 18.89 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.12 9.02 58.91 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.056 -0.858 . . . . 0.0 113.578 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.36 -64.44 0.92 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 119.664 1.732 . . . . 0.0 108.267 157.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.85 -20.12 3.2 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.31 0.644 . . . . 0.0 111.852 -156.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.98 46.83 2.36 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 124.692 1.139 . . . . 0.0 110.96 175.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -100.32 132.21 45.82 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 p -76.75 131.18 38.59 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.3 mt -121.63 168.63 11.55 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 126.464 1.905 . . . . 0.0 108.983 -176.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -123.47 109.57 14.0 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.652 1.981 . . . . 0.0 107.985 -167.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.8 165.11 28.03 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -174.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.41 ' HB3' HG22 ' A' ' 33' ' ' VAL . 64.1 Cg_endo -70.45 172.25 52.59 Favored 'Cis proline' 0 C--N 1.348 0.546 0 C-N-CA 124.694 -0.961 . . . . 0.0 110.027 -18.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.4 p -148.86 148.16 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 121.482 0.658 . . . . 0.0 109.77 -174.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.4 mm -116.74 112.27 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 104.767 -2.309 . . . . 0.0 104.767 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -76.34 99.86 4.95 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 162.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 75.6 m -91.7 -175.62 4.22 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 173.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -63.04 -24.92 68.14 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -166.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -64.93 -47.59 77.16 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.192 1.397 . . . . 0.0 109.878 173.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -74.11 -13.74 60.87 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.168 0.987 . . . . 0.0 111.027 -174.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.516 HD13 ' HB3' ' A' ' 28' ' ' LYS . 14.0 mt -116.79 19.55 14.4 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.991 1.716 . . . . 0.0 111.048 -175.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.73 13.54 0.36 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.006 1.722 . . . . 0.0 113.418 174.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.6 HG23 HG22 ' A' ' 64' ' ' VAL . 0.9 OUTLIER -131.29 160.17 42.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 127.338 2.255 . . . . 0.0 109.257 -162.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.79 -32.1 73.5 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.975 0.91 . . . . 0.0 113.032 -176.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -163.94 121.16 1.74 Allowed 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -158.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.6 HG22 HG23 ' A' ' 61' ' ' VAL . 1.8 t -132.1 93.17 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -170.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.3 m -82.35 130.2 35.05 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 175.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -130.95 146.48 52.37 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 176.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.4 t -145.75 171.46 14.73 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.342 0.657 . . . . 0.0 110.114 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.5 p -79.14 165.45 23.31 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.493 0.664 . . . . 0.0 110.165 168.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 61.1 p -89.85 1.17 56.51 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.522 -0.736 . . . . 0.0 111.439 166.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -172.53 -163.52 26.49 Favored Glycine 0 N--CA 1.444 -0.794 0 O-C-N 120.926 -1.109 . . . . 0.0 113.806 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.34 119.3 3.95 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 128.47 2.708 . . . . 0.0 109.663 171.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.494 ' C ' HD13 ' A' ' 73' ' ' ILE . . . -125.38 167.15 15.35 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.465 0.706 . . . . 0.0 110.455 175.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.494 HD13 ' C ' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -125.71 -3.06 5.32 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 C-N-CA 124.354 1.062 . . . . 0.0 110.861 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 129' ' ' ASN . 60.9 mt-10 -151.52 162.71 40.5 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 119.736 1.153 . . . . 0.0 109.823 171.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -161.47 72.3 0.41 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.347 1.459 . . . . 0.0 109.108 176.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.27 144.09 55.0 Favored 'General case' 0 C--N 1.333 -0.144 0 O-C-N 121.735 -0.603 . . . . 0.0 110.198 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 64.9 t -142.06 114.04 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 126.643 1.977 . . . . 0.0 106.526 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.9 m -129.13 158.85 37.82 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.003 0.921 . . . . 0.0 108.649 171.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 154.08 -172.44 32.72 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-N 118.569 0.622 . . . . 0.0 111.777 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.75 173.4 41.43 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.355 1.455 . . . . 0.0 111.375 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -147.92 134.34 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.345 1.458 . . . . 0.0 110.651 172.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.419 HG21 HG13 ' A' ' 119' ' ' ILE . 0.6 OUTLIER -141.23 155.06 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 126.342 1.857 . . . . 0.0 110.387 159.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -53.91 121.87 8.88 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 127.907 2.483 . . . . 0.0 108.133 -174.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.83 -4.72 85.92 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 118.47 -1.183 . . . . 0.0 113.61 -173.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -135.38 172.26 13.26 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.184 1.492 . . . . 0.0 112.115 -162.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -138.32 32.52 2.33 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 127.28 2.232 . . . . 0.0 108.908 -175.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -151.24 -6.02 0.16 Allowed Glycine 0 CA--C 1.52 0.35 0 CA-C-O 118.375 -1.236 . . . . 0.0 113.822 -170.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.4 t -129.81 83.41 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 CA-C-N 120.023 1.912 . . . . 0.0 106.773 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.8 t -59.96 98.96 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.796 1.238 . . . . 0.0 107.738 176.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -112.98 161.29 17.2 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 126.872 2.069 . . . . 0.0 109.841 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -74.32 152.1 87.9 Favored Pre-proline 0 C--O 1.224 -0.255 0 CA-C-O 118.77 -0.633 . . . . 0.0 109.453 169.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -81.65 -179.35 4.82 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.342 2.028 . . . . 0.0 113.985 -172.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 6.5 ptm -133.82 168.6 18.45 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.221 1.01 . . . . 0.0 111.786 -166.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -140.56 153.51 46.16 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 126.702 2.001 . . . . 0.0 107.443 170.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.487 ' CG ' HD11 ' A' ' 17' ' ' ILE . 3.9 m0 -116.17 114.61 24.69 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 103.943 -2.614 . . . . 0.0 103.943 172.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.9 t -94.23 127.02 46.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 164.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 m -139.26 94.02 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 -163.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.7 m -95.57 164.94 12.58 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.8 t -135.61 122.86 35.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 164.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -96.05 156.81 16.18 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 125.93 1.692 . . . . 0.0 107.744 168.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.465 ' HG2' HD22 ' A' ' 102' ' ' ASN . 31.4 tttt -108.72 -162.48 0.82 Allowed 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.505 1.922 . . . . 0.0 106.956 171.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.465 HD22 ' HG2' ' A' ' 101' ' ' LYS . 0.9 OUTLIER -63.02 82.83 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.268 1.827 . . . . 0.0 109.396 170.425 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.34 16.31 59.13 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.459 1.504 . . . . 0.0 115.146 167.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -153.35 168.92 24.42 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.633 1.717 . . . . 0.0 111.368 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -97.91 135.25 39.9 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.426 1.491 . . . . 0.0 108.823 176.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.21 -14.52 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.72 1.145 . . . . 0.0 113.859 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -129.9 153.42 48.34 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 173.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.9 tttm -160.39 78.77 0.65 Allowed 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.4 169.4 11.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.566 0.698 . . . . 0.0 110.435 177.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.4 t -156.84 155.24 31.16 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.628 ' N ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -131.03 -174.56 3.41 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 125.906 1.682 . . . . 0.0 107.078 179.461 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.4 p -167.87 119.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 126.308 1.843 . . . . 0.0 108.515 -158.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.411 ' CE2' HD11 ' A' ' 119' ' ' ILE . 0.3 OUTLIER -143.4 167.96 20.95 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.555 -0.716 . . . . 0.0 110.353 171.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -144.26 173.83 11.42 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.23 1.412 . . . . 0.0 108.704 -173.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.26 141.6 4.51 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 126.949 2.1 . . . . 0.0 111.233 164.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 108.6 8.66 28.17 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-O 118.525 -1.153 . . . . 0.0 115.331 157.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -138.63 93.22 2.7 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 119.651 1.725 . . . . 0.0 111.715 -174.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -64.34 100.12 0.33 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.779 0.832 . . . . 0.0 111.624 169.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.419 HG13 HG21 ' A' ' 82' ' ' VAL . 2.5 pp -145.57 174.58 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 128.105 2.562 . . . . 0.0 107.696 -178.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -168.78 7.24 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 168.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.0 p -135.78 30.47 3.11 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 125.097 1.359 . . . . 0.0 110.396 -166.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -153.12 56.94 0.78 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.39 -83.37 0.37 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -177.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 mt -113.15 128.02 56.36 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.304 1.042 . . . . 0.0 111.598 -175.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -139.75 82.84 1.9 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 128.473 2.709 . . . . 0.0 106.6 174.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.2 mp -120.01 128.57 53.66 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.854 1.262 . . . . 0.0 107.875 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.5 72.34 1.38 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -176.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -74.6 150.09 39.81 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.284 175.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 31.8 p-10 . . . . . 0 C--O 1.257 1.466 0 C-N-CA 126.738 2.015 . . . . 0.0 109.989 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.676 0 N-CA-C 108.033 -2.027 . . . . 0.0 108.033 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.0 t70 74.19 108.82 0.07 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 104.017 -2.586 . . . . 0.0 104.017 -131.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -143.53 154.26 43.44 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 -157.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -145.7 155.77 43.2 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 125.858 1.663 . . . . 0.0 107.755 -158.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -157.15 86.6 2.76 Favored Pre-proline 0 C--O 1.237 0.412 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -64.46 149.15 90.51 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 120.693 0.929 . . . . 0.0 109.898 173.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 162.33 62.45 0.02 OUTLIER Glycine 0 C--N 1.333 0.373 0 N-CA-C 115.949 1.14 . . . . 0.0 115.949 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.68 -102.77 0.18 Allowed Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 164.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -162.97 154.32 17.44 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.026 1.731 . . . . 0.0 107.207 -175.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.66 -147.0 4.96 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.384 1.945 . . . . 0.0 109.28 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.97 177.55 9.05 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.062 1.431 . . . . 0.0 111.335 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.11 150.96 21.83 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.366 1.866 . . . . 0.0 108.723 157.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.52 ' HE1' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -157.44 134.69 10.34 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 128.428 2.691 . . . . 0.0 109.664 178.339 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -127.33 137.58 52.83 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 128.199 2.599 . . . . 0.0 104.96 169.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.1 p -110.16 150.14 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 165.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.0 p -124.03 159.53 29.66 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 164.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 tp -129.1 135.23 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 C-N-CA 127.94 2.496 . . . . 0.0 105.645 168.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -111.03 138.7 47.11 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 155.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -121.67 116.53 24.72 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 m -143.76 171.76 13.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 118.335 0.516 . . . . 0.0 110.985 -172.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.71 -95.18 2.07 Favored Glycine 0 C--N 1.334 0.453 0 N-CA-C 105.066 -3.214 . . . . 0.0 105.066 -164.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -142.19 173.33 11.62 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.495 1.518 . . . . 0.0 107.448 165.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -157.71 8.33 0.16 Allowed 'General case' 0 C--N 1.328 -0.361 0 O-C-N 120.852 -1.155 . . . . 0.0 112.173 169.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -54.95 -41.74 71.48 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.478 1.111 . . . . 0.0 113.297 -172.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 m -128.37 51.89 1.95 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.623 1.169 . . . . 0.0 109.788 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.414 ' HB3' HG21 ' A' ' 81' ' ' VAL . 28.4 m-85 -122.85 107.97 12.47 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -176.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 51.3 mt -73.22 88.64 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 125.515 1.526 . . . . 0.0 108.481 -168.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.4 pttm -112.41 125.32 54.08 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.414 1.485 . . . . 0.0 110.351 -166.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.6 m -127.95 159.7 34.15 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.728 1.211 . . . . 0.0 109.317 168.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 85.8 t -140.45 133.68 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.4 t -84.88 135.79 24.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 125.731 1.612 . . . . 0.0 107.196 169.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.6 t -136.58 128.26 43.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 168.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.3 t -138.65 119.4 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.96 156.22 36.77 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 167.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -118.83 119.49 34.52 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.737 1.615 . . . . 0.0 109.613 -175.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.24 -6.81 56.27 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.769 1.176 . . . . 0.0 114.857 161.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.407 ' CG2' ' HB2' ' A' ' 72' ' ' ALA . 14.7 t -140.67 -164.14 1.67 Allowed 'General case' 0 C--O 1.242 0.695 0 C-N-CA 126.548 1.939 . . . . 0.0 107.813 -176.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -122.05 177.49 5.3 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 120.904 -1.123 . . . . 0.0 109.308 174.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.83 167.58 10.38 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 125.038 1.335 . . . . 0.0 109.013 -173.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -136.67 114.12 10.92 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.225 1.01 . . . . 0.0 108.53 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -69.23 127.05 31.69 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.62 -22.43 69.82 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-O 118.226 -1.319 . . . . 0.0 113.85 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.07 -51.7 68.59 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 119.505 1.653 . . . . 0.0 110.322 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.81 -9.35 1.6 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.955 0.902 . . . . 0.0 111.552 -160.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.6 13.22 80.51 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.262 0.934 . . . . 0.0 112.506 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -55.1 123.56 14.04 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.901 1.681 . . . . 0.0 108.699 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.83 104.35 12.14 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.8 mt -85.7 163.16 18.41 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.699 0.8 . . . . 0.0 109.483 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.95 109.92 17.64 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.604 1.962 . . . . 0.0 106.243 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 66.2 m -82.36 151.33 65.62 Favored Pre-proline 0 C--N 1.323 -0.55 0 C-N-CA 126.895 2.078 . . . . 0.0 111.913 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.61 163.87 89.43 Favored 'Cis proline' 0 CA--C 1.535 0.561 0 CA-C-N 119.13 0.725 . . . . 0.0 111.658 -1.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 p -156.61 157.87 3.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 123.607 0.763 . . . . 0.0 109.758 170.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.9 mm -116.15 116.37 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 125.896 1.678 . . . . 0.0 107.082 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.8 mt -71.94 145.29 48.54 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 165.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 m -108.59 176.77 5.0 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.24 171.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -58.39 -22.96 55.78 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.611 1.964 . . . . 0.0 112.665 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -66.18 -27.29 67.88 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.147 1.779 . . . . 0.0 112.47 175.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -100.76 -24.06 14.48 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.637 1.575 . . . . 0.0 110.463 -171.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.7 mt -97.72 15.82 22.47 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.673 1.989 . . . . 0.0 110.297 -175.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.46 14.57 0.17 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.907 1.683 . . . . 0.0 114.278 -175.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.7 m -128.03 170.91 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 126.919 2.088 . . . . 0.0 111.008 -162.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -76.36 -20.43 57.21 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.055 0.942 . . . . 0.0 112.651 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.14 133.78 16.68 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.599 1.56 . . . . 0.0 110.006 -168.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.5 t -140.04 82.37 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.415 0.626 . . . . 0.0 110.209 173.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 90.4 m -73.44 130.54 40.33 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.74 1.216 . . . . 0.0 109.436 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -132.4 129.56 39.5 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.548 1.067 . . . . 0.0 109.112 175.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.0 t -141.28 168.18 20.39 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.768 1.627 . . . . 0.0 108.481 175.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.33 153.77 18.99 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 123.961 0.904 . . . . 0.0 110.231 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.3 p -83.33 11.48 6.68 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.726 1.21 . . . . 0.0 112.063 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 173.34 -172.49 45.22 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 173.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.61 141.28 48.67 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.671 1.236 . . . . 0.0 109.165 174.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.52 ' HB3' ' HE1' ' A' ' 13' ' ' TYR . . . -124.75 178.38 5.5 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.496 1.118 . . . . 0.0 108.547 172.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.2 mm -116.13 -11.61 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.863 0.865 . . . . 0.0 111.113 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -143.89 156.2 44.36 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.366 1.066 . . . . 0.0 108.746 169.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -145.08 103.28 3.85 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 160.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.86 122.12 46.92 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.12 121.94 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 C-N-CA 127.752 2.421 . . . . 0.0 109.162 -171.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.1 t -147.56 153.16 39.1 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -169.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.76 -177.02 43.44 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 171.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.05 176.41 38.47 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 106.196 -2.762 . . . . 0.0 106.196 167.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.414 HG21 ' HB3' ' A' ' 26' ' ' PHE . 7.2 p -156.37 155.92 5.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 166.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.01 172.93 10.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 125.613 1.565 . . . . 0.0 107.635 168.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.91 136.44 47.19 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 160.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -107.2 -12.53 23.4 Favored Glycine 0 C--N 1.322 -0.214 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 170.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -93.37 162.03 14.15 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -159.69 66.69 0.38 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 173.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 160.33 -13.7 0.18 Allowed Glycine 0 CA--C 1.531 1.065 0 N-CA-C 115.474 0.95 . . . . 0.0 115.474 -167.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.0 p -122.36 136.4 59.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-N 119.782 1.791 . . . . 0.0 107.495 165.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.99 119.5 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 124.48 1.112 . . . . 0.0 108.402 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -139.36 138.36 36.53 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 171.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.75 154.46 94.3 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 119.409 -0.329 . . . . 0.0 110.117 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -84.6 -175.99 2.33 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.29 2.66 . . . . 0.0 112.792 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 19.5 ptm -148.03 176.19 10.39 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.339 -0.851 . . . . 0.0 113.254 -160.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -142.3 157.18 45.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.462 1.905 . . . . 0.0 108.39 169.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 21.9 m0 -116.23 122.07 43.91 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 162.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.274 7.1 p -116.69 103.92 15.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 168.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.0 m -97.53 168.91 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.46 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.2 m -156.2 147.37 22.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.7 t -121.46 132.04 71.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -119.31 117.01 27.42 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.868 1.667 . . . . 0.0 107.246 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.3 tptt -74.8 -164.73 0.31 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.414 1.886 . . . . 0.0 108.784 172.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.17 79.93 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.037 2.535 . . . . 0.0 108.769 173.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.16 36.77 50.33 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.178 1.371 . . . . 0.0 114.133 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -157.32 152.5 26.05 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 118.199 1.0 . . . . 0.0 109.651 164.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -77.98 140.28 39.19 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 166.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 3.0 pt -130.92 -17.43 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -148.92 144.32 26.77 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -174.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -148.14 39.27 0.91 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -174.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.04 148.52 41.88 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.683 -1.261 . . . . 0.0 111.964 -173.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.9 p -122.04 153.16 38.98 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 127.575 2.35 . . . . 0.0 109.138 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.0 mt -131.9 170.47 14.83 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.237 1.415 . . . . 0.0 109.3 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 t -146.44 146.8 18.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 124.719 1.208 . . . . 0.0 108.406 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.409 ' CE2' HG21 ' A' ' 121' ' ' THR . 12.2 m-85 -139.5 145.19 38.44 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 152.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -140.79 103.89 4.59 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 172.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 14.9 t0 58.59 -175.9 0.08 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.259 1.424 . . . . 0.0 111.405 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 137.45 -63.85 0.57 Allowed Glycine 0 CA--C 1.5 -0.902 0 C-N-CA 126.328 1.918 . . . . 0.0 109.728 160.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.19 169.79 0.22 Allowed 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 129.066 2.947 . . . . 0.0 108.059 167.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.453 ' O ' HG23 ' A' ' 119' ' ' ILE . 0.0 OUTLIER -56.32 141.72 40.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 125.168 1.387 . . . . 0.0 110.774 156.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 118' ' ' GLU . 2.1 pp -165.37 -172.83 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 129.925 3.29 . . . . 0.0 105.377 173.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.5 p -114.43 156.69 24.05 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 154.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.409 HG21 ' CE2' ' A' ' 113' ' ' PHE . 14.6 t -153.01 150.76 29.53 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -116.07 30.43 7.35 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 125.281 1.432 . . . . 0.0 108.085 -169.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -61.68 -36.19 80.16 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 128.124 2.57 . . . . 0.0 111.387 -168.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.9 tt -89.74 115.45 27.11 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 162.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -139.6 113.36 8.61 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 167.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 62.9 mt -139.62 115.2 10.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -177.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -134.2 129.7 36.13 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -141.51 163.07 33.91 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.453 1.501 . . . . 0.0 108.549 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 117.013 -1.47 . . . . 0.0 111.071 -174.418 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.212 0 N-CA-C 107.849 -2.1 . . . . 0.0 107.849 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.2 t0 61.21 90.37 0.07 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 -111.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -150.67 112.68 4.56 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 128.358 2.663 . . . . 0.0 103.962 -168.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -158.78 125.35 4.67 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 120.352 1.433 . . . . 0.0 108.249 170.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -153.82 85.38 4.0 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 127.214 2.206 . . . . 0.0 106.457 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -81.01 176.19 9.16 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.197 2.598 . . . . 0.0 110.103 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -153.7 -127.58 1.19 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 107.516 -2.234 . . . . 0.0 107.516 163.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -106.84 28.1 14.23 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-O 118.796 -1.002 . . . . 0.0 114.37 -174.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -108.74 93.97 4.8 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.932 1.366 . . . . 0.0 110.1 171.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.55 ' HA2' ' HE3' ' A' ' 71' ' ' LYS . . . 118.77 130.44 4.15 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 124.275 0.941 . . . . 0.0 114.792 155.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.51 122.32 36.25 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 163.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 35.3 mtp -75.18 175.01 8.68 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 145.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 75' ' ' PHE . 1.4 p90 -167.57 171.28 10.44 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 125.499 1.52 . . . . 0.0 110.88 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -161.21 105.9 1.33 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.974 1.31 . . . . 0.0 107.565 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.6 p -80.75 158.57 4.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 119.917 -1.739 . . . . 0.0 109.445 166.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.6 p -128.7 158.95 37.16 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.826 1.25 . . . . 0.0 108.132 168.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.54 HD11 ' CD2' ' A' ' 95' ' ' TRP . 3.0 tp -136.85 97.99 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 172.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -75.0 147.17 41.02 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 164.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -118.26 150.25 39.77 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 161.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.0 162.82 34.59 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.54 -153.81 39.58 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -173.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -83.89 76.87 9.99 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 124.9 1.28 . . . . 0.0 109.898 -169.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -75.18 13.07 0.76 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 116.716 -1.611 . . . . 0.0 113.73 -175.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.6 mtt-85 -106.28 5.29 29.6 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 121.465 1.939 . . . . 0.0 114.766 -164.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.0 m -144.48 53.93 1.26 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.822 1.192 . . . . 0.0 111.959 175.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -135.47 137.6 42.32 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.238 1.015 . . . . 0.0 109.746 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.8 mm -78.28 93.67 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.583 1.153 . . . . 0.0 108.812 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -89.87 151.11 21.91 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 121.146 -0.971 . . . . 0.0 109.24 -176.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.1 m -138.79 142.99 38.74 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.347 1.059 . . . . 0.0 109.448 174.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.4 t -138.92 128.04 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 166.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.1 t -107.91 105.83 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 171.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.5 p -117.61 128.93 74.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 125.796 1.639 . . . . 0.0 110.583 -171.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.4 t -133.53 138.24 51.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -175.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.38 107.49 9.55 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 164.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.576 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 24.6 t-20 -63.6 113.98 3.67 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 171.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.66 -12.71 64.46 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.264 1.411 . . . . 0.0 116.108 169.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.9 t -149.82 172.06 15.75 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.351 2.076 . . . . 0.0 110.996 -172.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -89.74 160.85 16.35 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 122.641 1.21 . . . . 0.0 110.525 173.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.91 162.37 16.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 112.894 -1.957 . . . . 0.0 108.145 169.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -123.9 124.76 43.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 171.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -74.48 120.59 20.25 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.13 -20.83 75.25 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 117.636 -1.647 . . . . 0.0 113.695 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.64 -42.1 74.71 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.713 1.756 . . . . 0.0 112.583 -170.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.1 p -126.97 0.57 6.58 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.121 0.873 . . . . 0.0 112.896 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.11 28.63 40.42 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 123.812 0.72 . . . . 0.0 111.471 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -77.72 172.35 13.56 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.12 1.368 . . . . 0.0 109.055 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.8 t -123.73 130.73 53.09 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.648 0.737 . . . . 0.0 110.084 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 49.8 mt -118.91 121.32 39.69 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.362 -1.745 . . . . 0.0 108.864 -163.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.95 92.19 1.61 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.5 p -73.5 165.11 55.9 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-O 118.332 -0.842 . . . . 0.0 109.995 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -60.74 149.61 50.16 Favored 'Cis proline' 0 N--CA 1.452 -0.958 0 CA-C-N 120.354 1.162 . . . . 0.0 110.673 -13.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.4 p -142.31 158.71 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.8 mm -114.83 117.11 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 104.215 -2.513 . . . . 0.0 104.215 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 64.3 mt -77.69 159.9 28.83 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 169.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.5 m -138.82 -173.52 3.59 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.523 1.529 . . . . 0.0 108.256 -176.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -55.85 -41.3 74.13 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.407 1.483 . . . . 0.0 113.138 -174.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -67.19 -39.33 86.35 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.234 1.014 . . . . 0.0 111.133 -176.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -67.68 -22.51 65.28 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.729 0.812 . . . . 0.0 110.281 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 16.6 mt -115.82 20.12 14.75 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.664 1.985 . . . . 0.0 111.259 -173.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.15 3.89 7.86 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.667 1.187 . . . . 0.0 113.584 -172.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.3 m -122.8 167.13 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.539 1.536 . . . . 0.0 111.105 -165.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -57.08 -23.09 44.3 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.64 134.68 5.37 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 117.157 -1.401 . . . . 0.0 108.92 -168.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.0 t -126.45 161.94 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 164.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.4 m -142.04 127.21 18.54 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.989 1.715 . . . . 0.0 106.901 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -128.75 132.21 47.92 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.6 t -148.41 164.5 33.93 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 126.346 1.859 . . . . 0.0 106.601 -169.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.5 p -97.37 157.74 15.82 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 122.976 1.369 . . . . 0.0 112.869 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.6 p -76.2 -25.24 54.95 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.326 171.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -152.17 -169.11 17.21 Favored Glycine 0 CA--C 1.531 1.074 0 O-C-N 120.879 -1.138 . . . . 0.0 112.025 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.585 ' HE2' ' CD1' ' A' ' 73' ' ' ILE . 71.8 tttt -48.17 139.34 8.5 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 168.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -125.04 178.48 5.51 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 161.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.585 ' CD1' ' HE2' ' A' ' 71' ' ' LYS . 5.1 mm -111.43 -15.16 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.722 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.576 ' HG2' ' HB2' ' A' ' 35' ' ' ASN . 7.6 pt-20 -156.82 159.42 38.22 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -174.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.42 ' HB2' ' CE2' ' A' ' 13' ' ' TYR . 11.6 t80 -146.88 104.58 3.72 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.044 1.738 . . . . 0.0 109.738 165.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.41 148.19 22.48 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 118.548 -0.739 . . . . 0.0 109.724 176.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 t -149.17 112.65 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 124.97 1.308 . . . . 0.0 108.719 176.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.4 p -131.63 171.36 13.55 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 120.047 -1.658 . . . . 0.0 110.2 167.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 164.88 -99.05 0.16 Allowed Glycine 0 C--N 1.333 0.401 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 168.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.17 -175.3 15.7 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.371 0.986 . . . . 0.0 111.1 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.98 93.39 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.0 p -75.29 148.78 7.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 161.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.17 153.7 17.95 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.926 1.69 . . . . 0.0 107.601 166.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -125.48 13.2 7.39 Favored Glycine 0 N--CA 1.457 0.096 0 CA-C-O 117.724 -1.598 . . . . 0.0 112.99 -172.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -126.9 -179.17 4.69 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 118.834 1.317 . . . . 0.0 110.645 -176.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -169.26 125.53 0.9 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 125.999 1.72 . . . . 0.0 106.903 -169.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.86 -8.52 69.34 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.234 -0.759 . . . . 0.0 113.102 173.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.9 m -58.56 165.46 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.463 1.105 . . . . 0.0 110.052 168.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.3 t -124.95 78.62 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -102.42 179.31 4.34 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 125.332 1.453 . . . . 0.0 109.98 -170.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -109.2 162.96 18.14 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 123.482 0.713 . . . . 0.0 109.707 162.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -82.67 174.01 9.98 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.615 2.21 . . . . 0.0 112.637 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.3 ptm -143.9 163.25 33.97 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.574 0.749 . . . . 0.0 112.365 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -133.64 162.06 32.96 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.116 1.766 . . . . 0.0 109.617 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.54 ' CD2' HD11 ' A' ' 17' ' ' ILE . 2.4 m0 -127.52 150.42 49.69 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 125.922 1.689 . . . . 0.0 107.523 171.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.3 t -128.21 134.77 64.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 159.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 m -135.84 70.29 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -168.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.6 m -85.49 138.4 32.24 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -173.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.6 t -113.1 120.62 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -103.84 157.17 17.27 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 122.944 1.354 . . . . 0.0 108.325 168.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -116.34 176.62 5.02 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 130.127 3.371 . . . . 0.0 105.955 172.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -47.96 87.68 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 129.395 3.078 . . . . 0.0 108.941 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.4 58.64 10.5 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.133 1.349 . . . . 0.0 114.604 -171.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.83 154.09 6.2 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.045 1.922 . . . . 0.0 109.893 150.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -73.12 143.02 47.5 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.573 1.149 . . . . 0.0 108.906 165.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.1 pt -135.48 5.28 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 119.092 0.86 . . . . 0.0 113.065 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -152.73 160.15 43.13 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 120.548 -1.345 . . . . 0.0 108.522 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.9 tttm -158.09 86.71 0.9 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.176 0.898 . . . . 0.0 110.941 168.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.08 158.04 34.79 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 121.452 -0.78 . . . . 0.0 110.849 168.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.18 160.05 42.05 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 129.517 3.127 . . . . 0.0 107.46 177.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.9 mt -126.09 154.73 42.67 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.241 1.016 . . . . 0.0 108.297 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.5 p -136.31 130.57 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -129.66 173.6 10.47 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.239 1.015 . . . . 0.0 108.715 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 12.5 mtm180 -136.64 12.26 3.19 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.506 1.922 . . . . 0.0 111.739 -166.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.9 t70 63.49 170.61 0.16 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.228 2.211 . . . . 0.0 111.636 -163.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 51.58 54.83 22.81 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 127.813 2.625 . . . . 0.0 115.579 170.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.8 mmtt -154.59 125.74 7.28 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 118.995 1.398 . . . . 0.0 112.255 -176.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -56.47 159.86 3.47 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.964 1.706 . . . . 0.0 111.101 159.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.74 159.5 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 125.247 1.419 . . . . 0.0 109.307 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.72 28.55 0.05 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.505 1.122 . . . . 0.0 111.074 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 20.9 p -104.43 171.32 7.4 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.14 1.376 . . . . 0.0 110.089 -170.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -83.08 28.77 0.5 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.427 1.091 . . . . 0.0 110.576 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -52.52 -40.03 61.99 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.796 1.638 . . . . 0.0 111.461 -170.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.46 91.82 2.58 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -153.65 81.72 1.16 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.866 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mp -114.85 146.87 40.61 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 126.692 1.997 . . . . 0.0 110.54 -173.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.99 110.25 3.73 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 177.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -115.16 117.19 29.82 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--O 1.246 0.883 0 C-N-CA 124.293 1.037 . . . . 0.0 110.039 -179.608 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.809 0 N-CA-C 106.412 -2.675 . . . . 0.0 106.412 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -145.31 115.94 7.68 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 -169.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -153.4 80.46 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 -163.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -159.38 147.24 17.41 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.535 1.534 . . . . 0.0 107.649 -159.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -154.21 69.37 6.13 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 124.146 0.978 . . . . 0.0 109.805 167.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.44 132.72 32.17 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.815 1.677 . . . . 0.0 112.826 -174.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.31 -98.65 0.15 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.738 1.637 . . . . 0.0 110.36 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 103.26 157.08 24.95 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 124.85 1.214 . . . . 0.0 111.525 166.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -132.23 137.07 47.41 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -177.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.56 -130.72 2.19 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 128.114 2.768 . . . . 0.0 108.185 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -154.02 -157.01 0.73 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.696 1.198 . . . . 0.0 109.659 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 37.3 mtp -121.61 161.5 22.32 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 154.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -133.9 152.02 51.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 123.836 0.71 . . . . 0.0 109.477 167.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -147.63 121.47 9.32 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.7 p -123.05 145.95 29.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 124.854 1.262 . . . . 0.0 108.868 -168.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 73.3 p -118.0 162.67 17.78 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 122.186 0.993 . . . . 0.0 110.647 174.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.1 tp -144.73 90.92 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 165.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.532 ' HB2' HG13 ' A' ' 96' ' ' VAL . 31.5 mt-10 -75.56 132.97 41.05 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 162.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -112.43 111.26 21.99 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.705 2.002 . . . . 0.0 106.864 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -87.56 177.95 6.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.836 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.85 -134.2 52.07 Favored Glycine 0 C--N 1.335 0.485 0 C-N-CA 123.201 0.429 . . . . 0.0 112.756 163.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.74 38.78 1.15 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -162.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.432 ' HA ' ' SD ' ' A' ' 93' ' ' MET . 25.0 p90 -55.86 4.19 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 119.699 3.222 . . . . 0.0 119.699 -162.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.67 13.61 17.41 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 126.349 1.859 . . . . 0.0 113.152 -155.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.7 m -150.87 23.19 0.77 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -169.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -135.26 129.89 34.31 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.323 1.049 . . . . 0.0 108.453 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -68.69 93.32 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 119.704 1.138 . . . . 0.0 110.553 -177.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.79 151.37 22.93 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.433 -0.792 . . . . 0.0 110.522 173.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.6 m -140.04 150.49 44.45 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.273 1.829 . . . . 0.0 107.066 170.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.4 t -140.69 115.05 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.89 150.9 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 164.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.8 p -136.1 133.51 50.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 158.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.4 t -114.55 153.15 16.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 170.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.48 159.56 44.39 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.099 0.96 . . . . 0.0 108.547 169.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -125.04 117.09 23.21 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 127.09 2.156 . . . . 0.0 107.075 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.05 -1.29 67.56 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-O 118.365 -1.241 . . . . 0.0 114.607 163.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.617 HG22 ' HB2' ' A' ' 72' ' ' ALA . 1.4 t -159.3 174.91 14.05 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.8 1.8 . . . . 0.0 109.153 174.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -97.75 176.08 5.94 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.263 1.025 . . . . 0.0 111.173 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.37 161.41 13.94 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.337 1.055 . . . . 0.0 109.14 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -133.54 131.61 39.96 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 125.704 1.601 . . . . 0.0 107.227 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -101.22 119.5 38.85 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 123.918 0.761 . . . . 0.0 109.943 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.84 -7.99 5.26 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 118.016 -1.435 . . . . 0.0 114.205 171.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.94 -45.73 82.55 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 120.462 2.131 . . . . 0.0 111.509 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.23 -11.38 0.12 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.821 1.248 . . . . 0.0 112.508 -167.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.3 2.02 55.71 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.507 1.051 . . . . 0.0 112.199 -166.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -63.15 119.27 9.22 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.849 1.324 . . . . 0.0 110.203 -173.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.76 134.82 35.48 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.648 1.579 . . . . 0.0 108.8 172.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 41.3 mt -129.71 169.81 14.62 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.884 1.273 . . . . 0.0 109.384 -173.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.03 101.88 7.96 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 126.36 1.864 . . . . 0.0 108.179 -166.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.4 168.59 23.55 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 125.33 1.452 . . . . 0.0 112.438 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -72.28 141.57 71.27 Favored 'Cis proline' 0 C--N 1.35 0.639 0 N-CA-C 109.559 -0.977 . . . . 0.0 109.559 -8.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.9 p -145.11 161.51 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 121.435 -0.79 . . . . 0.0 110.125 -175.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.4 mm -118.66 114.62 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -177.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -80.5 133.65 35.85 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 169.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.411 ' H ' ' HG2' ' A' ' 58' ' ' GLU . 6.9 m -101.88 -177.91 3.56 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.944 1.697 . . . . 0.0 110.082 -175.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -52.64 -46.3 67.06 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.423 1.489 . . . . 0.0 111.676 -173.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -74.19 -30.25 62.13 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.212 0.605 . . . . 0.0 112.627 -171.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.411 ' HG2' ' H ' ' A' ' 55' ' ' SER . 2.2 mm-40 -67.75 -32.9 73.82 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.266 0.626 . . . . 0.0 109.993 173.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.652 HD13 HG21 ' A' ' 64' ' ' VAL . 3.7 mm? -92.69 7.25 44.34 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.106 1.762 . . . . 0.0 112.373 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.85 45.02 0.68 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.857 1.663 . . . . 0.0 112.488 -170.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.0 m -138.52 170.0 17.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 127.978 2.511 . . . . 0.0 109.537 -175.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -72.57 -24.83 61.16 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.207 -0.933 . . . . 0.0 112.964 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -152.46 145.93 24.88 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.652 HG21 HD13 ' A' ' 59' ' ' LEU . 2.2 t -120.9 153.06 24.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 160.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.401 ' C ' HD22 ' A' ' 66' ' ' LEU . 93.0 m -149.2 135.84 19.51 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 120.148 -1.595 . . . . 0.0 108.551 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.401 HD22 ' C ' ' A' ' 65' ' ' THR . 3.0 mm? -134.8 164.05 28.42 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 125.24 1.416 . . . . 0.0 109.019 -172.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.0 t -152.86 158.53 42.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.783 0.833 . . . . 0.0 108.876 173.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.415 HG21 ' HB3' ' A' ' 72' ' ' ALA . 18.0 p -65.84 138.3 57.79 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.551 1.541 . . . . 0.0 109.205 163.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 74.3 p -75.29 -16.74 60.41 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 120.359 1.436 . . . . 0.0 113.449 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -156.83 -163.8 12.82 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 -174.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.35 115.7 7.29 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.617 ' HB2' HG22 ' A' ' 37' ' ' THR . . . -124.44 176.04 6.74 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.859 1.264 . . . . 0.0 111.312 -173.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.517 HD13 ' O ' ' A' ' 72' ' ' ALA . 0.7 OUTLIER -137.41 5.37 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -172.319 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -147.55 164.55 33.1 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 121.178 1.808 . . . . 0.0 111.982 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -156.41 86.44 1.01 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.324 1.45 . . . . 0.0 107.679 155.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.01 138.89 34.79 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 121.482 -0.761 . . . . 0.0 109.209 166.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.2 t -143.15 130.83 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.8 m -143.71 169.22 18.15 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.051 1.341 . . . . 0.0 108.059 166.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 164.69 -175.15 40.72 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -174.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.8 -175.27 41.46 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 176.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -148.31 162.99 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 126.838 2.055 . . . . 0.0 108.415 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.2 m -119.1 167.25 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 C-N-CA 126.405 1.882 . . . . 0.0 107.671 158.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -114.2 148.59 37.08 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 112.539 -2.119 . . . . 0.0 105.668 138.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -143.96 36.94 1.47 Allowed Glycine 0 C--N 1.318 -0.458 0 C-N-CA 125.505 1.526 . . . . 0.0 111.269 176.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -108.94 149.72 28.78 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.423 0.63 . . . . 0.0 109.468 177.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -148.12 95.18 2.43 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -166.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 121.11 22.22 2.96 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 123.745 0.688 . . . . 0.0 113.337 -171.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.0 m -124.89 -179.66 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.003 1.721 . . . . 0.0 109.064 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.3 t -137.59 86.84 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 174.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -78.09 -178.43 5.58 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.675 1.19 . . . . 0.0 109.494 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -120.77 160.72 43.36 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 125.144 1.378 . . . . 0.0 107.784 157.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -81.17 178.85 6.4 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.077 1.851 . . . . 0.0 112.436 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.432 ' SD ' ' HA ' ' A' ' 23' ' ' PHE . 15.7 ptm -146.28 163.27 36.01 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 122.008 0.908 . . . . 0.0 111.145 173.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -122.82 158.77 29.53 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.394 1.477 . . . . 0.0 107.715 177.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 21.0 m0 -126.64 132.93 51.11 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 176.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 18' ' ' GLU 0.273 2.1 p -130.03 106.97 14.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 179.063 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.0 m -117.75 106.05 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 125.779 1.632 . . . . 0.0 106.98 -166.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.2 m -88.38 160.42 17.59 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 174.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.5 t -125.73 138.38 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 159.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -116.03 151.4 35.57 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 126.904 2.082 . . . . 0.0 107.843 170.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.476 ' HG2' HD22 ' A' ' 102' ' ' ASN . 15.3 tttm -99.69 -172.54 2.26 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 128.986 2.914 . . . . 0.0 107.895 174.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.476 HD22 ' HG2' ' A' ' 101' ' ' LYS . 0.1 OUTLIER -61.82 75.36 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.682 1.593 . . . . 0.0 110.547 167.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.43 42.44 6.95 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.711 1.624 . . . . 0.0 114.292 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -159.21 151.67 21.43 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.351 1.576 . . . . 0.0 108.448 165.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -76.17 137.73 40.23 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 159.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.7 pt -130.12 -18.39 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 118.295 -0.86 . . . . 0.0 113.262 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -143.7 139.23 29.4 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 120.156 1.344 . . . . 0.0 110.062 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -144.94 104.14 3.96 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -174.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -141.8 174.58 10.45 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 173.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.7 t -148.35 159.6 43.84 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.12 1.368 . . . . 0.0 109.271 174.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.3 mt -125.34 164.86 19.46 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.613 1.965 . . . . 0.0 109.001 -176.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.56 86.2 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 125.704 1.602 . . . . 0.0 108.828 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -72.14 173.11 8.98 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 168.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -139.42 171.92 13.57 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 123.039 1.4 . . . . 0.0 110.409 176.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -109.55 164.69 12.29 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 130.154 3.381 . . . . 0.0 110.791 -166.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.38 -76.12 0.79 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 126.701 2.096 . . . . 0.0 110.85 -170.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . 0.292 0.0 OUTLIER -164.76 16.32 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -152.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -131.18 108.24 9.58 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.4 pp -151.8 168.05 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.684 0 C-N-CA 127.829 2.452 . . . . 0.0 108.862 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.7 p -114.48 160.28 19.38 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 122.217 1.008 . . . . 0.0 108.931 162.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 17.2 p -83.57 -7.96 59.42 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.293 1.037 . . . . 0.0 112.434 171.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 50.3 p30 -114.43 15.28 17.94 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -159.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.41 -18.83 64.13 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -172.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -132.18 134.65 45.62 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.814 1.643 . . . . 0.0 110.872 172.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.72 89.06 1.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 158.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 29.6 mt -110.15 140.43 44.26 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -153.64 73.93 0.98 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.729 1.612 . . . . 0.0 108.28 -176.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -73.39 148.31 43.48 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 121.661 -0.649 . . . . 0.0 109.843 170.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.5 p30 . . . . . 0 C--O 1.248 1.008 0 C-N-CA 127.116 2.166 . . . . 0.0 106.058 156.484 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.084 0 N-CA-C 105.767 -2.933 . . . . 0.0 105.767 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -151.84 109.32 3.61 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 103.013 -2.958 . . . . 0.0 103.013 -136.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -159.32 125.58 4.45 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 127.422 2.289 . . . . 0.0 105.425 -164.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -155.42 166.69 32.76 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.413 1.006 . . . . 0.0 112.102 -176.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -154.27 87.14 3.59 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 125.766 1.626 . . . . 0.0 107.518 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -80.49 63.75 8.8 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.359 2.706 . . . . 0.0 110.863 -167.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.81 1.76 78.79 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.126 -1.035 . . . . 0.0 115.144 -148.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.57 154.49 16.5 Favored Glycine 0 C--O 1.24 0.508 0 C-N-CA 124.532 1.063 . . . . 0.0 110.529 -172.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -153.1 166.4 32.6 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 128.608 2.763 . . . . 0.0 105.571 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -160.53 -131.76 1.27 Allowed Glycine 0 CA--C 1.523 0.587 0 C-N-CA 124.235 0.921 . . . . 0.0 111.204 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -143.34 -160.52 1.12 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.764 1.226 . . . . 0.0 110.92 -171.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 30.4 mtp -135.27 167.06 21.72 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 128.58 2.752 . . . . 0.0 107.307 157.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -154.92 156.05 35.39 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.417 1.887 . . . . 0.0 108.87 -174.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -168.41 126.66 1.12 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.234 2.214 . . . . 0.0 106.23 -172.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.456 HG22 ' CE2' ' A' ' 75' ' ' PHE . 1.6 m -136.72 158.94 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 125.656 1.583 . . . . 0.0 110.177 -170.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.6 p -126.5 159.24 33.96 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.334 0.654 . . . . 0.0 111.062 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 tp -132.33 111.12 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 167.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -97.42 145.67 25.95 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 162.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -127.32 128.52 46.06 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.945 1.698 . . . . 0.0 107.717 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.1 m -149.85 178.88 8.5 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.524 1.53 . . . . 0.0 108.791 -167.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.52 -149.4 51.25 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -166.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -80.04 60.21 3.51 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.108 1.363 . . . . 0.0 111.691 -173.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.457 ' HA ' ' HE3' ' A' ' 93' ' ' MET . 52.1 p90 -76.44 30.57 0.12 Allowed 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.397 -1.439 . . . . 0.0 114.462 -174.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.9 mtt85 -106.83 -10.18 16.13 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -163.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.4 t -154.03 83.37 1.14 Allowed 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -145.95 165.85 27.75 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.975 0.91 . . . . 0.0 110.538 172.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.4 mt -132.11 88.47 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 125.473 1.509 . . . . 0.0 107.767 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.71 168.12 16.55 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.098 -1.002 . . . . 0.0 111.336 176.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.0 t -124.75 161.03 27.29 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 161.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -140.55 113.92 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 160.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.5 t -74.94 131.45 34.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 159.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.2 t -129.43 143.48 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 C-N-CA 124.541 1.136 . . . . 0.0 108.184 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 t -138.25 147.06 25.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.24 119.62 11.59 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.998 1.319 . . . . 0.0 108.111 169.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -76.78 127.39 32.67 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 118.166 -0.921 . . . . 0.0 109.859 173.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.82 0.05 69.36 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.085 1.326 . . . . 0.0 114.946 163.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.5 t -161.47 -179.43 7.34 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.621 1.21 . . . . 0.0 110.666 -170.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -104.42 169.94 8.18 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.073 1.349 . . . . 0.0 109.689 169.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.3 tp -101.77 164.43 11.74 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 127.274 2.23 . . . . 0.0 109.299 -174.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -130.11 114.21 15.46 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 126.144 1.777 . . . . 0.0 106.622 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -69.61 118.79 12.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 174.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.88 -7.24 55.31 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 117.671 -1.627 . . . . 0.0 113.52 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.2 -60.11 4.27 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 120.567 2.183 . . . . 0.0 110.067 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.98 3.09 3.7 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.304 1.841 . . . . 0.0 111.46 -167.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.57 17.73 67.76 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.843 1.211 . . . . 0.0 112.153 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -69.79 124.85 25.04 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.98 1.312 . . . . 0.0 109.854 -169.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.77 111.99 10.53 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.354 1.062 . . . . 0.0 109.933 173.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.4 mt -121.66 142.78 49.8 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 123.593 0.757 . . . . 0.0 109.44 -177.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.86 95.09 9.97 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.434 1.111 . . . . 0.0 108.6 175.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.3 p -51.24 154.51 2.82 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.199 157.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.76 130.57 20.85 Favored 'Cis proline' 0 N--CA 1.457 -0.648 0 CA-C-N 120.747 1.302 . . . . 0.0 111.159 -2.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.0 p -132.28 154.21 39.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 124.554 1.142 . . . . 0.0 108.618 -169.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.4 mm -117.55 120.14 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.1 mt -87.89 136.19 33.07 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.85 171.1 14.97 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.239 1.816 . . . . 0.0 108.932 171.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -61.23 -35.4 77.14 Favored 'General case' 0 C--O 1.22 -0.463 0 O-C-N 121.031 -1.043 . . . . 0.0 109.903 164.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -59.56 -25.69 64.76 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.707 1.203 . . . . 0.0 111.937 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -90.98 -28.55 17.95 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.768 1.227 . . . . 0.0 110.716 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.3 mt -113.08 5.08 16.96 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 124.376 1.07 . . . . 0.0 113.587 -169.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.03 45.66 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.387 2.675 . . . . 0.0 111.224 168.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.6 m -119.74 160.4 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 129.135 2.974 . . . . 0.0 108.303 173.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.64 -44.65 93.44 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 121.564 -0.71 . . . . 0.0 111.25 170.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.23 152.1 29.93 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 120.794 -1.191 . . . . 0.0 109.221 -175.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.9 p -142.19 165.4 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.419 0.628 . . . . 0.0 109.35 158.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.8 m -111.7 142.66 43.75 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 127.212 2.205 . . . . 0.0 105.993 170.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -123.33 133.27 54.15 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 169.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.47 177.89 8.14 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -174.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.1 p -119.19 147.29 44.38 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 118.894 0.77 . . . . 0.0 112.984 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.7 p -71.64 -12.63 61.44 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.634 1.173 . . . . 0.0 113.16 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -165.72 -169.73 29.71 Favored Glycine 0 N--CA 1.448 -0.562 0 O-C-N 120.596 -1.315 . . . . 0.0 110.522 -165.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.449 ' CE ' HD11 ' A' ' 73' ' ' ILE . 14.5 ttpt -55.46 115.6 2.39 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.624 1.57 . . . . 0.0 109.343 -176.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -111.33 145.42 38.87 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.449 HD11 ' CE ' ' A' ' 71' ' ' LYS . 1.3 mt -131.23 -11.23 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 118.878 -0.582 . . . . 0.0 112.02 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -144.4 137.87 27.36 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.456 ' CE2' HG22 ' A' ' 15' ' ' VAL . 0.9 OUTLIER -125.69 100.2 6.32 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 165.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.21 152.89 21.34 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 163.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.32 123.79 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 170.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.4 p -142.33 170.49 15.61 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.759 0.709 . . . . 0.0 111.027 164.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 142.41 -75.96 0.31 Allowed Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 176.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.559 ' H ' HD12 ' A' ' 124' ' ' LEU . . . 69.95 -152.38 51.22 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.9 p -159.13 157.27 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.315 1.046 . . . . 0.0 110.477 -176.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.8 p -143.24 170.14 10.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 128.131 2.573 . . . . 0.0 104.727 156.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -106.9 144.04 34.11 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 118.597 0.635 . . . . 0.0 109.343 165.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.89 -21.96 34.66 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-O 119.279 -0.734 . . . . 0.0 112.142 -176.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -68.76 150.61 47.67 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 118.393 1.097 . . . . 0.0 109.195 -170.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.88 10.32 7.64 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.387 1.075 . . . . 0.0 110.662 -174.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.82 19.07 3.54 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 127.23 2.348 . . . . 0.0 112.316 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.6 t -133.91 137.07 52.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.7 p -134.94 147.89 29.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.9 1.68 . . . . 0.0 106.644 173.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -150.0 -168.87 3.23 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 123.438 0.695 . . . . 0.0 109.414 -164.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -87.84 165.74 28.15 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 123.768 0.827 . . . . 0.0 110.895 158.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -78.65 173.57 13.49 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.442 2.761 . . . . 0.0 112.741 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.53 ' CE ' ' HE1' ' A' ' 95' ' ' TRP . 2.7 ptm -125.2 162.23 25.13 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.355 -0.841 . . . . 0.0 111.508 176.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -142.8 144.81 32.72 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 124.992 1.317 . . . . 0.0 108.147 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.53 ' HE1' ' CE ' ' A' ' 93' ' ' MET . 52.7 m0 -123.35 156.92 34.43 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.2 t -133.26 117.92 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.7 m -128.54 123.85 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -165.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.2 m -121.75 156.96 32.04 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -173.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.9 t -131.65 131.56 62.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 123.808 0.843 . . . . 0.0 108.955 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -114.45 166.35 11.79 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.205 1.802 . . . . 0.0 109.099 170.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.02 -156.0 0.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.383 1.873 . . . . 0.0 108.094 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -65.76 68.7 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.563 1.145 . . . . 0.0 112.151 164.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.17 38.0 4.7 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.826 1.203 . . . . 0.0 113.428 166.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.54 152.72 12.35 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.555 1.177 . . . . 0.0 109.831 168.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -64.33 137.91 58.15 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 157.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 18.4 pt -123.86 -27.92 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 117.579 -1.201 . . . . 0.0 112.209 172.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -140.15 149.96 43.65 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.376 1.444 . . . . 0.0 109.39 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -152.83 108.94 3.36 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.663 1.985 . . . . 0.0 105.784 -174.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.68 154.09 39.17 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.175 170.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.87 157.83 27.91 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 125.593 1.557 . . . . 0.0 109.268 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 73.8 mt -129.82 147.64 51.62 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.432 1.093 . . . . 0.0 108.199 -163.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.9 p -129.82 100.87 5.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.62 0.724 . . . . 0.0 109.175 -171.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -92.32 179.56 5.51 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 122.119 0.962 . . . . 0.0 108.488 167.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 48.0 mtm180 -134.23 -164.36 1.49 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.918 2.087 . . . . 0.0 106.833 -168.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -47.05 146.95 1.54 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.213 1.005 . . . . 0.0 108.888 164.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -55.81 -34.18 60.84 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-O 119.485 -0.62 . . . . 0.0 113.376 -173.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -89.64 19.4 4.66 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 -169.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -160.38 91.92 0.95 Allowed 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 127.892 2.477 . . . . 0.0 111.979 -161.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.8 pp -142.43 159.59 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 O-C-N 118.729 -2.482 . . . . 0.0 111.391 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.8 p 179.87 82.32 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.582 1.553 . . . . 0.0 111.343 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.63 151.71 46.21 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 -170.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.73 56.49 1.16 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 158.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.28 -82.65 0.03 OUTLIER 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.838 1.255 . . . . 0.0 110.429 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.559 HD12 ' H ' ' A' ' 80' ' ' GLY . 19.6 mt -111.16 96.18 5.98 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 -176.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -153.65 58.97 0.75 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.617 175.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 83.2 mt -107.91 145.36 33.88 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -153.18 72.19 0.93 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.002 0.906 . . . . 0.0 109.794 -176.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -65.15 133.53 51.76 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 171.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.3 p30 . . . . . 0 C--O 1.255 1.38 0 C-N-CA 125.363 1.465 . . . . 0.0 109.863 175.335 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.76 0 N-CA-C 105.053 -3.219 . . . . 0.0 105.053 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 75.1 68.55 0.08 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 163.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -153.38 149.44 27.81 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 129.004 2.922 . . . . 0.0 106.281 -134.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -171.18 164.55 7.31 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 128.257 2.623 . . . . 0.0 106.979 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -153.64 85.19 4.1 Favored Pre-proline 0 C--O 1.237 0.397 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -79.35 161.18 25.79 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.406 2.071 . . . . 0.0 110.837 176.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.38 32.79 0.64 Allowed Glycine 0 CA--C 1.525 0.713 0 O-C-N 121.273 -0.892 . . . . 0.0 111.512 -173.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.87 -174.92 14.31 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 125.229 1.395 . . . . 0.0 111.077 -171.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -146.27 166.05 27.42 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.06 -135.42 2.19 Favored Glycine 0 C--N 1.317 -0.484 0 C-N-CA 127.842 2.639 . . . . 0.0 106.899 177.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.64 174.58 11.3 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.238 1.019 . . . . 0.0 109.232 -176.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.8 mtp -84.39 -174.05 5.06 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 119.764 -1.835 . . . . 0.0 109.253 154.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -153.2 148.6 27.08 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.366 0.667 . . . . 0.0 110.487 152.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -142.06 144.63 33.68 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.898 2.079 . . . . 0.0 108.354 172.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 p -138.53 153.54 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 126.957 2.103 . . . . 0.0 110.105 175.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -114.31 153.84 29.06 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.465 1.506 . . . . 0.0 109.185 167.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.596 HG22 HG12 ' A' ' 64' ' ' VAL . 6.2 tp -105.34 148.4 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 155.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -139.92 115.25 9.88 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 167.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -104.59 128.65 52.65 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 126.014 1.726 . . . . 0.0 107.474 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -138.02 173.92 11.11 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 122.702 0.401 . . . . 0.0 110.666 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.64 -82.34 1.59 Allowed Glycine 0 CA--C 1.52 0.373 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -175.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.414 ' CG ' HH11 ' A' ' 24' ' ' ARG . 17.9 t0 -168.54 104.32 0.43 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 117.997 0.899 . . . . 0.0 112.927 175.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -96.25 24.61 5.57 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.515 -1.366 . . . . 0.0 112.363 -178.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.414 HH11 ' CG ' ' A' ' 22' ' ' ASP . 69.6 mtt85 -69.34 -47.23 64.98 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -172.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.4 m -127.26 69.15 1.28 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.807 1.185 . . . . 0.0 109.465 -177.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.526 ' HB3' HG21 ' A' ' 81' ' ' VAL . 65.9 m-85 -143.02 117.66 9.81 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -177.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.7 mm -84.62 79.06 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.567 ' H ' ' CD ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -79.44 145.41 33.32 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.209 1.403 . . . . 0.0 108.614 167.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.4 m -135.8 174.72 10.3 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 169.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.2 t -141.52 160.51 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 174.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.8 p -114.56 151.34 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 158.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.5 p -139.31 139.25 39.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 118.626 0.648 . . . . 0.0 110.413 162.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.5 t -126.47 144.81 35.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 126.49 1.916 . . . . 0.0 106.299 169.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.61 95.43 2.65 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.981 1.312 . . . . 0.0 109.048 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -62.56 100.3 0.18 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.314 1.446 . . . . 0.0 110.072 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.65 1.28 25.94 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 117.405 1.722 . . . . 0.0 117.405 159.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.422 HG22 ' HB2' ' A' ' 72' ' ' ALA . 2.6 t -157.78 179.11 9.52 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.934 2.367 . . . . 0.0 109.086 174.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -91.38 161.35 15.04 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.481 0.658 . . . . 0.0 110.471 175.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.3 mt -84.42 171.93 12.17 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.563 0.745 . . . . 0.0 109.731 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -135.74 129.09 32.07 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.779 1.232 . . . . 0.0 108.42 170.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.456 ' HA ' HD23 ' A' ' 66' ' ' LEU . 11.0 t0 -89.4 117.19 28.14 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.634 1.173 . . . . 0.0 109.808 173.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.96 11.72 5.86 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.079 1.323 . . . . 0.0 114.235 175.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.72 -48.16 56.01 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 120.123 1.962 . . . . 0.0 108.973 168.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.31 -9.71 0.57 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.686 1.194 . . . . 0.0 111.715 -167.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.86 13.4 55.01 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.244 1.878 . . . . 0.0 112.903 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -68.51 138.5 55.24 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -174.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.449 ' O ' HD23 ' A' ' 48' ' ' LEU . 4.7 m -71.54 147.23 47.89 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 170.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 47' ' ' SER . 2.4 mt -130.07 158.8 38.64 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 118.491 0.587 . . . . 0.0 109.56 171.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.48 103.59 10.25 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 126.77 2.028 . . . . 0.0 108.267 -173.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.95 165.54 52.38 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.233 169.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.98 140.05 64.91 Favored 'Cis proline' 0 N--CA 1.454 -0.813 0 N-CA-C 109.791 -0.888 . . . . 0.0 109.791 -8.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.2 p -143.37 160.05 17.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.03 0.932 . . . . 0.0 110.891 -177.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.0 mm -118.89 125.06 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 126.968 2.107 . . . . 0.0 107.111 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.3 mt -83.11 144.59 29.76 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 166.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.25 175.7 5.32 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.36 2.264 . . . . 0.0 109.544 176.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -59.39 -35.37 73.82 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.725 1.21 . . . . 0.0 113.428 -175.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -70.68 -28.48 64.8 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.962 0.801 . . . . 0.0 112.611 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -70.29 -52.98 18.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.434 ' O ' ' HE2' ' A' ' 28' ' ' LYS . 32.1 mt -77.28 24.61 0.18 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.786 2.034 . . . . 0.0 111.379 -175.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.07 -11.11 59.89 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.459 1.104 . . . . 0.0 112.155 175.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.9 m -84.1 148.61 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.442 1.097 . . . . 0.0 110.177 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -61.78 -33.24 73.75 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.638 -0.664 . . . . 0.0 112.19 173.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -154.4 141.05 18.96 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 -166.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.596 HG12 HG22 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -140.98 158.62 23.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -134.46 119.46 18.55 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -175.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 41' ' ' ASP . 17.7 mt -136.65 137.79 40.42 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 118.991 0.814 . . . . 0.0 109.626 -172.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -147.62 -168.23 3.01 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -168.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.22 147.54 42.41 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 127.369 2.268 . . . . 0.0 108.99 176.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 79.9 p -73.93 -20.84 60.26 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.515 -0.74 . . . . 0.0 111.302 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -156.59 -156.37 7.83 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 124.25 0.928 . . . . 0.0 111.05 -177.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -67.75 137.37 55.4 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.875 0.87 . . . . 0.0 109.793 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.422 ' HB2' HG22 ' A' ' 37' ' ' THR . . . -138.16 174.62 10.36 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.079 1.752 . . . . 0.0 109.783 172.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.73 21.07 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 123.544 0.738 . . . . 0.0 109.426 -174.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 129' ' ' ASN . 3.8 mt-10 -155.0 158.08 38.61 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 119.217 -2.177 . . . . 0.0 109.371 168.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.75 85.22 1.42 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.15 1.38 . . . . 0.0 107.547 160.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 127' ' ' TYR . . . -78.85 137.59 37.75 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 171.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.3 t -148.88 105.88 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 126.811 2.044 . . . . 0.0 106.445 -174.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.0 m -141.55 173.02 11.89 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.699 1.2 . . . . 0.0 111.082 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.66 -89.7 0.11 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 123.992 0.806 . . . . 0.0 111.361 167.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.01 133.43 7.94 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 108.796 -1.721 . . . . 0.0 108.796 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.526 HG21 ' HB3' ' A' ' 26' ' ' PHE . 9.4 p -96.07 168.86 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.8 p -125.74 -177.96 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 175.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -112.18 105.03 13.27 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -94.99 7.99 70.08 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 124.484 1.04 . . . . 0.0 112.741 -165.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -122.3 176.79 5.67 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.557 1.543 . . . . 0.0 107.308 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -167.08 125.51 1.33 Allowed 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.06 1.744 . . . . 0.0 106.406 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.64 30.7 66.04 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.538 1.066 . . . . 0.0 112.188 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.6 m -102.62 -164.6 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 125.771 1.628 . . . . 0.0 109.901 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.28 110.65 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 160.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -141.11 -179.38 6.06 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.947 1.699 . . . . 0.0 107.251 165.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -119.71 160.2 43.3 Favored Pre-proline 0 C--N 1.33 -0.271 0 C-N-CA 124.646 1.179 . . . . 0.0 109.424 172.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -84.24 178.78 4.98 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.923 2.415 . . . . 0.0 112.312 176.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.5 ptm -148.37 171.2 16.41 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.287 -0.883 . . . . 0.0 112.164 -169.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -140.04 159.12 42.9 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 126.882 2.073 . . . . 0.0 107.547 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.0 m0 -128.3 141.58 51.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.018 1.327 . . . . 0.0 107.672 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -124.81 105.42 15.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 103.59 -2.745 . . . . 0.0 103.59 164.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.0 m -83.25 157.45 3.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 155.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 28.6 m -138.79 133.43 32.11 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 169.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.9 t -112.52 141.15 28.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -125.0 138.85 54.21 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.79 2.036 . . . . 0.0 108.529 -175.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -101.14 -174.79 2.69 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.341 1.457 . . . . 0.0 107.613 174.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -68.78 65.89 0.13 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.608 2.363 . . . . 0.0 109.031 -177.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 165.21 -68.81 0.2 Allowed Glycine 0 N--CA 1.448 -0.55 0 CA-C-O 118.675 -1.069 . . . . 0.0 112.278 -172.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -157.01 -176.59 6.07 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.534 1.133 . . . . 0.0 111.289 -174.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.86 139.03 14.03 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.899 1.68 . . . . 0.0 110.037 169.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.9 pt -129.12 -22.9 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 117.822 -1.085 . . . . 0.0 112.253 171.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -124.09 128.01 48.66 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 120.092 1.315 . . . . 0.0 110.411 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -126.6 90.89 3.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.052 1.741 . . . . 0.0 107.479 175.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -130.51 162.85 28.32 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 167.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.6 t -151.06 151.98 32.8 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.63 1.572 . . . . 0.0 107.026 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 36.9 mt -121.68 161.87 21.76 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.621 1.568 . . . . 0.0 109.112 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.0 p -137.75 132.82 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -120.96 106.44 11.61 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -147.39 104.37 3.64 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -169.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -169.72 -166.86 0.61 Allowed 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 127.491 2.317 . . . . 0.0 106.894 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.76 14.6 0.34 Allowed Glycine 0 CA--C 1.525 0.713 0 CA-C-O 118.931 -0.927 . . . . 0.0 112.242 169.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -141.62 174.74 10.28 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.817 1.308 . . . . 0.0 109.17 -170.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -60.39 133.27 55.94 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 173.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.9 pp -150.99 176.6 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 126.801 2.04 . . . . 0.0 107.488 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.1 m -157.83 90.11 1.05 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.411 1.484 . . . . 0.0 107.661 166.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.56 164.57 24.56 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 122.203 1.001 . . . . 0.0 109.251 156.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -116.94 60.22 0.75 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 162.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -68.07 -15.8 63.75 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -173.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.0 tp -122.55 114.98 21.39 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -154.28 53.71 0.68 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.345 1.458 . . . . 0.0 110.531 -159.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.3 mt -118.56 140.11 50.4 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -171.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 81.7 m-85 -151.71 67.65 0.88 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.968 1.307 . . . . 0.0 109.451 -168.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -64.89 159.76 22.03 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.003 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 3.8 t30 . . . . . 0 C--O 1.25 1.094 0 C-N-CA 128.408 2.683 . . . . 0.0 106.123 -176.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.635 0 N-CA-C 105.915 -2.874 . . . . 0.0 105.915 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -175.12 128.64 0.28 Allowed 'General case' 0 C--O 1.245 0.86 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 -155.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -136.49 -12.11 1.83 Allowed 'General case' 0 C--O 1.236 0.365 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -156.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -85.29 106.22 16.53 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.935 1.698 . . . . 0.0 109.63 169.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -154.26 82.52 4.33 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 162.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -78.52 142.43 18.43 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.95 2.433 . . . . 0.0 110.222 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -109.37 -61.15 0.52 Allowed Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.67 -149.04 21.14 Favored Glycine 0 C--N 1.333 0.413 0 O-C-N 121.352 -1.087 . . . . 0.0 110.845 -168.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.2 pttt -129.76 150.7 50.96 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 125.8 1.64 . . . . 0.0 108.995 -174.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.26 -126.55 1.14 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 129.684 3.516 . . . . 0.0 107.688 172.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -152.02 -175.3 5.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.52 1.928 . . . . 0.0 108.694 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.446 ' H ' ' HB3' ' A' ' 102' ' ' ASN . 49.5 mtp -103.54 166.86 10.17 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 155.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -133.61 153.89 51.31 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.558 1.143 . . . . 0.0 108.033 169.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -148.36 145.19 27.98 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.29 133.76 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 127.195 2.198 . . . . 0.0 106.512 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 p -94.4 171.36 8.87 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 64' ' ' VAL . 11.3 tp -132.87 146.49 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 160.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -136.24 117.57 14.63 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 161.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -107.06 128.97 54.85 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 173.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.3 p -149.1 168.4 23.3 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 122.141 -0.35 . . . . 0.0 111.335 171.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.48 -114.53 3.96 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 107.284 -2.326 . . . . 0.0 107.284 -170.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -116.11 90.24 3.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 122.008 0.909 . . . . 0.0 110.709 -174.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -102.57 21.76 14.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.958 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.0 19.31 4.1 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.552 1.541 . . . . 0.0 112.311 -168.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.8 m -134.75 -1.27 2.77 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.302 1.441 . . . . 0.0 113.484 -173.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -119.24 -174.47 2.73 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.363 1.065 . . . . 0.0 108.328 -171.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.9 mp -129.87 80.8 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.48 ' HE2' ' OD2' ' A' ' 56' ' ' ASP . 2.3 pttt -81.1 162.42 23.71 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 121.835 -0.541 . . . . 0.0 110.091 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 m -145.35 158.06 43.91 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 171.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 74.4 t -142.28 105.77 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 p -68.49 149.11 11.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 159.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.04 142.23 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 124.982 1.313 . . . . 0.0 108.207 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.4 t -137.58 149.33 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 171.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.0 93.84 2.64 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 172.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -69.82 104.71 2.54 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.11 7.05 38.75 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.75 -1.028 . . . . 0.0 114.284 165.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.9 t -161.89 177.59 9.69 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.546 1.173 . . . . 0.0 109.024 -174.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -100.05 170.29 8.59 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.091 0.956 . . . . 0.0 108.739 171.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 tp -84.48 170.14 13.79 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.316 0.646 . . . . 0.0 109.396 164.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -134.67 120.19 19.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.898 1.279 . . . . 0.0 108.087 171.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -69.49 129.32 39.38 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.124 0.97 . . . . 0.0 109.37 176.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.69 -8.79 84.06 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 118.892 -0.949 . . . . 0.0 113.126 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.57 -46.75 86.9 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.128 1.464 . . . . 0.0 108.635 173.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.68 -16.04 1.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.688 0.795 . . . . 0.0 112.088 -160.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.38 63.27 2.82 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -173.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -123.48 140.11 53.33 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.481 1.112 . . . . 0.0 108.333 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.85 112.16 17.98 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -178.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.7 mt -97.09 128.23 43.82 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.75 0.786 . . . . 0.0 109.352 -174.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.16 79.54 6.7 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.35 1.46 . . . . 0.0 109.493 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.2 m -63.02 163.67 15.96 Favored Pre-proline 0 N--CA 1.444 -0.767 0 C-N-CA 123.724 0.809 . . . . 0.0 110.949 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -68.93 140.66 59.29 Favored 'Cis proline' 0 CA--C 1.536 0.617 0 CA-C-N 119.211 0.754 . . . . 0.0 110.625 -9.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.7 p -145.68 149.24 16.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 124.002 0.921 . . . . 0.0 109.651 -171.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.4 mm -125.47 98.24 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 124.032 0.933 . . . . 0.0 109.295 -173.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.2 mt -72.43 131.19 42.27 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 175.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.7 m -87.93 -177.05 5.68 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.11 1.364 . . . . 0.0 109.709 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.48 ' OD2' ' HE2' ' A' ' 28' ' ' LYS . 12.5 t70 -61.21 -43.89 98.16 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.902 0.881 . . . . 0.0 112.16 -172.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -67.83 -38.85 83.74 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -174.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.15 -32.55 73.96 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.33 20.33 0.15 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.919 1.688 . . . . 0.0 115.22 176.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.36 19.34 0.08 Allowed 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 120.691 1.587 . . . . 0.0 114.993 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.8 m -95.92 153.94 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 O-C-N 120.567 -1.333 . . . . 0.0 111.554 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -75.62 -41.43 54.31 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.561 -0.712 . . . . 0.0 111.853 175.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.72 107.36 0.87 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -166.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.52 ' H ' HG22 ' A' ' 17' ' ' ILE . 93.1 t -138.6 118.91 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 123.14 1.448 . . . . 0.0 111.239 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.9 m -69.26 125.53 26.97 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 128.231 2.613 . . . . 0.0 109.093 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.49 140.8 47.81 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.479 1.036 . . . . 0.0 108.225 170.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.4 t -150.69 178.17 9.36 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.08 1.352 . . . . 0.0 107.781 176.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.9 p -87.55 165.42 15.5 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.245 0.618 . . . . 0.0 110.484 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.8 p -80.41 -13.55 59.05 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.855 -0.528 . . . . 0.0 111.372 165.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -166.43 -170.73 31.71 Favored Glycine 0 CA--C 1.527 0.812 0 O-C-N 120.388 -1.445 . . . . 0.0 113.457 -167.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -63.02 132.43 51.96 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.432 1.093 . . . . 0.0 109.057 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.452 ' C ' HD13 ' A' ' 73' ' ' ILE . . . -133.61 160.66 36.83 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.624 1.17 . . . . 0.0 111.741 -175.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.452 HD13 ' C ' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -128.2 14.35 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 118.478 -0.772 . . . . 0.0 110.35 178.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -149.27 158.05 43.85 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.483 1.492 . . . . 0.0 110.701 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -161.48 99.33 1.15 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.197 1.399 . . . . 0.0 107.664 165.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.95 142.2 28.02 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.348 1.459 . . . . 0.0 110.949 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 t -145.63 107.84 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 124.526 1.13 . . . . 0.0 108.274 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.8 m -141.07 166.65 24.21 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 121.041 -1.037 . . . . 0.0 109.67 169.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.04 -65.22 0.3 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 167.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.65 176.22 25.04 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 121.123 0.29 . . . . 0.0 112.378 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.5 m -128.86 158.97 41.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 126.006 1.722 . . . . 0.0 107.368 165.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.2 p -114.68 158.9 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 169.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -98.4 8.01 45.43 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.104 0.962 . . . . 0.0 111.344 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.15 23.27 1.83 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.745 1.64 . . . . 0.0 116.178 -158.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -54.87 146.66 16.9 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 118.766 1.283 . . . . 0.0 108.444 167.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -148.95 89.05 1.64 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 137.82 -6.58 3.5 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.93 1.252 . . . . 0.0 113.206 -170.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.4 p -143.13 166.69 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 126.42 1.888 . . . . 0.0 107.653 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.6 p -116.35 159.42 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 171.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -129.73 163.12 26.87 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 174.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -82.16 165.5 42.51 Favored Pre-proline 0 CA--C 1.538 0.518 0 O-C-N 121.502 -0.749 . . . . 0.0 110.192 164.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -75.69 167.01 27.26 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.264 1.976 . . . . 0.0 112.36 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.0 ppp? -149.36 174.19 12.71 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.02 0.528 . . . . 0.0 111.11 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -135.1 156.4 49.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.138 1.375 . . . . 0.0 108.753 173.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -141.25 90.9 2.35 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -178.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.7 t -82.28 137.18 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 168.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 m -144.63 54.7 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 125.254 1.422 . . . . 0.0 108.67 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.0 m -65.93 140.23 58.32 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 120.703 -1.248 . . . . 0.0 108.206 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.9 m -103.83 154.63 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 CA-C-O 122.889 1.328 . . . . 0.0 109.693 172.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -127.26 172.84 10.24 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 126.889 2.076 . . . . 0.0 108.098 167.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -120.92 -162.13 0.94 Allowed 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 130.644 3.578 . . . . 0.0 105.234 -176.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.446 ' HB3' ' H ' ' A' ' 12' ' ' MET . 0.6 OUTLIER -67.99 72.72 0.18 Allowed 'General case' 0 CA--C 1.551 1.002 0 O-C-N 121.226 -0.921 . . . . 0.0 109.416 165.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.25 29.37 56.47 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 126.003 1.763 . . . . 0.0 115.067 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -136.04 178.64 6.9 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.744 1.772 . . . . 0.0 108.209 166.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -120.53 140.7 51.08 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 127.322 2.249 . . . . 0.0 106.705 170.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -117.09 -27.33 2.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 125.353 1.461 . . . . 0.0 111.768 175.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -149.82 143.54 25.42 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.253 0.933 . . . . 0.0 109.164 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.8 tttt -137.45 43.77 2.29 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.517 0.727 . . . . 0.0 110.359 -173.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -69.26 142.4 54.16 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.4 t -138.76 160.14 40.39 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.268 1.827 . . . . 0.0 107.828 168.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 31.3 mt -125.32 144.5 50.46 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.993 1.717 . . . . 0.0 107.984 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 98.7 t -135.27 126.82 46.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.315 1.446 . . . . 0.0 107.24 -175.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -116.58 166.37 12.18 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.324 1.049 . . . . 0.0 109.174 175.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 30.7 mtt-85 -136.81 -2.04 2.17 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 117.322 -1.323 . . . . 0.0 114.168 -168.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 61.98 133.84 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.748 1.219 . . . . 0.0 110.198 -152.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.35 60.22 4.88 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.554 1.074 . . . . 0.0 112.442 172.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -129.87 139.34 51.2 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.715 -1.462 . . . . 0.0 112.997 -173.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -78.77 112.2 15.66 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 126.005 1.722 . . . . 0.0 108.718 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.2 pp -131.96 169.88 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.804 2.041 . . . . 0.0 109.814 176.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.7 t -146.92 -179.6 6.91 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.006 0.922 . . . . 0.0 108.909 168.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.0 p -72.86 37.03 0.08 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 128.078 2.551 . . . . 0.0 115.101 -162.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -134.62 20.72 3.6 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.464 1.506 . . . . 0.0 109.997 174.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.15 -39.12 66.22 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.193 1.397 . . . . 0.0 112.519 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.09 112.63 6.86 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 172.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -144.38 70.02 1.28 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -176.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.84 139.79 44.51 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.71 2.004 . . . . 0.0 107.224 -176.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -153.08 135.72 15.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 169.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -119.93 148.32 43.67 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.837 1.255 . . . . 0.0 109.09 171.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.3 p30 . . . . . 0 C--O 1.248 0.974 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 152.823 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.483 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 t0 66.97 74.88 0.32 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 127.82 2.448 . . . . 0.0 106.777 -172.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -101.09 62.71 0.98 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 112.265 -2.243 . . . . 0.0 107.023 -138.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.43 ' CG ' ' H ' ' A' ' 5' ' ' GLU . 10.3 t70 58.15 -178.89 0.07 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.079 2.152 . . . . 0.0 110.985 -146.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.43 ' H ' ' CG ' ' A' ' 4' ' ' ASP . 5.5 pt-20 -168.5 66.42 0.68 Allowed Pre-proline 0 CA--C 1.548 0.897 0 O-C-N 120.257 -1.527 . . . . 0.0 108.962 -167.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.1 176.37 10.21 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.269 2.646 . . . . 0.0 112.278 -173.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.41 -67.9 0.28 Allowed Glycine 0 C--N 1.337 0.595 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.65 167.78 39.42 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 173.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -137.73 153.24 49.77 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.623 1.169 . . . . 0.0 108.937 -171.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.37 -137.68 4.55 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 127.119 2.295 . . . . 0.0 108.523 172.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.15 -178.06 6.28 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.7 0.8 . . . . 0.0 111.227 -170.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.9 mtp -107.39 156.15 19.24 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 160.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -133.94 137.52 44.92 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.843 0.857 . . . . 0.0 110.637 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 39.3 tt0 -133.93 133.54 41.53 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 127.984 2.514 . . . . 0.0 107.921 171.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.05 155.78 11.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 126.511 1.924 . . . . 0.0 108.094 168.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.32 143.92 36.07 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 172.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.441 HD11 ' CG ' ' A' ' 95' ' ' TRP . 1.5 tp -133.29 97.0 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.46 143.83 34.6 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 161.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -120.67 130.79 54.25 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 173.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 m -112.18 165.79 11.83 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 122.385 0.274 . . . . 0.0 110.388 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 62.19 -147.8 48.84 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -79.3 77.38 5.83 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-O 122.112 0.958 . . . . 0.0 110.34 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -83.8 -5.97 59.32 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.006 -1.059 . . . . 0.0 112.541 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 90.9 mtt-85 -70.14 -57.43 4.95 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.8 m -78.74 35.34 0.24 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.735 1.614 . . . . 0.0 113.272 -157.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.704 ' HB3' HG21 ' A' ' 81' ' ' VAL . 36.6 m-85 -154.49 113.77 3.71 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.788 1.235 . . . . 0.0 111.392 -158.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.6 pt -67.68 74.99 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 127.791 2.436 . . . . 0.0 112.649 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -77.85 160.62 28.19 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 128.181 2.592 . . . . 0.0 111.851 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.5 t -156.63 152.91 27.75 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.636 -0.665 . . . . 0.0 109.798 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.5 t -128.19 139.95 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 125.628 1.571 . . . . 0.0 108.4 175.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.4 t -106.15 129.05 60.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 127.878 2.471 . . . . 0.0 104.761 164.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.62 147.08 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 119.696 1.135 . . . . 0.0 110.234 176.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.9 t -140.87 150.56 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.2 100.52 3.29 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 170.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -68.67 118.36 11.57 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.012 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.19 -14.11 40.17 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 119.408 -0.662 . . . . 0.0 114.106 159.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.4 t -148.87 178.3 8.8 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.872 1.269 . . . . 0.0 110.052 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -89.8 155.03 19.45 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.462 0.705 . . . . 0.0 109.816 173.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.5 tp -77.47 166.96 22.42 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.423 1.089 . . . . 0.0 108.883 168.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -137.07 128.36 28.07 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.152 1.781 . . . . 0.0 107.209 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.423 ' HB2' HD11 ' A' ' 48' ' ' LEU . 8.7 t0 -84.67 121.32 27.49 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.93 -8.25 57.52 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-O 119.125 -0.819 . . . . 0.0 113.693 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.8 -26.52 40.53 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.047 1.423 . . . . 0.0 111.729 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 p -134.09 -43.91 0.79 Allowed 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 124.299 1.04 . . . . 0.0 110.808 -169.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.57 13.1 56.16 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.724 -1.042 . . . . 0.0 111.058 -163.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -67.29 156.9 35.22 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 118.705 1.252 . . . . 0.0 109.253 168.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.4 p -112.96 133.62 54.84 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.39 1.476 . . . . 0.0 108.962 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.423 HD11 ' HB2' ' A' ' 41' ' ' ASP . 44.9 mt -130.93 137.58 49.36 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.79 0.836 . . . . 0.0 109.515 -162.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -85.02 63.28 8.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.227 1.411 . . . . 0.0 111.059 -167.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.7 m -53.5 150.64 12.12 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-O 118.832 -0.604 . . . . 0.0 110.948 172.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.03 140.61 68.28 Favored 'Cis proline' 0 CA--C 1.535 0.541 0 CA-C-N 119.857 0.985 . . . . 0.0 113.359 2.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.0 t -144.7 165.48 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.384 1.873 . . . . 0.0 108.222 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.4 mm -114.69 138.96 43.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 C-N-CA 126.63 1.972 . . . . 0.0 107.001 172.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -115.71 125.98 53.52 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.53 174.04 12.0 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 126.018 1.727 . . . . 0.0 110.461 -172.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -51.38 -38.88 55.65 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.743 1.617 . . . . 0.0 112.705 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -70.2 -39.6 75.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.078 0.551 . . . . 0.0 110.876 -175.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -63.92 -40.18 95.87 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.06 11.92 10.66 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.605 1.962 . . . . 0.0 113.376 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.87 19.26 0.07 Allowed 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 122.21 2.277 . . . . 0.0 115.83 -172.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.7 m -124.97 169.76 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 120.185 -1.572 . . . . 0.0 112.795 -159.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -66.78 -30.22 70.37 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.201 -0.937 . . . . 0.0 112.193 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 23.7 tttp -154.32 151.35 28.98 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 119.475 1.034 . . . . 0.0 110.278 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -125.45 156.69 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 158.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.5 m -136.59 126.23 25.42 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 126.165 1.786 . . . . 0.0 106.529 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.9 mp -140.7 146.61 38.02 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 120.319 1.418 . . . . 0.0 110.695 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 14' ' ' GLU . 20.9 t -132.4 -167.08 1.83 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.43 1.092 . . . . 0.0 109.743 -177.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.94 147.55 36.85 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.749 1.62 . . . . 0.0 108.609 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.1 p -77.47 -14.14 59.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.438 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.53 -167.21 20.73 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -173.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -66.36 133.08 49.77 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.1 153.76 38.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 173.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -113.61 -0.7 9.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 123.392 0.677 . . . . 0.0 109.473 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 129' ' ' ASN . 46.2 mt-10 -149.88 157.72 43.46 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 119.394 0.997 . . . . 0.0 108.487 173.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.5 157.23 44.96 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.513 1.925 . . . . 0.0 106.182 159.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.26 143.95 36.2 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 164.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.8 t -129.68 90.85 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 102.97 -2.974 . . . . 0.0 102.97 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.1 t -125.17 160.43 29.18 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.37 -152.35 21.49 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 -165.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.68 -165.39 24.81 Favored Glycine 0 C--O 1.239 0.451 0 N-CA-C 107.829 -2.109 . . . . 0.0 107.829 -167.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.704 HG21 ' HB3' ' A' ' 26' ' ' PHE . 14.9 p -146.6 163.78 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 C-N-CA 123.74 0.816 . . . . 0.0 109.228 177.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 p -133.7 155.88 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 167.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -86.24 127.16 34.71 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -95.91 3.41 64.85 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.893 1.711 . . . . 0.0 112.868 173.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -121.64 172.67 7.95 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.673 1.989 . . . . 0.0 109.28 -176.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -177.45 101.03 0.05 OUTLIER 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.111 2.165 . . . . 0.0 106.149 168.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 145.17 -38.44 1.25 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 125.096 1.331 . . . . 0.0 111.584 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.3 p -81.6 82.94 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 118.743 1.272 . . . . 0.0 109.178 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.0 t -60.99 95.82 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 124.776 1.23 . . . . 0.0 109.664 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -107.8 -156.98 0.6 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.148 1.779 . . . . 0.0 108.977 -173.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -96.89 164.71 17.37 Favored Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 120.856 1.662 . . . . 0.0 111.606 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.18 175.36 10.01 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.896 1.731 . . . . 0.0 112.93 164.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.1 ptm -154.6 -179.27 7.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.903 1.681 . . . . 0.0 107.805 -172.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -169.25 165.66 10.83 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.093 1.357 . . . . 0.0 107.375 171.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.535 ' HB2' HD12 ' A' ' 111' ' ' LEU . 36.0 m0 -104.21 144.39 31.67 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 162.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 96.9 t -128.52 79.31 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 101.42 -3.548 . . . . 0.0 101.42 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.433 ' CG1' HD13 ' A' ' 17' ' ' ILE . 17.0 m -83.92 144.65 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.3 m -133.61 142.98 48.35 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.5 t -127.84 130.86 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -117.43 142.74 46.76 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.195 1.398 . . . . 0.0 109.127 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.431 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 18.5 ttpt -83.08 -162.33 0.59 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 163.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.431 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 7.1 p30 -59.09 74.24 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.352 2.261 . . . . 0.0 110.043 167.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.38 40.16 24.34 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.864 1.221 . . . . 0.0 114.643 173.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.14 148.93 28.22 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.429 1.491 . . . . 0.0 107.765 167.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -77.7 146.58 35.92 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 169.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 39.7 pt -132.05 -21.9 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.849 1.26 . . . . 0.0 112.165 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -137.78 146.39 43.53 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.018 -1.051 . . . . 0.0 108.732 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 41.9 tttt -142.35 27.14 1.75 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.524 1.13 . . . . 0.0 110.584 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.476 ' HE2' HD21 ' A' ' 126' ' ' LEU . 33.4 ttpt -80.54 131.67 35.56 Favored 'General case' 0 CA--C 1.517 -0.29 0 O-C-N 121.538 -0.726 . . . . 0.0 110.239 -171.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 p -106.49 167.53 9.78 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 125.895 1.678 . . . . 0.0 109.021 177.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.535 HD12 ' HB2' ' A' ' 95' ' ' TRP . 45.9 mt -127.92 -177.2 4.03 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.466 1.507 . . . . 0.0 108.073 -174.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.9 p -151.21 146.86 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 175.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -157.11 172.37 18.79 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.956 1.703 . . . . 0.0 108.18 162.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 12.6 mtm180 -138.97 174.22 10.75 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.454 1.102 . . . . 0.0 111.099 168.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -55.55 145.59 22.72 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 129.394 3.078 . . . . 0.0 112.361 167.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 47.67 51.51 17.19 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 127.323 2.392 . . . . 0.0 112.635 164.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 30.2 mmtt -143.89 166.4 25.04 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.319 1.059 . . . . 0.0 111.9 -170.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -46.54 143.29 2.7 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.36 1.464 . . . . 0.0 110.513 160.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.4 pp -142.57 167.34 14.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 127.867 2.467 . . . . 0.0 104.829 170.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.3 m -133.3 149.96 51.91 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 168.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.18 59.34 1.34 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.416 1.486 . . . . 0.0 108.334 168.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.6 p30 -143.28 -1.27 1.06 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.497 1.519 . . . . 0.0 113.981 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.402 ' OD2' HD13 ' A' ' 111' ' ' LEU . 27.0 t0 -64.57 -38.16 90.04 Favored 'General case' 0 CA--C 1.523 -0.072 0 C-N-CA 124.033 0.933 . . . . 0.0 111.918 -162.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.509 ' HG ' HD11 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -127.04 111.71 14.37 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -169.535 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -138.41 50.53 1.88 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.545 1.138 . . . . 0.0 109.757 -172.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.476 HD21 ' HE2' ' A' ' 109' ' ' LYS . 92.6 mt -101.68 144.75 30.0 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.055 -1.028 . . . . 0.0 108.614 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -156.71 149.57 23.8 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.736 1.614 . . . . 0.0 107.864 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -144.91 152.51 40.33 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.671 1.189 . . . . 0.0 109.247 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 4.6 p30 . . . . . 0 C--O 1.251 1.142 0 C-N-CA 125.479 1.511 . . . . 0.0 109.167 166.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.582 0 N-CA-C 107.592 -2.203 . . . . 0.0 107.592 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 175.55 145.17 0.07 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 128.387 2.675 . . . . 0.0 103.831 -155.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.95 14.54 0.72 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.634 0.773 . . . . 0.0 112.461 175.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -68.14 158.25 33.55 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.079 0.952 . . . . 0.0 110.534 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -161.9 60.57 1.15 Allowed Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 124.571 1.148 . . . . 0.0 110.743 -175.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.08 146.85 25.93 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.398 2.065 . . . . 0.0 111.655 -172.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -162.63 -81.67 0.04 OUTLIER Glycine 0 C--N 1.335 0.479 0 N-CA-C 110.464 -1.055 . . . . 0.0 110.464 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.39 -152.58 9.48 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 117.79 0.795 . . . . 0.0 113.048 -175.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -134.25 114.82 13.44 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.965 0.906 . . . . 0.0 110.255 -169.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.489 ' H ' ' HD2' ' A' ' 71' ' ' LYS . . . -149.98 -130.51 1.8 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 106.158 -2.777 . . . . 0.0 106.158 169.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.78 145.59 38.42 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 118.716 1.258 . . . . 0.0 110.235 -172.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.1 mtp -63.03 147.0 51.98 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 154.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -135.18 148.63 49.74 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 164.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -143.77 110.36 5.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.338 1.855 . . . . 0.0 106.679 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 p -89.25 142.94 12.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 169.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.02 156.23 36.85 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 169.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.404 HD11 ' CG ' ' A' ' 95' ' ' TRP . 6.3 tp -138.16 143.2 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 169.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -129.89 97.06 4.37 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 172.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -83.78 125.46 31.95 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.6 t -151.43 167.73 27.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.5 -158.2 52.59 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -159.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -76.7 52.26 0.81 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.288 1.044 . . . . 0.0 113.779 -170.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -64.35 -8.5 13.32 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.336 -1.477 . . . . 0.0 114.427 -174.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -58.88 -60.73 3.39 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 119.25 0.932 . . . . 0.0 109.902 -174.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.9 m -79.1 28.38 0.23 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.183 1.793 . . . . 0.0 113.352 -167.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.407 ' O ' ' HE3' ' A' ' 28' ' ' LYS . 40.4 m-85 -123.95 123.1 39.66 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.075 0.95 . . . . 0.0 108.58 -172.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.4 mm -70.09 98.44 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -177.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.423 ' HD2' ' H ' ' A' ' 28' ' ' LYS . 2.2 mptt -75.29 131.35 40.25 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.639 0.776 . . . . 0.0 109.258 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.2 m -137.53 134.41 35.66 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.275 1.03 . . . . 0.0 108.603 169.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 89.8 t -137.34 113.91 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 165.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.5 p -70.24 132.75 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 158.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.94 143.69 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 126.33 1.852 . . . . 0.0 108.163 176.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.7 t -140.58 158.31 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.879 1.272 . . . . 0.0 107.739 -171.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.62 154.43 34.18 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.308 1.043 . . . . 0.0 108.809 168.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.441 ' HB2' ' HG2' ' A' ' 74' ' ' GLU . 18.2 t-20 -118.16 101.84 8.54 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 124.979 1.312 . . . . 0.0 109.587 178.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.17 -80.23 0.27 Allowed Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 106.186 -2.765 . . . . 0.0 106.186 171.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.9 t -70.79 174.76 5.64 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 125.31 1.444 . . . . 0.0 110.505 -175.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -110.32 172.82 6.64 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.149 0.98 . . . . 0.0 111.149 -175.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.26 164.49 11.93 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.1 1.36 . . . . 0.0 108.424 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -138.48 124.15 19.72 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.61 0.764 . . . . 0.0 109.66 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -73.78 126.78 31.14 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 123.956 0.785 . . . . 0.0 109.607 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.99 6.66 19.1 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 117.58 -1.678 . . . . 0.0 114.321 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.49 -62.07 1.7 Allowed 'General case' 0 C--O 1.23 0.066 0 CA-C-N 120.621 2.21 . . . . 0.0 109.065 171.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.93 7.62 4.73 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.68 1.192 . . . . 0.0 111.787 -170.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.19 32.19 83.11 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -65.9 126.78 29.62 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 175.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.94 104.78 17.33 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -170.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 68.7 mt -91.06 -175.01 4.18 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.424 1.489 . . . . 0.0 110.673 -165.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.15 109.27 5.78 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.064 1.346 . . . . 0.0 107.427 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.44 165.01 46.92 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.822 -0.549 . . . . 0.0 110.74 174.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.67 142.74 65.34 Favored 'Cis proline' 0 CA--C 1.537 0.673 0 CA-C-N 118.569 0.525 . . . . 0.0 111.722 -9.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.5 p -145.09 165.05 12.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 126.092 1.757 . . . . 0.0 111.12 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.4 mm -119.59 118.5 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 126.222 1.809 . . . . 0.0 107.361 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.2 mt -73.6 104.68 4.63 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 159.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.0 m -76.5 179.73 5.73 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.55 1.14 . . . . 0.0 110.479 168.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -50.96 -34.23 27.9 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.126 1.37 . . . . 0.0 112.32 170.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -66.84 -32.42 73.68 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.55 1.14 . . . . 0.0 112.169 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -86.84 -47.77 8.77 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.2 mt -76.04 21.56 0.17 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.614 1.966 . . . . 0.0 111.887 174.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.78 -4.87 37.32 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.104 1.362 . . . . 0.0 112.893 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.76 HG23 HG22 ' A' ' 64' ' ' VAL . 1.4 m -108.54 160.89 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 127.333 2.253 . . . . 0.0 110.875 -177.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -68.19 -33.12 73.85 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.289 1.036 . . . . 0.0 112.319 -176.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -143.77 126.31 15.91 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -165.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.76 HG22 HG23 ' A' ' 61' ' ' VAL . 1.7 t -136.17 90.44 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -172.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.2 m -81.58 114.86 20.57 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.787 0.835 . . . . 0.0 109.418 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -116.08 132.12 56.75 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 t -147.64 168.52 21.82 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.274 0.559 . . . . 0.0 109.569 -175.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.19 139.51 32.25 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.188 1.795 . . . . 0.0 111.133 -171.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.3 p -68.14 -28.93 67.73 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -175.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -132.81 -86.37 0.3 Allowed Glycine 0 C--N 1.338 0.672 0 CA-C-N 118.82 0.736 . . . . 0.0 112.891 -173.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.489 ' HD2' ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -150.99 139.48 20.5 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 130.764 3.625 . . . . 0.0 107.614 162.044 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.423 ' HB1' ' H ' ' A' ' 35' ' ' ASN . . . -101.51 -169.13 1.65 Allowed 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 169.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.1 mm -115.32 -19.71 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.788 170.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.441 ' HG2' ' HB2' ' A' ' 35' ' ' ASN . 19.3 pt-20 -150.4 164.62 35.39 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.643 -1.286 . . . . 0.0 109.571 -160.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -164.52 124.03 1.92 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.66 1.584 . . . . 0.0 109.982 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.35 155.85 19.54 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 120.037 1.29 . . . . 0.0 109.73 167.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.7 t -150.16 92.76 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 127.501 2.32 . . . . 0.0 105.287 174.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.9 m -137.0 159.93 40.43 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.287 -0.883 . . . . 0.0 110.437 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.24 -97.3 0.18 Allowed Glycine 0 C--N 1.333 0.38 0 N-CA-C 106.978 -2.449 . . . . 0.0 106.978 176.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.9 -168.38 21.31 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -175.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -138.64 161.21 30.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 161.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.6 p -143.24 139.74 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 171.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -65.38 146.6 54.7 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.55 1.14 . . . . 0.0 110.077 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.6 -7.92 85.46 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.897 1.236 . . . . 0.0 111.835 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -147.77 154.21 40.22 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 122.017 0.913 . . . . 0.0 112.138 -171.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -146.3 102.06 3.56 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 159.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 144.0 5.12 0.66 Allowed Glycine 0 CA--C 1.536 1.406 0 N-CA-C 115.992 1.157 . . . . 0.0 115.992 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.9 m -117.62 179.86 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 119.806 1.803 . . . . 0.0 109.637 173.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.47 98.94 7.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.463 1.105 . . . . 0.0 108.134 175.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -113.12 -163.88 0.88 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.229 1.812 . . . . 0.0 106.944 176.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -123.37 163.5 33.82 Favored Pre-proline 0 CA--C 1.533 0.322 0 O-C-N 121.331 -0.856 . . . . 0.0 108.938 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.05 175.68 10.92 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.712 2.275 . . . . 0.0 111.129 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.0 ptm -146.61 168.86 20.23 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -142.87 160.08 41.01 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 122.295 1.045 . . . . 0.0 109.292 172.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.404 ' CG ' HD11 ' A' ' 17' ' ' ILE . 4.0 m0 -127.07 112.1 14.81 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 171.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.5 t -92.87 132.39 37.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 159.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.82 161.95 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 174.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.91 155.84 28.43 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.276 -1.749 . . . . 0.0 106.276 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 75.8 t -125.27 91.61 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 171.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -72.58 163.14 28.53 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 170.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -127.63 -154.33 0.63 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.478 2.311 . . . . 0.0 109.552 -168.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -62.17 61.34 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.719 2.007 . . . . 0.0 111.449 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.34 65.99 2.93 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 120.264 -1.522 . . . . 0.0 110.964 -169.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -165.74 165.13 18.76 Favored 'General case' 0 C--N 1.335 -0.059 0 C-N-CA 125.746 1.618 . . . . 0.0 107.999 150.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -77.83 147.75 35.04 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.925 1.69 . . . . 0.0 107.442 159.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 6.4 pt -134.51 -10.36 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.367 1.467 . . . . 0.0 112.553 166.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -145.97 159.35 43.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.237 1.815 . . . . 0.0 108.78 -165.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -153.69 25.76 0.51 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -173.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -47.67 128.16 12.47 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.94 0.896 . . . . 0.0 111.394 177.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.0 p -147.42 140.46 25.09 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.286 1.034 . . . . 0.0 109.469 -177.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.619 ' N ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -133.73 -173.45 3.24 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 123.256 1.503 . . . . 0.0 109.645 -174.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.7 p -159.83 141.34 4.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 128.96 2.904 . . . . 0.0 108.689 -177.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -138.97 171.38 14.41 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 172.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -133.11 162.23 32.28 Favored 'General case' 0 CA--C 1.513 -0.481 0 O-C-N 121.699 -0.626 . . . . 0.0 111.325 -162.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -61.5 116.73 4.94 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 124.153 0.908 . . . . 0.0 109.224 164.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.36 55.3 3.49 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 160.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -145.13 99.29 3.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 117.156 0.478 . . . . 0.0 110.413 174.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -62.0 145.79 52.03 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 158.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.7 pp -150.52 -177.44 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 127.066 2.147 . . . . 0.0 107.52 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.5 m -160.33 118.19 2.56 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.087 1.755 . . . . 0.0 106.345 155.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 16.2 p -148.46 152.29 36.67 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.661 1.184 . . . . 0.0 109.96 -172.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.16 31.1 0.1 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.103 1.761 . . . . 0.0 110.679 175.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.43 -17.04 41.7 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.238 1.415 . . . . 0.0 113.111 -166.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.7 tp -134.56 112.81 11.17 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -156.11 54.11 0.57 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 126.93 2.092 . . . . 0.0 107.925 -172.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tp -106.43 143.27 34.78 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.23 1.012 . . . . 0.0 108.984 -171.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -158.95 136.88 10.39 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.199 0.6 . . . . 0.0 109.461 -167.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -137.48 127.36 25.64 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 128.278 2.631 . . . . 0.0 106.062 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.257 1.494 0 C-N-CA 128.987 2.915 . . . . 0.0 104.888 153.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.783 0 N-CA-C 105.959 -2.857 . . . . 0.0 105.959 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -150.63 122.58 8.18 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 -150.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -144.71 108.21 4.63 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 104.054 -2.573 . . . . 0.0 104.054 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -152.57 147.25 25.96 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.914 1.286 . . . . 0.0 108.596 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -154.02 61.88 3.58 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.837 1.255 . . . . 0.0 109.437 -175.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -62.94 154.85 64.06 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.826 1.684 . . . . 0.0 111.93 -173.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.43 112.58 0.55 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 -169.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -142.87 -129.97 2.4 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 125.72 1.629 . . . . 0.0 109.804 173.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -150.85 158.92 44.74 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.09 1.445 . . . . 0.0 109.214 -174.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.471 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . 167.52 -148.91 13.59 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 128.714 3.054 . . . . 0.0 108.471 171.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.52 165.44 17.81 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.544 0.738 . . . . 0.0 112.291 -163.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.461 ' H ' ' HB3' ' A' ' 102' ' ' ASN . 25.2 mtp -116.02 170.15 8.72 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 144.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -173.71 160.8 3.78 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 131.131 3.773 . . . . 0.0 106.902 -178.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -153.43 112.24 3.72 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.58 158.35 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.173 0.989 . . . . 0.0 109.169 175.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 p -136.43 160.27 39.25 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 160.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.7 tp -130.04 143.69 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 126.479 1.912 . . . . 0.0 106.031 173.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -131.63 139.18 49.06 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 126.944 2.098 . . . . 0.0 106.671 170.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -104.13 144.85 31.03 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.441 1.496 . . . . 0.0 107.975 176.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.3 t -154.38 170.7 20.72 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.816 1.246 . . . . 0.0 108.76 -176.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 54.66 -147.46 24.35 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.564 1.078 . . . . 0.0 110.646 -165.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -84.22 95.87 8.8 Favored 'General case' 0 C--O 1.222 -0.357 0 O-C-N 121.622 -0.928 . . . . 0.0 110.451 175.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -96.52 8.18 44.73 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 120.344 -1.473 . . . . 0.0 112.73 -175.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -94.92 -5.6 44.45 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -157.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.5 t -127.13 23.45 6.49 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.11 0.868 . . . . 0.0 110.972 -165.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -135.99 118.29 15.63 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.082 0.953 . . . . 0.0 110.908 -164.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.7 mt -66.63 108.44 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -80.75 149.93 29.46 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.547 1.139 . . . . 0.0 109.237 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 m -150.85 138.21 19.46 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 169.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.4 t -136.41 139.48 45.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.501 HG22 HD12 ' A' ' 53' ' ' ILE . 58.1 t -106.19 132.16 54.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 128.321 2.649 . . . . 0.0 108.695 169.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.4 p -126.56 166.29 23.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 126.613 1.965 . . . . 0.0 109.219 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.1 p -139.4 165.0 23.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 158.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.29 100.13 3.82 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 162.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -66.26 106.44 1.68 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.38 6.7 58.56 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 117.974 -1.459 . . . . 0.0 115.71 166.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.448 HG22 ' HB2' ' A' ' 72' ' ' ALA . 1.3 t -155.14 -174.39 4.96 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.913 1.856 . . . . 0.0 109.473 167.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -92.14 164.4 13.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.687 1.195 . . . . 0.0 111.703 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.5 tp -90.13 163.12 14.97 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.781 1.232 . . . . 0.0 108.426 172.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.416 ' HE2' ' HA2' ' A' ' 45' ' ' GLY . 77.8 tttt -125.2 117.66 24.34 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.357 1.463 . . . . 0.0 107.204 174.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -75.97 114.73 14.93 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.514 1.133 . . . . 0.0 109.166 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.91 0.68 35.97 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-O 118.524 -1.153 . . . . 0.0 114.283 -173.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.25 -40.6 81.89 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 119.837 1.819 . . . . 0.0 111.427 170.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.94 -18.97 1.17 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.001 0.92 . . . . 0.0 113.006 -169.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.416 ' HA2' ' HE2' ' A' ' 40' ' ' LYS . . . 86.23 19.43 57.21 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 119.25 -0.75 . . . . 0.0 111.936 -170.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -71.19 128.82 37.2 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.574 1.187 . . . . 0.0 109.171 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.65 133.21 50.64 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 126.334 1.854 . . . . 0.0 110.043 169.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 30.6 mt -128.93 152.22 48.8 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.612 1.165 . . . . 0.0 111.048 176.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.63 91.67 5.87 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.718 1.207 . . . . 0.0 110.156 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.81 153.46 42.58 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.643 0.777 . . . . 0.0 111.672 173.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.02 128.73 15.2 Favored 'Cis proline' 0 C--N 1.349 0.599 0 CA-C-N 120.229 1.117 . . . . 0.0 111.709 -8.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.419 ' O ' HD13 ' A' ' 53' ' ' ILE . 99.8 t -96.42 155.71 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 172.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.501 HD12 HG22 ' A' ' 31' ' ' VAL . 18.2 mm -114.12 120.53 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 105.234 -2.135 . . . . 0.0 105.234 166.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.69 163.37 26.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 122.123 0.963 . . . . 0.0 109.017 172.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.589 ' H ' ' HG2' ' A' ' 58' ' ' GLU . 4.9 m -129.32 -153.79 0.59 Allowed 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 127.95 2.5 . . . . 0.0 109.106 -169.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.01 -29.69 13.99 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.774 1.63 . . . . 0.0 110.935 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -67.05 -40.27 87.07 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 125.221 1.409 . . . . 0.0 110.516 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.589 ' HG2' ' H ' ' A' ' 55' ' ' SER . 1.8 pp20? -62.31 -29.83 70.72 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 123.92 0.888 . . . . 0.0 112.265 -177.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.9 mt -89.14 27.9 1.31 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.401 2.281 . . . . 0.0 111.457 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.46 17.36 2.19 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.616 -1.303 . . . . 0.0 114.163 -172.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.773 HG23 ' H ' ' A' ' 63' ' ' LYS . 13.9 m -123.93 -163.84 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 120.74 1.609 . . . . 0.0 108.337 166.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -76.02 -30.64 58.55 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 169.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.773 ' H ' HG23 ' A' ' 61' ' ' VAL . 2.2 tmtp? -153.3 131.54 11.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 117.217 -1.373 . . . . 0.0 111.808 -162.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.86 165.31 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 119.618 1.099 . . . . 0.0 108.85 176.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.4 m -134.83 127.72 31.33 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 128.081 2.552 . . . . 0.0 106.386 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -129.52 133.2 47.12 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 121.218 1.826 . . . . 0.0 108.255 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.6 t -135.26 176.18 8.91 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.308 -0.87 . . . . 0.0 108.867 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.6 p -90.09 153.73 20.33 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 166.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.7 p -76.21 -13.36 60.18 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.859 -0.525 . . . . 0.0 112.311 173.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.63 -168.12 18.17 Favored Glycine 0 N--CA 1.449 -0.491 0 O-C-N 120.875 -1.141 . . . . 0.0 110.903 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.471 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 5.0 ttpt -60.26 139.02 57.82 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 170.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.448 ' HB2' HG22 ' A' ' 37' ' ' THR . . . -135.16 177.81 7.52 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 168.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.2 mm -115.5 -11.04 12.11 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 118.087 -0.959 . . . . 0.0 111.017 -177.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -152.39 155.33 37.36 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 120.568 1.531 . . . . 0.0 110.556 172.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -141.45 107.43 5.17 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.369 1.468 . . . . 0.0 109.565 170.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.91 153.98 21.18 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.643 1.111 . . . . 0.0 110.45 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.8 t -146.53 95.72 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 173.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.7 m -131.19 159.83 36.58 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.581 -0.699 . . . . 0.0 109.404 174.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.92 -179.58 19.77 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-N 119.206 0.912 . . . . 0.0 113.267 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.43 -160.38 24.08 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 123.92 0.771 . . . . 0.0 111.308 -169.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.35 119.04 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 126.04 1.736 . . . . 0.0 110.822 -176.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.38 170.86 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.473 0 O-C-N 121.185 -0.947 . . . . 0.0 111.084 164.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -146.93 109.55 4.6 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.463 1.105 . . . . 0.0 109.125 158.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.43 2.65 84.65 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.255 -1.303 . . . . 0.0 113.083 174.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -89.51 140.94 29.03 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 120.058 1.929 . . . . 0.0 109.145 172.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -144.87 1.93 1.02 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.481 1.112 . . . . 0.0 111.628 175.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.34 28.58 4.25 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 126.681 2.086 . . . . 0.0 112.346 -177.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.8 p -144.51 130.98 15.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 125.377 1.471 . . . . 0.0 107.25 171.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.99 145.68 12.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -143.98 -165.66 2.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.481 1.112 . . . . 0.0 109.074 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -125.27 163.88 35.43 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 126.006 1.722 . . . . 0.0 109.635 168.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.42 175.07 9.29 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.74 2.293 . . . . 0.0 112.683 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 6.9 ptm -137.26 173.64 11.47 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.658 0.783 . . . . 0.0 110.291 -172.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -138.85 147.78 42.88 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.47 1.108 . . . . 0.0 108.763 170.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -117.61 133.11 56.31 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 170.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.1 t -128.16 111.7 24.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 -177.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.6 t -134.38 121.18 35.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 -160.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.6 m -110.87 159.8 17.35 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -173.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.9 t -125.61 129.4 72.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 162.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -97.04 134.91 39.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 104.74 -2.319 . . . . 0.0 104.74 163.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.3 tptm -91.56 -173.33 3.52 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 172.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.461 ' HB3' ' H ' ' A' ' 12' ' ' MET . 0.7 OUTLIER -59.35 74.21 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.047 2.139 . . . . 0.0 109.581 167.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 157.33 -72.32 0.24 Allowed Glycine 0 CA--C 1.523 0.545 0 C-N-CA 126.72 2.105 . . . . 0.0 111.64 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.45 -177.15 6.35 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.291 1.436 . . . . 0.0 111.024 -171.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.16 144.06 7.57 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.452 1.501 . . . . 0.0 109.846 173.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.6 pt -133.41 -27.41 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 123.897 0.879 . . . . 0.0 111.624 168.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -148.21 151.44 35.51 Favored 'General case' 0 N--CA 1.461 0.082 0 CA-C-N 119.746 1.157 . . . . 0.0 111.517 -162.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -151.59 68.49 0.9 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.124 1.769 . . . . 0.0 110.453 -159.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.444 ' HE2' HD13 ' A' ' 126' ' ' LEU . 6.0 mmmt -86.25 118.76 25.91 Favored 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 120.539 -1.35 . . . . 0.0 109.225 176.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.54 139.46 52.3 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 125.064 1.345 . . . . 0.0 110.087 178.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 111' ' ' LEU . 1.2 mp -131.44 -178.37 4.82 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.484 2.314 . . . . 0.0 109.564 -177.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.7 p -154.08 44.79 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 124.793 1.237 . . . . 0.0 112.204 -162.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -72.44 169.2 16.9 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.407 -0.808 . . . . 0.0 112.53 -173.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.5 mtm-85 -147.39 175.1 11.07 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.207 1.003 . . . . 0.0 111.574 -168.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -61.31 160.29 10.92 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 131.191 3.796 . . . . 0.0 115.237 172.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 122.63 -42.87 1.54 Allowed Glycine 0 C--N 1.34 0.769 0 C-N-CA 125.637 1.589 . . . . 0.0 116.02 157.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.36 179.55 6.72 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 120.051 1.925 . . . . 0.0 110.527 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -107.36 137.07 46.07 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 125.975 1.71 . . . . 0.0 108.199 -176.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.441 ' C ' HD12 ' A' ' 119' ' ' ILE . 2.5 pp -147.0 168.29 5.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 126.205 1.802 . . . . 0.0 107.252 175.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.18 17.4 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 175.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.35 -1.19 1.2 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 -161.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -142.82 62.81 1.4 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 122.691 1.234 . . . . 0.0 109.193 163.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -121.21 -82.75 0.65 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 127.936 2.495 . . . . 0.0 107.982 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.5 tp -138.25 121.71 17.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -167.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -141.26 80.86 1.76 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 169.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.444 HD13 ' HE2' ' A' ' 109' ' ' LYS . 1.4 tp -109.07 151.38 26.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -152.72 126.86 9.12 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -178.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -117.83 161.78 19.17 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.61 1.564 . . . . 0.0 110.521 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.39 0 C-N-CA 128.283 2.633 . . . . 0.0 106.849 164.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.782 0 N-CA-C 106.622 -2.591 . . . . 0.0 106.622 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -155.8 145.65 21.31 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 102.882 -3.007 . . . . 0.0 102.882 -158.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -109.0 15.28 23.5 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 127.537 2.335 . . . . 0.0 110.992 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -135.57 161.27 35.98 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.463 2.305 . . . . 0.0 108.723 173.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -153.56 85.86 4.03 Favored Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 167.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -81.05 -172.31 1.48 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.932 2.422 . . . . 0.0 110.412 -174.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.43 -10.04 73.17 Favored Glycine 0 CA--C 1.527 0.797 0 O-C-N 120.913 -1.117 . . . . 0.0 113.125 171.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.15 -126.21 7.85 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 178.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -148.9 161.12 42.49 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 173.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.58 -119.05 1.01 Allowed Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 154.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.18 -162.2 1.19 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.31 1.044 . . . . 0.0 108.324 -164.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.1 mtp -137.1 161.42 36.15 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 127.894 2.478 . . . . 0.0 105.332 161.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -136.65 148.89 47.67 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 173.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -143.6 138.05 28.77 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 103.676 -2.712 . . . . 0.0 103.676 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.2 157.5 38.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 169.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 p -124.83 154.09 41.54 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 164.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.459 HD11 ' CD2' ' A' ' 95' ' ' TRP . 7.1 tt -120.65 156.95 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 C-N-CA 122.44 0.296 . . . . 0.0 110.514 155.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -139.98 131.96 27.78 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 166.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -117.12 109.04 16.44 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.801 2.04 . . . . 0.0 107.13 -165.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.5 p -139.27 179.88 6.27 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 175.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 93' ' ' MET . . . 58.26 -157.96 17.69 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -152.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -85.15 106.93 16.96 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.176 0.988 . . . . 0.0 112.604 -168.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -113.79 -4.57 13.34 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 121.402 1.91 . . . . 0.0 115.299 -172.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.97 34.0 1.43 Allowed 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.316 -0.865 . . . . 0.0 111.159 -171.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.8 m -143.67 7.0 1.46 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.4 1.08 . . . . 0.0 112.317 -165.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -140.97 152.44 44.96 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 120.404 1.456 . . . . 0.0 111.346 -159.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 84.9 mt -84.95 95.29 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 174.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.64 148.32 22.39 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 172.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.8 t -142.6 157.55 44.59 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.409 1.884 . . . . 0.0 108.158 -175.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -143.48 160.03 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 165.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.485 ' CG1' ' H ' ' A' ' 78' ' ' SER . 2.4 p -128.69 141.45 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 126.713 2.005 . . . . 0.0 106.182 160.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.9 t -137.87 130.98 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.6 t -140.23 138.59 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.81 89.88 2.29 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.57 1.077 . . . . 0.0 111.896 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.472 ' H ' ' HB2' ' A' ' 74' ' ' GLU . 39.3 t-20 -58.16 105.26 0.26 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.223 1.409 . . . . 0.0 112.689 -174.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.44 -1.25 27.9 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 118.602 -1.11 . . . . 0.0 114.185 164.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.3 t -154.18 -168.1 2.84 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.054 1.427 . . . . 0.0 110.236 -169.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -116.75 159.51 22.18 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.017 1.727 . . . . 0.0 109.484 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.2 164.16 17.37 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 124.289 1.035 . . . . 0.0 108.693 176.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -133.06 123.16 25.27 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 173.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -79.9 117.19 20.54 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 166.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.83 -17.82 55.44 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.625 -1.097 . . . . 0.0 114.339 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.85 -39.11 87.86 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 119.855 1.827 . . . . 0.0 110.205 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.06 -10.58 1.13 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -169.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.1 29.36 64.76 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -171.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -69.13 115.31 8.27 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 170.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.78 103.69 11.64 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.5 mt -91.24 -173.7 3.71 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.156 0.983 . . . . 0.0 108.923 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.52 94.24 3.61 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -177.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.52 162.31 27.66 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.708 -0.663 . . . . 0.0 109.596 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.32 143.81 66.04 Favored 'Cis proline' 0 N--CA 1.459 -0.519 0 CA-C-N 120.142 1.086 . . . . 0.0 112.696 -1.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.7 t -142.07 149.11 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.28 1.432 . . . . 0.0 108.818 -169.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.8 mm -135.89 97.72 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 126.61 1.964 . . . . 0.0 107.124 -159.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -82.5 140.94 33.05 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.076 0.95 . . . . 0.0 108.913 -174.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.4 p -110.24 -166.23 1.07 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.22 1.008 . . . . 0.0 110.477 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -64.09 -48.28 76.75 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.684 1.994 . . . . 0.0 111.782 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -61.23 -27.44 68.44 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 125.04 1.336 . . . . 0.0 110.797 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -95.1 -11.9 27.44 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.317 0.647 . . . . 0.0 110.344 -169.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -96.98 17.77 16.18 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.862 2.065 . . . . 0.0 112.673 176.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.15 39.69 0.15 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.174 1.789 . . . . 0.0 113.378 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.1 m -136.46 162.48 35.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 126.281 1.832 . . . . 0.0 108.778 -170.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -85.5 -17.06 37.51 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.293 -0.88 . . . . 0.0 113.04 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -155.14 151.67 28.52 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 125.196 1.398 . . . . 0.0 107.911 -166.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.446 ' HB ' HG22 ' A' ' 17' ' ' ILE . 11.2 t -143.77 140.9 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 164.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.3 m -118.07 135.09 54.41 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 168.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.5 mt -140.0 146.04 38.58 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.6 169.25 22.01 Favored 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 121.649 -0.657 . . . . 0.0 110.148 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.427 HG21 ' HB2' ' A' ' 72' ' ' ALA . 3.3 p -95.44 155.97 16.52 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 117.801 0.273 . . . . 0.0 111.163 174.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.4 p -82.3 -3.38 55.17 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.524 -0.735 . . . . 0.0 112.015 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.72 -156.88 15.68 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -176.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.488 ' HE2' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -60.93 137.13 58.24 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 117.483 0.641 . . . . 0.0 110.218 -168.446 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.427 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -129.33 141.63 51.03 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 176.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.488 HD11 ' HE2' ' A' ' 71' ' ' LYS . 0.8 OUTLIER -133.94 21.5 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 C-N-CA 123.723 0.809 . . . . 0.0 110.254 174.718 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 129' ' ' ASN . 40.3 mt-10 -142.77 147.33 35.37 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 168.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -154.56 86.11 1.13 Allowed 'General case' 0 C--O 1.232 0.164 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 157.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 127' ' ' TYR . . . -76.4 145.9 39.04 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.164 175.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.2 t -143.92 108.7 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.105 1.362 . . . . 0.0 107.712 166.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.485 ' H ' ' CG1' ' A' ' 31' ' ' VAL . 1.6 t -109.38 173.67 6.22 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 152.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 150.55 -166.07 30.14 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 -170.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 146.21 166.77 12.28 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.513 1.054 . . . . 0.0 110.822 174.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.9 m -142.88 114.17 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 174.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.7 m -86.11 177.44 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -159.64 90.73 0.95 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 166.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -121.32 27.82 6.23 Favored Glycine 0 N--CA 1.465 0.615 0 C-N-CA 124.049 0.833 . . . . 0.0 111.213 -172.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.75 157.94 20.71 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.447 1.499 . . . . 0.0 109.407 -160.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -119.94 0.41 10.8 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.026 0.931 . . . . 0.0 112.489 -173.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -110.65 -44.96 0.93 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 125.086 1.327 . . . . 0.0 110.228 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.6 t -89.56 71.21 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 118.056 0.928 . . . . 0.0 109.569 -174.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.9 p -61.6 142.67 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 164.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.55 -166.6 2.28 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 170.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -87.22 164.08 37.26 Favored Pre-proline 0 CA--C 1.541 0.617 0 O-C-N 121.45 -0.781 . . . . 0.0 109.505 159.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -76.73 175.33 11.51 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.058 2.505 . . . . 0.0 112.913 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.403 ' HA ' ' HA3' ' A' ' 21' ' ' GLY . 14.3 ptm -139.94 164.0 31.16 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.722 1.209 . . . . 0.0 111.646 -173.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -140.26 156.52 46.44 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.208 1.403 . . . . 0.0 109.66 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.459 ' CD2' HD11 ' A' ' 17' ' ' ILE . 1.5 m0 -127.19 124.69 39.58 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 176.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 t -95.68 121.23 46.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 162.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.6 p -127.54 137.41 57.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 170.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.9 m -148.22 142.61 26.31 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.457 ' H ' ' HB3' ' A' ' 107' ' ' GLU . 3.4 t -117.01 145.31 22.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 124.209 1.004 . . . . 0.0 108.399 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -128.77 130.77 47.49 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 128.034 2.534 . . . . 0.0 106.103 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -84.45 -163.71 0.84 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.13 77.45 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.313 1.045 . . . . 0.0 109.261 166.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 151.87 -56.81 0.44 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.162 -1.355 . . . . 0.0 114.428 168.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.71 -176.84 5.96 Favored 'General case' 0 C--N 1.34 0.196 0 CA-C-N 119.958 1.879 . . . . 0.0 110.966 176.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -44.78 138.32 3.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 130.034 3.334 . . . . 0.0 111.935 176.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.8 pt -139.07 -2.03 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.95 1.7 . . . . 0.0 112.226 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.457 ' HB3' ' H ' ' A' ' 99' ' ' VAL . 0.0 OUTLIER -127.02 170.89 11.83 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.358 1.463 . . . . 0.0 107.43 -176.762 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.6 tttm -159.62 21.47 0.18 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.262 1.425 . . . . 0.0 111.628 175.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.41 87.9 1.57 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.388 -1.445 . . . . 0.0 110.54 -174.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 p -73.15 161.97 29.98 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.3 1.04 . . . . 0.0 110.441 170.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.2 mt -140.39 138.21 34.6 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.338 1.455 . . . . 0.0 108.417 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.5 p -142.61 81.69 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 122.489 1.138 . . . . 0.0 110.11 -172.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -73.13 167.17 21.7 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.423 1.489 . . . . 0.0 110.399 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -139.36 162.32 35.3 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 123.634 0.774 . . . . 0.0 110.173 -175.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -75.28 149.05 38.9 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.882 0.873 . . . . 0.0 108.838 167.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.21 36.14 13.43 Favored Glycine 0 C--O 1.239 0.437 0 CA-C-O 117.35 -1.806 . . . . 0.0 115.346 153.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.07 117.0 3.47 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 120.785 2.292 . . . . 0.0 114.99 -172.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.62 119.36 5.17 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.69 0.677 . . . . 0.0 110.461 169.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.9 pp -143.42 163.9 15.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 125.898 1.679 . . . . 0.0 110.342 174.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.7 p -164.35 8.73 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 116.87 2.174 . . . . 0.0 116.87 177.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.5 p -146.95 9.85 1.01 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 116.215 1.932 . . . . 0.0 116.215 -156.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -140.94 70.33 1.35 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.707 1.14 . . . . 0.0 108.134 167.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -122.19 -85.77 0.65 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-O 117.732 -1.127 . . . . 0.0 110.916 173.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 37.0 mt -142.25 101.22 3.87 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 120.16 1.345 . . . . 0.0 110.456 -165.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -130.01 51.53 2.08 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.174 2.189 . . . . 0.0 107.402 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 mp -107.55 139.17 42.5 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.801 1.24 . . . . 0.0 108.916 177.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 59.5 t80 -151.32 91.2 1.65 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -178.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -83.68 153.46 24.21 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.283 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 177.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.79 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -153.83 102.2 2.5 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 169.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.6 t0 174.45 127.79 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -144.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -158.67 122.95 4.05 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.897 1.279 . . . . 0.0 108.802 -169.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -153.57 85.45 4.08 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 124.496 1.118 . . . . 0.0 109.403 -172.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -86.81 142.55 6.75 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.401 2.067 . . . . 0.0 111.92 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -110.07 75.27 0.21 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 170.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 149.23 -168.05 29.58 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 124.495 1.045 . . . . 0.0 111.333 176.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.3 tttm -123.97 166.92 14.86 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 159.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . -164.61 -148.6 5.51 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 127.803 2.621 . . . . 0.0 107.79 166.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.88 179.03 6.62 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.079 0.952 . . . . 0.0 109.991 -168.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.2 mtp -107.96 166.21 10.89 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 155.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.51 ' HB3' ' CD2' ' A' ' 75' ' ' PHE . 71.0 m-85 -147.65 139.99 24.47 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -142.4 120.93 12.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -178.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p -105.36 161.69 5.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 123.002 1.382 . . . . 0.0 109.063 176.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 p -132.86 148.7 52.3 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.519 1.528 . . . . 0.0 106.977 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.4 tp -139.51 132.65 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 174.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -132.95 123.73 26.47 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 127.133 2.173 . . . . 0.0 106.563 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -103.86 137.54 41.72 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.031 0.932 . . . . 0.0 109.291 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 m -135.99 172.15 13.44 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.295 -0.878 . . . . 0.0 110.707 170.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.88 -150.54 32.66 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-O 121.642 0.579 . . . . 0.0 111.987 173.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -72.89 98.09 2.39 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 159.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -113.71 23.59 12.94 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.146 0.498 . . . . 0.0 110.65 170.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.2 mtt180 -102.92 -29.32 11.5 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 118.498 -0.763 . . . . 0.0 111.693 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.8 m -114.55 22.44 13.62 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -152.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -128.41 144.83 51.19 Favored 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 121.476 -0.765 . . . . 0.0 109.251 -173.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.2 mp -76.03 89.11 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 171.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -89.64 146.99 24.16 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.006 1.322 . . . . 0.0 108.953 -177.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.3 t -138.69 148.91 44.55 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.457 1.503 . . . . 0.0 108.536 -174.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.4 t -136.87 106.79 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 161.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.3 t -65.73 117.01 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 160.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 91.8 t -116.72 123.62 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 175.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.454 HG22 ' HB3' ' A' ' 51' ' ' PRO . 16.8 t -129.72 156.76 42.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 162.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.29 120.91 9.79 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.969 1.708 . . . . 0.0 107.42 165.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -75.1 109.31 8.47 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 118.039 -0.981 . . . . 0.0 108.707 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.43 10.66 50.35 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 116.844 1.498 . . . . 0.0 116.844 161.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.854 HG22 ' HB2' ' A' ' 72' ' ' ALA . 14.8 t -157.0 -174.8 5.09 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 119.536 1.668 . . . . 0.0 107.969 164.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -106.46 165.27 11.39 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 122.309 1.052 . . . . 0.0 113.699 168.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.15 169.07 13.43 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 112.272 -2.24 . . . . 0.0 109.772 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -144.15 123.5 13.08 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.301 1.441 . . . . 0.0 109.215 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -71.93 131.77 43.43 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.301 1.04 . . . . 0.0 110.341 -177.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.07 -18.41 72.83 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.31 -1.272 . . . . 0.0 113.904 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.0 -60.38 3.96 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 119.057 1.428 . . . . 0.0 109.367 174.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.28 0.61 1.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -157.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.04 12.35 83.44 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-O 119.854 -0.414 . . . . 0.0 112.371 174.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -65.12 130.43 43.34 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.3 m -68.82 125.01 25.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 175.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.7 mt -112.71 128.92 56.54 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -174.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -95.81 88.36 4.93 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.303 1.041 . . . . 0.0 109.088 -170.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.7 m -51.15 156.67 1.76 Allowed Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 128.423 2.689 . . . . 0.0 112.128 172.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.454 ' HB3' HG22 ' A' ' 33' ' ' VAL . 66.7 Cg_endo -73.42 154.22 99.49 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 N-CA-C 109.435 -1.025 . . . . 0.0 109.435 -8.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.2 t -138.55 144.21 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.0 mm -120.68 81.35 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 28.4 mt -63.1 136.19 57.64 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 m -110.27 175.74 5.32 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 125.902 1.681 . . . . 0.0 110.088 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -46.9 -48.04 21.34 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 127.306 2.243 . . . . 0.0 113.744 -175.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -69.6 -40.53 76.6 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.512 0.596 . . . . 0.0 110.89 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -68.4 -10.88 58.14 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.064 0.945 . . . . 0.0 111.081 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.9 mt -121.29 10.49 10.61 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.179 2.191 . . . . 0.0 111.141 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.92 11.97 0.46 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.067 1.347 . . . . 0.0 112.662 171.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.1 m -66.44 -168.5 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 126.054 1.742 . . . . 0.0 111.135 164.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -110.91 -36.24 5.73 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.909 1.684 . . . . 0.0 111.466 168.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.18 143.03 26.78 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 127.327 2.251 . . . . 0.0 105.941 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.2 p -146.63 102.6 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 120.363 1.438 . . . . 0.0 112.436 161.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m -66.04 134.48 52.96 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.434 -1.417 . . . . 0.0 109.933 172.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 mt -132.99 146.52 51.85 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 124.307 1.043 . . . . 0.0 108.455 -175.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.4 t -162.7 160.12 25.16 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -161.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -86.85 151.23 23.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.422 0.629 . . . . 0.0 112.466 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.2 p -82.75 -20.91 35.01 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.614 1.566 . . . . 0.0 112.165 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -146.55 -163.87 10.67 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 125.873 1.702 . . . . 0.0 108.871 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.425 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 16.1 ttpt -77.47 141.91 39.44 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 175.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.854 ' HB2' HG22 ' A' ' 37' ' ' THR . . . -132.95 175.52 9.29 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.957 0.903 . . . . 0.0 109.833 171.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 mm -121.6 -13.53 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.409 1.084 . . . . 0.0 110.205 -167.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -151.51 162.2 41.37 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.614 1.166 . . . . 0.0 108.828 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.51 ' CD2' ' HB3' ' A' ' 13' ' ' TYR . 3.0 t80 -155.58 85.91 1.06 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.695 0.798 . . . . 0.0 109.202 173.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.16 149.72 28.99 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.998 -0.439 . . . . 0.0 110.73 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 t -142.65 124.25 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 125.248 1.419 . . . . 0.0 108.368 171.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.09 169.76 17.24 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 158.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.35 -125.74 0.88 Allowed Glycine 0 CA--C 1.52 0.394 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 173.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.32 173.03 13.48 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 123.614 0.626 . . . . 0.0 112.203 173.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.2 m -146.47 129.53 9.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 125.232 1.413 . . . . 0.0 109.175 173.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.86 159.1 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 123.896 0.878 . . . . 0.0 108.703 157.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -69.54 150.45 47.12 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.403 168.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -115.41 28.43 7.88 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 126.012 1.768 . . . . 0.0 112.628 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -128.65 -164.29 1.37 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.713 1.756 . . . . 0.0 108.039 171.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -143.09 110.63 5.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 105.807 -1.924 . . . . 0.0 105.807 169.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.27 18.04 58.02 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-O 119.166 -0.797 . . . . 0.0 113.417 174.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.2 p -59.66 156.49 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.988 0.899 . . . . 0.0 109.912 169.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.9 t -124.84 88.72 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -115.02 -154.34 0.54 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.986 1.715 . . . . 0.0 108.346 173.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -129.4 164.46 39.42 Favored Pre-proline 0 C--N 1.333 -0.127 0 O-C-N 120.551 -1.343 . . . . 0.0 111.614 176.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -73.0 175.19 10.8 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.485 1.457 . . . . 0.0 111.976 176.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -138.16 168.72 19.13 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.068 0.947 . . . . 0.0 110.414 177.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -135.98 157.04 47.79 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 169.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.539 ' CE3' HD12 ' A' ' 111' ' ' LEU . 33.2 m0 -123.46 133.82 54.0 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 168.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.1 t -90.28 135.57 26.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 151.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.7 130.68 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 172.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 m -135.94 147.63 48.17 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -176.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.2 t -118.07 131.2 71.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -116.1 166.92 11.46 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 128.682 2.793 . . . . 0.0 107.988 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -118.67 -154.3 0.56 Allowed 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 129.224 3.01 . . . . 0.0 107.616 -171.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -69.34 85.43 0.4 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 162.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.75 16.64 69.96 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 117.98 -1.456 . . . . 0.0 115.258 164.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.7 167.49 28.02 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 120.785 2.293 . . . . 0.0 112.116 172.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -90.21 141.05 29.08 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.09 1.356 . . . . 0.0 109.16 -174.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.8 pt -129.02 -19.81 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 119.124 0.874 . . . . 0.0 113.357 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -132.42 160.5 36.2 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -157.79 87.16 0.93 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 176.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.33 164.05 24.4 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 171.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.5 t -138.93 163.33 32.61 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.539 HD12 ' CE3' ' A' ' 95' ' ' TRP . 24.2 mt -126.14 157.49 37.98 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 123.61 0.764 . . . . 0.0 109.013 -177.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.3 p -147.2 114.68 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 -173.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -123.55 171.6 9.4 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 44.9 mtp85 -136.82 159.79 40.79 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.466 0.65 . . . . 0.0 110.285 174.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -65.59 158.24 27.68 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 127.095 2.158 . . . . 0.0 111.473 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.09 -73.58 0.28 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.302 1.429 . . . . 0.0 113.512 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -158.99 29.47 0.21 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 118.604 2.816 . . . . 0.0 118.604 -148.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -144.21 84.59 1.77 Allowed 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.206 -1.559 . . . . 0.0 113.666 -175.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.1 pp -144.8 -174.62 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 127.063 2.145 . . . . 0.0 109.767 174.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.3 t -153.24 148.04 26.39 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 121.364 -0.835 . . . . 0.0 110.078 168.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.0 p -69.45 30.0 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 129.862 3.265 . . . . 0.0 114.138 -175.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -126.86 56.56 1.49 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 158.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -56.46 10.24 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.75 143.49 50.78 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.884 1.274 . . . . 0.0 108.834 174.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -153.1 25.17 0.55 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.779 1.632 . . . . 0.0 111.586 -157.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 88.3 mt -97.15 124.41 41.18 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.71 1.604 . . . . 0.0 107.829 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -139.89 46.64 1.86 Allowed 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.542 0.737 . . . . 0.0 109.019 -170.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -55.26 137.67 46.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.85 -168.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.086 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 167.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.696 0 N-CA-C 107.524 -2.23 . . . . 0.0 107.524 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -149.38 -64.8 0.22 Allowed 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -157.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -171.11 155.79 4.54 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 129.329 3.052 . . . . 0.0 104.33 -164.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -141.16 99.11 3.51 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -172.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -152.82 57.17 1.96 Allowed Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.659 1.184 . . . . 0.0 110.329 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.42 111.01 2.18 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.356 2.038 . . . . 0.0 111.593 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.81 13.34 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.036 -0.984 . . . . 0.0 113.538 -156.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 173.89 -160.69 30.78 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -175.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.83 130.71 54.48 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.615 1.166 . . . . 0.0 109.107 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.41 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . -159.75 -126.3 0.84 Allowed Glycine 0 C--N 1.317 -0.485 0 C-N-CA 127.534 2.492 . . . . 0.0 107.137 164.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.64 161.4 35.23 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.724 0.81 . . . . 0.0 110.86 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 7.8 mtp -91.89 153.62 19.39 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 158.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.489 ' CD1' ' HB2' ' A' ' 75' ' ' PHE . 8.6 m-85 -143.65 114.66 7.81 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 126.282 1.833 . . . . 0.0 106.448 -170.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -127.29 144.76 50.99 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.743 2.017 . . . . 0.0 106.885 172.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.42 132.94 38.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 127.133 2.173 . . . . 0.0 108.89 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.5 p -96.0 163.56 13.08 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.749 0.785 . . . . 0.0 109.913 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.426 HD11 ' CD2' ' A' ' 95' ' ' TRP . 4.0 tp -140.75 112.6 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 167.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -114.29 135.97 53.48 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -176.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -122.19 115.4 22.33 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 124.287 1.035 . . . . 0.0 108.732 -161.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 m -120.92 -179.01 3.88 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.17 -99.29 0.56 Allowed Glycine 0 C--N 1.338 0.651 0 C-N-CA 127.301 2.382 . . . . 0.0 110.417 176.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.6 113.39 9.11 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -117.53 11.02 13.69 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -170.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -102.57 -1.06 31.09 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.079 1.352 . . . . 0.0 113.941 -168.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.1 m -143.45 95.12 2.7 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 164.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -176.94 110.83 0.08 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 128.08 2.552 . . . . 0.0 106.433 174.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.3 pt -66.39 86.8 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 127.221 2.208 . . . . 0.0 112.36 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.42 144.68 55.63 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 121.113 -0.992 . . . . 0.0 109.942 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.9 m -148.36 130.03 15.03 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 170.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.8 t -140.39 165.77 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 175.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.647 HG13 ' CD1' ' A' ' 53' ' ' ILE . 30.0 t -141.13 52.42 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 125.786 1.635 . . . . 0.0 110.806 -157.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.7 p -65.91 135.85 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 O-C-N 119.248 -2.157 . . . . 0.0 111.215 -170.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.6 t -117.56 148.12 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 171.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.32 133.74 20.77 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.93 0.892 . . . . 0.0 108.615 171.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -102.7 85.83 2.64 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.186 1.394 . . . . 0.0 109.022 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.09 -78.76 0.29 Allowed Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 162.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.8 t -76.55 179.51 5.9 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.106 0.963 . . . . 0.0 109.914 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -96.67 168.05 10.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.833 1.253 . . . . 0.0 111.232 174.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.59 168.31 15.48 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.38 1.472 . . . . 0.0 109.38 176.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -137.01 128.14 27.83 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.795 1.638 . . . . 0.0 109.524 172.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -92.2 110.32 21.71 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.547 1.939 . . . . 0.0 109.45 -165.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -57.69 -23.12 49.06 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 118.989 0.813 . . . . 0.0 114.553 -169.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.87 -56.97 15.32 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.325 1.45 . . . . 0.0 112.032 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.5 p -125.67 0.15 7.46 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.608 1.563 . . . . 0.0 111.144 -164.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.78 22.56 54.04 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 125.395 1.474 . . . . 0.0 112.171 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.32 158.2 26.17 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 118.24 1.02 . . . . 0.0 109.358 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.4 m -117.4 106.15 12.9 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 122.391 1.091 . . . . 0.0 110.207 -167.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 45.3 mt -93.59 159.47 15.21 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 125.109 1.364 . . . . 0.0 111.874 -164.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.86 95.69 9.67 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.926 2.09 . . . . 0.0 108.763 -172.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.2 p -58.74 167.72 1.73 Allowed Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.053 0.941 . . . . 0.0 111.468 172.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.72 145.38 79.18 Favored 'Cis proline' 0 CA--C 1.537 0.629 0 N-CA-C 109.733 -0.91 . . . . 0.0 109.733 -19.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.6 p -135.19 156.93 39.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 O-C-N 121.242 -0.911 . . . . 0.0 109.939 -170.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.647 ' CD1' HG13 ' A' ' 31' ' ' VAL . 30.5 mm -114.02 126.83 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 175.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.8 mt -92.43 164.83 13.33 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 128.154 2.582 . . . . 0.0 110.327 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.571 ' H ' ' HG2' ' A' ' 58' ' ' GLU . 57.4 p -132.64 -163.35 1.33 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.417 2.287 . . . . 0.0 111.126 -165.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -88.08 -21.01 24.96 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 126.565 1.946 . . . . 0.0 110.292 175.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.32 -36.52 61.05 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.286 1.434 . . . . 0.0 111.973 -177.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.571 ' HG2' ' H ' ' A' ' 55' ' ' SER . 2.3 pp20? -75.95 -32.09 59.37 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.262 1.825 . . . . 0.0 111.776 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.6 mt -95.99 24.16 5.78 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.5 1.12 . . . . 0.0 112.655 -176.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -77.41 33.24 0.16 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.629 1.972 . . . . 0.0 113.467 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.6 m -130.45 -167.83 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.511 1.924 . . . . 0.0 109.871 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -98.57 -24.08 15.25 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.335 1.454 . . . . 0.0 113.246 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -159.64 148.89 18.04 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 117.838 -1.077 . . . . 0.0 108.927 171.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.26 165.22 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 165.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 83.3 m -134.59 124.06 24.83 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 128.553 2.741 . . . . 0.0 105.685 171.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.6 140.51 49.54 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 174.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.1 t -145.42 -177.08 5.38 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.284 0.634 . . . . 0.0 110.405 -174.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.92 136.01 53.05 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 128.339 2.656 . . . . 0.0 110.306 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.9 p -75.24 -43.21 52.83 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 118.752 -1.179 . . . . 0.0 109.647 -171.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -107.98 -98.71 2.57 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.41 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -147.23 147.64 30.66 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.959 1.703 . . . . 0.0 109.964 174.235 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.468 ' C ' HD13 ' A' ' 73' ' ' ILE . . . -127.23 -178.56 4.48 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.345 1.058 . . . . 0.0 109.088 170.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.468 HD13 ' C ' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -122.84 -0.03 6.52 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.598 0 CA-C-O 117.664 -1.16 . . . . 0.0 110.814 176.413 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -149.63 158.0 43.77 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 120.561 1.528 . . . . 0.0 110.435 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.489 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -153.53 117.52 4.79 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 166.045 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -121.95 135.32 54.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.2 t -137.53 112.94 10.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -172.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.3 m -136.06 178.4 7.08 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.226 0.61 . . . . 0.0 110.134 173.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.01 -85.17 0.13 Allowed Glycine 0 C--N 1.333 0.39 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 155.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.34 179.12 18.98 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 127.37 2.414 . . . . 0.0 108.328 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.6 p -155.67 156.55 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 118.577 1.189 . . . . 0.0 109.379 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.6 t -135.27 170.1 19.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 127.826 2.451 . . . . 0.0 106.326 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.446 ' HB3' ' HA3' ' A' ' 116' ' ' GLY . 21.5 t0 -123.18 101.28 7.3 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 163.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.11 13.19 67.67 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.678 1.608 . . . . 0.0 113.865 -171.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.84 173.65 1.28 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.04 1.736 . . . . 0.0 110.709 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -165.63 125.69 1.78 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.84 -6.16 32.86 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 123.97 0.795 . . . . 0.0 113.506 174.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.0 p -146.72 140.44 20.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 171.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.3 p -94.71 136.04 27.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 169.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -109.14 -162.61 0.82 Allowed 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 170.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -124.23 165.83 22.41 Favored Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 120.906 1.685 . . . . 0.0 112.082 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.55 174.38 11.9 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.959 2.44 . . . . 0.0 113.547 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.7 ptp -148.0 -176.01 5.11 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.998 0.919 . . . . 0.0 111.131 -168.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -141.15 161.34 38.1 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 128.143 2.577 . . . . 0.0 106.616 169.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.426 ' CD2' HD11 ' A' ' 17' ' ' ILE . 2.4 m0 -130.68 112.28 12.97 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 104.972 -2.233 . . . . 0.0 104.972 173.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.02 127.3 45.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 168.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 m -139.39 104.45 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -167.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.3 m -118.63 153.29 34.54 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -169.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.93 124.89 51.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -174.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -121.14 121.06 37.02 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.962 1.705 . . . . 0.0 108.246 -172.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -73.05 -166.52 0.31 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.594 1.958 . . . . 0.0 109.771 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -58.66 90.44 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 163.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.4 29.58 75.57 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.535 2.017 . . . . 0.0 115.771 171.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -145.06 176.44 9.5 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 120.016 1.908 . . . . 0.0 109.746 165.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -98.1 154.33 17.81 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.97 1.708 . . . . 0.0 108.278 170.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 43.1 pt -132.17 -13.44 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.698 1.199 . . . . 0.0 112.753 168.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -140.91 150.12 42.77 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 119.776 1.171 . . . . 0.0 108.101 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -146.55 52.67 1.11 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.698 1.199 . . . . 0.0 108.076 170.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -75.85 169.7 17.64 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 122.23 1.014 . . . . 0.0 109.888 174.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.8 t -152.02 164.99 36.05 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.095 1.758 . . . . 0.0 106.455 171.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 37.6 mt -135.32 174.48 10.57 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.105 2.162 . . . . 0.0 109.033 176.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 p -152.9 68.05 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.394 1.077 . . . . 0.0 109.169 -175.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -66.71 123.39 19.97 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.033 1.333 . . . . 0.0 109.517 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -136.15 167.17 21.77 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.727 1.211 . . . . 0.0 109.995 176.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 50.98 86.68 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 129.729 3.211 . . . . 0.0 111.325 169.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.446 ' HA3' ' HB3' ' A' ' 83' ' ' ASP . . . -49.99 69.27 0.0 OUTLIER Glycine 0 C--N 1.338 0.668 0 C-N-CA 129.847 3.594 . . . . 0.0 115.422 166.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -123.12 174.79 7.01 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.423 1.889 . . . . 0.0 109.745 171.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -64.39 107.89 1.47 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.4 pp -141.77 165.63 17.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 126.804 2.042 . . . . 0.0 108.844 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.5 p -154.16 140.31 18.45 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.467 1.507 . . . . 0.0 107.284 161.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.3 p -144.0 163.17 34.26 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.145 0.978 . . . . 0.0 109.515 169.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -89.56 40.18 0.98 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 169.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.86 -42.56 65.33 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.847 2.059 . . . . 0.0 111.74 -178.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.47 106.27 16.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 176.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -161.86 87.11 0.65 Allowed 'General case' 0 C--O 1.234 0.286 0 O-C-N 123.479 0.487 . . . . 0.0 111.024 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.7 mt -133.67 150.15 51.54 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.171 1.388 . . . . 0.0 109.511 -172.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -143.23 146.86 34.02 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.843 1.657 . . . . 0.0 109.397 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -145.78 155.08 42.7 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.414 1.486 . . . . 0.0 109.069 172.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--O 1.249 1.065 0 C-N-CA 126.569 1.948 . . . . 0.0 106.663 173.37 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.601 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -82.81 -83.97 0.13 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -155.14 129.3 8.87 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -167.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -135.55 -86.15 0.37 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -169.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -162.41 75.22 2.14 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 127.101 2.161 . . . . 0.0 106.292 -176.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -76.12 171.95 17.17 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.546 2.164 . . . . 0.0 110.707 171.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.19 82.66 0.05 OUTLIER Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 175.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -158.57 166.92 34.49 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 177.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -110.7 121.64 45.84 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.419 1.088 . . . . 0.0 109.629 -173.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.86 -124.08 0.72 Allowed Glycine 0 CA--C 1.53 1.031 0 C-N-CA 128.641 3.02 . . . . 0.0 108.127 163.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.21 168.62 26.55 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.526 1.663 . . . . 0.0 109.767 -174.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.6 mtp -107.86 164.58 12.14 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.484 1.114 . . . . 0.0 111.82 162.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -177.36 153.78 0.96 Allowed 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 131.132 3.773 . . . . 0.0 110.054 -169.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -145.1 147.84 32.98 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.601 2.76 . . . . 0.0 105.137 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -124.06 146.74 29.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 125.83 1.652 . . . . 0.0 108.438 175.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.449 ' CG2' HG23 ' A' ' 65' ' ' THR . 1.3 p -130.01 116.35 18.44 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.477 HG22 ' HB ' ' A' ' 64' ' ' VAL . 0.7 OUTLIER -79.09 143.81 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 117.532 -1.667 . . . . 0.0 106.9 160.334 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -124.0 117.94 25.89 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 104.167 -2.531 . . . . 0.0 104.167 158.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -94.53 110.19 22.02 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 173.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 m -84.35 158.39 21.16 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 123.343 0.402 . . . . 0.0 110.184 172.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.97 -145.26 25.66 Favored Glycine 0 C--O 1.241 0.59 0 O-C-N 123.784 0.677 . . . . 0.0 112.684 168.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -82.67 128.91 34.79 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 168.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -132.64 17.94 4.3 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.681 1.192 . . . . 0.0 111.091 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -120.95 35.23 4.95 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.088 1.355 . . . . 0.0 110.402 -168.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.1 t -145.57 -6.33 0.62 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.245 1.418 . . . . 0.0 110.835 -173.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.439 ' HB3' ' CG2' ' A' ' 81' ' ' VAL . 20.7 m-85 -101.98 170.55 8.05 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 120.699 -1.25 . . . . 0.0 108.2 -153.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.2 mp -137.53 96.76 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -169.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.8 tptt 174.32 -162.03 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.739 2.015 . . . . 0.0 110.81 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.3 m -155.65 174.42 15.31 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.683 1.993 . . . . 0.0 110.569 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 t -115.97 144.69 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.026 1.331 . . . . 0.0 107.426 170.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.7 t -99.62 150.48 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 126.454 1.902 . . . . 0.0 108.247 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -145.33 145.32 20.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 124.073 0.949 . . . . 0.0 110.542 163.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.3 t -135.97 137.82 48.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 165.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.7 107.41 5.91 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.318 1.047 . . . . 0.0 108.517 173.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -59.85 112.0 1.68 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.071 1.349 . . . . 0.0 109.737 -177.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.25 32.76 27.72 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-O 118.395 -1.225 . . . . 0.0 114.743 165.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.532 ' CG2' ' HB2' ' A' ' 72' ' ' ALA . 11.4 t -156.51 -170.5 3.36 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.137 1.469 . . . . 0.0 110.103 175.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -111.87 164.64 12.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.941 1.696 . . . . 0.0 110.506 159.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.55 168.67 10.22 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 127.973 2.509 . . . . 0.0 108.255 176.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -130.23 132.24 45.89 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.328 1.851 . . . . 0.0 106.642 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -82.57 116.71 22.1 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 164.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.59 -10.02 62.9 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 118.573 -1.126 . . . . 0.0 114.476 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.16 -52.49 58.78 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 118.912 1.356 . . . . 0.0 109.922 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.33 -9.48 5.79 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.053 1.341 . . . . 0.0 111.47 -170.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.73 56.28 5.52 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -176.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -102.29 129.59 48.77 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 38.1 t -71.89 145.38 48.56 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.014 0.824 . . . . 0.0 109.069 172.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 24.1 mt -137.66 130.05 29.45 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 124.842 1.257 . . . . 0.0 110.089 -170.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -86.36 87.64 7.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.912 -177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.43 156.7 40.16 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-O 117.864 -1.065 . . . . 0.0 110.679 170.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.4 144.17 79.66 Favored 'Cis proline' 0 C--N 1.348 0.546 0 CA-C-N 120.305 1.144 . . . . 0.0 111.268 -2.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.8 p -157.57 162.14 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.229 1.011 . . . . 0.0 111.168 -170.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.8 mm -129.99 107.98 15.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 126.623 1.969 . . . . 0.0 108.494 -169.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.2 mt -70.62 125.3 26.43 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.337 0.655 . . . . 0.0 109.812 175.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.47 -172.11 3.88 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.48 2.312 . . . . 0.0 110.589 -176.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -61.18 -42.55 98.77 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.502 -1.374 . . . . 0.0 112.72 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -51.42 -45.3 62.55 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.065 0.946 . . . . 0.0 110.798 -176.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.404 ' H ' ' HG2' ' A' ' 58' ' ' GLU . 2.3 mm-40 -68.59 -40.02 80.68 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.293 1.437 . . . . 0.0 109.704 -175.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -89.02 11.7 17.58 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.35 1.86 . . . . 0.0 112.258 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.19 16.87 0.21 Allowed 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.046 -1.659 . . . . 0.0 113.03 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.1 m -131.62 163.75 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 126.319 1.847 . . . . 0.0 111.252 -172.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -65.62 -27.32 68.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.122 1.369 . . . . 0.0 112.75 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -152.48 126.54 9.11 Favored 'General case' 0 CA--C 1.511 -0.555 0 O-C-N 121.088 -1.008 . . . . 0.0 109.962 -173.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.477 ' HB ' HG22 ' A' ' 17' ' ' ILE . 23.3 t -120.54 140.68 43.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 173.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.449 HG23 ' CG2' ' A' ' 16' ' ' THR . 25.5 m -138.0 106.89 5.96 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.071 1.348 . . . . 0.0 108.446 -163.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.2 mt -124.0 139.3 54.08 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -167.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.6 t -145.45 159.99 42.25 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.5 p -72.84 140.95 47.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.733 168.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.5 p -71.85 -53.0 14.61 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.093 174.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -112.54 170.58 13.55 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 124.992 1.282 . . . . 0.0 110.014 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.46 134.56 56.77 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.111 0.964 . . . . 0.0 109.646 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.532 ' HB2' ' CG2' ' A' ' 37' ' ' THR . . . -117.97 179.76 3.99 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 125.678 1.591 . . . . 0.0 107.541 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.526 HD13 ' C ' ' A' ' 72' ' ' ALA . 1.1 mm -117.19 -10.63 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.503 0.721 . . . . 0.0 111.163 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -148.05 165.14 31.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 167.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -144.33 107.31 4.5 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.683 1.593 . . . . 0.0 107.716 168.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.66 153.09 19.71 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.391 0.676 . . . . 0.0 109.958 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.5 t -144.98 115.35 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 127.274 2.23 . . . . 0.0 105.84 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 95.4 p -154.63 -172.73 4.3 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 120.688 -1.258 . . . . 0.0 111.162 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.48 -161.34 12.77 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -170.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.6 175.22 36.63 Favored Glycine 0 N--CA 1.464 0.531 0 N-CA-C 106.752 -2.539 . . . . 0.0 106.752 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.447 HG12 ' CZ2' ' A' ' 95' ' ' TRP . 1.8 p -157.42 163.58 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 120.697 2.249 . . . . 0.0 109.79 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.9 p -151.94 160.16 3.61 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 160.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -87.81 129.92 35.04 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 171.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -95.19 -3.55 61.63 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 117.325 -1.819 . . . . 0.0 112.497 176.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -63.03 120.32 11.19 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 119.367 1.583 . . . . 0.0 108.18 167.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -126.86 37.95 4.19 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 170.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -131.81 -22.18 0.95 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.155 1.36 . . . . 0.0 113.007 -175.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.9 p -107.34 143.39 18.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 125.517 1.527 . . . . 0.0 107.479 174.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.4 p -83.28 126.99 40.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 166.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -126.1 -168.64 1.88 Allowed 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -115.76 154.92 48.12 Favored Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 155.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -80.47 -166.95 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.849 3.033 . . . . 0.0 112.288 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.4 ptm -145.62 167.44 23.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.638 0.732 . . . . 0.0 111.923 -171.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -132.61 131.52 41.51 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 168.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.447 ' CZ2' HG12 ' A' ' 81' ' ' VAL . 13.2 m0 -79.9 105.0 10.86 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 156.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.3 t -79.59 135.89 24.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 149.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.9 t -138.76 91.21 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 172.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.22 152.02 38.39 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.013 1.325 . . . . 0.0 108.415 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 t -134.81 131.7 53.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 175.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -102.91 159.24 15.67 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 128.208 2.603 . . . . 0.0 107.634 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.414 ' HG3' ' H ' ' A' ' 102' ' ' ASN . 22.0 tptm -129.21 -172.1 2.65 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 127.848 2.459 . . . . 0.0 105.41 177.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.414 ' H ' ' HG3' ' A' ' 101' ' ' LYS . 11.6 p30 -54.1 50.12 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 130.166 3.386 . . . . 0.0 115.387 177.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 169.03 -58.2 0.2 Allowed Glycine 0 CA--C 1.524 0.622 0 O-C-N 119.541 -1.974 . . . . 0.0 112.145 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.76 -175.32 5.08 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.217 1.407 . . . . 0.0 111.339 -171.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -55.15 141.18 35.87 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.625 1.57 . . . . 0.0 108.923 175.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 15.9 pt -121.39 -34.05 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 125.57 1.548 . . . . 0.0 111.066 167.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -133.34 149.99 51.87 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 120.241 1.382 . . . . 0.0 109.723 -175.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.7 pttt -155.46 42.29 0.43 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.249 2.219 . . . . 0.0 108.857 -153.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.57 ' HE2' HD11 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -111.53 149.3 31.59 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.655 0.782 . . . . 0.0 110.744 -172.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.0 t -142.06 162.34 35.73 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.22 1.408 . . . . 0.0 109.341 -169.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.536 ' N ' HD12 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -124.61 -163.71 1.2 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.618 1.967 . . . . 0.0 106.409 -179.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.57 144.89 15.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 127.641 2.377 . . . . 0.0 107.331 168.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -130.29 146.83 51.94 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 106.503 -1.665 . . . . 0.0 106.503 170.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 48.1 mtm105 -134.07 158.57 43.26 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.113 0.965 . . . . 0.0 108.613 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.99 162.07 26.21 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 126.982 2.113 . . . . 0.0 109.403 -153.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.29 35.46 60.28 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 124.281 0.943 . . . . 0.0 114.016 168.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.6 mmtt -139.14 172.35 12.96 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.673 1.237 . . . . 0.0 110.08 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.42 98.72 3.3 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 120.743 -1.223 . . . . 0.0 109.198 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.3 pp -127.54 163.79 30.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 123.982 0.913 . . . . 0.0 110.141 -172.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.45 36.26 0.16 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.819 1.247 . . . . 0.0 110.064 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.2 p -63.11 163.18 10.44 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 120.795 -1.191 . . . . 0.0 110.66 167.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -65.83 49.4 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 129.457 3.103 . . . . 0.0 110.08 164.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.32 -29.84 59.07 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.323 1.449 . . . . 0.0 111.633 169.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.57 HD11 ' HE2' ' A' ' 109' ' ' LYS . 8.0 tp -138.17 146.4 42.68 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.427 0.632 . . . . 0.0 109.38 169.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -176.48 76.67 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.811 2.044 . . . . 0.0 105.966 -171.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.7 tp -126.12 137.34 53.59 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.919 0.888 . . . . 0.0 109.214 -168.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -140.45 144.52 36.13 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.019 1.328 . . . . 0.0 109.697 -176.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -140.18 155.54 46.9 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.485 1.514 . . . . 0.0 109.108 171.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.0 p30 . . . . . 0 C--O 1.25 1.097 0 C-N-CA 127.591 2.356 . . . . 0.0 105.906 158.308 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.204 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -158.53 66.57 0.44 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 164.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -157.47 128.45 6.64 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.635 -1.166 . . . . 0.0 107.883 -150.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -166.51 175.9 7.73 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 131.127 3.771 . . . . 0.0 105.139 -173.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.47 75.28 6.47 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 176.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -71.86 161.51 44.75 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.059 1.84 . . . . 0.0 110.846 -166.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.35 47.7 2.99 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.341 0.972 . . . . 0.0 111.694 175.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.84 136.79 4.42 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 119.641 1.72 . . . . 0.0 112.509 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -138.35 165.09 27.63 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 126.827 2.051 . . . . 0.0 107.496 166.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.593 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . 156.72 -160.36 30.24 Favored Glycine 0 CA--C 1.525 0.686 1 C-N-CA 131.601 4.429 . . . . 0.0 107.736 -178.762 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.18 167.88 20.17 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.787 0.835 . . . . 0.0 112.009 -167.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.9 mtp -86.41 153.26 22.04 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 161.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -147.55 130.39 16.14 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 125.834 1.959 . . . . 0.0 108.578 -175.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -140.96 149.75 42.21 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.217 2.207 . . . . 0.0 106.814 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.404 HG23 HG22 ' A' ' 99' ' ' VAL . 11.2 p -144.86 158.95 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 C-N-CA 124.833 1.253 . . . . 0.0 109.686 177.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.2 124.88 14.95 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 -165.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.1 tp -119.51 109.24 25.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -171.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -108.96 122.66 47.7 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.743 2.017 . . . . 0.0 109.537 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -105.45 139.69 39.69 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.179 -0.95 . . . . 0.0 109.982 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.5 m -143.46 166.99 23.26 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.781 0.832 . . . . 0.0 111.321 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.83 -156.32 28.33 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -168.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -76.59 92.0 3.44 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 121.39 -1.065 . . . . 0.0 108.801 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -97.5 14.76 25.35 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -173.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.38 9.05 10.27 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -158.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.0 m -141.17 40.17 1.77 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.08 2.152 . . . . 0.0 108.749 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.42 ' O ' ' HE2' ' A' ' 28' ' ' LYS . 46.7 m-85 -136.23 130.18 32.71 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 124.999 1.319 . . . . 0.0 109.36 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.9 mt -72.76 90.35 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.42 ' HE2' ' O ' ' A' ' 26' ' ' PHE . 27.0 mtmt -79.78 162.0 25.38 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.815 1.246 . . . . 0.0 110.252 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.4 t -146.72 154.18 41.12 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.902 0.881 . . . . 0.0 110.302 165.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 69.9 t -142.73 109.45 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 127.208 2.203 . . . . 0.0 105.676 164.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.9 p -73.02 147.5 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 149.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 p -131.58 137.71 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 126.202 1.801 . . . . 0.0 106.52 167.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 t -119.59 163.31 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 123.878 0.871 . . . . 0.0 108.923 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.56 153.42 40.35 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.844 1.258 . . . . 0.0 109.906 169.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -129.16 105.45 8.17 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 169.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.42 29.24 50.06 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 118.598 -1.112 . . . . 0.0 114.618 165.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.582 HG22 ' HB2' ' A' ' 72' ' ' ALA . 5.0 t -164.3 -164.72 0.88 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.21 1.804 . . . . 0.0 106.698 158.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -123.89 170.69 10.33 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.125 1.37 . . . . 0.0 109.974 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.41 166.01 12.28 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.904 1.281 . . . . 0.0 109.789 -175.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -134.52 116.79 15.49 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 125.338 1.455 . . . . 0.0 107.827 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -82.84 132.04 35.18 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 124.982 1.313 . . . . 0.0 109.167 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.28 -22.47 50.61 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 118.842 -0.977 . . . . 0.0 113.854 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.24 -52.31 16.36 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 127.572 2.349 . . . . 0.0 111.746 -177.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 t -148.17 -4.84 0.46 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.759 -0.638 . . . . 0.0 111.379 175.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.41 27.96 8.84 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 119.863 1.21 . . . . 0.0 111.668 -160.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -64.13 124.28 21.25 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.63 110.81 20.66 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.184 1.794 . . . . 0.0 111.029 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.9 mt -114.12 145.78 41.17 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 122.375 1.083 . . . . 0.0 112.631 -163.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.14 67.91 5.09 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.05 1.34 . . . . 0.0 112.153 -171.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.2 m -52.83 156.2 3.54 Favored Pre-proline 0 CA--C 1.543 0.692 0 O-C-N 121.054 -1.029 . . . . 0.0 113.097 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.9 144.85 75.85 Favored 'Cis proline' 0 CA--C 1.536 0.606 0 CA-C-N 119.071 0.704 . . . . 0.0 112.495 -5.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.6 t -140.73 155.38 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 126.134 1.774 . . . . 0.0 107.815 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.3 mm -116.59 144.74 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 125.575 1.55 . . . . 0.0 106.857 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.4 mt -120.97 115.89 24.06 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.983 1.313 . . . . 0.0 107.686 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 m -72.16 174.41 7.21 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 124.753 1.283 . . . . 0.0 110.389 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.65 -31.77 68.46 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.822 1.649 . . . . 0.0 113.074 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -63.82 -42.46 97.65 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 121.355 -0.84 . . . . 0.0 110.478 174.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -75.6 -32.12 60.19 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -175.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.8 mt -85.63 27.36 0.85 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.673 1.989 . . . . 0.0 111.792 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.05 1.4 27.9 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 176.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.8 m -88.76 149.12 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 119.427 1.012 . . . . 0.0 111.498 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -57.25 -37.01 71.68 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.451 1.101 . . . . 0.0 112.76 172.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -165.39 149.09 8.28 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -176.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.5 p -149.99 167.29 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 166.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.1 t -121.92 158.97 27.85 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 167.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 mt -135.89 155.03 50.92 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 173.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.4 t -164.44 158.03 17.98 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.5 p -78.34 158.17 28.89 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 122.858 0.463 . . . . 0.0 110.551 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.3 p -75.4 -13.67 60.41 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.349 -0.844 . . . . 0.0 111.722 171.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -167.37 -167.51 28.16 Favored Glycine 0 C--N 1.336 0.535 0 O-C-N 120.662 -1.274 . . . . 0.0 111.559 -175.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.593 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 2.6 ttpt -52.01 130.85 30.79 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 168.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.582 ' HB2' HG22 ' A' ' 37' ' ' THR . . . -134.59 176.63 8.45 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.306 1.442 . . . . 0.0 107.629 173.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.61 9.29 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 118.707 -0.663 . . . . 0.0 109.705 176.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -146.46 151.76 37.93 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 120.191 1.36 . . . . 0.0 113.115 168.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.58 66.41 0.94 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.454 2.302 . . . . 0.0 108.888 165.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.87 138.91 33.73 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.244 -0.91 . . . . 0.0 109.705 174.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 69.1 t -138.58 124.19 23.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 125.689 1.595 . . . . 0.0 107.598 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.3 t -142.69 170.46 15.65 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.61 -88.66 0.12 Allowed Glycine 0 C--N 1.332 0.335 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.89 -165.51 16.26 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -176.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.43 152.17 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 106.347 -1.724 . . . . 0.0 106.347 159.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.441 HG23 ' H ' ' A' ' 119' ' ' ILE . 12.5 p -124.15 152.23 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 159.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -77.73 149.59 34.54 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 171.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.99 21.22 3.0 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 125.911 1.72 . . . . 0.0 109.15 166.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.29 6.0 pt-20 -120.86 160.91 22.46 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.608 1.204 . . . . 0.0 110.146 170.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -168.3 87.96 0.23 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.912 2.085 . . . . 0.0 106.263 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.69 -28.3 2.87 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.246 1.403 . . . . 0.0 113.778 174.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.0 p -77.99 135.49 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 119.327 1.564 . . . . 0.0 108.477 174.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.6 t -105.78 81.72 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -177.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -77.76 174.79 10.6 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.658 1.183 . . . . 0.0 110.618 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -79.51 157.4 74.93 Favored Pre-proline 0 CA--C 1.533 0.313 0 O-C-N 120.511 -1.368 . . . . 0.0 109.568 157.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -82.94 -177.86 3.57 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.633 2.889 . . . . 0.0 112.179 -178.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 13.0 ptm -141.38 171.36 14.16 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.279 0.632 . . . . 0.0 112.249 -171.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -144.86 165.4 28.21 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.041 1.336 . . . . 0.0 109.445 166.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -128.42 136.29 50.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 170.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.2 t -115.86 129.35 72.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 161.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.9 t -114.54 151.67 16.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 103.895 -2.631 . . . . 0.0 103.895 166.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.3 m -135.94 136.7 40.64 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.404 HG22 HG23 ' A' ' 15' ' ' VAL . 19.3 t -116.5 141.61 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 176.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -123.67 148.03 46.88 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.046 1.738 . . . . 0.0 107.185 174.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.454 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 4.0 ttpm? -111.96 -159.29 0.68 Allowed 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.355 1.062 . . . . 0.0 108.295 178.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.454 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 3.3 p30 -60.96 81.65 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.029 1.332 . . . . 0.0 107.961 159.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 152.46 -74.83 0.25 Allowed Glycine 0 N--CA 1.45 -0.376 0 O-C-N 121.12 -0.987 . . . . 0.0 112.577 169.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.23 -171.45 3.87 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.076 1.75 . . . . 0.0 110.127 -173.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -46.1 141.27 3.37 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.829 2.052 . . . . 0.0 109.727 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.1 pt -141.95 -11.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 124.225 1.01 . . . . 0.0 113.492 178.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -142.16 149.27 39.54 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.663 1.12 . . . . 0.0 108.354 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -144.68 93.61 2.44 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.011 0.924 . . . . 0.0 109.124 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.69 151.48 43.09 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.772 0.796 . . . . 0.0 112.246 163.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.443 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -146.52 155.59 42.63 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 127.162 2.185 . . . . 0.0 107.785 179.102 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -133.33 -174.22 3.43 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 123.804 1.764 . . . . 0.0 107.139 -172.47 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.9 p -154.02 146.9 13.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 C-N-CA 127.085 2.154 . . . . 0.0 109.88 -177.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -146.29 155.57 42.75 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 165.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -146.72 15.82 1.24 Allowed 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 75.76 163.99 0.26 Allowed 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 128.145 2.578 . . . . 0.0 113.205 -173.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 173.62 -72.56 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 CA-C-O 118.922 -0.932 . . . . 0.0 111.473 172.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -169.31 164.62 10.84 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 127.204 2.202 . . . . 0.0 107.404 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -60.05 149.89 30.95 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.211 0.604 . . . . 0.0 111.93 175.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.441 ' H ' HG23 ' A' ' 82' ' ' VAL . 2.6 pp -153.25 -176.49 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 127.927 2.491 . . . . 0.0 109.863 -170.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.5 p -145.29 118.75 9.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 157.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.4 p -134.31 125.77 28.34 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.337 1.055 . . . . 0.0 108.287 -176.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -76.11 49.59 0.57 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.719 1.607 . . . . 0.0 109.577 171.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -62.93 -23.96 67.63 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.352 1.461 . . . . 0.0 111.429 173.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 tp -126.72 111.08 13.84 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -159.38 71.24 0.5 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.792 0.837 . . . . 0.0 109.624 166.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 mp -82.72 149.86 27.05 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.584 1.154 . . . . 0.0 109.637 170.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -137.65 125.81 23.03 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 127.427 2.291 . . . . 0.0 106.536 171.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -127.39 145.12 50.93 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 164.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 C--O 1.257 1.461 0 C-N-CA 127.17 2.188 . . . . 0.0 108.355 -168.971 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.914 0 N-CA-C 104.786 -3.326 . . . . 0.0 104.786 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.56 45.22 1.62 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -147.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -150.94 99.65 2.72 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.351 -145.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.85 -176.13 0.47 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 128.207 2.603 . . . . 0.0 112.559 -169.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.51 73.48 7.42 Favored Pre-proline 0 CA--C 1.54 0.59 0 O-C-N 120.783 -1.198 . . . . 0.0 109.002 162.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.44 124.78 11.12 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.717 2.278 . . . . 0.0 109.478 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 169.22 122.26 0.62 Allowed Glycine 0 CA--C 1.53 1.02 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -176.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.18 -48.22 11.54 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 117.822 0.811 . . . . 0.0 113.554 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -171.48 165.51 6.94 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.069 1.748 . . . . 0.0 107.92 175.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -160.62 -133.23 1.45 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 126.49 1.995 . . . . 0.0 108.548 165.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.24 -175.24 4.18 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.372 1.869 . . . . 0.0 107.626 167.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.2 mmm -97.14 163.1 13.07 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 144.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -146.8 154.41 41.34 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 125.233 1.413 . . . . 0.0 109.609 171.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -152.49 134.76 15.06 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 127.594 2.357 . . . . 0.0 106.359 -175.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 p -125.61 152.91 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 125.446 1.498 . . . . 0.0 110.144 174.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.4 p -120.48 157.7 28.84 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.108 0.963 . . . . 0.0 110.002 171.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.8 tp -143.08 110.46 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 174.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -107.92 132.33 53.58 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -116.76 120.96 40.2 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.286 1.034 . . . . 0.0 109.64 -169.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 m -134.5 172.39 12.98 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.418 0.687 . . . . 0.0 110.593 174.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.6 -163.76 46.28 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -163.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -86.0 59.18 5.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.744 0.783 . . . . 0.0 111.021 -160.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -63.0 21.7 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.782 2.433 . . . . 0.0 115.825 -178.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -115.62 12.04 15.96 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.125 1.77 . . . . 0.0 109.009 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.4 m -143.39 -0.74 1.08 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -157.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -137.49 126.48 24.27 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.69 1.196 . . . . 0.0 109.73 -168.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.4 mt -61.87 89.82 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.488 1.115 . . . . 0.0 110.511 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -74.66 163.45 27.7 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.996 0.903 . . . . 0.0 109.083 176.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.8 p -158.99 137.56 10.89 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.14 1.776 . . . . 0.0 108.965 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 t -138.45 98.1 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 119.454 1.024 . . . . 0.0 108.353 172.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.4 t -68.09 127.3 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 163.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.0 t -139.11 127.82 28.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 119.694 1.134 . . . . 0.0 109.114 171.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.4 t -109.8 154.79 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.491 1.516 . . . . 0.0 108.743 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.08 103.19 3.71 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.943 0.897 . . . . 0.0 109.917 165.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -58.76 100.87 0.07 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.549 1.54 . . . . 0.0 109.12 168.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.44 7.97 50.54 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 117.219 -1.878 . . . . 0.0 117.74 158.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.548 HG21 ' H ' ' A' ' 70' ' ' GLY . 2.0 t -165.14 178.45 6.98 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 121.016 2.408 . . . . 0.0 108.615 162.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -94.8 161.47 14.16 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.281 1.032 . . . . 0.0 110.785 -175.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.57 HD12 HD12 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -90.46 169.03 11.4 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.928 1.291 . . . . 0.0 109.288 -178.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -137.09 119.92 16.31 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 124.741 1.216 . . . . 0.0 107.892 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -75.64 148.44 38.74 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.606 0.717 . . . . 0.0 109.755 176.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.1 -25.26 67.93 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 118.399 -1.223 . . . . 0.0 112.636 167.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.21 -60.48 2.92 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 126.609 1.963 . . . . 0.0 111.164 -171.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.666 HG22 ' HG3' ' A' ' 46' ' ' GLU . 1.3 t -144.74 8.43 1.3 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.182 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.4 24.7 56.21 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 118.969 0.804 . . . . 0.0 111.136 -165.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.666 ' HG3' HG22 ' A' ' 44' ' ' THR . 74.7 mt-10 -55.86 118.73 4.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.713 1.205 . . . . 0.0 108.507 174.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 m -78.78 122.17 25.71 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 174.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 76.6 mt -113.03 134.19 54.63 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.76 1.224 . . . . 0.0 110.881 -170.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.36 73.92 1.36 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.85 2.06 . . . . 0.0 113.144 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.1 150.97 37.63 Favored Pre-proline 0 CA--C 1.545 0.785 0 O-C-N 120.979 -1.075 . . . . 0.0 111.151 171.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.52 155.74 85.92 Favored 'Cis proline' 0 C--N 1.348 0.509 0 CA-C-N 119.504 0.859 . . . . 0.0 110.785 -12.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.4 p -144.46 161.34 14.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 175.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.6 mm -108.69 99.24 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 166.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.83 104.94 3.05 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.384 -1.709 . . . . 0.0 106.384 168.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.9 m -74.05 175.15 7.7 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.64 0.733 . . . . 0.0 109.443 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -49.72 -37.98 31.47 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.794 1.637 . . . . 0.0 110.601 175.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -69.23 -32.16 71.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.484 1.913 . . . . 0.0 112.621 -175.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -76.61 -32.27 57.97 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.31 1.044 . . . . 0.0 108.93 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -90.13 16.28 8.75 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.701 1.6 . . . . 0.0 112.708 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.71 45.1 0.18 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.714 2.005 . . . . 0.0 112.295 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.0 m -140.85 162.92 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 128.434 2.694 . . . . 0.0 108.668 -173.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -75.19 -26.83 59.33 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.294 -0.879 . . . . 0.0 113.003 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.39 147.05 10.55 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.214 1.006 . . . . 0.0 109.436 -174.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -132.59 161.14 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.95 0.881 . . . . 0.0 109.81 163.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 m -128.5 116.28 19.45 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 130.029 3.331 . . . . 0.0 104.968 172.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.57 HD12 HD12 ' A' ' 39' ' ' LEU . 4.3 mm? -119.9 132.12 55.44 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 119.506 1.048 . . . . 0.0 108.342 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.43 166.49 24.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.02 -170.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 p -80.62 142.97 33.49 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.913 1.685 . . . . 0.0 110.125 -178.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.8 p -80.33 -51.22 9.14 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.503 -0.748 . . . . 0.0 110.74 172.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.548 ' H ' HG21 ' A' ' 37' ' ' THR . . . -106.6 -80.74 1.35 Allowed Glycine 0 C--N 1.335 0.486 0 O-C-N 121.534 -0.729 . . . . 0.0 112.407 -162.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.0 tttt -168.84 135.69 1.86 Allowed 'General case' 0 C--O 1.239 0.516 1 C-N-CA 131.849 4.06 . . . . 0.0 104.12 170.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -133.37 165.47 24.76 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 123.163 0.585 . . . . 0.0 110.066 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.23 -0.89 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 123.308 0.643 . . . . 0.0 110.673 -165.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -153.02 156.12 38.21 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.039 -1.038 . . . . 0.0 108.282 168.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.08 109.44 5.61 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 166.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.52 127.68 54.76 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.5 t -129.66 118.09 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 -174.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.0 157.94 45.09 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -169.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 154.85 -167.57 32.71 Favored Glycine 0 C--N 1.331 0.284 0 O-C-N 121.87 -0.519 . . . . 0.0 112.037 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.82 179.88 43.08 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.407 1.004 . . . . 0.0 112.155 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -132.62 -170.9 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 126.396 1.878 . . . . 0.0 108.463 171.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.491 HG22 ' H ' ' A' ' 84' ' ' GLY . 7.8 p -120.04 167.9 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 128.501 2.721 . . . . 0.0 107.534 167.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -137.37 17.76 2.94 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.419 1.888 . . . . 0.0 110.219 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.491 ' H ' HG22 ' A' ' 82' ' ' VAL . . . -90.9 12.63 68.37 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 125.73 1.634 . . . . 0.0 114.763 -156.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -68.14 135.78 52.66 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.195 1.398 . . . . 0.0 109.32 -168.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -137.69 -6.65 1.7 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.778 1.631 . . . . 0.0 112.221 -169.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -105.3 -4.16 40.99 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.769 1.652 . . . . 0.0 113.355 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.2 p -146.94 178.81 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 124.992 1.317 . . . . 0.0 108.679 -172.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.0 p -122.51 96.1 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 171.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -95.9 169.08 10.24 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.747 0.819 . . . . 0.0 109.002 172.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.94 160.96 31.33 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 159.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -84.35 -179.03 3.67 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.248 1.966 . . . . 0.0 111.5 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.406 ' CE ' ' HE1' ' A' ' 95' ' ' TRP . 4.6 ptm -131.31 160.28 35.43 Favored 'General case' 0 C--O 1.231 0.109 0 O-C-N 121.154 -0.966 . . . . 0.0 112.977 -176.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.418 ' NE2' HH21 ' A' ' 114' ' ' ARG . 12.5 mt-30 -142.01 143.31 33.11 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.536 1.134 . . . . 0.0 108.94 177.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.406 ' HE1' ' CE ' ' A' ' 93' ' ' MET . 54.4 m0 -116.9 139.46 50.61 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.23 1.012 . . . . 0.0 108.366 174.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.16 141.08 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 153.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.5 m -141.62 160.33 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 C-N-CA 127.074 2.149 . . . . 0.0 106.443 -177.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.8 m -152.59 142.94 22.55 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 174.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.36 136.59 48.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 169.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -123.19 113.69 19.29 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.698 2.399 . . . . 0.0 106.862 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -68.02 171.51 6.75 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 161.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -44.19 83.2 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.561 2.344 . . . . 0.0 114.128 -175.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 62.46 43.69 98.68 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.273 1.416 . . . . 0.0 113.465 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.0 mmtt -155.55 141.26 18.0 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.815 1.807 . . . . 0.0 109.463 155.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -68.31 143.83 55.05 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 125.932 1.693 . . . . 0.0 108.507 170.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.95 -13.94 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 120.218 1.372 . . . . 0.0 113.234 172.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -142.88 162.04 36.53 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.66 1.584 . . . . 0.0 107.085 -167.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.4 pttt -162.78 37.8 0.1 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.152 0.887 . . . . 0.0 112.637 -175.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -73.55 166.8 22.59 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.219 -1.55 . . . . 0.0 110.373 -176.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.7 t -151.59 160.08 43.81 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 127.168 2.187 . . . . 0.0 106.234 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 94.3 mt -132.6 141.49 48.7 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.924 0.89 . . . . 0.0 109.238 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.4 p -135.87 114.77 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 126.196 1.798 . . . . 0.0 107.319 174.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -108.79 122.6 47.51 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 166.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.418 HH21 ' NE2' ' A' ' 94' ' ' GLN . 76.7 mtt-85 -149.35 104.18 3.36 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 175.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.5 t70 53.92 89.53 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 125.88 1.672 . . . . 0.0 109.918 -171.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -112.47 -81.9 1.15 Allowed Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 172.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm 174.47 172.23 0.22 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 128.391 2.677 . . . . 0.0 108.692 -165.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -72.62 106.55 4.7 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 153.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.6 pp -136.23 164.17 32.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 129.857 3.263 . . . . 0.0 105.953 173.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.6 m -159.12 6.99 0.11 Allowed 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.0 t -161.48 50.29 0.23 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.177 0.991 . . . . 0.0 111.61 -172.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -143.52 17.9 1.85 Allowed 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.067 -1.02 . . . . 0.0 112.031 174.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -93.79 -77.24 0.46 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.687 1.195 . . . . 0.0 111.312 -173.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.92 124.6 47.47 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.669 0.788 . . . . 0.0 109.314 -155.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -148.96 32.67 0.76 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.985 2.114 . . . . 0.0 111.802 -157.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.2 mp -80.77 148.58 30.0 Favored 'General case' 0 C--O 1.24 0.566 0 O-C-N 121.45 -0.781 . . . . 0.0 110.559 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -159.51 136.09 9.19 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.978 2.111 . . . . 0.0 109.963 173.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -142.17 158.66 43.48 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.078 2.151 . . . . 0.0 110.297 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.3 p30 . . . . . 0 C--O 1.249 1.035 0 C-N-CA 126.816 2.046 . . . . 0.0 109.3 177.926 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.087 0 CA-C-O 119.179 -0.79 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . 0.354 0.0 OUTLIER 76.71 -78.27 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 116.252 -1.832 . . . . 0.0 109.708 -113.572 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -144.79 104.29 4.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 121.288 1.858 . . . . 0.0 108.864 -162.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -159.54 86.39 0.8 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.658 0.783 . . . . 0.0 109.983 -165.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -154.26 86.13 3.74 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 123.954 0.902 . . . . 0.0 109.472 177.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -86.45 140.05 6.15 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.559 2.172 . . . . 0.0 112.224 173.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.55 78.28 0.36 Allowed Glycine 0 CA--C 1.526 0.722 0 O-C-N 121.701 -0.624 . . . . 0.0 112.196 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.6 -165.17 11.7 Favored Glycine 0 CA--C 1.52 0.379 0 O-C-N 121.372 -1.075 . . . . 0.0 111.468 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.6 pttm -144.75 165.4 28.18 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 126.766 2.026 . . . . 0.0 107.898 164.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.502 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . 157.01 -152.04 23.39 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 128.064 2.745 . . . . 0.0 107.697 -174.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.66 -172.61 2.96 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.158 0.979 . . . . 0.0 112.667 -162.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.1 mtp -113.69 158.77 20.47 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 147.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -144.77 143.2 30.55 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 125.256 1.597 . . . . 0.0 108.951 174.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -142.94 143.81 32.14 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.619 2.368 . . . . 0.0 105.065 172.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p -122.07 155.11 26.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 124.557 1.143 . . . . 0.0 109.108 171.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.04 151.11 52.07 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 173.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.6 tp -133.2 114.42 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.11 138.02 41.21 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 126.361 1.864 . . . . 0.0 107.45 176.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -128.46 122.34 31.04 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.453 1.101 . . . . 0.0 108.96 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.97 165.31 11.67 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.296 1.038 . . . . 0.0 108.772 172.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.49 -154.07 52.12 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 176.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -75.67 75.38 2.66 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 123.733 1.73 . . . . 0.0 113.108 -170.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -81.49 17.33 1.42 Allowed 'General case' 0 C--N 1.324 -0.536 0 O-C-N 119.715 -1.866 . . . . 0.0 114.116 -171.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 ptt-85 -137.64 28.34 2.7 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.559 1.527 . . . . 0.0 113.123 -170.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.4 m -127.97 17.29 6.74 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -171.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -134.81 -169.18 2.3 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.9 1.227 . . . . 0.0 112.556 -165.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.7 mm -114.91 87.88 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 106.104 -1.814 . . . . 0.0 106.104 163.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.409 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 0.4 OUTLIER -85.16 160.22 19.97 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.246 0.93 . . . . 0.0 110.588 168.394 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.34 156.67 42.81 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.065 0.946 . . . . 0.0 108.565 169.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.1 t -138.02 104.02 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.198 1.399 . . . . 0.0 107.334 170.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.711 HG22 HD12 ' A' ' 53' ' ' ILE . 84.9 t -69.07 135.37 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 163.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.9 t -138.19 138.41 43.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.5 t -135.18 150.14 29.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.08 141.98 49.37 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.265 1.826 . . . . 0.0 109.955 168.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -118.27 103.61 9.98 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 130.158 3.383 . . . . 0.0 106.481 -178.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.47 0.98 32.9 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 125.163 1.364 . . . . 0.0 113.205 172.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.537 HG22 ' HB2' ' A' ' 72' ' ' ALA . 15.0 t -165.74 -174.44 3.08 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.582 1.191 . . . . 0.0 109.23 -174.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -109.73 -175.75 2.83 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.871 1.668 . . . . 0.0 109.702 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.5 mt -119.18 165.58 14.03 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.313 1.445 . . . . 0.0 109.677 -177.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -138.26 122.6 18.26 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.095 0.958 . . . . 0.0 110.113 -170.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -70.08 135.29 49.09 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.755 0.822 . . . . 0.0 109.977 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.84 0.34 86.35 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-O 117.867 -1.518 . . . . 0.0 115.29 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.14 -51.35 15.88 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 120.196 1.998 . . . . 0.0 108.331 174.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.57 -22.8 3.56 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.836 1.254 . . . . 0.0 111.413 -167.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.94 20.55 28.06 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 118.444 -1.198 . . . . 0.0 112.24 -172.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -57.89 136.87 57.09 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 118.978 1.389 . . . . 0.0 109.42 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.13 138.77 49.93 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.268 1.027 . . . . 0.0 108.573 167.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.8 mt -126.91 -171.2 2.35 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.167 1.387 . . . . 0.0 109.306 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -143.03 117.94 9.98 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.685 1.994 . . . . 0.0 106.588 173.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.52 172.0 10.53 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.137 177.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.81 157.99 94.53 Favored 'Cis proline' 0 C--O 1.239 0.567 0 N-CA-C 108.525 -1.375 . . . . 0.0 108.525 -5.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 p -144.8 147.47 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 O-C-N 121.534 -0.728 . . . . 0.0 109.084 -171.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.711 HD12 HG22 ' A' ' 31' ' ' VAL . 18.0 mm -120.13 114.18 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 175.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.68 128.01 36.02 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 169.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.4 m -95.72 -175.69 3.51 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.93 1.692 . . . . 0.0 110.884 -174.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.409 ' HA ' ' HG2' ' A' ' 28' ' ' LYS . 29.5 t70 -61.93 -37.71 85.72 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 123.769 0.828 . . . . 0.0 111.848 -170.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -66.76 -36.4 82.35 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.072 0.949 . . . . 0.0 111.212 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -66.73 -36.49 82.59 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 122.44 1.114 . . . . 0.0 110.073 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.8 10.47 32.95 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.581 1.952 . . . . 0.0 112.874 -174.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.17 31.07 0.06 Allowed 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 120.392 1.451 . . . . 0.0 114.111 -174.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.7 m -131.37 167.27 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.504 1.522 . . . . 0.0 111.691 -169.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -59.38 -34.15 72.07 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.471 1.508 . . . . 0.0 113.415 175.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -157.95 147.28 19.68 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-O 117.116 -1.421 . . . . 0.0 109.913 -177.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 t -129.58 163.02 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 119.106 0.866 . . . . 0.0 108.74 163.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.3 m -139.29 109.39 6.41 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.702 2.801 . . . . 0.0 107.791 -172.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -122.4 131.58 53.95 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 121.053 1.751 . . . . 0.0 109.618 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.49 176.29 8.75 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.244 0.618 . . . . 0.0 111.455 -168.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 p -101.95 148.48 25.29 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.812 0.845 . . . . 0.0 109.954 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.3 p -84.27 -0.7 53.37 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.61 -0.681 . . . . 0.0 112.442 176.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.64 -172.73 37.95 Favored Glycine 0 N--CA 1.448 -0.525 0 O-C-N 119.877 -1.764 . . . . 0.0 109.498 -171.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.502 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 7.1 ttpt -70.43 129.35 39.05 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.537 ' HB2' HG22 ' A' ' 37' ' ' THR . . . -126.4 169.69 12.71 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.121 0.568 . . . . 0.0 110.536 176.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -119.46 -2.69 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -175.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -141.65 172.48 12.62 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.836 1.198 . . . . 0.0 110.605 -177.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -164.61 89.75 0.52 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 120.073 1.306 . . . . 0.0 111.312 166.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.77 150.4 25.82 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.584 0.354 . . . . 0.0 110.766 176.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 t -140.76 123.6 15.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 126.207 1.803 . . . . 0.0 106.241 164.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 m -140.59 156.62 46.23 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 174.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.4 -153.35 23.46 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -167.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.38 -168.96 31.56 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -175.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.538 HG23 ' CE1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -125.32 -179.94 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.178 1.391 . . . . 0.0 109.323 165.718 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.3 m -134.16 169.62 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 129.921 3.288 . . . . 0.0 107.024 168.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.406 ' HB3' ' H ' ' A' ' 117' ' ' LYS . 22.9 t0 -155.15 100.96 2.21 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 168.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -142.48 48.81 0.76 Allowed Glycine 0 N--CA 1.452 -0.237 0 N-CA-C 108.834 -1.707 . . . . 0.0 108.834 -174.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -118.67 133.59 55.74 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.943 0.877 . . . . 0.0 111.406 -174.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -117.62 88.89 3.0 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 -172.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 135.11 -34.39 2.32 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.725 1.155 . . . . 0.0 112.604 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.5 t -86.03 66.28 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 118.428 1.114 . . . . 0.0 108.371 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.81 116.12 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -123.16 168.78 11.97 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.006 1.722 . . . . 0.0 108.973 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -75.51 157.82 84.02 Favored Pre-proline 0 CA--C 1.532 0.263 0 O-C-N 121.986 -0.446 . . . . 0.0 111.155 173.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -72.37 169.21 22.22 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 121.083 1.188 . . . . 0.0 111.722 171.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.4 ptm -139.59 172.53 12.66 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 125.046 1.338 . . . . 0.0 110.33 -174.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -143.91 153.3 42.16 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.23 1.012 . . . . 0.0 109.422 -177.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -127.59 140.75 51.91 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.518 1.527 . . . . 0.0 108.982 176.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.9 t -132.8 110.75 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 164.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 m -92.07 143.07 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 163.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 m -129.59 142.12 50.81 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.8 t -122.14 126.1 73.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -113.57 119.0 35.99 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 175.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.439 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 2.2 ttpt -80.01 -156.91 0.13 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 175.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.439 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 4.6 p30 -66.02 83.34 0.08 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 163.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 139.2 -43.48 1.16 Allowed Glycine 0 CA--C 1.524 0.615 0 CA-C-O 118.03 -1.428 . . . . 0.0 115.2 156.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -151.93 -174.98 5.04 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 119.66 1.73 . . . . 0.0 111.309 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -55.74 143.44 30.79 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 171.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 6.7 pt -128.14 -24.85 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-O 117.674 -1.155 . . . . 0.0 112.706 168.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -150.94 148.9 28.97 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 120.631 1.559 . . . . 0.0 108.319 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -148.67 54.79 1.0 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.107 1.363 . . . . 0.0 107.97 -169.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.17 113.02 2.35 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.72 135.0 50.54 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.955 1.302 . . . . 0.0 108.014 -169.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -133.12 -172.8 3.03 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 122.275 1.036 . . . . 0.0 109.85 -170.117 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 78.3 t -148.09 111.46 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 127.554 2.342 . . . . 0.0 106.481 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.538 ' CE1' HG23 ' A' ' 81' ' ' VAL . 1.8 t80 -81.31 169.63 17.03 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 169.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.6 169.94 19.22 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -74.0 128.34 35.26 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.171 1.789 . . . . 0.0 110.942 177.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.11 53.0 7.26 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 124.691 1.139 . . . . 0.0 112.685 170.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.406 ' H ' ' HB3' ' A' ' 83' ' ' ASP . 6.6 mmtm -137.03 103.85 5.27 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 119.577 1.689 . . . . 0.0 112.151 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -82.5 98.38 8.91 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 122.889 1.328 . . . . 0.0 108.212 177.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.5 pp -127.11 164.55 27.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 127.621 2.369 . . . . 0.0 106.176 173.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.4 t -159.73 9.85 0.11 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.3 1.04 . . . . 0.0 112.36 166.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 63.2 p -132.83 21.29 4.19 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.258 1.423 . . . . 0.0 111.284 -164.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -149.89 26.66 0.81 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.675 -163.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -128.52 -82.94 0.58 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.325 0.65 . . . . 0.0 111.305 -177.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.1 tp -104.93 104.47 14.23 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -156.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.73 66.67 0.93 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -166.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 mp -119.58 141.78 48.97 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -161.19 111.39 1.69 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -97.64 146.57 25.19 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.204 1.002 . . . . 0.0 109.618 169.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.267 0 C-N-CA 126.868 2.067 . . . . 0.0 109.431 171.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.745 0 N-CA-C 105.692 -2.963 . . . . 0.0 105.692 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 73.99 58.46 0.09 Allowed 'General case' 0 CA--C 1.534 0.346 0 O-C-N 125.89 1.583 . . . . 0.0 109.115 142.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -152.3 78.54 1.22 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.793 1.637 . . . . 0.0 106.804 -149.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -160.73 126.71 3.96 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.056 0.942 . . . . 0.0 112.045 -165.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -155.14 85.73 3.47 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 125.646 1.579 . . . . 0.0 108.933 158.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.41 156.88 41.26 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.049 2.499 . . . . 0.0 111.228 -179.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.21 -138.39 9.64 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 122.206 0.892 . . . . 0.0 112.815 -171.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.94 14.53 82.23 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 127.438 2.447 . . . . 0.0 113.209 -170.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -84.54 105.48 15.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.446 ' H ' ' HD2' ' A' ' 71' ' ' LYS . . . -73.07 -85.51 0.23 Allowed Glycine 0 CA--C 1.522 0.471 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -147.3 152.41 38.21 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 117.499 0.65 . . . . 0.0 112.57 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.5 mtp -83.51 154.4 23.9 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.477 1.111 . . . . 0.0 108.685 158.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -137.88 152.71 49.31 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.607 1.163 . . . . 0.0 109.026 168.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -141.32 134.42 29.25 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 165.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.593 HG12 HG22 ' A' ' 99' ' ' VAL . 3.8 m -134.65 145.87 31.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 125.262 1.425 . . . . 0.0 107.854 -173.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.2 p -123.24 152.78 40.97 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -175.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.4 tp -136.31 92.87 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 170.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -72.74 139.52 47.21 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 165.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -124.02 126.25 45.95 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 173.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -136.47 176.72 8.44 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.037 0.935 . . . . 0.0 111.73 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.55 -83.46 1.62 Allowed Glycine 0 C--N 1.334 0.431 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 -175.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -149.78 158.9 44.61 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.336 1.855 . . . . 0.0 106.482 172.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -146.44 71.9 1.26 Allowed 'General case' 0 C--N 1.327 -0.375 0 O-C-N 119.739 -1.85 . . . . 0.0 109.355 164.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -133.45 -0.75 3.22 Favored 'General case' 0 C--N 1.332 -0.155 0 O-C-N 120.782 -1.198 . . . . 0.0 112.872 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.4 t -152.5 53.08 0.78 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.999 1.272 . . . . 0.0 110.304 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -148.02 116.56 6.63 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 116.675 -1.631 . . . . 0.0 109.729 -178.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.0 mt -55.14 98.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 125.333 1.453 . . . . 0.0 108.969 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.6 mtmm -82.86 136.73 34.53 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 170.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t -142.46 144.2 32.94 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 172.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.8 t -135.05 155.79 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 167.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 p -119.22 147.39 22.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 103.967 -2.605 . . . . 0.0 103.967 156.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.7 p -148.81 131.11 6.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 171.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.5 t -128.65 164.34 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.916 0.886 . . . . 0.0 108.798 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.58 107.1 4.07 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 166.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.526 ' H ' ' HG3' ' A' ' 74' ' ' GLU . 32.4 t-20 -65.22 89.55 0.09 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.248 1.023 . . . . 0.0 110.217 172.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.38 -79.63 0.34 Allowed Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 169.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -81.19 -165.02 0.84 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.255 1.022 . . . . 0.0 111.017 -174.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -110.29 162.28 14.78 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.916 1.686 . . . . 0.0 111.156 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -84.41 156.31 21.86 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.764 1.626 . . . . 0.0 109.651 167.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -128.63 114.46 16.7 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 127.275 2.23 . . . . 0.0 107.308 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.74 119.31 17.79 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.657 1.983 . . . . 0.0 109.088 -176.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.91 -3.39 50.99 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.56 1.076 . . . . 0.0 113.74 176.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.45 -51.91 67.51 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.933 1.293 . . . . 0.0 110.098 169.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.3 p -152.39 9.3 0.48 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.454 1.502 . . . . 0.0 112.394 -161.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.32 13.82 79.58 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 120.486 -1.384 . . . . 0.0 112.617 -175.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -65.65 124.19 21.71 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.772 1.229 . . . . 0.0 111.092 -171.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.2 m -74.2 127.28 32.55 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 169.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 75.8 mt -119.76 176.64 5.3 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.397 1.079 . . . . 0.0 109.925 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.99 110.13 12.23 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.043 1.337 . . . . 0.0 109.553 -173.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.0 p -77.12 170.37 16.67 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.284 1.434 . . . . 0.0 112.175 -172.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.66 146.41 76.73 Favored 'Cis proline' 0 CA--C 1.535 0.526 0 N-CA-C 109.287 -1.082 . . . . 0.0 109.287 -19.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.8 p -137.13 147.15 27.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 118.439 0.563 . . . . 0.0 110.842 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.7 mm -114.08 127.29 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 127.543 2.337 . . . . 0.0 107.044 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -103.33 140.41 37.46 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.666 0.787 . . . . 0.0 109.414 172.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.3 m -81.0 172.48 13.68 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.846 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.77 -24.96 67.98 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.418 2.287 . . . . 0.0 112.547 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -72.57 -37.03 68.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 118.465 -0.779 . . . . 0.0 111.519 172.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -74.21 -44.16 54.29 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -173.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.76 8.09 2.65 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.968 1.307 . . . . 0.0 114.357 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.66 41.39 0.09 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.221 2.208 . . . . 0.0 113.581 -174.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.6 m -133.1 159.1 43.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 126.013 1.725 . . . . 0.0 111.087 -171.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -67.05 -27.19 67.18 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.278 1.431 . . . . 0.0 113.546 -175.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -158.62 137.39 11.16 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 -172.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -123.04 150.67 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 158.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.5 m -133.65 134.52 43.26 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 173.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 31.4 mt -134.2 147.78 50.78 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -170.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.5 t -157.71 165.91 34.18 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -173.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.78 141.55 28.32 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.248 1.419 . . . . 0.0 109.659 -177.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 58.2 p -80.34 -1.0 39.22 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 175.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -158.94 -99.32 0.15 Allowed Glycine 0 C--N 1.339 0.743 0 O-C-N 120.61 -1.306 . . . . 0.0 112.851 -174.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.446 ' HD2' ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -134.69 152.06 51.48 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 126.67 1.988 . . . . 0.0 108.655 166.3 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.13 -178.71 4.05 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 158.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.9 mm -111.44 -14.01 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.582 0.706 . . . . 0.0 109.746 173.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.526 ' HG3' ' H ' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -148.9 163.2 38.13 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 126.521 1.928 . . . . 0.0 107.262 -163.115 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.423 ' HD2' HG11 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -154.34 96.22 1.9 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 128.991 2.917 . . . . 0.0 105.818 168.813 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -91.63 114.93 27.6 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.328 0.651 . . . . 0.0 110.433 177.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 52.7 t -129.1 115.57 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.913 1.285 . . . . 0.0 108.654 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.457 ' HA ' ' HB3' ' A' ' 124' ' ' LEU . 46.7 t -139.71 168.54 19.59 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.933 2.093 . . . . 0.0 108.255 175.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.65 -156.57 27.75 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 127.075 2.274 . . . . 0.0 108.299 -162.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 139.27 123.97 2.14 Favored Glycine 0 N--CA 1.473 1.141 0 CA-C-N 119.171 1.485 . . . . 0.0 112.554 174.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.98 104.96 17.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 121.767 0.794 . . . . 0.0 110.038 -169.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.469 HG23 ' H ' ' A' ' 119' ' ' ILE . 7.7 p -82.88 143.91 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 122.06 0.933 . . . . 0.0 109.413 174.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -80.27 94.09 6.03 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 127.202 2.201 . . . . 0.0 109.29 170.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.99 51.77 3.55 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.6 1.571 . . . . 0.0 110.473 167.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.88 -163.32 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.833 1.653 . . . . 0.0 110.975 164.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 50.0 t0 66.49 34.17 6.29 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 123.054 1.407 . . . . 0.0 109.309 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.09 -12.95 0.03 OUTLIER Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.562 1.077 . . . . 0.0 114.826 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.66 147.61 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 120.168 1.984 . . . . 0.0 112.763 -170.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.2 p -112.12 96.75 4.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 171.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -138.93 -175.03 4.01 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 127.088 2.155 . . . . 0.0 107.902 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -105.29 160.7 25.13 Favored Pre-proline 0 C--N 1.328 -0.36 0 C-N-CA 123.641 0.776 . . . . 0.0 110.59 171.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -78.5 178.24 7.79 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.769 2.98 . . . . 0.0 111.784 173.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.3 ptm -138.12 169.53 17.62 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 122.558 1.17 . . . . 0.0 111.197 -172.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -140.54 151.26 44.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.823 2.049 . . . . 0.0 106.325 175.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -118.11 151.19 38.03 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 168.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.7 t -125.89 134.23 67.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 161.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.7 t -144.31 124.25 7.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 -168.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.4 m -141.43 150.7 42.66 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 -163.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.593 HG22 HG12 ' A' ' 15' ' ' VAL . 37.1 t -124.47 135.52 63.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.59 0.709 . . . . 0.0 111.002 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -118.35 158.66 24.83 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 128.467 2.707 . . . . 0.0 107.938 173.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.4 tptt -124.88 -153.44 0.56 Allowed 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 127.573 2.349 . . . . 0.0 107.402 -168.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -55.86 68.47 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.895 2.078 . . . . 0.0 110.633 160.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 64.14 58.98 9.09 Favored Glycine 0 CA--C 1.531 1.061 0 O-C-N 120.106 -1.621 . . . . 0.0 113.172 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -179.61 153.3 0.55 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 128.546 2.738 . . . . 0.0 107.595 162.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -64.84 155.85 32.7 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.358 1.463 . . . . 0.0 109.659 167.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.0 pt -136.18 -17.4 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 125.032 1.333 . . . . 0.0 113.949 167.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -150.7 129.1 12.09 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -170.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -136.98 106.98 6.28 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -175.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.492 ' HE2' HD21 ' A' ' 126' ' ' LEU . 32.2 pttt -145.58 173.18 12.27 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.817 0.818 . . . . 0.0 112.724 169.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.52 ' O ' HD23 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -135.55 171.94 13.73 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 127.702 2.401 . . . . 0.0 109.79 173.409 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.528 HD22 ' OD1' ' A' ' 123' ' ' ASP . 14.3 mt -138.85 151.61 47.13 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.7 p -129.93 138.68 53.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -125.55 163.42 22.76 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -140.41 -164.6 1.75 Allowed 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.848 0.859 . . . . 0.0 109.693 -167.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.27 128.84 51.58 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 128.063 2.545 . . . . 0.0 104.37 164.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -177.49 -26.41 0.04 OUTLIER Glycine 0 CA--C 1.527 0.803 0 CA-C-O 116.585 -2.231 . . . . 0.0 116.755 166.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 174.13 176.44 0.14 Allowed 'General case' 0 C--N 1.343 0.299 0 C-N-CA 129.462 3.105 . . . . 0.0 108.307 156.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -57.09 136.33 56.36 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.817 -0.552 . . . . 0.0 109.902 168.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.469 ' H ' HG23 ' A' ' 82' ' ' VAL . 2.4 pp -139.43 -179.91 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 127.174 2.19 . . . . 0.0 109.443 -177.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 62.3 p -151.91 106.15 3.18 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.996 1.319 . . . . 0.0 108.14 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.9 p -127.8 154.0 45.92 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.66 0.784 . . . . 0.0 109.49 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -83.68 13.01 5.03 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.839 1.256 . . . . 0.0 112.267 -171.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.528 ' OD1' HD22 ' A' ' 111' ' ' LEU . 0.8 OUTLIER -43.25 -43.77 5.0 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 129.999 3.32 . . . . 0.0 114.749 -153.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' A' ' 123' ' ' ASP . 3.5 mm? -90.07 78.58 6.64 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -116.32 58.36 0.75 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.046 1.739 . . . . 0.0 109.25 -172.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.492 HD21 ' HE2' ' A' ' 109' ' ' LYS . 63.5 mt -124.83 107.95 11.43 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -177.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -132.54 81.92 1.98 Allowed 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -175.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -70.81 132.17 44.91 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 165.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.429 ' HA ' ' CB ' ' A' ' 74' ' ' GLU . 8.0 p-10 . . . . . 0 C--O 1.25 1.105 0 C-N-CA 128.315 2.646 . . . . 0.0 109.093 174.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.872 0 N-CA-C 106.007 -2.837 . . . . 0.0 106.007 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.39 108.42 3.55 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 102.545 -3.131 . . . . 0.0 102.545 -137.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -151.09 80.19 1.31 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.711 0.804 . . . . 0.0 109.014 -159.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.58 143.38 11.55 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.975 0.91 . . . . 0.0 110.767 173.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -153.95 54.7 1.16 Allowed Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.274 1.03 . . . . 0.0 111.372 176.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.11 119.16 6.12 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 O-C-N 118.163 -1.546 . . . . 0.0 111.624 -173.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.42 -101.23 0.77 Allowed Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.134 -169.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.69 178.87 49.0 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 175.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -124.66 135.14 52.81 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -173.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.438 ' N ' ' HE2' ' A' ' 71' ' ' LYS . . . 167.05 -156.83 28.95 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 127.189 2.328 . . . . 0.0 109.901 177.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -148.13 -164.14 1.94 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.205 1.802 . . . . 0.0 111.163 -162.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.4 mtp -120.87 163.67 17.83 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 125.584 1.554 . . . . 0.0 108.101 147.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -143.13 143.87 31.99 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 125.91 2.006 . . . . 0.0 110.845 -178.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -150.65 145.09 25.63 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.939 1.696 . . . . 0.0 107.355 174.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.47 144.5 32.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 126.657 1.983 . . . . 0.0 107.936 176.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.7 127.98 54.95 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 167.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 tp -100.29 154.15 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 163.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.664 ' CD ' ' H ' ' A' ' 96' ' ' VAL . 0.0 OUTLIER -152.83 -174.63 4.99 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 127.801 2.44 . . . . 0.0 106.941 176.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -148.27 166.32 28.35 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 168.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -141.81 165.85 26.33 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 124.141 0.976 . . . . 0.0 110.381 171.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.69 -147.66 39.9 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -75.22 111.91 10.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.394 0.616 . . . . 0.0 110.274 177.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -113.15 33.38 5.11 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.32 1.048 . . . . 0.0 109.679 173.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -124.95 0.5 7.97 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.435 1.494 . . . . 0.0 110.363 -166.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.11 28.67 0.59 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.182 1.393 . . . . 0.0 112.837 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -122.64 116.7 24.26 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 120.72 -1.238 . . . . 0.0 107.773 172.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.7 mm -65.63 121.97 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 175.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -90.69 160.65 15.74 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.155 0.982 . . . . 0.0 110.345 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.4 m -152.48 136.69 16.57 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.373 1.869 . . . . 0.0 107.569 158.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.3 t -137.84 147.18 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 170.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.52 HG22 HD12 ' A' ' 53' ' ' ILE . 82.1 t -117.19 128.21 74.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 126.874 2.069 . . . . 0.0 105.851 170.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.33 147.63 19.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 167.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.9 t -128.69 147.73 33.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 170.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.76 91.75 1.91 Allowed 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 173.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -65.06 127.28 30.98 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 172.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.69 -14.66 19.89 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-O 118.735 -1.036 . . . . 0.0 114.503 153.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 t -161.07 -168.49 2.07 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -101.44 160.86 14.07 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.797 0.839 . . . . 0.0 111.302 173.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 tp -74.86 165.23 25.58 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 170.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -133.67 129.96 37.54 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 171.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.425 ' HA ' HD23 ' A' ' 66' ' ' LEU . 5.9 t70 -84.01 129.51 34.91 Favored 'General case' 0 CA--C 1.52 -0.211 0 O-C-N 123.719 0.637 . . . . 0.0 109.545 175.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.47 -23.16 70.13 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 118.107 -1.385 . . . . 0.0 112.986 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.72 -61.25 2.56 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.019 1.41 . . . . 0.0 111.116 -176.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.03 10.84 7.61 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.139 0.975 . . . . 0.0 111.029 -177.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.24 23.99 77.47 Favored Glycine 0 N--CA 1.446 -0.639 0 O-C-N 121.141 -0.974 . . . . 0.0 111.544 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -74.98 125.35 28.71 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -171.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.2 m -64.42 129.27 39.24 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 165.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 34.2 mt -107.42 -164.18 0.96 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.801 1.64 . . . . 0.0 108.247 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.67 98.26 3.37 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.693 -0.63 . . . . 0.0 110.55 173.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.425 ' HA ' HG23 ' A' ' 52' ' ' VAL . 4.5 m -73.48 168.37 26.09 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 122.705 0.402 . . . . 0.0 111.798 177.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -61.26 149.27 52.92 Favored 'Cis proline' 0 CA--C 1.538 0.691 0 N-CA-C 110.366 -0.667 . . . . 0.0 110.366 -16.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.425 HG23 ' HA ' ' A' ' 50' ' ' SER . 12.6 t -127.48 151.48 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.52 HD12 HG22 ' A' ' 31' ' ' VAL . 18.0 mm -113.95 132.52 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 169.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.9 153.93 21.27 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 122.293 1.044 . . . . 0.0 108.899 170.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.72 -177.94 4.58 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.822 2.449 . . . . 0.0 107.601 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -61.19 -43.95 98.07 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -172.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -62.35 -31.26 71.88 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 123.546 0.738 . . . . 0.0 110.8 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -83.21 -17.98 40.9 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 118.755 -0.64 . . . . 0.0 110.202 -173.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 mt -114.25 6.09 16.06 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.897 1.679 . . . . 0.0 113.921 -168.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.57 34.21 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 128.429 2.692 . . . . 0.0 114.428 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.5 m -100.94 175.38 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 127.777 2.431 . . . . 0.0 110.346 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -95.3 -31.01 13.66 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 118.394 -0.812 . . . . 0.0 111.672 164.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 18' ' ' GLU . 71.7 tttt -157.43 139.12 14.02 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 125.223 1.409 . . . . 0.0 109.189 176.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.0 t -135.73 130.65 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 119.415 1.007 . . . . 0.0 108.53 162.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.8 m -78.27 138.54 38.66 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 121.079 -1.013 . . . . 0.0 108.418 158.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 41' ' ' ASP . 77.8 mt -125.51 137.82 53.96 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 167.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.93 -174.59 4.12 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -172.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.83 146.68 37.24 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.329 1.061 . . . . 0.0 110.932 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.3 p -73.59 -22.91 59.9 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.136 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.21 -165.22 13.89 Favored Glycine 0 N--CA 1.449 -0.497 0 O-C-N 121.192 -0.943 . . . . 0.0 110.798 -170.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.438 ' HE2' ' N ' ' A' ' 10' ' ' GLY . 47.7 tttt -57.86 135.81 56.91 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 168.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -137.03 161.47 35.97 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 174.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.34 -7.94 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 123.51 0.724 . . . . 0.0 109.945 -164.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -144.67 150.63 37.67 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -137.56 156.33 48.22 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 155.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -158.13 152.41 24.38 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 121.014 -1.054 . . . . 0.0 108.785 174.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.8 t -142.39 106.32 1.37 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.2 t -116.39 169.48 9.28 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.734 1.214 . . . . 0.0 107.888 156.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.22 -165.3 30.32 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 125.173 1.368 . . . . 0.0 110.277 -172.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.54 175.48 38.11 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 108.088 -2.005 . . . . 0.0 108.088 172.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.5 m -125.59 173.33 11.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.296 1.038 . . . . 0.0 108.446 169.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.9 p -139.61 142.32 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 162.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -65.84 24.81 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 131.026 3.731 . . . . 0.0 113.448 170.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.36 -49.55 2.66 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 125.626 1.584 . . . . 0.0 110.161 -176.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 176.05 165.28 0.4 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.229 1.811 . . . . 0.0 112.649 -173.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -64.65 -13.32 53.33 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.429 1.892 . . . . 0.0 115.098 -174.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -117.94 12.13 13.23 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 126.523 2.011 . . . . 0.0 112.844 -175.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 72.4 t -75.68 167.9 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 118.89 1.345 . . . . 0.0 109.969 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.6 p -141.81 94.36 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 126.396 1.878 . . . . 0.0 108.617 -169.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -141.6 -154.56 0.52 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.172 0.989 . . . . 0.0 109.114 -174.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.79 166.48 10.68 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 126.69 1.996 . . . . 0.0 109.711 152.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -84.37 -177.0 2.77 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.564 2.842 . . . . 0.0 111.954 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.5 ptp -141.67 163.46 32.85 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 172.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -138.99 150.19 45.56 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 126.018 1.727 . . . . 0.0 108.976 173.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 20.7 m0 -125.3 151.05 46.51 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.547 1.539 . . . . 0.0 108.689 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.664 ' H ' ' CD ' ' A' ' 18' ' ' GLU . 13.7 p -136.45 81.04 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 126.85 2.06 . . . . 0.0 108.766 169.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 p -83.98 89.12 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.64 145.29 31.74 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 176.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.99 140.66 46.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -126.7 145.6 50.52 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 128.417 2.687 . . . . 0.0 107.883 -172.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.54 -174.69 2.51 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.03 1.332 . . . . 0.0 107.553 170.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -52.32 69.09 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.708 2.803 . . . . 0.0 113.053 176.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.53 -15.96 3.6 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 115.957 -2.58 . . . . 0.0 116.326 171.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.54 177.79 0.18 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 121.714 2.757 . . . . 0.0 111.918 175.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -50.99 150.81 2.85 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 128.724 2.81 . . . . 0.0 110.913 175.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.47 -20.44 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.638 1.175 . . . . 0.0 111.572 162.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -152.65 151.79 31.0 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 120.315 1.416 . . . . 0.0 110.739 -170.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -141.17 22.69 2.22 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 125.494 1.518 . . . . 0.0 112.842 -161.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.412 ' HE3' HD13 ' A' ' 126' ' ' LEU . 1.7 ttpm? -60.95 142.54 56.38 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.612 0.72 . . . . 0.0 110.106 -175.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.439 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -155.07 137.57 15.06 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 125.258 1.423 . . . . 0.0 109.703 -163.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.548 ' N ' HD12 ' A' ' 111' ' ' LEU . 2.2 mp -126.85 177.87 6.31 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 123.413 1.578 . . . . 0.0 108.462 -166.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.2 p -149.93 146.8 16.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-N 111.438 -2.619 . . . . 0.0 110.945 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -141.45 151.4 43.36 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.571 1.948 . . . . 0.0 107.237 169.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 39.4 mtp180 -136.36 173.63 11.5 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 118.725 0.693 . . . . 0.0 111.753 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -60.62 134.17 56.81 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 128.299 2.64 . . . . 0.0 109.658 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.37 45.19 91.66 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 124.58 1.086 . . . . 0.0 113.151 165.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt -126.01 162.26 25.68 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 123.064 1.412 . . . . 0.0 113.496 -168.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -84.21 127.38 33.91 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.3 pp -132.81 173.56 14.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 126.169 1.788 . . . . 0.0 108.398 -176.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.3 m -152.07 150.93 30.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.0 0.92 . . . . 0.0 108.896 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.4 p -81.18 54.55 2.29 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.99 1.716 . . . . 0.0 109.76 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -148.38 -13.84 0.34 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -167.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.68 -15.96 23.21 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.283 1.433 . . . . 0.0 113.668 -170.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -120.93 120.7 36.24 Favored 'General case' 0 CA--C 1.517 -0.288 0 O-C-N 120.691 -1.256 . . . . 0.0 107.79 173.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -150.68 72.09 1.07 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 125.671 1.589 . . . . 0.0 110.522 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.412 HD13 ' HE3' ' A' ' 109' ' ' LYS . 4.5 mp -119.08 154.22 33.54 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.761 1.224 . . . . 0.0 110.727 178.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -145.83 148.89 33.38 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.31 2.244 . . . . 0.0 109.172 175.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -141.26 142.53 33.9 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.195 2.198 . . . . 0.0 107.813 177.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.5 p30 . . . . . 0 C--O 1.258 1.535 0 C-N-CA 128.202 2.601 . . . . 0.0 107.047 170.512 . . . . . . . . 0 0 . 1 stop_ save_